data_1u7q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1u7q _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.522 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 89.1 mm-40 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.129 0.49 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.512 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -60.6 138.63 58.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.83 177.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 9.4 m -122.16 -42.75 2.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.005 . . . . 0.0 110.217 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 320' ' ' SER . 68.3 mt-10 -154.17 150.81 28.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.475 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.667 ' CZ ' ' CD1' ' A' ' 360' ' ' PHE . 14.9 p90 -137.46 141.85 41.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.957 -1.089 . . . . 0.0 111.709 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.508 HG22 ' CD ' ' A' ' 419' ' ' LYS . 3.7 mp -113.1 143.75 29.79 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.811 -0.555 . . . . 0.0 109.69 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.67 142.89 36.72 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.63 1.331 . . . . 0.0 111.605 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.603 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.72 152.65 42.6 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 108.862 165.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -58.57 128.45 37.25 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.734 -1.229 . . . . 0.0 110.172 -172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.404 ' O ' HG21 ' A' ' 328' ' ' VAL . . . 103.89 -0.83 44.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 46.3 t -136.61 139.86 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.71 -1.465 . . . . 0.0 110.762 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.432 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.89 152.82 40.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.397 -0.815 . . . . 0.0 110.176 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.539 ' CD ' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -62.16 -40.91 97.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.056 -1.027 . . . . 0.0 110.47 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.29 -43.33 92.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.694 -1.254 . . . . 0.0 109.678 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.444 ' HB ' HG11 ' A' ' 328' ' ' VAL . 92.7 m -55.51 -44.12 76.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.769 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.1 tp -59.16 -39.01 81.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.3 -41.24 85.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.967 -1.083 . . . . 0.0 110.779 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.546 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.26 -49.22 74.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.936 -1.102 . . . . 0.0 109.805 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.606 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.52 -31.37 70.57 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.982 -1.074 . . . . 0.0 109.888 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.523 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.28 64.62 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 108.834 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 13.5 mt-30 -74.54 -55.92 5.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.594 -0.691 . . . . 0.0 110.919 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.2 OUTLIER -65.77 -33.77 76.64 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.009 -171.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 395' ' ' LYS . . . -66.34 -21.62 66.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.112 . . . . 0.0 110.109 172.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.464 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 94.4 p -107.58 10.59 29.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.142 -0.974 . . . . 0.0 111.536 -173.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.589 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 46.1 mt -66.98 -44.48 80.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.591 -1.318 . . . . 0.0 109.672 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.12 1.2 49.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.865 -170.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.81 130.45 44.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 109.942 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 5.4 51.58 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.532 0.682 . . . . 0.0 109.887 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.26 152.57 83.97 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.582 -0.699 . . . . 0.0 109.412 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -56.02 -38.49 94.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.689 1.363 . . . . 0.0 109.147 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.38 -28.31 69.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.548 -0.72 . . . . 0.0 110.395 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.23 -38.17 76.45 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.453 ' O ' HD11 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.95 -36.73 56.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -1.209 . . . . 0.0 110.54 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.522 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 2.0 m -61.5 -39.25 90.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 85.4 mt -68.12 -48.33 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.537 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 25.3 t -61.46 -34.03 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.453 HD11 ' O ' ' A' ' 350' ' ' ARG . 29.7 mt -72.43 -32.27 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.673 -1.267 . . . . 0.0 110.548 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.623 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.02 -40.58 89.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.96 -1.088 . . . . 0.0 110.444 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.529 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.76 -43.73 98.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 70.2 mttt -71.44 -49.83 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.614 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.55 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 1.8 pt20 -70.87 -42.54 69.94 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.704 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.7 mmt180 -73.62 -46.01 49.5 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 111.147 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.667 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 72.3 m-85 -135.93 -36.59 0.75 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.57 -1.331 . . . . 0.0 112.226 -169.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.479 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.0 t30 -159.57 103.16 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.549 -1.344 . . . . 0.0 111.682 -169.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 33.1 mt -57.78 89.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.893 -1.129 . . . . 0.0 109.113 171.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.543 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.0 tpt180 -135.43 164.71 27.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.436 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.9 mt-10 -135.8 -157.14 0.77 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.016 -1.052 . . . . 0.0 110.495 -177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 36.8 ptt180 -97.48 165.14 12.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.674 -0.641 . . . . 0.0 110.716 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.466 ' OD1' HD13 ' A' ' 388' ' ' ILE . 55.0 p30 -138.05 45.52 2.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.379 -0.826 . . . . 0.0 110.758 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.63 ' CG2' ' CZ ' ' A' ' 374' ' ' PHE . 92.7 t -71.15 -42.38 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.334 -0.854 . . . . 0.0 110.341 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.78 -21.32 66.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 111.032 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -29.39 25.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.04 -1.038 . . . . 0.0 110.026 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 16.6 mt -105.38 -3.68 22.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.552 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 24.0 m80 62.11 53.33 2.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 109.649 -173.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.527 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.19 174.96 6.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.501 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.0 m -120.9 136.4 54.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.416 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.63 ' CZ ' ' CG2' ' A' ' 367' ' ' VAL . 89.0 m-85 -90.62 145.1 25.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.668 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 21.5 t -118.6 101.32 50.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.11 155.18 19.88 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.105 1.582 . . . . 0.0 110.613 -175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.534 ' CE2' ' N ' ' A' ' 383' ' ' MET . 50.5 t80 -71.92 134.7 46.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 110.442 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.785 174.322 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.475 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.7 mtt-85 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.497 0.665 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.534 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 3.1 ptp -165.34 171.23 13.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.781 0.8 . . . . 0.0 111.288 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 39.8 p -156.31 165.31 36.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.82 -165.96 34.11 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.025 -1.56 . . . . 0.0 110.637 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 339' ' ' LEU . 1.3 tt -143.34 147.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.935 . . . . 0.0 110.399 -174.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.459 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 56.1 m-20 -115.78 134.25 55.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.902 -1.124 . . . . 0.0 108.974 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.562 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 2.2 tt -142.63 154.41 17.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.9 -1.125 . . . . 0.0 109.611 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 88.7 m-20 -23.95 -62.02 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 112.298 173.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.5 t-20 -95.87 -5.45 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.539 -0.725 . . . . 0.0 111.801 -167.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.546 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 18.1 mtp180 -145.5 147.73 32.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.684 -1.26 . . . . 0.0 110.74 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.3 mtm -132.51 95.68 3.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.831 -1.168 . . . . 0.0 108.789 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 336' ' ' ALA . 7.6 mt -122.58 146.25 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.946 -1.096 . . . . 0.0 110.429 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.479 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 40.2 mtt180 -133.51 159.14 41.29 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 110.767 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.481 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.43 128.86 34.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.425 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -155.51 174.32 33.59 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.0 m -56.36 151.35 13.14 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.956 -1.32 . . . . 0.0 108.496 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.539 ' CG2' HG12 ' A' ' 420' ' ' VAL . 53.4 t -57.08 -34.28 44.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.027 -1.046 . . . . 0.0 109.887 -176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 19.7 t70 -62.86 -47.48 83.18 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.52 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -68.2 -49.12 62.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.042 -1.036 . . . . 0.0 110.652 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.524 HG23 ' CG1' ' A' ' 432' ' ' VAL . 45.0 mm -65.06 -43.29 95.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.108 -0.995 . . . . 0.0 110.809 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.58 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 2.4 ttt180 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.0 mtt-85 -61.14 -37.75 83.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.979 -1.075 . . . . 0.0 109.607 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.517 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.2 t-80 -67.62 -35.85 79.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 111.222 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.85 -48.98 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.673 -1.267 . . . . 0.0 110.187 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.2 -34.45 77.68 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.291 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.99 79.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.954 -1.091 . . . . 0.0 110.021 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.532 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 6.3 m-80 -61.55 -27.67 68.79 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.491 -0.756 . . . . 0.0 109.114 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.13 19.77 27.53 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.1 -169.14 15.85 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -143.86 153.61 42.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -1.215 . . . . 0.0 111.328 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.582 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 8.3 p90 -108.01 149.66 39.39 Favored Pre-proline 0 N--CA 1.501 2.105 0 O-C-N 121.625 -0.672 . . . . 0.0 110.24 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.547 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.95 125.21 9.2 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.853 1.449 . . . . 0.0 110.573 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.79 -34.32 77.56 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.161 -0.962 . . . . 0.0 111.051 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.7 m-20 -60.84 -33.08 72.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 108.864 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 53.0 t -83.78 -42.57 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.017 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 71.9 m-20 -54.85 -37.29 66.01 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.48 171.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.4 mt-30 -63.31 -48.68 77.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.292 -1.505 . . . . 0.0 110.102 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.508 ' CD ' HG22 ' A' ' 323' ' ' ILE . 26.3 mttt -56.84 -34.85 68.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.704 -1.248 . . . . 0.0 110.392 177.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 109.171 171.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.9 t0 -66.62 -36.66 83.13 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.791 0.805 . . . . 0.0 109.517 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 84.8 mt-30 -67.04 -37.02 83.34 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.631 -0.668 . . . . 0.0 110.612 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 68.0 t -62.43 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.125 . . . . 0.0 110.005 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.68 -43.96 87.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -0.908 . . . . 0.0 110.435 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 6.0 mtp85 -64.98 -29.86 70.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 110.517 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.28 -3.87 53.84 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.683 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.52 22.1 38.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.512 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -106.39 164.26 12.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.395 -1.062 . . . . 0.0 109.727 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.466 ' O ' HD12 ' A' ' 445' ' ' LEU . 28.4 m -109.57 107.04 59.19 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.512 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.0 Cg_endo -75.61 108.27 2.66 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 O-C-N 124.014 1.534 . . . . 0.0 110.62 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.533 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.1 mt -92.6 134.13 35.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.872 -1.142 . . . . 0.0 108.622 167.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG12 ' A' ' 439' ' ' VAL . 90.3 t -100.51 134.29 40.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.771 -1.205 . . . . 0.0 109.504 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.473 ' O ' HD11 ' A' ' 440' ' ' LEU . 42.3 t -115.03 139.09 43.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -119.89 160.09 20.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.458 -0.776 . . . . 0.0 109.587 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.499 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.5 tt0 -135.01 130.38 35.61 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.58 -129.22 27.74 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -167.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.532 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 78.0 p -106.16 7.64 31.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.244 . . . . 0.0 111.082 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -118.99 170.43 9.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.588 -1.32 . . . . 0.0 110.048 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.529 HG12 ' CG1' ' A' ' 432' ' ' VAL . 24.3 t -92.67 134.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.606 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.4 pp -96.68 -20.6 18.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.721 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.555 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.76 176.53 38.46 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 118.815 -1.659 . . . . 0.0 111.024 168.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 55.8 t -107.7 142.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.242 -1.152 . . . . 0.0 109.95 173.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.523 HD11 ' CB ' ' A' ' 337' ' ' ALA . 81.7 mt -101.32 110.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 109.023 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.525 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -91.7 118.31 30.54 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.047 -1.033 . . . . 0.0 109.831 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.533 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -101.67 141.67 34.18 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.564 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 11.0 mtmt . . . . . 0 C--N 1.299 -1.612 0 O-C-N 120.763 -1.211 . . . . 0.0 111.038 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.478 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 63.4 tt0 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.133 0.492 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 445' ' ' LEU . . . -54.72 138.62 41.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.992 -1.067 . . . . 0.0 109.815 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.508 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.41 -45.16 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.99 . . . . 0.0 110.339 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 320' ' ' SER . 72.4 mt-10 -154.53 154.59 33.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.228 -0.92 . . . . 0.0 110.511 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.672 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 15.6 p90 -135.51 151.5 50.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.956 -1.09 . . . . 0.0 111.572 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 324' ' ' PRO . 3.4 mt -125.56 140.59 36.79 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.699 -0.625 . . . . 0.0 109.336 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.544 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.78 143.12 45.08 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.617 1.325 . . . . 0.0 111.64 -173.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.602 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -70.22 151.29 45.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.455 -0.778 . . . . 0.0 108.977 165.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.99 129.13 40.51 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.704 -1.247 . . . . 0.0 110.069 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.65 -0.35 49.25 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 46.5 t -135.36 138.05 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.578 -1.543 . . . . 0.0 110.759 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.417 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.6 m-20 -73.12 148.98 43.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.346 -0.846 . . . . 0.0 110.275 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.2 tt0 -60.59 -34.15 73.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.039 -1.038 . . . . 0.0 109.778 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -58.85 -43.73 90.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 109.139 175.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.444 HG23 HG11 ' A' ' 328' ' ' VAL . 88.9 m -61.17 -42.26 98.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.417 -0.802 . . . . 0.0 110.333 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.57 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 6.1 tp -60.48 -39.61 88.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.51 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.93 -44.04 77.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 110.69 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.9 m-20 -63.51 -48.07 79.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.912 -1.118 . . . . 0.0 110.063 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -69.17 -31.25 69.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.007 -1.058 . . . . 0.0 109.991 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.521 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.13 -35.55 64.81 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 0.0 108.915 172.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 14.8 mt-30 -74.3 -55.71 5.71 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.72 . . . . 0.0 111.023 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -64.9 -33.61 76.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.741 -1.183 . . . . 0.0 110.177 -172.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -67.72 -21.03 65.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.882 -1.136 . . . . 0.0 110.009 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.464 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 93.2 p -107.32 10.51 29.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.104 -0.997 . . . . 0.0 111.536 -174.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.587 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 43.6 mt -66.1 -45.18 82.09 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.612 -1.305 . . . . 0.0 109.758 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.05 0.73 49.13 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.976 -170.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 11.7 p30 -63.02 130.47 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.745 -1.222 . . . . 0.0 109.977 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.66 5.31 51.77 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.576 0.703 . . . . 0.0 109.923 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.05 152.87 84.52 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.666 -0.646 . . . . 0.0 109.443 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.58 -38.56 94.02 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.645 1.339 . . . . 0.0 109.117 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.32 -28.91 70.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.499 -0.751 . . . . 0.0 110.41 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.02 -37.49 71.41 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -76.92 -38.9 52.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -1.223 . . . . 0.0 110.598 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.478 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.8 m -62.13 -37.37 84.91 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 110.477 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 88.6 mt -68.55 -48.82 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.066 -1.021 . . . . 0.0 110.493 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.532 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 22.0 t -60.9 -32.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.825 -1.172 . . . . 0.0 109.797 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.491 ' CG2' ' OE1' ' A' ' 358' ' ' GLN . 39.5 mt -72.8 -33.1 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 110.628 171.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.63 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.6 -41.08 84.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.866 -1.146 . . . . 0.0 110.274 178.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.495 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.27 -45.58 87.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.624 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.535 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 33.7 mtmt -72.36 -49.29 35.23 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.53 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.498 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.3 pt20 -72.23 -42.82 65.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.519 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -73.83 -43.75 57.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 111.227 -172.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.672 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 82.6 m-85 -135.42 -38.8 0.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.349 -1.341 . . . . 0.0 111.83 -168.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 363' ' ' ARG . 16.7 t-20 -162.77 108.36 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.576 -1.328 . . . . 0.0 111.423 -167.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 68.6 mt -57.1 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.016 -1.053 . . . . 0.0 109.096 172.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.1 tpt180 -122.59 164.77 17.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.774 . . . . 0.0 109.408 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.1 mt-10 -141.21 -161.84 1.28 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.587 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 32.1 ptt-85 -97.6 163.67 12.74 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.638 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -129.67 41.8 3.38 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.331 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.579 HG11 ' CE2' ' A' ' 374' ' ' PHE . 41.3 t -73.02 -46.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.19 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 111.109 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.11 -30.12 28.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.692 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.53 ' CB ' HD12 ' A' ' 388' ' ' ILE . 21.5 mt -102.69 -4.64 24.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.684 -177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 71.4 m-70 60.43 52.21 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.536 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -94.02 174.51 7.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.491 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 24.0 m -117.12 134.77 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.566 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.579 ' CE2' HG11 ' A' ' 367' ' ' VAL . 92.1 m-85 -90.13 145.91 24.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 6.5 t -119.11 101.22 49.99 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.649 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.54 153.71 22.41 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.073 1.565 . . . . 0.0 110.515 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.549 ' CE2' ' N ' ' A' ' 383' ' ' MET . 55.0 t80 -69.45 134.68 49.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 110.448 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.373 -0.829 . . . . 0.0 109.753 174.638 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.48 0.657 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.549 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.2 ptp -165.44 171.55 13.21 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.779 0.799 . . . . 0.0 111.258 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.522 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 29.0 p -155.46 165.36 36.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.5 -165.73 34.09 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.048 -1.548 . . . . 0.0 110.694 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.522 HD13 ' CG2' ' A' ' 367' ' ' VAL . 4.5 tt -140.02 151.51 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.921 . . . . 0.0 110.208 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -127.54 135.55 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 109.693 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -140.93 155.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.816 -1.178 . . . . 0.0 109.174 172.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.502 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.5 m-20 -23.08 -63.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.389 0.614 . . . . 0.0 112.502 171.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.45 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 37.1 t30 -96.46 -5.1 40.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 111.808 -167.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.546 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.2 mtp180 -144.97 143.0 30.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.719 -1.238 . . . . 0.0 110.342 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -133.66 108.52 8.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 108.897 169.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 7.8 mt -128.65 146.03 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 0.0 109.931 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.483 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.1 mmt85 -134.43 159.7 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.295 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.1 OUTLIER -133.13 126.65 32.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.471 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.19 174.39 32.63 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -57.04 151.28 15.36 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.976 -1.308 . . . . 0.0 108.566 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.542 ' CG2' HG11 ' A' ' 420' ' ' VAL . 56.0 t -56.7 -35.01 44.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.851 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.85 -47.02 85.17 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.261 -0.9 . . . . 0.0 110.321 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.491 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -67.91 -49.18 63.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.963 -1.086 . . . . 0.0 110.59 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.522 HG22 ' CG1' ' A' ' 432' ' ' VAL . 39.4 mm -65.59 -43.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.06 -1.025 . . . . 0.0 110.817 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.8 ttp180 -59.22 -43.26 92.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.243 -0.911 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.5 mtp180 -61.88 -36.37 81.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 173.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -67.93 -36.25 79.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.878 . . . . 0.0 111.236 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.62 -49.13 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.479 -1.388 . . . . 0.0 110.103 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -34.34 77.46 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.325 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.73 78.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.946 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.529 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 10.9 m-80 -61.8 -27.31 68.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.11 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.89 19.57 28.62 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.57 -169.02 16.17 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -143.21 153.41 42.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.163 -1.198 . . . . 0.0 111.324 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.584 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.5 p90 -108.39 149.75 39.71 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.642 -0.661 . . . . 0.0 110.182 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.71 124.0 8.45 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.879 1.463 . . . . 0.0 110.5 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.25 -34.22 77.51 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.986 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 91.1 m-20 -60.82 -33.03 72.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 108.836 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.602 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 53.7 t -83.52 -42.48 17.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.3 m-20 -54.8 -37.41 66.03 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.559 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.25 -48.32 78.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.17 -1.581 . . . . 0.0 110.104 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 19.1 mttp -56.58 -35.2 67.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.6 -1.313 . . . . 0.0 110.429 176.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -59.65 -40.98 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.885 -1.135 . . . . 0.0 109.208 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.76 -36.28 82.06 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.824 0.821 . . . . 0.0 109.581 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.67 -36.78 81.34 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.689 -0.632 . . . . 0.0 110.692 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.523 ' CG2' ' HB1' ' A' ' 444' ' ' ALA . 79.2 t -62.84 -37.95 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.005 -1.059 . . . . 0.0 110.043 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.13 85.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 110.406 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -67.91 -31.5 71.31 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 110.922 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.31 -3.47 55.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.724 175.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.92 22.04 29.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.52 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -106.99 164.09 12.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.562 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.473 ' O ' HD11 ' A' ' 445' ' ' LEU . 93.9 m -109.89 107.29 58.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.077 -1.014 . . . . 0.0 109.691 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.496 ' CG ' HG12 ' A' ' 420' ' ' VAL . 39.7 Cg_endo -75.95 108.04 2.6 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 123.88 1.463 . . . . 0.0 110.613 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.539 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 13.4 mt -92.83 134.33 35.18 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.837 -1.164 . . . . 0.0 108.64 166.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.528 ' CG1' HG12 ' A' ' 439' ' ' VAL . 89.4 t -100.67 134.6 40.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 120.698 -1.251 . . . . 0.0 109.445 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 45.3 t -115.09 136.36 52.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.4 m -117.09 159.92 16.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.41 -0.806 . . . . 0.0 109.601 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.462 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.91 130.63 34.07 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.08 -133.17 31.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 77.8 p -102.46 8.34 40.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.105 -1.232 . . . . 0.0 111.053 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -120.44 171.01 8.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.546 -1.346 . . . . 0.0 109.995 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.528 HG12 ' CG1' ' A' ' 432' ' ' VAL . 23.7 t -92.59 134.52 30.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.845 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.609 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -94.42 -22.13 18.49 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.308 -0.87 . . . . 0.0 109.793 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.555 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.47 176.95 38.64 Favored Glycine 0 N--CA 1.499 2.851 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.965 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 55.5 t -107.95 142.83 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.247 -1.149 . . . . 0.0 109.915 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.521 HD12 ' CB ' ' A' ' 337' ' ' ALA . 77.1 mt -101.49 111.42 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 108.907 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -91.85 118.58 30.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.917 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.539 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 26.9 mttt . . . . . 0 C--N 1.299 -1.614 0 O-C-N 120.759 -1.213 . . . . 0.0 110.974 -178.864 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.511 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.8 mt-30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.122 0.487 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -59.85 138.27 57.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 109.965 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.47 ' O ' ' HD2' ' A' ' 359' ' ' ARG . 46.6 m -122.13 -40.98 2.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.501 ' HG2' ' NH2' ' A' ' 359' ' ' ARG . 65.9 mt-10 -154.94 149.82 26.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.683 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 10.5 p90 -135.97 157.74 46.09 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.48 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.473 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.4 mt -134.84 140.16 34.38 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.604 -0.685 . . . . 0.0 109.397 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.545 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.54 144.82 50.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.644 1.339 . . . . 0.0 111.568 -172.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.74 151.52 43.5 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.134 -0.979 . . . . 0.0 108.829 164.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.86 129.4 41.95 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.658 -1.276 . . . . 0.0 110.095 -172.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.09 -1.48 44.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.3 t -136.16 138.92 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.473 . . . . 0.0 110.647 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.466 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.3 m-20 -73.36 151.88 41.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.166 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -62.86 -39.81 95.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.023 -1.048 . . . . 0.0 110.362 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.92 -42.93 90.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.782 -1.198 . . . . 0.0 109.438 175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 94.4 m -56.9 -43.62 81.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.859 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.7 tp -59.1 -40.58 85.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.33 -41.37 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.761 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -64.07 -49.73 71.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.914 -1.116 . . . . 0.0 109.92 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.98 -31.25 70.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.903 -1.123 . . . . 0.0 109.569 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.515 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.59 -35.23 65.59 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.324 -0.86 . . . . 0.0 108.985 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 22.7 mt-30 -74.25 -55.84 5.58 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.479 -0.763 . . . . 0.0 110.861 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.78 -36.14 80.22 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.681 -1.208 . . . . 0.0 109.807 -172.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -66.74 -20.67 66.01 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.055 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.463 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 91.2 p -107.35 9.18 29.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.215 -0.928 . . . . 0.0 111.552 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.4 -44.46 82.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.564 -1.335 . . . . 0.0 109.626 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -97.17 1.61 50.04 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.816 -170.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.49 ' OD2' ' NZ ' ' A' ' 395' ' ' LYS . 12.5 p30 -64.34 130.6 44.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.732 -1.23 . . . . 0.0 109.944 175.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.72 5.44 51.39 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.58 0.705 . . . . 0.0 109.872 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.31 150.43 80.1 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.53 -0.731 . . . . 0.0 109.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.74 -38.14 84.75 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.651 1.342 . . . . 0.0 109.148 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.29 -28.58 69.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.496 -0.752 . . . . 0.0 110.377 176.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.33 -37.6 74.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -175.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.455 ' O ' HD13 ' A' ' 354' ' ' ILE . 96.1 mtt180 -77.32 -38.0 51.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.658 174.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.511 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 9.6 m -61.36 -37.97 85.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 110.365 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 88.8 mt -68.51 -49.31 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.069 -1.02 . . . . 0.0 110.602 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.524 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 28.7 t -61.17 -33.36 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.935 -1.103 . . . . 0.0 110.167 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 350' ' ' ARG . 32.6 mt -72.84 -32.58 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.704 -1.248 . . . . 0.0 110.603 171.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.53 -40.82 88.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.964 -1.085 . . . . 0.0 110.414 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.26 -44.67 94.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.497 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.526 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 67.4 mttt -71.33 -47.37 56.96 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.743 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.536 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.5 pt20 -70.7 -42.58 70.45 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.667 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 40.8 mtp85 -79.89 -42.23 24.59 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 111.517 -170.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 85.5 m-85 -134.98 -35.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.437 -1.414 . . . . 0.0 112.097 -170.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 363' ' ' ARG . 57.0 t-20 -161.86 101.87 1.15 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.632 -1.293 . . . . 0.0 111.669 -169.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 32.5 mt -57.47 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.816 -1.177 . . . . 0.0 108.908 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.542 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.9 tpt180 -134.34 164.31 27.69 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.416 -0.802 . . . . 0.0 109.241 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.507 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -135.74 -157.08 0.76 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.962 -1.086 . . . . 0.0 110.355 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 37.1 ptt180 -94.54 163.24 13.47 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.651 -0.655 . . . . 0.0 110.494 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 370' ' ' LEU . 88.3 m-20 -130.82 42.26 3.26 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.398 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 374' ' ' PHE . 61.5 t -73.56 -45.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 110.345 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.78 -24.11 64.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.351 -0.843 . . . . 0.0 111.146 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.42 -32.85 32.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.013 -1.054 . . . . 0.0 109.719 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.527 ' CB ' HD11 ' A' ' 388' ' ' ILE . 12.4 mt -104.73 -2.64 24.64 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.565 -0.709 . . . . 0.0 110.569 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 70.8 m-70 61.06 51.93 4.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 109.827 -176.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -92.78 174.64 7.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 0.0 110.533 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.8 m -119.18 136.22 54.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.478 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 367' ' ' VAL . 73.4 m-85 -89.69 149.09 22.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 48.7 t -124.31 100.84 35.2 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.124 -0.985 . . . . 0.0 109.629 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -57.04 149.59 61.52 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.995 1.524 . . . . 0.0 110.251 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 21.4 t80 -63.61 129.95 42.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.87 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.336 -0.853 . . . . 0.0 109.747 176.621 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 82.7 mtm180 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.308 0.575 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.526 ' HG2' ' CB ' ' A' ' 400' ' ' ALA . 0.7 OUTLIER -150.29 161.54 42.24 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.604 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 10.1 p -153.47 164.94 37.31 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 174.29 -164.94 36.26 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.881 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.516 HD13 ' CG2' ' A' ' 367' ' ' VAL . 3.6 tt -141.0 150.53 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.697 -0.884 . . . . 0.0 110.143 -176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -126.67 137.6 53.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.624 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.549 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 2.0 tt -141.53 154.7 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.352 172.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.506 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 88.9 m-20 -20.88 -62.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.48 0.657 . . . . 0.0 112.568 171.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.456 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t-20 -98.01 -7.49 29.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 111.934 -166.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 17.8 mtp180 -142.4 149.88 39.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.71 -1.244 . . . . 0.0 110.604 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -137.47 102.13 4.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 0.0 109.188 170.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.529 ' CD1' ' CB ' ' A' ' 336' ' ' ALA . 6.0 mt -121.64 146.09 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.097 -1.002 . . . . 0.0 110.007 -173.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.488 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 0.0 OUTLIER -136.77 155.32 49.98 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 110.261 177.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 43.7 pttt -129.23 145.82 51.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.17 173.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.405 ' CA ' ' CG1' ' A' ' 401' ' ' ILE . . . -170.54 174.89 44.51 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 52.5 p -55.85 150.45 13.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.784 -1.421 . . . . 0.0 108.526 170.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.538 ' CG2' ' CG2' ' A' ' 432' ' ' VAL . 64.1 t -59.78 -34.96 57.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.064 -1.023 . . . . 0.0 109.977 -174.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.517 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 49.2 t0 -62.32 -45.89 91.21 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.196 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.526 ' CB ' ' HG2' ' A' ' 383' ' ' MET . . . -70.75 -52.01 23.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.085 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.522 HD13 ' CE ' ' A' ' 383' ' ' MET . 21.1 mm -62.98 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.998 -1.064 . . . . 0.0 110.505 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 13.4 ttp85 -59.46 -43.91 93.11 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.517 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 93.1 mtt180 -61.23 -36.99 81.46 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.448 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -66.9 -35.86 80.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 437' ' ' SER . 55.3 t -64.81 -49.72 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.455 -1.403 . . . . 0.0 110.152 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.63 -34.67 77.52 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.86 -1.15 . . . . 0.0 110.239 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.14 -35.76 78.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.995 -1.066 . . . . 0.0 109.971 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.53 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.7 m-80 -61.38 -27.38 68.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 109.134 173.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.87 19.59 28.62 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -169.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.42 -169.32 16.38 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -145.26 153.94 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -1.161 . . . . 0.0 111.232 -174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 10.3 p90 -109.11 149.26 39.44 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.457 -0.777 . . . . 0.0 109.978 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.528 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.29 126.89 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.929 1.489 . . . . 0.0 110.401 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.462 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.3 t -66.92 -34.86 78.71 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.989 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.1 m-20 -62.01 -33.31 74.1 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.898 -1.126 . . . . 0.0 108.882 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 52.6 t -83.46 -41.77 17.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 110.987 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.33 -38.5 68.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.826 -1.171 . . . . 0.0 109.416 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.1 -47.92 80.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.374 -1.453 . . . . 0.0 110.264 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 66.9 mttm -56.39 -35.19 67.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.691 -1.256 . . . . 0.0 110.372 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.586 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -60.65 -40.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.405 172.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -65.85 -36.24 82.9 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 425' ' ' ARG . 94.9 mm-40 -68.38 -38.2 81.13 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.526 HG11 ' CB ' ' A' ' 428' ' ' ALA . 63.0 t -61.0 -37.03 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.689 -1.257 . . . . 0.0 110.056 175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.0 82.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.969 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 422' ' ' GLN . 17.7 ptt180 -70.86 -28.68 64.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.721 -1.237 . . . . 0.0 111.097 -171.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 1.0 OUTLIER -82.62 -8.55 59.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.895 -1.128 . . . . 0.0 109.64 174.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.43 22.21 13.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.526 ' CB ' HG11 ' A' ' 423' ' ' VAL . . . -102.9 161.9 13.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -1.157 . . . . 0.0 109.323 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 445' ' ' LEU . 2.0 m -109.16 106.94 59.49 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.062 . . . . 0.0 109.778 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.478 ' CG ' HG13 ' A' ' 420' ' ' VAL . 44.5 Cg_endo -76.57 107.67 2.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 124.015 1.534 . . . . 0.0 110.452 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 10.3 mt -92.43 133.47 35.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.92 -1.112 . . . . 0.0 108.533 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.538 ' CG2' ' CG2' ' A' ' 398' ' ' VAL . 89.2 t -99.01 135.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.711 -1.243 . . . . 0.0 109.424 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 44.0 t -117.66 136.7 53.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 108.91 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -117.86 160.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.458 ' CB ' HD21 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.52 129.01 34.47 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.69 -131.6 28.98 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -167.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.53 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 73.1 p -103.06 6.79 38.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.13 -1.218 . . . . 0.0 111.118 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -119.95 171.0 8.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.644 -1.285 . . . . 0.0 110.069 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 42.9 t -90.57 134.61 28.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.4 pp -93.17 -22.6 18.96 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.672 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.548 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.33 176.87 39.04 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 118.883 -1.627 . . . . 0.0 110.721 170.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.586 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 56.6 t -107.94 142.84 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.161 -1.2 . . . . 0.0 109.994 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 337' ' ' ALA . 82.8 mt -101.83 110.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 170.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -92.08 118.48 30.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.826 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.529 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -101.23 146.09 27.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.457 ' HG2' ' HB2' ' A' ' 320' ' ' SER . 15.2 mmtp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 120.566 -1.334 . . . . 0.0 110.58 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 351' ' ' SER . 93.4 mt-30 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.126 0.489 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.52 ' CB ' HD23 ' A' ' 445' ' ' LEU . . . -57.32 135.96 56.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.841 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.527 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 2.4 m -127.48 -37.21 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 110.385 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.469 ' N ' HD11 ' A' ' 355' ' ' LEU . 65.2 mt-10 -153.58 148.07 26.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.958 . . . . 0.0 110.597 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.639 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 6.1 p90 -137.86 147.4 44.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.726 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.475 HG22 ' HD2' ' A' ' 324' ' ' PRO . 2.8 mt -119.96 141.83 32.16 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 109.625 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.02 143.23 40.06 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.735 1.387 . . . . 0.0 111.481 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -70.85 152.65 43.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.185 -0.947 . . . . 0.0 108.662 165.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -57.56 127.85 34.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.679 -1.263 . . . . 0.0 110.336 -172.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 115.68 -28.0 8.03 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 42.4 t -115.0 140.49 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.738 -1.448 . . . . 0.0 110.943 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.03 150.13 44.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 109.788 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -61.35 -39.47 90.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -60.51 -45.12 94.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.795 -1.191 . . . . 0.0 109.735 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.436 ' HB ' HG12 ' A' ' 328' ' ' VAL . 92.4 m -55.97 -43.92 78.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.698 173.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.529 HD13 ' CD1' ' A' ' 440' ' ' LEU . 5.1 tp -58.03 -39.14 77.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.817 . . . . 0.0 110.233 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.92 -42.1 81.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 0.0 110.691 -176.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -62.87 -48.35 79.4 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.924 -1.11 . . . . 0.0 109.832 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.02 -31.86 71.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.026 -1.046 . . . . 0.0 109.765 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.52 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.32 -35.25 64.93 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 172.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 20.6 mt-30 -74.67 -56.28 4.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.501 -0.749 . . . . 0.0 110.838 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -60.97 -35.39 76.67 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.756 -1.177 . . . . 0.0 109.772 -172.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 395' ' ' LYS . . . -68.03 -19.52 64.91 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.088 -1.007 . . . . 0.0 109.782 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.457 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.1 p -108.23 9.41 28.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.206 -0.934 . . . . 0.0 111.639 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.541 HD11 ' CB ' ' A' ' 365' ' ' ARG . 36.8 mt -64.71 -44.84 88.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.551 -1.343 . . . . 0.0 109.705 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -98.49 1.72 46.94 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.707 -169.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.1 p30 -62.61 130.28 44.36 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.952 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.68 5.35 51.63 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.528 0.68 . . . . 0.0 109.891 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.56 152.4 83.3 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.607 -0.683 . . . . 0.0 109.432 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.95 -38.79 94.15 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.713 1.375 . . . . 0.0 109.08 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.35 -28.87 70.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.458 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.51 -37.26 66.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.444 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -76.69 -37.37 56.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.219 . . . . 0.0 110.553 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 318' ' ' GLN . 11.3 m -61.36 -38.44 86.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.001 -1.062 . . . . 0.0 110.42 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.526 ' CG2' HD11 ' A' ' 443' ' ' ILE . 83.7 mt -68.98 -48.84 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.051 . . . . 0.0 110.534 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.513 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 30.4 t -61.67 -34.03 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.952 -1.092 . . . . 0.0 110.076 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.4 mt -72.89 -32.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.601 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.68 -40.91 89.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.39 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.93 99.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 82.7 mttt -71.26 -50.21 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.892 -1.13 . . . . 0.0 110.924 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.548 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.9 pt20 -70.36 -42.38 71.89 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.497 -174.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 30.6 mmt180 -74.16 -46.02 44.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 111.24 -172.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 78.3 m-85 -135.51 -35.5 0.81 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.437 -1.305 . . . . 0.0 112.437 -168.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.498 ' OD1' ' CB ' ' A' ' 363' ' ' ARG . 23.1 t-20 -160.52 97.85 1.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.484 -1.385 . . . . 0.0 111.677 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.534 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 5.5 mp -58.77 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.933 -1.105 . . . . 0.0 109.59 171.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.8 tpt180 -147.84 163.08 37.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.387 -0.821 . . . . 0.0 109.618 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.512 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.7 mt-10 -125.97 -157.36 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.541 ' CB ' HD11 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -96.66 165.35 12.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.531 -0.73 . . . . 0.0 110.596 -178.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.469 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -121.0 38.08 4.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.428 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.639 ' CG1' ' CZ ' ' A' ' 374' ' ' PHE . 71.0 t -69.28 -44.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.787 . . . . 0.0 110.307 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -67.43 -26.6 66.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.971 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -29.14 25.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.904 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.602 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.7 mt -103.45 -2.36 27.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.777 . . . . 0.0 110.837 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 27.2 m80 62.62 52.65 2.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.09 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.544 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -94.99 174.71 6.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.9 m -115.97 134.32 55.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 110.421 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.639 ' CZ ' ' CG1' ' A' ' 367' ' ' VAL . 68.3 m-85 -89.19 149.26 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.541 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 24.1 t -122.71 100.97 40.29 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.11 151.45 42.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.124 1.592 . . . . 0.0 110.486 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.51 131.63 46.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.096 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 175.813 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 72.3 mtt85 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.542 0.687 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.519 ' CE ' HD12 ' A' ' 401' ' ' ILE . 3.3 ptp -158.69 168.61 26.41 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.948 0.88 . . . . 0.0 111.277 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 34.1 p -152.86 165.19 36.22 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.74 -165.89 32.96 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.04 -1.552 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.527 HD13 ' CG2' ' A' ' 367' ' ' VAL . 9.4 tt -144.1 150.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -1.03 . . . . 0.0 110.104 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 394' ' ' ARG . 43.0 m-20 -127.59 133.04 49.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.864 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.602 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.6 tt -139.28 155.03 25.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.75 -1.219 . . . . 0.0 109.165 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.504 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 90.7 m-20 -23.8 -62.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 172.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.436 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 49.5 t30 -92.36 -9.58 41.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 111.884 -167.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.558 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.4 mtp180 -140.56 147.4 39.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.613 -1.304 . . . . 0.0 110.744 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.5 mtt -138.3 100.67 4.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.983 -1.073 . . . . 0.0 109.112 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.527 HD13 ' CD1' ' A' ' 339' ' ' LEU . 7.5 mt -122.66 146.47 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.934 -1.104 . . . . 0.0 110.296 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 387' ' ' ASN . 66.6 mmt-85 -130.49 156.84 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.142 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -132.91 125.46 29.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.458 -0.776 . . . . 0.0 108.97 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -153.85 173.94 32.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.717 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.4 m -56.09 150.74 13.36 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.916 -1.343 . . . . 0.0 108.537 169.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.536 ' CG2' HG11 ' A' ' 420' ' ' VAL . 17.7 t -55.69 -37.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 109.932 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -64.04 -43.74 94.62 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.287 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.517 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -68.35 -51.2 47.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.529 HG22 ' CG1' ' A' ' 432' ' ' VAL . 33.5 mm -64.96 -44.07 96.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 120.995 -1.066 . . . . 0.0 110.789 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.588 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.5 ttt180 -59.47 -42.94 93.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.192 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.9 mtp85 -61.65 -36.32 80.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.9 t-80 -67.49 -38.37 84.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 111.323 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.88 -47.42 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.08 -34.25 77.6 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.859 -1.151 . . . . 0.0 110.33 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.34 80.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.093 . . . . 0.0 109.857 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 24.5 m-80 -62.01 -27.15 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.73 30.53 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -168.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.26 -170.67 18.37 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -146.9 153.92 40.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.173 -1.192 . . . . 0.0 111.111 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.8 p90 -108.99 151.9 42.15 Favored Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.456 -0.778 . . . . 0.0 110.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.533 ' CG ' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.4 125.99 11.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.909 1.478 . . . . 0.0 110.344 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.3 t -67.55 -32.74 73.71 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.7 m-20 -62.96 -33.6 75.73 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.895 -1.128 . . . . 0.0 108.808 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.594 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 51.1 t -83.71 -41.74 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.018 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.06 -38.37 67.94 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.8 -1.188 . . . . 0.0 109.475 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.3 mm-40 -63.48 -48.1 79.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 110.294 171.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 48.7 mttm -56.44 -35.25 67.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.611 -1.306 . . . . 0.0 110.411 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.9 t -60.14 -41.31 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.965 -1.084 . . . . 0.0 109.327 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.15 -35.91 81.74 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.852 0.835 . . . . 0.0 109.442 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -68.48 -37.62 80.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.582 -0.699 . . . . 0.0 110.886 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 70.9 t -62.85 -37.87 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.974 -1.079 . . . . 0.0 110.008 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.17 -40.38 82.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.945 . . . . 0.0 110.373 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.54 -31.22 70.3 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.252 -0.905 . . . . 0.0 110.931 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.46 -3.83 54.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.064 -1.023 . . . . 0.0 109.607 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 21.83 30.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.454 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.91 169.99 8.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 109.798 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.475 ' O ' HD13 ' A' ' 445' ' ' LEU . 16.7 m -113.18 106.82 54.52 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.04 -1.037 . . . . 0.0 110.075 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.491 ' CG ' HG12 ' A' ' 420' ' ' VAL . 49.4 Cg_endo -79.39 107.38 2.16 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 O-C-N 123.898 1.473 . . . . 0.0 110.489 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.8 mt -93.09 137.95 31.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.883 -1.136 . . . . 0.0 108.625 167.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG22 ' A' ' 401' ' ' ILE . 92.4 t -101.56 134.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.678 -1.264 . . . . 0.0 109.613 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 42.7 t -114.52 134.53 57.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 108.824 174.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.528 ' CG1' HG21 ' A' ' 439' ' ' VAL . 2.5 m -118.4 160.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.451 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.52 130.15 32.04 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.88 -127.99 28.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.66 13.53 25.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -1.223 . . . . 0.0 111.233 -178.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -126.35 170.42 11.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 109.949 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.528 HG21 ' CG1' ' A' ' 434' ' ' VAL . 60.5 t -89.87 133.73 31.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.76 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.609 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -92.74 -21.36 20.0 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.323 -0.861 . . . . 0.0 109.574 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.544 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.93 176.86 39.36 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 118.909 -1.615 . . . . 0.0 111.093 169.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 56.4 t -107.88 142.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.071 -1.252 . . . . 0.0 109.777 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.526 HD11 ' CG2' ' A' ' 352' ' ' ILE . 77.5 mt -101.44 113.08 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.373 -0.83 . . . . 0.0 109.036 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.524 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.38 118.63 31.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.036 -1.04 . . . . 0.0 109.881 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.536 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.8 144.23 30.72 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.527 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.67 0 O-C-N 120.574 -1.329 . . . . 0.0 110.986 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.511 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.1 mt-30 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.118 0.485 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.512 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -57.79 136.83 56.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.97 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 3.4 m -118.98 -42.94 2.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 320' ' ' SER . 67.7 mt-10 -154.69 150.89 28.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.444 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.628 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 6.8 p90 -137.53 145.11 42.55 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.763 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.26 144.42 34.96 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.596 -0.69 . . . . 0.0 109.775 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.6 143.62 38.39 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.764 1.402 . . . . 0.0 111.531 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.53 153.1 41.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 108.793 165.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.85 128.41 37.06 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.675 -1.266 . . . . 0.0 110.146 -172.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.86 -2.6 38.64 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.4 t -136.18 139.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.67 -1.488 . . . . 0.0 110.866 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.65 152.67 41.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.578 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.7 tt0 -62.01 -39.23 91.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.053 -1.029 . . . . 0.0 110.365 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -61.08 -45.21 95.67 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.816 -1.177 . . . . 0.0 109.765 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.424 ' HB ' HG11 ' A' ' 328' ' ' VAL . 92.2 m -55.8 -44.17 77.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.197 -0.94 . . . . 0.0 109.596 173.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.541 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.3 tp -57.99 -39.87 79.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.315 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.08 -1.013 . . . . 0.0 110.788 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.0 m-20 -63.44 -49.27 74.33 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.872 -1.143 . . . . 0.0 109.758 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.48 -31.67 71.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.821 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.52 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -54.69 -35.55 63.71 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.066 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.4 mt-30 -75.23 -55.79 5.36 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.506 -0.746 . . . . 0.0 110.999 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.28 -34.99 76.1 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.786 -172.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -66.89 -21.51 66.0 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.14 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 90.9 p -108.09 10.32 28.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.097 -1.002 . . . . 0.0 111.632 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.28 -44.67 82.92 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.696 -1.252 . . . . 0.0 109.694 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -97.26 1.43 49.62 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.885 -170.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 341' ' ' SER . 12.7 p30 -64.96 130.22 42.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.753 -1.217 . . . . 0.0 110.03 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.61 4.08 53.43 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.555 0.693 . . . . 0.0 109.863 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.2 p -73.79 152.62 89.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 109.38 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -55.94 -39.26 92.28 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.724 1.381 . . . . 0.0 109.149 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.8 mt-10 -65.05 -27.68 68.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.504 -0.747 . . . . 0.0 110.474 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.06 -39.24 79.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.451 ' O ' HD11 ' A' ' 354' ' ' ILE . 65.4 mtt85 -78.55 -35.78 45.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.6 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.511 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 6.3 m -60.98 -38.92 87.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.954 -1.091 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.525 ' CG2' HD13 ' A' ' 443' ' ' ILE . 88.2 mt -68.45 -49.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.062 . . . . 0.0 110.655 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.517 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 24.3 t -61.06 -34.57 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.988 -1.07 . . . . 0.0 110.124 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 350' ' ' ARG . 31.4 mt -72.52 -31.97 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 110.455 171.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.628 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.9 OUTLIER -60.12 -40.96 91.57 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.941 -1.099 . . . . 0.0 110.494 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.39 98.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 110.326 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 71.0 mttt -71.33 -49.09 45.99 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.68 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 11.7 pt20 -71.98 -43.26 65.42 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.73 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.572 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 78.7 mmt-85 -73.63 -44.44 56.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 111.435 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.578 ' CE2' ' OE2' ' A' ' 330' ' ' GLU . 60.3 m-85 -135.27 -38.72 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.522 -1.361 . . . . 0.0 112.125 -168.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.478 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.9 t30 -159.45 104.11 1.62 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.214 . . . . 0.0 111.58 -168.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 41.4 mt -57.42 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.875 -1.141 . . . . 0.0 108.912 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.492 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.7 tpt180 -131.42 164.06 26.56 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.477 -0.764 . . . . 0.0 109.25 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.9 mt-10 -138.13 -158.13 0.83 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.978 -1.076 . . . . 0.0 110.543 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.584 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.9 ptt85 -97.2 162.54 13.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 110.677 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 365' ' ' ARG . 89.2 m-20 -133.49 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.507 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 374' ' ' PHE . 63.6 t -73.4 -47.61 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.491 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.02 -23.55 65.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -30.43 27.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.021 -1.05 . . . . 0.0 109.753 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.591 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 16.9 mt -103.53 -4.97 23.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.523 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 56.5 m-70 64.22 52.06 2.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.186 -176.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.545 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.86 174.91 6.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.631 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.4 m -117.98 136.03 53.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.1 m-85 -88.5 149.11 23.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.596 174.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 61.8 t -122.31 101.06 41.39 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.133 -0.979 . . . . 0.0 109.658 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.48 151.18 38.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.003 1.528 . . . . 0.0 110.413 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 15.1 t80 -65.02 132.31 48.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 110.048 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.303 -1.436 0 O-C-N 121.354 -0.841 . . . . 0.0 109.611 175.359 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 79.9 mtm180 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.44 0.638 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.524 ' HE1' ' CB ' ' A' ' 400' ' ' ALA . 3.4 ptp -158.78 168.41 26.9 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.362 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.519 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.7 p -153.6 164.93 37.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.32 -166.68 35.54 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.714 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.518 HD11 ' CG2' ' A' ' 367' ' ' VAL . 4.2 tt -138.9 148.99 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.681 -0.894 . . . . 0.0 110.021 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -127.49 134.91 49.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.892 -1.13 . . . . 0.0 109.678 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.591 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.8 tt -139.84 154.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.922 -1.111 . . . . 0.0 109.443 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.2 -62.99 0.06 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.48 0.657 . . . . 0.0 112.259 172.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 54.0 t30 -90.93 -10.21 43.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 111.686 -168.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.539 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 23.2 mtp180 -142.31 147.02 35.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.612 -1.305 . . . . 0.0 110.76 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.7 mtt -135.6 108.54 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.916 -1.115 . . . . 0.0 108.996 169.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 8.4 mt -128.17 145.9 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.008 -1.057 . . . . 0.0 110.058 -175.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.471 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 33.4 mtt180 -136.14 160.76 37.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 0.0 110.833 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.482 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.59 128.05 34.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.469 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -153.62 173.94 32.28 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 28.5 m -57.27 152.22 14.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.97 -1.312 . . . . 0.0 108.721 170.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.531 ' CG2' HG13 ' A' ' 420' ' ' VAL . 79.1 t -55.72 -35.99 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 109.783 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.6 t0 -63.25 -46.62 86.04 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.359 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.524 ' CB ' ' HE1' ' A' ' 383' ' ' MET . . . -68.14 -50.57 53.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.497 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.529 HG23 ' CG1' ' A' ' 432' ' ' VAL . 28.4 mm -64.59 -43.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.788 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.589 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.4 ttp180 -59.64 -43.71 93.76 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 67.2 mtp180 -61.93 -36.19 80.65 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.075 -1.015 . . . . 0.0 109.501 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -68.5 -36.46 78.94 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 111.353 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 437' ' ' SER . 55.8 t -65.97 -48.91 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.585 -1.322 . . . . 0.0 110.102 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.37 -34.21 77.22 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.2 79.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.074 . . . . 0.0 109.931 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.532 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.6 m-80 -61.34 -27.7 68.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 109.153 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.12 19.8 27.45 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -169.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.63 -170.05 15.92 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -144.95 153.79 41.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.186 -1.185 . . . . 0.0 111.097 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.2 p90 -107.9 150.21 40.02 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.506 -0.746 . . . . 0.0 110.085 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.535 ' CG ' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.98 126.25 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.902 1.475 . . . . 0.0 110.291 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 2.0 t -67.64 -32.48 73.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.976 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 88.7 m-20 -63.43 -33.41 75.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.893 -1.13 . . . . 0.0 108.728 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.594 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 49.1 t -83.57 -40.99 16.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.938 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 52.4 t0 -55.19 -38.5 68.46 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.691 -1.204 . . . . 0.0 109.452 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.6 mt-30 -63.4 -48.62 77.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.433 -1.417 . . . . 0.0 110.285 171.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 50.1 mmtt -56.16 -35.15 66.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.667 -1.271 . . . . 0.0 110.488 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -59.65 -41.59 85.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 109.149 171.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -65.72 -35.81 81.82 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.896 0.855 . . . . 0.0 109.458 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.73 -36.94 81.49 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.556 -0.715 . . . . 0.0 110.724 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.513 HG23 ' CB ' ' A' ' 444' ' ' ALA . 68.7 t -62.94 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 110.046 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.82 85.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.307 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -69.42 -30.69 68.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.243 -0.91 . . . . 0.0 110.862 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.7 -3.57 56.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.7 21.89 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.458 ' HB3' HG11 ' A' ' 423' ' ' VAL . . . -107.42 166.41 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -1.139 . . . . 0.0 109.689 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 445' ' ' LEU . 2.8 m -110.77 107.24 57.99 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.039 -1.038 . . . . 0.0 109.732 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.519 ' CG ' HG11 ' A' ' 420' ' ' VAL . 40.8 Cg_endo -76.12 108.4 2.67 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 O-C-N 123.898 1.473 . . . . 0.0 110.431 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.5 mt -92.5 139.85 30.17 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.968 -1.083 . . . . 0.0 108.665 167.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG23 ' A' ' 401' ' ' ILE . 21.5 t -100.28 134.02 41.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.781 -1.199 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' A' ' 440' ' ' LEU . 13.9 t -115.13 132.89 63.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 108.591 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -119.33 160.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -175.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.2 tt0 -135.7 131.79 36.09 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.45 -128.41 30.16 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.532 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 69.3 p -106.34 8.75 31.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.054 -1.262 . . . . 0.0 111.193 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -123.93 170.52 10.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.603 -1.31 . . . . 0.0 110.115 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 61.0 t -89.7 133.4 31.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.41 -0.806 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.602 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.7 pp -93.79 -19.9 20.6 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.498 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.548 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 170.34 176.72 40.03 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.846 -1.645 . . . . 0.0 110.894 167.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 55.1 t -107.82 143.0 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.121 -1.223 . . . . 0.0 109.86 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.525 HD13 ' CG2' ' A' ' 352' ' ' ILE . 75.8 mt -101.59 111.82 32.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 108.996 170.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.513 ' CB ' HG23 ' A' ' 423' ' ' VAL . . . -91.75 117.85 30.14 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.097 -1.002 . . . . 0.0 109.775 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.529 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -100.65 144.68 29.33 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.447 ' HG2' ' HB2' ' A' ' 428' ' ' ALA . 32.3 mttp . . . . . 0 N--CA 1.491 1.61 0 O-C-N 120.783 -1.198 . . . . 0.0 111.056 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.517 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.4 mt-30 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.088 0.47 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.477 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -61.06 139.32 58.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.803 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.522 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -123.37 -34.93 3.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.556 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.421 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.9 tt0 -163.79 149.41 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.36 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 16.4 p90 -135.74 145.45 46.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.847 -1.158 . . . . 0.0 111.725 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 324' ' ' PRO . 11.4 mt -116.66 141.56 28.31 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.538 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.61 142.62 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.635 1.334 . . . . 0.0 111.712 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.6 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -70.41 151.66 44.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.348 -0.845 . . . . 0.0 108.86 165.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -58.08 129.21 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.735 -1.228 . . . . 0.0 110.09 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.44 -0.04 50.07 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 53.5 t -135.28 138.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.74 -1.447 . . . . 0.0 110.764 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.7 m-20 -73.13 148.84 43.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.544 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.6 tt0 -60.22 -35.43 75.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.991 -1.068 . . . . 0.0 109.86 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.524 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.25 -43.44 87.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.001 -1.062 . . . . 0.0 109.297 176.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 92.7 m -60.81 -42.49 97.76 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 6.0 tp -60.49 -39.1 86.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.242 -0.911 . . . . 0.0 110.573 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.44 -44.2 79.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.061 . . . . 0.0 110.666 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.543 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 89.4 m-20 -63.73 -49.05 74.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.908 -1.12 . . . . 0.0 110.056 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -69.03 -30.78 69.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.027 -1.046 . . . . 0.0 109.868 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -54.97 -35.69 64.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.125 -0.984 . . . . 0.0 108.953 171.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.68 -55.91 5.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.519 -0.738 . . . . 0.0 111.116 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -64.51 -33.86 76.89 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.033 -171.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 395' ' ' LYS . . . -67.07 -21.48 65.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.965 -1.084 . . . . 0.0 110.147 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.468 ' OG ' HG21 ' A' ' 353' ' ' VAL . 78.5 p -106.46 10.57 31.36 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.188 -0.945 . . . . 0.0 111.473 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 50.6 mt -66.32 -44.68 82.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.562 -1.336 . . . . 0.0 109.672 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -96.74 2.79 52.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.997 -171.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.472 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 15.8 p30 -63.85 130.64 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.756 -1.215 . . . . 0.0 109.995 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.69 5.7 50.77 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.571 0.701 . . . . 0.0 109.949 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.4 p -77.11 149.78 80.02 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.614 -0.679 . . . . 0.0 109.541 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.85 -40.77 79.16 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.679 1.358 . . . . 0.0 109.255 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.16 -27.87 69.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.768 . . . . 0.0 110.382 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.472 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -54.92 -36.79 60.91 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.44 ' O ' HD13 ' A' ' 354' ' ' ILE . 94.4 mtt180 -75.91 -37.26 58.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.108 -1.23 . . . . 0.0 110.432 172.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.517 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.5 m -61.95 -38.04 87.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.049 -1.032 . . . . 0.0 110.418 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 83.4 mt -68.6 -49.21 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.907 -1.121 . . . . 0.0 110.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.528 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 21.5 t -61.2 -32.84 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.943 -1.098 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 350' ' ' ARG . 42.4 mt -72.89 -31.76 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.771 -1.206 . . . . 0.0 110.808 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.635 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.73 -41.48 90.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.784 -1.198 . . . . 0.0 110.249 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.526 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.496 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 66.7 mttt -72.16 -51.07 23.01 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.544 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.2 pt20 -70.78 -42.73 70.0 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.706 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.9 mmm180 -74.94 -43.19 55.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 111.147 -172.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 55.2 m-85 -134.98 -39.48 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.675 -1.265 . . . . 0.0 112.012 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.479 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.5 t-20 -162.58 106.36 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.532 -167.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 54.1 mt -57.62 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.948 -1.095 . . . . 0.0 109.188 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.497 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.8 tpt180 -124.36 156.44 37.05 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.28 -0.888 . . . . 0.0 109.866 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 20.3 pt-20 -122.93 -167.66 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.023 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.586 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.5 ptt-85 -93.52 164.71 13.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 110.542 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.459 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.6 m-20 -129.43 40.84 3.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.577 HG11 ' CE2' ' A' ' 374' ' ' PHE . 93.8 t -73.75 -48.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.436 -0.79 . . . . 0.0 110.43 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.419 -0.801 . . . . 0.0 111.134 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -30.21 29.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 109.79 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.6 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.0 mt -102.83 -4.58 24.67 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 110.628 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.7 m-70 64.07 52.94 1.92 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.552 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.6 174.98 6.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 110.677 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.6 m -117.65 134.22 55.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.604 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.577 ' CE2' HG11 ' A' ' 367' ' ' VAL . 92.4 m-85 -89.71 143.55 26.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.577 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.473 HG22 ' ND2' ' A' ' 387' ' ' ASN . 41.9 t -118.2 101.22 51.58 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.9 Cg_endo -55.57 152.22 34.78 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.089 1.573 . . . . 0.0 110.343 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.545 ' CZ ' ' C ' ' A' ' 382' ' ' ARG . 19.2 t80 -63.4 132.31 51.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 0.0 110.174 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.569 174.898 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.545 ' C ' ' CZ ' ' A' ' 377' ' ' PHE . 90.8 mtt-85 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.468 0.652 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.526 ' HE3' ' CB ' ' A' ' 400' ' ' ALA . 3.0 ptp -160.62 168.27 25.28 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.957 0.884 . . . . 0.0 111.328 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.0 p -153.59 164.88 37.49 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.44 -165.62 34.46 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 118.945 -1.597 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 339' ' ' LEU . 1.5 tt -139.11 148.51 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.663 -0.904 . . . . 0.0 109.989 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.473 ' ND2' HG22 ' A' ' 375' ' ' VAL . 28.1 m-20 -127.24 135.33 50.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.676 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.6 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.7 tt -139.87 154.87 24.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.867 -1.145 . . . . 0.0 109.363 171.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.492 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 89.7 m-20 -25.36 -63.16 0.06 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.447 0.641 . . . . 0.0 112.263 172.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.444 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 42.9 t-20 -92.14 -7.47 48.37 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.777 . . . . 0.0 111.804 -168.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.556 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 33.3 mtp180 -144.5 144.95 31.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.643 -1.286 . . . . 0.0 110.645 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.1 mtm -135.34 110.42 8.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.915 -1.116 . . . . 0.0 109.149 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.516 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 8.6 mt -130.49 145.96 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 110.001 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.483 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 41.8 mtt180 -135.9 160.88 37.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 110.76 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.495 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.2 128.58 34.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -155.39 174.4 33.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -174.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -57.52 151.55 16.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.949 -1.324 . . . . 0.0 108.357 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.543 ' CG2' HG11 ' A' ' 420' ' ' VAL . 61.2 t -57.69 -34.57 47.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.074 -1.017 . . . . 0.0 109.951 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.6 t70 -62.65 -46.59 87.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.526 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -68.24 -50.02 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.985 -1.072 . . . . 0.0 110.562 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 432' ' ' VAL . 32.2 mm -64.54 -43.82 96.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.656 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 6.1 ttt180 -59.87 -42.74 94.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 73.5 mtp180 -61.42 -36.16 79.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.572 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -67.33 -38.21 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 437' ' ' SER . 68.9 t -65.5 -47.56 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.573 -1.329 . . . . 0.0 110.138 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -35.02 78.91 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.783 -1.198 . . . . 0.0 110.354 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.0 -1.063 . . . . 0.0 109.949 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 22.0 m-80 -62.11 -27.11 68.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.24 19.16 31.3 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.04 -169.19 18.19 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.425 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.33 153.38 42.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.102 -1.234 . . . . 0.0 111.478 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.627 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 9.0 p90 -108.46 149.81 39.82 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.664 -0.647 . . . . 0.0 110.153 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.552 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.13 123.57 7.91 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.849 1.447 . . . . 0.0 110.465 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.27 -34.49 78.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.031 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.4 m-20 -60.63 -32.99 72.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.951 -1.093 . . . . 0.0 108.91 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 54.6 t -83.55 -42.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.001 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.574 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.6 m-20 -55.49 -36.8 67.03 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.659 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 98.9 mm-40 -63.79 -48.77 75.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.326 -1.484 . . . . 0.0 110.184 171.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 65.3 mttm -56.78 -34.99 68.16 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.661 -1.274 . . . . 0.0 110.309 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.593 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -59.33 -41.24 83.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.987 -1.07 . . . . 0.0 109.279 171.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.6 t0 -66.47 -36.14 82.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 83.6 mt-30 -66.93 -37.38 84.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.522 HG13 ' CB ' ' A' ' 428' ' ' ALA . 54.0 t -60.53 -38.9 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 109.942 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.85 92.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.943 . . . . 0.0 110.366 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 2.6 mtp180 -64.16 -31.54 72.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.134 -0.979 . . . . 0.0 110.722 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 2.8 mt-30 -80.96 -5.14 57.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.61 40.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.522 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.0 172.81 6.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -1.103 . . . . 0.0 109.855 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 445' ' ' LEU . 14.4 m -114.37 106.55 52.55 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.96 -1.088 . . . . 0.0 109.99 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' A' ' 420' ' ' VAL . 48.3 Cg_endo -79.76 107.26 2.08 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.927 1.488 . . . . 0.0 110.498 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.537 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 14.8 mt -93.41 135.67 34.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.878 -1.139 . . . . 0.0 108.785 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.527 ' CG2' HG21 ' A' ' 398' ' ' VAL . 89.5 t -100.91 134.36 41.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 O-C-N 120.802 -1.186 . . . . 0.0 109.53 175.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 54.1 t -115.54 137.23 49.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.043 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.527 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -118.14 159.96 18.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.374 -0.829 . . . . 0.0 109.635 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.519 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.85 131.92 33.88 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.19 -129.07 31.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.497 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.45 12.24 28.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.117 -1.226 . . . . 0.0 111.09 -179.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -126.09 170.88 11.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.598 -1.314 . . . . 0.0 109.938 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.527 HG13 ' CG1' ' A' ' 432' ' ' VAL . 23.3 t -90.88 134.23 30.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.762 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.61 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -94.45 -22.28 18.38 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.793 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.557 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.61 177.15 38.86 Favored Glycine 0 N--CA 1.501 3.005 0 C-N-CA 118.857 -1.639 . . . . 0.0 111.085 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.593 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 51.5 t -107.84 142.69 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.049 -1.265 . . . . 0.0 109.964 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.513 HD11 ' CB ' ' A' ' 337' ' ' ALA . 82.2 mt -101.37 112.86 35.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 423' ' ' VAL . . . -92.28 119.32 31.76 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.537 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.43 146.94 27.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 2.7 pttp . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.477 -1.389 . . . . 0.0 110.706 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.8 mt-30 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.078 0.466 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.522 ' CB ' HD21 ' A' ' 445' ' ' LEU . . . -61.43 137.95 58.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.995 . . . . 0.0 109.924 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.62 -38.35 2.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.473 ' N ' HD12 ' A' ' 355' ' ' LEU . 70.7 mt-10 -153.57 149.55 27.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.928 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.671 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 7.7 p90 -136.02 158.77 43.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.023 -1.048 . . . . 0.0 111.569 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 324' ' ' PRO . 1.2 mp -133.94 139.7 34.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.536 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.21 144.2 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.613 1.323 . . . . 0.0 111.619 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.592 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.51 151.35 43.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 108.791 164.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.86 129.19 40.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.686 -1.259 . . . . 0.0 110.098 -172.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.12 -2.33 40.71 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.8 t -135.99 139.1 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.715 -1.462 . . . . 0.0 110.785 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.5 m-20 -73.31 152.48 40.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.895 . . . . 0.0 110.203 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -63.41 -40.55 97.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 0.0 110.538 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.3 -43.12 92.63 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.687 -1.258 . . . . 0.0 109.543 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 93.8 m -55.86 -43.72 77.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.834 173.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.548 ' CD2' ' HA3' ' A' ' 441' ' ' GLY . 4.3 tp -59.6 -39.03 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.68 -42.96 81.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.768 -176.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.87 -48.61 76.03 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.803 -1.186 . . . . 0.0 109.901 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.54 -31.98 72.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.891 -1.131 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.509 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.72 -35.47 66.16 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.211 -0.931 . . . . 0.0 109.127 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.544 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 29.9 mt-30 -73.64 -55.79 5.83 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 110.893 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -62.93 -34.68 77.97 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.929 -171.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.43 -21.07 65.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -0.991 . . . . 0.0 110.014 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 92.3 p -107.68 10.24 29.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.227 -0.921 . . . . 0.0 111.569 -174.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.8 mt -65.88 -44.78 84.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.581 -1.324 . . . . 0.0 109.68 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.77 0.42 46.86 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.841 -170.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 341' ' ' SER . 11.3 p30 -63.03 130.45 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.778 -1.201 . . . . 0.0 109.926 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.65 5.69 50.8 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.568 0.699 . . . . 0.0 109.857 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.6 p -77.18 150.81 80.92 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.559 -0.713 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -53.42 -38.47 82.86 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.686 1.361 . . . . 0.0 109.14 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.53 -28.48 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.543 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.459 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.83 -37.95 71.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.446 ' O ' HD11 ' A' ' 354' ' ' ILE . 95.3 mtt180 -77.32 -38.13 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -1.18 . . . . 0.0 110.593 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.518 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 11.4 m -61.2 -38.29 86.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.878 -1.139 . . . . 0.0 110.359 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.527 ' CG2' HD11 ' A' ' 443' ' ' ILE . 85.2 mt -68.68 -48.94 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.058 -1.026 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 24.6 t -61.36 -32.72 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.043 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.495 ' CG2' ' OE1' ' A' ' 358' ' ' GLN . 34.0 mt -72.73 -33.57 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.752 -1.218 . . . . 0.0 110.678 171.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.53 -40.8 83.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.8 -1.187 . . . . 0.0 110.397 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.48 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 24.9 mtmt -72.24 -49.4 35.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.547 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.495 ' OE1' ' CG2' ' A' ' 354' ' ' ILE . 13.7 pt20 -71.52 -42.49 67.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.32 -0.862 . . . . 0.0 110.843 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.574 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 39.0 mmt180 -73.75 -45.33 52.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.084 -1.01 . . . . 0.0 111.23 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.671 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 86.8 m-85 -135.59 -37.66 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.329 -1.349 . . . . 0.0 112.117 -169.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' A' ' 363' ' ' ARG . 14.1 t-20 -160.57 105.9 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.627 -1.296 . . . . 0.0 111.492 -168.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.53 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 51.9 mt -57.63 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.0 109.349 172.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.3 tpt180 -128.08 164.16 23.03 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -137.91 -160.43 1.06 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 110.085 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.71 163.91 12.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.522 -0.736 . . . . 0.0 110.67 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -131.39 42.63 3.18 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.507 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.577 ' CG2' ' CZ ' ' A' ' 374' ' ' PHE . 42.3 t -72.7 -46.36 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 110.259 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.83 -27.31 66.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 111.152 -175.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.02 -30.1 28.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.756 176.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.529 ' CB ' HD13 ' A' ' 388' ' ' ILE . 21.8 mt -102.47 -5.02 24.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.524 -0.735 . . . . 0.0 110.635 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.4 m-70 60.3 52.27 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 109.761 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.533 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -94.04 174.57 7.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.456 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.9 m -117.12 134.64 54.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 110.499 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.577 ' CZ ' ' CG2' ' A' ' 367' ' ' VAL . 89.7 m-85 -89.23 145.17 25.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.04 101.15 50.24 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.633 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -55.22 151.37 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.067 1.562 . . . . 0.0 110.548 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 10.2 t80 -64.48 131.91 48.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.87 . . . . 0.0 110.078 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--N 1.302 -1.48 0 O-C-N 121.405 -0.81 . . . . 0.0 109.715 175.885 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 69.9 mtt85 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.503 0.668 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.526 ' CE ' HD11 ' A' ' 401' ' ' ILE . 2.5 ptp -159.46 167.96 27.4 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.934 0.873 . . . . 0.0 111.203 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 17.3 p -154.41 165.14 37.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.33 -165.8 34.11 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.988 -1.577 . . . . 0.0 110.521 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 367' ' ' VAL . 4.8 tt -138.68 151.6 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.639 -0.918 . . . . 0.0 110.231 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -127.39 133.99 49.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 109.747 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.9 tt -140.38 155.18 23.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.937 -1.102 . . . . 0.0 109.2 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.6 m-20 -21.91 -63.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.47 0.652 . . . . 0.0 112.555 170.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.449 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 44.3 t-20 -95.57 -7.58 37.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 111.911 -167.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.548 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.4 mtp180 -142.95 144.92 32.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.745 -1.222 . . . . 0.0 110.55 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -135.3 101.33 4.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.845 -1.159 . . . . 0.0 108.967 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.521 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 8.1 mt -123.89 146.03 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 110.143 -172.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.472 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 33.7 mtt180 -135.85 160.42 38.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.905 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.53 131.25 39.55 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -157.01 174.01 34.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.4 m -56.91 150.17 17.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.941 -1.329 . . . . 0.0 108.441 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.539 ' CG2' HG12 ' A' ' 420' ' ' VAL . 16.9 t -54.54 -36.97 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.969 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.5 m-20 -63.8 -44.25 93.87 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.319 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.433 ' C ' ' HE1' ' A' ' 383' ' ' MET . . . -68.42 -51.53 42.79 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.951 -1.093 . . . . 0.0 110.574 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.526 HD11 ' CE ' ' A' ' 383' ' ' MET . 30.6 mm -64.64 -42.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.082 -1.011 . . . . 0.0 110.736 -176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.591 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.9 ttp180 -59.15 -43.74 92.06 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.8 mtp180 -61.62 -36.8 81.76 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.506 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -68.18 -36.68 79.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.301 -0.874 . . . . 0.0 111.367 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 437' ' ' SER . 54.4 t -66.24 -47.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.59 -1.319 . . . . 0.0 110.16 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -34.8 78.6 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.756 -1.215 . . . . 0.0 110.293 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.22 81.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.968 -1.082 . . . . 0.0 109.883 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.53 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 5.3 m-80 -60.94 -28.24 68.81 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.509 -0.744 . . . . 0.0 109.084 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.4 19.8 26.82 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 -169.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -116.05 -168.84 15.32 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.37 153.88 41.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.213 -1.169 . . . . 0.0 111.149 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.591 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.7 p90 -107.98 150.68 40.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.589 -0.694 . . . . 0.0 110.061 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.532 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.56 127.4 12.42 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.891 1.469 . . . . 0.0 110.49 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.2 t -66.99 -34.93 78.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 111.024 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.5 m-20 -61.43 -33.73 74.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.817 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.592 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 54.7 t -83.5 -41.68 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.37 -38.51 68.92 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.347 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.38 -48.0 79.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.324 -1.485 . . . . 0.0 110.309 171.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 35.8 mttm -56.71 -34.87 67.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.668 -1.27 . . . . 0.0 110.512 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -59.7 -41.68 86.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.91 -1.119 . . . . 0.0 109.136 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -65.94 -36.18 82.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.915 0.864 . . . . 0.0 109.493 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.5 -38.18 80.73 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 110.886 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 69.4 t -62.3 -37.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.975 -1.078 . . . . 0.0 109.945 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.42 87.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.219 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.05 -33.08 74.99 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.258 -0.901 . . . . 0.0 111.208 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -80.98 -4.38 54.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.012 -1.055 . . . . 0.0 109.456 174.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.24 30.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.505 ' HB1' ' CG1' ' A' ' 423' ' ' VAL . . . -104.42 170.91 7.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -1.141 . . . . 0.0 109.863 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.473 ' O ' HD12 ' A' ' 445' ' ' LEU . 7.5 m -112.45 106.62 55.71 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.988 -1.07 . . . . 0.0 110.108 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.466 ' HG3' ' O ' ' A' ' 420' ' ' VAL . 55.3 Cg_endo -80.05 107.23 2.03 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 O-C-N 123.864 1.454 . . . . 0.0 110.541 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.544 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.7 mt -93.6 140.44 29.61 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.915 -1.116 . . . . 0.0 108.717 167.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.528 ' CG1' HG12 ' A' ' 439' ' ' VAL . 98.5 t -101.07 135.6 36.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.798 -1.189 . . . . 0.0 109.568 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 440' ' ' LEU . 22.3 t -115.93 136.19 53.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 108.745 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -120.53 160.44 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.459 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.4 tt0 -135.49 129.97 33.96 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.26 -131.3 29.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.53 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 76.5 p -103.29 8.97 38.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.087 -1.243 . . . . 0.0 111.138 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -123.32 170.84 9.89 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.555 -1.34 . . . . 0.0 110.152 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 61.9 t -91.04 134.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.357 -0.84 . . . . 0.0 109.824 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.602 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.3 pp -92.83 -22.49 19.27 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.48 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.553 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 169.22 177.42 39.89 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.048 -1.549 . . . . 0.0 110.871 170.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 60.0 t -107.72 143.91 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.109 -1.23 . . . . 0.0 109.82 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.527 HD11 ' CG2' ' A' ' 352' ' ' ILE . 81.3 mt -101.62 112.62 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.448 -0.783 . . . . 0.0 108.997 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.36 118.24 30.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.861 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.544 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.66 148.15 25.93 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -175.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 16.1 pttt . . . . . 0 C--N 1.297 -1.691 0 O-C-N 120.563 -1.335 . . . . 0.0 110.343 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 87.6 mt-30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.085 0.469 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.522 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -64.2 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.934 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.463 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -117.37 -33.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -169.95 151.03 3.96 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.008 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.644 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 11.4 p90 -136.0 145.87 46.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.774 -1.204 . . . . 0.0 111.814 -177.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.4 mp -116.53 143.16 30.73 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.667 -0.646 . . . . 0.0 109.631 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.535 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.8 Cg_endo -72.37 143.71 39.56 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.69 1.363 . . . . 0.0 111.583 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.65 152.4 41.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 108.782 165.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.78 128.96 39.84 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.575 -1.328 . . . . 0.0 110.097 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.66 -1.8 42.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.5 t -136.43 138.84 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.463 . . . . 0.0 110.749 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.439 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.4 m-20 -73.5 152.32 40.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -61.98 -40.11 94.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.037 -1.039 . . . . 0.0 110.443 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.13 -43.44 91.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 109.568 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 95.1 m -56.36 -43.56 79.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.88 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.572 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.6 tp -59.23 -39.8 83.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.268 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.17 -41.75 85.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 110.774 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.5 -49.16 74.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.892 -1.13 . . . . 0.0 109.971 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.7 -31.67 71.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.994 -1.066 . . . . 0.0 109.776 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 334' ' ' ALA . . . -55.79 -34.9 65.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 16.2 mt-30 -74.02 -55.79 5.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.516 -0.74 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.34 -35.96 78.85 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.885 -173.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 395' ' ' LYS . . . -67.16 -20.81 65.8 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.06 -1.025 . . . . 0.0 110.015 173.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 96.5 p -107.43 8.93 29.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.129 -0.982 . . . . 0.0 111.504 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.3 mt -65.48 -44.71 86.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.655 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.61 1.45 48.8 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.9 -170.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.47 130.2 43.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.803 -1.186 . . . . 0.0 110.057 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.92 5.45 51.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.595 0.712 . . . . 0.0 109.906 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -77.05 153.36 82.61 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.27 -38.33 95.26 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.734 1.386 . . . . 0.0 109.149 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.4 mt-10 -64.53 -29.66 70.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.75 . . . . 0.0 110.477 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.12 -35.51 59.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.457 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.3 mtt180 -76.97 -38.04 54.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.143 -1.21 . . . . 0.0 110.521 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.9 m -60.85 -38.09 84.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.92 -1.113 . . . . 0.0 110.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 80.0 mt -69.01 -49.24 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.019 -1.051 . . . . 0.0 110.627 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.517 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 28.7 t -61.54 -33.84 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.0 110.198 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 350' ' ' ARG . 34.2 mt -72.45 -33.09 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.741 -1.225 . . . . 0.0 110.553 171.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.644 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -59.68 -40.29 87.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.931 -1.106 . . . . 0.0 110.59 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.507 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.78 -45.12 91.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.284 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.525 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 30.1 mtmt -71.61 -49.26 41.95 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.706 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.6 pt20 -71.08 -42.4 69.41 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.76 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.56 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 37.8 mmt180 -73.11 -46.52 50.79 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 111.218 -172.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 73.6 m-85 -136.44 -35.82 0.73 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.411 -169.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.469 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 56.3 t-20 -158.91 102.43 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.546 -1.346 . . . . 0.0 111.619 -168.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 34.3 mt -57.8 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.858 -1.152 . . . . 0.0 109.295 171.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.525 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.6 tpt85 -135.96 163.64 29.8 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.34 -0.85 . . . . 0.0 108.941 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.51 -155.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.951 -1.093 . . . . 0.0 110.32 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.7 ptt180 -95.19 163.03 13.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.478 0.656 . . . . 0.0 110.523 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.469 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -127.78 40.24 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 110.464 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.571 HG23 ' CE1' ' A' ' 374' ' ' PHE . 57.4 t -74.61 -47.94 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.449 -0.782 . . . . 0.0 110.28 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.77 -26.02 65.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 110.954 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.44 -29.93 27.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 109.818 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.596 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 18.6 mt -103.83 -3.88 24.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 110.718 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.9 m80 62.77 53.15 2.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.43 174.92 6.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.672 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.2 m -116.3 134.27 55.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.567 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' A' ' 367' ' ' VAL . 81.4 m-85 -88.29 149.02 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 50.6 t -122.26 101.12 41.48 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.81 153.36 25.02 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.09 1.574 . . . . 0.0 110.443 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.586 ' CE2' ' N ' ' A' ' 383' ' ' MET . 58.3 t80 -69.07 134.27 49.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.797 174.86 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 97.4 mtt180 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.44 0.638 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.586 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.4 ptp -165.03 170.41 15.17 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.839 0.828 . . . . 0.0 111.283 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.514 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.3 p -154.84 165.55 36.28 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.94 -165.7 34.27 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 118.771 -1.68 . . . . 0.0 110.821 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.523 HD13 ' CG2' ' A' ' 367' ' ' VAL . 3.7 tt -140.86 148.67 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.641 -0.917 . . . . 0.0 110.133 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -127.72 135.06 49.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.869 -1.145 . . . . 0.0 109.724 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.596 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.7 tt -140.55 154.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.861 -1.149 . . . . 0.0 109.446 171.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 89.3 m-20 -25.4 -62.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.299 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.446 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.2 t30 -92.03 -7.83 47.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 -168.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.7 mtp180 -144.03 144.97 31.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.699 -1.25 . . . . 0.0 110.574 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.71 109.94 8.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.833 -1.167 . . . . 0.0 109.02 169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 8.6 mt -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.047 -1.033 . . . . 0.0 110.052 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.478 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.0 mmt85 -134.54 160.47 37.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.449 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.514 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.03 126.83 32.75 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -152.71 173.7 31.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.6 t -58.21 150.76 20.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.901 -1.352 . . . . 0.0 108.554 170.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 420' ' ' VAL . 53.5 t -55.63 -35.48 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.971 -1.08 . . . . 0.0 109.607 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.09 -46.45 89.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.165 -0.96 . . . . 0.0 110.366 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.497 ' CB ' ' HE2' ' A' ' 383' ' ' MET . . . -69.17 -51.02 42.3 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.028 -1.045 . . . . 0.0 110.639 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.521 HD13 ' CE ' ' A' ' 383' ' ' MET . 28.7 mm -64.28 -41.62 92.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 110.816 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.585 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 34.8 ttt-85 -59.65 -45.17 92.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.3 mtp85 -62.59 -35.51 79.75 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.205 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 111.212 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.84 -48.95 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.501 -1.375 . . . . 0.0 110.109 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.4 -34.11 77.02 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 110.253 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.97 -36.19 79.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.941 -1.099 . . . . 0.0 109.923 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.531 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.6 m-80 -61.63 -27.49 68.7 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.511 -0.743 . . . . 0.0 109.228 173.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.06 19.43 28.64 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -170.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.78 -170.34 16.49 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.66 153.59 41.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 111.098 -174.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.4 p90 -107.21 150.15 39.57 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.528 -0.733 . . . . 0.0 110.039 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.54 ' CG ' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -72.27 127.4 12.63 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.846 1.445 . . . . 0.0 110.42 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -67.0 -34.96 78.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 111.016 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 55.9 t0 -62.12 -33.05 73.74 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.865 -1.147 . . . . 0.0 108.823 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 49.8 t -83.52 -41.66 16.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.906 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.8 t0 -55.14 -38.17 67.88 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.455 171.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.66 -48.16 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.33 -1.481 . . . . 0.0 110.299 171.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 15.0 mmtt -56.2 -35.36 67.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.59 -1.319 . . . . 0.0 110.384 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 3.3 t -60.23 -41.31 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.963 -1.086 . . . . 0.0 109.435 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -65.83 -36.04 82.37 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.922 0.868 . . . . 0.0 109.398 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.24 -37.58 80.95 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.868 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 66.9 t -63.05 -37.35 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.91 -1.119 . . . . 0.0 110.01 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.36 85.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.71 -30.03 67.57 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.352 -0.842 . . . . 0.0 110.892 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.37 -3.53 55.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.785 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.23 21.79 28.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.466 ' HB3' HG12 ' A' ' 423' ' ' VAL . . . -106.58 170.89 7.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -1.081 . . . . 0.0 109.47 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.552 ' O ' ' CD1' ' A' ' 445' ' ' LEU . 21.3 m -116.92 106.85 47.01 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 109.52 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.529 ' CG ' HG12 ' A' ' 420' ' ' VAL . 36.3 Cg_endo -74.59 107.43 2.46 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 O-C-N 123.965 1.508 . . . . 0.0 110.331 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 15.8 mt -92.57 132.67 36.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.913 -1.117 . . . . 0.0 108.38 167.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.522 ' CG2' HG22 ' A' ' 398' ' ' VAL . 60.6 t -100.75 136.43 32.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.834 -1.166 . . . . 0.0 109.681 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.48 ' O ' HD12 ' A' ' 440' ' ' LEU . 41.8 t -115.25 138.17 46.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 108.991 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.7 159.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.461 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.6 tt0 -134.56 133.78 40.62 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 170.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.44 -126.83 31.07 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -168.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 71.7 p -108.14 8.08 27.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.021 -1.281 . . . . 0.0 111.228 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -123.98 171.03 10.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.542 -1.349 . . . . 0.0 110.147 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.53 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 60.5 t -88.94 134.62 27.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.933 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.61 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.3 pp -92.71 -22.12 19.59 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.602 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.551 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 171.04 176.31 40.15 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 118.803 -1.665 . . . . 0.0 110.816 168.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 48.2 t -107.88 143.18 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.239 . . . . 0.0 109.616 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.503 ' O ' HD11 ' A' ' 445' ' ' LEU . 80.7 mt -101.47 118.62 48.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.326 -0.858 . . . . 0.0 108.773 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -98.14 117.58 32.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -176.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 429' ' ' THR . 3.6 mp -112.24 145.28 40.21 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.014 -1.054 . . . . 0.0 109.781 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.491 1.578 0 O-C-N 120.728 -1.233 . . . . 0.0 111.199 -174.058 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 90.5 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.118 0.485 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 355' ' ' LEU . . . -59.3 137.56 57.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.02 . . . . 0.0 109.765 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.516 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.9 m -117.89 -44.02 2.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.1 -1.0 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 320' ' ' SER . 66.1 mt-10 -154.81 151.48 28.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -0.908 . . . . 0.0 110.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.612 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 14.6 p90 -136.0 140.43 43.9 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.918 -1.114 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.4 mt -112.67 143.84 29.79 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.784 -0.573 . . . . 0.0 109.708 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.76 142.55 35.81 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.678 1.357 . . . . 0.0 111.614 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.597 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.48 152.81 42.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 108.861 165.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.11 128.64 38.21 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.586 -1.321 . . . . 0.0 110.178 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.46 46.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 46.3 t -136.73 139.38 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.677 -1.484 . . . . 0.0 110.703 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.8 m-20 -74.32 152.37 39.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.9 tt0 -61.53 -40.28 94.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.038 -1.039 . . . . 0.0 110.278 -177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.5 -43.84 93.26 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.665 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.428 ' HB ' HG11 ' A' ' 328' ' ' VAL . 93.4 m -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.742 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.3 tp -59.21 -39.2 81.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.296 175.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.44 -41.4 84.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.991 -1.068 . . . . 0.0 110.729 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 88.4 m-20 -63.28 -49.92 72.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.975 -1.078 . . . . 0.0 109.84 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.597 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.0 -31.98 72.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 109.901 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.26 -35.35 64.9 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.166 -0.959 . . . . 0.0 108.961 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 15.9 mt-30 -75.5 -55.89 5.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.564 -0.71 . . . . 0.0 110.971 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -62.36 -35.24 78.52 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.756 -172.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.07 -20.87 65.89 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.984 -1.072 . . . . 0.0 109.978 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.463 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 94.8 p -107.82 9.95 28.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.205 -0.934 . . . . 0.0 111.547 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.9 mt -66.36 -44.37 83.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.516 -1.365 . . . . 0.0 109.633 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -97.39 2.15 50.13 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.787 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 14.0 p30 -64.17 130.08 42.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.739 -1.226 . . . . 0.0 110.015 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.42 4.44 53.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.508 0.671 . . . . 0.0 109.873 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.1 p -74.17 152.95 88.4 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 109.404 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.74 -40.05 87.01 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.737 1.388 . . . . 0.0 109.162 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.68 -27.56 69.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 0.0 110.481 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.22 -37.74 65.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.5 mtt180 -77.15 -37.83 53.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -1.223 . . . . 0.0 110.514 173.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.4 m -61.04 -38.06 84.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 348' ' ' GLU . 90.6 mt -68.12 -49.61 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.515 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 37.2 t -60.87 -33.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.014 . . . . 0.0 110.07 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.4 mt -72.92 -32.91 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.701 -1.25 . . . . 0.0 110.565 171.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.612 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.43 -40.17 85.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.809 -1.182 . . . . 0.0 110.545 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.69 93.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 16.1 mtmt -71.46 -49.6 39.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.638 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.525 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.6 pt20 -71.51 -42.54 67.87 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 110.793 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.525 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.9 mmt180 -72.86 -45.7 56.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 111.24 -172.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.571 ' CE2' ' OE2' ' A' ' 330' ' ' GLU . 56.1 m-85 -135.76 -38.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.143 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 363' ' ' ARG . 49.3 t30 -159.0 105.18 1.75 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.758 -1.214 . . . . 0.0 111.528 -168.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 46.7 mt -57.45 89.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.842 -1.161 . . . . 0.0 109.163 171.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.535 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.1 tpt180 -131.14 164.49 25.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.236 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.4 mt-10 -136.88 -157.19 0.76 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.153 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 31.8 ptt-85 -94.65 162.52 13.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 88.4 m-20 -128.68 41.21 3.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.287 176.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.571 HG13 ' CE2' ' A' ' 374' ' ' PHE . 26.0 t -73.47 -45.73 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.45 -28.18 66.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 111.079 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.19 -29.87 28.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.037 -1.039 . . . . 0.0 109.763 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.525 ' CB ' HD13 ' A' ' 388' ' ' ILE . 26.0 mt -103.64 -4.63 23.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.494 -0.754 . . . . 0.0 110.613 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.1 m-70 60.64 52.49 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.842 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.09 174.39 7.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.409 -0.807 . . . . 0.0 110.638 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.3 m -117.35 135.68 53.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.571 ' CE2' HG13 ' A' ' 367' ' ' VAL . 74.2 m-85 -89.39 148.79 23.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.626 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 64.0 t -122.17 100.69 42.21 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.26 150.36 49.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.046 1.551 . . . . 0.0 110.512 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.9 t80 -62.99 131.79 49.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.797 . . . . 0.0 109.639 175.411 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 87.7 mtt180 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.53 0.681 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.524 ' CE ' ' CB ' ' A' ' 400' ' ' ALA . 3.4 ptp -160.05 169.07 24.15 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.895 0.855 . . . . 0.0 111.314 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.517 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.6 p -153.64 164.92 37.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.15 -167.11 35.6 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.643 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 386' ' ' ILE . 4.0 tt -140.04 150.28 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.554 -0.968 . . . . 0.0 110.136 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -126.53 134.52 50.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.956 -1.09 . . . . 0.0 109.809 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -142.41 155.22 18.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.947 -1.096 . . . . 0.0 109.181 173.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 91.5 m-20 -22.41 -63.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.413 0.625 . . . . 0.0 112.582 171.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t30 -96.35 -6.01 38.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 111.776 -167.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.548 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.5 mtp180 -143.74 143.89 31.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.705 -1.247 . . . . 0.0 110.381 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -134.02 99.43 4.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.974 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 7.2 mt -121.29 145.96 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.036 -1.04 . . . . 0.0 110.103 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.465 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 31.4 mtt180 -133.83 159.68 39.9 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.08 -1.013 . . . . 0.0 110.689 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.19 127.23 31.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.344 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -154.23 174.07 32.7 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -173.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 35.7 m -56.99 151.51 14.75 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.854 -1.38 . . . . 0.0 108.572 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.532 ' CG2' HG11 ' A' ' 420' ' ' VAL . 57.7 t -57.02 -34.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.993 -1.067 . . . . 0.0 109.856 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.8 t0 -62.88 -46.54 87.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.218 -0.926 . . . . 0.0 110.414 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.524 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -67.9 -50.42 56.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.006 -1.059 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.526 HG23 ' CG1' ' A' ' 432' ' ' VAL . 32.5 mm -65.38 -43.69 94.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 110.763 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.578 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.7 ttp85 -58.9 -43.57 91.04 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.348 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.0 mtp180 -61.92 -36.26 80.83 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 109.44 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.534 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -67.61 -37.03 81.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 111.277 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 437' ' ' SER . 55.9 t -66.03 -48.26 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.657 -1.277 . . . . 0.0 110.157 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.99 -34.2 77.46 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.845 -1.16 . . . . 0.0 110.395 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.67 -36.39 80.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.924 -1.11 . . . . 0.0 109.816 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.534 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.1 m-80 -61.63 -27.62 68.79 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.22 173.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.02 20.35 28.43 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -168.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.44 -170.87 17.6 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -143.96 153.79 42.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -1.221 . . . . 0.0 111.186 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 5.3 p90 -107.37 150.96 40.68 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.61 -0.681 . . . . 0.0 110.098 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.543 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -73.3 124.41 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.869 1.457 . . . . 0.0 110.202 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -65.99 -34.87 79.09 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 111.064 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 54.1 t0 -61.41 -33.05 73.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.949 -1.094 . . . . 0.0 108.859 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.597 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 53.2 t -83.7 -42.44 17.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 111.009 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 9.3 m-20 -55.46 -37.26 67.53 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.575 171.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.7 mt-30 -63.72 -48.96 74.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.29 -1.506 . . . . 0.0 110.205 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 72.6 mmtt -56.65 -34.79 67.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.717 -1.239 . . . . 0.0 110.373 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -59.73 -41.23 84.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.0 -1.062 . . . . 0.0 109.283 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -66.48 -36.25 82.29 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.03 -38.19 82.25 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.565 -0.709 . . . . 0.0 110.782 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.532 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 72.5 t -62.48 -37.56 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.902 -1.124 . . . . 0.0 110.016 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.3 87.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 110.192 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -65.9 -33.8 76.66 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.38 -0.825 . . . . 0.0 111.177 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -81.69 -4.2 55.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 175.055 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 22.56 28.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.532 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -103.23 165.31 11.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -1.115 . . . . 0.0 109.618 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.466 ' O ' HD12 ' A' ' 445' ' ' LEU . 10.0 m -110.89 106.87 57.83 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.018 -1.051 . . . . 0.0 109.863 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.509 ' CB ' HG12 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.35 108.42 2.7 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.972 1.512 . . . . 0.0 110.64 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.533 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 12.7 mt -91.86 133.96 35.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.861 -1.149 . . . . 0.0 108.497 166.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 401' ' ' ILE . 83.8 t -99.86 134.73 38.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 120.799 -1.188 . . . . 0.0 109.465 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.503 HG12 ' CD1' ' A' ' 440' ' ' LEU . 23.5 t -114.46 138.57 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.881 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -122.12 160.45 24.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.657 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.453 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.17 129.26 33.51 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.25 -129.33 28.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 5.4 p -104.96 10.18 34.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.105 -1.232 . . . . 0.0 111.089 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -121.85 170.83 9.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.574 -1.329 . . . . 0.0 110.128 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.524 ' HA ' ' CG1' ' A' ' 434' ' ' VAL . 41.2 t -93.8 134.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.315 -0.866 . . . . 0.0 109.762 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.597 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.3 pp -95.96 -20.5 18.69 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.805 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.55 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.54 176.5 38.88 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 118.719 -1.705 . . . . 0.0 110.981 168.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 47.3 t -107.96 142.13 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.091 -1.24 . . . . 0.0 109.938 173.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.517 HD12 ' CB ' ' A' ' 337' ' ' ALA . 81.8 mt -101.53 111.25 30.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.042 170.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -91.75 118.65 30.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.099 -1.0 . . . . 0.0 109.909 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.533 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -101.07 144.62 29.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.468 ' HG2' ' HB3' ' A' ' 428' ' ' ALA . 70.5 mttt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 111.153 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 61.4 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.048 0.451 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 445' ' ' LEU . . . -54.66 138.61 41.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 109.789 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.528 ' O ' ' CZ ' ' A' ' 359' ' ' ARG . 20.8 m -124.34 -40.04 2.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.988 . . . . 0.0 110.276 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 320' ' ' SER . 57.9 mt-10 -154.66 146.54 23.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.669 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 9.2 p90 -137.6 142.34 41.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.593 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.513 HG22 ' CD ' ' A' ' 419' ' ' LYS . 1.9 mt -116.11 145.82 35.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.758 -0.589 . . . . 0.0 109.827 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -73.42 143.03 34.13 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.778 1.409 . . . . 0.0 111.468 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.6 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.22 152.72 42.02 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 108.881 165.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.82 128.43 37.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.74 -1.225 . . . . 0.0 110.058 -173.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 328' ' ' VAL . . . 105.62 -2.61 39.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.7 t -136.74 140.34 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.667 -1.49 . . . . 0.0 110.809 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -74.08 152.98 39.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.07 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.1 tt0 -62.18 -38.73 90.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.354 -176.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -60.92 -45.66 93.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.697 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 95.0 m -55.99 -43.73 77.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.534 HD13 ' CA ' ' A' ' 441' ' ' GLY . 5.2 tp -58.08 -40.55 81.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.15 -39.86 82.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.08 -1.013 . . . . 0.0 110.717 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.1 m-20 -62.82 -49.09 76.29 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 109.757 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.29 -31.49 70.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.884 -1.135 . . . . 0.0 109.73 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.515 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.28 -34.9 64.51 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 172.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 17.7 mt-30 -74.25 -55.6 5.85 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 110.827 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -62.05 -35.24 78.03 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.048 -172.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 395' ' ' LYS . . . -67.66 -21.08 65.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 110.131 174.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.464 ' HB2' ' OD2' ' A' ' 344' ' ' ASP . 89.3 p -107.52 10.04 29.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.0 111.508 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.5 mt -65.68 -45.51 82.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.622 -1.299 . . . . 0.0 109.793 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.5 0.85 48.28 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.865 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 10.7 p30 -64.25 130.57 44.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.817 -1.177 . . . . 0.0 110.023 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.83 5.61 50.89 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.566 0.698 . . . . 0.0 109.863 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.0 p -75.76 154.72 85.25 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.68 -39.5 90.71 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.786 1.414 . . . . 0.0 109.222 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 352' ' ' ILE . 96.1 mt-10 -64.9 -27.46 68.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.47 -0.769 . . . . 0.0 110.634 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 353' ' ' VAL . . . -55.61 -39.83 76.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -174.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -78.02 -36.81 48.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -1.182 . . . . 0.0 110.662 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.518 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.5 m -61.25 -38.97 88.6 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.928 -1.108 . . . . 0.0 110.4 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.478 ' CG2' HD13 ' A' ' 443' ' ' ILE . 87.4 mt -69.11 -48.33 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.708 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.516 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 34.8 t -62.14 -34.52 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.846 -1.159 . . . . 0.0 110.204 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.6 mt -73.2 -32.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.686 -1.259 . . . . 0.0 110.632 171.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -58.19 -41.27 83.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.97 -1.081 . . . . 0.0 110.2 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.99 -44.07 93.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.556 -0.715 . . . . 0.0 110.618 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.518 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 74.6 mttt -69.8 -49.56 51.55 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.662 -173.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.7 pt20 -72.27 -42.85 65.11 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.644 -172.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.528 ' CZ ' ' O ' ' A' ' 320' ' ' SER . 84.6 mtt-85 -78.89 -39.52 34.74 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 111.707 -171.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.669 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 76.3 m-85 -134.77 -38.64 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.462 -1.399 . . . . 0.0 112.088 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.476 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 48.6 t30 -160.57 99.79 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.585 -1.322 . . . . 0.0 111.649 -169.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 34.1 mt -57.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.865 -1.147 . . . . 0.0 109.329 171.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.541 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.4 tpt180 -141.58 164.04 31.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.169 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.7 mt-10 -130.23 -154.24 0.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.474 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.7 ptt-85 -94.11 162.97 13.66 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.686 -0.634 . . . . 0.0 110.576 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.469 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.3 p30 -125.49 39.09 4.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 374' ' ' PHE . 61.6 t -74.53 -47.5 39.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.352 -0.843 . . . . 0.0 110.281 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.86 -26.26 65.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 111.004 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.77 -29.74 27.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.001 . . . . 0.0 109.724 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.597 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.9 mt -104.33 -3.63 23.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.449 -0.782 . . . . 0.0 110.711 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.3 m80 62.6 53.22 2.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -177.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.55 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.46 175.01 6.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 0.0 110.646 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.3 m -115.94 134.43 54.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.476 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.573 ' CE1' HG22 ' A' ' 367' ' ' VAL . 80.5 m-85 -88.32 149.04 23.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 25.6 t -121.56 101.11 43.62 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 109.735 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -55.03 153.05 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 110.468 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.566 ' CE2' ' N ' ' A' ' 383' ' ' MET . 56.8 t80 -70.54 134.44 47.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.386 -0.821 . . . . 0.0 109.777 174.843 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.6 mtt180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.485 0.66 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.566 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.6 ptp -165.28 171.3 13.73 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.878 0.847 . . . . 0.0 111.237 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.518 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 49.8 p -155.79 165.43 36.54 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.8 -165.82 34.38 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.822 -1.656 . . . . 0.0 110.79 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.51 HD12 ' CG2' ' A' ' 367' ' ' VAL . 3.5 tt -140.52 149.2 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.623 -0.928 . . . . 0.0 110.143 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -127.82 134.81 49.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 109.695 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.597 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.8 tt -140.15 154.85 23.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.791 -1.193 . . . . 0.0 109.437 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 90.0 m-20 -25.37 -63.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.444 0.64 . . . . 0.0 112.277 172.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 34.1 t30 -91.94 -7.69 48.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.738 . . . . 0.0 111.828 -168.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.6 mtp180 -143.98 144.64 31.77 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.667 -1.271 . . . . 0.0 110.581 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.6 mtm -134.42 111.73 10.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 108.945 169.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 9.6 mt -131.66 146.16 33.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.0 109.978 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.483 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 26.2 mmt85 -134.41 159.32 41.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.069 -1.019 . . . . 0.0 110.356 175.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.518 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.06 127.21 33.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.459 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.12 174.23 31.88 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.635 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.2 m -56.0 150.56 13.36 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.958 -1.319 . . . . 0.0 108.551 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.545 ' CG2' HG11 ' A' ' 420' ' ' VAL . 20.4 t -54.84 -37.36 40.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.083 -1.011 . . . . 0.0 109.904 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.4 m-20 -64.23 -45.01 90.08 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.252 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.486 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -67.48 -48.98 65.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.972 -1.08 . . . . 0.0 110.655 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.529 HG21 ' CG1' ' A' ' 432' ' ' VAL . 35.1 mm -65.98 -43.85 92.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.008 -1.057 . . . . 0.0 110.945 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.621 ' NE ' ' CZ ' ' A' ' 412' ' ' PHE . 4.0 ttt180 -60.29 -42.61 95.85 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.062 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 88.8 mtt-85 -61.28 -37.49 83.37 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.635 172.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.4 t-80 -67.68 -36.21 80.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 111.289 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.71 -49.05 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.621 -1.3 . . . . 0.0 110.154 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -34.3 77.38 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.891 -1.13 . . . . 0.0 110.218 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.13 79.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.96 -1.088 . . . . 0.0 109.994 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.531 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 8.0 m-80 -61.45 -27.71 68.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.174 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.93 19.81 27.87 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.84 -169.37 16.09 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.39 153.62 42.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 111.435 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.621 ' CZ ' ' NE ' ' A' ' 402' ' ' ARG . 7.7 p90 -108.4 149.85 39.84 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.668 -0.645 . . . . 0.0 110.304 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.02 125.56 9.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.807 1.425 . . . . 0.0 110.52 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.25 -32.37 72.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -0.986 . . . . 0.0 111.075 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.5 m-20 -63.47 -31.67 72.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 108.848 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 46.0 t -83.58 -42.58 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.388 -0.82 . . . . 0.0 110.765 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.2 m-20 -55.22 -36.64 66.2 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.669 -1.212 . . . . 0.0 109.625 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.91 -49.75 71.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.337 -1.477 . . . . 0.0 109.662 173.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.513 ' CD ' HG22 ' A' ' 323' ' ' ILE . 79.2 mttt -56.8 -34.83 68.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.785 -1.197 . . . . 0.0 110.278 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -59.47 -40.98 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -66.09 -36.61 83.65 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.959 0.885 . . . . 0.0 109.255 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -66.75 -36.68 83.01 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 110.511 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 428' ' ' ALA . 68.3 t -63.11 -37.69 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.026 -1.047 . . . . 0.0 110.161 175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.05 81.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 110.286 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.75 -30.72 68.37 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.252 -0.905 . . . . 0.0 111.006 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.43 -3.32 57.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 109.777 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.05 22.1 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.528 ' HB2' ' CG1' ' A' ' 423' ' ' VAL . . . -105.68 160.92 14.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -1.052 . . . . 0.0 109.474 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.461 ' O ' HD12 ' A' ' 445' ' ' LEU . 1.2 m -108.88 106.89 59.56 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.935 -1.103 . . . . 0.0 109.798 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.504 ' CB ' HG12 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.69 107.86 2.56 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.01 1.531 . . . . 0.0 110.769 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.543 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 12.9 mt -92.62 133.29 36.12 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.845 -1.16 . . . . 0.0 108.542 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG21 ' A' ' 401' ' ' ILE . 87.7 t -99.74 134.09 40.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.608 -1.308 . . . . 0.0 109.452 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 46.9 t -114.43 134.95 55.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.999 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.0 m -117.07 159.94 16.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.491 -0.755 . . . . 0.0 109.639 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.499 ' CB ' HD21 ' A' ' 440' ' ' LEU . 4.1 tt0 -135.28 132.52 37.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.01 -129.15 32.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 -167.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 75.6 p -106.46 8.02 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.125 -1.221 . . . . 0.0 111.13 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -120.11 170.73 9.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.643 -1.286 . . . . 0.0 109.977 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.523 HG12 ' CG1' ' A' ' 432' ' ' VAL . 26.1 t -91.82 133.85 32.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.612 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -96.14 -20.04 18.92 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.822 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.555 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 169.07 176.41 39.11 Favored Glycine 0 N--CA 1.501 2.976 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.03 168.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 45.1 t -107.86 141.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.234 -1.157 . . . . 0.0 109.802 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 337' ' ' ALA . 80.4 mt -101.42 110.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 108.939 170.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.522 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -92.31 119.06 31.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.03 -1.044 . . . . 0.0 109.911 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.543 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -102.62 144.88 30.45 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.418 -0.802 . . . . 0.0 108.871 -175.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.494 ' HG2' ' CB ' ' A' ' 320' ' ' SER . 37.8 mmtm . . . . . 0 C--N 1.3 -1.586 0 O-C-N 120.697 -1.252 . . . . 0.0 110.7 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.525 ' CA ' ' HB3' ' A' ' 351' ' ' SER . 92.5 mt-30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.099 0.476 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -58.69 137.5 57.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.065 -1.022 . . . . 0.0 109.889 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.52 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.45 -34.04 2.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.604 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -161.81 146.06 12.71 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.936 -1.105 . . . . 0.0 110.246 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.632 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 15.9 p90 -136.78 147.79 46.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.818 -1.176 . . . . 0.0 111.656 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.468 HG21 ' HD2' ' A' ' 324' ' ' PRO . 7.5 mt -119.96 142.5 33.42 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.737 -0.602 . . . . 0.0 109.674 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.541 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.69 143.86 42.86 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.667 1.351 . . . . 0.0 111.732 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.606 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.8 153.02 42.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 108.907 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.59 128.6 37.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.631 -1.293 . . . . 0.0 110.12 -172.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.46 0.6 50.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.3 t -135.36 138.33 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.677 -1.484 . . . . 0.0 110.606 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.454 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.5 m-20 -73.58 149.97 41.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.372 -0.83 . . . . 0.0 110.148 176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.541 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -60.85 -37.22 81.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.983 -1.073 . . . . 0.0 110.025 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -59.53 -41.21 89.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.918 -1.114 . . . . 0.0 109.324 176.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 99.3 m -60.09 -42.95 95.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 110.031 173.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.555 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 6.5 tp -60.01 -39.01 84.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 110.531 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.568 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -68.31 -45.45 72.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 110.734 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.8 m-20 -63.48 -48.71 76.53 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.885 -1.134 . . . . 0.0 109.931 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.598 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.62 -31.51 71.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 109.815 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.44 -35.47 65.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 172.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 19.3 mt-30 -74.04 -55.52 6.02 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.545 -0.722 . . . . 0.0 111.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.31 -36.25 79.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.097 -172.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 395' ' ' LYS . . . -67.82 -18.94 65.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.834 174.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 90.2 p -107.95 8.57 28.5 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.244 -0.91 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.536 HD13 ' CB ' ' A' ' 365' ' ' ARG . 32.2 mt -65.37 -45.77 82.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.557 -1.339 . . . . 0.0 109.67 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.44 1.57 49.34 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.869 -170.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -62.58 130.36 44.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.683 -1.26 . . . . 0.0 109.905 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.16 5.17 52.54 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.585 0.707 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.9 p -75.53 151.1 85.01 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.561 -0.712 . . . . 0.0 109.385 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.1 -39.31 92.02 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.669 1.352 . . . . 0.0 109.152 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.09 -28.02 69.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -0.789 . . . . 0.0 110.412 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.43 -37.82 67.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.463 ' O ' HD13 ' A' ' 354' ' ' ILE . 96.3 mtt180 -76.63 -35.98 57.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.24 . . . . 0.0 110.466 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.525 ' HB3' ' CA ' ' A' ' 318' ' ' GLN . 3.7 m -61.66 -38.91 89.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.976 -1.078 . . . . 0.0 110.348 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.527 ' CG2' HD11 ' A' ' 443' ' ' ILE . 79.6 mt -69.24 -48.89 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.029 -1.044 . . . . 0.0 110.494 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.509 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 21.8 t -60.64 -32.17 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.797 -1.189 . . . . 0.0 109.84 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 350' ' ' ARG . 45.4 mt -72.98 -32.29 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.861 -1.149 . . . . 0.0 110.744 171.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.632 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.87 -42.51 89.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 110.053 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.71 93.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.817 . . . . 0.0 110.592 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.54 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 81.0 mttt -71.97 -51.11 23.55 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.691 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.0 pt20 -71.82 -42.54 66.89 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.7 mmt180 -73.09 -43.83 61.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 111.031 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 87.5 m-85 -134.88 -38.73 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 112.052 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.468 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 52.3 t30 -163.01 102.51 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.51 -1.369 . . . . 0.0 111.624 -167.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.54 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 25.5 mt -57.97 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.902 -1.124 . . . . 0.0 108.994 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.527 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.2 tpt180 -145.64 163.02 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.892 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 88.9 mt-10 -134.06 -171.26 2.7 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.04 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.539 ' CD ' ' HB3' ' A' ' 339' ' ' LEU . 1.2 tpt180 -100.47 155.67 17.7 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.175 -0.953 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.1 m-20 -104.68 48.42 0.84 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.196 -0.94 . . . . 0.0 110.968 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.644 ' CG1' ' CZ ' ' A' ' 374' ' ' PHE . 78.0 t -66.79 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 176.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.59 -26.89 66.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 110.979 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -28.3 25.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.599 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 17.8 mt -104.13 -1.75 26.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 22.9 m80 64.29 53.49 1.72 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 110.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.563 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -97.12 175.03 6.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 110.758 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.8 m -115.42 132.18 56.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 110.375 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.644 ' CZ ' ' CG1' ' A' ' 367' ' ' VAL . 70.6 m-85 -87.86 149.13 24.31 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 59.9 t -125.31 100.78 32.04 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.066 -1.021 . . . . 0.0 109.866 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.3 151.93 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.089 1.573 . . . . 0.0 110.404 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 12.8 t80 -62.19 131.75 50.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 110.118 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--N 1.301 -1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.553 175.633 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 94.1 mtt180 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.515 0.674 . . . . 0.0 109.691 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.518 ' CE ' HD13 ' A' ' 401' ' ' ILE . 2.0 ptp -160.92 172.91 16.11 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.155 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.515 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 22.3 p -154.43 165.04 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -179.65 -165.1 33.14 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.772 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.519 ' CD1' ' CG2' ' A' ' 367' ' ' VAL . 6.7 tt -142.51 148.31 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.956 . . . . 0.0 110.04 -175.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.429 ' ND2' HG22 ' A' ' 375' ' ' VAL . 34.5 m-20 -128.28 135.15 49.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.803 -1.186 . . . . 0.0 109.912 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.599 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.9 tt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 109.421 169.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.257 88.3 m-20 -25.88 -63.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.444 0.64 . . . . 0.0 112.251 173.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.436 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 19.9 t-20 -91.45 -7.97 49.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.807 . . . . 0.0 111.723 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.545 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 26.4 mtp180 -143.23 145.53 32.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.669 -1.27 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.91 113.56 10.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.131 . . . . 0.0 109.033 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 10.0 mt -131.8 146.08 33.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.043 -177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.465 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 26.9 mtt180 -135.52 160.74 37.53 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.613 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.515 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.87 138.69 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.485 -0.759 . . . . 0.0 109.185 174.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.497 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -165.36 174.55 41.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.6 m -57.34 150.97 17.04 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.024 -1.28 . . . . 0.0 108.654 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.541 ' CG2' HG13 ' A' ' 420' ' ' VAL . 19.7 t -53.72 -37.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.9 m-20 -64.11 -44.71 91.43 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.392 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.468 ' HB3' ' HE3' ' A' ' 383' ' ' MET . . . -68.44 -50.57 51.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.907 -1.12 . . . . 0.0 110.574 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.527 HG22 ' CG1' ' A' ' 432' ' ' VAL . 25.9 mm -64.9 -43.56 96.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.027 -1.046 . . . . 0.0 110.847 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.588 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 14.0 ttp180 -59.39 -43.17 92.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 62.5 mtp180 -61.92 -36.09 80.32 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 109.433 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.23 -37.48 83.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.203 -0.935 . . . . 0.0 111.291 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 437' ' ' SER . 58.3 t -65.66 -47.86 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.538 -1.351 . . . . 0.0 110.246 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.4 -34.67 78.24 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.795 -1.19 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.27 80.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.901 -1.125 . . . . 0.0 109.962 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 15.6 m-80 -61.7 -27.27 68.58 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.244 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.48 19.41 30.04 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.52 -169.44 17.08 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -143.88 153.92 42.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -1.214 . . . . 0.0 111.378 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.4 p90 -106.97 149.18 38.24 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.626 -0.671 . . . . 0.0 110.255 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.46 123.7 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.809 1.426 . . . . 0.0 110.433 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.33 -33.99 76.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.925 . . . . 0.0 111.053 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 90.7 m-20 -61.04 -32.99 72.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.9 -1.125 . . . . 0.0 108.841 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.606 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 50.8 t -84.1 -42.62 17.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 60.7 m-20 -54.2 -36.99 64.05 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.456 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.6 mm-40 -63.18 -48.82 76.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.254 -1.529 . . . . 0.0 110.228 170.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 16.5 mmtt -56.29 -35.38 67.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.751 -1.218 . . . . 0.0 110.412 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.585 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -59.79 -40.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 109.151 171.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.874 0.845 . . . . 0.0 109.346 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 94.7 mm-40 -66.83 -38.06 85.68 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.644 -0.66 . . . . 0.0 110.666 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.511 ' CG2' ' HB1' ' A' ' 444' ' ' ALA . 65.5 t -63.09 -36.92 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.934 -1.104 . . . . 0.0 110.14 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.14 82.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -70.37 -30.67 67.65 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 111.108 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 423' ' ' VAL . 5.9 pt20 -82.15 -6.35 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.901 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 96.44 22.02 20.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.444 ' HB1' HG11 ' A' ' 423' ' ' VAL . . . -110.19 170.99 7.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 110.026 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.475 ' O ' HD13 ' A' ' 445' ' ' LEU . 1.7 m -113.44 107.02 53.84 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.075 -1.016 . . . . 0.0 110.078 -174.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 420' ' ' VAL . 43.3 Cg_endo -77.38 108.59 2.62 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.538 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 13.7 mt -93.48 139.68 30.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.919 -1.113 . . . . 0.0 108.851 167.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.527 ' CG1' HG22 ' A' ' 401' ' ' ILE . 88.3 t -102.5 135.76 38.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.749 -1.219 . . . . 0.0 109.587 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 395' ' ' LYS . 46.3 t -118.25 135.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 108.758 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -118.26 160.56 17.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.464 ' CB ' HD21 ' A' ' 440' ' ' LEU . 3.9 tt0 -136.67 133.64 36.4 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 171.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.82 -124.2 23.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.494 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 1.9 p -114.19 12.48 17.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.269 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -127.19 171.36 11.5 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 109.843 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.527 HG11 ' CG1' ' A' ' 432' ' ' VAL . 47.4 t -88.17 136.19 23.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.089 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.598 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.6 pp -94.34 -22.33 18.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.46 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.17 177.44 39.34 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.976 169.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.585 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 52.3 t -107.66 142.88 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.178 -1.19 . . . . 0.0 109.811 172.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.527 HD11 ' CG2' ' A' ' 352' ' ' ILE . 78.1 mt -101.43 112.93 36.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.511 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -91.81 119.0 31.23 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 109.869 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.538 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -101.38 144.88 29.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.52 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 13.8 pttt . . . . . 0 C--N 1.299 -1.616 0 O-C-N 120.597 -1.314 . . . . 0.0 110.738 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.528 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.3 mt-30 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.12 0.486 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 355' ' ' LEU . . . -62.03 137.87 58.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.842 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -122.98 -32.87 3.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.48 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -163.22 146.13 10.38 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.348 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.644 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 10.1 p90 -134.24 142.19 47.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.875 -1.141 . . . . 0.0 111.482 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.466 HG22 ' HD2' ' A' ' 324' ' ' PRO . 1.3 mp -113.53 139.71 23.64 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.612 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.543 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.0 143.14 44.11 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.713 1.375 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.597 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -69.06 153.87 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 108.724 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.83 128.26 36.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.68 -1.262 . . . . 0.0 110.378 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 112.67 -22.27 17.23 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 61.2 t -115.84 139.93 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.727 -1.455 . . . . 0.0 111.071 -172.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.444 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.6 m-20 -72.19 148.39 45.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -60.56 -39.28 87.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 110.496 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.447 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.4 ttmt -58.76 -43.6 90.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.713 -1.242 . . . . 0.0 109.641 175.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 93.1 m -56.75 -43.83 81.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.539 ' CD2' ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -58.66 -39.7 81.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.81 -40.99 83.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.074 -1.016 . . . . 0.0 110.817 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -63.66 -50.02 70.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 109.823 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.18 -31.5 71.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 109.711 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.521 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.08 -35.4 64.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.954 . . . . 0.0 109.033 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 20.6 mt-30 -74.79 -55.86 5.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.535 -0.728 . . . . 0.0 110.882 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.15 -35.6 77.54 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.77 -172.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -67.53 -20.49 65.43 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.072 -1.018 . . . . 0.0 110.063 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.456 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.5 p -107.15 9.08 30.39 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.161 -0.962 . . . . 0.0 111.471 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.8 mt -66.2 -44.61 83.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.614 -1.304 . . . . 0.0 109.665 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -97.15 1.87 50.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.919 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.28 130.47 44.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.726 -1.234 . . . . 0.0 109.879 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.48 5.4 51.68 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.551 0.691 . . . . 0.0 109.926 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.5 152.04 83.25 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.643 -0.661 . . . . 0.0 109.478 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.07 -39.71 89.48 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.748 1.394 . . . . 0.0 109.144 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.44 -27.98 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 110.409 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -54.99 -37.26 62.25 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -175.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.448 ' O ' HD11 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.72 -37.36 56.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -1.231 . . . . 0.0 110.513 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.9 m -61.28 -37.95 85.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.952 -1.092 . . . . 0.0 110.358 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.509 ' CG2' HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.78 -49.26 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 25.8 t -61.06 -33.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 358' ' ' GLN . 33.2 mt -72.58 -33.62 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.698 -1.251 . . . . 0.0 110.652 171.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.644 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.01 -40.53 85.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.935 -1.103 . . . . 0.0 110.402 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.06 -45.15 90.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 40.7 mtmt -72.29 -49.51 34.17 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.616 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.5 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.8 pt20 -71.56 -42.77 67.42 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.891 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.5 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.5 mmt180 -72.67 -45.46 58.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.138 -0.976 . . . . 0.0 111.164 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.576 ' CZ ' ' OE2' ' A' ' 330' ' ' GLU . 60.0 m-85 -135.83 -38.68 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.391 -1.323 . . . . 0.0 112.114 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.464 ' OD1' ' HB2' ' A' ' 363' ' ' ARG . 13.8 t-20 -159.99 106.17 1.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.698 -1.251 . . . . 0.0 111.542 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 52.6 mt -57.7 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 0.0 109.323 172.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.536 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.7 tpt180 -128.07 164.0 23.38 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.5 mt-10 -137.98 -159.58 0.97 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.592 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.3 ptt180 -95.98 162.86 13.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.523 -0.736 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -130.34 41.86 3.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 110.465 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 374' ' ' PHE . 42.9 t -72.97 -45.65 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.191 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.29 -27.48 67.21 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.487 -0.758 . . . . 0.0 111.021 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -29.64 27.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.713 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.529 ' CB ' HD12 ' A' ' 388' ' ' ILE . 20.4 mt -103.36 -5.03 23.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 110.662 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 367' ' ' VAL . 73.5 m-70 60.57 51.73 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 0.0 109.752 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.536 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.99 174.62 7.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.81 . . . . 0.0 110.521 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.0 m -117.15 134.89 54.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.342 -0.849 . . . . 0.0 110.58 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.58 ' CE2' HG11 ' A' ' 367' ' ' VAL . 82.3 m-85 -88.58 147.47 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 60.7 t -120.43 100.98 46.91 Favored Pre-proline 0 C--N 1.299 -1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.07 151.39 34.66 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.019 1.537 . . . . 0.0 110.529 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 16.4 t80 -66.44 131.87 47.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.732 175.593 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 81.4 mtm180 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.48 0.657 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.525 ' CE ' HD13 ' A' ' 401' ' ' ILE . 3.0 ptp -157.54 166.3 33.3 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.923 0.868 . . . . 0.0 111.357 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.93 165.0 37.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.63 -166.96 35.61 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 118.923 -1.608 . . . . 0.0 110.733 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 367' ' ' VAL . 3.9 tt -139.45 149.58 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.556 -0.967 . . . . 0.0 110.178 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -127.16 134.84 50.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 0.0 109.798 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -141.51 155.21 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 90.4 m-20 -23.02 -63.04 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.406 0.622 . . . . 0.0 112.49 171.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.45 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 53.7 t30 -95.99 -5.7 40.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.788 . . . . 0.0 111.855 -167.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.543 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.1 mtp180 -144.13 143.96 31.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.741 -1.225 . . . . 0.0 110.434 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.9 mtm -134.72 102.26 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.896 -1.128 . . . . 0.0 109.071 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 8.1 mt -124.31 146.03 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -172.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.472 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 39.9 mtt180 -134.37 159.98 39.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 0.0 110.872 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.65 127.96 32.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -154.33 173.83 32.8 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.319 -1.419 . . . . 0.0 109.566 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.2 m -55.82 149.26 15.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.757 -1.437 . . . . 0.0 108.343 168.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.52 ' CG2' HG11 ' A' ' 420' ' ' VAL . 61.3 t -58.24 -34.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.899 -1.126 . . . . 0.0 109.917 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.2 t0 -61.85 -45.32 94.3 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.503 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -68.84 -51.27 42.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.955 -1.09 . . . . 0.0 110.591 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.525 HD13 ' CE ' ' A' ' 383' ' ' MET . 31.0 mm -64.49 -42.93 96.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 110.742 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.588 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.8 ttp85 -59.31 -43.73 92.61 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 70.6 mtp180 -61.8 -36.57 81.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.403 173.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.544 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -68.45 -36.14 78.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 111.197 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 437' ' ' SER . 52.9 t -65.81 -49.29 78.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.587 -1.32 . . . . 0.0 110.127 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.73 -33.91 76.7 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.949 -1.095 . . . . 0.0 110.285 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.19 79.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.991 -1.068 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.544 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 14.2 m-80 -62.25 -27.17 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.69 19.46 29.41 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -169.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.73 -171.4 18.27 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -144.88 153.68 41.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 111.037 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.3 p90 -108.78 150.7 41.15 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.521 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.93 128.33 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.83 1.437 . . . . 0.0 110.388 -175.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.8 t -67.3 -35.57 79.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.251 -0.905 . . . . 0.0 110.992 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -61.52 -34.06 74.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.912 -1.118 . . . . 0.0 108.816 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.597 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 55.0 t -83.48 -42.6 17.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.956 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.67 -38.22 69.32 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.543 172.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.4 mm-40 -63.77 -47.93 78.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.343 -1.473 . . . . 0.0 110.295 171.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 66.2 mttm -56.76 -35.06 68.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.639 -1.288 . . . . 0.0 110.431 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.9 t -60.04 -41.36 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.879 -1.138 . . . . 0.0 109.371 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.0 -36.0 82.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.812 0.815 . . . . 0.0 109.418 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.52 -37.87 80.41 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.648 -0.658 . . . . 0.0 110.861 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.467 HG12 ' HB1' ' A' ' 428' ' ' ALA . 68.8 t -62.95 -37.56 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.092 . . . . 0.0 110.022 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -40.12 83.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.332 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -68.25 -31.16 70.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 110.972 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -80.87 -3.47 51.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.045 -1.035 . . . . 0.0 109.705 174.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.25 21.77 34.26 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.467 ' HB1' HG12 ' A' ' 423' ' ' VAL . . . -106.63 173.87 6.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.143 . . . . 0.0 109.827 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.512 ' HB ' ' CD1' ' A' ' 445' ' ' LEU . 1.4 m -115.89 106.72 49.34 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.978 -1.076 . . . . 0.0 110.03 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.48 ' CG ' HG12 ' A' ' 420' ' ' VAL . 54.9 Cg_endo -79.85 107.47 2.1 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.91 1.479 . . . . 0.0 110.243 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.538 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.7 mt -91.94 135.61 33.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.898 -1.126 . . . . 0.0 108.482 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 439' ' ' VAL . 88.3 t -99.71 133.96 40.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.747 -1.22 . . . . 0.0 109.341 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 440' ' ' LEU . 25.0 t -113.47 136.78 48.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.8 m -122.19 160.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 121.379 -0.825 . . . . 0.0 109.719 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.452 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.5 tt0 -135.14 130.98 36.27 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.84 -128.1 28.72 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.526 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 84.8 p -106.33 8.7 31.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 111.132 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.479 ' NH1' ' HG3' ' A' ' 438' ' ' ARG . 35.2 ptt85 -122.87 174.23 7.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.59 -1.319 . . . . 0.0 110.257 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 52.9 t -94.49 134.5 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.609 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.2 pp -93.88 -21.22 19.38 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.748 175.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.539 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 169.42 176.55 39.41 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 118.868 -1.634 . . . . 0.0 110.961 168.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 48.9 t -107.99 142.64 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.009 -1.289 . . . . 0.0 109.974 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.521 HD12 ' CB ' ' A' ' 337' ' ' ALA . 82.3 mt -101.38 112.36 34.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.352 -0.842 . . . . 0.0 109.104 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.416 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.28 119.44 31.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.793 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.538 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.4 mt -102.59 146.33 28.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.579 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 1.4 ptpm? . . . . . 0 N--CA 1.491 1.576 0 O-C-N 120.575 -1.328 . . . . 0.0 110.777 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.8 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.168 0.509 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -55.59 139.35 44.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.074 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 39.8 m -123.34 -38.67 2.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.494 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -163.03 148.97 12.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.149 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.684 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 16.1 p90 -134.54 143.57 47.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.759 -1.213 . . . . 0.0 111.802 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.524 HG22 ' CD ' ' A' ' 419' ' ' LYS . 2.6 mt -113.68 143.99 30.54 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.542 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.74 142.72 36.17 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.708 1.372 . . . . 0.0 111.569 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.598 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.98 151.72 43.02 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 108.876 165.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.79 129.04 40.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.684 -1.26 . . . . 0.0 109.983 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.39 -1.8 46.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 52.1 t -136.01 139.07 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.573 -1.545 . . . . 0.0 110.748 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 332' ' ' THR . 6.5 p-10 -73.52 151.89 40.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 110.158 176.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 83.5 tt0 -61.06 -34.7 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.108 -0.995 . . . . 0.0 109.658 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.519 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 109.473 177.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.525 ' CG2' HG11 ' A' ' 328' ' ' VAL . 3.2 m -62.98 -39.14 93.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 175.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 6.2 tp -59.83 -40.12 87.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.048 -1.033 . . . . 0.0 110.412 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -68.02 -43.96 77.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.953 -1.092 . . . . 0.0 110.711 -176.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.5 t0 -63.15 -48.84 76.74 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.878 -1.139 . . . . 0.0 110.068 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.74 -31.05 69.83 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 109.918 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -54.8 -35.99 64.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.134 -0.979 . . . . 0.0 108.884 172.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.531 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.8 mt-30 -75.06 -55.76 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.663 -0.648 . . . . 0.0 111.06 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.545 ' HA ' ' CG ' ' A' ' 342' ' ' LEU . 0.2 OUTLIER -64.97 -32.92 74.87 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.136 -171.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 395' ' ' LYS . . . -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.86 -1.15 . . . . 0.0 110.07 172.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 99.1 p -107.95 11.4 27.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.143 -0.973 . . . . 0.0 111.541 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.5 mt -66.74 -45.17 79.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.722 -1.236 . . . . 0.0 109.859 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -97.07 1.08 49.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.864 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 341' ' ' SER . 12.2 p30 -63.92 130.3 43.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.746 -1.221 . . . . 0.0 109.979 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 4.6 52.97 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.633 0.73 . . . . 0.0 109.85 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.1 p -74.13 152.69 88.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.434 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.75 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.757 1.399 . . . . 0.0 109.227 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.2 mt-10 -64.45 -28.44 69.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.41 -38.53 69.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.443 ' O ' HD13 ' A' ' 354' ' ' ILE . 69.3 mtt85 -77.91 -37.2 48.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -1.157 . . . . 0.0 110.58 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 5.5 m -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 110.338 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 86.0 mt -68.66 -48.6 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.023 -1.048 . . . . 0.0 110.652 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.531 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 25.1 t -60.83 -32.77 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 350' ' ' ARG . 32.9 mt -72.54 -32.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 110.719 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.614 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.84 -41.11 90.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.801 -1.187 . . . . 0.0 110.396 178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.505 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.23 -42.55 99.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.359 -0.838 . . . . 0.0 110.363 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.521 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 73.1 mttt -72.54 -51.54 19.46 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.711 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.547 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.1 pt20 -70.7 -42.4 70.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.547 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.5 mmm180 -74.59 -43.85 53.61 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 111.084 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.684 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 50.6 m-85 -135.2 -39.48 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.658 -1.276 . . . . 0.0 111.986 -169.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.484 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.5 t30 -161.03 105.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.716 -1.24 . . . . 0.0 111.588 -168.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 42.0 mt -57.57 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.899 -1.125 . . . . 0.0 109.075 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.512 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.7 tpt85 -135.09 163.73 29.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.006 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -134.03 -156.25 0.72 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.903 -1.123 . . . . 0.0 110.457 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.582 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.7 ptt85 -97.4 161.43 13.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.505 0.669 . . . . 0.0 110.717 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -128.08 41.77 3.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.305 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.567 HG22 ' CE1' ' A' ' 374' ' ' PHE . 88.5 t -73.49 -49.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.413 -0.804 . . . . 0.0 110.464 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -69.16 -23.87 64.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 111.073 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -31.94 31.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 109.691 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.598 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.2 mt -101.57 -3.61 28.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 110.554 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 371' ' ' HIS . 8.6 m170 63.74 53.93 1.91 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.551 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -96.72 175.01 6.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.6 m -117.45 135.14 54.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.57 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.567 ' CE1' HG22 ' A' ' 367' ' ' VAL . 93.0 m-85 -90.28 143.11 27.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 19.8 t -116.68 101.23 53.66 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.973 . . . . 0.0 109.608 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.13 151.53 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.034 1.544 . . . . 0.0 110.603 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.1 t80 -64.43 132.0 48.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.84 . . . . 0.0 109.664 175.694 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 71.1 mtt85 . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.558 0.694 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 400' ' ' ALA . 2.4 ptp -158.18 167.65 29.21 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.236 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.521 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 24.8 p -155.38 165.19 37.38 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.58 -165.55 33.83 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.618 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.489 HG23 ' HB2' ' A' ' 339' ' ' LEU . 1.5 tt -140.21 149.51 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.631 -0.923 . . . . 0.0 110.104 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -127.23 134.62 50.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 109.756 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.598 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.8 tt -139.82 154.87 24.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.875 -1.141 . . . . 0.0 109.381 171.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 89.8 m-20 -25.53 -63.09 0.06 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.407 0.622 . . . . 0.0 112.251 172.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.444 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 51.2 t30 -91.62 -7.76 49.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 111.692 -168.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.548 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.3 mtp180 -144.7 144.65 31.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.636 -1.29 . . . . 0.0 110.536 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.93 110.46 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.871 -1.143 . . . . 0.0 109.067 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 8.7 mt -131.3 145.91 34.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 110.201 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.475 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 49.6 mtt-85 -134.94 160.95 36.66 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.834 175.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.521 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.52 128.74 33.93 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -157.03 174.31 34.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.4 m -57.27 151.09 16.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.934 -1.333 . . . . 0.0 108.597 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.539 ' CG2' HG13 ' A' ' 420' ' ' VAL . 60.1 t -56.62 -35.1 43.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.075 -1.016 . . . . 0.0 109.894 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.3 t70 -63.03 -46.13 89.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.306 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.523 ' CB ' ' HE2' ' A' ' 383' ' ' MET . . . -68.82 -51.82 36.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.985 -1.072 . . . . 0.0 110.482 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.523 HG23 ' CG1' ' A' ' 432' ' ' VAL . 36.7 mm -63.51 -42.77 97.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 121.126 -0.984 . . . . 0.0 110.64 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.624 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 9.1 ttt180 -60.24 -43.21 96.26 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 52.1 mtp85 -61.62 -35.86 79.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.052 -1.03 . . . . 0.0 109.562 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.505 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.45 -37.72 83.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.187 -0.945 . . . . 0.0 111.269 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 437' ' ' SER . 59.5 t -65.66 -47.7 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.558 -1.339 . . . . 0.0 110.16 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.1 -34.98 78.77 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.795 -1.19 . . . . 0.0 110.28 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -35.92 79.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.505 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.2 m-80 -61.53 -27.47 68.63 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.159 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.43 19.69 29.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.85 -169.38 16.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -143.31 153.52 42.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.094 -1.239 . . . . 0.0 111.488 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.624 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 7.5 p90 -107.5 150.27 39.88 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.772 -0.58 . . . . 0.0 110.202 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.75 123.14 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.904 1.476 . . . . 0.0 110.495 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.82 -32.6 73.99 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.098 -1.002 . . . . 0.0 111.026 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.6 m-20 -61.96 -32.88 73.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.896 -1.128 . . . . 0.0 108.844 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.598 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 50.3 t -83.6 -42.4 17.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.999 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 67.9 m-20 -55.39 -37.13 67.17 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.616 171.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.0 mt-30 -63.75 -48.76 75.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.337 -1.477 . . . . 0.0 110.099 171.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.524 ' CD ' HG22 ' A' ' 323' ' ' ILE . 95.9 mttt -57.22 -34.7 68.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.68 -1.262 . . . . 0.0 110.355 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -59.5 -40.76 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 0.0 109.257 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -66.81 -36.74 83.07 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.873 0.844 . . . . 0.0 109.448 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 83.9 mt-30 -67.48 -36.66 81.56 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.622 -0.673 . . . . 0.0 110.472 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.528 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 71.0 t -62.97 -37.89 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 110.029 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.86 -40.16 83.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.335 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -69.07 -31.06 69.54 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.287 -0.883 . . . . 0.0 110.942 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.25 -3.02 57.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.808 176.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.6 21.94 27.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.528 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -106.43 161.62 14.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -1.097 . . . . 0.0 109.478 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.474 ' O ' HD12 ' A' ' 445' ' ' LEU . 28.2 m -109.02 107.22 59.84 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.03 . . . . 0.0 109.703 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.474 ' HB2' HG11 ' A' ' 420' ' ' VAL . 39.0 Cg_endo -76.26 107.94 2.56 Favored 'Trans proline' 0 C--N 1.298 -2.09 0 O-C-N 123.924 1.486 . . . . 0.0 110.643 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.538 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 14.0 mt -93.04 134.43 35.19 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.825 -1.172 . . . . 0.0 108.677 167.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 439' ' ' VAL . 91.3 t -100.74 134.93 39.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 120.72 -1.238 . . . . 0.0 109.504 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 45.2 t -115.38 137.02 50.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.8 m -117.56 159.59 17.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.373 -0.829 . . . . 0.0 109.676 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.497 ' CB ' HD21 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.17 132.45 35.98 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.28 -129.3 31.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.493 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.93 11.87 27.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -1.218 . . . . 0.0 110.945 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -126.18 170.89 11.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.697 -1.252 . . . . 0.0 109.908 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.526 HG13 ' CG1' ' A' ' 432' ' ' VAL . 22.7 t -90.3 134.77 28.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.342 -0.849 . . . . 0.0 109.874 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.609 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -94.77 -22.12 18.28 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.85 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.563 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.11 176.6 38.71 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.997 169.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 48.0 t -107.77 141.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.216 -1.167 . . . . 0.0 109.887 173.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 337' ' ' ALA . 78.3 mt -101.31 111.71 31.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 108.987 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.22 119.39 31.8 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.85 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.538 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.25 143.22 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.521 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 10.5 mtmt . . . . . 0 C--N 1.3 -1.562 0 O-C-N 120.619 -1.301 . . . . 0.0 110.984 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 24.9 mt-30 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.179 0.514 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -58.66 136.63 57.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.957 -1.09 . . . . 0.0 109.889 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.406 ' C ' HD12 ' A' ' 355' ' ' LEU . 1.8 m -121.24 -34.5 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.203 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -165.61 147.04 7.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.182 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.637 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 12.9 p90 -136.51 147.66 47.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.827 -1.17 . . . . 0.0 111.663 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.526 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -118.85 144.13 35.07 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.728 -0.607 . . . . 0.0 109.593 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.534 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.53 143.85 39.17 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.76 1.4 . . . . 0.0 111.521 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.601 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.39 152.48 42.0 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 108.818 165.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.32 128.55 37.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.682 -1.261 . . . . 0.0 110.126 -172.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.98 -0.77 44.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.4 t -136.49 139.92 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.481 . . . . 0.0 110.73 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.0 m-20 -74.12 152.48 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.534 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 86.1 tt0 -62.61 -40.23 96.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.487 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -59.18 -43.29 92.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.57 -1.331 . . . . 0.0 109.63 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 94.1 m -55.73 -43.55 76.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.857 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.8 tp -59.71 -40.17 87.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.251 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -66.59 -40.79 89.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.92 -1.112 . . . . 0.0 110.917 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 82.3 m-20 -64.62 -50.2 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.895 -1.128 . . . . 0.0 109.766 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.7 -30.79 70.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.951 -1.093 . . . . 0.0 109.636 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.42 -35.54 65.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.103 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 356' ' ' ALA . 14.3 mt-30 -73.43 -55.69 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.551 -0.718 . . . . 0.0 111.06 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -62.97 -35.72 81.1 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.559 -1.257 . . . . 0.0 109.894 -172.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.445 ' HB1' ' HG2' ' A' ' 395' ' ' LYS . . . -66.72 -20.73 66.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.088 -1.007 . . . . 0.0 110.053 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.464 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 94.2 p -107.03 8.84 30.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.121 -0.987 . . . . 0.0 111.579 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.585 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 41.4 mt -66.5 -44.47 82.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.531 -1.355 . . . . 0.0 109.584 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.76 1.0 50.36 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 341' ' ' SER . 12.5 p30 -63.67 130.53 44.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.714 -1.241 . . . . 0.0 109.979 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.62 5.61 51.03 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.511 0.672 . . . . 0.0 109.845 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.35 150.17 79.69 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.652 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -53.68 -38.21 84.37 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.678 1.357 . . . . 0.0 109.172 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.23 -28.55 69.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 110.393 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.82 -36.93 67.51 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.456 ' O ' HD12 ' A' ' 354' ' ' ILE . 42.2 mmt180 -76.65 -37.93 55.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.118 -1.225 . . . . 0.0 110.525 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.523 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.41 -38.17 86.14 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.962 -1.086 . . . . 0.0 110.372 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 86.0 mt -68.55 -49.42 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.005 -1.059 . . . . 0.0 110.594 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.524 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 23.9 t -60.56 -33.67 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.1 mt -72.23 -33.3 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.689 -1.257 . . . . 0.0 110.68 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.637 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.57 -40.8 88.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.534 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -61.92 -43.1 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 110.273 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 83.3 mttt -69.64 -48.73 58.87 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.745 -174.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 10.2 pt20 -70.75 -43.46 68.78 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 110.499 -173.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.2 mmm180 -73.98 -46.09 45.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 111.312 -173.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 330' ' ' GLU . 27.8 m-85 -135.67 -35.97 0.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.666 -167.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.513 ' ND2' ' HD3' ' A' ' 363' ' ' ARG . 55.9 t-20 -158.59 93.89 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.512 -1.368 . . . . 0.0 111.808 -169.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.532 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -61.35 95.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.987 -1.07 . . . . 0.0 110.178 172.087 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.513 ' HD3' ' ND2' ' A' ' 361' ' ' ASN . 30.8 ptt85 -150.01 -179.06 6.86 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 363' ' ' ARG . 22.2 pt-20 -124.78 -157.39 0.77 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 110.531 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.585 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.9 ptt180 -90.62 165.59 13.65 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.743 -0.598 . . . . 0.0 110.492 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -123.99 38.63 4.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.422 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 374' ' ' PHE . 43.9 t -74.34 -49.82 30.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 110.376 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -67.75 -25.1 65.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 111.039 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.08 -30.09 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.99 . . . . 0.0 109.8 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.596 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 19.3 mt -103.65 -4.19 24.12 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 110.672 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 31.1 m80 62.84 53.94 2.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.427 -0.796 . . . . 0.0 110.168 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.552 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.9 175.03 6.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 110.606 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.9 m -116.67 134.27 55.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.573 ' CE1' HG22 ' A' ' 367' ' ' VAL . 84.2 m-85 -88.89 147.96 24.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 25.9 t -122.93 100.97 39.61 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.13 -0.981 . . . . 0.0 109.604 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.64 151.15 40.39 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.983 1.518 . . . . 0.0 110.475 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.16 131.55 46.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 110.07 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 175.687 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.523 0.678 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.52 ' CE ' HD12 ' A' ' 401' ' ' ILE . 2.4 ptp -161.0 169.34 22.75 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.408 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 5.2 p -156.88 165.3 36.57 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.78 -165.18 33.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.523 HD13 ' CG2' ' A' ' 367' ' ' VAL . 3.3 tt -138.82 149.08 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.698 -0.884 . . . . 0.0 110.125 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -127.79 135.15 49.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 109.654 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.596 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.8 tt -140.06 154.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.875 -1.14 . . . . 0.0 109.389 171.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.6 -63.17 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.434 0.635 . . . . 0.0 112.242 172.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.444 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 40.8 t-20 -91.66 -7.89 48.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.51 -0.744 . . . . 0.0 111.755 -168.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.552 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 31.2 mtp180 -144.19 145.67 32.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.707 -1.246 . . . . 0.0 110.605 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.4 mtt -135.49 110.8 9.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.903 -1.123 . . . . 0.0 108.999 169.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.582 ' CD1' ' CB ' ' A' ' 336' ' ' ALA . 8.9 mt -130.35 146.13 34.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.989 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.492 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.4 mmt85 -134.13 159.69 40.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.109 -0.994 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.525 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.1 OUTLIER -132.61 137.55 47.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -164.37 174.36 40.42 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.267 -1.444 . . . . 0.0 109.625 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -56.94 149.93 17.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.278 . . . . 0.0 108.684 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.541 ' CG2' HG11 ' A' ' 420' ' ' VAL . 22.8 t -55.03 -37.62 43.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 109.975 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.7 m-20 -64.24 -44.35 92.12 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.221 -0.924 . . . . 0.0 110.343 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.467 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.21 -50.24 55.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.963 -1.085 . . . . 0.0 110.662 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.523 HG21 ' CG1' ' A' ' 432' ' ' VAL . 30.9 mm -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.746 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.5 ttp85 -59.85 -42.92 94.68 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.1 mtt180 -61.47 -36.3 80.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.576 173.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.506 ' CE1' HG22 ' A' ' 434' ' ' VAL . 3.5 t-80 -66.61 -38.5 87.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 111.245 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 437' ' ' SER . 71.3 t -65.47 -47.28 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.623 -1.298 . . . . 0.0 110.268 178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.48 -34.8 78.56 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.785 -1.197 . . . . 0.0 110.436 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.933 -1.104 . . . . 0.0 109.951 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.489 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 27.1 m-80 -62.04 -27.1 68.65 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.26 18.93 31.94 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -169.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -111.58 -169.95 18.73 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -144.1 153.69 42.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -1.223 . . . . 0.0 111.461 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 7.7 p90 -108.88 150.43 40.86 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.719 -0.613 . . . . 0.0 110.143 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.547 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.9 124.01 8.36 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.845 1.445 . . . . 0.0 110.488 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.32 -32.77 73.95 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.928 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.8 m-20 -61.65 -32.84 73.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.863 -1.148 . . . . 0.0 108.872 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.601 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 50.0 t -83.76 -42.55 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.391 -0.818 . . . . 0.0 110.975 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.581 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 68.8 m-20 -55.17 -37.2 66.72 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.584 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.8 mm-40 -63.94 -48.76 75.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.254 -1.529 . . . . 0.0 110.232 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.526 ' CD ' HG21 ' A' ' 323' ' ' ILE . 43.2 mttt -57.56 -34.27 69.02 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.638 -1.289 . . . . 0.0 110.416 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.591 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -59.21 -41.24 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.206 171.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -66.46 -36.22 82.22 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.921 0.867 . . . . 0.0 109.418 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.45 -37.63 83.25 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 110.798 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.525 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 68.8 t -63.31 -37.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.005 -1.059 . . . . 0.0 110.088 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.12 84.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.329 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -68.51 -31.18 70.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.394 -0.816 . . . . 0.0 110.889 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.508 ' NE2' ' HE2' ' A' ' 446' ' ' LYS . 2.0 tt0 -82.59 -3.01 55.42 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.852 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.85 27.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.525 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -107.67 163.18 13.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -1.064 . . . . 0.0 109.64 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 445' ' ' LEU . 53.7 m -110.12 107.12 58.66 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.809 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.515 ' CG ' HG12 ' A' ' 420' ' ' VAL . 37.5 Cg_endo -75.82 108.22 2.64 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 123.979 1.515 . . . . 0.0 110.773 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 12.3 mt -92.71 135.05 34.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.854 -1.154 . . . . 0.0 108.599 166.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 439' ' ' VAL . 97.9 t -100.08 136.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.651 -1.28 . . . . 0.0 109.568 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.469 ' O ' HD12 ' A' ' 440' ' ' LEU . 44.5 t -117.33 136.96 52.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 108.992 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -117.75 160.03 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.497 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.07 132.08 35.7 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -128.65 31.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.496 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.11 11.36 27.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.185 -1.185 . . . . 0.0 110.968 -179.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -123.45 170.78 10.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.633 -1.292 . . . . 0.0 109.925 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 432' ' ' VAL . 22.5 t -91.39 134.03 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.7 pp -94.79 -21.71 18.54 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.862 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.99 177.02 38.97 Favored Glycine 0 N--CA 1.499 2.896 0 C-N-CA 118.847 -1.644 . . . . 0.0 110.985 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.591 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 47.1 t -107.78 142.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.183 -1.187 . . . . 0.0 109.819 173.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.515 HD11 ' CB ' ' A' ' 337' ' ' ALA . 80.1 mt -101.29 111.28 30.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 108.94 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.52 ' HB3' ' CG1' ' A' ' 423' ' ' VAL . . . -91.55 118.93 31.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.99 -1.069 . . . . 0.0 109.7 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.536 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -99.72 143.43 29.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.508 ' HE2' ' NE2' ' A' ' 426' ' ' GLN . 53.1 mttt . . . . . 0 C--N 1.3 -1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 111.146 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 14.4 pt20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.188 0.518 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -60.75 137.59 58.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.636 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -118.49 -35.79 3.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 110.121 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.613 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 14.3 p90 -135.69 142.76 45.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.821 -1.174 . . . . 0.0 111.676 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.513 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.6 mp -114.38 144.59 32.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.725 -0.61 . . . . 0.0 109.706 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.72 143.49 37.64 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.738 1.388 . . . . 0.0 111.448 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.599 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.94 152.0 42.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.821 165.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -57.59 128.61 37.9 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 110.11 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.17 -1.33 43.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.6 t -136.56 140.03 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.706 -1.467 . . . . 0.0 110.751 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.23 152.42 39.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CD ' ' CZ ' ' A' ' 360' ' ' PHE . 85.1 tt0 -62.3 -40.33 95.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.459 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.2 -43.33 92.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.6 -1.313 . . . . 0.0 109.639 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.456 ' HB ' HG11 ' A' ' 328' ' ' VAL . 93.7 m -55.97 -43.81 77.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 173.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.57 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.9 tp -59.21 -39.45 82.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.319 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.16 -41.31 86.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.11 . . . . 0.0 110.777 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.3 m-20 -63.87 -50.03 70.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.926 -1.109 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.49 -31.13 70.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.981 -1.074 . . . . 0.0 109.722 176.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.21 -35.66 65.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.912 172.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 14.6 mt-30 -74.77 -55.84 5.42 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.583 -0.698 . . . . 0.0 110.9 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -63.72 -34.46 77.93 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.846 -171.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 395' ' ' LYS . . . -67.04 -21.4 65.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.934 -1.104 . . . . 0.0 110.076 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.464 ' OG ' HG22 ' A' ' 353' ' ' VAL . 77.3 p -107.27 10.4 29.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.16 -0.963 . . . . 0.0 111.538 -174.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.573 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 45.9 mt -66.34 -43.78 85.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.55 -1.344 . . . . 0.0 109.502 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -97.25 0.38 48.09 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.931 -170.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.3 p30 -62.37 130.44 45.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.742 -1.224 . . . . 0.0 109.872 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.54 5.39 51.66 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.6 0.714 . . . . 0.0 109.886 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.45 151.91 83.31 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.52 -0.737 . . . . 0.0 109.451 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.64 -39.53 90.54 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.643 1.338 . . . . 0.0 109.09 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.56 -27.83 69.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.503 -0.748 . . . . 0.0 110.436 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.66 -37.94 70.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.453 ' O ' HD13 ' A' ' 354' ' ' ILE . 90.2 mtt-85 -76.14 -36.59 58.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.018 -1.284 . . . . 0.0 110.376 172.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 29.3 p -62.72 -37.22 85.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.957 -1.089 . . . . 0.0 110.377 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 87.6 mt -68.53 -49.48 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.536 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.528 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 26.2 t -61.24 -33.61 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 0.0 110.148 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 350' ' ' ARG . 29.9 mt -72.2 -32.9 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.601 -1.312 . . . . 0.0 110.523 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.613 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.43 -40.21 90.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.832 -1.168 . . . . 0.0 110.528 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.474 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.03 -43.18 99.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 77.3 mttt -71.65 -48.53 47.13 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.769 -175.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.549 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -70.26 -42.8 71.69 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.587 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.3 mmm180 -74.23 -46.51 41.25 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 111.214 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.548 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 76.4 m-85 -136.28 -34.45 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.252 -1.379 . . . . 0.0 112.564 -169.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 363' ' ' ARG . 18.0 t-20 -160.11 98.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.441 -1.412 . . . . 0.0 111.763 -168.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 5.5 mp -58.96 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.029 -1.045 . . . . 0.0 109.705 171.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.5 tpt180 -142.15 163.45 32.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.86 . . . . 0.0 109.344 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.475 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.0 mt-10 -127.37 -153.81 0.59 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.01 -1.056 . . . . 0.0 110.629 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.573 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.2 ptt-85 -95.51 163.58 13.16 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.638 -0.664 . . . . 0.0 110.733 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -128.19 40.71 3.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.553 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.568 HG23 ' CE1' ' A' ' 374' ' ' PHE . 61.6 t -73.47 -46.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.192 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.79 -26.6 66.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.465 -0.772 . . . . 0.0 111.11 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.44 -30.66 29.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.107 -0.995 . . . . 0.0 109.745 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.527 ' CB ' HD13 ' A' ' 388' ' ' ILE . 20.6 mt -101.41 -3.96 27.76 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.541 -0.724 . . . . 0.0 110.636 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 367' ' ' VAL . 50.7 m80 59.3 52.51 5.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.957 . . . . 0.0 109.795 -175.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.533 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.61 174.6 7.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 110.378 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.9 m -116.38 134.94 54.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 110.473 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.568 ' CE1' HG23 ' A' ' 367' ' ' VAL . 88.0 m-85 -89.73 147.39 23.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.33 101.18 46.96 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -54.54 153.7 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.003 1.528 . . . . 0.0 110.545 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.556 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.7 t80 -70.68 134.8 47.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.829 . . . . 0.0 110.383 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.855 . . . . 0.0 109.832 174.454 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.515 0.674 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.556 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.9 ptp -165.45 170.98 13.86 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.795 0.807 . . . . 0.0 111.287 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.521 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 49.6 p -155.54 165.53 36.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.29 -164.28 31.6 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.756 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.517 HD11 ' CG2' ' A' ' 367' ' ' VAL . 2.2 tt -142.45 149.48 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.623 -0.928 . . . . 0.0 110.154 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -127.29 136.32 51.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 109.755 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.9 tt -140.8 155.24 22.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.993 -1.067 . . . . 0.0 109.221 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.5 m-20 -21.96 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.452 0.644 . . . . 0.0 112.62 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.446 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.9 t-20 -95.99 -7.01 37.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.449 -0.782 . . . . 0.0 111.858 -167.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.547 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 29.8 mtp180 -143.64 146.18 33.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.661 -1.275 . . . . 0.0 110.639 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -136.15 104.3 5.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.863 -1.148 . . . . 0.0 109.119 170.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 8.0 mt -125.05 146.07 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.996 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.475 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 23.6 mmt85 -134.29 159.55 40.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.011 . . . . 0.0 110.324 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.521 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.43 126.03 30.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.464 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -152.42 174.33 31.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.9 m -56.21 151.33 12.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.973 -1.31 . . . . 0.0 108.646 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.545 ' CG2' HG13 ' A' ' 420' ' ' VAL . 23.0 t -54.57 -37.65 39.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.915 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.2 m-20 -64.62 -44.99 88.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.3 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.493 ' CB ' ' HE2' ' A' ' 383' ' ' MET . . . -67.14 -48.95 66.52 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.944 -1.097 . . . . 0.0 110.635 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.522 HG22 ' CG1' ' A' ' 432' ' ' VAL . 39.9 mm -66.53 -44.31 90.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.029 -1.045 . . . . 0.0 111.007 -176.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.582 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.3 ttp180 -59.52 -43.08 93.53 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 92.2 mtt180 -61.69 -37.05 82.68 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.04 -1.038 . . . . 0.0 109.579 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.2 t-80 -67.3 -36.47 81.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 111.273 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 437' ' ' SER . 54.7 t -65.54 -49.13 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.6 -1.313 . . . . 0.0 110.161 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.47 -34.34 77.55 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.943 -1.098 . . . . 0.0 110.371 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.74 78.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.111 . . . . 0.0 109.982 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.532 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 18.0 m-80 -62.08 -27.05 68.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.429 -0.794 . . . . 0.0 109.155 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.83 19.35 29.39 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.89 -169.66 16.88 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -143.09 153.36 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.139 -1.212 . . . . 0.0 111.395 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.582 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 7.9 p90 -108.17 149.32 39.04 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.635 -0.665 . . . . 0.0 110.182 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.1 125.14 9.06 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.873 1.459 . . . . 0.0 110.531 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.09 -32.32 72.55 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.6 m-20 -63.24 -31.81 73.06 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.878 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.599 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 46.6 t -83.57 -42.77 17.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.88 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.58 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 69.1 m-20 -55.08 -36.34 65.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.729 -1.232 . . . . 0.0 109.648 171.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.39 -50.13 68.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.434 -1.416 . . . . 0.0 109.639 173.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.513 ' CD ' HG21 ' A' ' 323' ' ' ILE . 85.9 mttt -56.83 -34.53 67.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.757 -1.215 . . . . 0.0 110.286 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -58.99 -41.6 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 171.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.07 -36.18 82.52 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.955 0.883 . . . . 0.0 109.409 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.5 mm-40 -67.25 -38.25 84.86 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.725 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.545 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 68.2 t -62.61 -37.13 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.074 . . . . 0.0 110.125 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.29 84.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -68.18 -32.38 72.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 0.0 110.983 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -82.73 -2.89 55.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.77 22.56 30.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.545 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -104.19 163.5 12.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -1.143 . . . . 0.0 109.538 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.469 ' O ' HD11 ' A' ' 445' ' ' LEU . 18.5 m -110.5 107.0 58.26 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.058 -1.026 . . . . 0.0 109.855 -175.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.518 ' CB ' HG11 ' A' ' 420' ' ' VAL . 33.6 Cg_endo -74.82 107.93 2.59 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 O-C-N 123.984 1.518 . . . . 0.0 110.73 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.533 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 13.3 mt -92.69 132.76 36.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 108.509 166.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.528 ' CG1' HG11 ' A' ' 439' ' ' VAL . 99.8 t -100.04 134.98 37.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 O-C-N 120.746 -1.222 . . . . 0.0 109.512 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.475 ' O ' HD13 ' A' ' 440' ' ' LEU . 40.8 t -114.73 138.46 44.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.116 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -119.56 160.55 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 109.655 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.34 129.64 33.74 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.2 -131.79 30.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -167.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.532 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 79.6 p -102.93 7.75 39.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -1.23 . . . . 0.0 111.071 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -118.4 170.71 8.69 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.647 -1.283 . . . . 0.0 110.127 -175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.528 HG11 ' CG1' ' A' ' 432' ' ' VAL . 24.6 t -93.58 134.48 31.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.336 -0.853 . . . . 0.0 109.719 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.4 pp -95.3 -21.72 18.23 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.772 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.7 176.77 39.16 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.003 169.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 44.4 t -107.74 141.45 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.153 -1.204 . . . . 0.0 109.923 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 337' ' ' ALA . 78.7 mt -101.45 111.06 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 108.986 170.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.512 ' HB2' ' CG1' ' A' ' 423' ' ' VAL . . . -91.94 119.35 31.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.956 -1.09 . . . . 0.0 109.801 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.533 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -100.09 142.75 31.14 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.463 ' HG2' ' HB1' ' A' ' 428' ' ' ALA . 51.0 mttt . . . . . 0 C--N 1.298 -1.653 0 O-C-N 120.848 -1.158 . . . . 0.0 111.078 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.9 tt0 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.136 0.493 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 355' ' ' LEU . . . -57.05 139.76 51.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.1 -1.0 . . . . 0.0 109.946 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.517 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 74.5 m -122.69 -36.71 2.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -165.7 150.82 8.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.054 -1.029 . . . . 0.0 110.184 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.687 ' CZ ' ' CD1' ' A' ' 360' ' ' PHE . 13.4 p90 -135.13 158.26 44.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.839 -1.163 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.457 HG21 ' HD2' ' A' ' 324' ' ' PRO . 1.2 mp -134.17 139.04 31.85 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.534 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.11 144.82 53.32 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.65 1.342 . . . . 0.0 111.824 -171.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.608 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -69.32 152.47 44.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 108.768 165.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -57.79 128.99 39.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.658 -1.276 . . . . 0.0 110.269 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 109.54 -21.39 26.12 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 53.3 t -114.0 138.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.393 . . . . 0.0 110.907 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.0 m-20 -72.21 145.08 48.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 109.891 173.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.545 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.3 tt0 -59.87 -34.01 72.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.917 -1.114 . . . . 0.0 109.868 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.51 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.51 -42.41 87.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 109.25 175.125 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 99.5 m -61.59 -42.76 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.3 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.8 tp -60.28 -39.8 88.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.451 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.74 -43.3 80.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.083 . . . . 0.0 110.772 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 47.8 t0 -63.41 -49.9 71.93 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.912 -1.117 . . . . 0.0 110.055 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.88 -31.02 70.53 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.8 -35.78 66.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.079 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.0 mt-30 -73.3 -55.75 5.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.565 -0.709 . . . . 0.0 110.996 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -65.1 -33.83 76.96 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.205 -171.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -67.52 -20.89 65.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.067 173.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 91.2 p -107.29 10.65 29.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.225 -0.922 . . . . 0.0 111.521 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.3 mt -66.66 -45.48 78.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.546 -1.346 . . . . 0.0 109.73 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -96.59 0.14 49.53 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.986 -171.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 341' ' ' SER . 11.0 p30 -62.93 130.66 45.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.214 . . . . 0.0 109.898 176.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.67 5.32 51.73 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.516 0.674 . . . . 0.0 109.864 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.05 150.87 83.69 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 109.467 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.51 -38.32 83.34 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.708 1.373 . . . . 0.0 109.132 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.53 -28.6 69.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.404 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.27 -37.83 75.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -77.29 -38.64 50.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.095 -1.238 . . . . 0.0 110.631 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.8 m -62.35 -37.8 87.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.919 -1.113 . . . . 0.0 110.466 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 87.9 mt -68.13 -48.66 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.936 -1.103 . . . . 0.0 110.492 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 24.4 t -60.62 -33.17 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.23 . . . . 0.0 109.772 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.455 HG21 ' OE1' ' A' ' 358' ' ' GLN . 38.7 mt -72.76 -31.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.79 -1.194 . . . . 0.0 110.722 171.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.627 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.9 -41.5 91.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.866 -1.146 . . . . 0.0 110.242 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.516 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.36 -43.18 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 110.422 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.526 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 78.8 mttt -72.08 -51.23 22.58 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.635 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -71.17 -42.61 68.86 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.508 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.552 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.5 mmt180 -73.66 -44.31 57.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 111.101 -172.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 81.6 m-85 -135.31 -37.57 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.623 -1.298 . . . . 0.0 112.159 -169.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.481 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 60.9 t-20 -162.68 105.38 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.489 -1.382 . . . . 0.0 111.55 -168.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 46.9 mt -57.56 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.858 -1.151 . . . . 0.0 109.056 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 335' ' ' ASP . 56.5 ttt180 -129.21 168.14 16.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.44 ' N ' ' HG2' ' A' ' 363' ' ' ARG . 87.5 mt-10 -139.69 -157.82 0.8 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.8 ptt-85 -98.1 165.45 11.89 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.627 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.437 ' HB3' HD13 ' A' ' 370' ' ' LEU . 89.9 m-20 -131.47 42.47 3.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 110.56 175.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.623 ' CG2' ' CZ ' ' A' ' 374' ' ' PHE . 47.6 t -72.19 -45.77 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 0.0 110.152 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.34 -23.91 64.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.862 . . . . 0.0 111.166 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -31.85 30.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.778 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 388' ' ' ILE . 9.3 mt -104.42 -2.77 24.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.536 -0.727 . . . . 0.0 110.624 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 367' ' ' VAL . 81.7 m-70 59.25 52.37 6.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.698 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -91.79 174.49 7.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 110.308 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.6 m -118.46 135.5 54.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.478 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.623 ' CZ ' ' CG2' ' A' ' 367' ' ' VAL . 90.8 m-85 -90.36 145.22 25.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 9.1 t -118.45 101.36 51.04 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.776 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.8 Cg_endo -54.72 154.23 21.47 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.079 1.568 . . . . 0.0 110.524 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.58 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.1 t80 -69.66 134.64 48.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.37 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 174.841 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.505 0.669 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.58 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.1 ptp -165.15 171.26 13.96 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.822 0.82 . . . . 0.0 111.225 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.52 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 47.9 p -155.92 165.32 36.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.58 -165.57 34.3 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.704 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.521 HD11 ' CG2' ' A' ' 367' ' ' VAL . 4.5 tt -139.82 152.57 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.902 . . . . 0.0 110.232 -175.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -127.24 138.4 53.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.045 -1.034 . . . . 0.0 109.458 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.549 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -140.85 154.36 21.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.842 -1.161 . . . . 0.0 109.362 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.267 89.0 m-20 -21.37 -61.83 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.438 0.637 . . . . 0.0 112.53 172.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.46 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 51.9 t-20 -98.99 -7.14 27.34 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.512 -0.742 . . . . 0.0 111.901 -166.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 15.9 mtp180 -142.91 147.97 36.18 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.681 -1.262 . . . . 0.0 110.573 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.6 mtm -134.98 111.07 9.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.942 -1.099 . . . . 0.0 108.995 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 8.1 mt -129.52 146.09 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.557 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 31.2 mtt85 -136.76 161.92 34.63 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.16 -0.962 . . . . 0.0 111.035 176.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.52 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.88 128.24 32.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -153.78 174.34 32.34 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 37.7 m -56.49 150.98 14.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.848 -1.384 . . . . 0.0 108.526 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 420' ' ' VAL . 63.2 t -56.82 -35.33 46.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -0.999 . . . . 0.0 109.81 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.2 t0 -63.07 -46.75 85.97 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.315 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.52 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -67.18 -49.13 65.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.065 -1.022 . . . . 0.0 110.514 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.522 HG21 ' CG1' ' A' ' 432' ' ' VAL . 41.7 mm -66.41 -43.84 90.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.099 -1.001 . . . . 0.0 110.931 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.585 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 7.8 ttp180 -59.86 -43.58 94.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.211 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 14.6 mtp-105 -61.8 -36.54 81.41 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.459 173.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.557 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 3.0 t-80 -68.69 -35.55 77.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.231 -0.918 . . . . 0.0 111.378 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 437' ' ' SER . 52.1 t -66.06 -50.42 69.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.533 -1.354 . . . . 0.0 110.171 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.966 -1.084 . . . . 0.0 110.37 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.26 76.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.924 -1.11 . . . . 0.0 110.085 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.547 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.9 m-80 -62.58 -26.81 68.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.132 174.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 98.12 17.83 28.56 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.43 -169.04 16.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -142.87 153.62 43.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.112 -1.228 . . . . 0.0 111.351 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 9.5 p90 -105.82 147.64 35.1 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.272 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.554 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.95 123.95 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.808 1.425 . . . . 0.0 110.407 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.15 -32.73 74.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 111.033 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.9 m-20 -61.92 -33.04 73.53 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 0.0 108.963 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 52.8 t -83.63 -42.83 17.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.37 -0.832 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.4 m-20 -54.55 -37.46 65.46 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.76 -1.213 . . . . 0.0 109.507 171.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.5 mm-40 -63.38 -48.18 78.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.265 -1.522 . . . . 0.0 110.077 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 20.1 mttp -56.64 -35.24 68.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -59.78 -40.68 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.979 -1.075 . . . . 0.0 109.285 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.76 -36.25 82.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.842 0.829 . . . . 0.0 109.46 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -67.37 -36.81 82.1 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.63 -0.669 . . . . 0.0 110.62 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 72.0 t -62.88 -37.9 80.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.954 -1.091 . . . . 0.0 110.009 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.6 -40.01 84.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 0.0 110.385 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -68.11 -31.53 71.2 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.282 -0.886 . . . . 0.0 110.955 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.55 -3.11 55.47 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.783 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.51 22.14 29.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.53 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -106.34 163.48 12.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -1.079 . . . . 0.0 109.541 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.47 ' O ' HD12 ' A' ' 445' ' ' LEU . 1.3 m -109.98 107.12 58.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.525 ' CG ' HG13 ' A' ' 420' ' ' VAL . 40.1 Cg_endo -75.79 108.28 2.65 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 123.97 1.511 . . . . 0.0 110.589 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.541 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 13.9 mt -92.81 134.77 34.74 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 108.598 167.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.53 ' CG1' HG13 ' A' ' 439' ' ' VAL . 96.8 t -100.7 134.27 41.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.754 -1.216 . . . . 0.0 109.428 176.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 42.5 t -114.82 137.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 176.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.1 m -118.09 160.27 17.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.413 -0.804 . . . . 0.0 109.721 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.462 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.39 130.77 35.39 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.07 -132.32 30.86 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.52 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 82.9 p -102.75 7.52 39.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.081 -1.247 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -120.05 171.09 8.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.661 -1.275 . . . . 0.0 110.142 -175.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.53 HG13 ' CG1' ' A' ' 432' ' ' VAL . 26.0 t -92.25 133.4 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.418 -0.801 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.612 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.6 pp -92.93 -22.2 19.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.29 177.62 39.01 Favored Glycine 0 N--CA 1.5 2.939 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.987 169.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 51.2 t -107.81 142.95 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.22 -1.165 . . . . 0.0 110.075 174.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.518 HD13 ' CB ' ' A' ' 337' ' ' ALA . 75.8 mt -101.79 112.62 35.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 108.974 170.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.518 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -93.13 119.31 32.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.987 -1.071 . . . . 0.0 109.891 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.541 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -103.17 144.17 31.66 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.396 -0.815 . . . . 0.0 108.808 -175.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.517 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 16.2 mtmt . . . . . 0 C--N 1.3 -1.562 0 O-C-N 120.585 -1.322 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.2 mt-30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.113 0.482 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -59.93 138.64 57.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.07 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -122.31 -37.62 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 110.433 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.458 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.1 tt0 -162.84 148.32 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.187 -178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.685 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 14.1 p90 -133.95 142.88 47.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.803 -1.186 . . . . 0.0 111.704 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.476 HG21 ' HD2' ' A' ' 324' ' ' PRO . 4.4 mt -113.84 141.57 26.37 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.534 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.64 142.73 40.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.656 1.345 . . . . 0.0 111.528 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.592 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -70.83 151.13 45.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 108.856 165.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.46 128.88 39.28 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.744 -1.222 . . . . 0.0 110.098 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.66 -1.35 45.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.6 t -135.68 137.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.645 -1.503 . . . . 0.0 110.649 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.8 m-20 -72.74 150.44 42.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.534 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.4 tt0 -60.87 -38.04 84.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.462 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.0 OUTLIER -59.88 -40.3 88.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.929 -1.107 . . . . 0.0 109.224 177.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.452 ' HB ' HG13 ' A' ' 328' ' ' VAL . 98.9 m -60.51 -43.13 97.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 110.0 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.544 ' CD2' ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.12 -38.43 83.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.373 -0.83 . . . . 0.0 110.502 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.75 -44.42 77.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.706 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 89.9 m-20 -63.69 -48.74 75.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 110.017 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.604 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.61 -32.03 72.47 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.03 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.22 -36.0 65.5 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.011 172.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 15.2 mt-30 -74.1 -55.67 5.82 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.546 -0.721 . . . . 0.0 111.064 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -64.4 -33.96 77.07 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.066 -171.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -67.89 -20.31 65.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.982 -1.074 . . . . 0.0 109.991 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.469 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 96.3 p -107.62 10.42 29.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.134 -0.979 . . . . 0.0 111.502 -174.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.589 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 47.3 mt -66.53 -45.04 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.622 -1.299 . . . . 0.0 109.821 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.03 2.05 50.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.842 -170.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 341' ' ' SER . 13.9 p30 -65.09 130.29 42.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.798 -1.189 . . . . 0.0 110.061 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.7 4.47 52.97 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.574 0.702 . . . . 0.0 109.887 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.0 p -74.47 150.84 87.21 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.572 -0.705 . . . . 0.0 109.426 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.78 -40.74 78.96 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.723 1.381 . . . . 0.0 109.358 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.65 -28.07 69.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.1 -38.11 65.53 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.449 ' O ' HD13 ' A' ' 354' ' ' ILE . 68.5 mtt85 -77.4 -37.3 52.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.239 . . . . 0.0 110.501 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.2 m -61.36 -37.83 84.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.069 . . . . 0.0 110.324 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.489 ' CG2' HD13 ' A' ' 443' ' ' ILE . 83.1 mt -69.55 -49.38 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.631 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.527 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 23.4 t -59.9 -32.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.865 -1.147 . . . . 0.0 109.813 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 350' ' ' ARG . 34.6 mt -72.74 -34.22 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 110.637 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.641 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.06 -40.25 80.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.817 -1.177 . . . . 0.0 110.239 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.461 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.02 -45.77 87.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.522 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 48.2 mtmt -72.02 -49.25 38.5 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.844 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.549 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 10.6 pt20 -70.87 -42.96 69.38 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.668 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.3 mmt180 -74.42 -45.36 47.04 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 111.145 -171.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 90.9 m-85 -135.57 -37.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.446 -1.301 . . . . 0.0 112.218 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 363' ' ' ARG . 51.2 t30 -162.91 105.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.494 -1.379 . . . . 0.0 111.652 -168.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.522 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.5 OUTLIER -57.87 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.754 -1.216 . . . . 0.0 109.203 171.391 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.539 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.0 tpt180 -126.64 164.02 22.17 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 109.11 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.503 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 83.9 mt-10 -137.22 -159.38 0.95 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.933 -1.105 . . . . 0.0 110.369 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.8 ptt180 -97.69 163.82 12.66 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 110.586 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -130.87 42.13 3.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.366 -0.834 . . . . 0.0 110.544 175.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.576 HG13 ' CE2' ' A' ' 374' ' ' PHE . 64.8 t -73.52 -48.43 41.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.312 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.56 -26.09 66.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 111.067 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -30.14 27.91 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 176.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.597 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.6 mt -103.25 -4.0 24.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 110.731 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 367' ' ' VAL . 61.4 m-70 63.11 53.04 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.317 -0.864 . . . . 0.0 110.148 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.546 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.57 174.89 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.618 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.3 m -116.89 133.5 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.47 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.576 ' CE2' HG13 ' A' ' 367' ' ' VAL . 89.8 m-85 -87.67 143.42 27.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.472 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.415 ' CG2' ' ND2' ' A' ' 387' ' ' ASN . 16.8 t -117.14 101.15 53.32 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 109.628 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.412 ' O ' HG23 ' A' ' 378' ' ' THR . 8.5 Cg_endo -55.23 151.27 36.47 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.056 1.556 . . . . 0.0 110.55 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.7 t80 -62.32 130.86 47.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.038 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 376' ' ' PRO . 24.3 p . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.9 mtt180 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.555 0.693 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.525 ' CE ' HD12 ' A' ' 401' ' ' ILE . 2.1 ptp -157.98 167.53 29.67 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.852 0.834 . . . . 0.0 111.174 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.516 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 24.9 p -153.65 165.26 36.49 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.8 -166.24 35.29 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.524 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.486 HG21 ' HB2' ' A' ' 339' ' ' LEU . 14.5 tt -139.51 150.75 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.634 -0.921 . . . . 0.0 110.176 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.452 ' OD1' ' NH1' ' A' ' 394' ' ' ARG . 37.8 m-20 -127.6 133.26 49.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 0.0 109.755 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.597 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.7 tt -139.57 154.81 24.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.84 -1.162 . . . . 0.0 109.302 170.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 88.6 m-20 -25.62 -62.99 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.429 0.633 . . . . 0.0 112.266 172.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.0 t30 -90.96 -8.56 48.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 111.767 -168.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.554 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 35.7 mtp180 -143.38 143.93 31.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.643 -1.286 . . . . 0.0 110.627 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.7 mtm -134.08 107.47 7.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 108.909 168.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 7.4 mt -129.45 146.11 34.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.21 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.475 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 20.8 mtt-85 -135.64 162.12 33.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 110.995 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.516 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -135.22 127.79 30.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -154.7 174.05 33.04 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.7 m -57.28 150.73 17.35 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.978 -1.307 . . . . 0.0 108.601 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.537 ' CG2' HG12 ' A' ' 420' ' ' VAL . 20.0 t -54.82 -37.91 42.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.849 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.8 m-20 -63.72 -44.01 94.85 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.29 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.466 ' O ' ' HE2' ' A' ' 383' ' ' MET . . . -68.29 -52.14 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.876 -1.14 . . . . 0.0 110.535 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.525 HD12 ' CE ' ' A' ' 383' ' ' MET . 27.6 mm -64.29 -42.22 94.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.106 -0.996 . . . . 0.0 110.828 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.2 ttp85 -59.94 -43.96 94.67 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.228 -0.92 . . . . 0.0 110.313 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 95.1 mtt180 -61.5 -37.16 82.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.515 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -68.21 -36.24 79.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.869 . . . . 0.0 111.319 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.65 -48.99 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.534 -1.354 . . . . 0.0 110.126 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.18 -34.33 77.4 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.914 -1.116 . . . . 0.0 110.145 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -36.23 80.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.952 -1.092 . . . . 0.0 109.958 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.531 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.0 m-80 -61.82 -27.33 68.69 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.202 173.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.79 19.46 29.17 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -169.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.49 -170.67 16.81 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -144.3 153.62 42.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -1.233 . . . . 0.0 111.231 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 9.8 p90 -108.85 149.97 40.25 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.475 -0.766 . . . . 0.0 110.068 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.534 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -73.02 126.31 11.11 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.877 1.462 . . . . 0.0 110.455 -175.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.3 t -67.18 -33.49 75.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 111.04 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.9 m-20 -63.36 -32.19 73.54 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.984 -1.072 . . . . 0.0 108.77 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.592 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 49.2 t -83.64 -41.69 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.395 -0.816 . . . . 0.0 110.824 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 56.4 t0 -54.9 -37.19 66.03 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 109.444 171.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.28 -50.99 65.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.447 -1.408 . . . . 0.0 109.635 172.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 45.0 mttm -55.77 -34.56 65.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.868 -1.145 . . . . 0.0 110.263 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -58.9 -42.5 86.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.172 170.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.5 -36.1 82.85 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 109.425 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.5 mm-40 -67.87 -37.13 81.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.697 -0.627 . . . . 0.0 110.65 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.541 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 67.4 t -63.34 -37.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.025 . . . . 0.0 110.044 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.54 85.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -69.08 -30.38 68.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.296 -0.878 . . . . 0.0 110.888 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.75 -3.56 56.72 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.045 -1.034 . . . . 0.0 109.717 175.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.19 21.84 28.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.541 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -107.62 163.47 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -1.067 . . . . 0.0 109.626 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 445' ' ' LEU . 22.1 m -109.75 107.2 59.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.989 -1.069 . . . . 0.0 109.731 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.504 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.2 Cg_endo -76.18 108.13 2.61 Favored 'Trans proline' 0 C--N 1.297 -2.158 0 O-C-N 123.878 1.462 . . . . 0.0 110.462 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.544 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 14.5 mt -92.29 136.31 33.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 0.0 108.64 167.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.519 ' CG1' HG23 ' A' ' 401' ' ' ILE . 94.6 t -99.93 135.06 37.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.675 -1.266 . . . . 0.0 109.462 175.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.478 ' O ' HD11 ' A' ' 440' ' ' LEU . 27.3 t -115.83 137.76 48.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.291 -0.88 . . . . 0.0 108.831 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.7 m -120.45 160.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.272 -0.892 . . . . 0.0 109.734 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.492 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -134.37 132.9 40.0 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.18 -130.09 32.29 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 74.1 p -105.64 8.71 33.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.034 -1.274 . . . . 0.0 111.129 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -122.12 170.64 9.67 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.588 -1.32 . . . . 0.0 110.107 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.526 ' HA ' ' CG1' ' A' ' 434' ' ' VAL . 47.0 t -89.48 133.86 30.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 109.95 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.604 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.2 pp -92.22 -22.83 19.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.552 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 170.32 177.51 40.55 Favored Glycine 0 N--CA 1.5 2.943 0 C-N-CA 118.945 -1.598 . . . . 0.0 110.87 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 47.9 t -107.9 142.36 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.119 -1.224 . . . . 0.0 109.869 172.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 337' ' ' ALA . 78.9 mt -101.3 112.02 32.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.416 -0.802 . . . . 0.0 108.941 170.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.478 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -92.09 119.38 31.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 109.837 -178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.544 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.29 142.82 32.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.476 ' HG3' ' HB2' ' A' ' 320' ' ' SER . 28.9 mtmt . . . . . 0 C--N 1.299 -1.611 0 O-C-N 120.657 -1.277 . . . . 0.0 111.056 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.3 tt0 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.137 0.494 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.525 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -54.92 138.91 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.884 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.54 -44.34 2.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.07 -1.019 . . . . 0.0 110.278 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.1 mt-10 -154.44 152.34 30.04 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.427 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.647 ' CZ ' ' CD1' ' A' ' 360' ' ' PHE . 16.5 p90 -137.22 143.15 42.15 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.731 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.517 HG22 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -114.93 144.66 32.44 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.747 -0.596 . . . . 0.0 109.657 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.7 143.71 38.15 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.758 1.399 . . . . 0.0 111.525 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.602 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.39 152.72 41.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 108.847 165.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -57.87 128.43 37.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.654 -1.279 . . . . 0.0 110.081 -173.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.67 -0.82 45.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.9 t -136.61 140.08 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.686 -1.479 . . . . 0.0 110.743 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.4 m-20 -74.15 152.67 39.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 85.0 tt0 -62.37 -40.76 97.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.985 -1.072 . . . . 0.0 110.471 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.25 -43.09 92.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.682 -1.261 . . . . 0.0 109.612 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.455 ' HB ' HG11 ' A' ' 328' ' ' VAL . 93.3 m -55.53 -43.93 76.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.75 173.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.7 tp -59.77 -39.24 84.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 110.285 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.0 -41.85 86.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.837 -1.164 . . . . 0.0 110.841 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.0 t0 -63.83 -49.83 71.3 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.832 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.27 -31.44 71.77 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.718 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.96 -35.09 66.33 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.142 172.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 18.0 mt-30 -73.85 -55.79 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.596 -0.69 . . . . 0.0 110.815 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.71 -34.7 76.24 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.894 -173.197 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 395' ' ' LYS . . . -67.54 -20.43 65.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.927 174.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 97.1 p -108.91 9.75 26.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.199 -0.938 . . . . 0.0 111.631 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.541 HD12 ' CB ' ' A' ' 365' ' ' ARG . 35.5 mt -64.1 -45.78 87.14 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.652 -1.28 . . . . 0.0 109.806 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.7 -0.8 42.12 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.788 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 341' ' ' SER . 10.5 p30 -61.8 130.51 46.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.927 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.03 5.89 50.13 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.612 0.72 . . . . 0.0 109.951 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.56 154.59 81.42 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.579 -0.7 . . . . 0.0 109.45 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.15 -36.85 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.624 1.329 . . . . 0.0 109.128 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.3 -29.2 70.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.448 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.451 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -57.47 -38.54 87.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.454 ' O ' HD13 ' A' ' 354' ' ' ILE . 98.0 mtt180 -77.33 -37.38 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -1.177 . . . . 0.0 110.629 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.0 m -61.68 -38.85 89.34 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.042 -1.036 . . . . 0.0 110.368 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 84.7 mt -69.18 -48.37 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.693 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.52 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 28.7 t -60.64 -34.54 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.06 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 350' ' ' ARG . 36.4 mt -72.54 -32.26 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.628 -1.295 . . . . 0.0 110.653 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.634 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.87 -41.06 90.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.937 -1.102 . . . . 0.0 110.394 179.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.79 -42.85 99.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 0.0 110.383 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 83.4 mttt -70.69 -50.55 35.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.913 -1.117 . . . . 0.0 110.772 -174.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.505 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.9 pt20 -71.0 -42.59 69.43 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 110.561 -173.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.574 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 40.1 mmt180 -73.06 -46.16 53.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 111.21 -173.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.647 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 79.3 m-85 -135.96 -36.03 0.76 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.542 -1.349 . . . . 0.0 112.39 -169.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.518 ' ND2' ' HD2' ' A' ' 363' ' ' ARG . 56.0 t-20 -158.59 98.55 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.557 -1.34 . . . . 0.0 111.7 -169.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 24.3 mt -58.38 91.17 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 0.0 109.509 171.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.518 ' HD2' ' ND2' ' A' ' 361' ' ' ASN . 13.8 ptm180 -145.6 -176.81 5.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.287 -0.883 . . . . 0.0 109.983 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.28 -158.53 0.9 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 110.329 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.541 ' CB ' HD12 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -97.96 166.81 11.27 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.661 -0.649 . . . . 0.0 110.558 -178.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.0 m-20 -121.02 41.1 3.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.637 ' CG1' ' CZ ' ' A' ' 374' ' ' PHE . 43.0 t -70.45 -45.54 74.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 110.21 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -68.2 -29.02 67.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.159 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -29.66 27.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.07 -1.019 . . . . 0.0 109.767 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.527 ' CB ' HD13 ' A' ' 388' ' ' ILE . 22.6 mt -102.66 -3.22 26.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 110.777 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.1 m80 58.82 53.8 5.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 0.0 109.895 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.539 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.89 174.68 7.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 110.513 -177.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.1 m -114.79 134.02 55.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.357 -0.84 . . . . 0.0 110.396 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.637 ' CZ ' ' CG1' ' A' ' 367' ' ' VAL . 72.4 m-85 -88.7 149.38 23.52 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 5.0 t -122.75 100.81 40.32 Favored Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.3 150.66 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.031 1.543 . . . . 0.0 110.473 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.6 t80 -66.91 131.75 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 110.141 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--N 1.302 -1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 109.639 175.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 73.2 mtt85 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.531 0.682 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.519 ' HE3' ' CB ' ' A' ' 400' ' ' ALA . 2.8 ptp -158.6 169.71 23.81 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.949 0.881 . . . . 0.0 111.339 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.518 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 31.1 p -154.84 165.22 37.33 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.15 -165.33 33.25 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.897 -1.621 . . . . 0.0 110.751 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.527 HD12 ' CG2' ' A' ' 367' ' ' VAL . 2.4 tt -142.28 149.38 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.63 -0.923 . . . . 0.0 110.054 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -127.91 136.0 50.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.957 -1.09 . . . . 0.0 109.911 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -140.45 155.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.859 -1.151 . . . . 0.0 109.22 171.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.498 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 91.2 m-20 -23.46 -63.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.398 0.618 . . . . 0.0 112.436 171.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 46.4 t-20 -95.82 -5.56 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.513 -0.742 . . . . 0.0 111.871 -167.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.6 mtp180 -143.98 143.8 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.66 -1.275 . . . . 0.0 110.375 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -134.02 112.25 11.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.822 -1.174 . . . . 0.0 108.913 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.534 ' CD1' ' CB ' ' A' ' 336' ' ' ALA . 9.6 mt -131.49 146.16 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.47 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 35.1 mtt180 -133.75 159.92 39.15 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.078 -1.014 . . . . 0.0 110.58 174.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.518 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.09 128.92 35.18 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.412 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -155.87 174.22 33.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -174.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.6 m -56.91 151.58 14.37 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.871 -1.37 . . . . 0.0 108.653 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.537 ' CG2' HG13 ' A' ' 420' ' ' VAL . 53.5 t -56.51 -34.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 109.942 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.516 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 46.2 t0 -63.26 -47.19 83.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.323 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.519 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -67.77 -50.05 59.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.523 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.518 HG22 ' CG1' ' A' ' 432' ' ' VAL . 35.8 mm -64.97 -42.99 96.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.053 -1.029 . . . . 0.0 110.794 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.57 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.5 ttp180 -59.36 -43.39 92.84 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.309 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.516 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 88.9 mtt180 -61.31 -37.16 82.25 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.517 173.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.4 t-80 -67.5 -36.95 82.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 0.0 111.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 437' ' ' SER . 53.4 t -65.93 -48.35 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.5 -1.375 . . . . 0.0 110.206 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.6 -34.24 77.38 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.901 -1.124 . . . . 0.0 110.355 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.77 -36.26 80.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.939 -1.101 . . . . 0.0 109.886 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 9.4 m-80 -61.03 -27.84 68.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 109.124 173.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.35 27.2 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -169.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.59 -169.05 15.59 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -144.36 153.66 42.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.131 -1.217 . . . . 0.0 111.404 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 6.7 p90 -108.22 150.35 40.39 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.769 -0.582 . . . . 0.0 110.258 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -75.0 125.53 9.39 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.812 1.427 . . . . 0.0 110.572 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -67.39 -33.82 75.98 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.172 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -62.12 -32.01 72.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.98 -1.075 . . . . 0.0 108.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.602 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 50.4 t -83.72 -42.69 17.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 110.942 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.585 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 66.8 m-20 -55.28 -36.22 65.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.629 171.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.88 -50.85 67.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.377 -1.452 . . . . 0.0 109.537 172.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 323' ' ' ILE . 81.9 mttt -56.46 -34.36 66.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.338 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -58.86 -41.65 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.964 -1.085 . . . . 0.0 109.171 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -66.34 -36.51 83.08 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.936 0.874 . . . . 0.0 109.414 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.24 -37.28 83.28 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.586 -0.696 . . . . 0.0 110.703 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 77.0 t -62.39 -37.86 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 110.063 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.18 -37.97 86.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -66.26 -33.81 76.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.193 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -83.23 -1.82 54.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 176.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.05 22.54 32.44 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -104.12 162.47 13.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -1.084 . . . . 0.0 109.485 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.47 ' O ' HD11 ' A' ' 445' ' ' LEU . 34.8 m -109.5 107.0 59.24 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 109.741 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.483 ' CB ' HG11 ' A' ' 420' ' ' VAL . 36.9 Cg_endo -74.98 108.09 2.64 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 O-C-N 124.05 1.553 . . . . 0.0 110.596 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.7 mt -92.54 134.18 35.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.816 -1.177 . . . . 0.0 108.578 167.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.524 ' CG1' HG12 ' A' ' 439' ' ' VAL . 74.6 t -100.35 134.17 40.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.669 -1.269 . . . . 0.0 109.457 176.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 440' ' ' LEU . 55.3 t -115.78 136.42 52.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.063 175.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -117.75 160.15 17.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.484 -0.76 . . . . 0.0 109.632 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.496 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.22 133.19 36.82 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.83 -123.57 22.24 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -168.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.479 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 2.3 p -114.2 11.37 17.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.095 -1.238 . . . . 0.0 110.987 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -123.88 171.08 9.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.629 -1.294 . . . . 0.0 109.907 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.524 HG12 ' CG1' ' A' ' 432' ' ' VAL . 40.3 t -90.04 134.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.312 -0.867 . . . . 0.0 109.821 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.6 pp -94.33 -21.77 18.77 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 109.693 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.558 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.02 176.12 38.28 Favored Glycine 0 N--CA 1.499 2.883 0 C-N-CA 118.938 -1.601 . . . . 0.0 110.904 170.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 49.7 t -107.87 142.06 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.12 -1.224 . . . . 0.0 109.953 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.517 HD12 ' CB ' ' A' ' 337' ' ' ALA . 80.1 mt -101.32 110.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.424 -0.798 . . . . 0.0 108.961 170.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.525 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.36 118.18 30.67 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.031 -1.043 . . . . 0.0 109.864 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.536 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.08 144.32 30.81 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 19.9 mttt . . . . . 0 C--N 1.3 -1.583 0 O-C-N 120.675 -1.266 . . . . 0.0 110.905 179.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 50.9 tt0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.103 0.478 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.529 ' HB2' ' CD1' ' A' ' 355' ' ' LEU . . . -59.59 142.37 52.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.528 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -117.54 -34.17 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -0.981 . . . . 0.0 110.439 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -169.45 150.57 4.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 0.0 110.029 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.635 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 13.9 p90 -134.87 143.98 47.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.85 -1.156 . . . . 0.0 111.643 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.516 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.3 mt -114.49 144.03 31.02 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.611 -0.681 . . . . 0.0 109.666 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.536 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.88 143.78 37.49 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.767 1.404 . . . . 0.0 111.357 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.0 152.26 42.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 108.831 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.16 128.77 38.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.665 -1.272 . . . . 0.0 110.188 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.54 42.83 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.0 t -136.48 139.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.65 -1.5 . . . . 0.0 110.736 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.459 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.18 152.44 39.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.154 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.565 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -62.47 -40.13 95.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.993 . . . . 0.0 110.437 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.09 -43.15 91.81 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.701 -1.25 . . . . 0.0 109.62 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.463 ' HB ' HG12 ' A' ' 328' ' ' VAL . 94.3 m -56.11 -43.54 78.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.885 173.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.2 tp -59.68 -40.08 86.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.291 -0.881 . . . . 0.0 110.281 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -66.66 -41.21 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.914 -1.116 . . . . 0.0 110.742 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.546 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.3 t0 -64.22 -50.87 66.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.854 -1.153 . . . . 0.0 109.928 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.03 -30.62 69.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.909 -1.119 . . . . 0.0 109.779 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 334' ' ' ALA . . . -55.17 -35.91 65.29 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.133 -0.979 . . . . 0.0 109.028 171.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 17.3 mt-30 -74.25 -55.71 5.73 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.569 -0.707 . . . . 0.0 110.914 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.552 ' HA ' ' CG ' ' A' ' 342' ' ' LEU . 0.1 OUTLIER -63.92 -33.78 76.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.908 -171.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 395' ' ' LYS . . . -66.77 -21.48 66.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.986 -1.072 . . . . 0.0 110.045 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 97.5 p -107.65 10.79 28.95 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.04 -1.037 . . . . 0.0 111.598 -173.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.581 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 46.3 mt -67.15 -43.75 81.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.624 -1.297 . . . . 0.0 109.652 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -96.52 2.67 52.64 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.863 -171.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.515 ' OD2' ' CA ' ' A' ' 349' ' ' GLY . 18.3 p30 -65.0 130.0 41.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.773 -1.204 . . . . 0.0 110.088 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.72 4.43 52.98 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.573 0.701 . . . . 0.0 109.909 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.38 151.77 85.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.711 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -56.38 -39.4 91.53 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.702 1.369 . . . . 0.0 109.09 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.6 mt-10 -64.31 -29.63 70.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.484 -0.76 . . . . 0.0 110.367 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.515 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . . . -55.31 -36.04 61.91 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 354' ' ' ILE . 65.9 mtt85 -77.18 -36.53 54.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 0.0 110.543 174.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 13.2 m -60.78 -39.08 87.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 81.0 mt -68.19 -48.99 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.562 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.533 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 27.5 t -62.18 -33.94 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.945 -1.097 . . . . 0.0 110.192 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 350' ' ' ARG . 31.7 mt -72.22 -31.98 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.597 -1.314 . . . . 0.0 110.576 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.635 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -60.61 -40.61 92.48 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 110.568 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.518 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.33 -42.93 99.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 0.0 110.274 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 70.4 mttt -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.73 -175.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.9 pt20 -70.09 -42.22 73.0 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 110.785 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.6 mmm180 -74.68 -46.24 39.18 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 111.189 -171.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.592 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 77.8 m-85 -136.22 -34.97 0.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.399 -1.321 . . . . 0.0 112.31 -170.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.477 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 53.5 t-20 -159.66 103.33 1.55 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.551 -1.343 . . . . 0.0 111.598 -169.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 37.0 mt -57.66 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.872 -1.142 . . . . 0.0 109.066 170.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 25.3 tpt180 -134.19 163.83 28.73 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.419 -0.8 . . . . 0.0 109.344 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.3 mt-10 -136.12 -158.05 0.84 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.581 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.3 ptt85 -97.66 163.69 12.72 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.661 -0.649 . . . . 0.0 110.841 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.9 m-20 -134.5 44.49 2.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.821 . . . . 0.0 110.554 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.57 HG11 ' CE2' ' A' ' 374' ' ' PHE . 61.0 t -72.41 -46.95 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.44 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -67.9 -26.15 65.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 111.264 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -31.18 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.057 . . . . 0.0 109.715 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.524 ' CB ' HD13 ' A' ' 388' ' ' ILE . 19.8 mt -100.68 -4.09 28.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.498 -0.751 . . . . 0.0 110.606 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 46.8 m80 59.99 51.73 5.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -174.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.504 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.06 172.99 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.9 m -118.82 135.61 54.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 110.374 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.57 ' CE2' HG11 ' A' ' 367' ' ' VAL . 86.3 m-85 -90.01 145.16 25.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.651 175.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 47.9 t -118.73 100.99 50.92 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.16 150.75 38.24 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.068 1.562 . . . . 0.0 110.526 -175.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 8.4 t80 -63.27 131.35 48.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.357 -0.839 . . . . 0.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--N 1.301 -1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.706 176.124 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 88.7 mtt180 . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.519 0.676 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 400' ' ' ALA . 2.6 ptp -158.75 168.48 26.73 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.26 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.526 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 12.2 p -155.39 165.16 37.49 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.6 -164.16 31.55 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.956 -1.592 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 339' ' ' LEU . 1.9 tt -141.96 149.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.665 -0.903 . . . . 0.0 110.173 -174.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -127.22 138.86 53.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.9 tt -141.37 154.59 20.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.87 -1.144 . . . . 0.0 109.365 172.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.264 88.3 m-20 -21.4 -62.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.391 0.615 . . . . 0.0 112.608 171.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 24.8 t-20 -99.03 -6.78 27.89 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 111.819 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.539 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 18.3 mtp180 -142.97 145.86 33.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.746 -1.221 . . . . 0.0 110.553 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 89.9 mtp -134.16 113.27 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.909 -1.119 . . . . 0.0 109.08 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.5 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 9.3 mt -131.75 146.05 34.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.051 -1.031 . . . . 0.0 110.142 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.473 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 32.8 mtt180 -135.92 161.9 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.005 . . . . 0.0 110.779 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.526 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.45 134.23 41.34 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.531 -0.731 . . . . 0.0 109.11 174.132 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.507 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -159.76 174.06 36.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -58.51 153.0 16.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.921 -1.34 . . . . 0.0 108.438 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.535 ' CG2' HG13 ' A' ' 420' ' ' VAL . 20.8 t -54.87 -37.52 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.82 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.1 m-20 -64.25 -44.51 91.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.523 ' CB ' ' HE2' ' A' ' 383' ' ' MET . . . -68.78 -51.84 36.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.923 -1.111 . . . . 0.0 110.503 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.524 HG23 ' CG1' ' A' ' 432' ' ' VAL . 25.2 mm -63.82 -42.28 95.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.096 -1.003 . . . . 0.0 110.805 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.586 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.4 ttt180 -60.81 -43.29 98.38 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.299 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 89.8 mtt180 -61.15 -36.54 80.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.07 -1.019 . . . . 0.0 109.643 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.511 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -67.45 -38.15 84.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 111.33 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 437' ' ' SER . 63.7 t -66.07 -47.22 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.473 -1.392 . . . . 0.0 110.219 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.73 -34.63 78.3 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.738 -1.226 . . . . 0.0 110.337 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.47 -36.29 80.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.986 -1.071 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.511 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.1 m-80 -61.15 -27.81 68.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.442 -0.786 . . . . 0.0 109.126 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.61 19.85 28.51 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.01 -170.26 16.3 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -144.61 153.98 42.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.247 . . . . 0.0 111.321 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.586 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.1 p90 -106.87 150.99 40.43 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.63 -0.669 . . . . 0.0 110.096 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.534 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.81 125.61 10.64 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.853 1.449 . . . . 0.0 110.237 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.2 t -66.69 -34.13 77.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 111.136 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.9 m-20 -62.97 -32.31 73.61 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.931 -1.106 . . . . 0.0 108.858 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 48.4 t -83.41 -42.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -0.846 . . . . 0.0 110.809 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 5.3 m-20 -55.58 -36.42 66.84 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.595 171.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.94 -50.16 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 0.0 109.686 172.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.516 ' CD ' HG21 ' A' ' 323' ' ' ILE . 35.7 mttt -56.65 -34.6 67.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.764 -1.21 . . . . 0.0 110.332 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.8 t -59.09 -41.78 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.932 -1.105 . . . . 0.0 109.369 170.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.66 -35.95 82.26 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.943 0.878 . . . . 0.0 109.296 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.39 -37.92 83.89 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.566 -0.709 . . . . 0.0 110.769 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 444' ' ' ALA . 64.5 t -63.44 -36.81 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.0 110.193 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.34 85.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -70.08 -28.95 65.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.326 -0.859 . . . . 0.0 110.599 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -80.36 -3.75 50.82 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.009 . . . . 0.0 109.74 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.7 21.96 35.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.466 ' HB3' HG12 ' A' ' 423' ' ' VAL . . . -107.74 175.96 5.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.722 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 445' ' ' LEU . 59.1 m -119.15 106.92 42.4 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.942 -1.099 . . . . 0.0 109.874 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.522 ' CG ' HG11 ' A' ' 420' ' ' VAL . 31.4 Cg_endo -74.06 106.78 2.28 Favored 'Trans proline' 0 C--N 1.296 -2.204 0 O-C-N 123.911 1.479 . . . . 0.0 110.354 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 15.8 mt -93.08 131.79 37.78 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 167.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 439' ' ' VAL . 72.6 t -100.57 137.54 27.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.823 -1.173 . . . . 0.0 109.777 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.481 ' O ' HD11 ' A' ' 440' ' ' LEU . 42.7 t -116.2 137.74 48.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 108.928 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.05 159.98 20.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 121.351 -0.843 . . . . 0.0 109.757 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.463 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.4 tt0 -136.11 132.77 36.52 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.41 -126.82 31.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -168.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -109.91 13.41 23.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.238 . . . . 0.0 111.123 -178.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -128.33 170.66 12.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.017 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.527 HG13 ' CG1' ' A' ' 432' ' ' VAL . 53.3 t -88.35 134.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 109.776 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.5 pp -92.3 -22.3 19.81 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.665 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.552 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 170.88 176.36 40.09 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.963 168.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 46.9 t -107.94 142.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.16 -1.2 . . . . 0.0 109.539 171.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.513 ' O ' HD13 ' A' ' 445' ' ' LEU . 78.3 mt -101.67 119.24 49.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 169.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' A' ' 423' ' ' VAL . . . -99.0 117.49 33.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.55 ' CD1' ' O ' ' A' ' 429' ' ' THR . 3.6 mp -113.63 146.34 39.9 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.095 -1.003 . . . . 0.0 109.819 -173.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.528 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 O-C-N 120.749 -1.22 . . . . 0.0 110.773 -174.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.5 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.158 0.504 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.524 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -54.57 138.6 40.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 0.0 109.802 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 4.9 m -119.53 -44.7 2.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.086 -1.009 . . . . 0.0 110.197 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 320' ' ' SER . 69.7 mt-10 -154.59 152.33 29.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 0.0 110.448 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.62 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 16.9 p90 -136.12 141.82 44.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.755 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.481 HG22 ' HD2' ' A' ' 324' ' ' PRO . 4.3 mt -114.79 141.76 27.3 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.73 -0.607 . . . . 0.0 109.598 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -71.61 142.86 40.97 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.708 1.373 . . . . 0.0 111.55 -176.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.596 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.01 152.56 43.44 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 108.829 165.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.44 128.35 36.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.692 -1.255 . . . . 0.0 110.143 -172.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.94 -0.75 44.76 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.8 t -136.13 139.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.716 -1.461 . . . . 0.0 110.727 177.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.447 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.93 152.07 40.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.163 177.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -62.17 -39.76 93.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.057 -1.027 . . . . 0.0 110.457 -176.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.3 ttmt -59.19 -43.38 92.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.806 -1.184 . . . . 0.0 109.56 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 95.8 m -56.15 -43.63 78.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.817 173.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.1 tp -59.69 -39.64 85.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.37 -42.04 84.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.089 . . . . 0.0 110.757 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.4 m-20 -64.19 -49.48 71.88 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.118 . . . . 0.0 109.921 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.17 -31.3 70.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.937 -1.102 . . . . 0.0 109.664 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.19 -35.64 65.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.964 172.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 30.3 mt-30 -74.52 -55.81 5.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.989 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.38 -35.71 78.23 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.787 -172.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -66.8 -20.89 66.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 173.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 95.9 p -108.4 10.15 27.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -174.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.581 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.2 mt -65.98 -44.95 83.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.657 -1.277 . . . . 0.0 109.802 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.54 0.72 47.94 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.821 -170.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 11.9 p30 -63.87 130.29 43.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.841 -1.162 . . . . 0.0 109.925 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.76 4.76 52.64 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.512 0.672 . . . . 0.0 109.886 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.3 152.88 86.03 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.592 -0.693 . . . . 0.0 109.443 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -56.0 -38.14 95.14 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.74 1.39 . . . . 0.0 109.132 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.19 -29.23 70.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.484 -0.76 . . . . 0.0 110.406 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.461 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.47 -38.56 80.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.9 mtt85 -78.2 -37.76 44.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.075 -1.25 . . . . 0.0 110.591 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.519 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.4 -38.02 85.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.932 -1.105 . . . . 0.0 110.352 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 90.7 mt -68.92 -49.09 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 0.0 110.625 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.529 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 38.4 t -60.87 -34.06 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.864 -1.147 . . . . 0.0 110.101 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.466 ' CG2' ' OE1' ' A' ' 358' ' ' GLN . 32.3 mt -72.62 -33.22 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.681 -1.262 . . . . 0.0 110.621 170.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.46 -40.35 86.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.938 -1.101 . . . . 0.0 110.489 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.27 88.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.47 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.536 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 18.0 mtmt -72.35 -49.48 33.82 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.743 -1.183 . . . . 0.0 110.6 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . 0.497 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.7 pt20 -71.3 -42.43 68.69 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 110.814 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.556 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -72.63 -46.31 54.68 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.109 -0.995 . . . . 0.0 111.078 -172.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . 0.57 ' CZ ' ' OE2' ' A' ' 330' ' ' GLU . 84.0 m-85 -136.5 -36.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.205 -169.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.465 ' OD1' ' HB2' ' A' ' 363' ' ' ARG . 15.2 t-20 -160.02 106.64 1.6 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.605 -1.309 . . . . 0.0 111.508 -168.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 59.9 mt -57.56 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.368 172.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . 0.534 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.7 tpt180 -125.64 164.39 20.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 109.325 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.4 mt-10 -140.06 -161.77 1.25 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.0 -1.062 . . . . 0.0 110.121 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.581 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.67 162.45 13.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.747 . . . . 0.0 110.521 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -130.3 41.74 3.36 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.381 175.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.571 HG21 ' CE1' ' A' ' 374' ' ' PHE . 59.4 t -74.16 -46.23 45.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.09 -27.46 66.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.344 -0.848 . . . . 0.0 111.122 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.78 -30.55 28.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.965 . . . . 0.0 109.656 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.524 ' CB ' HD12 ' A' ' 388' ' ' ILE . 22.9 mt -102.5 -3.66 26.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.557 -0.714 . . . . 0.0 110.674 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 367' ' ' VAL . 51.6 m80 59.11 52.57 6.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.55 174.67 7.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 110.51 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.1 m -116.45 134.62 54.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.396 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.571 ' CE1' HG21 ' A' ' 367' ' ' VAL . 83.6 m-85 -88.61 147.8 24.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 87.2 t -120.34 101.12 46.99 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.616 175.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.22 150.36 40.68 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.077 1.567 . . . . 0.0 110.511 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.2 t80 -65.47 131.41 46.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 109.695 176.183 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 74.0 mtt85 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.517 0.675 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.512 ' CE ' ' CB ' ' A' ' 400' ' ' ALA . 3.3 ptp -157.44 167.38 30.4 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.993 0.901 . . . . 0.0 111.4 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.523 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 26.9 p -154.43 165.36 36.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.8 -166.55 35.05 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.705 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 367' ' ' VAL . 3.8 tt -140.92 149.84 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.995 . . . . 0.0 110.208 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -127.25 134.73 50.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.045 . . . . 0.0 109.804 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.559 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 2.0 tt -140.73 155.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 109.211 171.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.0 m-20 -21.65 -63.03 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.388 0.614 . . . . 0.0 112.583 170.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.439 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 22.9 t-20 -96.49 -7.14 35.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 111.931 -167.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.9 mtp180 -141.86 145.84 35.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.594 -1.317 . . . . 0.0 110.503 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -136.22 100.93 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.132 . . . . 0.0 109.18 170.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 7.7 mt -122.96 146.18 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.04 -1.037 . . . . 0.0 110.092 -172.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.472 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 26.0 mmt85 -133.19 159.1 41.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.329 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.523 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.41 126.84 30.36 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.426 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -154.44 174.0 32.86 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.596 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.4 m -56.47 150.84 14.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.863 -1.375 . . . . 0.0 108.592 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 420' ' ' VAL . 56.5 t -57.72 -34.6 48.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.887 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.4 t0 -62.55 -45.81 91.23 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.512 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -68.85 -51.07 44.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.93 -1.106 . . . . 0.0 110.61 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.516 HG22 ' CG1' ' A' ' 432' ' ' VAL . 34.2 mm -63.98 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.063 -1.023 . . . . 0.0 110.59 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.0 ttp180 -58.47 -43.69 89.0 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.461 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 55.2 mtp85 -61.54 -36.12 79.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.061 -1.024 . . . . 0.0 109.459 173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.503 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.4 t-80 -67.65 -38.5 83.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 111.299 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.91 -47.29 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.616 -1.302 . . . . 0.0 110.26 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.21 -34.21 77.57 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.814 -1.178 . . . . 0.0 110.362 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.65 -36.3 80.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.092 . . . . 0.0 109.895 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 26.7 m-80 -62.12 -27.09 68.68 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 109.225 173.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.86 19.56 31.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.24 -171.13 18.52 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -144.81 153.85 42.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.168 -1.195 . . . . 0.0 111.07 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.5 p90 -109.51 151.92 42.46 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.54 -0.725 . . . . 0.0 109.978 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.54 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.15 124.76 10.27 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.913 1.48 . . . . 0.0 110.221 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.3 t -66.95 -33.21 75.08 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.3 m-20 -63.45 -32.48 73.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 108.853 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.596 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 49.3 t -83.64 -41.89 17.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.908 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.481 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.7 t0 -55.04 -37.55 66.83 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.404 171.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.503 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.66 -49.71 72.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.457 -1.402 . . . . 0.0 109.697 172.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.503 ' N ' ' HG2' ' A' ' 418' ' ' GLN . 57.1 mttm -56.28 -34.79 66.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.802 -1.187 . . . . 0.0 110.444 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -59.32 -41.85 85.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.962 -1.086 . . . . 0.0 109.21 171.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.84 -36.26 82.97 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.906 0.86 . . . . 0.0 109.414 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.02 -37.89 81.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.609 -0.682 . . . . 0.0 110.74 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 72.2 t -62.28 -37.65 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.979 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.09 87.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 110.151 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -67.02 -33.43 75.54 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.285 -0.884 . . . . 0.0 111.229 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.1 OUTLIER -83.0 -3.4 57.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.012 -1.055 . . . . 0.0 109.597 176.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.33 29.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.516 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.72 163.34 12.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 445' ' ' LEU . 70.5 m -109.65 107.02 59.1 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.081 -1.012 . . . . 0.0 109.744 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.512 ' CG ' HG12 ' A' ' 420' ' ' VAL . 38.6 Cg_endo -75.6 107.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.07 0 O-C-N 123.893 1.47 . . . . 0.0 110.52 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.5 mt -92.44 134.24 35.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.886 -1.134 . . . . 0.0 108.625 167.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.516 ' CG1' HG22 ' A' ' 401' ' ' ILE . 96.8 t -100.32 134.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.701 -1.25 . . . . 0.0 109.477 176.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.473 ' O ' HD12 ' A' ' 440' ' ' LEU . 40.9 t -114.95 137.33 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.243 -0.91 . . . . 0.0 108.955 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.526 ' CG1' HG22 ' A' ' 439' ' ' VAL . 2.5 m -120.28 160.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.589 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.455 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.82 129.89 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.56 -128.42 29.84 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -168.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.53 15.41 23.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.052 -1.263 . . . . 0.0 111.171 -179.109 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -125.76 170.27 11.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.532 -1.355 . . . . 0.0 109.878 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.526 HG22 ' CG1' ' A' ' 434' ' ' VAL . 46.7 t -91.7 134.31 30.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.189 -0.945 . . . . 0.0 109.57 176.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.5 pp -94.36 -21.28 19.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.691 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.548 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.27 176.39 38.64 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 118.794 -1.669 . . . . 0.0 110.962 169.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 53.9 t -107.97 142.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 173.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.518 HD13 ' CB ' ' A' ' 337' ' ' ALA . 82.2 mt -101.32 110.91 29.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.523 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -91.99 118.12 30.47 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.863 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.535 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.28 30.54 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 59.3 mttt . . . . . 0 C--N 1.3 -1.578 0 O-C-N 120.612 -1.305 . . . . 0.0 111.121 -179.16 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.237 0.541 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.463 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 98.1 mtt180 -122.59 149.78 43.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.092 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.522 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 89.1 mm-40 -123.45 142.83 50.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.123 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.512 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -60.6 138.63 58.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.83 177.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 9.4 m -122.16 -42.75 2.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.005 . . . . 0.0 110.217 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 320' ' ' SER . 68.3 mt-10 -154.17 150.81 28.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.475 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.667 ' CZ ' ' CD1' ' A' ' 360' ' ' PHE . 14.9 p90 -137.46 141.85 41.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.957 -1.089 . . . . 0.0 111.709 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.508 HG22 ' CD ' ' A' ' 419' ' ' LYS . 3.7 mp -113.1 143.75 29.79 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.811 -0.555 . . . . 0.0 109.69 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.67 142.89 36.72 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.63 1.331 . . . . 0.0 111.605 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.603 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.72 152.65 42.6 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 108.862 165.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -58.57 128.45 37.25 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.734 -1.229 . . . . 0.0 110.172 -172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.404 ' O ' HG21 ' A' ' 328' ' ' VAL . . . 103.89 -0.83 44.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 46.3 t -136.61 139.86 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.71 -1.465 . . . . 0.0 110.762 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.432 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.89 152.82 40.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.397 -0.815 . . . . 0.0 110.176 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.539 ' CD ' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -62.16 -40.91 97.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.056 -1.027 . . . . 0.0 110.47 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.29 -43.33 92.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.694 -1.254 . . . . 0.0 109.678 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.444 ' HB ' HG11 ' A' ' 328' ' ' VAL . 92.7 m -55.51 -44.12 76.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.769 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.1 tp -59.16 -39.01 81.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.3 -41.24 85.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.967 -1.083 . . . . 0.0 110.779 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.546 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.26 -49.22 74.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.936 -1.102 . . . . 0.0 109.805 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.606 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.52 -31.37 70.57 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.982 -1.074 . . . . 0.0 109.888 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.523 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.28 64.62 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 108.834 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 13.5 mt-30 -74.54 -55.92 5.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.594 -0.691 . . . . 0.0 110.919 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.2 OUTLIER -65.77 -33.77 76.64 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.009 -171.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 395' ' ' LYS . . . -66.34 -21.62 66.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.112 . . . . 0.0 110.109 172.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.464 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 94.4 p -107.58 10.59 29.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.142 -0.974 . . . . 0.0 111.536 -173.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.589 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 46.1 mt -66.98 -44.48 80.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.591 -1.318 . . . . 0.0 109.672 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.12 1.2 49.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.865 -170.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.81 130.45 44.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 109.942 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 5.4 51.58 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.532 0.682 . . . . 0.0 109.887 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.26 152.57 83.97 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.582 -0.699 . . . . 0.0 109.412 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -56.02 -38.49 94.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.689 1.363 . . . . 0.0 109.147 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.38 -28.31 69.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.548 -0.72 . . . . 0.0 110.395 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.23 -38.17 76.45 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.453 ' O ' HD11 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.95 -36.73 56.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -1.209 . . . . 0.0 110.54 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.522 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 2.0 m -61.5 -39.25 90.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 85.4 mt -68.12 -48.33 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.537 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 25.3 t -61.46 -34.03 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.453 HD11 ' O ' ' A' ' 350' ' ' ARG . 29.7 mt -72.43 -32.27 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.673 -1.267 . . . . 0.0 110.548 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.623 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.02 -40.58 89.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.96 -1.088 . . . . 0.0 110.444 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.529 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.76 -43.73 98.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 70.2 mttt -71.44 -49.83 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.614 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.55 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 1.8 pt20 -70.87 -42.54 69.94 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.704 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.7 mmt180 -73.62 -46.01 49.5 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 111.147 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.667 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 72.3 m-85 -135.93 -36.59 0.75 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.57 -1.331 . . . . 0.0 112.226 -169.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.479 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.0 t30 -159.57 103.16 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.549 -1.344 . . . . 0.0 111.682 -169.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 33.1 mt -57.78 89.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.893 -1.129 . . . . 0.0 109.113 171.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.543 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.0 tpt180 -135.43 164.71 27.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.436 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.9 mt-10 -135.8 -157.14 0.77 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.016 -1.052 . . . . 0.0 110.495 -177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 36.8 ptt180 -97.48 165.14 12.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.674 -0.641 . . . . 0.0 110.716 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.466 ' OD1' HD13 ' A' ' 388' ' ' ILE . 55.0 p30 -138.05 45.52 2.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.379 -0.826 . . . . 0.0 110.758 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.63 ' CG2' ' CZ ' ' A' ' 374' ' ' PHE . 92.7 t -71.15 -42.38 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.334 -0.854 . . . . 0.0 110.341 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.78 -21.32 66.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 111.032 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -29.39 25.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.04 -1.038 . . . . 0.0 110.026 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 16.6 mt -105.38 -3.68 22.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.552 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 24.0 m80 62.11 53.33 2.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 109.649 -173.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.527 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.19 174.96 6.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.501 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.0 m -120.9 136.4 54.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.416 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.63 ' CZ ' ' CG2' ' A' ' 367' ' ' VAL . 89.0 m-85 -90.62 145.1 25.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.668 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 21.5 t -118.6 101.32 50.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.11 155.18 19.88 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.105 1.582 . . . . 0.0 110.613 -175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.534 ' CE2' ' N ' ' A' ' 383' ' ' MET . 50.5 t80 -71.92 134.7 46.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 110.442 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 4.8 p -114.56 143.48 44.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.785 174.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.51 -25.08 59.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.646 -0.659 . . . . 0.0 110.357 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.81 -43.74 98.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' A' ' 383' ' ' MET . 74.2 m -93.81 -14.41 26.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 110.164 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.475 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.7 mtt-85 57.45 48.21 15.01 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.617 -0.677 . . . . 0.0 109.646 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.534 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 3.1 ptp -165.34 171.23 13.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.781 0.8 . . . . 0.0 111.288 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 39.8 p -156.31 165.31 36.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.82 -165.96 34.11 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.025 -1.56 . . . . 0.0 110.637 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 339' ' ' LEU . 1.3 tt -143.34 147.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.935 . . . . 0.0 110.399 -174.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.459 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 56.1 m-20 -115.78 134.25 55.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.902 -1.124 . . . . 0.0 108.974 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.562 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 2.2 tt -142.63 154.41 17.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.9 -1.125 . . . . 0.0 109.611 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 88.7 m-20 -23.95 -62.02 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 112.298 173.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.5 t-20 -95.87 -5.45 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.539 -0.725 . . . . 0.0 111.801 -167.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.546 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 18.1 mtp180 -145.5 147.73 32.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.684 -1.26 . . . . 0.0 110.74 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.3 mtm -132.51 95.68 3.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.831 -1.168 . . . . 0.0 108.789 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 336' ' ' ALA . 7.6 mt -122.58 146.25 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.946 -1.096 . . . . 0.0 110.429 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.479 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 40.2 mtt180 -133.51 159.14 41.29 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 110.767 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.481 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.43 128.86 34.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.425 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -155.51 174.32 33.59 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.0 m -56.36 151.35 13.14 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.956 -1.32 . . . . 0.0 108.496 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.539 ' CG2' HG12 ' A' ' 420' ' ' VAL . 53.4 t -57.08 -34.28 44.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.027 -1.046 . . . . 0.0 109.887 -176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 19.7 t70 -62.86 -47.48 83.18 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.52 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -68.2 -49.12 62.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.042 -1.036 . . . . 0.0 110.652 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.524 HG23 ' CG1' ' A' ' 432' ' ' VAL . 45.0 mm -65.06 -43.29 95.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.108 -0.995 . . . . 0.0 110.809 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.58 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 2.4 ttt180 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.0 mtt-85 -61.14 -37.75 83.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.979 -1.075 . . . . 0.0 109.607 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.517 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.2 t-80 -67.62 -35.85 79.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 111.222 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.85 -48.98 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.673 -1.267 . . . . 0.0 110.187 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.2 -34.45 77.68 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.291 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.99 79.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.954 -1.091 . . . . 0.0 110.021 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.532 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 6.3 m-80 -61.55 -27.67 68.79 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.491 -0.756 . . . . 0.0 109.114 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.13 19.77 27.53 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.1 -169.14 15.85 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -143.86 153.61 42.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -1.215 . . . . 0.0 111.328 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.582 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 8.3 p90 -108.01 149.66 39.39 Favored Pre-proline 0 N--CA 1.501 2.105 0 O-C-N 121.625 -0.672 . . . . 0.0 110.24 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.547 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.95 125.21 9.2 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.853 1.449 . . . . 0.0 110.573 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.79 -34.32 77.56 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.161 -0.962 . . . . 0.0 111.051 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.7 m-20 -60.84 -33.08 72.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 108.864 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 53.0 t -83.78 -42.57 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.017 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 71.9 m-20 -54.85 -37.29 66.01 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.48 171.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.4 mt-30 -63.31 -48.68 77.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.292 -1.505 . . . . 0.0 110.102 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.508 ' CD ' HG22 ' A' ' 323' ' ' ILE . 26.3 mttt -56.84 -34.85 68.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.704 -1.248 . . . . 0.0 110.392 177.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 109.171 171.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.9 t0 -66.62 -36.66 83.13 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.791 0.805 . . . . 0.0 109.517 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 84.8 mt-30 -67.04 -37.02 83.34 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.631 -0.668 . . . . 0.0 110.612 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 68.0 t -62.43 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.125 . . . . 0.0 110.005 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.68 -43.96 87.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -0.908 . . . . 0.0 110.435 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 6.0 mtp85 -64.98 -29.86 70.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 110.517 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.28 -3.87 53.84 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.683 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.52 22.1 38.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.512 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -106.39 164.26 12.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.395 -1.062 . . . . 0.0 109.727 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.466 ' O ' HD12 ' A' ' 445' ' ' LEU . 28.4 m -109.57 107.04 59.19 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.512 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.0 Cg_endo -75.61 108.27 2.66 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 O-C-N 124.014 1.534 . . . . 0.0 110.62 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.533 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.1 mt -92.6 134.13 35.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.872 -1.142 . . . . 0.0 108.622 167.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG12 ' A' ' 439' ' ' VAL . 90.3 t -100.51 134.29 40.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.771 -1.205 . . . . 0.0 109.504 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.473 ' O ' HD11 ' A' ' 440' ' ' LEU . 42.3 t -115.03 139.09 43.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -119.89 160.09 20.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.458 -0.776 . . . . 0.0 109.587 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.499 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.5 tt0 -135.01 130.38 35.61 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.58 -129.22 27.74 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -167.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.532 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 78.0 p -106.16 7.64 31.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.244 . . . . 0.0 111.082 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -118.99 170.43 9.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.588 -1.32 . . . . 0.0 110.048 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.529 HG12 ' CG1' ' A' ' 432' ' ' VAL . 24.3 t -92.67 134.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.606 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.4 pp -96.68 -20.6 18.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.721 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.555 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.76 176.53 38.46 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 118.815 -1.659 . . . . 0.0 111.024 168.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 55.8 t -107.7 142.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.242 -1.152 . . . . 0.0 109.95 173.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.523 HD11 ' CB ' ' A' ' 337' ' ' ALA . 81.7 mt -101.32 110.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 109.023 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.525 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -91.7 118.31 30.54 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.047 -1.033 . . . . 0.0 109.831 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.533 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -101.67 141.67 34.18 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.564 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 11.0 mtmt -115.7 162.11 17.73 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.763 -1.211 . . . . 0.0 111.038 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -81.15 144.62 31.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.599 -0.688 . . . . 0.0 110.227 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.6 tp -119.99 153.67 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 110.267 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.54 135.05 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.246 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -92.96 144.99 24.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 110.21 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.989 -1.45 . . . . 0.0 109.505 179.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.185 0.517 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.461 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 70.8 mtt85 -122.1 144.18 49.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.132 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.478 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 63.4 tt0 -122.5 130.75 53.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 110.354 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 445' ' ' LEU . . . -54.72 138.62 41.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.992 -1.067 . . . . 0.0 109.815 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.508 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.41 -45.16 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.99 . . . . 0.0 110.339 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 320' ' ' SER . 72.4 mt-10 -154.53 154.59 33.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.228 -0.92 . . . . 0.0 110.511 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.672 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 15.6 p90 -135.51 151.5 50.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.956 -1.09 . . . . 0.0 111.572 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 324' ' ' PRO . 3.4 mt -125.56 140.59 36.79 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.699 -0.625 . . . . 0.0 109.336 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.544 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.78 143.12 45.08 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.617 1.325 . . . . 0.0 111.64 -173.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.602 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -70.22 151.29 45.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.455 -0.778 . . . . 0.0 108.977 165.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.99 129.13 40.51 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.704 -1.247 . . . . 0.0 110.069 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.65 -0.35 49.25 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 46.5 t -135.36 138.05 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.578 -1.543 . . . . 0.0 110.759 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.417 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.6 m-20 -73.12 148.98 43.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.346 -0.846 . . . . 0.0 110.275 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.2 tt0 -60.59 -34.15 73.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.039 -1.038 . . . . 0.0 109.778 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -58.85 -43.73 90.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 109.139 175.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.444 HG23 HG11 ' A' ' 328' ' ' VAL . 88.9 m -61.17 -42.26 98.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.417 -0.802 . . . . 0.0 110.333 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.57 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 6.1 tp -60.48 -39.61 88.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.51 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.93 -44.04 77.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 110.69 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.9 m-20 -63.51 -48.07 79.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.912 -1.118 . . . . 0.0 110.063 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -69.17 -31.25 69.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.007 -1.058 . . . . 0.0 109.991 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.521 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.13 -35.55 64.81 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 0.0 108.915 172.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 14.8 mt-30 -74.3 -55.71 5.71 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.72 . . . . 0.0 111.023 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -64.9 -33.61 76.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.741 -1.183 . . . . 0.0 110.177 -172.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -67.72 -21.03 65.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.882 -1.136 . . . . 0.0 110.009 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.464 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 93.2 p -107.32 10.51 29.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.104 -0.997 . . . . 0.0 111.536 -174.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.587 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 43.6 mt -66.1 -45.18 82.09 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.612 -1.305 . . . . 0.0 109.758 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.05 0.73 49.13 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.976 -170.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 11.7 p30 -63.02 130.47 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.745 -1.222 . . . . 0.0 109.977 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.66 5.31 51.77 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.576 0.703 . . . . 0.0 109.923 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.05 152.87 84.52 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.666 -0.646 . . . . 0.0 109.443 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.58 -38.56 94.02 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.645 1.339 . . . . 0.0 109.117 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.32 -28.91 70.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.499 -0.751 . . . . 0.0 110.41 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.02 -37.49 71.41 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -76.92 -38.9 52.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -1.223 . . . . 0.0 110.598 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.478 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.8 m -62.13 -37.37 84.91 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 110.477 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 88.6 mt -68.55 -48.82 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.066 -1.021 . . . . 0.0 110.493 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.532 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 22.0 t -60.9 -32.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.825 -1.172 . . . . 0.0 109.797 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.491 ' CG2' ' OE1' ' A' ' 358' ' ' GLN . 39.5 mt -72.8 -33.1 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 110.628 171.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.63 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.6 -41.08 84.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.866 -1.146 . . . . 0.0 110.274 178.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.495 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.27 -45.58 87.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.624 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.535 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 33.7 mtmt -72.36 -49.29 35.23 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.53 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.498 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.3 pt20 -72.23 -42.82 65.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.519 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -73.83 -43.75 57.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 111.227 -172.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.672 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 82.6 m-85 -135.42 -38.8 0.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.349 -1.341 . . . . 0.0 111.83 -168.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 363' ' ' ARG . 16.7 t-20 -162.77 108.36 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.576 -1.328 . . . . 0.0 111.423 -167.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 68.6 mt -57.1 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.016 -1.053 . . . . 0.0 109.096 172.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.1 tpt180 -122.59 164.77 17.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.774 . . . . 0.0 109.408 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.1 mt-10 -141.21 -161.84 1.28 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.587 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 32.1 ptt-85 -97.6 163.67 12.74 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.638 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -129.67 41.8 3.38 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.331 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.579 HG11 ' CE2' ' A' ' 374' ' ' PHE . 41.3 t -73.02 -46.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.19 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 111.109 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.11 -30.12 28.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.692 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.53 ' CB ' HD12 ' A' ' 388' ' ' ILE . 21.5 mt -102.69 -4.64 24.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.684 -177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 71.4 m-70 60.43 52.21 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.536 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -94.02 174.51 7.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.491 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 24.0 m -117.12 134.77 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.566 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.579 ' CE2' HG11 ' A' ' 367' ' ' VAL . 92.1 m-85 -90.13 145.91 24.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 6.5 t -119.11 101.22 49.99 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.649 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.54 153.71 22.41 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.073 1.565 . . . . 0.0 110.515 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.549 ' CE2' ' N ' ' A' ' 383' ' ' MET . 55.0 t80 -69.45 134.68 49.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 110.448 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 5.6 p -115.3 143.48 45.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.373 -0.829 . . . . 0.0 109.753 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.47 -24.8 59.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.689 -0.632 . . . . 0.0 110.418 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -61.55 -44.15 97.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 109.733 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 383' ' ' MET . 87.5 p -94.71 -13.57 25.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 110.183 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 381' ' ' SER . 98.2 mtt180 57.75 48.09 14.46 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.606 -0.684 . . . . 0.0 109.803 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.549 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.2 ptp -165.44 171.55 13.21 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.779 0.799 . . . . 0.0 111.258 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.522 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 29.0 p -155.46 165.36 36.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.5 -165.73 34.09 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.048 -1.548 . . . . 0.0 110.694 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.522 HD13 ' CG2' ' A' ' 367' ' ' VAL . 4.5 tt -140.02 151.51 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.921 . . . . 0.0 110.208 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -127.54 135.55 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 109.693 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -140.93 155.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.816 -1.178 . . . . 0.0 109.174 172.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.502 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.5 m-20 -23.08 -63.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.389 0.614 . . . . 0.0 112.502 171.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.45 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 37.1 t30 -96.46 -5.1 40.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 111.808 -167.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.546 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.2 mtp180 -144.97 143.0 30.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.719 -1.238 . . . . 0.0 110.342 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -133.66 108.52 8.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 108.897 169.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 7.8 mt -128.65 146.03 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 0.0 109.931 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.483 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.1 mmt85 -134.43 159.7 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.295 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.1 OUTLIER -133.13 126.65 32.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.471 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.19 174.39 32.63 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -57.04 151.28 15.36 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.976 -1.308 . . . . 0.0 108.566 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.542 ' CG2' HG11 ' A' ' 420' ' ' VAL . 56.0 t -56.7 -35.01 44.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.851 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.85 -47.02 85.17 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.261 -0.9 . . . . 0.0 110.321 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.491 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -67.91 -49.18 63.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.963 -1.086 . . . . 0.0 110.59 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.522 HG22 ' CG1' ' A' ' 432' ' ' VAL . 39.4 mm -65.59 -43.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.06 -1.025 . . . . 0.0 110.817 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.8 ttp180 -59.22 -43.26 92.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.243 -0.911 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.5 mtp180 -61.88 -36.37 81.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 173.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -67.93 -36.25 79.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.878 . . . . 0.0 111.236 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.62 -49.13 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.479 -1.388 . . . . 0.0 110.103 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -34.34 77.46 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.325 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.73 78.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.946 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.529 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 10.9 m-80 -61.8 -27.31 68.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.11 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.89 19.57 28.62 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.57 -169.02 16.17 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -143.21 153.41 42.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.163 -1.198 . . . . 0.0 111.324 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.584 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.5 p90 -108.39 149.75 39.71 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.642 -0.661 . . . . 0.0 110.182 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.71 124.0 8.45 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.879 1.463 . . . . 0.0 110.5 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.25 -34.22 77.51 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.986 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 91.1 m-20 -60.82 -33.03 72.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 108.836 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.602 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 53.7 t -83.52 -42.48 17.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.3 m-20 -54.8 -37.41 66.03 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.559 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.25 -48.32 78.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.17 -1.581 . . . . 0.0 110.104 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 19.1 mttp -56.58 -35.2 67.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.6 -1.313 . . . . 0.0 110.429 176.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -59.65 -40.98 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.885 -1.135 . . . . 0.0 109.208 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.76 -36.28 82.06 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.824 0.821 . . . . 0.0 109.581 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.67 -36.78 81.34 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.689 -0.632 . . . . 0.0 110.692 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.523 ' CG2' ' HB1' ' A' ' 444' ' ' ALA . 79.2 t -62.84 -37.95 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.005 -1.059 . . . . 0.0 110.043 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.13 85.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 110.406 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -67.91 -31.5 71.31 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 110.922 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.31 -3.47 55.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.724 175.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.92 22.04 29.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.52 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -106.99 164.09 12.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.562 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.473 ' O ' HD11 ' A' ' 445' ' ' LEU . 93.9 m -109.89 107.29 58.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.077 -1.014 . . . . 0.0 109.691 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.496 ' CG ' HG12 ' A' ' 420' ' ' VAL . 39.7 Cg_endo -75.95 108.04 2.6 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 123.88 1.463 . . . . 0.0 110.613 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.539 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 13.4 mt -92.83 134.33 35.18 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.837 -1.164 . . . . 0.0 108.64 166.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.528 ' CG1' HG12 ' A' ' 439' ' ' VAL . 89.4 t -100.67 134.6 40.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 120.698 -1.251 . . . . 0.0 109.445 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 45.3 t -115.09 136.36 52.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.4 m -117.09 159.92 16.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.41 -0.806 . . . . 0.0 109.601 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.462 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.91 130.63 34.07 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.08 -133.17 31.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 77.8 p -102.46 8.34 40.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.105 -1.232 . . . . 0.0 111.053 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -120.44 171.01 8.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.546 -1.346 . . . . 0.0 109.995 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.528 HG12 ' CG1' ' A' ' 432' ' ' VAL . 23.7 t -92.59 134.52 30.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.845 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.609 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -94.42 -22.13 18.49 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.308 -0.87 . . . . 0.0 109.793 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.555 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.47 176.95 38.64 Favored Glycine 0 N--CA 1.499 2.851 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.965 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 55.5 t -107.95 142.83 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.247 -1.149 . . . . 0.0 109.915 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.521 HD12 ' CB ' ' A' ' 337' ' ' ALA . 77.1 mt -101.49 111.42 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 108.907 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -91.85 118.58 30.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.917 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.539 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -113.47 162.02 16.64 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.759 -1.213 . . . . 0.0 110.974 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -73.63 144.73 45.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.638 -0.663 . . . . 0.0 110.207 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.3 tp -120.69 153.46 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 110.227 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.21 135.44 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.27 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -90.59 145.39 24.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.187 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 117.937 -1.479 . . . . 0.0 109.501 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.228 0.537 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 97.3 mtt180 -122.85 146.69 47.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.893 . . . . 0.0 110.181 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.511 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.8 mt-30 -133.81 147.95 51.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.247 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -59.85 138.27 57.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 109.965 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.47 ' O ' ' HD2' ' A' ' 359' ' ' ARG . 46.6 m -122.13 -40.98 2.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.501 ' HG2' ' NH2' ' A' ' 359' ' ' ARG . 65.9 mt-10 -154.94 149.82 26.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.683 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 10.5 p90 -135.97 157.74 46.09 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.48 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.473 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.4 mt -134.84 140.16 34.38 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.604 -0.685 . . . . 0.0 109.397 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.545 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.54 144.82 50.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.644 1.339 . . . . 0.0 111.568 -172.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.74 151.52 43.5 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.134 -0.979 . . . . 0.0 108.829 164.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.86 129.4 41.95 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.658 -1.276 . . . . 0.0 110.095 -172.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.09 -1.48 44.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.3 t -136.16 138.92 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.473 . . . . 0.0 110.647 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.466 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.3 m-20 -73.36 151.88 41.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.166 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -62.86 -39.81 95.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.023 -1.048 . . . . 0.0 110.362 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.92 -42.93 90.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.782 -1.198 . . . . 0.0 109.438 175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 94.4 m -56.9 -43.62 81.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.859 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.7 tp -59.1 -40.58 85.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.33 -41.37 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.761 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -64.07 -49.73 71.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.914 -1.116 . . . . 0.0 109.92 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.98 -31.25 70.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.903 -1.123 . . . . 0.0 109.569 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.515 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.59 -35.23 65.59 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.324 -0.86 . . . . 0.0 108.985 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 22.7 mt-30 -74.25 -55.84 5.58 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.479 -0.763 . . . . 0.0 110.861 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.78 -36.14 80.22 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.681 -1.208 . . . . 0.0 109.807 -172.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -66.74 -20.67 66.01 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.055 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.463 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 91.2 p -107.35 9.18 29.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.215 -0.928 . . . . 0.0 111.552 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.4 -44.46 82.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.564 -1.335 . . . . 0.0 109.626 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -97.17 1.61 50.04 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.816 -170.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.49 ' OD2' ' NZ ' ' A' ' 395' ' ' LYS . 12.5 p30 -64.34 130.6 44.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.732 -1.23 . . . . 0.0 109.944 175.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.72 5.44 51.39 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.58 0.705 . . . . 0.0 109.872 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.31 150.43 80.1 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.53 -0.731 . . . . 0.0 109.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.74 -38.14 84.75 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.651 1.342 . . . . 0.0 109.148 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.29 -28.58 69.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.496 -0.752 . . . . 0.0 110.377 176.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.33 -37.6 74.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -175.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.455 ' O ' HD13 ' A' ' 354' ' ' ILE . 96.1 mtt180 -77.32 -38.0 51.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.658 174.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.511 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 9.6 m -61.36 -37.97 85.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 110.365 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 88.8 mt -68.51 -49.31 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.069 -1.02 . . . . 0.0 110.602 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.524 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 28.7 t -61.17 -33.36 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.935 -1.103 . . . . 0.0 110.167 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 350' ' ' ARG . 32.6 mt -72.84 -32.58 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.704 -1.248 . . . . 0.0 110.603 171.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.53 -40.82 88.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.964 -1.085 . . . . 0.0 110.414 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.26 -44.67 94.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.497 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.526 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 67.4 mttt -71.33 -47.37 56.96 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.743 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.536 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.5 pt20 -70.7 -42.58 70.45 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.667 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.536 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 40.8 mtp85 -79.89 -42.23 24.59 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 111.517 -170.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 85.5 m-85 -134.98 -35.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.437 -1.414 . . . . 0.0 112.097 -170.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 363' ' ' ARG . 57.0 t-20 -161.86 101.87 1.15 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.632 -1.293 . . . . 0.0 111.669 -169.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 32.5 mt -57.47 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.816 -1.177 . . . . 0.0 108.908 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.542 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.9 tpt180 -134.34 164.31 27.69 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.416 -0.802 . . . . 0.0 109.241 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.507 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -135.74 -157.08 0.76 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.962 -1.086 . . . . 0.0 110.355 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 37.1 ptt180 -94.54 163.24 13.47 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.651 -0.655 . . . . 0.0 110.494 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 370' ' ' LEU . 88.3 m-20 -130.82 42.26 3.26 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.398 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 374' ' ' PHE . 61.5 t -73.56 -45.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 110.345 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.78 -24.11 64.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.351 -0.843 . . . . 0.0 111.146 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.42 -32.85 32.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.013 -1.054 . . . . 0.0 109.719 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.527 ' CB ' HD11 ' A' ' 388' ' ' ILE . 12.4 mt -104.73 -2.64 24.64 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.565 -0.709 . . . . 0.0 110.569 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 70.8 m-70 61.06 51.93 4.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 109.827 -176.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -92.78 174.64 7.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 0.0 110.533 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.8 m -119.18 136.22 54.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.478 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 367' ' ' VAL . 73.4 m-85 -89.69 149.09 22.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 48.7 t -124.31 100.84 35.2 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.124 -0.985 . . . . 0.0 109.629 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -57.04 149.59 61.52 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.995 1.524 . . . . 0.0 110.251 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 21.4 t80 -63.61 129.95 42.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.87 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p -118.78 150.66 39.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.336 -0.853 . . . . 0.0 109.747 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.54 -4.26 47.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.584 -0.698 . . . . 0.0 109.985 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.55 -36.38 64.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.531 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 73.7 m -139.7 10.35 2.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 110.33 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 82.7 mtm180 58.1 52.77 7.28 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.311 -0.868 . . . . 0.0 109.735 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.526 ' HG2' ' CB ' ' A' ' 400' ' ' ALA . 0.7 OUTLIER -150.29 161.54 42.24 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.604 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 10.1 p -153.47 164.94 37.31 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 174.29 -164.94 36.26 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.881 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.516 HD13 ' CG2' ' A' ' 367' ' ' VAL . 3.6 tt -141.0 150.53 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.697 -0.884 . . . . 0.0 110.143 -176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -126.67 137.6 53.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.624 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.549 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 2.0 tt -141.53 154.7 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.352 172.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.506 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 88.9 m-20 -20.88 -62.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.48 0.657 . . . . 0.0 112.568 171.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.456 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t-20 -98.01 -7.49 29.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 111.934 -166.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 17.8 mtp180 -142.4 149.88 39.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.71 -1.244 . . . . 0.0 110.604 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -137.47 102.13 4.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 0.0 109.188 170.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.529 ' CD1' ' CB ' ' A' ' 336' ' ' ALA . 6.0 mt -121.64 146.09 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.097 -1.002 . . . . 0.0 110.007 -173.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.488 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 0.0 OUTLIER -136.77 155.32 49.98 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 110.261 177.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 43.7 pttt -129.23 145.82 51.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.17 173.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.405 ' CA ' ' CG1' ' A' ' 401' ' ' ILE . . . -170.54 174.89 44.51 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 52.5 p -55.85 150.45 13.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.784 -1.421 . . . . 0.0 108.526 170.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.538 ' CG2' ' CG2' ' A' ' 432' ' ' VAL . 64.1 t -59.78 -34.96 57.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.064 -1.023 . . . . 0.0 109.977 -174.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.517 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 49.2 t0 -62.32 -45.89 91.21 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.196 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.526 ' CB ' ' HG2' ' A' ' 383' ' ' MET . . . -70.75 -52.01 23.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.085 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.522 HD13 ' CE ' ' A' ' 383' ' ' MET . 21.1 mm -62.98 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.998 -1.064 . . . . 0.0 110.505 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 13.4 ttp85 -59.46 -43.91 93.11 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.517 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 93.1 mtt180 -61.23 -36.99 81.46 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.448 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -66.9 -35.86 80.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 437' ' ' SER . 55.3 t -64.81 -49.72 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.455 -1.403 . . . . 0.0 110.152 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.63 -34.67 77.52 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.86 -1.15 . . . . 0.0 110.239 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.14 -35.76 78.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.995 -1.066 . . . . 0.0 109.971 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.53 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.7 m-80 -61.38 -27.38 68.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 109.134 173.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.87 19.59 28.62 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -169.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.42 -169.32 16.38 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -145.26 153.94 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -1.161 . . . . 0.0 111.232 -174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 10.3 p90 -109.11 149.26 39.44 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.457 -0.777 . . . . 0.0 109.978 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.528 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.29 126.89 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.929 1.489 . . . . 0.0 110.401 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.462 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.3 t -66.92 -34.86 78.71 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.989 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.1 m-20 -62.01 -33.31 74.1 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.898 -1.126 . . . . 0.0 108.882 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 52.6 t -83.46 -41.77 17.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 110.987 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.33 -38.5 68.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.826 -1.171 . . . . 0.0 109.416 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.1 -47.92 80.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.374 -1.453 . . . . 0.0 110.264 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 66.9 mttm -56.39 -35.19 67.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.691 -1.256 . . . . 0.0 110.372 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.586 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -60.65 -40.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.405 172.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -65.85 -36.24 82.9 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 425' ' ' ARG . 94.9 mm-40 -68.38 -38.2 81.13 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.526 HG11 ' CB ' ' A' ' 428' ' ' ALA . 63.0 t -61.0 -37.03 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.689 -1.257 . . . . 0.0 110.056 175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.0 82.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.969 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 422' ' ' GLN . 17.7 ptt180 -70.86 -28.68 64.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.721 -1.237 . . . . 0.0 111.097 -171.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 1.0 OUTLIER -82.62 -8.55 59.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.895 -1.128 . . . . 0.0 109.64 174.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.43 22.21 13.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.526 ' CB ' HG11 ' A' ' 423' ' ' VAL . . . -102.9 161.9 13.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -1.157 . . . . 0.0 109.323 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 445' ' ' LEU . 2.0 m -109.16 106.94 59.49 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.062 . . . . 0.0 109.778 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.478 ' CG ' HG13 ' A' ' 420' ' ' VAL . 44.5 Cg_endo -76.57 107.67 2.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 124.015 1.534 . . . . 0.0 110.452 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 10.3 mt -92.43 133.47 35.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.92 -1.112 . . . . 0.0 108.533 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.538 ' CG2' ' CG2' ' A' ' 398' ' ' VAL . 89.2 t -99.01 135.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.711 -1.243 . . . . 0.0 109.424 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 44.0 t -117.66 136.7 53.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 108.91 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -117.86 160.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.458 ' CB ' HD21 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.52 129.01 34.47 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.69 -131.6 28.98 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -167.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.53 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 73.1 p -103.06 6.79 38.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.13 -1.218 . . . . 0.0 111.118 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -119.95 171.0 8.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.644 -1.285 . . . . 0.0 110.069 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 42.9 t -90.57 134.61 28.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.4 pp -93.17 -22.6 18.96 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.672 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.548 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.33 176.87 39.04 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 118.883 -1.627 . . . . 0.0 110.721 170.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.586 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 56.6 t -107.94 142.84 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.161 -1.2 . . . . 0.0 109.994 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 337' ' ' ALA . 82.8 mt -101.83 110.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 170.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -92.08 118.48 30.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.826 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.529 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -101.23 146.09 27.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.457 ' HG2' ' HB2' ' A' ' 320' ' ' SER . 15.2 mmtp -107.61 150.38 26.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.566 -1.334 . . . . 0.0 110.58 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -101.13 148.16 25.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.708 -0.62 . . . . 0.0 110.255 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.5 tp -119.61 153.58 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 110.237 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.57 135.52 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.902 . . . . 0.0 110.329 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -90.75 145.6 24.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.22 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.561 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 75.9 mtt85 -123.05 150.29 43.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.254 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 351' ' ' SER . 93.4 mt-30 -125.31 147.83 48.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.863 . . . . 0.0 109.994 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.52 ' CB ' HD23 ' A' ' 445' ' ' LEU . . . -57.32 135.96 56.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.841 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.527 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 2.4 m -127.48 -37.21 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 110.385 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.469 ' N ' HD11 ' A' ' 355' ' ' LEU . 65.2 mt-10 -153.58 148.07 26.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.958 . . . . 0.0 110.597 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.639 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 6.1 p90 -137.86 147.4 44.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.726 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.475 HG22 ' HD2' ' A' ' 324' ' ' PRO . 2.8 mt -119.96 141.83 32.16 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 109.625 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.02 143.23 40.06 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.735 1.387 . . . . 0.0 111.481 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -70.85 152.65 43.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.185 -0.947 . . . . 0.0 108.662 165.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -57.56 127.85 34.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.679 -1.263 . . . . 0.0 110.336 -172.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 115.68 -28.0 8.03 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 42.4 t -115.0 140.49 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.738 -1.448 . . . . 0.0 110.943 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.03 150.13 44.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 109.788 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -61.35 -39.47 90.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -60.51 -45.12 94.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.795 -1.191 . . . . 0.0 109.735 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.436 ' HB ' HG12 ' A' ' 328' ' ' VAL . 92.4 m -55.97 -43.92 78.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.698 173.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.529 HD13 ' CD1' ' A' ' 440' ' ' LEU . 5.1 tp -58.03 -39.14 77.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.817 . . . . 0.0 110.233 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.92 -42.1 81.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 0.0 110.691 -176.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -62.87 -48.35 79.4 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.924 -1.11 . . . . 0.0 109.832 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.02 -31.86 71.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.026 -1.046 . . . . 0.0 109.765 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.52 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.32 -35.25 64.93 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 172.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 20.6 mt-30 -74.67 -56.28 4.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.501 -0.749 . . . . 0.0 110.838 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -60.97 -35.39 76.67 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.756 -1.177 . . . . 0.0 109.772 -172.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 395' ' ' LYS . . . -68.03 -19.52 64.91 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.088 -1.007 . . . . 0.0 109.782 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.457 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.1 p -108.23 9.41 28.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.206 -0.934 . . . . 0.0 111.639 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.541 HD11 ' CB ' ' A' ' 365' ' ' ARG . 36.8 mt -64.71 -44.84 88.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.551 -1.343 . . . . 0.0 109.705 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -98.49 1.72 46.94 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.707 -169.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.1 p30 -62.61 130.28 44.36 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.952 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.68 5.35 51.63 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.528 0.68 . . . . 0.0 109.891 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.56 152.4 83.3 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.607 -0.683 . . . . 0.0 109.432 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.95 -38.79 94.15 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.713 1.375 . . . . 0.0 109.08 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.35 -28.87 70.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.458 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.51 -37.26 66.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.444 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -76.69 -37.37 56.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.219 . . . . 0.0 110.553 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 318' ' ' GLN . 11.3 m -61.36 -38.44 86.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.001 -1.062 . . . . 0.0 110.42 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.526 ' CG2' HD11 ' A' ' 443' ' ' ILE . 83.7 mt -68.98 -48.84 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.051 . . . . 0.0 110.534 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.513 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 30.4 t -61.67 -34.03 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.952 -1.092 . . . . 0.0 110.076 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.4 mt -72.89 -32.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.601 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.68 -40.91 89.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.39 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.93 99.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 82.7 mttt -71.26 -50.21 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.892 -1.13 . . . . 0.0 110.924 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.548 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.9 pt20 -70.36 -42.38 71.89 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.497 -174.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 30.6 mmt180 -74.16 -46.02 44.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 111.24 -172.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 78.3 m-85 -135.51 -35.5 0.81 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.437 -1.305 . . . . 0.0 112.437 -168.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.498 ' OD1' ' CB ' ' A' ' 363' ' ' ARG . 23.1 t-20 -160.52 97.85 1.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.484 -1.385 . . . . 0.0 111.677 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.534 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 5.5 mp -58.77 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.933 -1.105 . . . . 0.0 109.59 171.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.8 tpt180 -147.84 163.08 37.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.387 -0.821 . . . . 0.0 109.618 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.512 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.7 mt-10 -125.97 -157.36 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.541 ' CB ' HD11 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -96.66 165.35 12.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.531 -0.73 . . . . 0.0 110.596 -178.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.469 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -121.0 38.08 4.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.428 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.639 ' CG1' ' CZ ' ' A' ' 374' ' ' PHE . 71.0 t -69.28 -44.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.787 . . . . 0.0 110.307 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -67.43 -26.6 66.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.971 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -29.14 25.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.904 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.602 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.7 mt -103.45 -2.36 27.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.777 . . . . 0.0 110.837 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 27.2 m80 62.62 52.65 2.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.09 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.544 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -94.99 174.71 6.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.9 m -115.97 134.32 55.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 110.421 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.639 ' CZ ' ' CG1' ' A' ' 367' ' ' VAL . 68.3 m-85 -89.19 149.26 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.541 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 24.1 t -122.71 100.97 40.29 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.11 151.45 42.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.124 1.592 . . . . 0.0 110.486 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.51 131.63 46.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.096 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.1 p -120.71 152.94 37.62 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.44 -6.02 51.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.511 -0.743 . . . . 0.0 109.967 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.81 -32.86 66.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.872 . . . . 0.0 109.823 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 2.7 m -139.51 10.2 2.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 110.237 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 72.3 mtt85 56.91 51.06 11.2 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.519 ' CE ' HD12 ' A' ' 401' ' ' ILE . 3.3 ptp -158.69 168.61 26.41 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.948 0.88 . . . . 0.0 111.277 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 34.1 p -152.86 165.19 36.22 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.74 -165.89 32.96 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.04 -1.552 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.527 HD13 ' CG2' ' A' ' 367' ' ' VAL . 9.4 tt -144.1 150.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -1.03 . . . . 0.0 110.104 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 394' ' ' ARG . 43.0 m-20 -127.59 133.04 49.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.864 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.602 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.6 tt -139.28 155.03 25.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.75 -1.219 . . . . 0.0 109.165 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.504 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 90.7 m-20 -23.8 -62.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 172.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.436 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 49.5 t30 -92.36 -9.58 41.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 111.884 -167.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.558 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.4 mtp180 -140.56 147.4 39.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.613 -1.304 . . . . 0.0 110.744 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.5 mtt -138.3 100.67 4.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.983 -1.073 . . . . 0.0 109.112 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.527 HD13 ' CD1' ' A' ' 339' ' ' LEU . 7.5 mt -122.66 146.47 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.934 -1.104 . . . . 0.0 110.296 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 387' ' ' ASN . 66.6 mmt-85 -130.49 156.84 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.142 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -132.91 125.46 29.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.458 -0.776 . . . . 0.0 108.97 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -153.85 173.94 32.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.717 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.4 m -56.09 150.74 13.36 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.916 -1.343 . . . . 0.0 108.537 169.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.536 ' CG2' HG11 ' A' ' 420' ' ' VAL . 17.7 t -55.69 -37.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 109.932 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -64.04 -43.74 94.62 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.287 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.517 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -68.35 -51.2 47.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.529 HG22 ' CG1' ' A' ' 432' ' ' VAL . 33.5 mm -64.96 -44.07 96.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 120.995 -1.066 . . . . 0.0 110.789 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.588 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.5 ttt180 -59.47 -42.94 93.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.192 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.9 mtp85 -61.65 -36.32 80.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.9 t-80 -67.49 -38.37 84.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 111.323 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.88 -47.42 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.08 -34.25 77.6 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.859 -1.151 . . . . 0.0 110.33 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.34 80.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.093 . . . . 0.0 109.857 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 24.5 m-80 -62.01 -27.15 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.73 30.53 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -168.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.26 -170.67 18.37 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -146.9 153.92 40.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.173 -1.192 . . . . 0.0 111.111 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.8 p90 -108.99 151.9 42.15 Favored Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.456 -0.778 . . . . 0.0 110.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.533 ' CG ' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.4 125.99 11.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.909 1.478 . . . . 0.0 110.344 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.3 t -67.55 -32.74 73.71 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.7 m-20 -62.96 -33.6 75.73 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.895 -1.128 . . . . 0.0 108.808 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.594 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 51.1 t -83.71 -41.74 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.018 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.06 -38.37 67.94 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.8 -1.188 . . . . 0.0 109.475 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.3 mm-40 -63.48 -48.1 79.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 110.294 171.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 48.7 mttm -56.44 -35.25 67.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.611 -1.306 . . . . 0.0 110.411 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.9 t -60.14 -41.31 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.965 -1.084 . . . . 0.0 109.327 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.15 -35.91 81.74 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.852 0.835 . . . . 0.0 109.442 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -68.48 -37.62 80.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.582 -0.699 . . . . 0.0 110.886 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 70.9 t -62.85 -37.87 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.974 -1.079 . . . . 0.0 110.008 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.17 -40.38 82.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.945 . . . . 0.0 110.373 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.54 -31.22 70.3 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.252 -0.905 . . . . 0.0 110.931 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.46 -3.83 54.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.064 -1.023 . . . . 0.0 109.607 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 21.83 30.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.454 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.91 169.99 8.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 109.798 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.475 ' O ' HD13 ' A' ' 445' ' ' LEU . 16.7 m -113.18 106.82 54.52 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.04 -1.037 . . . . 0.0 110.075 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.491 ' CG ' HG12 ' A' ' 420' ' ' VAL . 49.4 Cg_endo -79.39 107.38 2.16 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 O-C-N 123.898 1.473 . . . . 0.0 110.489 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.8 mt -93.09 137.95 31.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.883 -1.136 . . . . 0.0 108.625 167.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG22 ' A' ' 401' ' ' ILE . 92.4 t -101.56 134.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.678 -1.264 . . . . 0.0 109.613 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 42.7 t -114.52 134.53 57.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 108.824 174.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.528 ' CG1' HG21 ' A' ' 439' ' ' VAL . 2.5 m -118.4 160.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.451 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.52 130.15 32.04 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.88 -127.99 28.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.66 13.53 25.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -1.223 . . . . 0.0 111.233 -178.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -126.35 170.42 11.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 109.949 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.528 HG21 ' CG1' ' A' ' 434' ' ' VAL . 60.5 t -89.87 133.73 31.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.76 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.609 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -92.74 -21.36 20.0 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.323 -0.861 . . . . 0.0 109.574 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.544 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.93 176.86 39.36 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 118.909 -1.615 . . . . 0.0 111.093 169.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 56.4 t -107.88 142.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.071 -1.252 . . . . 0.0 109.777 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.526 HD11 ' CG2' ' A' ' 352' ' ' ILE . 77.5 mt -101.44 113.08 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.373 -0.83 . . . . 0.0 109.036 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.524 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.38 118.63 31.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.036 -1.04 . . . . 0.0 109.881 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.536 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.8 144.23 30.72 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.527 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.6 OUTLIER -137.4 168.32 19.87 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.574 -1.329 . . . . 0.0 110.986 -177.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -71.0 148.27 47.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.517 -0.739 . . . . 0.0 110.292 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.7 tp -117.27 154.31 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 110.117 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.25 136.36 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.336 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -142.17 147.48 36.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.011 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.547 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.241 0.543 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 94.5 mtt180 -123.22 144.1 49.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.511 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.1 mt-30 -130.37 148.81 52.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.081 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.512 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -57.79 136.83 56.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.97 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 3.4 m -118.98 -42.94 2.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 320' ' ' SER . 67.7 mt-10 -154.69 150.89 28.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.444 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.628 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 6.8 p90 -137.53 145.11 42.55 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.763 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.26 144.42 34.96 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.596 -0.69 . . . . 0.0 109.775 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.6 143.62 38.39 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.764 1.402 . . . . 0.0 111.531 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.53 153.1 41.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 108.793 165.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.85 128.41 37.06 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.675 -1.266 . . . . 0.0 110.146 -172.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.86 -2.6 38.64 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.4 t -136.18 139.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.67 -1.488 . . . . 0.0 110.866 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.65 152.67 41.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.578 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.7 tt0 -62.01 -39.23 91.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.053 -1.029 . . . . 0.0 110.365 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -61.08 -45.21 95.67 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.816 -1.177 . . . . 0.0 109.765 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.424 ' HB ' HG11 ' A' ' 328' ' ' VAL . 92.2 m -55.8 -44.17 77.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.197 -0.94 . . . . 0.0 109.596 173.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.541 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.3 tp -57.99 -39.87 79.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.315 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.08 -1.013 . . . . 0.0 110.788 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.0 m-20 -63.44 -49.27 74.33 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.872 -1.143 . . . . 0.0 109.758 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.48 -31.67 71.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.821 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.52 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -54.69 -35.55 63.71 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.066 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.4 mt-30 -75.23 -55.79 5.36 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.506 -0.746 . . . . 0.0 110.999 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.28 -34.99 76.1 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.786 -172.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -66.89 -21.51 66.0 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.14 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 90.9 p -108.09 10.32 28.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.097 -1.002 . . . . 0.0 111.632 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.28 -44.67 82.92 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.696 -1.252 . . . . 0.0 109.694 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -97.26 1.43 49.62 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.885 -170.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 341' ' ' SER . 12.7 p30 -64.96 130.22 42.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.753 -1.217 . . . . 0.0 110.03 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.61 4.08 53.43 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.555 0.693 . . . . 0.0 109.863 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.2 p -73.79 152.62 89.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 109.38 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -55.94 -39.26 92.28 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.724 1.381 . . . . 0.0 109.149 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.8 mt-10 -65.05 -27.68 68.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.504 -0.747 . . . . 0.0 110.474 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.06 -39.24 79.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.451 ' O ' HD11 ' A' ' 354' ' ' ILE . 65.4 mtt85 -78.55 -35.78 45.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.6 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.511 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 6.3 m -60.98 -38.92 87.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.954 -1.091 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.525 ' CG2' HD13 ' A' ' 443' ' ' ILE . 88.2 mt -68.45 -49.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.062 . . . . 0.0 110.655 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.517 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 24.3 t -61.06 -34.57 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.988 -1.07 . . . . 0.0 110.124 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 350' ' ' ARG . 31.4 mt -72.52 -31.97 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 110.455 171.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.628 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.9 OUTLIER -60.12 -40.96 91.57 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.941 -1.099 . . . . 0.0 110.494 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.39 98.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 110.326 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 71.0 mttt -71.33 -49.09 45.99 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.68 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 11.7 pt20 -71.98 -43.26 65.42 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.73 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.572 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 78.7 mmt-85 -73.63 -44.44 56.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 111.435 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.578 ' CE2' ' OE2' ' A' ' 330' ' ' GLU . 60.3 m-85 -135.27 -38.72 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.522 -1.361 . . . . 0.0 112.125 -168.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.478 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.9 t30 -159.45 104.11 1.62 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.214 . . . . 0.0 111.58 -168.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 41.4 mt -57.42 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.875 -1.141 . . . . 0.0 108.912 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.492 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.7 tpt180 -131.42 164.06 26.56 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.477 -0.764 . . . . 0.0 109.25 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.9 mt-10 -138.13 -158.13 0.83 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.978 -1.076 . . . . 0.0 110.543 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.584 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.9 ptt85 -97.2 162.54 13.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 110.677 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 365' ' ' ARG . 89.2 m-20 -133.49 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.507 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 374' ' ' PHE . 63.6 t -73.4 -47.61 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.491 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.02 -23.55 65.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -30.43 27.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.021 -1.05 . . . . 0.0 109.753 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.591 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 16.9 mt -103.53 -4.97 23.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.523 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 56.5 m-70 64.22 52.06 2.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.186 -176.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.545 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.86 174.91 6.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.631 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.4 m -117.98 136.03 53.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.1 m-85 -88.5 149.11 23.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.596 174.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 61.8 t -122.31 101.06 41.39 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.133 -0.979 . . . . 0.0 109.658 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.48 151.18 38.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.003 1.528 . . . . 0.0 110.413 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 15.1 t80 -65.02 132.31 48.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 110.048 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.4 p -120.67 151.96 38.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.354 -0.841 . . . . 0.0 109.611 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.43 -6.79 54.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.555 -0.716 . . . . 0.0 109.868 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -57.11 -32.87 66.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.768 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.523 ' OG ' ' CG ' ' A' ' 383' ' ' MET . 6.8 p -138.4 9.61 2.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.331 -0.856 . . . . 0.0 110.353 174.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 79.9 mtm180 57.2 50.86 11.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.55 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.524 ' HE1' ' CB ' ' A' ' 400' ' ' ALA . 3.4 ptp -158.78 168.41 26.9 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.362 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.519 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.7 p -153.6 164.93 37.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.32 -166.68 35.54 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.714 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.518 HD11 ' CG2' ' A' ' 367' ' ' VAL . 4.2 tt -138.9 148.99 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.681 -0.894 . . . . 0.0 110.021 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -127.49 134.91 49.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.892 -1.13 . . . . 0.0 109.678 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.591 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.8 tt -139.84 154.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.922 -1.111 . . . . 0.0 109.443 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.2 -62.99 0.06 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.48 0.657 . . . . 0.0 112.259 172.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 54.0 t30 -90.93 -10.21 43.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 111.686 -168.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.539 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 23.2 mtp180 -142.31 147.02 35.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.612 -1.305 . . . . 0.0 110.76 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.7 mtt -135.6 108.54 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.916 -1.115 . . . . 0.0 108.996 169.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 8.4 mt -128.17 145.9 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.008 -1.057 . . . . 0.0 110.058 -175.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.471 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 33.4 mtt180 -136.14 160.76 37.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 0.0 110.833 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.482 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.59 128.05 34.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.469 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -153.62 173.94 32.28 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 28.5 m -57.27 152.22 14.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.97 -1.312 . . . . 0.0 108.721 170.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.531 ' CG2' HG13 ' A' ' 420' ' ' VAL . 79.1 t -55.72 -35.99 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 109.783 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.6 t0 -63.25 -46.62 86.04 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.359 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.524 ' CB ' ' HE1' ' A' ' 383' ' ' MET . . . -68.14 -50.57 53.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.497 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.529 HG23 ' CG1' ' A' ' 432' ' ' VAL . 28.4 mm -64.59 -43.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.788 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.589 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.4 ttp180 -59.64 -43.71 93.76 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 67.2 mtp180 -61.93 -36.19 80.65 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.075 -1.015 . . . . 0.0 109.501 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -68.5 -36.46 78.94 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 111.353 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 437' ' ' SER . 55.8 t -65.97 -48.91 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.585 -1.322 . . . . 0.0 110.102 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.37 -34.21 77.22 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.2 79.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.074 . . . . 0.0 109.931 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.532 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.6 m-80 -61.34 -27.7 68.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 109.153 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.12 19.8 27.45 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -169.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.63 -170.05 15.92 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -144.95 153.79 41.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.186 -1.185 . . . . 0.0 111.097 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.2 p90 -107.9 150.21 40.02 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.506 -0.746 . . . . 0.0 110.085 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.535 ' CG ' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.98 126.25 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.902 1.475 . . . . 0.0 110.291 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 2.0 t -67.64 -32.48 73.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.976 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 88.7 m-20 -63.43 -33.41 75.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.893 -1.13 . . . . 0.0 108.728 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.594 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 49.1 t -83.57 -40.99 16.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.938 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 52.4 t0 -55.19 -38.5 68.46 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.691 -1.204 . . . . 0.0 109.452 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.6 mt-30 -63.4 -48.62 77.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.433 -1.417 . . . . 0.0 110.285 171.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 50.1 mmtt -56.16 -35.15 66.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.667 -1.271 . . . . 0.0 110.488 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -59.65 -41.59 85.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 109.149 171.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -65.72 -35.81 81.82 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.896 0.855 . . . . 0.0 109.458 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.73 -36.94 81.49 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.556 -0.715 . . . . 0.0 110.724 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.513 HG23 ' CB ' ' A' ' 444' ' ' ALA . 68.7 t -62.94 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 110.046 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.82 85.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.307 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -69.42 -30.69 68.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.243 -0.91 . . . . 0.0 110.862 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.7 -3.57 56.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.7 21.89 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.458 ' HB3' HG11 ' A' ' 423' ' ' VAL . . . -107.42 166.41 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -1.139 . . . . 0.0 109.689 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 445' ' ' LEU . 2.8 m -110.77 107.24 57.99 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.039 -1.038 . . . . 0.0 109.732 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.519 ' CG ' HG11 ' A' ' 420' ' ' VAL . 40.8 Cg_endo -76.12 108.4 2.67 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 O-C-N 123.898 1.473 . . . . 0.0 110.431 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.5 mt -92.5 139.85 30.17 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.968 -1.083 . . . . 0.0 108.665 167.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG23 ' A' ' 401' ' ' ILE . 21.5 t -100.28 134.02 41.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.781 -1.199 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' A' ' 440' ' ' LEU . 13.9 t -115.13 132.89 63.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 108.591 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -119.33 160.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -175.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.2 tt0 -135.7 131.79 36.09 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.45 -128.41 30.16 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.532 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 69.3 p -106.34 8.75 31.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.054 -1.262 . . . . 0.0 111.193 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -123.93 170.52 10.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.603 -1.31 . . . . 0.0 110.115 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 61.0 t -89.7 133.4 31.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.41 -0.806 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.602 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.7 pp -93.79 -19.9 20.6 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.498 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.548 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 170.34 176.72 40.03 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.846 -1.645 . . . . 0.0 110.894 167.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 55.1 t -107.82 143.0 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.121 -1.223 . . . . 0.0 109.86 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.525 HD13 ' CG2' ' A' ' 352' ' ' ILE . 75.8 mt -101.59 111.82 32.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 108.996 170.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.513 ' CB ' HG23 ' A' ' 423' ' ' VAL . . . -91.75 117.85 30.14 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.097 -1.002 . . . . 0.0 109.775 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.529 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -100.65 144.68 29.33 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.447 ' HG2' ' HB2' ' A' ' 428' ' ' ALA . 32.3 mttp -120.86 161.2 21.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.783 -1.198 . . . . 0.0 111.056 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -79.77 143.38 34.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.647 -0.658 . . . . 0.0 110.278 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 8.6 tt -112.65 152.77 14.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.344 -0.847 . . . . 0.0 110.36 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.5 t -103.65 136.28 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.311 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -90.87 145.94 24.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.243 0.544 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -122.65 141.8 51.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.517 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.4 mt-30 -134.97 152.81 52.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.171 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.477 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -61.06 139.32 58.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.803 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.522 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -123.37 -34.93 3.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.556 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.421 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.9 tt0 -163.79 149.41 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.36 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 16.4 p90 -135.74 145.45 46.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.847 -1.158 . . . . 0.0 111.725 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 324' ' ' PRO . 11.4 mt -116.66 141.56 28.31 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.538 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.61 142.62 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.635 1.334 . . . . 0.0 111.712 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.6 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -70.41 151.66 44.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.348 -0.845 . . . . 0.0 108.86 165.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -58.08 129.21 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.735 -1.228 . . . . 0.0 110.09 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.44 -0.04 50.07 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 53.5 t -135.28 138.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.74 -1.447 . . . . 0.0 110.764 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.7 m-20 -73.13 148.84 43.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.544 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.6 tt0 -60.22 -35.43 75.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.991 -1.068 . . . . 0.0 109.86 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.524 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.25 -43.44 87.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.001 -1.062 . . . . 0.0 109.297 176.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 92.7 m -60.81 -42.49 97.76 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 6.0 tp -60.49 -39.1 86.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.242 -0.911 . . . . 0.0 110.573 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.44 -44.2 79.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.061 . . . . 0.0 110.666 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.543 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 89.4 m-20 -63.73 -49.05 74.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.908 -1.12 . . . . 0.0 110.056 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -69.03 -30.78 69.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.027 -1.046 . . . . 0.0 109.868 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -54.97 -35.69 64.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.125 -0.984 . . . . 0.0 108.953 171.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.68 -55.91 5.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.519 -0.738 . . . . 0.0 111.116 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -64.51 -33.86 76.89 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.033 -171.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 395' ' ' LYS . . . -67.07 -21.48 65.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.965 -1.084 . . . . 0.0 110.147 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.468 ' OG ' HG21 ' A' ' 353' ' ' VAL . 78.5 p -106.46 10.57 31.36 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.188 -0.945 . . . . 0.0 111.473 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 50.6 mt -66.32 -44.68 82.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.562 -1.336 . . . . 0.0 109.672 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -96.74 2.79 52.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.997 -171.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.472 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 15.8 p30 -63.85 130.64 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.756 -1.215 . . . . 0.0 109.995 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.69 5.7 50.77 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.571 0.701 . . . . 0.0 109.949 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.4 p -77.11 149.78 80.02 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.614 -0.679 . . . . 0.0 109.541 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.85 -40.77 79.16 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.679 1.358 . . . . 0.0 109.255 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.16 -27.87 69.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.768 . . . . 0.0 110.382 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.472 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -54.92 -36.79 60.91 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.44 ' O ' HD13 ' A' ' 354' ' ' ILE . 94.4 mtt180 -75.91 -37.26 58.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.108 -1.23 . . . . 0.0 110.432 172.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.517 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.5 m -61.95 -38.04 87.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.049 -1.032 . . . . 0.0 110.418 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 83.4 mt -68.6 -49.21 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.907 -1.121 . . . . 0.0 110.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.528 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 21.5 t -61.2 -32.84 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.943 -1.098 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 350' ' ' ARG . 42.4 mt -72.89 -31.76 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.771 -1.206 . . . . 0.0 110.808 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.635 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.73 -41.48 90.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.784 -1.198 . . . . 0.0 110.249 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.526 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.496 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 66.7 mttt -72.16 -51.07 23.01 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.544 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.2 pt20 -70.78 -42.73 70.0 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.706 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.9 mmm180 -74.94 -43.19 55.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 111.147 -172.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 55.2 m-85 -134.98 -39.48 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.675 -1.265 . . . . 0.0 112.012 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.479 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.5 t-20 -162.58 106.36 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.532 -167.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 54.1 mt -57.62 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.948 -1.095 . . . . 0.0 109.188 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.497 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.8 tpt180 -124.36 156.44 37.05 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.28 -0.888 . . . . 0.0 109.866 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 20.3 pt-20 -122.93 -167.66 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.023 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.586 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.5 ptt-85 -93.52 164.71 13.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 110.542 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.459 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.6 m-20 -129.43 40.84 3.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.577 HG11 ' CE2' ' A' ' 374' ' ' PHE . 93.8 t -73.75 -48.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.436 -0.79 . . . . 0.0 110.43 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.419 -0.801 . . . . 0.0 111.134 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -30.21 29.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 109.79 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.6 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.0 mt -102.83 -4.58 24.67 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 110.628 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.7 m-70 64.07 52.94 1.92 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.552 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.6 174.98 6.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 110.677 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.6 m -117.65 134.22 55.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.604 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.577 ' CE2' HG11 ' A' ' 367' ' ' VAL . 92.4 m-85 -89.71 143.55 26.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.577 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.473 HG22 ' ND2' ' A' ' 387' ' ' ASN . 41.9 t -118.2 101.22 51.58 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.9 Cg_endo -55.57 152.22 34.78 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.089 1.573 . . . . 0.0 110.343 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.545 ' CZ ' ' C ' ' A' ' 382' ' ' ARG . 19.2 t80 -63.4 132.31 51.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 0.0 110.174 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p -120.95 152.07 38.96 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.569 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.52 -6.96 55.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.547 -0.721 . . . . 0.0 109.864 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -57.17 -32.6 66.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 109.963 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.514 ' OG ' ' CG ' ' A' ' 383' ' ' MET . 10.3 p -138.07 9.05 2.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.382 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.545 ' C ' ' CZ ' ' A' ' 377' ' ' PHE . 90.8 mtt-85 58.12 50.87 9.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.526 ' HE3' ' CB ' ' A' ' 400' ' ' ALA . 3.0 ptp -160.62 168.27 25.28 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.957 0.884 . . . . 0.0 111.328 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.0 p -153.59 164.88 37.49 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.44 -165.62 34.46 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 118.945 -1.597 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 339' ' ' LEU . 1.5 tt -139.11 148.51 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.663 -0.904 . . . . 0.0 109.989 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.473 ' ND2' HG22 ' A' ' 375' ' ' VAL . 28.1 m-20 -127.24 135.33 50.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.676 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.6 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.7 tt -139.87 154.87 24.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.867 -1.145 . . . . 0.0 109.363 171.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.492 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 89.7 m-20 -25.36 -63.16 0.06 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.447 0.641 . . . . 0.0 112.263 172.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.444 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 42.9 t-20 -92.14 -7.47 48.37 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.777 . . . . 0.0 111.804 -168.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.556 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 33.3 mtp180 -144.5 144.95 31.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.643 -1.286 . . . . 0.0 110.645 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.1 mtm -135.34 110.42 8.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.915 -1.116 . . . . 0.0 109.149 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.516 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 8.6 mt -130.49 145.96 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 110.001 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.483 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 41.8 mtt180 -135.9 160.88 37.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 110.76 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.495 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.2 128.58 34.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -155.39 174.4 33.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -174.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -57.52 151.55 16.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.949 -1.324 . . . . 0.0 108.357 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.543 ' CG2' HG11 ' A' ' 420' ' ' VAL . 61.2 t -57.69 -34.57 47.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.074 -1.017 . . . . 0.0 109.951 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.6 t70 -62.65 -46.59 87.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.526 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -68.24 -50.02 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.985 -1.072 . . . . 0.0 110.562 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 432' ' ' VAL . 32.2 mm -64.54 -43.82 96.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.656 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 6.1 ttt180 -59.87 -42.74 94.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 73.5 mtp180 -61.42 -36.16 79.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.572 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -67.33 -38.21 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 437' ' ' SER . 68.9 t -65.5 -47.56 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.573 -1.329 . . . . 0.0 110.138 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -35.02 78.91 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.783 -1.198 . . . . 0.0 110.354 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.0 -1.063 . . . . 0.0 109.949 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 22.0 m-80 -62.11 -27.11 68.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.24 19.16 31.3 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.04 -169.19 18.19 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.425 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.33 153.38 42.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.102 -1.234 . . . . 0.0 111.478 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.627 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 9.0 p90 -108.46 149.81 39.82 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.664 -0.647 . . . . 0.0 110.153 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.552 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.13 123.57 7.91 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.849 1.447 . . . . 0.0 110.465 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.27 -34.49 78.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.031 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.4 m-20 -60.63 -32.99 72.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.951 -1.093 . . . . 0.0 108.91 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 54.6 t -83.55 -42.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.001 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.574 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.6 m-20 -55.49 -36.8 67.03 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.659 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 98.9 mm-40 -63.79 -48.77 75.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.326 -1.484 . . . . 0.0 110.184 171.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 65.3 mttm -56.78 -34.99 68.16 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.661 -1.274 . . . . 0.0 110.309 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.593 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -59.33 -41.24 83.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.987 -1.07 . . . . 0.0 109.279 171.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.6 t0 -66.47 -36.14 82.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 83.6 mt-30 -66.93 -37.38 84.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.522 HG13 ' CB ' ' A' ' 428' ' ' ALA . 54.0 t -60.53 -38.9 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 109.942 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.85 92.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.943 . . . . 0.0 110.366 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 2.6 mtp180 -64.16 -31.54 72.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.134 -0.979 . . . . 0.0 110.722 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 2.8 mt-30 -80.96 -5.14 57.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.61 40.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.522 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.0 172.81 6.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -1.103 . . . . 0.0 109.855 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 445' ' ' LEU . 14.4 m -114.37 106.55 52.55 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.96 -1.088 . . . . 0.0 109.99 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' A' ' 420' ' ' VAL . 48.3 Cg_endo -79.76 107.26 2.08 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.927 1.488 . . . . 0.0 110.498 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.537 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 14.8 mt -93.41 135.67 34.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.878 -1.139 . . . . 0.0 108.785 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.527 ' CG2' HG21 ' A' ' 398' ' ' VAL . 89.5 t -100.91 134.36 41.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 O-C-N 120.802 -1.186 . . . . 0.0 109.53 175.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 54.1 t -115.54 137.23 49.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.043 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.527 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -118.14 159.96 18.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.374 -0.829 . . . . 0.0 109.635 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.519 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.85 131.92 33.88 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.19 -129.07 31.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.497 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.45 12.24 28.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.117 -1.226 . . . . 0.0 111.09 -179.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -126.09 170.88 11.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.598 -1.314 . . . . 0.0 109.938 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.527 HG13 ' CG1' ' A' ' 432' ' ' VAL . 23.3 t -90.88 134.23 30.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.762 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.61 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -94.45 -22.28 18.38 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.793 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.557 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.61 177.15 38.86 Favored Glycine 0 N--CA 1.501 3.005 0 C-N-CA 118.857 -1.639 . . . . 0.0 111.085 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.593 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 51.5 t -107.84 142.69 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.049 -1.265 . . . . 0.0 109.964 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.513 HD11 ' CB ' ' A' ' 337' ' ' ALA . 82.2 mt -101.37 112.86 35.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 423' ' ' VAL . . . -92.28 119.32 31.76 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.537 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.43 146.94 27.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 2.7 pttp -138.22 166.6 23.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.477 -1.389 . . . . 0.0 110.706 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -79.03 144.72 34.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.528 -0.733 . . . . 0.0 110.147 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.6 tp -119.53 153.36 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 110.173 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.19 136.71 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -90.32 145.75 24.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 CA-C-O 118.045 -1.419 . . . . 0.0 109.61 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.463 ' O ' ' OD1' ' A' ' 316' ' ' ASN . 37.7 p-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.269 0.557 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 97.2 mtt180 -123.3 147.89 46.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.243 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.8 mt-30 -128.48 145.92 50.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.522 ' CB ' HD21 ' A' ' 445' ' ' LEU . . . -61.43 137.95 58.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.995 . . . . 0.0 109.924 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.62 -38.35 2.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.473 ' N ' HD12 ' A' ' 355' ' ' LEU . 70.7 mt-10 -153.57 149.55 27.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.928 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.671 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 7.7 p90 -136.02 158.77 43.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.023 -1.048 . . . . 0.0 111.569 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 324' ' ' PRO . 1.2 mp -133.94 139.7 34.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.536 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.21 144.2 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.613 1.323 . . . . 0.0 111.619 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.592 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.51 151.35 43.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 108.791 164.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.86 129.19 40.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.686 -1.259 . . . . 0.0 110.098 -172.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.12 -2.33 40.71 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.8 t -135.99 139.1 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.715 -1.462 . . . . 0.0 110.785 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.5 m-20 -73.31 152.48 40.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.895 . . . . 0.0 110.203 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -63.41 -40.55 97.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 0.0 110.538 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.3 -43.12 92.63 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.687 -1.258 . . . . 0.0 109.543 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 93.8 m -55.86 -43.72 77.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.834 173.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.548 ' CD2' ' HA3' ' A' ' 441' ' ' GLY . 4.3 tp -59.6 -39.03 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.68 -42.96 81.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.768 -176.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.87 -48.61 76.03 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.803 -1.186 . . . . 0.0 109.901 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.54 -31.98 72.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.891 -1.131 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.509 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.72 -35.47 66.16 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.211 -0.931 . . . . 0.0 109.127 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.544 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 29.9 mt-30 -73.64 -55.79 5.83 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 110.893 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -62.93 -34.68 77.97 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.929 -171.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.43 -21.07 65.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -0.991 . . . . 0.0 110.014 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 92.3 p -107.68 10.24 29.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.227 -0.921 . . . . 0.0 111.569 -174.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.8 mt -65.88 -44.78 84.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.581 -1.324 . . . . 0.0 109.68 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.77 0.42 46.86 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.841 -170.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 341' ' ' SER . 11.3 p30 -63.03 130.45 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.778 -1.201 . . . . 0.0 109.926 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.65 5.69 50.8 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.568 0.699 . . . . 0.0 109.857 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.6 p -77.18 150.81 80.92 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.559 -0.713 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -53.42 -38.47 82.86 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.686 1.361 . . . . 0.0 109.14 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.53 -28.48 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.543 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.459 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.83 -37.95 71.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.446 ' O ' HD11 ' A' ' 354' ' ' ILE . 95.3 mtt180 -77.32 -38.13 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -1.18 . . . . 0.0 110.593 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.518 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 11.4 m -61.2 -38.29 86.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.878 -1.139 . . . . 0.0 110.359 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.527 ' CG2' HD11 ' A' ' 443' ' ' ILE . 85.2 mt -68.68 -48.94 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.058 -1.026 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 24.6 t -61.36 -32.72 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.043 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.495 ' CG2' ' OE1' ' A' ' 358' ' ' GLN . 34.0 mt -72.73 -33.57 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.752 -1.218 . . . . 0.0 110.678 171.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.53 -40.8 83.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.8 -1.187 . . . . 0.0 110.397 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.48 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 24.9 mtmt -72.24 -49.4 35.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.547 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.495 ' OE1' ' CG2' ' A' ' 354' ' ' ILE . 13.7 pt20 -71.52 -42.49 67.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.32 -0.862 . . . . 0.0 110.843 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.574 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 39.0 mmt180 -73.75 -45.33 52.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.084 -1.01 . . . . 0.0 111.23 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.671 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 86.8 m-85 -135.59 -37.66 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.329 -1.349 . . . . 0.0 112.117 -169.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' A' ' 363' ' ' ARG . 14.1 t-20 -160.57 105.9 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.627 -1.296 . . . . 0.0 111.492 -168.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.53 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 51.9 mt -57.63 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.0 109.349 172.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.3 tpt180 -128.08 164.16 23.03 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -137.91 -160.43 1.06 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 110.085 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.71 163.91 12.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.522 -0.736 . . . . 0.0 110.67 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -131.39 42.63 3.18 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.507 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.577 ' CG2' ' CZ ' ' A' ' 374' ' ' PHE . 42.3 t -72.7 -46.36 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 110.259 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.83 -27.31 66.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 111.152 -175.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.02 -30.1 28.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.756 176.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.529 ' CB ' HD13 ' A' ' 388' ' ' ILE . 21.8 mt -102.47 -5.02 24.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.524 -0.735 . . . . 0.0 110.635 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.4 m-70 60.3 52.27 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 109.761 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.533 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -94.04 174.57 7.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.456 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.9 m -117.12 134.64 54.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 110.499 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.577 ' CZ ' ' CG2' ' A' ' 367' ' ' VAL . 89.7 m-85 -89.23 145.17 25.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.04 101.15 50.24 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.633 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -55.22 151.37 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.067 1.562 . . . . 0.0 110.548 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 10.2 t80 -64.48 131.91 48.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.87 . . . . 0.0 110.078 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.3 p -120.45 152.7 37.62 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.405 -0.81 . . . . 0.0 109.715 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.73 -6.54 54.34 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -56.97 -32.96 66.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.857 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.516 ' OG ' ' CG ' ' A' ' 383' ' ' MET . 4.9 p -138.86 9.79 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.335 -0.853 . . . . 0.0 110.375 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 69.9 mtt85 57.49 51.03 10.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.198 -0.939 . . . . 0.0 109.434 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.526 ' CE ' HD11 ' A' ' 401' ' ' ILE . 2.5 ptp -159.46 167.96 27.4 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.934 0.873 . . . . 0.0 111.203 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 17.3 p -154.41 165.14 37.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.33 -165.8 34.11 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.988 -1.577 . . . . 0.0 110.521 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 367' ' ' VAL . 4.8 tt -138.68 151.6 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.639 -0.918 . . . . 0.0 110.231 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -127.39 133.99 49.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 109.747 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.9 tt -140.38 155.18 23.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.937 -1.102 . . . . 0.0 109.2 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.6 m-20 -21.91 -63.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.47 0.652 . . . . 0.0 112.555 170.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.449 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 44.3 t-20 -95.57 -7.58 37.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 111.911 -167.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.548 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.4 mtp180 -142.95 144.92 32.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.745 -1.222 . . . . 0.0 110.55 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -135.3 101.33 4.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.845 -1.159 . . . . 0.0 108.967 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.521 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 8.1 mt -123.89 146.03 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 110.143 -172.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.472 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 33.7 mtt180 -135.85 160.42 38.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.905 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.53 131.25 39.55 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -157.01 174.01 34.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.4 m -56.91 150.17 17.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.941 -1.329 . . . . 0.0 108.441 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.539 ' CG2' HG12 ' A' ' 420' ' ' VAL . 16.9 t -54.54 -36.97 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.969 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.5 m-20 -63.8 -44.25 93.87 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.319 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 381' ' ' SER . . . -68.42 -51.53 42.79 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.951 -1.093 . . . . 0.0 110.574 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.526 HD11 ' CE ' ' A' ' 383' ' ' MET . 30.6 mm -64.64 -42.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.082 -1.011 . . . . 0.0 110.736 -176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.591 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.9 ttp180 -59.15 -43.74 92.06 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.8 mtp180 -61.62 -36.8 81.76 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.506 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -68.18 -36.68 79.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.301 -0.874 . . . . 0.0 111.367 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 437' ' ' SER . 54.4 t -66.24 -47.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.59 -1.319 . . . . 0.0 110.16 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -34.8 78.6 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.756 -1.215 . . . . 0.0 110.293 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.22 81.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.968 -1.082 . . . . 0.0 109.883 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.53 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 5.3 m-80 -60.94 -28.24 68.81 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.509 -0.744 . . . . 0.0 109.084 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.4 19.8 26.82 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 -169.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -116.05 -168.84 15.32 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.37 153.88 41.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.213 -1.169 . . . . 0.0 111.149 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.591 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.7 p90 -107.98 150.68 40.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.589 -0.694 . . . . 0.0 110.061 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.532 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.56 127.4 12.42 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.891 1.469 . . . . 0.0 110.49 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.2 t -66.99 -34.93 78.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 111.024 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.5 m-20 -61.43 -33.73 74.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.817 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.592 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 54.7 t -83.5 -41.68 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.37 -38.51 68.92 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.347 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.38 -48.0 79.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.324 -1.485 . . . . 0.0 110.309 171.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 35.8 mttm -56.71 -34.87 67.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.668 -1.27 . . . . 0.0 110.512 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -59.7 -41.68 86.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.91 -1.119 . . . . 0.0 109.136 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -65.94 -36.18 82.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.915 0.864 . . . . 0.0 109.493 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.5 -38.18 80.73 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 110.886 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 69.4 t -62.3 -37.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.975 -1.078 . . . . 0.0 109.945 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.42 87.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.219 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.05 -33.08 74.99 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.258 -0.901 . . . . 0.0 111.208 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -80.98 -4.38 54.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.012 -1.055 . . . . 0.0 109.456 174.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.24 30.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.505 ' HB1' ' CG1' ' A' ' 423' ' ' VAL . . . -104.42 170.91 7.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -1.141 . . . . 0.0 109.863 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.473 ' O ' HD12 ' A' ' 445' ' ' LEU . 7.5 m -112.45 106.62 55.71 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.988 -1.07 . . . . 0.0 110.108 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.466 ' HG3' ' O ' ' A' ' 420' ' ' VAL . 55.3 Cg_endo -80.05 107.23 2.03 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 O-C-N 123.864 1.454 . . . . 0.0 110.541 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.544 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.7 mt -93.6 140.44 29.61 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.915 -1.116 . . . . 0.0 108.717 167.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.528 ' CG1' HG12 ' A' ' 439' ' ' VAL . 98.5 t -101.07 135.6 36.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.798 -1.189 . . . . 0.0 109.568 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 440' ' ' LEU . 22.3 t -115.93 136.19 53.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 108.745 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -120.53 160.44 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.459 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.4 tt0 -135.49 129.97 33.96 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.26 -131.3 29.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.53 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 76.5 p -103.29 8.97 38.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.087 -1.243 . . . . 0.0 111.138 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -123.32 170.84 9.89 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.555 -1.34 . . . . 0.0 110.152 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 61.9 t -91.04 134.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.357 -0.84 . . . . 0.0 109.824 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.602 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.3 pp -92.83 -22.49 19.27 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.48 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.553 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 169.22 177.42 39.89 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.048 -1.549 . . . . 0.0 110.871 170.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 60.0 t -107.72 143.91 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.109 -1.23 . . . . 0.0 109.82 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.527 HD11 ' CG2' ' A' ' 352' ' ' ILE . 81.3 mt -101.62 112.62 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.448 -0.783 . . . . 0.0 108.997 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.36 118.24 30.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.861 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.544 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.66 148.15 25.93 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -175.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 16.1 pttt -125.62 165.09 19.17 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.563 -1.335 . . . . 0.0 110.343 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -78.52 139.26 38.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.395 -0.815 . . . . 0.0 110.473 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.2 tp -124.02 152.52 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.492 -0.755 . . . . 0.0 110.165 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.7 t -105.38 132.44 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.919 . . . . 0.0 110.354 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -93.63 145.63 24.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 110.208 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 117.932 -1.482 . . . . 0.0 109.539 179.843 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.303 0.573 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.499 ' NE ' ' OE2' ' A' ' 348' ' ' GLU . 85.2 mtm180 -123.38 143.95 49.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 87.6 mt-30 -133.69 145.99 50.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.224 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.522 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -64.2 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.934 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.463 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -117.37 -33.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -169.95 151.03 3.96 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.008 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.644 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 11.4 p90 -136.0 145.87 46.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.774 -1.204 . . . . 0.0 111.814 -177.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.4 mp -116.53 143.16 30.73 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.667 -0.646 . . . . 0.0 109.631 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.535 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.8 Cg_endo -72.37 143.71 39.56 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.69 1.363 . . . . 0.0 111.583 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.65 152.4 41.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 108.782 165.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.78 128.96 39.84 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.575 -1.328 . . . . 0.0 110.097 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.66 -1.8 42.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.5 t -136.43 138.84 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.463 . . . . 0.0 110.749 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.439 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.4 m-20 -73.5 152.32 40.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -61.98 -40.11 94.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.037 -1.039 . . . . 0.0 110.443 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.13 -43.44 91.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 109.568 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 95.1 m -56.36 -43.56 79.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.88 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.572 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.6 tp -59.23 -39.8 83.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.268 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.17 -41.75 85.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 110.774 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.5 -49.16 74.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.892 -1.13 . . . . 0.0 109.971 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.7 -31.67 71.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.994 -1.066 . . . . 0.0 109.776 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 334' ' ' ALA . . . -55.79 -34.9 65.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 16.2 mt-30 -74.02 -55.79 5.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.516 -0.74 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.34 -35.96 78.85 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.885 -173.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 395' ' ' LYS . . . -67.16 -20.81 65.8 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.06 -1.025 . . . . 0.0 110.015 173.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 96.5 p -107.43 8.93 29.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.129 -0.982 . . . . 0.0 111.504 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.3 mt -65.48 -44.71 86.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.655 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.61 1.45 48.8 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.9 -170.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.47 130.2 43.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.803 -1.186 . . . . 0.0 110.057 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.92 5.45 51.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.595 0.712 . . . . 0.0 109.906 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -77.05 153.36 82.61 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.27 -38.33 95.26 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.734 1.386 . . . . 0.0 109.149 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.499 ' OE2' ' NE ' ' A' ' 317' ' ' ARG . 97.4 mt-10 -64.53 -29.66 70.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.75 . . . . 0.0 110.477 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.12 -35.51 59.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.457 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.3 mtt180 -76.97 -38.04 54.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.143 -1.21 . . . . 0.0 110.521 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.9 m -60.85 -38.09 84.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.92 -1.113 . . . . 0.0 110.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 80.0 mt -69.01 -49.24 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.019 -1.051 . . . . 0.0 110.627 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.517 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 28.7 t -61.54 -33.84 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.0 110.198 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 350' ' ' ARG . 34.2 mt -72.45 -33.09 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.741 -1.225 . . . . 0.0 110.553 171.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.644 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -59.68 -40.29 87.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.931 -1.106 . . . . 0.0 110.59 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.507 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.78 -45.12 91.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.284 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.525 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 30.1 mtmt -71.61 -49.26 41.95 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.706 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.6 pt20 -71.08 -42.4 69.41 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.76 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.56 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 37.8 mmt180 -73.11 -46.52 50.79 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 111.218 -172.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 73.6 m-85 -136.44 -35.82 0.73 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.411 -169.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.469 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 56.3 t-20 -158.91 102.43 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.546 -1.346 . . . . 0.0 111.619 -168.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 34.3 mt -57.8 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.858 -1.152 . . . . 0.0 109.295 171.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.525 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.6 tpt85 -135.96 163.64 29.8 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.34 -0.85 . . . . 0.0 108.941 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.51 -155.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.951 -1.093 . . . . 0.0 110.32 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.7 ptt180 -95.19 163.03 13.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.478 0.656 . . . . 0.0 110.523 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.469 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -127.78 40.24 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 110.464 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.571 HG23 ' CE1' ' A' ' 374' ' ' PHE . 57.4 t -74.61 -47.94 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.449 -0.782 . . . . 0.0 110.28 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.77 -26.02 65.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 110.954 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.44 -29.93 27.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 109.818 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.596 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 18.6 mt -103.83 -3.88 24.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 110.718 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.9 m80 62.77 53.15 2.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.43 174.92 6.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.672 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.2 m -116.3 134.27 55.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.567 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' A' ' 367' ' ' VAL . 81.4 m-85 -88.29 149.02 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 50.6 t -122.26 101.12 41.48 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.81 153.36 25.02 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.09 1.574 . . . . 0.0 110.443 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.586 ' CE2' ' N ' ' A' ' 383' ' ' MET . 58.3 t80 -69.07 134.27 49.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 11.0 p -115.14 144.24 43.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.797 174.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.03 -21.74 58.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.668 -0.645 . . . . 0.0 110.356 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.07 -45.21 94.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 109.729 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 383' ' ' MET . 66.6 m -95.64 -12.75 25.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 110.25 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 97.4 mtt180 57.83 49.74 11.6 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.6 -0.688 . . . . 0.0 109.627 -174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.586 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.4 ptp -165.03 170.41 15.17 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.839 0.828 . . . . 0.0 111.283 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.514 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.3 p -154.84 165.55 36.28 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.94 -165.7 34.27 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 118.771 -1.68 . . . . 0.0 110.821 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.523 HD13 ' CG2' ' A' ' 367' ' ' VAL . 3.7 tt -140.86 148.67 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.641 -0.917 . . . . 0.0 110.133 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -127.72 135.06 49.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.869 -1.145 . . . . 0.0 109.724 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.596 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.7 tt -140.55 154.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.861 -1.149 . . . . 0.0 109.446 171.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 89.3 m-20 -25.4 -62.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.299 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.446 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.2 t30 -92.03 -7.83 47.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 -168.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.7 mtp180 -144.03 144.97 31.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.699 -1.25 . . . . 0.0 110.574 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.71 109.94 8.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.833 -1.167 . . . . 0.0 109.02 169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 8.6 mt -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.047 -1.033 . . . . 0.0 110.052 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.478 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.0 mmt85 -134.54 160.47 37.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.449 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.514 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.03 126.83 32.75 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -152.71 173.7 31.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.6 t -58.21 150.76 20.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.901 -1.352 . . . . 0.0 108.554 170.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 420' ' ' VAL . 53.5 t -55.63 -35.48 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.971 -1.08 . . . . 0.0 109.607 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.09 -46.45 89.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.165 -0.96 . . . . 0.0 110.366 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.497 ' CB ' ' HE2' ' A' ' 383' ' ' MET . . . -69.17 -51.02 42.3 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.028 -1.045 . . . . 0.0 110.639 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.521 HD13 ' CE ' ' A' ' 383' ' ' MET . 28.7 mm -64.28 -41.62 92.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 110.816 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.585 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 34.8 ttt-85 -59.65 -45.17 92.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.3 mtp85 -62.59 -35.51 79.75 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.205 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 111.212 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.84 -48.95 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.501 -1.375 . . . . 0.0 110.109 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.4 -34.11 77.02 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 110.253 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.97 -36.19 79.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.941 -1.099 . . . . 0.0 109.923 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.531 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.6 m-80 -61.63 -27.49 68.7 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.511 -0.743 . . . . 0.0 109.228 173.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.06 19.43 28.64 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -170.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.78 -170.34 16.49 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.66 153.59 41.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 111.098 -174.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.4 p90 -107.21 150.15 39.57 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.528 -0.733 . . . . 0.0 110.039 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.54 ' CG ' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -72.27 127.4 12.63 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.846 1.445 . . . . 0.0 110.42 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -67.0 -34.96 78.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 111.016 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 55.9 t0 -62.12 -33.05 73.74 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.865 -1.147 . . . . 0.0 108.823 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 49.8 t -83.52 -41.66 16.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.906 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.8 t0 -55.14 -38.17 67.88 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.455 171.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.66 -48.16 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.33 -1.481 . . . . 0.0 110.299 171.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 15.0 mmtt -56.2 -35.36 67.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.59 -1.319 . . . . 0.0 110.384 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 3.3 t -60.23 -41.31 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.963 -1.086 . . . . 0.0 109.435 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -65.83 -36.04 82.37 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.922 0.868 . . . . 0.0 109.398 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.24 -37.58 80.95 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.868 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 66.9 t -63.05 -37.35 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.91 -1.119 . . . . 0.0 110.01 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.36 85.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.71 -30.03 67.57 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.352 -0.842 . . . . 0.0 110.892 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.37 -3.53 55.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.785 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.23 21.79 28.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.466 ' HB3' HG12 ' A' ' 423' ' ' VAL . . . -106.58 170.89 7.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -1.081 . . . . 0.0 109.47 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.552 ' O ' ' CD1' ' A' ' 445' ' ' LEU . 21.3 m -116.92 106.85 47.01 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 109.52 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.529 ' CG ' HG12 ' A' ' 420' ' ' VAL . 36.3 Cg_endo -74.59 107.43 2.46 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 O-C-N 123.965 1.508 . . . . 0.0 110.331 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 15.8 mt -92.57 132.67 36.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.913 -1.117 . . . . 0.0 108.38 167.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.522 ' CG2' HG22 ' A' ' 398' ' ' VAL . 60.6 t -100.75 136.43 32.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.834 -1.166 . . . . 0.0 109.681 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.48 ' O ' HD12 ' A' ' 440' ' ' LEU . 41.8 t -115.25 138.17 46.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 108.991 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.7 159.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.461 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.6 tt0 -134.56 133.78 40.62 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 170.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.44 -126.83 31.07 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -168.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 71.7 p -108.14 8.08 27.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.021 -1.281 . . . . 0.0 111.228 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -123.98 171.03 10.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.542 -1.349 . . . . 0.0 110.147 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.53 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 60.5 t -88.94 134.62 27.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.933 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.61 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.3 pp -92.71 -22.12 19.59 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.602 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.551 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 171.04 176.31 40.15 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 118.803 -1.665 . . . . 0.0 110.816 168.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 48.2 t -107.88 143.18 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.239 . . . . 0.0 109.616 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.503 ' O ' HD11 ' A' ' 445' ' ' LEU . 80.7 mt -101.47 118.62 48.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.326 -0.858 . . . . 0.0 108.773 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -98.14 117.58 32.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -176.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 429' ' ' THR . 3.6 mp -112.24 145.28 40.21 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.014 -1.054 . . . . 0.0 109.781 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -110.92 159.86 17.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.728 -1.233 . . . . 0.0 111.199 -174.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -93.72 148.52 22.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.769 -0.582 . . . . 0.0 110.085 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.6 tp -117.57 152.92 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.231 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.1 136.31 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.867 . . . . 0.0 110.365 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -91.89 144.32 25.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 110.177 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.533 -179.881 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.27 0.557 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 89.9 mtt180 -122.28 149.56 43.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.127 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 90.5 mt-30 -126.02 146.67 49.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.213 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 355' ' ' LEU . . . -59.3 137.56 57.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.02 . . . . 0.0 109.765 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.516 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.9 m -117.89 -44.02 2.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.1 -1.0 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 320' ' ' SER . 66.1 mt-10 -154.81 151.48 28.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -0.908 . . . . 0.0 110.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.612 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 14.6 p90 -136.0 140.43 43.9 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.918 -1.114 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.4 mt -112.67 143.84 29.79 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.784 -0.573 . . . . 0.0 109.708 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.76 142.55 35.81 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.678 1.357 . . . . 0.0 111.614 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.597 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.48 152.81 42.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 108.861 165.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.11 128.64 38.21 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.586 -1.321 . . . . 0.0 110.178 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.46 46.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 46.3 t -136.73 139.38 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.677 -1.484 . . . . 0.0 110.703 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.8 m-20 -74.32 152.37 39.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.9 tt0 -61.53 -40.28 94.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.038 -1.039 . . . . 0.0 110.278 -177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.5 -43.84 93.26 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.665 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.428 ' HB ' HG11 ' A' ' 328' ' ' VAL . 93.4 m -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.742 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.3 tp -59.21 -39.2 81.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.296 175.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.44 -41.4 84.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.991 -1.068 . . . . 0.0 110.729 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 88.4 m-20 -63.28 -49.92 72.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.975 -1.078 . . . . 0.0 109.84 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.597 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.0 -31.98 72.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 109.901 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.26 -35.35 64.9 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.166 -0.959 . . . . 0.0 108.961 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 15.9 mt-30 -75.5 -55.89 5.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.564 -0.71 . . . . 0.0 110.971 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -62.36 -35.24 78.52 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.756 -172.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.07 -20.87 65.89 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.984 -1.072 . . . . 0.0 109.978 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.463 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 94.8 p -107.82 9.95 28.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.205 -0.934 . . . . 0.0 111.547 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.9 mt -66.36 -44.37 83.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.516 -1.365 . . . . 0.0 109.633 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -97.39 2.15 50.13 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.787 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 14.0 p30 -64.17 130.08 42.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.739 -1.226 . . . . 0.0 110.015 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.42 4.44 53.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.508 0.671 . . . . 0.0 109.873 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.1 p -74.17 152.95 88.4 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 109.404 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.74 -40.05 87.01 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.737 1.388 . . . . 0.0 109.162 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.68 -27.56 69.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 0.0 110.481 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.22 -37.74 65.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.5 mtt180 -77.15 -37.83 53.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -1.223 . . . . 0.0 110.514 173.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.4 m -61.04 -38.06 84.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 348' ' ' GLU . 90.6 mt -68.12 -49.61 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.515 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 37.2 t -60.87 -33.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.014 . . . . 0.0 110.07 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.4 mt -72.92 -32.91 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.701 -1.25 . . . . 0.0 110.565 171.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.612 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.43 -40.17 85.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.809 -1.182 . . . . 0.0 110.545 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.69 93.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 16.1 mtmt -71.46 -49.6 39.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.638 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.525 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.6 pt20 -71.51 -42.54 67.87 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 110.793 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.525 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.9 mmt180 -72.86 -45.7 56.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 111.24 -172.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.571 ' CE2' ' OE2' ' A' ' 330' ' ' GLU . 56.1 m-85 -135.76 -38.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.143 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 363' ' ' ARG . 49.3 t30 -159.0 105.18 1.75 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.758 -1.214 . . . . 0.0 111.528 -168.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 46.7 mt -57.45 89.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.842 -1.161 . . . . 0.0 109.163 171.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.535 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.1 tpt180 -131.14 164.49 25.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.236 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.4 mt-10 -136.88 -157.19 0.76 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.153 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 31.8 ptt-85 -94.65 162.52 13.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 88.4 m-20 -128.68 41.21 3.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.287 176.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.571 HG13 ' CE2' ' A' ' 374' ' ' PHE . 26.0 t -73.47 -45.73 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.45 -28.18 66.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 111.079 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.19 -29.87 28.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.037 -1.039 . . . . 0.0 109.763 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.525 ' CB ' HD13 ' A' ' 388' ' ' ILE . 26.0 mt -103.64 -4.63 23.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.494 -0.754 . . . . 0.0 110.613 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.1 m-70 60.64 52.49 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.842 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.09 174.39 7.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.409 -0.807 . . . . 0.0 110.638 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.3 m -117.35 135.68 53.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.571 ' CE2' HG13 ' A' ' 367' ' ' VAL . 74.2 m-85 -89.39 148.79 23.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.626 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 64.0 t -122.17 100.69 42.21 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.26 150.36 49.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.046 1.551 . . . . 0.0 110.512 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.9 t80 -62.99 131.79 49.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p -121.23 152.95 38.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.797 . . . . 0.0 109.639 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.31 -5.81 50.89 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.545 -0.722 . . . . 0.0 109.936 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.1 -32.75 66.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.873 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 383' ' ' MET . 1.4 m -139.48 9.97 2.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.295 175.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 87.7 mtt180 57.6 51.15 9.91 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 109.465 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.524 ' CE ' ' CB ' ' A' ' 400' ' ' ALA . 3.4 ptp -160.05 169.07 24.15 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.895 0.855 . . . . 0.0 111.314 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.517 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.6 p -153.64 164.92 37.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.15 -167.11 35.6 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.643 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 386' ' ' ILE . 4.0 tt -140.04 150.28 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.554 -0.968 . . . . 0.0 110.136 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -126.53 134.52 50.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.956 -1.09 . . . . 0.0 109.809 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -142.41 155.22 18.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.947 -1.096 . . . . 0.0 109.181 173.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 91.5 m-20 -22.41 -63.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.413 0.625 . . . . 0.0 112.582 171.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t30 -96.35 -6.01 38.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 111.776 -167.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.548 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.5 mtp180 -143.74 143.89 31.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.705 -1.247 . . . . 0.0 110.381 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -134.02 99.43 4.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.974 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 7.2 mt -121.29 145.96 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.036 -1.04 . . . . 0.0 110.103 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.465 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 31.4 mtt180 -133.83 159.68 39.9 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.08 -1.013 . . . . 0.0 110.689 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.19 127.23 31.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.344 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -154.23 174.07 32.7 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -173.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 35.7 m -56.99 151.51 14.75 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.854 -1.38 . . . . 0.0 108.572 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.532 ' CG2' HG11 ' A' ' 420' ' ' VAL . 57.7 t -57.02 -34.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.993 -1.067 . . . . 0.0 109.856 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.8 t0 -62.88 -46.54 87.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.218 -0.926 . . . . 0.0 110.414 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.524 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -67.9 -50.42 56.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.006 -1.059 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.526 HG23 ' CG1' ' A' ' 432' ' ' VAL . 32.5 mm -65.38 -43.69 94.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 110.763 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.578 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.7 ttp85 -58.9 -43.57 91.04 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.348 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.0 mtp180 -61.92 -36.26 80.83 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 109.44 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.534 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -67.61 -37.03 81.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 111.277 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 437' ' ' SER . 55.9 t -66.03 -48.26 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.657 -1.277 . . . . 0.0 110.157 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.99 -34.2 77.46 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.845 -1.16 . . . . 0.0 110.395 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.67 -36.39 80.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.924 -1.11 . . . . 0.0 109.816 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.534 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.1 m-80 -61.63 -27.62 68.79 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.22 173.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.02 20.35 28.43 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -168.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.44 -170.87 17.6 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -143.96 153.79 42.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -1.221 . . . . 0.0 111.186 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 5.3 p90 -107.37 150.96 40.68 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.61 -0.681 . . . . 0.0 110.098 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.543 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -73.3 124.41 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.869 1.457 . . . . 0.0 110.202 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -65.99 -34.87 79.09 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 111.064 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 54.1 t0 -61.41 -33.05 73.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.949 -1.094 . . . . 0.0 108.859 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.597 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 53.2 t -83.7 -42.44 17.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 111.009 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 9.3 m-20 -55.46 -37.26 67.53 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.575 171.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.7 mt-30 -63.72 -48.96 74.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.29 -1.506 . . . . 0.0 110.205 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 72.6 mmtt -56.65 -34.79 67.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.717 -1.239 . . . . 0.0 110.373 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -59.73 -41.23 84.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.0 -1.062 . . . . 0.0 109.283 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -66.48 -36.25 82.29 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.03 -38.19 82.25 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.565 -0.709 . . . . 0.0 110.782 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.532 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 72.5 t -62.48 -37.56 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.902 -1.124 . . . . 0.0 110.016 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.3 87.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 110.192 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -65.9 -33.8 76.66 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.38 -0.825 . . . . 0.0 111.177 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -81.69 -4.2 55.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 175.055 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 22.56 28.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.532 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -103.23 165.31 11.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -1.115 . . . . 0.0 109.618 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.466 ' O ' HD12 ' A' ' 445' ' ' LEU . 10.0 m -110.89 106.87 57.83 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.018 -1.051 . . . . 0.0 109.863 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.509 ' CB ' HG12 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.35 108.42 2.7 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.972 1.512 . . . . 0.0 110.64 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.533 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 12.7 mt -91.86 133.96 35.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.861 -1.149 . . . . 0.0 108.497 166.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 401' ' ' ILE . 83.8 t -99.86 134.73 38.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 120.799 -1.188 . . . . 0.0 109.465 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.503 HG12 ' CD1' ' A' ' 440' ' ' LEU . 23.5 t -114.46 138.57 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.881 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -122.12 160.45 24.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.657 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.453 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.17 129.26 33.51 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.25 -129.33 28.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 5.4 p -104.96 10.18 34.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.105 -1.232 . . . . 0.0 111.089 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -121.85 170.83 9.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.574 -1.329 . . . . 0.0 110.128 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.524 ' HA ' ' CG1' ' A' ' 434' ' ' VAL . 41.2 t -93.8 134.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.315 -0.866 . . . . 0.0 109.762 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.597 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.3 pp -95.96 -20.5 18.69 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.805 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.55 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.54 176.5 38.88 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 118.719 -1.705 . . . . 0.0 110.981 168.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 47.3 t -107.96 142.13 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.091 -1.24 . . . . 0.0 109.938 173.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.517 HD12 ' CB ' ' A' ' 337' ' ' ALA . 81.8 mt -101.53 111.25 30.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.042 170.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -91.75 118.65 30.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.099 -1.0 . . . . 0.0 109.909 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.533 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -101.07 144.62 29.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.468 ' HG2' ' HB3' ' A' ' 428' ' ' ALA . 70.5 mttt -121.59 160.49 24.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 111.153 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -100.14 143.32 30.48 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.23 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 8.3 tp -123.78 151.93 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 110.335 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 55.3 t -136.99 135.9 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -145.12 146.21 31.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 CA-C-O 117.987 -1.452 . . . . 0.0 109.567 179.706 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.286 0.565 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.523 ' CB ' ' OE2' ' A' ' 348' ' ' GLU . 84.7 mtm180 -123.36 140.64 52.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 110.221 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 61.4 tt0 -126.69 131.01 51.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.264 -0.898 . . . . 0.0 110.354 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 445' ' ' LEU . . . -54.66 138.61 41.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 109.789 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.528 ' O ' ' CZ ' ' A' ' 359' ' ' ARG . 20.8 m -124.34 -40.04 2.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.988 . . . . 0.0 110.276 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 320' ' ' SER . 57.9 mt-10 -154.66 146.54 23.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.669 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 9.2 p90 -137.6 142.34 41.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.593 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.513 HG22 ' CD ' ' A' ' 419' ' ' LYS . 1.9 mt -116.11 145.82 35.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.758 -0.589 . . . . 0.0 109.827 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -73.42 143.03 34.13 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.778 1.409 . . . . 0.0 111.468 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.6 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.22 152.72 42.02 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 108.881 165.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.82 128.43 37.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.74 -1.225 . . . . 0.0 110.058 -173.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 328' ' ' VAL . . . 105.62 -2.61 39.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.7 t -136.74 140.34 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.667 -1.49 . . . . 0.0 110.809 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -74.08 152.98 39.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.07 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.1 tt0 -62.18 -38.73 90.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.354 -176.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -60.92 -45.66 93.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.697 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 95.0 m -55.99 -43.73 77.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.534 HD13 ' CA ' ' A' ' 441' ' ' GLY . 5.2 tp -58.08 -40.55 81.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.15 -39.86 82.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.08 -1.013 . . . . 0.0 110.717 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.1 m-20 -62.82 -49.09 76.29 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 109.757 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.29 -31.49 70.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.884 -1.135 . . . . 0.0 109.73 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.515 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.28 -34.9 64.51 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 172.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 17.7 mt-30 -74.25 -55.6 5.85 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 110.827 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -62.05 -35.24 78.03 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.048 -172.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 395' ' ' LYS . . . -67.66 -21.08 65.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 110.131 174.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.464 ' HB2' ' OD2' ' A' ' 344' ' ' ASP . 89.3 p -107.52 10.04 29.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.0 111.508 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.5 mt -65.68 -45.51 82.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.622 -1.299 . . . . 0.0 109.793 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.5 0.85 48.28 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.865 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 10.7 p30 -64.25 130.57 44.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.817 -1.177 . . . . 0.0 110.023 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.83 5.61 50.89 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.566 0.698 . . . . 0.0 109.863 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.0 p -75.76 154.72 85.25 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.68 -39.5 90.71 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.786 1.414 . . . . 0.0 109.222 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.523 ' OE2' ' CB ' ' A' ' 317' ' ' ARG . 96.1 mt-10 -64.9 -27.46 68.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.47 -0.769 . . . . 0.0 110.634 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 353' ' ' VAL . . . -55.61 -39.83 76.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -174.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -78.02 -36.81 48.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -1.182 . . . . 0.0 110.662 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.518 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.5 m -61.25 -38.97 88.6 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.928 -1.108 . . . . 0.0 110.4 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.478 ' CG2' HD13 ' A' ' 443' ' ' ILE . 87.4 mt -69.11 -48.33 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.708 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.516 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 34.8 t -62.14 -34.52 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.846 -1.159 . . . . 0.0 110.204 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.6 mt -73.2 -32.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.686 -1.259 . . . . 0.0 110.632 171.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -58.19 -41.27 83.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.97 -1.081 . . . . 0.0 110.2 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.99 -44.07 93.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.556 -0.715 . . . . 0.0 110.618 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.518 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 74.6 mttt -69.8 -49.56 51.55 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.662 -173.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.7 pt20 -72.27 -42.85 65.11 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.644 -172.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.528 ' CZ ' ' O ' ' A' ' 320' ' ' SER . 84.6 mtt-85 -78.89 -39.52 34.74 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 111.707 -171.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.669 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 76.3 m-85 -134.77 -38.64 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.462 -1.399 . . . . 0.0 112.088 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.476 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 48.6 t30 -160.57 99.79 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.585 -1.322 . . . . 0.0 111.649 -169.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 34.1 mt -57.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.865 -1.147 . . . . 0.0 109.329 171.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.541 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.4 tpt180 -141.58 164.04 31.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.169 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.7 mt-10 -130.23 -154.24 0.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.474 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.7 ptt-85 -94.11 162.97 13.66 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.686 -0.634 . . . . 0.0 110.576 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.469 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.3 p30 -125.49 39.09 4.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 374' ' ' PHE . 61.6 t -74.53 -47.5 39.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.352 -0.843 . . . . 0.0 110.281 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.86 -26.26 65.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 111.004 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.77 -29.74 27.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.001 . . . . 0.0 109.724 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.597 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.9 mt -104.33 -3.63 23.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.449 -0.782 . . . . 0.0 110.711 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.3 m80 62.6 53.22 2.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -177.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.55 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.46 175.01 6.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 0.0 110.646 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.3 m -115.94 134.43 54.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.476 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.573 ' CE1' HG22 ' A' ' 367' ' ' VAL . 80.5 m-85 -88.32 149.04 23.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 25.6 t -121.56 101.11 43.62 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 109.735 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -55.03 153.05 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 110.468 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.566 ' CE2' ' N ' ' A' ' 383' ' ' MET . 56.8 t80 -70.54 134.44 47.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.6 p -115.62 143.57 45.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.386 -0.821 . . . . 0.0 109.777 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.18 -23.65 59.26 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.365 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -61.5 -44.62 96.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.138 -0.976 . . . . 0.0 109.731 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.467 ' O ' ' HG2' ' A' ' 383' ' ' MET . 74.6 m -94.85 -13.54 25.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 110.146 176.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.6 mtt180 57.53 48.41 14.43 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.563 -0.71 . . . . 0.0 109.578 -175.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.566 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.6 ptp -165.28 171.3 13.73 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.878 0.847 . . . . 0.0 111.237 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.518 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 49.8 p -155.79 165.43 36.54 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.8 -165.82 34.38 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.822 -1.656 . . . . 0.0 110.79 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.51 HD12 ' CG2' ' A' ' 367' ' ' VAL . 3.5 tt -140.52 149.2 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.623 -0.928 . . . . 0.0 110.143 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -127.82 134.81 49.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 109.695 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.597 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.8 tt -140.15 154.85 23.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.791 -1.193 . . . . 0.0 109.437 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 90.0 m-20 -25.37 -63.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.444 0.64 . . . . 0.0 112.277 172.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 34.1 t30 -91.94 -7.69 48.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.738 . . . . 0.0 111.828 -168.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.6 mtp180 -143.98 144.64 31.77 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.667 -1.271 . . . . 0.0 110.581 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.6 mtm -134.42 111.73 10.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 108.945 169.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 9.6 mt -131.66 146.16 33.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.0 109.978 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.483 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 26.2 mmt85 -134.41 159.32 41.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.069 -1.019 . . . . 0.0 110.356 175.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.518 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.06 127.21 33.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.459 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.12 174.23 31.88 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.635 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.2 m -56.0 150.56 13.36 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.958 -1.319 . . . . 0.0 108.551 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.545 ' CG2' HG11 ' A' ' 420' ' ' VAL . 20.4 t -54.84 -37.36 40.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.083 -1.011 . . . . 0.0 109.904 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.4 m-20 -64.23 -45.01 90.08 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.252 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.486 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -67.48 -48.98 65.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.972 -1.08 . . . . 0.0 110.655 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.529 HG21 ' CG1' ' A' ' 432' ' ' VAL . 35.1 mm -65.98 -43.85 92.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.008 -1.057 . . . . 0.0 110.945 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.621 ' NE ' ' CZ ' ' A' ' 412' ' ' PHE . 4.0 ttt180 -60.29 -42.61 95.85 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.062 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 88.8 mtt-85 -61.28 -37.49 83.37 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.635 172.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.4 t-80 -67.68 -36.21 80.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 111.289 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.71 -49.05 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.621 -1.3 . . . . 0.0 110.154 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -34.3 77.38 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.891 -1.13 . . . . 0.0 110.218 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.13 79.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.96 -1.088 . . . . 0.0 109.994 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.531 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 8.0 m-80 -61.45 -27.71 68.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.174 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.93 19.81 27.87 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.84 -169.37 16.09 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.39 153.62 42.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 111.435 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.621 ' CZ ' ' NE ' ' A' ' 402' ' ' ARG . 7.7 p90 -108.4 149.85 39.84 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.668 -0.645 . . . . 0.0 110.304 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.02 125.56 9.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.807 1.425 . . . . 0.0 110.52 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.25 -32.37 72.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -0.986 . . . . 0.0 111.075 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.5 m-20 -63.47 -31.67 72.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 108.848 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 46.0 t -83.58 -42.58 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.388 -0.82 . . . . 0.0 110.765 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.2 m-20 -55.22 -36.64 66.2 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.669 -1.212 . . . . 0.0 109.625 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.91 -49.75 71.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.337 -1.477 . . . . 0.0 109.662 173.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.513 ' CD ' HG22 ' A' ' 323' ' ' ILE . 79.2 mttt -56.8 -34.83 68.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.785 -1.197 . . . . 0.0 110.278 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -59.47 -40.98 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -66.09 -36.61 83.65 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.959 0.885 . . . . 0.0 109.255 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -66.75 -36.68 83.01 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 110.511 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 428' ' ' ALA . 68.3 t -63.11 -37.69 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.026 -1.047 . . . . 0.0 110.161 175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.05 81.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 110.286 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.75 -30.72 68.37 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.252 -0.905 . . . . 0.0 111.006 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.43 -3.32 57.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 109.777 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.05 22.1 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.528 ' HB2' ' CG1' ' A' ' 423' ' ' VAL . . . -105.68 160.92 14.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -1.052 . . . . 0.0 109.474 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.493 HG22 ' NH1' ' A' ' 317' ' ' ARG . 1.2 m -108.88 106.89 59.56 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.935 -1.103 . . . . 0.0 109.798 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.504 ' CB ' HG12 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.69 107.86 2.56 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.01 1.531 . . . . 0.0 110.769 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.543 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 12.9 mt -92.62 133.29 36.12 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.845 -1.16 . . . . 0.0 108.542 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG21 ' A' ' 401' ' ' ILE . 87.7 t -99.74 134.09 40.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.608 -1.308 . . . . 0.0 109.452 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 46.9 t -114.43 134.95 55.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.999 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.0 m -117.07 159.94 16.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.491 -0.755 . . . . 0.0 109.639 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.499 ' CB ' HD21 ' A' ' 440' ' ' LEU . 4.1 tt0 -135.28 132.52 37.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.01 -129.15 32.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 -167.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 75.6 p -106.46 8.02 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.125 -1.221 . . . . 0.0 111.13 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -120.11 170.73 9.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.643 -1.286 . . . . 0.0 109.977 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.523 HG12 ' CG1' ' A' ' 432' ' ' VAL . 26.1 t -91.82 133.85 32.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.612 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -96.14 -20.04 18.92 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.822 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.555 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 169.07 176.41 39.11 Favored Glycine 0 N--CA 1.501 2.976 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.03 168.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 45.1 t -107.86 141.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.234 -1.157 . . . . 0.0 109.802 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 337' ' ' ALA . 80.4 mt -101.42 110.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 108.939 170.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.522 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -92.31 119.06 31.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.03 -1.044 . . . . 0.0 109.911 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.543 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -102.62 144.88 30.45 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.418 -0.802 . . . . 0.0 108.871 -175.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.494 ' HG2' ' CB ' ' A' ' 320' ' ' SER . 37.8 mmtm -105.97 151.24 24.86 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.697 -1.252 . . . . 0.0 110.7 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -83.86 145.43 28.63 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.353 0.597 . . . . 0.0 110.175 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.5 tp -119.45 152.84 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.7 t -136.36 136.75 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -92.65 145.06 24.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 110.193 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 118.037 -1.424 . . . . 0.0 109.555 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.289 0.566 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -123.54 146.55 48.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.288 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.525 ' CA ' ' HB3' ' A' ' 351' ' ' SER . 92.5 mt-30 -131.12 152.66 50.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.155 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -58.69 137.5 57.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.065 -1.022 . . . . 0.0 109.889 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.52 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.45 -34.04 2.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.604 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -161.81 146.06 12.71 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.936 -1.105 . . . . 0.0 110.246 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.632 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 15.9 p90 -136.78 147.79 46.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.818 -1.176 . . . . 0.0 111.656 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.468 HG21 ' HD2' ' A' ' 324' ' ' PRO . 7.5 mt -119.96 142.5 33.42 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.737 -0.602 . . . . 0.0 109.674 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.541 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.69 143.86 42.86 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.667 1.351 . . . . 0.0 111.732 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.606 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.8 153.02 42.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 108.907 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.59 128.6 37.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.631 -1.293 . . . . 0.0 110.12 -172.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.46 0.6 50.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.3 t -135.36 138.33 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.677 -1.484 . . . . 0.0 110.606 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.454 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.5 m-20 -73.58 149.97 41.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.372 -0.83 . . . . 0.0 110.148 176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.541 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -60.85 -37.22 81.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.983 -1.073 . . . . 0.0 110.025 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -59.53 -41.21 89.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.918 -1.114 . . . . 0.0 109.324 176.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 99.3 m -60.09 -42.95 95.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 110.031 173.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.555 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 6.5 tp -60.01 -39.01 84.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 110.531 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.568 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -68.31 -45.45 72.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 110.734 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.8 m-20 -63.48 -48.71 76.53 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.885 -1.134 . . . . 0.0 109.931 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.598 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.62 -31.51 71.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 109.815 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.44 -35.47 65.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 172.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 19.3 mt-30 -74.04 -55.52 6.02 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.545 -0.722 . . . . 0.0 111.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.31 -36.25 79.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.097 -172.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 395' ' ' LYS . . . -67.82 -18.94 65.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.834 174.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 90.2 p -107.95 8.57 28.5 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.244 -0.91 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.536 HD13 ' CB ' ' A' ' 365' ' ' ARG . 32.2 mt -65.37 -45.77 82.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.557 -1.339 . . . . 0.0 109.67 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.44 1.57 49.34 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.869 -170.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.468 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -62.58 130.36 44.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.683 -1.26 . . . . 0.0 109.905 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.16 5.17 52.54 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.585 0.707 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.9 p -75.53 151.1 85.01 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.561 -0.712 . . . . 0.0 109.385 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.1 -39.31 92.02 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.669 1.352 . . . . 0.0 109.152 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.09 -28.02 69.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -0.789 . . . . 0.0 110.412 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.43 -37.82 67.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.463 ' O ' HD13 ' A' ' 354' ' ' ILE . 96.3 mtt180 -76.63 -35.98 57.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.24 . . . . 0.0 110.466 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.525 ' HB3' ' CA ' ' A' ' 318' ' ' GLN . 3.7 m -61.66 -38.91 89.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.976 -1.078 . . . . 0.0 110.348 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.527 ' CG2' HD11 ' A' ' 443' ' ' ILE . 79.6 mt -69.24 -48.89 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.029 -1.044 . . . . 0.0 110.494 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.509 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 21.8 t -60.64 -32.17 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.797 -1.189 . . . . 0.0 109.84 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 350' ' ' ARG . 45.4 mt -72.98 -32.29 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.861 -1.149 . . . . 0.0 110.744 171.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.632 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.87 -42.51 89.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 110.053 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.71 93.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.817 . . . . 0.0 110.592 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.54 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 81.0 mttt -71.97 -51.11 23.55 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.691 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.0 pt20 -71.82 -42.54 66.89 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.7 mmt180 -73.09 -43.83 61.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 111.031 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 87.5 m-85 -134.88 -38.73 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 112.052 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.468 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 52.3 t30 -163.01 102.51 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.51 -1.369 . . . . 0.0 111.624 -167.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.54 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 25.5 mt -57.97 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.902 -1.124 . . . . 0.0 108.994 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.527 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.2 tpt180 -145.64 163.02 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.892 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 88.9 mt-10 -134.06 -171.26 2.7 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.04 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.539 ' CD ' ' HB3' ' A' ' 339' ' ' LEU . 1.2 tpt180 -100.47 155.67 17.7 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.175 -0.953 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.1 m-20 -104.68 48.42 0.84 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.196 -0.94 . . . . 0.0 110.968 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.644 ' CG1' ' CZ ' ' A' ' 374' ' ' PHE . 78.0 t -66.79 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 176.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.59 -26.89 66.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 110.979 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -28.3 25.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.599 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 17.8 mt -104.13 -1.75 26.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 22.9 m80 64.29 53.49 1.72 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 110.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.563 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -97.12 175.03 6.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 110.758 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.8 m -115.42 132.18 56.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 110.375 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.644 ' CZ ' ' CG1' ' A' ' 367' ' ' VAL . 70.6 m-85 -87.86 149.13 24.31 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 59.9 t -125.31 100.78 32.04 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.066 -1.021 . . . . 0.0 109.866 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.3 151.93 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.089 1.573 . . . . 0.0 110.404 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 12.8 t80 -62.19 131.75 50.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 110.118 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.8 p -120.7 153.37 37.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.553 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.12 -4.89 49.68 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.882 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -56.65 -33.56 66.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.821 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.513 ' HB2' ' CG ' ' A' ' 383' ' ' MET . 5.3 m -139.77 9.77 2.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.841 . . . . 0.0 110.372 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 94.1 mtt180 58.51 51.89 7.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.329 -0.857 . . . . 0.0 109.691 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.518 ' CE ' HD13 ' A' ' 401' ' ' ILE . 2.0 ptp -160.92 172.91 16.11 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.155 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.515 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 22.3 p -154.43 165.04 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -179.65 -165.1 33.14 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.772 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.519 ' CD1' ' CG2' ' A' ' 367' ' ' VAL . 6.7 tt -142.51 148.31 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.956 . . . . 0.0 110.04 -175.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.429 ' ND2' HG22 ' A' ' 375' ' ' VAL . 34.5 m-20 -128.28 135.15 49.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.803 -1.186 . . . . 0.0 109.912 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.599 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.9 tt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 109.421 169.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.257 88.3 m-20 -25.88 -63.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.444 0.64 . . . . 0.0 112.251 173.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.436 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 19.9 t-20 -91.45 -7.97 49.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.807 . . . . 0.0 111.723 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.545 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 26.4 mtp180 -143.23 145.53 32.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.669 -1.27 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.91 113.56 10.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.131 . . . . 0.0 109.033 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 10.0 mt -131.8 146.08 33.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.043 -177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.465 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 26.9 mtt180 -135.52 160.74 37.53 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.613 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.515 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.87 138.69 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.485 -0.759 . . . . 0.0 109.185 174.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.497 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -165.36 174.55 41.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.6 m -57.34 150.97 17.04 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.024 -1.28 . . . . 0.0 108.654 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.541 ' CG2' HG13 ' A' ' 420' ' ' VAL . 19.7 t -53.72 -37.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.9 m-20 -64.11 -44.71 91.43 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.392 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.468 ' HB3' ' HE3' ' A' ' 383' ' ' MET . . . -68.44 -50.57 51.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.907 -1.12 . . . . 0.0 110.574 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.527 HG22 ' CG1' ' A' ' 432' ' ' VAL . 25.9 mm -64.9 -43.56 96.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.027 -1.046 . . . . 0.0 110.847 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.588 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 14.0 ttp180 -59.39 -43.17 92.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 62.5 mtp180 -61.92 -36.09 80.32 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 109.433 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.23 -37.48 83.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.203 -0.935 . . . . 0.0 111.291 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 437' ' ' SER . 58.3 t -65.66 -47.86 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.538 -1.351 . . . . 0.0 110.246 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.4 -34.67 78.24 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.795 -1.19 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.27 80.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.901 -1.125 . . . . 0.0 109.962 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 15.6 m-80 -61.7 -27.27 68.58 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.244 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.48 19.41 30.04 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.52 -169.44 17.08 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -143.88 153.92 42.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -1.214 . . . . 0.0 111.378 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.4 p90 -106.97 149.18 38.24 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.626 -0.671 . . . . 0.0 110.255 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.46 123.7 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.809 1.426 . . . . 0.0 110.433 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.33 -33.99 76.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.925 . . . . 0.0 111.053 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 90.7 m-20 -61.04 -32.99 72.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.9 -1.125 . . . . 0.0 108.841 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.606 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 50.8 t -84.1 -42.62 17.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 60.7 m-20 -54.2 -36.99 64.05 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.456 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.6 mm-40 -63.18 -48.82 76.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.254 -1.529 . . . . 0.0 110.228 170.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 16.5 mmtt -56.29 -35.38 67.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.751 -1.218 . . . . 0.0 110.412 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.585 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -59.79 -40.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 109.151 171.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.874 0.845 . . . . 0.0 109.346 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 94.7 mm-40 -66.83 -38.06 85.68 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.644 -0.66 . . . . 0.0 110.666 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.511 ' CG2' ' HB1' ' A' ' 444' ' ' ALA . 65.5 t -63.09 -36.92 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.934 -1.104 . . . . 0.0 110.14 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.14 82.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -70.37 -30.67 67.65 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 111.108 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 423' ' ' VAL . 5.9 pt20 -82.15 -6.35 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.901 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 96.44 22.02 20.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.444 ' HB1' HG11 ' A' ' 423' ' ' VAL . . . -110.19 170.99 7.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 110.026 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.475 ' O ' HD13 ' A' ' 445' ' ' LEU . 1.7 m -113.44 107.02 53.84 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.075 -1.016 . . . . 0.0 110.078 -174.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 420' ' ' VAL . 43.3 Cg_endo -77.38 108.59 2.62 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.538 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 13.7 mt -93.48 139.68 30.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.919 -1.113 . . . . 0.0 108.851 167.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.527 ' CG1' HG22 ' A' ' 401' ' ' ILE . 88.3 t -102.5 135.76 38.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.749 -1.219 . . . . 0.0 109.587 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 395' ' ' LYS . 46.3 t -118.25 135.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 108.758 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -118.26 160.56 17.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.464 ' CB ' HD21 ' A' ' 440' ' ' LEU . 3.9 tt0 -136.67 133.64 36.4 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 171.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.82 -124.2 23.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.494 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 1.9 p -114.19 12.48 17.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.269 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -127.19 171.36 11.5 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 109.843 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.527 HG11 ' CG1' ' A' ' 432' ' ' VAL . 47.4 t -88.17 136.19 23.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.089 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.598 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.6 pp -94.34 -22.33 18.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.46 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.17 177.44 39.34 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.976 169.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.585 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 52.3 t -107.66 142.88 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.178 -1.19 . . . . 0.0 109.811 172.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.527 HD11 ' CG2' ' A' ' 352' ' ' ILE . 78.1 mt -101.43 112.93 36.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.511 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -91.81 119.0 31.23 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 109.869 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.538 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -101.38 144.88 29.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.52 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 13.8 pttt -141.01 171.08 14.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.597 -1.314 . . . . 0.0 110.738 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -71.38 144.88 49.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.737 . . . . 0.0 110.17 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 9.3 tp -119.63 152.84 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 110.283 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.07 134.01 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 110.303 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -93.12 144.08 25.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.183 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.54 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.248 0.547 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -122.61 146.1 47.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.221 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.528 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.3 mt-30 -131.33 151.31 51.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.25 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 355' ' ' LEU . . . -62.03 137.87 58.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.842 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -122.98 -32.87 3.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.48 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -163.22 146.13 10.38 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.348 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.644 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 10.1 p90 -134.24 142.19 47.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.875 -1.141 . . . . 0.0 111.482 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.466 HG22 ' HD2' ' A' ' 324' ' ' PRO . 1.3 mp -113.53 139.71 23.64 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.612 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.543 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.0 143.14 44.11 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.713 1.375 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.597 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -69.06 153.87 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 108.724 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.83 128.26 36.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.68 -1.262 . . . . 0.0 110.378 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 112.67 -22.27 17.23 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 61.2 t -115.84 139.93 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.727 -1.455 . . . . 0.0 111.071 -172.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.444 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.6 m-20 -72.19 148.39 45.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -60.56 -39.28 87.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 110.496 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.447 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.4 ttmt -58.76 -43.6 90.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.713 -1.242 . . . . 0.0 109.641 175.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 93.1 m -56.75 -43.83 81.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.539 ' CD2' ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -58.66 -39.7 81.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.81 -40.99 83.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.074 -1.016 . . . . 0.0 110.817 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -63.66 -50.02 70.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 109.823 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.18 -31.5 71.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 109.711 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.521 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.08 -35.4 64.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.954 . . . . 0.0 109.033 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 20.6 mt-30 -74.79 -55.86 5.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.535 -0.728 . . . . 0.0 110.882 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.15 -35.6 77.54 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.77 -172.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -67.53 -20.49 65.43 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.072 -1.018 . . . . 0.0 110.063 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.456 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.5 p -107.15 9.08 30.39 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.161 -0.962 . . . . 0.0 111.471 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.8 mt -66.2 -44.61 83.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.614 -1.304 . . . . 0.0 109.665 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -97.15 1.87 50.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.919 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.28 130.47 44.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.726 -1.234 . . . . 0.0 109.879 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.48 5.4 51.68 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.551 0.691 . . . . 0.0 109.926 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.5 152.04 83.25 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.643 -0.661 . . . . 0.0 109.478 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.07 -39.71 89.48 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.748 1.394 . . . . 0.0 109.144 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.44 -27.98 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 110.409 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -54.99 -37.26 62.25 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -175.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.448 ' O ' HD11 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.72 -37.36 56.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -1.231 . . . . 0.0 110.513 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.9 m -61.28 -37.95 85.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.952 -1.092 . . . . 0.0 110.358 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.509 ' CG2' HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.78 -49.26 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 25.8 t -61.06 -33.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 358' ' ' GLN . 33.2 mt -72.58 -33.62 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.698 -1.251 . . . . 0.0 110.652 171.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.644 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.01 -40.53 85.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.935 -1.103 . . . . 0.0 110.402 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.06 -45.15 90.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 40.7 mtmt -72.29 -49.51 34.17 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.616 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.5 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.8 pt20 -71.56 -42.77 67.42 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.891 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.5 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.5 mmt180 -72.67 -45.46 58.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.138 -0.976 . . . . 0.0 111.164 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.576 ' CZ ' ' OE2' ' A' ' 330' ' ' GLU . 60.0 m-85 -135.83 -38.68 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.391 -1.323 . . . . 0.0 112.114 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.464 ' OD1' ' HB2' ' A' ' 363' ' ' ARG . 13.8 t-20 -159.99 106.17 1.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.698 -1.251 . . . . 0.0 111.542 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 52.6 mt -57.7 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 0.0 109.323 172.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.536 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.7 tpt180 -128.07 164.0 23.38 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.5 mt-10 -137.98 -159.58 0.97 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.592 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.3 ptt180 -95.98 162.86 13.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.523 -0.736 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -130.34 41.86 3.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 110.465 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 374' ' ' PHE . 42.9 t -72.97 -45.65 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.191 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.29 -27.48 67.21 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.487 -0.758 . . . . 0.0 111.021 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -29.64 27.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.713 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.529 ' CB ' HD12 ' A' ' 388' ' ' ILE . 20.4 mt -103.36 -5.03 23.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 110.662 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 367' ' ' VAL . 73.5 m-70 60.57 51.73 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 0.0 109.752 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.536 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.99 174.62 7.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.81 . . . . 0.0 110.521 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.0 m -117.15 134.89 54.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.342 -0.849 . . . . 0.0 110.58 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.58 ' CE2' HG11 ' A' ' 367' ' ' VAL . 82.3 m-85 -88.58 147.47 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 60.7 t -120.43 100.98 46.91 Favored Pre-proline 0 C--N 1.299 -1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.07 151.39 34.66 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.019 1.537 . . . . 0.0 110.529 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 16.4 t80 -66.44 131.87 47.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.5 p -120.01 151.76 38.51 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.732 175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.39 -6.63 54.08 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.536 -0.727 . . . . 0.0 109.881 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -56.89 -32.97 66.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.862 . . . . 0.0 109.838 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 400' ' ' ALA . 15.1 m -138.82 9.93 2.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.412 -0.805 . . . . 0.0 110.299 174.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 81.4 mtm180 56.79 50.98 11.51 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.185 -0.947 . . . . 0.0 109.424 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.525 ' CE ' HD13 ' A' ' 401' ' ' ILE . 3.0 ptp -157.54 166.3 33.3 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.923 0.868 . . . . 0.0 111.357 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.93 165.0 37.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.63 -166.96 35.61 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 118.923 -1.608 . . . . 0.0 110.733 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 367' ' ' VAL . 3.9 tt -139.45 149.58 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.556 -0.967 . . . . 0.0 110.178 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -127.16 134.84 50.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 0.0 109.798 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -141.51 155.21 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 90.4 m-20 -23.02 -63.04 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.406 0.622 . . . . 0.0 112.49 171.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.45 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 53.7 t30 -95.99 -5.7 40.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.788 . . . . 0.0 111.855 -167.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.543 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.1 mtp180 -144.13 143.96 31.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.741 -1.225 . . . . 0.0 110.434 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.9 mtm -134.72 102.26 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.896 -1.128 . . . . 0.0 109.071 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 8.1 mt -124.31 146.03 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -172.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.472 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 39.9 mtt180 -134.37 159.98 39.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 0.0 110.872 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.65 127.96 32.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -154.33 173.83 32.8 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.319 -1.419 . . . . 0.0 109.566 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.2 m -55.82 149.26 15.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.757 -1.437 . . . . 0.0 108.343 168.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.52 ' CG2' HG11 ' A' ' 420' ' ' VAL . 61.3 t -58.24 -34.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.899 -1.126 . . . . 0.0 109.917 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.2 t0 -61.85 -45.32 94.3 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.503 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -68.84 -51.27 42.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.955 -1.09 . . . . 0.0 110.591 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.525 HD13 ' CE ' ' A' ' 383' ' ' MET . 31.0 mm -64.49 -42.93 96.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 110.742 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.588 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.8 ttp85 -59.31 -43.73 92.61 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 70.6 mtp180 -61.8 -36.57 81.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.403 173.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.544 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -68.45 -36.14 78.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 111.197 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 437' ' ' SER . 52.9 t -65.81 -49.29 78.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.587 -1.32 . . . . 0.0 110.127 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.73 -33.91 76.7 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.949 -1.095 . . . . 0.0 110.285 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.19 79.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.991 -1.068 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.544 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 14.2 m-80 -62.25 -27.17 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.69 19.46 29.41 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -169.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.73 -171.4 18.27 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -144.88 153.68 41.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 111.037 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.3 p90 -108.78 150.7 41.15 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.521 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.93 128.33 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.83 1.437 . . . . 0.0 110.388 -175.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.8 t -67.3 -35.57 79.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.251 -0.905 . . . . 0.0 110.992 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -61.52 -34.06 74.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.912 -1.118 . . . . 0.0 108.816 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.597 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 55.0 t -83.48 -42.6 17.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.956 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.67 -38.22 69.32 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.543 172.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.4 mm-40 -63.77 -47.93 78.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.343 -1.473 . . . . 0.0 110.295 171.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 66.2 mttm -56.76 -35.06 68.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.639 -1.288 . . . . 0.0 110.431 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.9 t -60.04 -41.36 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.879 -1.138 . . . . 0.0 109.371 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.0 -36.0 82.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.812 0.815 . . . . 0.0 109.418 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.52 -37.87 80.41 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.648 -0.658 . . . . 0.0 110.861 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.467 HG12 ' HB1' ' A' ' 428' ' ' ALA . 68.8 t -62.95 -37.56 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.092 . . . . 0.0 110.022 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -40.12 83.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.332 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -68.25 -31.16 70.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 110.972 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -80.87 -3.47 51.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.045 -1.035 . . . . 0.0 109.705 174.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.25 21.77 34.26 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.467 ' HB1' HG12 ' A' ' 423' ' ' VAL . . . -106.63 173.87 6.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.143 . . . . 0.0 109.827 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.512 ' HB ' ' CD1' ' A' ' 445' ' ' LEU . 1.4 m -115.89 106.72 49.34 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.978 -1.076 . . . . 0.0 110.03 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.48 ' CG ' HG12 ' A' ' 420' ' ' VAL . 54.9 Cg_endo -79.85 107.47 2.1 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.91 1.479 . . . . 0.0 110.243 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.538 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.7 mt -91.94 135.61 33.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.898 -1.126 . . . . 0.0 108.482 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 439' ' ' VAL . 88.3 t -99.71 133.96 40.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.747 -1.22 . . . . 0.0 109.341 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 440' ' ' LEU . 25.0 t -113.47 136.78 48.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.8 m -122.19 160.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 121.379 -0.825 . . . . 0.0 109.719 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.452 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.5 tt0 -135.14 130.98 36.27 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.84 -128.1 28.72 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.526 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 84.8 p -106.33 8.7 31.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 111.132 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.479 ' NH1' ' HG3' ' A' ' 438' ' ' ARG . 35.2 ptt85 -122.87 174.23 7.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.59 -1.319 . . . . 0.0 110.257 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 412' ' ' PHE . 52.9 t -94.49 134.5 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.609 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.2 pp -93.88 -21.22 19.38 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.748 175.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.539 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 169.42 176.55 39.41 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 118.868 -1.634 . . . . 0.0 110.961 168.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 48.9 t -107.99 142.64 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.009 -1.289 . . . . 0.0 109.974 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.521 HD12 ' CB ' ' A' ' 337' ' ' ALA . 82.3 mt -101.38 112.36 34.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.352 -0.842 . . . . 0.0 109.104 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.416 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.28 119.44 31.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.793 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.538 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.4 mt -102.59 146.33 28.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.579 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 1.4 ptpm? -134.64 164.88 26.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.575 -1.328 . . . . 0.0 110.777 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -83.79 146.02 28.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.547 -0.721 . . . . 0.0 110.14 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.7 tp -119.02 153.09 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.853 . . . . 0.0 110.333 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.91 136.53 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.287 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -89.73 145.52 25.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 110.188 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 CA-C-O 118.005 -1.441 . . . . 0.0 109.561 -179.904 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.264 0.554 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.519 ' NE ' ' OE2' ' A' ' 348' ' ' GLU . 87.5 mtm-85 -122.96 145.03 48.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.895 . . . . 0.0 110.215 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.8 tt0 -120.37 133.59 55.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.372 -0.83 . . . . 0.0 110.089 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -55.59 139.35 44.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.074 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 39.8 m -123.34 -38.67 2.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.494 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -163.03 148.97 12.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.149 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.684 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 16.1 p90 -134.54 143.57 47.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.759 -1.213 . . . . 0.0 111.802 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.524 HG22 ' CD ' ' A' ' 419' ' ' LYS . 2.6 mt -113.68 143.99 30.54 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.542 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.74 142.72 36.17 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.708 1.372 . . . . 0.0 111.569 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.598 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.98 151.72 43.02 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 108.876 165.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.79 129.04 40.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.684 -1.26 . . . . 0.0 109.983 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.39 -1.8 46.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 52.1 t -136.01 139.07 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.573 -1.545 . . . . 0.0 110.748 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 332' ' ' THR . 6.5 p-10 -73.52 151.89 40.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 110.158 176.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 83.5 tt0 -61.06 -34.7 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.108 -0.995 . . . . 0.0 109.658 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.519 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 109.473 177.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.525 ' CG2' HG11 ' A' ' 328' ' ' VAL . 3.2 m -62.98 -39.14 93.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 175.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.563 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 6.2 tp -59.83 -40.12 87.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.048 -1.033 . . . . 0.0 110.412 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -68.02 -43.96 77.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.953 -1.092 . . . . 0.0 110.711 -176.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.5 t0 -63.15 -48.84 76.74 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.878 -1.139 . . . . 0.0 110.068 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.74 -31.05 69.83 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 109.918 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -54.8 -35.99 64.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.134 -0.979 . . . . 0.0 108.884 172.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.531 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.8 mt-30 -75.06 -55.76 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.663 -0.648 . . . . 0.0 111.06 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.545 ' HA ' ' CG ' ' A' ' 342' ' ' LEU . 0.2 OUTLIER -64.97 -32.92 74.87 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.136 -171.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 395' ' ' LYS . . . -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.86 -1.15 . . . . 0.0 110.07 172.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 99.1 p -107.95 11.4 27.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.143 -0.973 . . . . 0.0 111.541 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.5 mt -66.74 -45.17 79.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.722 -1.236 . . . . 0.0 109.859 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -97.07 1.08 49.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.864 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 341' ' ' SER . 12.2 p30 -63.92 130.3 43.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.746 -1.221 . . . . 0.0 109.979 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 4.6 52.97 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.633 0.73 . . . . 0.0 109.85 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.1 p -74.13 152.69 88.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.434 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.75 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.757 1.399 . . . . 0.0 109.227 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.519 ' OE2' ' NE ' ' A' ' 317' ' ' ARG . 99.2 mt-10 -64.45 -28.44 69.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.41 -38.53 69.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.443 ' O ' HD13 ' A' ' 354' ' ' ILE . 69.3 mtt85 -77.91 -37.2 48.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -1.157 . . . . 0.0 110.58 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 5.5 m -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 110.338 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 86.0 mt -68.66 -48.6 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.023 -1.048 . . . . 0.0 110.652 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.531 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 25.1 t -60.83 -32.77 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 350' ' ' ARG . 32.9 mt -72.54 -32.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 110.719 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.614 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.84 -41.11 90.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.801 -1.187 . . . . 0.0 110.396 178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.505 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.23 -42.55 99.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.359 -0.838 . . . . 0.0 110.363 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.521 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 73.1 mttt -72.54 -51.54 19.46 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.711 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.547 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.1 pt20 -70.7 -42.4 70.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.547 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.5 mmm180 -74.59 -43.85 53.61 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 111.084 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.684 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 50.6 m-85 -135.2 -39.48 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.658 -1.276 . . . . 0.0 111.986 -169.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.484 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.5 t30 -161.03 105.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.716 -1.24 . . . . 0.0 111.588 -168.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 42.0 mt -57.57 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.899 -1.125 . . . . 0.0 109.075 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.512 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.7 tpt85 -135.09 163.73 29.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.006 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -134.03 -156.25 0.72 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.903 -1.123 . . . . 0.0 110.457 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.582 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.7 ptt85 -97.4 161.43 13.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.505 0.669 . . . . 0.0 110.717 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -128.08 41.77 3.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.305 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.567 HG22 ' CE1' ' A' ' 374' ' ' PHE . 88.5 t -73.49 -49.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.413 -0.804 . . . . 0.0 110.464 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -69.16 -23.87 64.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 111.073 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -31.94 31.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 109.691 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.598 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.2 mt -101.57 -3.61 28.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 110.554 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 371' ' ' HIS . 8.6 m170 63.74 53.93 1.91 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.551 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -96.72 175.01 6.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.6 m -117.45 135.14 54.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.57 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.567 ' CE1' HG22 ' A' ' 367' ' ' VAL . 93.0 m-85 -90.28 143.11 27.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 19.8 t -116.68 101.23 53.66 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.973 . . . . 0.0 109.608 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.13 151.53 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.034 1.544 . . . . 0.0 110.603 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.1 t80 -64.43 132.0 48.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.1 p -120.43 152.37 38.05 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.84 . . . . 0.0 109.664 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.63 -6.63 54.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.504 -0.747 . . . . 0.0 109.918 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.86 -32.84 66.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.843 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 3.3 m -139.05 9.97 2.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.371 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 71.1 mtt85 56.93 51.27 10.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.203 -0.936 . . . . 0.0 109.485 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 400' ' ' ALA . 2.4 ptp -158.18 167.65 29.21 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.236 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.521 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 24.8 p -155.38 165.19 37.38 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.58 -165.55 33.83 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.618 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.489 HG23 ' HB2' ' A' ' 339' ' ' LEU . 1.5 tt -140.21 149.51 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.631 -0.923 . . . . 0.0 110.104 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -127.23 134.62 50.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 109.756 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.598 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.8 tt -139.82 154.87 24.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.875 -1.141 . . . . 0.0 109.381 171.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 89.8 m-20 -25.53 -63.09 0.06 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.407 0.622 . . . . 0.0 112.251 172.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.444 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 51.2 t30 -91.62 -7.76 49.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 111.692 -168.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.548 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.3 mtp180 -144.7 144.65 31.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.636 -1.29 . . . . 0.0 110.536 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.93 110.46 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.871 -1.143 . . . . 0.0 109.067 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 8.7 mt -131.3 145.91 34.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 110.201 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.475 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 49.6 mtt-85 -134.94 160.95 36.66 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.834 175.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.521 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.52 128.74 33.93 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -157.03 174.31 34.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.4 m -57.27 151.09 16.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.934 -1.333 . . . . 0.0 108.597 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.539 ' CG2' HG13 ' A' ' 420' ' ' VAL . 60.1 t -56.62 -35.1 43.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.075 -1.016 . . . . 0.0 109.894 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.3 t70 -63.03 -46.13 89.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.306 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.523 ' CB ' ' HE2' ' A' ' 383' ' ' MET . . . -68.82 -51.82 36.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.985 -1.072 . . . . 0.0 110.482 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.523 HG23 ' CG1' ' A' ' 432' ' ' VAL . 36.7 mm -63.51 -42.77 97.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 121.126 -0.984 . . . . 0.0 110.64 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.624 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 9.1 ttt180 -60.24 -43.21 96.26 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 52.1 mtp85 -61.62 -35.86 79.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.052 -1.03 . . . . 0.0 109.562 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.505 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.45 -37.72 83.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.187 -0.945 . . . . 0.0 111.269 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 437' ' ' SER . 59.5 t -65.66 -47.7 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.558 -1.339 . . . . 0.0 110.16 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.1 -34.98 78.77 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.795 -1.19 . . . . 0.0 110.28 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -35.92 79.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.505 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.2 m-80 -61.53 -27.47 68.63 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.159 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.43 19.69 29.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.85 -169.38 16.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -143.31 153.52 42.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.094 -1.239 . . . . 0.0 111.488 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.624 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 7.5 p90 -107.5 150.27 39.88 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.772 -0.58 . . . . 0.0 110.202 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.75 123.14 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.904 1.476 . . . . 0.0 110.495 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.82 -32.6 73.99 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.098 -1.002 . . . . 0.0 111.026 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.6 m-20 -61.96 -32.88 73.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.896 -1.128 . . . . 0.0 108.844 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.598 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 50.3 t -83.6 -42.4 17.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.999 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 67.9 m-20 -55.39 -37.13 67.17 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.616 171.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.0 mt-30 -63.75 -48.76 75.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.337 -1.477 . . . . 0.0 110.099 171.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.524 ' CD ' HG22 ' A' ' 323' ' ' ILE . 95.9 mttt -57.22 -34.7 68.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.68 -1.262 . . . . 0.0 110.355 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -59.5 -40.76 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 0.0 109.257 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -66.81 -36.74 83.07 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.873 0.844 . . . . 0.0 109.448 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 83.9 mt-30 -67.48 -36.66 81.56 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.622 -0.673 . . . . 0.0 110.472 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.528 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 71.0 t -62.97 -37.89 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 110.029 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.86 -40.16 83.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.335 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -69.07 -31.06 69.54 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.287 -0.883 . . . . 0.0 110.942 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.25 -3.02 57.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.808 176.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.6 21.94 27.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.528 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -106.43 161.62 14.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -1.097 . . . . 0.0 109.478 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.474 ' O ' HD12 ' A' ' 445' ' ' LEU . 28.2 m -109.02 107.22 59.84 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.03 . . . . 0.0 109.703 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.474 ' HB2' HG11 ' A' ' 420' ' ' VAL . 39.0 Cg_endo -76.26 107.94 2.56 Favored 'Trans proline' 0 C--N 1.298 -2.09 0 O-C-N 123.924 1.486 . . . . 0.0 110.643 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.538 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 14.0 mt -93.04 134.43 35.19 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.825 -1.172 . . . . 0.0 108.677 167.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 439' ' ' VAL . 91.3 t -100.74 134.93 39.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 120.72 -1.238 . . . . 0.0 109.504 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 45.2 t -115.38 137.02 50.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.8 m -117.56 159.59 17.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.373 -0.829 . . . . 0.0 109.676 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.497 ' CB ' HD21 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.17 132.45 35.98 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.28 -129.3 31.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.493 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.93 11.87 27.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -1.218 . . . . 0.0 110.945 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -126.18 170.89 11.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.697 -1.252 . . . . 0.0 109.908 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.526 HG13 ' CG1' ' A' ' 432' ' ' VAL . 22.7 t -90.3 134.77 28.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.342 -0.849 . . . . 0.0 109.874 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.609 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.8 pp -94.77 -22.12 18.28 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.85 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.563 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.11 176.6 38.71 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.997 169.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 48.0 t -107.77 141.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.216 -1.167 . . . . 0.0 109.887 173.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 337' ' ' ALA . 78.3 mt -101.31 111.71 31.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 108.987 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.22 119.39 31.8 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.85 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.538 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.25 143.22 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.521 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 10.5 mtmt -106.73 157.99 17.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.619 -1.301 . . . . 0.0 110.984 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -91.08 146.07 24.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.71 . . . . 0.0 110.35 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.8 tp -119.18 155.64 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.85 . . . . 0.0 110.117 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.1 t -101.34 134.52 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.148 -0.97 . . . . 0.0 110.294 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 451' ' ' GLY . 57.0 mtpt -93.88 145.53 24.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.9 . . . . 0.0 110.234 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 450' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.292 0.567 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 90.9 mtm-85 -122.91 145.96 48.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 110.183 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 24.9 mt-30 -131.97 148.6 52.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -58.66 136.63 57.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.957 -1.09 . . . . 0.0 109.889 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.406 ' C ' HD12 ' A' ' 355' ' ' LEU . 1.8 m -121.24 -34.5 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.203 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -165.61 147.04 7.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.182 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.637 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 12.9 p90 -136.51 147.66 47.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.827 -1.17 . . . . 0.0 111.663 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.526 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -118.85 144.13 35.07 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.728 -0.607 . . . . 0.0 109.593 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.534 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.53 143.85 39.17 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.76 1.4 . . . . 0.0 111.521 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.601 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.39 152.48 42.0 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 108.818 165.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.32 128.55 37.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.682 -1.261 . . . . 0.0 110.126 -172.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.98 -0.77 44.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.4 t -136.49 139.92 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.481 . . . . 0.0 110.73 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.0 m-20 -74.12 152.48 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.534 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 86.1 tt0 -62.61 -40.23 96.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.487 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -59.18 -43.29 92.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.57 -1.331 . . . . 0.0 109.63 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 94.1 m -55.73 -43.55 76.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.857 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.8 tp -59.71 -40.17 87.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.251 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -66.59 -40.79 89.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.92 -1.112 . . . . 0.0 110.917 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 82.3 m-20 -64.62 -50.2 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.895 -1.128 . . . . 0.0 109.766 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.7 -30.79 70.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.951 -1.093 . . . . 0.0 109.636 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.42 -35.54 65.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.103 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 356' ' ' ALA . 14.3 mt-30 -73.43 -55.69 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.551 -0.718 . . . . 0.0 111.06 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -62.97 -35.72 81.1 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.559 -1.257 . . . . 0.0 109.894 -172.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.445 ' HB1' ' HG2' ' A' ' 395' ' ' LYS . . . -66.72 -20.73 66.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.088 -1.007 . . . . 0.0 110.053 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.464 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 94.2 p -107.03 8.84 30.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.121 -0.987 . . . . 0.0 111.579 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.585 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 41.4 mt -66.5 -44.47 82.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.531 -1.355 . . . . 0.0 109.584 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.76 1.0 50.36 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 341' ' ' SER . 12.5 p30 -63.67 130.53 44.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.714 -1.241 . . . . 0.0 109.979 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.62 5.61 51.03 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.511 0.672 . . . . 0.0 109.845 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.35 150.17 79.69 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.652 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -53.68 -38.21 84.37 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.678 1.357 . . . . 0.0 109.172 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.23 -28.55 69.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 110.393 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.82 -36.93 67.51 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.456 ' O ' HD12 ' A' ' 354' ' ' ILE . 42.2 mmt180 -76.65 -37.93 55.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.118 -1.225 . . . . 0.0 110.525 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.523 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.41 -38.17 86.14 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.962 -1.086 . . . . 0.0 110.372 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 86.0 mt -68.55 -49.42 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.005 -1.059 . . . . 0.0 110.594 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.524 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 23.9 t -60.56 -33.67 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.1 mt -72.23 -33.3 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.689 -1.257 . . . . 0.0 110.68 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.637 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.57 -40.8 88.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.534 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -61.92 -43.1 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 110.273 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 83.3 mttt -69.64 -48.73 58.87 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.745 -174.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 10.2 pt20 -70.75 -43.46 68.78 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 110.499 -173.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.2 mmm180 -73.98 -46.09 45.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 111.312 -173.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 330' ' ' GLU . 27.8 m-85 -135.67 -35.97 0.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.666 -167.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.513 ' ND2' ' HD3' ' A' ' 363' ' ' ARG . 55.9 t-20 -158.59 93.89 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.512 -1.368 . . . . 0.0 111.808 -169.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.532 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -61.35 95.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.987 -1.07 . . . . 0.0 110.178 172.087 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.513 ' HD3' ' ND2' ' A' ' 361' ' ' ASN . 30.8 ptt85 -150.01 -179.06 6.86 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 363' ' ' ARG . 22.2 pt-20 -124.78 -157.39 0.77 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 110.531 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.585 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.9 ptt180 -90.62 165.59 13.65 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.743 -0.598 . . . . 0.0 110.492 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -123.99 38.63 4.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.422 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 374' ' ' PHE . 43.9 t -74.34 -49.82 30.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 110.376 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -67.75 -25.1 65.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 111.039 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.08 -30.09 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.99 . . . . 0.0 109.8 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.596 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 19.3 mt -103.65 -4.19 24.12 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 110.672 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 31.1 m80 62.84 53.94 2.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.427 -0.796 . . . . 0.0 110.168 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.552 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.9 175.03 6.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 110.606 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.9 m -116.67 134.27 55.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.573 ' CE1' HG22 ' A' ' 367' ' ' VAL . 84.2 m-85 -88.89 147.96 24.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 25.9 t -122.93 100.97 39.61 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.13 -0.981 . . . . 0.0 109.604 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.64 151.15 40.39 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.983 1.518 . . . . 0.0 110.475 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.16 131.55 46.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 110.07 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.8 p -120.77 152.89 37.76 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.99 -6.12 53.45 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.526 -0.734 . . . . 0.0 109.936 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -57.01 -33.04 66.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.804 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 383' ' ' MET . 0.5 OUTLIER -138.26 9.39 2.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 110.315 174.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 57.88 51.14 9.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.542 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.52 ' CE ' HD12 ' A' ' 401' ' ' ILE . 2.4 ptp -161.0 169.34 22.75 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.408 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 5.2 p -156.88 165.3 36.57 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.78 -165.18 33.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.523 HD13 ' CG2' ' A' ' 367' ' ' VAL . 3.3 tt -138.82 149.08 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.698 -0.884 . . . . 0.0 110.125 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -127.79 135.15 49.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 109.654 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.596 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.8 tt -140.06 154.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.875 -1.14 . . . . 0.0 109.389 171.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.6 -63.17 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.434 0.635 . . . . 0.0 112.242 172.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.444 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 40.8 t-20 -91.66 -7.89 48.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.51 -0.744 . . . . 0.0 111.755 -168.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.552 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 31.2 mtp180 -144.19 145.67 32.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.707 -1.246 . . . . 0.0 110.605 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.4 mtt -135.49 110.8 9.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.903 -1.123 . . . . 0.0 108.999 169.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.582 ' CD1' ' CB ' ' A' ' 336' ' ' ALA . 8.9 mt -130.35 146.13 34.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.989 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.492 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.4 mmt85 -134.13 159.69 40.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.109 -0.994 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.525 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.1 OUTLIER -132.61 137.55 47.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -164.37 174.36 40.42 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.267 -1.444 . . . . 0.0 109.625 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -56.94 149.93 17.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.278 . . . . 0.0 108.684 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.541 ' CG2' HG11 ' A' ' 420' ' ' VAL . 22.8 t -55.03 -37.62 43.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 109.975 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.7 m-20 -64.24 -44.35 92.12 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.221 -0.924 . . . . 0.0 110.343 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.467 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.21 -50.24 55.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.963 -1.085 . . . . 0.0 110.662 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.523 HG21 ' CG1' ' A' ' 432' ' ' VAL . 30.9 mm -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.746 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.5 ttp85 -59.85 -42.92 94.68 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.1 mtt180 -61.47 -36.3 80.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.576 173.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.506 ' CE1' HG22 ' A' ' 434' ' ' VAL . 3.5 t-80 -66.61 -38.5 87.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 111.245 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 437' ' ' SER . 71.3 t -65.47 -47.28 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.623 -1.298 . . . . 0.0 110.268 178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.48 -34.8 78.56 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.785 -1.197 . . . . 0.0 110.436 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.933 -1.104 . . . . 0.0 109.951 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.489 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 27.1 m-80 -62.04 -27.1 68.65 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.26 18.93 31.94 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -169.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -111.58 -169.95 18.73 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -144.1 153.69 42.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -1.223 . . . . 0.0 111.461 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 7.7 p90 -108.88 150.43 40.86 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.719 -0.613 . . . . 0.0 110.143 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.547 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.9 124.01 8.36 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.845 1.445 . . . . 0.0 110.488 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.32 -32.77 73.95 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.928 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.8 m-20 -61.65 -32.84 73.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.863 -1.148 . . . . 0.0 108.872 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.601 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 50.0 t -83.76 -42.55 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.391 -0.818 . . . . 0.0 110.975 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.581 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 68.8 m-20 -55.17 -37.2 66.72 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.584 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.8 mm-40 -63.94 -48.76 75.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.254 -1.529 . . . . 0.0 110.232 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.526 ' CD ' HG21 ' A' ' 323' ' ' ILE . 43.2 mttt -57.56 -34.27 69.02 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.638 -1.289 . . . . 0.0 110.416 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.591 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -59.21 -41.24 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.206 171.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -66.46 -36.22 82.22 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.921 0.867 . . . . 0.0 109.418 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.45 -37.63 83.25 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 110.798 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.525 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 68.8 t -63.31 -37.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.005 -1.059 . . . . 0.0 110.088 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.12 84.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.329 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -68.51 -31.18 70.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.394 -0.816 . . . . 0.0 110.889 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.508 ' NE2' ' HE2' ' A' ' 446' ' ' LYS . 2.0 tt0 -82.59 -3.01 55.42 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.852 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.85 27.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.525 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -107.67 163.18 13.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -1.064 . . . . 0.0 109.64 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 445' ' ' LEU . 53.7 m -110.12 107.12 58.66 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.809 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.515 ' CG ' HG12 ' A' ' 420' ' ' VAL . 37.5 Cg_endo -75.82 108.22 2.64 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 123.979 1.515 . . . . 0.0 110.773 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 12.3 mt -92.71 135.05 34.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.854 -1.154 . . . . 0.0 108.599 166.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 439' ' ' VAL . 97.9 t -100.08 136.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.651 -1.28 . . . . 0.0 109.568 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.469 ' O ' HD12 ' A' ' 440' ' ' LEU . 44.5 t -117.33 136.96 52.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 108.992 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -117.75 160.03 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.497 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.07 132.08 35.7 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -128.65 31.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.496 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.11 11.36 27.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.185 -1.185 . . . . 0.0 110.968 -179.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -123.45 170.78 10.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.633 -1.292 . . . . 0.0 109.925 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 432' ' ' VAL . 22.5 t -91.39 134.03 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.7 pp -94.79 -21.71 18.54 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.862 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.99 177.02 38.97 Favored Glycine 0 N--CA 1.499 2.896 0 C-N-CA 118.847 -1.644 . . . . 0.0 110.985 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.591 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 47.1 t -107.78 142.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.183 -1.187 . . . . 0.0 109.819 173.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.515 HD11 ' CB ' ' A' ' 337' ' ' ALA . 80.1 mt -101.29 111.28 30.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 108.94 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.52 ' HB3' ' CG1' ' A' ' 423' ' ' VAL . . . -91.55 118.93 31.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.99 -1.069 . . . . 0.0 109.7 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.536 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -99.72 143.43 29.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.508 ' HE2' ' NE2' ' A' ' 426' ' ' GLN . 53.1 mttt -120.37 161.15 21.68 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 111.146 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.91 143.46 34.23 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.385 0.612 . . . . 0.0 110.216 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 12.1 tt -112.04 153.79 13.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 110.242 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.81 134.52 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.182 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -91.74 145.54 24.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.202 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.227 0.537 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -65.69 145.96 55.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.191 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 14.4 pt20 -143.33 155.8 44.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.0 110.273 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -60.75 137.59 58.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.636 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -118.49 -35.79 3.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 110.121 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.613 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 14.3 p90 -135.69 142.76 45.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.821 -1.174 . . . . 0.0 111.676 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.513 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.6 mp -114.38 144.59 32.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.725 -0.61 . . . . 0.0 109.706 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.72 143.49 37.64 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.738 1.388 . . . . 0.0 111.448 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.599 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.94 152.0 42.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.821 165.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -57.59 128.61 37.9 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 110.11 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.17 -1.33 43.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.6 t -136.56 140.03 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.706 -1.467 . . . . 0.0 110.751 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.23 152.42 39.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CD ' ' CZ ' ' A' ' 360' ' ' PHE . 85.1 tt0 -62.3 -40.33 95.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.459 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.2 -43.33 92.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.6 -1.313 . . . . 0.0 109.639 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.456 ' HB ' HG11 ' A' ' 328' ' ' VAL . 93.7 m -55.97 -43.81 77.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 173.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.57 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.9 tp -59.21 -39.45 82.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.319 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.16 -41.31 86.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.11 . . . . 0.0 110.777 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.3 m-20 -63.87 -50.03 70.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.926 -1.109 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.49 -31.13 70.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.981 -1.074 . . . . 0.0 109.722 176.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.21 -35.66 65.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.912 172.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 14.6 mt-30 -74.77 -55.84 5.42 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.583 -0.698 . . . . 0.0 110.9 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -63.72 -34.46 77.93 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.846 -171.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 395' ' ' LYS . . . -67.04 -21.4 65.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.934 -1.104 . . . . 0.0 110.076 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.464 ' OG ' HG22 ' A' ' 353' ' ' VAL . 77.3 p -107.27 10.4 29.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.16 -0.963 . . . . 0.0 111.538 -174.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.573 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 45.9 mt -66.34 -43.78 85.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.55 -1.344 . . . . 0.0 109.502 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -97.25 0.38 48.09 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.931 -170.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.3 p30 -62.37 130.44 45.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.742 -1.224 . . . . 0.0 109.872 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.54 5.39 51.66 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.6 0.714 . . . . 0.0 109.886 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.45 151.91 83.31 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.52 -0.737 . . . . 0.0 109.451 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.64 -39.53 90.54 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.643 1.338 . . . . 0.0 109.09 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.56 -27.83 69.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.503 -0.748 . . . . 0.0 110.436 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.66 -37.94 70.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.453 ' O ' HD13 ' A' ' 354' ' ' ILE . 90.2 mtt-85 -76.14 -36.59 58.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.018 -1.284 . . . . 0.0 110.376 172.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 29.3 p -62.72 -37.22 85.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.957 -1.089 . . . . 0.0 110.377 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 87.6 mt -68.53 -49.48 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.536 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.528 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 26.2 t -61.24 -33.61 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 0.0 110.148 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 350' ' ' ARG . 29.9 mt -72.2 -32.9 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.601 -1.312 . . . . 0.0 110.523 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.613 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.43 -40.21 90.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.832 -1.168 . . . . 0.0 110.528 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.474 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.03 -43.18 99.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 77.3 mttt -71.65 -48.53 47.13 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.769 -175.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.549 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -70.26 -42.8 71.69 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.587 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.3 mmm180 -74.23 -46.51 41.25 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 111.214 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.548 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 76.4 m-85 -136.28 -34.45 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.252 -1.379 . . . . 0.0 112.564 -169.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 363' ' ' ARG . 18.0 t-20 -160.11 98.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.441 -1.412 . . . . 0.0 111.763 -168.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 5.5 mp -58.96 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.029 -1.045 . . . . 0.0 109.705 171.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.5 tpt180 -142.15 163.45 32.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.86 . . . . 0.0 109.344 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.475 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.0 mt-10 -127.37 -153.81 0.59 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.01 -1.056 . . . . 0.0 110.629 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.573 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.2 ptt-85 -95.51 163.58 13.16 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.638 -0.664 . . . . 0.0 110.733 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -128.19 40.71 3.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.553 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.568 HG23 ' CE1' ' A' ' 374' ' ' PHE . 61.6 t -73.47 -46.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.192 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.79 -26.6 66.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.465 -0.772 . . . . 0.0 111.11 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.44 -30.66 29.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.107 -0.995 . . . . 0.0 109.745 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.527 ' CB ' HD13 ' A' ' 388' ' ' ILE . 20.6 mt -101.41 -3.96 27.76 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.541 -0.724 . . . . 0.0 110.636 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 367' ' ' VAL . 50.7 m80 59.3 52.51 5.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.957 . . . . 0.0 109.795 -175.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.533 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.61 174.6 7.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 110.378 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.9 m -116.38 134.94 54.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 110.473 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.568 ' CE1' HG23 ' A' ' 367' ' ' VAL . 88.0 m-85 -89.73 147.39 23.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.33 101.18 46.96 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -54.54 153.7 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.003 1.528 . . . . 0.0 110.545 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.556 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.7 t80 -70.68 134.8 47.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.829 . . . . 0.0 110.383 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 6.4 p -115.64 143.42 45.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.855 . . . . 0.0 109.832 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.29 -24.4 59.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.656 -0.652 . . . . 0.0 110.341 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.84 -45.49 94.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.714 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 383' ' ' MET . 97.1 p -94.31 -12.76 27.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.256 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 57.16 47.9 16.3 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.592 -0.692 . . . . 0.0 109.67 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.556 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.9 ptp -165.45 170.98 13.86 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.795 0.807 . . . . 0.0 111.287 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.521 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 49.6 p -155.54 165.53 36.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.29 -164.28 31.6 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.756 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.517 HD11 ' CG2' ' A' ' 367' ' ' VAL . 2.2 tt -142.45 149.48 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.623 -0.928 . . . . 0.0 110.154 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -127.29 136.32 51.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 109.755 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.9 tt -140.8 155.24 22.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.993 -1.067 . . . . 0.0 109.221 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.5 m-20 -21.96 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.452 0.644 . . . . 0.0 112.62 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.446 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.9 t-20 -95.99 -7.01 37.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.449 -0.782 . . . . 0.0 111.858 -167.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.547 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 29.8 mtp180 -143.64 146.18 33.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.661 -1.275 . . . . 0.0 110.639 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -136.15 104.3 5.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.863 -1.148 . . . . 0.0 109.119 170.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 8.0 mt -125.05 146.07 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.996 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.475 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 23.6 mmt85 -134.29 159.55 40.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.011 . . . . 0.0 110.324 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.521 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.43 126.03 30.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.464 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -152.42 174.33 31.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.9 m -56.21 151.33 12.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.973 -1.31 . . . . 0.0 108.646 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.545 ' CG2' HG13 ' A' ' 420' ' ' VAL . 23.0 t -54.57 -37.65 39.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.915 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.2 m-20 -64.62 -44.99 88.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.3 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.493 ' CB ' ' HE2' ' A' ' 383' ' ' MET . . . -67.14 -48.95 66.52 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.944 -1.097 . . . . 0.0 110.635 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.522 HG22 ' CG1' ' A' ' 432' ' ' VAL . 39.9 mm -66.53 -44.31 90.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.029 -1.045 . . . . 0.0 111.007 -176.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.582 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.3 ttp180 -59.52 -43.08 93.53 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 92.2 mtt180 -61.69 -37.05 82.68 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.04 -1.038 . . . . 0.0 109.579 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.2 t-80 -67.3 -36.47 81.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 111.273 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 437' ' ' SER . 54.7 t -65.54 -49.13 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.6 -1.313 . . . . 0.0 110.161 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.47 -34.34 77.55 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.943 -1.098 . . . . 0.0 110.371 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.74 78.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.111 . . . . 0.0 109.982 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.532 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 18.0 m-80 -62.08 -27.05 68.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.429 -0.794 . . . . 0.0 109.155 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.83 19.35 29.39 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.89 -169.66 16.88 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -143.09 153.36 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.139 -1.212 . . . . 0.0 111.395 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.582 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 7.9 p90 -108.17 149.32 39.04 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.635 -0.665 . . . . 0.0 110.182 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.1 125.14 9.06 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.873 1.459 . . . . 0.0 110.531 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.09 -32.32 72.55 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.6 m-20 -63.24 -31.81 73.06 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.878 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.599 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 46.6 t -83.57 -42.77 17.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.88 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.58 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 69.1 m-20 -55.08 -36.34 65.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.729 -1.232 . . . . 0.0 109.648 171.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.39 -50.13 68.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.434 -1.416 . . . . 0.0 109.639 173.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.513 ' CD ' HG21 ' A' ' 323' ' ' ILE . 85.9 mttt -56.83 -34.53 67.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.757 -1.215 . . . . 0.0 110.286 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.5 t -58.99 -41.6 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 171.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.07 -36.18 82.52 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.955 0.883 . . . . 0.0 109.409 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.5 mm-40 -67.25 -38.25 84.86 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.725 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.545 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 68.2 t -62.61 -37.13 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.074 . . . . 0.0 110.125 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.29 84.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -68.18 -32.38 72.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 0.0 110.983 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -82.73 -2.89 55.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.77 22.56 30.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.545 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -104.19 163.5 12.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -1.143 . . . . 0.0 109.538 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.469 ' O ' HD11 ' A' ' 445' ' ' LEU . 18.5 m -110.5 107.0 58.26 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.058 -1.026 . . . . 0.0 109.855 -175.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.518 ' CB ' HG11 ' A' ' 420' ' ' VAL . 33.6 Cg_endo -74.82 107.93 2.59 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 O-C-N 123.984 1.518 . . . . 0.0 110.73 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.533 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 13.3 mt -92.69 132.76 36.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 108.509 166.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.528 ' CG1' HG11 ' A' ' 439' ' ' VAL . 99.8 t -100.04 134.98 37.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 O-C-N 120.746 -1.222 . . . . 0.0 109.512 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.475 ' O ' HD13 ' A' ' 440' ' ' LEU . 40.8 t -114.73 138.46 44.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.116 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -119.56 160.55 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 109.655 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.34 129.64 33.74 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.2 -131.79 30.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -167.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.532 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 79.6 p -102.93 7.75 39.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -1.23 . . . . 0.0 111.071 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -118.4 170.71 8.69 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.647 -1.283 . . . . 0.0 110.127 -175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.528 HG11 ' CG1' ' A' ' 432' ' ' VAL . 24.6 t -93.58 134.48 31.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.336 -0.853 . . . . 0.0 109.719 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.4 pp -95.3 -21.72 18.23 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.772 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.7 176.77 39.16 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.003 169.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 44.4 t -107.74 141.45 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.153 -1.204 . . . . 0.0 109.923 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 337' ' ' ALA . 78.7 mt -101.45 111.06 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 108.986 170.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.512 ' HB2' ' CG1' ' A' ' 423' ' ' VAL . . . -91.94 119.35 31.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.956 -1.09 . . . . 0.0 109.801 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.533 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -100.09 142.75 31.14 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.463 ' HG2' ' HB1' ' A' ' 428' ' ' ALA . 51.0 mttt -122.35 161.18 23.88 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.848 -1.158 . . . . 0.0 111.078 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -87.07 141.39 28.7 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.375 0.607 . . . . 0.0 110.105 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.3 tp -122.65 152.19 26.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.331 -0.855 . . . . 0.0 110.311 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.6 t -105.21 134.55 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.28 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -92.68 144.47 25.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.224 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.187 0.518 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.464 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 62.4 mtt85 -123.07 146.67 47.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.9 tt0 -124.21 132.72 53.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.492 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 355' ' ' LEU . . . -57.05 139.76 51.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.1 -1.0 . . . . 0.0 109.946 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.517 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 74.5 m -122.69 -36.71 2.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -165.7 150.82 8.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.054 -1.029 . . . . 0.0 110.184 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.687 ' CZ ' ' CD1' ' A' ' 360' ' ' PHE . 13.4 p90 -135.13 158.26 44.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.839 -1.163 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.457 HG21 ' HD2' ' A' ' 324' ' ' PRO . 1.2 mp -134.17 139.04 31.85 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.534 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.11 144.82 53.32 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.65 1.342 . . . . 0.0 111.824 -171.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.608 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -69.32 152.47 44.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 108.768 165.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -57.79 128.99 39.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.658 -1.276 . . . . 0.0 110.269 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 109.54 -21.39 26.12 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 53.3 t -114.0 138.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.393 . . . . 0.0 110.907 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.0 m-20 -72.21 145.08 48.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 109.891 173.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.545 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.3 tt0 -59.87 -34.01 72.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.917 -1.114 . . . . 0.0 109.868 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.51 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.51 -42.41 87.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 109.25 175.125 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 99.5 m -61.59 -42.76 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.3 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.8 tp -60.28 -39.8 88.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.451 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.74 -43.3 80.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.083 . . . . 0.0 110.772 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 47.8 t0 -63.41 -49.9 71.93 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.912 -1.117 . . . . 0.0 110.055 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.88 -31.02 70.53 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.8 -35.78 66.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.079 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.0 mt-30 -73.3 -55.75 5.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.565 -0.709 . . . . 0.0 110.996 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -65.1 -33.83 76.96 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.205 -171.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -67.52 -20.89 65.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.067 173.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 91.2 p -107.29 10.65 29.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.225 -0.922 . . . . 0.0 111.521 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.3 mt -66.66 -45.48 78.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.546 -1.346 . . . . 0.0 109.73 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -96.59 0.14 49.53 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.986 -171.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 341' ' ' SER . 11.0 p30 -62.93 130.66 45.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.214 . . . . 0.0 109.898 176.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.67 5.32 51.73 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.516 0.674 . . . . 0.0 109.864 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.05 150.87 83.69 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 109.467 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.51 -38.32 83.34 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.708 1.373 . . . . 0.0 109.132 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.53 -28.6 69.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.404 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.27 -37.83 75.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -77.29 -38.64 50.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.095 -1.238 . . . . 0.0 110.631 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.8 m -62.35 -37.8 87.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.919 -1.113 . . . . 0.0 110.466 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 87.9 mt -68.13 -48.66 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.936 -1.103 . . . . 0.0 110.492 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 24.4 t -60.62 -33.17 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.23 . . . . 0.0 109.772 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.455 HG21 ' OE1' ' A' ' 358' ' ' GLN . 38.7 mt -72.76 -31.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.79 -1.194 . . . . 0.0 110.722 171.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.627 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.9 -41.5 91.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.866 -1.146 . . . . 0.0 110.242 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.516 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.36 -43.18 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 110.422 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.526 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 78.8 mttt -72.08 -51.23 22.58 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.635 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -71.17 -42.61 68.86 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.508 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.552 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.5 mmt180 -73.66 -44.31 57.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 111.101 -172.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 81.6 m-85 -135.31 -37.57 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.623 -1.298 . . . . 0.0 112.159 -169.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.481 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 60.9 t-20 -162.68 105.38 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.489 -1.382 . . . . 0.0 111.55 -168.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 46.9 mt -57.56 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.858 -1.151 . . . . 0.0 109.056 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 335' ' ' ASP . 56.5 ttt180 -129.21 168.14 16.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.44 ' N ' ' HG2' ' A' ' 363' ' ' ARG . 87.5 mt-10 -139.69 -157.82 0.8 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.8 ptt-85 -98.1 165.45 11.89 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.627 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.437 ' HB3' HD13 ' A' ' 370' ' ' LEU . 89.9 m-20 -131.47 42.47 3.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 110.56 175.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.623 ' CG2' ' CZ ' ' A' ' 374' ' ' PHE . 47.6 t -72.19 -45.77 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 0.0 110.152 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.34 -23.91 64.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.862 . . . . 0.0 111.166 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -31.85 30.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.778 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 388' ' ' ILE . 9.3 mt -104.42 -2.77 24.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.536 -0.727 . . . . 0.0 110.624 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 367' ' ' VAL . 81.7 m-70 59.25 52.37 6.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.698 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -91.79 174.49 7.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 110.308 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.6 m -118.46 135.5 54.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.478 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.623 ' CZ ' ' CG2' ' A' ' 367' ' ' VAL . 90.8 m-85 -90.36 145.22 25.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 9.1 t -118.45 101.36 51.04 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.776 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.8 Cg_endo -54.72 154.23 21.47 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.079 1.568 . . . . 0.0 110.524 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.58 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.1 t80 -69.66 134.64 48.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.37 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 15.8 p -115.37 144.86 43.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.6 -19.88 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.641 -0.662 . . . . 0.0 110.355 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -62.34 -46.02 90.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.99 . . . . 0.0 109.695 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 70.9 m -95.97 -12.29 25.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 110.28 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 58.02 49.89 10.98 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.597 -0.689 . . . . 0.0 109.629 -174.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.58 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.1 ptp -165.15 171.26 13.96 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.822 0.82 . . . . 0.0 111.225 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.52 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 47.9 p -155.92 165.32 36.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.58 -165.57 34.3 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.704 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.521 HD11 ' CG2' ' A' ' 367' ' ' VAL . 4.5 tt -139.82 152.57 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.902 . . . . 0.0 110.232 -175.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -127.24 138.4 53.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.045 -1.034 . . . . 0.0 109.458 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.549 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -140.85 154.36 21.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.842 -1.161 . . . . 0.0 109.362 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.267 89.0 m-20 -21.37 -61.83 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.438 0.637 . . . . 0.0 112.53 172.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.46 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 51.9 t-20 -98.99 -7.14 27.34 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.512 -0.742 . . . . 0.0 111.901 -166.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 15.9 mtp180 -142.91 147.97 36.18 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.681 -1.262 . . . . 0.0 110.573 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.6 mtm -134.98 111.07 9.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.942 -1.099 . . . . 0.0 108.995 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 8.1 mt -129.52 146.09 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.557 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 31.2 mtt85 -136.76 161.92 34.63 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.16 -0.962 . . . . 0.0 111.035 176.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.52 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.88 128.24 32.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -153.78 174.34 32.34 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 37.7 m -56.49 150.98 14.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.848 -1.384 . . . . 0.0 108.526 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 420' ' ' VAL . 63.2 t -56.82 -35.33 46.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -0.999 . . . . 0.0 109.81 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.2 t0 -63.07 -46.75 85.97 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.315 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.52 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -67.18 -49.13 65.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.065 -1.022 . . . . 0.0 110.514 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.522 HG21 ' CG1' ' A' ' 432' ' ' VAL . 41.7 mm -66.41 -43.84 90.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.099 -1.001 . . . . 0.0 110.931 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.585 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 7.8 ttp180 -59.86 -43.58 94.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.211 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 14.6 mtp-105 -61.8 -36.54 81.41 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.459 173.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.557 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 3.0 t-80 -68.69 -35.55 77.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.231 -0.918 . . . . 0.0 111.378 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 437' ' ' SER . 52.1 t -66.06 -50.42 69.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.533 -1.354 . . . . 0.0 110.171 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.966 -1.084 . . . . 0.0 110.37 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.26 76.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.924 -1.11 . . . . 0.0 110.085 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.547 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.9 m-80 -62.58 -26.81 68.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.132 174.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 98.12 17.83 28.56 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.43 -169.04 16.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -142.87 153.62 43.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.112 -1.228 . . . . 0.0 111.351 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 9.5 p90 -105.82 147.64 35.1 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.272 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.554 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.95 123.95 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.808 1.425 . . . . 0.0 110.407 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.15 -32.73 74.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 111.033 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.9 m-20 -61.92 -33.04 73.53 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 0.0 108.963 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 52.8 t -83.63 -42.83 17.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.37 -0.832 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.4 m-20 -54.55 -37.46 65.46 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.76 -1.213 . . . . 0.0 109.507 171.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.5 mm-40 -63.38 -48.18 78.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.265 -1.522 . . . . 0.0 110.077 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 20.1 mttp -56.64 -35.24 68.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -59.78 -40.68 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.979 -1.075 . . . . 0.0 109.285 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.76 -36.25 82.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.842 0.829 . . . . 0.0 109.46 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -67.37 -36.81 82.1 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.63 -0.669 . . . . 0.0 110.62 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 72.0 t -62.88 -37.9 80.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.954 -1.091 . . . . 0.0 110.009 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.6 -40.01 84.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 0.0 110.385 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -68.11 -31.53 71.2 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.282 -0.886 . . . . 0.0 110.955 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.55 -3.11 55.47 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.783 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.51 22.14 29.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.53 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -106.34 163.48 12.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -1.079 . . . . 0.0 109.541 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.47 ' O ' HD12 ' A' ' 445' ' ' LEU . 1.3 m -109.98 107.12 58.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.525 ' CG ' HG13 ' A' ' 420' ' ' VAL . 40.1 Cg_endo -75.79 108.28 2.65 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 123.97 1.511 . . . . 0.0 110.589 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.541 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 13.9 mt -92.81 134.77 34.74 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 108.598 167.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.53 ' CG1' HG13 ' A' ' 439' ' ' VAL . 96.8 t -100.7 134.27 41.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.754 -1.216 . . . . 0.0 109.428 176.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 394' ' ' ARG . 42.5 t -114.82 137.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 176.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.1 m -118.09 160.27 17.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.413 -0.804 . . . . 0.0 109.721 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.462 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.39 130.77 35.39 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.07 -132.32 30.86 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.52 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 82.9 p -102.75 7.52 39.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.081 -1.247 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -120.05 171.09 8.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.661 -1.275 . . . . 0.0 110.142 -175.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.53 HG13 ' CG1' ' A' ' 432' ' ' VAL . 26.0 t -92.25 133.4 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.418 -0.801 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.612 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.6 pp -92.93 -22.2 19.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 167.29 177.62 39.01 Favored Glycine 0 N--CA 1.5 2.939 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.987 169.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 51.2 t -107.81 142.95 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.22 -1.165 . . . . 0.0 110.075 174.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.518 HD13 ' CB ' ' A' ' 337' ' ' ALA . 75.8 mt -101.79 112.62 35.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 108.974 170.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.518 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -93.13 119.31 32.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.987 -1.071 . . . . 0.0 109.891 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.541 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -103.17 144.17 31.66 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.396 -0.815 . . . . 0.0 108.808 -175.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.517 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 16.2 mtmt -105.72 156.87 17.87 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.585 -1.322 . . . . 0.0 110.833 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -104.25 148.17 26.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.653 -0.654 . . . . 0.0 110.366 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 9.0 tp -119.31 153.16 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 110.11 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.9 t -104.16 135.18 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.97 . . . . 0.0 110.319 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -144.58 145.86 32.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 0.0 110.197 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.971 -1.461 . . . . 0.0 109.529 -179.899 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.223 0.535 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 66.7 mtt85 -122.04 148.85 44.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.2 mt-30 -124.91 144.96 50.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.154 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 355' ' ' LEU . . . -59.93 138.64 57.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.07 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -122.31 -37.62 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 110.433 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.458 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.1 tt0 -162.84 148.32 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.187 -178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.685 ' CZ ' ' CD2' ' A' ' 360' ' ' PHE . 14.1 p90 -133.95 142.88 47.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.803 -1.186 . . . . 0.0 111.704 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.476 HG21 ' HD2' ' A' ' 324' ' ' PRO . 4.4 mt -113.84 141.57 26.37 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.534 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.64 142.73 40.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.656 1.345 . . . . 0.0 111.528 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.592 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -70.83 151.13 45.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 108.856 165.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.46 128.88 39.28 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.744 -1.222 . . . . 0.0 110.098 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.66 -1.35 45.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.6 t -135.68 137.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.645 -1.503 . . . . 0.0 110.649 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.8 m-20 -72.74 150.44 42.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.534 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.4 tt0 -60.87 -38.04 84.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.462 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.0 OUTLIER -59.88 -40.3 88.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.929 -1.107 . . . . 0.0 109.224 177.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.452 ' HB ' HG13 ' A' ' 328' ' ' VAL . 98.9 m -60.51 -43.13 97.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 110.0 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.544 ' CD2' ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.12 -38.43 83.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.373 -0.83 . . . . 0.0 110.502 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.75 -44.42 77.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.706 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 89.9 m-20 -63.69 -48.74 75.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 110.017 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.604 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.61 -32.03 72.47 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.03 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.22 -36.0 65.5 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.011 172.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 15.2 mt-30 -74.1 -55.67 5.82 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.546 -0.721 . . . . 0.0 111.064 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.1 OUTLIER -64.4 -33.96 77.07 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.066 -171.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -67.89 -20.31 65.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.982 -1.074 . . . . 0.0 109.991 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.469 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 96.3 p -107.62 10.42 29.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.134 -0.979 . . . . 0.0 111.502 -174.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.589 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 47.3 mt -66.53 -45.04 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.622 -1.299 . . . . 0.0 109.821 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.03 2.05 50.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.842 -170.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 341' ' ' SER . 13.9 p30 -65.09 130.29 42.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.798 -1.189 . . . . 0.0 110.061 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.7 4.47 52.97 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.574 0.702 . . . . 0.0 109.887 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.0 p -74.47 150.84 87.21 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.572 -0.705 . . . . 0.0 109.426 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.78 -40.74 78.96 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.723 1.381 . . . . 0.0 109.358 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.65 -28.07 69.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -55.1 -38.11 65.53 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.449 ' O ' HD13 ' A' ' 354' ' ' ILE . 68.5 mtt85 -77.4 -37.3 52.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.239 . . . . 0.0 110.501 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.2 m -61.36 -37.83 84.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.069 . . . . 0.0 110.324 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.489 ' CG2' HD13 ' A' ' 443' ' ' ILE . 83.1 mt -69.55 -49.38 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.631 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.527 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 23.4 t -59.9 -32.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.865 -1.147 . . . . 0.0 109.813 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 350' ' ' ARG . 34.6 mt -72.74 -34.22 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 110.637 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.641 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.06 -40.25 80.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.817 -1.177 . . . . 0.0 110.239 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.461 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.02 -45.77 87.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.522 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 48.2 mtmt -72.02 -49.25 38.5 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.844 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.549 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 10.6 pt20 -70.87 -42.96 69.38 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.668 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.3 mmt180 -74.42 -45.36 47.04 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 111.145 -171.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 90.9 m-85 -135.57 -37.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.446 -1.301 . . . . 0.0 112.218 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 363' ' ' ARG . 51.2 t30 -162.91 105.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.494 -1.379 . . . . 0.0 111.652 -168.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.522 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.5 OUTLIER -57.87 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.754 -1.216 . . . . 0.0 109.203 171.391 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.539 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.0 tpt180 -126.64 164.02 22.17 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 109.11 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.503 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 83.9 mt-10 -137.22 -159.38 0.95 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.933 -1.105 . . . . 0.0 110.369 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.8 ptt180 -97.69 163.82 12.66 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 110.586 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -130.87 42.13 3.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.366 -0.834 . . . . 0.0 110.544 175.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.576 HG13 ' CE2' ' A' ' 374' ' ' PHE . 64.8 t -73.52 -48.43 41.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.312 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.56 -26.09 66.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 111.067 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -30.14 27.91 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 176.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.597 ' CB ' ' CD1' ' A' ' 388' ' ' ILE . 20.6 mt -103.25 -4.0 24.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 110.731 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 367' ' ' VAL . 61.4 m-70 63.11 53.04 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.317 -0.864 . . . . 0.0 110.148 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.546 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -95.57 174.89 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.618 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.3 m -116.89 133.5 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.47 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.576 ' CE2' HG13 ' A' ' 367' ' ' VAL . 89.8 m-85 -87.67 143.42 27.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.472 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.415 ' CG2' ' ND2' ' A' ' 387' ' ' ASN . 16.8 t -117.14 101.15 53.32 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 109.628 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.412 ' O ' HG23 ' A' ' 378' ' ' THR . 8.5 Cg_endo -55.23 151.27 36.47 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.056 1.556 . . . . 0.0 110.55 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.7 t80 -62.32 130.86 47.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.038 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 376' ' ' PRO . 24.3 p -120.23 153.7 35.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.07 -4.95 49.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.517 -0.739 . . . . 0.0 109.948 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.42 -33.2 65.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.762 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 400' ' ' ALA . 22.5 m -141.49 10.85 2.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.361 -0.837 . . . . 0.0 110.374 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.9 mtt180 57.55 51.8 9.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.525 ' CE ' HD12 ' A' ' 401' ' ' ILE . 2.1 ptp -157.98 167.53 29.67 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.852 0.834 . . . . 0.0 111.174 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.516 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 24.9 p -153.65 165.26 36.49 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.8 -166.24 35.29 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.524 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.486 HG21 ' HB2' ' A' ' 339' ' ' LEU . 14.5 tt -139.51 150.75 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.634 -0.921 . . . . 0.0 110.176 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.452 ' OD1' ' NH1' ' A' ' 394' ' ' ARG . 37.8 m-20 -127.6 133.26 49.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 0.0 109.755 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.597 ' CD1' ' CB ' ' A' ' 370' ' ' LEU . 1.7 tt -139.57 154.81 24.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.84 -1.162 . . . . 0.0 109.302 170.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 88.6 m-20 -25.62 -62.99 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.429 0.633 . . . . 0.0 112.266 172.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.0 t30 -90.96 -8.56 48.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 111.767 -168.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.554 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 35.7 mtp180 -143.38 143.93 31.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.643 -1.286 . . . . 0.0 110.627 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.7 mtm -134.08 107.47 7.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 108.909 168.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 7.4 mt -129.45 146.11 34.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.21 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.475 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 20.8 mtt-85 -135.64 162.12 33.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 110.995 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.516 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -135.22 127.79 30.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 383' ' ' MET . . . -154.7 174.05 33.04 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.7 m -57.28 150.73 17.35 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.978 -1.307 . . . . 0.0 108.601 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.537 ' CG2' HG12 ' A' ' 420' ' ' VAL . 20.0 t -54.82 -37.91 42.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.849 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.8 m-20 -63.72 -44.01 94.85 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.29 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 381' ' ' SER . . . -68.29 -52.14 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.876 -1.14 . . . . 0.0 110.535 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.525 HD12 ' CE ' ' A' ' 383' ' ' MET . 27.6 mm -64.29 -42.22 94.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.106 -0.996 . . . . 0.0 110.828 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.2 ttp85 -59.94 -43.96 94.67 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.228 -0.92 . . . . 0.0 110.313 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 95.1 mtt180 -61.5 -37.16 82.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.515 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -68.21 -36.24 79.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.869 . . . . 0.0 111.319 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.65 -48.99 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.534 -1.354 . . . . 0.0 110.126 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.18 -34.33 77.4 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.914 -1.116 . . . . 0.0 110.145 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -36.23 80.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.952 -1.092 . . . . 0.0 109.958 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.531 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.0 m-80 -61.82 -27.33 68.69 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.202 173.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.79 19.46 29.17 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -169.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.49 -170.67 16.81 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -144.3 153.62 42.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -1.233 . . . . 0.0 111.231 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 9.8 p90 -108.85 149.97 40.25 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.475 -0.766 . . . . 0.0 110.068 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.534 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -73.02 126.31 11.11 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.877 1.462 . . . . 0.0 110.455 -175.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.3 t -67.18 -33.49 75.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 111.04 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.9 m-20 -63.36 -32.19 73.54 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.984 -1.072 . . . . 0.0 108.77 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.592 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 49.2 t -83.64 -41.69 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.395 -0.816 . . . . 0.0 110.824 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 56.4 t0 -54.9 -37.19 66.03 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 109.444 171.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.28 -50.99 65.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.447 -1.408 . . . . 0.0 109.635 172.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 45.0 mttm -55.77 -34.56 65.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.868 -1.145 . . . . 0.0 110.263 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -58.9 -42.5 86.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.172 170.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.5 -36.1 82.85 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 109.425 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.5 mm-40 -67.87 -37.13 81.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.697 -0.627 . . . . 0.0 110.65 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.541 ' CG1' ' CB ' ' A' ' 428' ' ' ALA . 67.4 t -63.34 -37.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.025 . . . . 0.0 110.044 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.54 85.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -69.08 -30.38 68.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.296 -0.878 . . . . 0.0 110.888 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.75 -3.56 56.72 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.045 -1.034 . . . . 0.0 109.717 175.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.19 21.84 28.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.541 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -107.62 163.47 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -1.067 . . . . 0.0 109.626 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 445' ' ' LEU . 22.1 m -109.75 107.2 59.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.989 -1.069 . . . . 0.0 109.731 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.504 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.2 Cg_endo -76.18 108.13 2.61 Favored 'Trans proline' 0 C--N 1.297 -2.158 0 O-C-N 123.878 1.462 . . . . 0.0 110.462 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.544 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 14.5 mt -92.29 136.31 33.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 0.0 108.64 167.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.519 ' CG1' HG23 ' A' ' 401' ' ' ILE . 94.6 t -99.93 135.06 37.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.675 -1.266 . . . . 0.0 109.462 175.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.478 ' O ' HD11 ' A' ' 440' ' ' LEU . 27.3 t -115.83 137.76 48.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.291 -0.88 . . . . 0.0 108.831 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.7 m -120.45 160.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.272 -0.892 . . . . 0.0 109.734 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.492 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -134.37 132.9 40.0 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.18 -130.09 32.29 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 74.1 p -105.64 8.71 33.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.034 -1.274 . . . . 0.0 111.129 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -122.12 170.64 9.67 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.588 -1.32 . . . . 0.0 110.107 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.526 ' HA ' ' CG1' ' A' ' 434' ' ' VAL . 47.0 t -89.48 133.86 30.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 109.95 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.604 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.2 pp -92.22 -22.83 19.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.552 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 170.32 177.51 40.55 Favored Glycine 0 N--CA 1.5 2.943 0 C-N-CA 118.945 -1.598 . . . . 0.0 110.87 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 47.9 t -107.9 142.36 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.119 -1.224 . . . . 0.0 109.869 172.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 337' ' ' ALA . 78.9 mt -101.3 112.02 32.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.416 -0.802 . . . . 0.0 108.941 170.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.478 ' HB1' ' CG2' ' A' ' 423' ' ' VAL . . . -92.09 119.38 31.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 109.837 -178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.544 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.29 142.82 32.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.476 ' HG3' ' HB2' ' A' ' 320' ' ' SER . 28.9 mtmt -111.08 158.23 19.08 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.657 -1.277 . . . . 0.0 111.056 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -87.93 146.79 25.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.671 -0.643 . . . . 0.0 110.319 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.7 tp -117.78 154.7 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.854 . . . . 0.0 110.169 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.0 t -102.58 134.11 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.258 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -93.67 146.0 24.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.232 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 118.011 -1.439 . . . . 0.0 109.526 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.302 0.573 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.464 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 74.9 mtt85 -122.72 143.31 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.153 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.3 tt0 -124.82 131.8 53.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.266 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.525 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -54.92 138.91 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.884 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.54 -44.34 2.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.07 -1.019 . . . . 0.0 110.278 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.1 mt-10 -154.44 152.34 30.04 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.427 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.647 ' CZ ' ' CD1' ' A' ' 360' ' ' PHE . 16.5 p90 -137.22 143.15 42.15 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.731 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.517 HG22 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -114.93 144.66 32.44 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.747 -0.596 . . . . 0.0 109.657 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.7 143.71 38.15 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.758 1.399 . . . . 0.0 111.525 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.602 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.39 152.72 41.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 108.847 165.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -57.87 128.43 37.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.654 -1.279 . . . . 0.0 110.081 -173.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.67 -0.82 45.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.9 t -136.61 140.08 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.686 -1.479 . . . . 0.0 110.743 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.4 m-20 -74.15 152.67 39.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 85.0 tt0 -62.37 -40.76 97.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.985 -1.072 . . . . 0.0 110.471 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.25 -43.09 92.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.682 -1.261 . . . . 0.0 109.612 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.455 ' HB ' HG11 ' A' ' 328' ' ' VAL . 93.3 m -55.53 -43.93 76.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.75 173.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.7 tp -59.77 -39.24 84.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 110.285 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.0 -41.85 86.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.837 -1.164 . . . . 0.0 110.841 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.0 t0 -63.83 -49.83 71.3 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.832 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.27 -31.44 71.77 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.718 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 443' ' ' ILE . . . -55.96 -35.09 66.33 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.142 172.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 18.0 mt-30 -73.85 -55.79 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.596 -0.69 . . . . 0.0 110.815 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.71 -34.7 76.24 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.894 -173.197 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 395' ' ' LYS . . . -67.54 -20.43 65.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.927 174.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.465 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 97.1 p -108.91 9.75 26.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.199 -0.938 . . . . 0.0 111.631 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.541 HD12 ' CB ' ' A' ' 365' ' ' ARG . 35.5 mt -64.1 -45.78 87.14 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.652 -1.28 . . . . 0.0 109.806 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.7 -0.8 42.12 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.788 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 341' ' ' SER . 10.5 p30 -61.8 130.51 46.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.927 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.03 5.89 50.13 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.612 0.72 . . . . 0.0 109.951 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.56 154.59 81.42 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.579 -0.7 . . . . 0.0 109.45 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.15 -36.85 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.624 1.329 . . . . 0.0 109.128 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.3 -29.2 70.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.448 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.451 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -57.47 -38.54 87.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.454 ' O ' HD13 ' A' ' 354' ' ' ILE . 98.0 mtt180 -77.33 -37.38 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -1.177 . . . . 0.0 110.629 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.0 m -61.68 -38.85 89.34 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.042 -1.036 . . . . 0.0 110.368 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 84.7 mt -69.18 -48.37 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.693 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.52 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 28.7 t -60.64 -34.54 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.06 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 350' ' ' ARG . 36.4 mt -72.54 -32.26 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.628 -1.295 . . . . 0.0 110.653 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.634 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.87 -41.06 90.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.937 -1.102 . . . . 0.0 110.394 179.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.79 -42.85 99.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 0.0 110.383 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 83.4 mttt -70.69 -50.55 35.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.913 -1.117 . . . . 0.0 110.772 -174.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.505 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.9 pt20 -71.0 -42.59 69.43 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 110.561 -173.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.574 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 40.1 mmt180 -73.06 -46.16 53.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 111.21 -173.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.647 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 79.3 m-85 -135.96 -36.03 0.76 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.542 -1.349 . . . . 0.0 112.39 -169.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.518 ' ND2' ' HD2' ' A' ' 363' ' ' ARG . 56.0 t-20 -158.59 98.55 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.557 -1.34 . . . . 0.0 111.7 -169.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 24.3 mt -58.38 91.17 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 0.0 109.509 171.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.518 ' HD2' ' ND2' ' A' ' 361' ' ' ASN . 13.8 ptm180 -145.6 -176.81 5.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.287 -0.883 . . . . 0.0 109.983 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.28 -158.53 0.9 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 110.329 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.541 ' CB ' HD12 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -97.96 166.81 11.27 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.661 -0.649 . . . . 0.0 110.558 -178.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.0 m-20 -121.02 41.1 3.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.637 ' CG1' ' CZ ' ' A' ' 374' ' ' PHE . 43.0 t -70.45 -45.54 74.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 110.21 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -68.2 -29.02 67.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.159 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -29.66 27.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.07 -1.019 . . . . 0.0 109.767 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.527 ' CB ' HD13 ' A' ' 388' ' ' ILE . 22.6 mt -102.66 -3.22 26.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 110.777 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.1 m80 58.82 53.8 5.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 0.0 109.895 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.539 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.89 174.68 7.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 110.513 -177.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.1 m -114.79 134.02 55.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.357 -0.84 . . . . 0.0 110.396 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.637 ' CZ ' ' CG1' ' A' ' 367' ' ' VAL . 72.4 m-85 -88.7 149.38 23.52 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 5.0 t -122.75 100.81 40.32 Favored Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.3 150.66 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.031 1.543 . . . . 0.0 110.473 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.6 t80 -66.91 131.75 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 110.141 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p -121.3 153.13 38.11 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 109.639 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.56 -6.35 53.38 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.606 -0.684 . . . . 0.0 109.897 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -54.77 -34.48 62.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 109.685 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' A' ' 383' ' ' MET . 1.8 m -139.11 10.27 2.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 110.241 175.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 73.2 mtt85 57.21 50.97 10.83 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.519 ' HE3' ' CB ' ' A' ' 400' ' ' ALA . 2.8 ptp -158.6 169.71 23.81 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.949 0.881 . . . . 0.0 111.339 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.518 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 31.1 p -154.84 165.22 37.33 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.15 -165.33 33.25 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.897 -1.621 . . . . 0.0 110.751 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.527 HD12 ' CG2' ' A' ' 367' ' ' VAL . 2.4 tt -142.28 149.38 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.63 -0.923 . . . . 0.0 110.054 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -127.91 136.0 50.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.957 -1.09 . . . . 0.0 109.911 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -140.45 155.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.859 -1.151 . . . . 0.0 109.22 171.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.498 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 91.2 m-20 -23.46 -63.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.398 0.618 . . . . 0.0 112.436 171.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 46.4 t-20 -95.82 -5.56 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.513 -0.742 . . . . 0.0 111.871 -167.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.6 mtp180 -143.98 143.8 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.66 -1.275 . . . . 0.0 110.375 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -134.02 112.25 11.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.822 -1.174 . . . . 0.0 108.913 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.534 ' CD1' ' CB ' ' A' ' 336' ' ' ALA . 9.6 mt -131.49 146.16 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.47 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 35.1 mtt180 -133.75 159.92 39.15 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.078 -1.014 . . . . 0.0 110.58 174.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.518 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.09 128.92 35.18 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.412 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -155.87 174.22 33.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -174.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.6 m -56.91 151.58 14.37 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.871 -1.37 . . . . 0.0 108.653 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.537 ' CG2' HG13 ' A' ' 420' ' ' VAL . 53.5 t -56.51 -34.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 109.942 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.516 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 46.2 t0 -63.26 -47.19 83.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.323 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.519 ' CB ' ' HE3' ' A' ' 383' ' ' MET . . . -67.77 -50.05 59.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.523 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.518 HG22 ' CG1' ' A' ' 432' ' ' VAL . 35.8 mm -64.97 -42.99 96.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.053 -1.029 . . . . 0.0 110.794 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.57 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.5 ttp180 -59.36 -43.39 92.84 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.309 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.516 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 88.9 mtt180 -61.31 -37.16 82.25 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.517 173.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.4 t-80 -67.5 -36.95 82.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 0.0 111.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 437' ' ' SER . 53.4 t -65.93 -48.35 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.5 -1.375 . . . . 0.0 110.206 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.6 -34.24 77.38 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.901 -1.124 . . . . 0.0 110.355 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.77 -36.26 80.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.939 -1.101 . . . . 0.0 109.886 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 9.4 m-80 -61.03 -27.84 68.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 109.124 173.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.35 27.2 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -169.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.59 -169.05 15.59 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -144.36 153.66 42.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.131 -1.217 . . . . 0.0 111.404 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 6.7 p90 -108.22 150.35 40.39 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.769 -0.582 . . . . 0.0 110.258 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -75.0 125.53 9.39 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.812 1.427 . . . . 0.0 110.572 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -67.39 -33.82 75.98 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.172 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -62.12 -32.01 72.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.98 -1.075 . . . . 0.0 108.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.602 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 50.4 t -83.72 -42.69 17.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 110.942 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.585 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 66.8 m-20 -55.28 -36.22 65.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.629 171.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.88 -50.85 67.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.377 -1.452 . . . . 0.0 109.537 172.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 323' ' ' ILE . 81.9 mttt -56.46 -34.36 66.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.338 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.4 t -58.86 -41.65 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.964 -1.085 . . . . 0.0 109.171 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -66.34 -36.51 83.08 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.936 0.874 . . . . 0.0 109.414 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.24 -37.28 83.28 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.586 -0.696 . . . . 0.0 110.703 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 77.0 t -62.39 -37.86 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 110.063 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.18 -37.97 86.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -66.26 -33.81 76.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.193 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -83.23 -1.82 54.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 176.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.05 22.54 32.44 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -104.12 162.47 13.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -1.084 . . . . 0.0 109.485 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.47 ' O ' HD11 ' A' ' 445' ' ' LEU . 34.8 m -109.5 107.0 59.24 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 109.741 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.483 ' CB ' HG11 ' A' ' 420' ' ' VAL . 36.9 Cg_endo -74.98 108.09 2.64 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 O-C-N 124.05 1.553 . . . . 0.0 110.596 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.536 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.7 mt -92.54 134.18 35.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.816 -1.177 . . . . 0.0 108.578 167.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.524 ' CG1' HG12 ' A' ' 439' ' ' VAL . 74.6 t -100.35 134.17 40.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.669 -1.269 . . . . 0.0 109.457 176.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 440' ' ' LEU . 55.3 t -115.78 136.42 52.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.063 175.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -117.75 160.15 17.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.484 -0.76 . . . . 0.0 109.632 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.496 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.22 133.19 36.82 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.83 -123.57 22.24 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -168.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.479 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 2.3 p -114.2 11.37 17.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.095 -1.238 . . . . 0.0 110.987 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -123.88 171.08 9.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.629 -1.294 . . . . 0.0 109.907 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.524 HG12 ' CG1' ' A' ' 432' ' ' VAL . 40.3 t -90.04 134.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.312 -0.867 . . . . 0.0 109.821 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.6 pp -94.33 -21.77 18.77 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 109.693 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.558 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.02 176.12 38.28 Favored Glycine 0 N--CA 1.499 2.883 0 C-N-CA 118.938 -1.601 . . . . 0.0 110.904 170.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 49.7 t -107.87 142.06 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.12 -1.224 . . . . 0.0 109.953 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.517 HD12 ' CB ' ' A' ' 337' ' ' ALA . 80.1 mt -101.32 110.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.424 -0.798 . . . . 0.0 108.961 170.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.525 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -92.36 118.18 30.67 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.031 -1.043 . . . . 0.0 109.864 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.536 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.08 144.32 30.81 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -109.37 159.38 17.04 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.675 -1.266 . . . . 0.0 110.905 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -83.23 140.69 32.38 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.433 0.635 . . . . 0.0 110.332 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 7.4 tt -115.07 152.42 16.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 110.278 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.2 t -104.53 135.47 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.369 -0.832 . . . . 0.0 110.308 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -92.23 144.56 25.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 CA-C-O 118.02 -1.433 . . . . 0.0 109.548 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.25 0.547 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.45 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 97.3 mtt180 -123.02 149.66 44.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.245 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 50.9 tt0 -122.73 137.96 54.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.877 . . . . 0.0 110.076 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.529 ' HB2' ' CD1' ' A' ' 355' ' ' LEU . . . -59.59 142.37 52.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.528 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -117.54 -34.17 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -0.981 . . . . 0.0 110.439 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -169.45 150.57 4.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 0.0 110.029 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.635 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 13.9 p90 -134.87 143.98 47.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.85 -1.156 . . . . 0.0 111.643 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.516 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.3 mt -114.49 144.03 31.02 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.611 -0.681 . . . . 0.0 109.666 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.536 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.88 143.78 37.49 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.767 1.404 . . . . 0.0 111.357 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -72.0 152.26 42.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 108.831 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.16 128.77 38.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.665 -1.272 . . . . 0.0 110.188 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.54 42.83 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.0 t -136.48 139.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.65 -1.5 . . . . 0.0 110.736 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.459 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.18 152.44 39.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.154 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.565 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -62.47 -40.13 95.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.993 . . . . 0.0 110.437 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.09 -43.15 91.81 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.701 -1.25 . . . . 0.0 109.62 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.463 ' HB ' HG12 ' A' ' 328' ' ' VAL . 94.3 m -56.11 -43.54 78.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.885 173.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 4.2 tp -59.68 -40.08 86.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.291 -0.881 . . . . 0.0 110.281 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -66.66 -41.21 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.914 -1.116 . . . . 0.0 110.742 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.546 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.3 t0 -64.22 -50.87 66.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.854 -1.153 . . . . 0.0 109.928 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.03 -30.62 69.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.909 -1.119 . . . . 0.0 109.779 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 334' ' ' ALA . . . -55.17 -35.91 65.29 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.133 -0.979 . . . . 0.0 109.028 171.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 17.3 mt-30 -74.25 -55.71 5.73 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.569 -0.707 . . . . 0.0 110.914 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.552 ' HA ' ' CG ' ' A' ' 342' ' ' LEU . 0.1 OUTLIER -63.92 -33.78 76.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.908 -171.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 395' ' ' LYS . . . -66.77 -21.48 66.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.986 -1.072 . . . . 0.0 110.045 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 97.5 p -107.65 10.79 28.95 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.04 -1.037 . . . . 0.0 111.598 -173.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.581 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 46.3 mt -67.15 -43.75 81.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.624 -1.297 . . . . 0.0 109.652 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -96.52 2.67 52.64 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.863 -171.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.515 ' OD2' ' CA ' ' A' ' 349' ' ' GLY . 18.3 p30 -65.0 130.0 41.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.773 -1.204 . . . . 0.0 110.088 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.72 4.43 52.98 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.573 0.701 . . . . 0.0 109.909 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.38 151.77 85.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.711 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -56.38 -39.4 91.53 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.702 1.369 . . . . 0.0 109.09 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.6 mt-10 -64.31 -29.63 70.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.484 -0.76 . . . . 0.0 110.367 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.515 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . . . -55.31 -36.04 61.91 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 354' ' ' ILE . 65.9 mtt85 -77.18 -36.53 54.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 0.0 110.543 174.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 13.2 m -60.78 -39.08 87.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 81.0 mt -68.19 -48.99 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.562 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.533 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 27.5 t -62.18 -33.94 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.945 -1.097 . . . . 0.0 110.192 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 350' ' ' ARG . 31.7 mt -72.22 -31.98 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.597 -1.314 . . . . 0.0 110.576 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.635 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -60.61 -40.61 92.48 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 110.568 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.518 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.33 -42.93 99.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 0.0 110.274 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 70.4 mttt -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.73 -175.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.9 pt20 -70.09 -42.22 73.0 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 110.785 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.6 mmm180 -74.68 -46.24 39.18 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 111.189 -171.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.592 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 77.8 m-85 -136.22 -34.97 0.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.399 -1.321 . . . . 0.0 112.31 -170.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.477 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 53.5 t-20 -159.66 103.33 1.55 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.551 -1.343 . . . . 0.0 111.598 -169.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 37.0 mt -57.66 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.872 -1.142 . . . . 0.0 109.066 170.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 25.3 tpt180 -134.19 163.83 28.73 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.419 -0.8 . . . . 0.0 109.344 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.3 mt-10 -136.12 -158.05 0.84 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.581 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.3 ptt85 -97.66 163.69 12.72 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.661 -0.649 . . . . 0.0 110.841 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.9 m-20 -134.5 44.49 2.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.821 . . . . 0.0 110.554 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.57 HG11 ' CE2' ' A' ' 374' ' ' PHE . 61.0 t -72.41 -46.95 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.44 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -67.9 -26.15 65.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 111.264 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -31.18 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.057 . . . . 0.0 109.715 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.524 ' CB ' HD13 ' A' ' 388' ' ' ILE . 19.8 mt -100.68 -4.09 28.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.498 -0.751 . . . . 0.0 110.606 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 46.8 m80 59.99 51.73 5.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -174.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.504 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.06 172.99 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.9 m -118.82 135.61 54.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 110.374 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.57 ' CE2' HG11 ' A' ' 367' ' ' VAL . 86.3 m-85 -90.01 145.16 25.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.651 175.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 47.9 t -118.73 100.99 50.92 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.16 150.75 38.24 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.068 1.562 . . . . 0.0 110.526 -175.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 8.4 t80 -63.27 131.35 48.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.357 -0.839 . . . . 0.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.7 p -120.5 153.0 37.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.706 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.69 -5.86 51.94 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.919 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.7 -33.18 66.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -0.867 . . . . 0.0 109.836 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.467 ' O ' ' HB1' ' A' ' 400' ' ' ALA . 1.8 m -139.47 10.25 2.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 110.293 174.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 88.7 mtt180 57.08 51.01 10.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 400' ' ' ALA . 2.6 ptp -158.75 168.48 26.73 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.26 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.526 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 12.2 p -155.39 165.16 37.49 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.6 -164.16 31.55 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.956 -1.592 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 339' ' ' LEU . 1.9 tt -141.96 149.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.665 -0.903 . . . . 0.0 110.173 -174.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -127.22 138.86 53.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.9 tt -141.37 154.59 20.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.87 -1.144 . . . . 0.0 109.365 172.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.264 88.3 m-20 -21.4 -62.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.391 0.615 . . . . 0.0 112.608 171.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 24.8 t-20 -99.03 -6.78 27.89 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 111.819 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.539 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 18.3 mtp180 -142.97 145.86 33.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.746 -1.221 . . . . 0.0 110.553 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 89.9 mtp -134.16 113.27 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.909 -1.119 . . . . 0.0 109.08 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.5 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 9.3 mt -131.75 146.05 34.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.051 -1.031 . . . . 0.0 110.142 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.473 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 32.8 mtt180 -135.92 161.9 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.005 . . . . 0.0 110.779 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.526 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.45 134.23 41.34 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.531 -0.731 . . . . 0.0 109.11 174.132 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.507 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -159.76 174.06 36.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -58.51 153.0 16.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.921 -1.34 . . . . 0.0 108.438 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.535 ' CG2' HG13 ' A' ' 420' ' ' VAL . 20.8 t -54.87 -37.52 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.82 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.1 m-20 -64.25 -44.51 91.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.523 ' CB ' ' HE2' ' A' ' 383' ' ' MET . . . -68.78 -51.84 36.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.923 -1.111 . . . . 0.0 110.503 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.524 HG23 ' CG1' ' A' ' 432' ' ' VAL . 25.2 mm -63.82 -42.28 95.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.096 -1.003 . . . . 0.0 110.805 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.586 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.4 ttt180 -60.81 -43.29 98.38 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.299 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 89.8 mtt180 -61.15 -36.54 80.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.07 -1.019 . . . . 0.0 109.643 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.511 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -67.45 -38.15 84.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 111.33 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 437' ' ' SER . 63.7 t -66.07 -47.22 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.473 -1.392 . . . . 0.0 110.219 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.73 -34.63 78.3 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.738 -1.226 . . . . 0.0 110.337 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.47 -36.29 80.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.986 -1.071 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.511 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.1 m-80 -61.15 -27.81 68.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.442 -0.786 . . . . 0.0 109.126 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.61 19.85 28.51 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.01 -170.26 16.3 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -144.61 153.98 42.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.247 . . . . 0.0 111.321 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.586 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.1 p90 -106.87 150.99 40.43 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.63 -0.669 . . . . 0.0 110.096 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.534 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.81 125.61 10.64 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.853 1.449 . . . . 0.0 110.237 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.2 t -66.69 -34.13 77.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 111.136 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.9 m-20 -62.97 -32.31 73.61 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.931 -1.106 . . . . 0.0 108.858 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 48.4 t -83.41 -42.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -0.846 . . . . 0.0 110.809 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 5.3 m-20 -55.58 -36.42 66.84 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.595 171.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.94 -50.16 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 0.0 109.686 172.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.516 ' CD ' HG21 ' A' ' 323' ' ' ILE . 35.7 mttt -56.65 -34.6 67.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.764 -1.21 . . . . 0.0 110.332 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.8 t -59.09 -41.78 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.932 -1.105 . . . . 0.0 109.369 170.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.66 -35.95 82.26 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.943 0.878 . . . . 0.0 109.296 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.39 -37.92 83.89 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.566 -0.709 . . . . 0.0 110.769 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 444' ' ' ALA . 64.5 t -63.44 -36.81 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.0 110.193 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.34 85.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -70.08 -28.95 65.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.326 -0.859 . . . . 0.0 110.599 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -80.36 -3.75 50.82 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.009 . . . . 0.0 109.74 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.7 21.96 35.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.466 ' HB3' HG12 ' A' ' 423' ' ' VAL . . . -107.74 175.96 5.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.722 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 445' ' ' LEU . 59.1 m -119.15 106.92 42.4 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.942 -1.099 . . . . 0.0 109.874 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.522 ' CG ' HG11 ' A' ' 420' ' ' VAL . 31.4 Cg_endo -74.06 106.78 2.28 Favored 'Trans proline' 0 C--N 1.296 -2.204 0 O-C-N 123.911 1.479 . . . . 0.0 110.354 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 15.8 mt -93.08 131.79 37.78 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 167.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 439' ' ' VAL . 72.6 t -100.57 137.54 27.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.823 -1.173 . . . . 0.0 109.777 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.481 ' O ' HD11 ' A' ' 440' ' ' LEU . 42.7 t -116.2 137.74 48.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 108.928 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.05 159.98 20.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 121.351 -0.843 . . . . 0.0 109.757 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.463 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.4 tt0 -136.11 132.77 36.52 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.41 -126.82 31.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -168.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -109.91 13.41 23.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.238 . . . . 0.0 111.123 -178.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -128.33 170.66 12.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.017 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.527 HG13 ' CG1' ' A' ' 432' ' ' VAL . 53.3 t -88.35 134.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 109.776 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.5 pp -92.3 -22.3 19.81 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.665 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.552 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 170.88 176.36 40.09 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.963 168.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 46.9 t -107.94 142.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.16 -1.2 . . . . 0.0 109.539 171.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.513 ' O ' HD13 ' A' ' 445' ' ' LEU . 78.3 mt -101.67 119.24 49.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 169.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' A' ' 423' ' ' VAL . . . -99.0 117.49 33.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.55 ' CD1' ' O ' ' A' ' 429' ' ' THR . 3.6 mp -113.63 146.34 39.9 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.095 -1.003 . . . . 0.0 109.819 -173.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.528 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.7 OUTLIER -134.53 170.28 16.02 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.749 -1.22 . . . . 0.0 110.773 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -71.16 145.59 49.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 110.113 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.5 tp -119.72 153.49 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.246 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.24 135.6 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.197 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -92.49 144.73 25.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.231 0.539 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.464 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 97.7 mtt180 -122.45 147.53 46.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 110.181 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.5 tt0 -121.53 133.05 55.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.239 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.524 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -54.57 138.6 40.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 0.0 109.802 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 4.9 m -119.53 -44.7 2.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.086 -1.009 . . . . 0.0 110.197 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 320' ' ' SER . 69.7 mt-10 -154.59 152.33 29.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 0.0 110.448 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.62 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 16.9 p90 -136.12 141.82 44.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.755 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.481 HG22 ' HD2' ' A' ' 324' ' ' PRO . 4.3 mt -114.79 141.76 27.3 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.73 -0.607 . . . . 0.0 109.598 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -71.61 142.86 40.97 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.708 1.373 . . . . 0.0 111.55 -176.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.596 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -71.01 152.56 43.44 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 108.829 165.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.44 128.35 36.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.692 -1.255 . . . . 0.0 110.143 -172.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.94 -0.75 44.76 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.8 t -136.13 139.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.716 -1.461 . . . . 0.0 110.727 177.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.447 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.93 152.07 40.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.163 177.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -62.17 -39.76 93.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.057 -1.027 . . . . 0.0 110.457 -176.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.3 ttmt -59.19 -43.38 92.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.806 -1.184 . . . . 0.0 109.56 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 95.8 m -56.15 -43.63 78.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.817 173.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.1 tp -59.69 -39.64 85.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.37 -42.04 84.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.089 . . . . 0.0 110.757 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.4 m-20 -64.19 -49.48 71.88 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.118 . . . . 0.0 109.921 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -68.17 -31.3 70.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.937 -1.102 . . . . 0.0 109.664 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.19 -35.64 65.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.964 172.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 30.3 mt-30 -74.52 -55.81 5.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.989 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.38 -35.71 78.23 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.787 -172.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -66.8 -20.89 66.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 173.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 95.9 p -108.4 10.15 27.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -174.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.581 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.2 mt -65.98 -44.95 83.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.657 -1.277 . . . . 0.0 109.802 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 374' ' ' PHE . . . -97.54 0.72 47.94 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.821 -170.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 11.9 p30 -63.87 130.29 43.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.841 -1.162 . . . . 0.0 109.925 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.76 4.76 52.64 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.512 0.672 . . . . 0.0 109.886 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.3 152.88 86.03 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.592 -0.693 . . . . 0.0 109.443 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -56.0 -38.14 95.14 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.74 1.39 . . . . 0.0 109.132 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.19 -29.23 70.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.484 -0.76 . . . . 0.0 110.406 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.461 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -56.47 -38.56 80.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.9 mtt85 -78.2 -37.76 44.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.075 -1.25 . . . . 0.0 110.591 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.519 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.4 -38.02 85.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.932 -1.105 . . . . 0.0 110.352 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 90.7 mt -68.92 -49.09 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 0.0 110.625 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.529 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 38.4 t -60.87 -34.06 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.864 -1.147 . . . . 0.0 110.101 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.466 ' CG2' ' OE1' ' A' ' 358' ' ' GLN . 32.3 mt -72.62 -33.22 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.681 -1.262 . . . . 0.0 110.621 170.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.46 -40.35 86.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.938 -1.101 . . . . 0.0 110.489 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.27 88.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.47 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.536 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 18.0 mtmt -72.35 -49.48 33.82 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.743 -1.183 . . . . 0.0 110.6 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.497 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.7 pt20 -71.3 -42.43 68.69 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 110.814 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.556 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -72.63 -46.31 54.68 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.109 -0.995 . . . . 0.0 111.078 -172.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.57 ' CZ ' ' OE2' ' A' ' 330' ' ' GLU . 84.0 m-85 -136.5 -36.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.205 -169.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.465 ' OD1' ' HB2' ' A' ' 363' ' ' ARG . 15.2 t-20 -160.02 106.64 1.6 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.605 -1.309 . . . . 0.0 111.508 -168.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 59.9 mt -57.56 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.368 172.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.534 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.7 tpt180 -125.64 164.39 20.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 109.325 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.4 mt-10 -140.06 -161.77 1.25 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.0 -1.062 . . . . 0.0 110.121 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.581 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.67 162.45 13.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.747 . . . . 0.0 110.521 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -130.3 41.74 3.36 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.381 175.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.571 HG21 ' CE1' ' A' ' 374' ' ' PHE . 59.4 t -74.16 -46.23 45.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.09 -27.46 66.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.344 -0.848 . . . . 0.0 111.122 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.78 -30.55 28.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.965 . . . . 0.0 109.656 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.524 ' CB ' HD12 ' A' ' 388' ' ' ILE . 22.9 mt -102.5 -3.66 26.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.557 -0.714 . . . . 0.0 110.674 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 367' ' ' VAL . 51.6 m80 59.11 52.57 6.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -93.55 174.67 7.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 110.51 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.1 m -116.45 134.62 54.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.396 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.571 ' CE1' HG21 ' A' ' 367' ' ' VAL . 83.6 m-85 -88.61 147.8 24.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 87.2 t -120.34 101.12 46.99 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.616 175.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.22 150.36 40.68 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.077 1.567 . . . . 0.0 110.511 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.2 t80 -65.47 131.41 46.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p -120.3 152.79 37.31 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 109.695 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.74 -5.82 51.9 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.91 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.78 -33.15 66.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.843 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 400' ' ' ALA . 3.2 m -139.54 10.27 2.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 110.278 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 74.0 mtt85 57.0 51.19 10.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.233 -0.917 . . . . 0.0 109.363 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.512 ' CE ' ' CB ' ' A' ' 400' ' ' ALA . 3.3 ptp -157.44 167.38 30.4 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.993 0.901 . . . . 0.0 111.4 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.523 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 26.9 p -154.43 165.36 36.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.8 -166.55 35.05 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.705 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 367' ' ' VAL . 3.8 tt -140.92 149.84 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.995 . . . . 0.0 110.208 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -127.25 134.73 50.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.045 . . . . 0.0 109.804 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.559 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 2.0 tt -140.73 155.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 109.211 171.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.0 m-20 -21.65 -63.03 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.388 0.614 . . . . 0.0 112.583 170.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.439 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 22.9 t-20 -96.49 -7.14 35.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 111.931 -167.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.9 mtp180 -141.86 145.84 35.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.594 -1.317 . . . . 0.0 110.503 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -136.22 100.93 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.132 . . . . 0.0 109.18 170.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 7.7 mt -122.96 146.18 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.04 -1.037 . . . . 0.0 110.092 -172.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.472 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 26.0 mmt85 -133.19 159.1 41.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.329 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.523 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.41 126.84 30.36 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.426 ' N ' HD12 ' A' ' 401' ' ' ILE . . . -154.44 174.0 32.86 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.596 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.4 m -56.47 150.84 14.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.863 -1.375 . . . . 0.0 108.592 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 420' ' ' VAL . 56.5 t -57.72 -34.6 48.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.887 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.4 t0 -62.55 -45.81 91.23 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.512 ' CB ' ' CE ' ' A' ' 383' ' ' MET . . . -68.85 -51.07 44.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.93 -1.106 . . . . 0.0 110.61 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.516 HG22 ' CG1' ' A' ' 432' ' ' VAL . 34.2 mm -63.98 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.063 -1.023 . . . . 0.0 110.59 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.0 ttp180 -58.47 -43.69 89.0 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.461 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 55.2 mtp85 -61.54 -36.12 79.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.061 -1.024 . . . . 0.0 109.459 173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.503 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.4 t-80 -67.65 -38.5 83.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 111.299 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.91 -47.29 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.616 -1.302 . . . . 0.0 110.26 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.21 -34.21 77.57 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.814 -1.178 . . . . 0.0 110.362 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.65 -36.3 80.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.092 . . . . 0.0 109.895 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 26.7 m-80 -62.12 -27.09 68.68 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 109.225 173.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.86 19.56 31.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.24 -171.13 18.52 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -144.81 153.85 42.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.168 -1.195 . . . . 0.0 111.07 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.5 p90 -109.51 151.92 42.46 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.54 -0.725 . . . . 0.0 109.978 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.54 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.15 124.76 10.27 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.913 1.48 . . . . 0.0 110.221 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.3 t -66.95 -33.21 75.08 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.3 m-20 -63.45 -32.48 73.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 108.853 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.596 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 49.3 t -83.64 -41.89 17.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.908 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.481 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.7 t0 -55.04 -37.55 66.83 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.404 171.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.503 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.66 -49.71 72.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.457 -1.402 . . . . 0.0 109.697 172.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.503 ' N ' ' HG2' ' A' ' 418' ' ' GLN . 57.1 mttm -56.28 -34.79 66.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.802 -1.187 . . . . 0.0 110.444 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.6 t -59.32 -41.85 85.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.962 -1.086 . . . . 0.0 109.21 171.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.84 -36.26 82.97 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.906 0.86 . . . . 0.0 109.414 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.02 -37.89 81.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.609 -0.682 . . . . 0.0 110.74 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' A' ' 444' ' ' ALA . 72.2 t -62.28 -37.65 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.979 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.09 87.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 110.151 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -67.02 -33.43 75.54 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.285 -0.884 . . . . 0.0 111.229 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.1 OUTLIER -83.0 -3.4 57.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.012 -1.055 . . . . 0.0 109.597 176.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.33 29.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.516 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.72 163.34 12.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 445' ' ' LEU . 70.5 m -109.65 107.02 59.1 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.081 -1.012 . . . . 0.0 109.744 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.512 ' CG ' HG12 ' A' ' 420' ' ' VAL . 38.6 Cg_endo -75.6 107.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.07 0 O-C-N 123.893 1.47 . . . . 0.0 110.52 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 11.5 mt -92.44 134.24 35.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.886 -1.134 . . . . 0.0 108.625 167.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.516 ' CG1' HG22 ' A' ' 401' ' ' ILE . 96.8 t -100.32 134.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.701 -1.25 . . . . 0.0 109.477 176.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.473 ' O ' HD12 ' A' ' 440' ' ' LEU . 40.9 t -114.95 137.33 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.243 -0.91 . . . . 0.0 108.955 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.526 ' CG1' HG22 ' A' ' 439' ' ' VAL . 2.5 m -120.28 160.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.589 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.455 ' CB ' HD22 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.82 129.89 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.56 -128.42 29.84 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -168.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.53 15.41 23.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.052 -1.263 . . . . 0.0 111.171 -179.109 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -125.76 170.27 11.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.532 -1.355 . . . . 0.0 109.878 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.526 HG22 ' CG1' ' A' ' 434' ' ' VAL . 46.7 t -91.7 134.31 30.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.189 -0.945 . . . . 0.0 109.57 176.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.5 pp -94.36 -21.28 19.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.691 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.548 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 168.27 176.39 38.64 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 118.794 -1.669 . . . . 0.0 110.962 169.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 53.9 t -107.97 142.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 173.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.518 HD13 ' CB ' ' A' ' 337' ' ' ALA . 82.2 mt -101.32 110.91 29.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.523 ' HB2' ' CG2' ' A' ' 423' ' ' VAL . . . -91.99 118.12 30.47 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.863 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.535 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.28 30.54 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -114.63 159.87 19.98 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.612 -1.305 . . . . 0.0 111.121 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -83.97 144.71 28.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.722 -0.611 . . . . 0.0 110.223 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.526 HD11 ' N ' ' A' ' 449' ' ' VAL . 0.0 OUTLIER -121.29 150.73 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.526 ' N ' HD11 ' A' ' 448' ' ' ILE . 46.7 t -136.26 136.1 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.161 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -92.87 144.8 24.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.237 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.548 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 89.1 mm-40 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.129 0.49 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -60.6 138.63 58.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.83 177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 9.4 m -122.16 -42.75 2.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.005 . . . . 0.0 110.217 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 320' ' ' SER . 68.3 mt-10 -154.17 150.81 28.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.475 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.0 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.9 p90 -137.46 141.85 41.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.957 -1.089 . . . . 0.0 111.709 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.694 HG21 ' HD3' ' A' ' 419' ' ' LYS . 3.7 mp -113.1 143.75 29.79 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.811 -0.555 . . . . 0.0 109.69 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.67 142.89 36.72 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.63 1.331 . . . . 0.0 111.605 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.036 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.72 152.65 42.6 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 108.862 165.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 23.6 tp60 -58.57 128.45 37.25 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.734 -1.229 . . . . 0.0 110.172 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.83 44.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.3 t -136.61 139.86 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.71 -1.465 . . . . 0.0 110.762 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.89 152.82 40.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.397 -0.815 . . . . 0.0 110.176 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.8 tt0 -62.16 -40.91 97.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.056 -1.027 . . . . 0.0 110.47 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.29 -43.33 92.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.694 -1.254 . . . . 0.0 109.678 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.516 HG21 HG13 ' A' ' 328' ' ' VAL . 92.7 m -55.51 -44.12 76.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.769 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 1.021 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -59.16 -39.01 81.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.0 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.3 -41.24 85.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.967 -1.083 . . . . 0.0 110.779 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.581 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.5 m-20 -63.26 -49.22 74.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.936 -1.102 . . . . 0.0 109.805 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.99 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.52 -31.37 70.57 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.982 -1.074 . . . . 0.0 109.888 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.714 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.28 64.62 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 108.834 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.5 mt-30 -74.54 -55.92 5.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.594 -0.691 . . . . 0.0 110.919 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.0 HD11 HD12 ' A' ' 393' ' ' ILE . 0.2 OUTLIER -65.77 -33.77 76.64 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.009 -171.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -66.34 -21.62 66.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.112 . . . . 0.0 110.109 172.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.609 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.4 p -107.58 10.59 29.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.142 -0.974 . . . . 0.0 111.536 -173.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.589 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 46.1 mt -66.98 -44.48 80.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.591 -1.318 . . . . 0.0 109.672 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.12 1.2 49.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.865 -170.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.483 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.81 130.45 44.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 109.942 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 5.4 51.58 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.532 0.682 . . . . 0.0 109.887 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.26 152.57 83.97 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.582 -0.699 . . . . 0.0 109.412 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -56.02 -38.49 94.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.689 1.363 . . . . 0.0 109.147 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.38 -28.31 69.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.548 -0.72 . . . . 0.0 110.395 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.23 -38.17 76.45 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.568 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.95 -36.73 56.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -1.209 . . . . 0.0 110.54 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 2.0 m -61.5 -39.25 90.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.605 HG23 HD13 ' A' ' 443' ' ' ILE . 85.4 mt -68.12 -48.33 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.537 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.609 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.3 t -61.46 -34.03 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.568 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.7 mt -72.43 -32.27 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.673 -1.267 . . . . 0.0 110.548 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.993 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.02 -40.58 89.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.96 -1.088 . . . . 0.0 110.444 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.542 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.76 -43.73 98.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.988 ' HB3' HD23 ' A' ' 362' ' ' LEU . 70.2 mttt -71.44 -49.83 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.614 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.55 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 1.8 pt20 -70.87 -42.54 69.94 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.704 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.7 mmt180 -73.62 -46.01 49.5 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 111.147 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.667 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 72.3 m-85 -135.93 -36.59 0.75 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.57 -1.331 . . . . 0.0 112.226 -169.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.0 t30 -159.57 103.16 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.549 -1.344 . . . . 0.0 111.682 -169.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.988 HD23 ' HB3' ' A' ' 357' ' ' LYS . 33.1 mt -57.78 89.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.893 -1.129 . . . . 0.0 109.113 171.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.543 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.0 tpt180 -135.43 164.71 27.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.436 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.9 mt-10 -135.8 -157.14 0.77 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.016 -1.052 . . . . 0.0 110.495 -177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 36.8 ptt180 -97.48 165.14 12.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.674 -0.641 . . . . 0.0 110.716 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.473 ' OD1' HD13 ' A' ' 388' ' ' ILE . 55.0 p30 -138.05 45.52 2.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.379 -0.826 . . . . 0.0 110.758 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.004 HG21 ' CE1' ' A' ' 374' ' ' PHE . 92.7 t -71.15 -42.38 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.334 -0.854 . . . . 0.0 110.341 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.78 -21.32 66.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 111.032 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -29.39 25.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.04 -1.038 . . . . 0.0 110.026 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 1.079 HD12 HD11 ' A' ' 388' ' ' ILE . 16.6 mt -105.38 -3.68 22.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.552 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 24.0 m80 62.11 53.33 2.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 109.649 -173.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.918 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.19 174.96 6.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.501 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.0 m -120.9 136.4 54.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.416 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.004 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.0 m-85 -90.62 145.1 25.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.668 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 21.5 t -118.6 101.32 50.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.11 155.18 19.88 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.105 1.582 . . . . 0.0 110.613 -175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.55 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 50.5 t80 -71.92 134.7 46.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 110.442 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.785 174.322 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.7 mtt-85 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.497 0.665 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.898 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.1 ptp -165.34 171.23 13.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.781 0.8 . . . . 0.0 111.288 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.55 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 39.8 p -156.31 165.31 36.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.82 -165.96 34.11 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.025 -1.56 . . . . 0.0 110.637 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 367' ' ' VAL . 1.3 tt -143.34 147.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.935 . . . . 0.0 110.399 -174.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.493 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 56.1 m-20 -115.78 134.25 55.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.902 -1.124 . . . . 0.0 108.974 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 1.079 HD11 HD12 ' A' ' 370' ' ' LEU . 2.2 tt -142.63 154.41 17.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.9 -1.125 . . . . 0.0 109.611 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 88.7 m-20 -23.95 -62.02 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 112.298 173.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.478 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.5 t-20 -95.87 -5.45 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.539 -0.725 . . . . 0.0 111.801 -167.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.602 ' NH2' HD21 ' A' ' 339' ' ' LEU . 18.1 mtp180 -145.5 147.73 32.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.684 -1.26 . . . . 0.0 110.74 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.3 mtm -132.51 95.68 3.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.831 -1.168 . . . . 0.0 108.789 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 339' ' ' LEU . 7.6 mt -122.58 146.25 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.946 -1.096 . . . . 0.0 110.429 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 40.2 mtt180 -133.51 159.14 41.29 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 110.767 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.611 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.43 128.86 34.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.694 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.51 174.32 33.59 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.0 m -56.36 151.35 13.14 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.956 -1.32 . . . . 0.0 108.496 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.13 HG21 HG11 ' A' ' 420' ' ' VAL . 53.4 t -57.08 -34.28 44.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.027 -1.046 . . . . 0.0 109.887 -176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 19.7 t70 -62.86 -47.48 83.18 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.898 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.2 -49.12 62.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.042 -1.036 . . . . 0.0 110.652 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.694 HD11 ' N ' ' A' ' 396' ' ' GLY . 45.0 mm -65.06 -43.29 95.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.108 -0.995 . . . . 0.0 110.809 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.579 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 2.4 ttt180 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.0 mtt-85 -61.14 -37.75 83.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.979 -1.075 . . . . 0.0 109.607 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.413 ' ND1' ' C ' ' A' ' 404' ' ' HIS . 2.2 t-80 -67.62 -35.85 79.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 111.222 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.564 ' CG2' HG11 ' A' ' 434' ' ' VAL . 56.0 t -65.85 -48.98 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.673 -1.267 . . . . 0.0 110.187 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.2 -34.45 77.68 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.291 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.99 79.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.954 -1.091 . . . . 0.0 110.021 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.552 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.5 m120 -61.55 -27.67 68.79 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.491 -0.756 . . . . 0.0 109.114 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.13 19.77 27.53 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.1 -169.14 15.85 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.424 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.86 153.61 42.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -1.215 . . . . 0.0 111.328 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.582 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 8.3 p90 -108.01 149.66 39.39 Favored Pre-proline 0 N--CA 1.501 2.105 0 O-C-N 121.625 -0.672 . . . . 0.0 110.24 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.821 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.95 125.21 9.2 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.853 1.449 . . . . 0.0 110.573 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.79 -34.32 77.56 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.161 -0.962 . . . . 0.0 111.051 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.7 m-20 -60.84 -33.08 72.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 108.864 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.036 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.0 t -83.78 -42.57 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.017 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 71.9 m-20 -54.85 -37.29 66.01 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.48 171.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.4 mt-30 -63.31 -48.68 77.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.292 -1.505 . . . . 0.0 110.102 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.694 ' HD3' HG21 ' A' ' 323' ' ' ILE . 26.3 mttt -56.84 -34.85 68.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.704 -1.248 . . . . 0.0 110.392 177.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.13 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 109.171 171.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.9 t0 -66.62 -36.66 83.13 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.791 0.805 . . . . 0.0 109.517 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 84.8 mt-30 -67.04 -37.02 83.34 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.631 -0.668 . . . . 0.0 110.612 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.797 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.0 t -62.43 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.125 . . . . 0.0 110.005 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.68 -43.96 87.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -0.908 . . . . 0.0 110.435 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 6.0 mtp85 -64.98 -29.86 70.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 110.517 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.28 -3.87 53.84 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.683 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.52 22.1 38.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.797 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.39 164.26 12.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.395 -1.062 . . . . 0.0 109.727 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.437 ' HB ' HD12 ' A' ' 445' ' ' LEU . 28.4 m -109.57 107.04 59.19 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.585 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.0 Cg_endo -75.61 108.27 2.66 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 O-C-N 124.014 1.534 . . . . 0.0 110.62 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.854 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.1 mt -92.6 134.13 35.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.872 -1.142 . . . . 0.0 108.622 167.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.994 ' CG2' HG22 ' A' ' 398' ' ' VAL . 90.3 t -100.51 134.29 40.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.771 -1.205 . . . . 0.0 109.504 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.778 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.3 t -115.03 139.09 43.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.816 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -119.89 160.09 20.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.458 -0.776 . . . . 0.0 109.587 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.51 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -135.01 130.38 35.61 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.58 -129.22 27.74 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -167.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.559 ' O ' HG13 ' A' ' 405' ' ' VAL . 78.0 p -106.16 7.64 31.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.244 . . . . 0.0 111.082 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -118.99 170.43 9.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.588 -1.32 . . . . 0.0 110.048 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.816 ' HA ' HG12 ' A' ' 434' ' ' VAL . 24.3 t -92.67 134.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.857 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -96.68 -20.6 18.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.721 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 1.021 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.76 176.53 38.46 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 118.815 -1.659 . . . . 0.0 111.024 168.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.079 HG21 HG23 ' A' ' 420' ' ' VAL . 55.8 t -107.7 142.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.242 -1.152 . . . . 0.0 109.95 173.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.714 HD11 ' CB ' ' A' ' 337' ' ' ALA . 81.7 mt -101.32 110.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 109.023 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.626 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.7 118.31 30.54 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.047 -1.033 . . . . 0.0 109.831 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.854 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -101.67 141.67 34.18 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.564 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 11.0 mtmt . . . . . 0 C--N 1.299 -1.612 0 O-C-N 120.763 -1.211 . . . . 0.0 111.038 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.4 tt0 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.133 0.492 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.786 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.72 138.62 41.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.992 -1.067 . . . . 0.0 109.815 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.508 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.41 -45.16 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.99 . . . . 0.0 110.339 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 320' ' ' SER . 72.4 mt-10 -154.53 154.59 33.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.228 -0.92 . . . . 0.0 110.511 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.06 ' CD1' HD21 ' A' ' 355' ' ' LEU . 15.6 p90 -135.51 151.5 50.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.956 -1.09 . . . . 0.0 111.572 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.692 HG21 ' HD3' ' A' ' 419' ' ' LYS . 3.4 mt -125.56 140.59 36.79 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.699 -0.625 . . . . 0.0 109.336 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.78 143.12 45.08 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.617 1.325 . . . . 0.0 111.64 -173.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.034 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.22 151.29 45.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.455 -0.778 . . . . 0.0 108.977 165.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -57.99 129.13 40.51 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.704 -1.247 . . . . 0.0 110.069 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.65 -0.35 49.25 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.5 t -135.36 138.05 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.578 -1.543 . . . . 0.0 110.759 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.6 m-20 -73.12 148.98 43.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.346 -0.846 . . . . 0.0 110.275 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.2 tt0 -60.59 -34.15 73.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.039 -1.038 . . . . 0.0 109.778 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -58.85 -43.73 90.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 109.139 175.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.547 HG21 HG13 ' A' ' 328' ' ' VAL . 88.9 m -61.17 -42.26 98.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.417 -0.802 . . . . 0.0 110.333 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.976 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.1 tp -60.48 -39.61 88.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.51 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.965 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.93 -44.04 77.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 110.69 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.562 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.9 m-20 -63.51 -48.07 79.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.912 -1.118 . . . . 0.0 110.063 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.959 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -69.17 -31.25 69.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.007 -1.058 . . . . 0.0 109.991 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.13 -35.55 64.81 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 0.0 108.915 172.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.8 mt-30 -74.3 -55.71 5.71 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.72 . . . . 0.0 111.023 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.055 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.9 -33.61 76.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.741 -1.183 . . . . 0.0 110.177 -172.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.72 -21.03 65.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.882 -1.136 . . . . 0.0 110.009 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.654 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.2 p -107.32 10.51 29.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.104 -0.997 . . . . 0.0 111.536 -174.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.587 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 43.6 mt -66.1 -45.18 82.09 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.612 -1.305 . . . . 0.0 109.758 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.05 0.73 49.13 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.976 -170.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.7 p30 -63.02 130.47 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.745 -1.222 . . . . 0.0 109.977 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.66 5.31 51.77 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.576 0.703 . . . . 0.0 109.923 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.05 152.87 84.52 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.666 -0.646 . . . . 0.0 109.443 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.58 -38.56 94.02 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.645 1.339 . . . . 0.0 109.117 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.32 -28.91 70.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.499 -0.751 . . . . 0.0 110.41 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.02 -37.49 71.41 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -76.92 -38.9 52.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -1.223 . . . . 0.0 110.598 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 4.8 m -62.13 -37.37 84.91 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 110.477 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.687 HG23 HD13 ' A' ' 443' ' ' ILE . 88.6 mt -68.55 -48.82 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.066 -1.021 . . . . 0.0 110.493 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.654 HG22 ' OG ' ' A' ' 341' ' ' SER . 22.0 t -60.9 -32.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.825 -1.172 . . . . 0.0 109.797 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.964 HG22 ' OE1' ' A' ' 358' ' ' GLN . 39.5 mt -72.8 -33.1 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 110.628 171.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.06 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.6 -41.08 84.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.866 -1.146 . . . . 0.0 110.274 178.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.508 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.27 -45.58 87.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.624 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.855 ' HB3' HD23 ' A' ' 362' ' ' LEU . 33.7 mtmt -72.36 -49.29 35.23 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.53 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.964 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.3 pt20 -72.23 -42.82 65.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.543 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -73.83 -43.75 57.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 111.227 -172.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.672 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 82.6 m-85 -135.42 -38.8 0.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.349 -1.341 . . . . 0.0 111.83 -168.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.5 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 16.7 t-20 -162.77 108.36 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.576 -1.328 . . . . 0.0 111.423 -167.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.855 HD23 ' HB3' ' A' ' 357' ' ' LYS . 68.6 mt -57.1 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.016 -1.053 . . . . 0.0 109.096 172.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.1 tpt180 -122.59 164.77 17.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.774 . . . . 0.0 109.408 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.502 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.1 mt-10 -141.21 -161.84 1.28 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.587 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 32.1 ptt-85 -97.6 163.67 12.74 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.638 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.479 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -129.67 41.8 3.38 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.331 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.056 HG21 ' CE1' ' A' ' 374' ' ' PHE . 41.3 t -73.02 -46.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.19 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 111.109 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.11 -30.12 28.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.692 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 388' ' ' ILE . 21.5 mt -102.69 -4.64 24.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.684 -177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 71.4 m-70 60.43 52.21 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.804 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.02 174.51 7.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.491 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 24.0 m -117.12 134.77 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.566 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.056 ' CE1' HG21 ' A' ' 367' ' ' VAL . 92.1 m-85 -90.13 145.91 24.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.438 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 6.5 t -119.11 101.22 49.99 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.649 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -54.54 153.71 22.41 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.073 1.565 . . . . 0.0 110.515 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.549 ' CE2' ' N ' ' A' ' 383' ' ' MET . 55.0 t80 -69.45 134.68 49.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 110.448 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.373 -0.829 . . . . 0.0 109.753 174.638 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.48 0.657 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.889 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.2 ptp -165.44 171.55 13.21 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.779 0.799 . . . . 0.0 111.258 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.541 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 29.0 p -155.46 165.36 36.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.506 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.5 -165.73 34.09 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.048 -1.548 . . . . 0.0 110.694 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.722 HD11 HG22 ' A' ' 367' ' ' VAL . 4.5 tt -140.02 151.51 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.921 . . . . 0.0 110.208 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -127.54 135.55 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 109.693 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.794 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.93 155.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.816 -1.178 . . . . 0.0 109.174 172.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.502 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.5 m-20 -23.08 -63.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.389 0.614 . . . . 0.0 112.502 171.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.459 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 37.1 t30 -96.46 -5.1 40.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 111.808 -167.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.56 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.2 mtp180 -144.97 143.0 30.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.719 -1.238 . . . . 0.0 110.342 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -133.66 108.52 8.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 108.897 169.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.055 HD12 HD11 ' A' ' 339' ' ' LEU . 7.8 mt -128.65 146.03 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 0.0 109.931 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 25.1 mmt85 -134.43 159.7 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.295 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.1 OUTLIER -133.13 126.65 32.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.684 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.19 174.39 32.63 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -57.04 151.28 15.36 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.976 -1.308 . . . . 0.0 108.566 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.129 HG21 HG11 ' A' ' 420' ' ' VAL . 56.0 t -56.7 -35.01 44.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.851 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.85 -47.02 85.17 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.261 -0.9 . . . . 0.0 110.321 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.889 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.91 -49.18 63.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.963 -1.086 . . . . 0.0 110.59 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.684 HD11 ' N ' ' A' ' 396' ' ' GLY . 39.4 mm -65.59 -43.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.06 -1.025 . . . . 0.0 110.817 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.589 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.8 ttp180 -59.22 -43.26 92.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.243 -0.911 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.5 mtp180 -61.88 -36.37 81.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 173.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -67.93 -36.25 79.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.878 . . . . 0.0 111.236 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.62 -49.13 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.479 -1.388 . . . . 0.0 110.103 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -34.34 77.46 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.325 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.73 78.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.946 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.548 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 10.9 m-80 -61.8 -27.31 68.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.11 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.89 19.57 28.62 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.57 -169.02 16.17 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.448 ' C ' HG11 ' A' ' 405' ' ' VAL . 77.5 m80 -143.21 153.41 42.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.163 -1.198 . . . . 0.0 111.324 -174.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.5 p90 -108.39 149.75 39.71 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.642 -0.661 . . . . 0.0 110.182 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.828 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.71 124.0 8.45 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.879 1.463 . . . . 0.0 110.5 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.25 -34.22 77.51 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.986 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 91.1 m-20 -60.82 -33.03 72.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 108.836 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.034 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.7 t -83.52 -42.48 17.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.3 m-20 -54.8 -37.41 66.03 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.559 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.25 -48.32 78.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.17 -1.581 . . . . 0.0 110.104 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.692 ' HD3' HG21 ' A' ' 323' ' ' ILE . 19.1 mttp -56.58 -35.2 67.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.6 -1.313 . . . . 0.0 110.429 176.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.129 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.65 -40.98 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.885 -1.135 . . . . 0.0 109.208 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.76 -36.28 82.06 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.824 0.821 . . . . 0.0 109.581 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.67 -36.78 81.34 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.689 -0.632 . . . . 0.0 110.692 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.758 HG13 ' HB3' ' A' ' 428' ' ' ALA . 79.2 t -62.84 -37.95 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.005 -1.059 . . . . 0.0 110.043 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.13 85.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 110.406 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -67.91 -31.5 71.31 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 110.922 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.31 -3.47 55.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.724 175.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.92 22.04 29.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.758 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.99 164.09 12.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.562 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.61 ' HB ' HD12 ' A' ' 445' ' ' LEU . 93.9 m -109.89 107.29 58.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.077 -1.014 . . . . 0.0 109.691 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.581 ' HB2' HG22 ' A' ' 420' ' ' VAL . 39.7 Cg_endo -75.95 108.04 2.6 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 123.88 1.463 . . . . 0.0 110.613 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.894 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.4 mt -92.83 134.33 35.18 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.837 -1.164 . . . . 0.0 108.64 166.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.984 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.4 t -100.67 134.6 40.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 120.698 -1.251 . . . . 0.0 109.445 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.744 ' CG1' HD11 ' A' ' 440' ' ' LEU . 45.3 t -115.09 136.36 52.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.816 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.4 m -117.09 159.92 16.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.41 -0.806 . . . . 0.0 109.601 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.507 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.91 130.63 34.07 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.08 -133.17 31.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 405' ' ' VAL . 77.8 p -102.46 8.34 40.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.105 -1.232 . . . . 0.0 111.053 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -120.44 171.01 8.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.546 -1.346 . . . . 0.0 109.995 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.816 ' HA ' HG12 ' A' ' 434' ' ' VAL . 23.7 t -92.59 134.52 30.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.845 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.839 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.42 -22.13 18.49 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.308 -0.87 . . . . 0.0 109.793 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.976 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.47 176.95 38.64 Favored Glycine 0 N--CA 1.499 2.851 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.965 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.052 HG21 HG23 ' A' ' 420' ' ' VAL . 55.5 t -107.95 142.83 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.247 -1.149 . . . . 0.0 109.915 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.764 HD11 ' HB1' ' A' ' 337' ' ' ALA . 77.1 mt -101.49 111.42 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 108.907 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.615 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.85 118.58 30.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.917 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.894 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 26.9 mttt . . . . . 0 C--N 1.299 -1.614 0 O-C-N 120.759 -1.213 . . . . 0.0 110.974 -178.864 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.534 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.8 mt-30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.122 0.487 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.802 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -59.85 138.27 57.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 109.965 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 321' ' ' GLU . 46.6 m -122.13 -40.98 2.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.526 ' HG2' ' NH2' ' A' ' 359' ' ' ARG . 65.9 mt-10 -154.94 149.82 26.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.066 ' CD1' HD21 ' A' ' 355' ' ' LEU . 10.5 p90 -135.97 157.74 46.09 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.48 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.71 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.4 mt -134.84 140.16 34.38 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.604 -0.685 . . . . 0.0 109.397 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.561 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.54 144.82 50.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.644 1.339 . . . . 0.0 111.568 -172.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.058 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.74 151.52 43.5 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.134 -0.979 . . . . 0.0 108.829 164.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -58.86 129.4 41.95 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.658 -1.276 . . . . 0.0 110.095 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.09 -1.48 44.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.3 t -136.16 138.92 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.473 . . . . 0.0 110.647 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.3 m-20 -73.36 151.88 41.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.166 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -62.86 -39.81 95.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.023 -1.048 . . . . 0.0 110.362 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.92 -42.93 90.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.782 -1.198 . . . . 0.0 109.438 175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.515 HG21 HG13 ' A' ' 328' ' ' VAL . 94.4 m -56.9 -43.62 81.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.859 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 1.022 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -59.1 -40.58 85.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.33 -41.37 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.761 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -64.07 -49.73 71.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.914 -1.116 . . . . 0.0 109.92 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.892 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.98 -31.25 70.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.903 -1.123 . . . . 0.0 109.569 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.696 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.59 -35.23 65.59 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.324 -0.86 . . . . 0.0 108.985 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.7 mt-30 -74.25 -55.84 5.58 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.479 -0.763 . . . . 0.0 110.861 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.097 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.78 -36.14 80.22 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.681 -1.208 . . . . 0.0 109.807 -172.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.401 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -66.74 -20.67 66.01 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.055 173.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.2 p -107.35 9.18 29.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.215 -0.928 . . . . 0.0 111.552 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.4 -44.46 82.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.564 -1.335 . . . . 0.0 109.626 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.17 1.61 50.04 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.816 -170.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.478 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -64.34 130.6 44.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.732 -1.23 . . . . 0.0 109.944 175.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.72 5.44 51.39 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.58 0.705 . . . . 0.0 109.872 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.31 150.43 80.1 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.53 -0.731 . . . . 0.0 109.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.74 -38.14 84.75 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.651 1.342 . . . . 0.0 109.148 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.29 -28.58 69.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.496 -0.752 . . . . 0.0 110.377 176.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.33 -37.6 74.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -175.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 354' ' ' ILE . 96.1 mtt180 -77.32 -38.0 51.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.658 174.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.534 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 9.6 m -61.36 -37.97 85.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 110.365 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.542 HG23 HD13 ' A' ' 443' ' ' ILE . 88.8 mt -68.51 -49.31 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.069 -1.02 . . . . 0.0 110.602 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.619 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -61.17 -33.36 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.935 -1.103 . . . . 0.0 110.167 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.6 mt -72.84 -32.58 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.704 -1.248 . . . . 0.0 110.603 171.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.53 -40.82 88.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.964 -1.085 . . . . 0.0 110.414 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.26 -44.67 94.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.497 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.995 ' HB3' HD23 ' A' ' 362' ' ' LEU . 67.4 mttt -71.33 -47.37 56.96 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.743 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.545 ' CG ' ' HG3' ' A' ' 359' ' ' ARG . 20.5 pt20 -70.7 -42.58 70.45 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.667 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.545 ' HG3' ' CG ' ' A' ' 358' ' ' GLN . 40.8 mtp85 -79.89 -42.23 24.59 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 111.517 -170.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 85.5 m-85 -134.98 -35.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.437 -1.414 . . . . 0.0 112.097 -170.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 57.0 t-20 -161.86 101.87 1.15 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.632 -1.293 . . . . 0.0 111.669 -169.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.995 HD23 ' HB3' ' A' ' 357' ' ' LYS . 32.5 mt -57.47 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.816 -1.177 . . . . 0.0 108.908 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.542 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.9 tpt180 -134.34 164.31 27.69 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.416 -0.802 . . . . 0.0 109.241 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -135.74 -157.08 0.76 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.962 -1.086 . . . . 0.0 110.355 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 37.1 ptt180 -94.54 163.24 13.47 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.651 -0.655 . . . . 0.0 110.494 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.787 ' O ' HD12 ' A' ' 370' ' ' LEU . 88.3 m-20 -130.82 42.26 3.26 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.398 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.995 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.5 t -73.56 -45.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 110.345 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.78 -24.11 64.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.351 -0.843 . . . . 0.0 111.146 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.42 -32.85 32.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.013 -1.054 . . . . 0.0 109.719 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 366' ' ' ASP . 12.4 mt -104.73 -2.64 24.64 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.565 -0.709 . . . . 0.0 110.569 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 70.8 m-70 61.06 51.93 4.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 109.827 -176.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.758 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -92.78 174.64 7.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 0.0 110.533 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.8 m -119.18 136.22 54.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.478 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.995 ' CE1' HG21 ' A' ' 367' ' ' VAL . 73.4 m-85 -89.69 149.09 22.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.473 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 48.7 t -124.31 100.84 35.2 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.124 -0.985 . . . . 0.0 109.629 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -57.04 149.59 61.52 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.995 1.524 . . . . 0.0 110.251 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 21.4 t80 -63.61 129.95 42.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.87 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.336 -0.853 . . . . 0.0 109.747 176.621 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 82.7 mtm180 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.308 0.575 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.832 ' HG2' ' HB1' ' A' ' 400' ' ' ALA . 0.7 OUTLIER -150.29 161.54 42.24 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.604 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 10.1 p -153.47 164.94 37.31 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 174.29 -164.94 36.26 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.881 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.901 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.6 tt -141.0 150.53 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.697 -0.884 . . . . 0.0 110.143 -176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -126.67 137.6 53.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.624 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.76 ' CD1' HD13 ' A' ' 370' ' ' LEU . 2.0 tt -141.53 154.7 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.352 172.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.506 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 88.9 m-20 -20.88 -62.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.48 0.657 . . . . 0.0 112.568 171.268 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.463 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t-20 -98.01 -7.49 29.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 111.934 -166.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.562 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 17.8 mtp180 -142.4 149.88 39.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.71 -1.244 . . . . 0.0 110.604 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -137.47 102.13 4.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 0.0 109.188 170.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.097 HD12 HD11 ' A' ' 339' ' ' LEU . 6.0 mt -121.64 146.09 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.097 -1.002 . . . . 0.0 110.007 -173.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.514 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 0.0 OUTLIER -136.77 155.32 49.98 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 110.261 177.534 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.608 ' HB3' HG22 ' A' ' 433' ' ' VAL . 43.7 pttt -129.23 145.82 51.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.17 173.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 401' ' ' ILE . . . -170.54 174.89 44.51 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 52.5 p -55.85 150.45 13.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.784 -1.421 . . . . 0.0 108.526 170.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.083 HG22 ' CG2' ' A' ' 432' ' ' VAL . 64.1 t -59.78 -34.96 57.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.064 -1.023 . . . . 0.0 109.977 -174.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.517 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 49.2 t0 -62.32 -45.89 91.21 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.196 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.832 ' HB1' ' HG2' ' A' ' 383' ' ' MET . . . -70.75 -52.01 23.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.085 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.769 HD13 ' CE ' ' A' ' 383' ' ' MET . 21.1 mm -62.98 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.998 -1.064 . . . . 0.0 110.505 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.595 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 13.4 ttp85 -59.46 -43.91 93.11 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.517 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 93.1 mtt180 -61.23 -36.99 81.46 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.448 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -66.9 -35.86 80.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -64.81 -49.72 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.455 -1.403 . . . . 0.0 110.152 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.63 -34.67 77.52 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.86 -1.15 . . . . 0.0 110.239 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.14 -35.76 78.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.995 -1.066 . . . . 0.0 109.971 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.7 m-80 -61.38 -27.38 68.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 109.134 173.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.87 19.59 28.62 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -169.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.42 -169.32 16.38 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -145.26 153.94 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -1.161 . . . . 0.0 111.232 -174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 439' ' ' VAL . 10.3 p90 -109.11 149.26 39.44 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.457 -0.777 . . . . 0.0 109.978 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.86 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.29 126.89 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.929 1.489 . . . . 0.0 110.401 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.3 t -66.92 -34.86 78.71 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.989 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.1 m-20 -62.01 -33.31 74.1 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.898 -1.126 . . . . 0.0 108.882 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.058 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.6 t -83.46 -41.77 17.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 110.987 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.33 -38.5 68.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.826 -1.171 . . . . 0.0 109.416 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.1 -47.92 80.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.374 -1.453 . . . . 0.0 110.264 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.71 ' HD3' HG21 ' A' ' 323' ' ' ILE . 66.9 mttm -56.39 -35.19 67.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.691 -1.256 . . . . 0.0 110.372 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.128 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -60.65 -40.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.405 172.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -65.85 -36.24 82.9 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 425' ' ' ARG . 94.9 mm-40 -68.38 -38.2 81.13 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 428' ' ' ALA . 63.0 t -61.0 -37.03 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.689 -1.257 . . . . 0.0 110.056 175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.0 82.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.969 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 422' ' ' GLN . 17.7 ptt180 -70.86 -28.68 64.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.721 -1.237 . . . . 0.0 111.097 -171.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 1.0 OUTLIER -82.62 -8.55 59.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.895 -1.128 . . . . 0.0 109.64 174.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.43 22.21 13.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.705 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -102.9 161.9 13.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -1.157 . . . . 0.0 109.323 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.873 ' HB ' HD12 ' A' ' 445' ' ' LEU . 2.0 m -109.16 106.94 59.49 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.062 . . . . 0.0 109.778 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 398' ' ' VAL . 44.5 Cg_endo -76.57 107.67 2.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 124.015 1.534 . . . . 0.0 110.452 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.86 ' HG ' HD11 ' A' ' 445' ' ' LEU . 10.3 mt -92.43 133.47 35.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.92 -1.112 . . . . 0.0 108.533 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 1.083 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.2 t -99.01 135.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.711 -1.243 . . . . 0.0 109.424 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.757 ' CG1' HD11 ' A' ' 440' ' ' LEU . 44.0 t -117.66 136.7 53.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 108.91 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -117.86 160.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.492 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.52 129.01 34.47 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.69 -131.6 28.98 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -167.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.608 ' O ' HG13 ' A' ' 405' ' ' VAL . 73.1 p -103.06 6.79 38.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.13 -1.218 . . . . 0.0 111.118 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -119.95 171.0 8.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.644 -1.285 . . . . 0.0 110.069 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.812 ' HA ' HG12 ' A' ' 434' ' ' VAL . 42.9 t -90.57 134.61 28.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.815 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -93.17 -22.6 18.96 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.672 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 1.022 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.33 176.87 39.04 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 118.883 -1.627 . . . . 0.0 110.721 170.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.128 HG21 HG23 ' A' ' 420' ' ' VAL . 56.6 t -107.94 142.84 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.161 -1.2 . . . . 0.0 109.994 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.8 mt -101.83 110.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 170.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.08 118.48 30.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.826 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.873 HD12 ' HB ' ' A' ' 429' ' ' THR . 0.9 OUTLIER -101.23 146.09 27.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.155 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 320' ' ' SER . 15.2 mmtp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 120.566 -1.334 . . . . 0.0 110.58 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 351' ' ' SER . 93.4 mt-30 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.126 0.489 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.77 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -57.32 135.96 56.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.841 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.527 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 2.4 m -127.48 -37.21 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 110.385 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 320' ' ' SER . 65.2 mt-10 -153.58 148.07 26.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.958 . . . . 0.0 110.597 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.07 ' CD1' HD21 ' A' ' 355' ' ' LEU . 6.1 p90 -137.86 147.4 44.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.726 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.693 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.8 mt -119.96 141.83 32.16 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 109.625 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.54 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.02 143.23 40.06 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.735 1.387 . . . . 0.0 111.481 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.086 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.85 152.65 43.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.185 -0.947 . . . . 0.0 108.662 165.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -57.56 127.85 34.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.679 -1.263 . . . . 0.0 110.336 -172.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 115.68 -28.0 8.03 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 440' ' ' LEU . 42.4 t -115.0 140.49 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.738 -1.448 . . . . 0.0 110.943 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.03 150.13 44.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 109.788 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -61.35 -39.47 90.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 31.8 ttmt -60.51 -45.12 94.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.795 -1.191 . . . . 0.0 109.735 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 92.4 m -55.97 -43.92 78.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.698 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.616 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -58.03 -39.14 77.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.817 . . . . 0.0 110.233 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.022 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.92 -42.1 81.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 0.0 110.691 -176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -62.87 -48.35 79.4 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.924 -1.11 . . . . 0.0 109.832 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.899 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.02 -31.86 71.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.026 -1.046 . . . . 0.0 109.765 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.32 -35.25 64.93 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 172.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.543 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 20.6 mt-30 -74.67 -56.28 4.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.501 -0.749 . . . . 0.0 110.838 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.987 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -60.97 -35.39 76.67 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.756 -1.177 . . . . 0.0 109.772 -172.077 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -68.03 -19.52 64.91 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.088 -1.007 . . . . 0.0 109.782 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.1 p -108.23 9.41 28.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.206 -0.934 . . . . 0.0 111.639 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.722 HD22 ' HD2' ' A' ' 365' ' ' ARG . 36.8 mt -64.71 -44.84 88.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.551 -1.343 . . . . 0.0 109.705 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.49 1.72 46.94 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.707 -169.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.1 p30 -62.61 130.28 44.36 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.952 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.68 5.35 51.63 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.528 0.68 . . . . 0.0 109.891 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.56 152.4 83.3 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.607 -0.683 . . . . 0.0 109.432 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.95 -38.79 94.15 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.713 1.375 . . . . 0.0 109.08 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.35 -28.87 70.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.458 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.51 -37.26 66.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.494 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -76.69 -37.37 56.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.219 . . . . 0.0 110.553 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 318' ' ' GLN . 11.3 m -61.36 -38.44 86.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.001 -1.062 . . . . 0.0 110.42 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.628 HG23 HD13 ' A' ' 443' ' ' ILE . 83.7 mt -68.98 -48.84 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.051 . . . . 0.0 110.534 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.628 HG22 ' OG ' ' A' ' 341' ' ' SER . 30.4 t -61.67 -34.03 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.952 -1.092 . . . . 0.0 110.076 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.4 mt -72.89 -32.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.601 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.07 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.68 -40.91 89.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.39 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.93 99.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 82.7 mttt -71.26 -50.21 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.892 -1.13 . . . . 0.0 110.924 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.548 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.9 pt20 -70.36 -42.38 71.89 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.497 -174.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 30.6 mmt180 -74.16 -46.02 44.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 111.24 -172.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 78.3 m-85 -135.51 -35.5 0.81 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.437 -1.305 . . . . 0.0 112.437 -168.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.501 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 23.1 t-20 -160.52 97.85 1.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.484 -1.385 . . . . 0.0 111.677 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 362' ' ' LEU . 5.5 mp -58.77 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.933 -1.105 . . . . 0.0 109.59 171.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.8 tpt180 -147.84 163.08 37.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.387 -0.821 . . . . 0.0 109.618 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.7 mt-10 -125.97 -157.36 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.722 ' HD2' HD22 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -96.66 165.35 12.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.531 -0.73 . . . . 0.0 110.596 -178.334 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.475 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -121.0 38.08 4.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.428 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.966 ' CG2' HD11 ' A' ' 386' ' ' ILE . 71.0 t -69.28 -44.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.787 . . . . 0.0 110.307 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -67.43 -26.6 66.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.971 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -29.14 25.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.904 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.964 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.7 mt -103.45 -2.36 27.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.777 . . . . 0.0 110.837 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 27.2 m80 62.62 52.65 2.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.09 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.925 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -94.99 174.71 6.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.9 m -115.97 134.32 55.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 110.421 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.941 ' CE2' HG11 ' A' ' 367' ' ' VAL . 68.3 m-85 -89.19 149.26 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.541 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 24.1 t -122.71 100.97 40.29 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.9 Cg_endo -56.11 151.45 42.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.124 1.592 . . . . 0.0 110.486 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.51 131.63 46.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.096 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 175.813 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 72.3 mtt85 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.542 0.687 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.868 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.3 ptp -158.69 168.61 26.41 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.948 0.88 . . . . 0.0 111.277 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 34.1 p -152.86 165.19 36.22 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -176.74 -165.89 32.96 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.04 -1.552 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.966 HD11 ' CG2' ' A' ' 367' ' ' VAL . 9.4 tt -144.1 150.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -1.03 . . . . 0.0 110.104 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 394' ' ' ARG . 43.0 m-20 -127.59 133.04 49.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.864 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.964 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.6 tt -139.28 155.03 25.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.75 -1.219 . . . . 0.0 109.165 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.504 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 90.7 m-20 -23.8 -62.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 172.208 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.445 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 49.5 t30 -92.36 -9.58 41.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 111.884 -167.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.587 ' H ' HG23 ' A' ' 388' ' ' ILE . 30.4 mtp180 -140.56 147.4 39.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.613 -1.304 . . . . 0.0 110.744 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.5 mtt -138.3 100.67 4.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.983 -1.073 . . . . 0.0 109.112 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.987 HD12 HD11 ' A' ' 339' ' ' LEU . 7.5 mt -122.66 146.47 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.934 -1.104 . . . . 0.0 110.296 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 387' ' ' ASN . 66.6 mmt-85 -130.49 156.84 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.142 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -132.91 125.46 29.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.458 -0.776 . . . . 0.0 108.97 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.529 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.85 173.94 32.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.717 -173.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.4 m -56.09 150.74 13.36 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.916 -1.343 . . . . 0.0 108.537 169.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.006 HG21 ' CG1' ' A' ' 420' ' ' VAL . 17.7 t -55.69 -37.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 109.932 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -64.04 -43.74 94.62 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.287 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.868 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.35 -51.2 47.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.555 HD13 ' HE1' ' A' ' 383' ' ' MET . 33.5 mm -64.96 -44.07 96.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 120.995 -1.066 . . . . 0.0 110.789 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.5 ttt180 -59.47 -42.94 93.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.192 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.9 mtp85 -61.65 -36.32 80.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.9 t-80 -67.49 -38.37 84.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 111.323 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.468 HG12 ' C ' ' A' ' 410' ' ' GLY . 67.9 t -65.88 -47.42 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.08 -34.25 77.6 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.859 -1.151 . . . . 0.0 110.33 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.34 80.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.093 . . . . 0.0 109.857 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 24.5 m-80 -62.01 -27.15 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.73 30.53 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -168.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.26 -170.67 18.37 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -146.9 153.92 40.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.173 -1.192 . . . . 0.0 111.111 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.628 ' HB3' HG21 ' A' ' 439' ' ' VAL . 6.8 p90 -108.99 151.9 42.15 Favored Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.456 -0.778 . . . . 0.0 110.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.874 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.4 125.99 11.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.909 1.478 . . . . 0.0 110.344 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.3 t -67.55 -32.74 73.71 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.7 m-20 -62.96 -33.6 75.73 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.895 -1.128 . . . . 0.0 108.808 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.086 HG21 ' HA ' ' A' ' 325' ' ' ALA . 51.1 t -83.71 -41.74 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.018 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.06 -38.37 67.94 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.8 -1.188 . . . . 0.0 109.475 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.3 mm-40 -63.48 -48.1 79.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 110.294 171.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.693 ' CD ' HG21 ' A' ' 323' ' ' ILE . 48.7 mttm -56.44 -35.25 67.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.611 -1.306 . . . . 0.0 110.411 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.034 HG23 HG21 ' A' ' 442' ' ' VAL . 2.9 t -60.14 -41.31 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.965 -1.084 . . . . 0.0 109.327 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.15 -35.91 81.74 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.852 0.835 . . . . 0.0 109.442 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -68.48 -37.62 80.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.582 -0.699 . . . . 0.0 110.886 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.696 HG13 ' HB3' ' A' ' 428' ' ' ALA . 70.9 t -62.85 -37.87 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.974 -1.079 . . . . 0.0 110.008 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.17 -40.38 82.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.945 . . . . 0.0 110.373 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.54 -31.22 70.3 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.252 -0.905 . . . . 0.0 110.931 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.46 -3.83 54.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.064 -1.023 . . . . 0.0 109.607 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 21.83 30.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.696 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.91 169.99 8.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 109.798 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.823 ' HB ' HD12 ' A' ' 445' ' ' LEU . 16.7 m -113.18 106.82 54.52 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.04 -1.037 . . . . 0.0 110.075 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.542 ' CG ' HG13 ' A' ' 420' ' ' VAL . 49.4 Cg_endo -79.39 107.38 2.16 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 O-C-N 123.898 1.473 . . . . 0.0 110.489 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.879 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.8 mt -93.09 137.95 31.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.883 -1.136 . . . . 0.0 108.625 167.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.912 ' CG2' HG22 ' A' ' 398' ' ' VAL . 92.4 t -101.56 134.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.678 -1.264 . . . . 0.0 109.613 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.812 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.7 t -114.52 134.53 57.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 108.824 174.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -118.4 160.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.501 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.52 130.15 32.04 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.88 -127.99 28.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.485 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.66 13.53 25.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -1.223 . . . . 0.0 111.233 -178.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -126.35 170.42 11.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 109.949 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.835 ' HA ' HG12 ' A' ' 434' ' ' VAL . 60.5 t -89.87 133.73 31.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.76 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -92.74 -21.36 20.0 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.323 -0.861 . . . . 0.0 109.574 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.825 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 168.93 176.86 39.36 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 118.909 -1.615 . . . . 0.0 111.093 169.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.034 HG21 HG23 ' A' ' 420' ' ' VAL . 56.4 t -107.88 142.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.071 -1.252 . . . . 0.0 109.777 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.701 HD11 ' HB1' ' A' ' 337' ' ' ALA . 77.5 mt -101.44 113.08 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.373 -0.83 . . . . 0.0 109.036 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.38 118.63 31.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.036 -1.04 . . . . 0.0 109.881 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.879 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.8 144.23 30.72 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.056 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.527 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.67 0 O-C-N 120.574 -1.329 . . . . 0.0 110.986 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.1 mt-30 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.118 0.485 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.707 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -57.79 136.83 56.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.97 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 3.4 m -118.98 -42.94 2.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 320' ' ' SER . 67.7 mt-10 -154.69 150.89 28.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.444 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.012 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 6.8 p90 -137.53 145.11 42.55 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.763 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.501 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.5 mp -118.26 144.42 34.96 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.596 -0.69 . . . . 0.0 109.775 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.554 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.6 143.62 38.39 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.764 1.402 . . . . 0.0 111.531 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.087 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.53 153.1 41.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 108.793 165.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -58.85 128.41 37.06 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.675 -1.266 . . . . 0.0 110.146 -172.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.86 -2.6 38.64 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.4 t -136.18 139.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.67 -1.488 . . . . 0.0 110.866 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.65 152.67 41.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.578 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.7 tt0 -62.01 -39.23 91.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.053 -1.029 . . . . 0.0 110.365 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -61.08 -45.21 95.67 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.816 -1.177 . . . . 0.0 109.765 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 92.2 m -55.8 -44.17 77.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.197 -0.94 . . . . 0.0 109.596 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.699 ' HA ' HD13 ' A' ' 440' ' ' LEU . 5.3 tp -57.99 -39.87 79.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.315 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.012 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.08 -1.013 . . . . 0.0 110.788 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.0 m-20 -63.44 -49.27 74.33 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.872 -1.143 . . . . 0.0 109.758 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.896 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.48 -31.67 71.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.821 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.656 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.69 -35.55 63.71 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.066 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.4 mt-30 -75.23 -55.79 5.36 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.506 -0.746 . . . . 0.0 110.999 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.039 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.28 -34.99 76.1 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.786 -172.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.414 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -66.89 -21.51 66.0 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.14 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.65 ' OG ' HG22 ' A' ' 353' ' ' VAL . 90.9 p -108.09 10.32 28.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.097 -1.002 . . . . 0.0 111.632 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.28 -44.67 82.92 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.696 -1.252 . . . . 0.0 109.694 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.26 1.43 49.62 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.885 -170.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.7 p30 -64.96 130.22 42.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.753 -1.217 . . . . 0.0 110.03 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.61 4.08 53.43 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.555 0.693 . . . . 0.0 109.863 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 346' ' ' THR . 3.2 p -73.79 152.62 89.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 109.38 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -55.94 -39.26 92.28 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.724 1.381 . . . . 0.0 109.149 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.8 mt-10 -65.05 -27.68 68.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.504 -0.747 . . . . 0.0 110.474 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.06 -39.24 79.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 354' ' ' ILE . 65.4 mtt85 -78.55 -35.78 45.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.6 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 6.3 m -60.98 -38.92 87.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.954 -1.091 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.616 HG23 HD13 ' A' ' 443' ' ' ILE . 88.2 mt -68.45 -49.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.062 . . . . 0.0 110.655 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.65 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.3 t -61.06 -34.57 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.988 -1.07 . . . . 0.0 110.124 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 350' ' ' ARG . 31.4 mt -72.52 -31.97 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 110.455 171.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.984 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.9 OUTLIER -60.12 -40.96 91.57 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.941 -1.099 . . . . 0.0 110.494 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.39 98.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 110.326 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 71.0 mttt -71.33 -49.09 45.99 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.68 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 11.7 pt20 -71.98 -43.26 65.42 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.73 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.594 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 78.7 mmt-85 -73.63 -44.44 56.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 111.435 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.594 ' CD2' ' HB3' ' A' ' 359' ' ' ARG . 60.3 m-85 -135.27 -38.72 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.522 -1.361 . . . . 0.0 112.125 -168.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.9 t30 -159.45 104.11 1.62 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.214 . . . . 0.0 111.58 -168.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 41.4 mt -57.42 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.875 -1.141 . . . . 0.0 108.912 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.492 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.7 tpt180 -131.42 164.06 26.56 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.477 -0.764 . . . . 0.0 109.25 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.9 mt-10 -138.13 -158.13 0.83 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.978 -1.076 . . . . 0.0 110.543 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.584 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.9 ptt85 -97.2 162.54 13.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 110.677 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 365' ' ' ARG . 89.2 m-20 -133.49 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.507 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.949 HG21 ' CE1' ' A' ' 374' ' ' PHE . 63.6 t -73.4 -47.61 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.491 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.02 -23.55 65.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -30.43 27.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.021 -1.05 . . . . 0.0 109.753 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.986 ' HB3' HD11 ' A' ' 388' ' ' ILE . 16.9 mt -103.53 -4.97 23.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.523 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 56.5 m-70 64.22 52.06 2.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.186 -176.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.912 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.86 174.91 6.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.631 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.4 m -117.98 136.03 53.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.949 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.1 m-85 -88.5 149.11 23.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.596 174.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 61.8 t -122.31 101.06 41.39 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.133 -0.979 . . . . 0.0 109.658 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.48 151.18 38.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.003 1.528 . . . . 0.0 110.413 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.632 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 15.1 t80 -65.02 132.31 48.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 110.048 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.303 -1.436 0 O-C-N 121.354 -0.841 . . . . 0.0 109.611 175.359 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 79.9 mtm180 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.44 0.638 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.777 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.4 ptp -158.78 168.41 26.9 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.362 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.7 p -153.6 164.93 37.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.32 -166.68 35.54 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.714 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.847 HG21 ' HB2' ' A' ' 339' ' ' LEU . 4.2 tt -138.9 148.99 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.681 -0.894 . . . . 0.0 110.021 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -127.49 134.91 49.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.892 -1.13 . . . . 0.0 109.678 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.986 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -139.84 154.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.922 -1.111 . . . . 0.0 109.443 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.2 -62.99 0.06 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.48 0.657 . . . . 0.0 112.259 172.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 54.0 t30 -90.93 -10.21 43.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 111.686 -168.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.602 HH21 HD13 ' A' ' 339' ' ' LEU . 23.2 mtp180 -142.31 147.02 35.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.612 -1.305 . . . . 0.0 110.76 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.7 mtt -135.6 108.54 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.916 -1.115 . . . . 0.0 108.996 169.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.039 HD12 HD11 ' A' ' 339' ' ' LEU . 8.4 mt -128.17 145.9 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.008 -1.057 . . . . 0.0 110.058 -175.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 33.4 mtt180 -136.14 160.76 37.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 0.0 110.833 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.482 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.59 128.05 34.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.641 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.62 173.94 32.28 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 28.5 m -57.27 152.22 14.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.97 -1.312 . . . . 0.0 108.721 170.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.994 HG21 ' CG1' ' A' ' 420' ' ' VAL . 79.1 t -55.72 -35.99 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 109.783 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.6 t0 -63.25 -46.62 86.04 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.359 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.777 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.14 -50.57 53.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.497 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.641 HD11 ' N ' ' A' ' 396' ' ' GLY . 28.4 mm -64.59 -43.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.788 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.591 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.4 ttp180 -59.64 -43.71 93.76 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 67.2 mtp180 -61.93 -36.19 80.65 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.075 -1.015 . . . . 0.0 109.501 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.413 ' ND1' ' C ' ' A' ' 404' ' ' HIS . 2.3 t-80 -68.5 -36.46 78.94 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 111.353 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 437' ' ' SER . 55.8 t -65.97 -48.91 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.585 -1.322 . . . . 0.0 110.102 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.37 -34.21 77.22 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.2 79.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.074 . . . . 0.0 109.931 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.7 m120 -61.34 -27.7 68.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 109.153 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.12 19.8 27.45 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -169.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.63 -170.05 15.92 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -144.95 153.79 41.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.186 -1.185 . . . . 0.0 111.097 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.591 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.2 p90 -107.9 150.21 40.02 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.506 -0.746 . . . . 0.0 110.085 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.884 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.98 126.25 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.902 1.475 . . . . 0.0 110.291 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 2.0 t -67.64 -32.48 73.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.976 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 88.7 m-20 -63.43 -33.41 75.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.893 -1.13 . . . . 0.0 108.728 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.087 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.1 t -83.57 -40.99 16.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.938 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 52.4 t0 -55.19 -38.5 68.46 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.691 -1.204 . . . . 0.0 109.452 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.502 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.6 mt-30 -63.4 -48.62 77.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.433 -1.417 . . . . 0.0 110.285 171.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 50.1 mmtt -56.16 -35.15 66.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.667 -1.271 . . . . 0.0 110.488 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.052 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.65 -41.59 85.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 109.149 171.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -65.72 -35.81 81.82 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.896 0.855 . . . . 0.0 109.458 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.73 -36.94 81.49 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.556 -0.715 . . . . 0.0 110.724 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.751 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.7 t -62.94 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 110.046 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.82 85.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.307 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -69.42 -30.69 68.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.243 -0.91 . . . . 0.0 110.862 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.7 -3.57 56.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.7 21.89 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.751 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.42 166.41 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -1.139 . . . . 0.0 109.689 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.846 ' HB ' HD12 ' A' ' 445' ' ' LEU . 2.8 m -110.77 107.24 57.99 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.039 -1.038 . . . . 0.0 109.732 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 398' ' ' VAL . 40.8 Cg_endo -76.12 108.4 2.67 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 O-C-N 123.898 1.473 . . . . 0.0 110.431 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.855 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.5 mt -92.5 139.85 30.17 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.968 -1.083 . . . . 0.0 108.665 167.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.704 ' CG2' HG22 ' A' ' 398' ' ' VAL . 21.5 t -100.28 134.02 41.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.781 -1.199 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.937 ' CG1' HD11 ' A' ' 440' ' ' LEU . 13.9 t -115.13 132.89 63.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 108.591 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -119.33 160.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -175.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.2 tt0 -135.7 131.79 36.09 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.45 -128.41 30.16 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.582 ' O ' HG13 ' A' ' 405' ' ' VAL . 69.3 p -106.34 8.75 31.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.054 -1.262 . . . . 0.0 111.193 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -123.93 170.52 10.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.603 -1.31 . . . . 0.0 110.115 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.844 ' HA ' HG12 ' A' ' 434' ' ' VAL . 61.0 t -89.7 133.4 31.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.41 -0.806 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.937 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.7 pp -93.79 -19.9 20.6 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.498 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.87 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 170.34 176.72 40.03 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.846 -1.645 . . . . 0.0 110.894 167.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.052 HG21 HG23 ' A' ' 420' ' ' VAL . 55.1 t -107.82 143.0 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.121 -1.223 . . . . 0.0 109.86 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.656 HD11 ' HB1' ' A' ' 337' ' ' ALA . 75.8 mt -101.59 111.82 32.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 108.996 170.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.75 117.85 30.14 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.097 -1.002 . . . . 0.0 109.775 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.855 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -100.65 144.68 29.33 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 32.3 mttp . . . . . 0 N--CA 1.491 1.61 0 O-C-N 120.783 -1.198 . . . . 0.0 111.056 -178.674 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.4 mt-30 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.088 0.47 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.707 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -61.06 139.32 58.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.803 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.522 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -123.37 -34.93 3.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.556 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.492 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.9 tt0 -163.79 149.41 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.36 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.073 ' CD1' HD21 ' A' ' 355' ' ' LEU . 16.4 p90 -135.74 145.45 46.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.847 -1.158 . . . . 0.0 111.725 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.742 HD13 ' HD3' ' A' ' 419' ' ' LYS . 11.4 mt -116.66 141.56 28.31 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.61 142.62 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.635 1.334 . . . . 0.0 111.712 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.033 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.41 151.66 44.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.348 -0.845 . . . . 0.0 108.86 165.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -58.08 129.21 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.735 -1.228 . . . . 0.0 110.09 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.44 -0.04 50.07 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 440' ' ' LEU . 53.5 t -135.28 138.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.74 -1.447 . . . . 0.0 110.764 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.7 m-20 -73.13 148.84 43.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.564 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.6 tt0 -60.22 -35.43 75.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.991 -1.068 . . . . 0.0 109.86 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.516 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.25 -43.44 87.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.001 -1.062 . . . . 0.0 109.297 176.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.528 HG21 HG13 ' A' ' 328' ' ' VAL . 92.7 m -60.81 -42.49 97.76 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.97 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.0 tp -60.49 -39.1 86.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.242 -0.911 . . . . 0.0 110.573 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.44 -44.2 79.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.061 . . . . 0.0 110.666 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.56 ' O ' HD23 ' A' ' 339' ' ' LEU . 89.4 m-20 -63.73 -49.05 74.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.908 -1.12 . . . . 0.0 110.056 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.937 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -69.03 -30.78 69.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.027 -1.046 . . . . 0.0 109.868 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.767 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.97 -35.69 64.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.125 -0.984 . . . . 0.0 108.953 171.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.574 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.68 -55.91 5.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.519 -0.738 . . . . 0.0 111.116 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.51 -33.86 76.89 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.033 -171.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.07 -21.48 65.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.965 -1.084 . . . . 0.0 110.147 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.731 ' OG ' HG22 ' A' ' 353' ' ' VAL . 78.5 p -106.46 10.57 31.36 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.188 -0.945 . . . . 0.0 111.473 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 50.6 mt -66.32 -44.68 82.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.562 -1.336 . . . . 0.0 109.672 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.74 2.79 52.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.997 -171.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.488 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 15.8 p30 -63.85 130.64 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.756 -1.215 . . . . 0.0 109.995 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.69 5.7 50.77 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.571 0.701 . . . . 0.0 109.949 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.4 p -77.11 149.78 80.02 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.614 -0.679 . . . . 0.0 109.541 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.85 -40.77 79.16 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.679 1.358 . . . . 0.0 109.255 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.16 -27.87 69.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.768 . . . . 0.0 110.382 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.92 -36.79 60.91 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.507 ' O ' HD12 ' A' ' 354' ' ' ILE . 94.4 mtt180 -75.91 -37.26 58.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.108 -1.23 . . . . 0.0 110.432 172.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.5 m -61.95 -38.04 87.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.049 -1.032 . . . . 0.0 110.418 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 443' ' ' ILE . 83.4 mt -68.6 -49.21 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.907 -1.121 . . . . 0.0 110.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.731 HG22 ' OG ' ' A' ' 341' ' ' SER . 21.5 t -61.2 -32.84 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.943 -1.098 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.672 HG22 ' OE1' ' A' ' 358' ' ' GLN . 42.4 mt -72.89 -31.76 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.771 -1.206 . . . . 0.0 110.808 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.073 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.73 -41.48 90.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.784 -1.198 . . . . 0.0 110.249 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.541 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.496 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.935 ' HB3' HD23 ' A' ' 362' ' ' LEU . 66.7 mttt -72.16 -51.07 23.01 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.672 ' OE1' HG22 ' A' ' 354' ' ' ILE . 20.2 pt20 -70.78 -42.73 70.0 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.706 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.9 mmm180 -74.94 -43.19 55.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 111.147 -172.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 55.2 m-85 -134.98 -39.48 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.675 -1.265 . . . . 0.0 112.012 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.514 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.5 t-20 -162.58 106.36 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.532 -167.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.935 HD23 ' HB3' ' A' ' 357' ' ' LYS . 54.1 mt -57.62 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.948 -1.095 . . . . 0.0 109.188 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.497 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.8 tpt180 -124.36 156.44 37.05 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.28 -0.888 . . . . 0.0 109.866 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 20.3 pt-20 -122.93 -167.66 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.023 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.586 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.5 ptt-85 -93.52 164.71 13.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 110.542 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.6 m-20 -129.43 40.84 3.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.965 HG21 ' CE1' ' A' ' 374' ' ' PHE . 93.8 t -73.75 -48.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.436 -0.79 . . . . 0.0 110.43 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.419 -0.801 . . . . 0.0 111.134 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -30.21 29.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 109.79 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.994 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.0 mt -102.83 -4.58 24.67 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 110.628 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.7 m-70 64.07 52.94 1.92 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.929 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.6 174.98 6.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 110.677 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.6 m -117.65 134.22 55.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.604 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.965 ' CE1' HG21 ' A' ' 367' ' ' VAL . 92.4 m-85 -89.71 143.55 26.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.577 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.458 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 41.9 t -118.2 101.22 51.58 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.9 Cg_endo -55.57 152.22 34.78 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.089 1.573 . . . . 0.0 110.343 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 19.2 t80 -63.4 132.31 51.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 0.0 110.174 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.569 174.898 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 90.8 mtt-85 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.468 0.652 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.702 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.0 ptp -160.62 168.27 25.28 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.957 0.884 . . . . 0.0 111.328 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.0 p -153.59 164.88 37.49 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.44 -165.62 34.46 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 118.945 -1.597 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 367' ' ' VAL . 1.5 tt -139.11 148.51 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.663 -0.904 . . . . 0.0 109.989 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -127.24 135.33 50.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.676 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.994 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -139.87 154.87 24.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.867 -1.145 . . . . 0.0 109.363 171.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.492 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 89.7 m-20 -25.36 -63.16 0.06 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.447 0.641 . . . . 0.0 112.263 172.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.45 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 42.9 t-20 -92.14 -7.47 48.37 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.777 . . . . 0.0 111.804 -168.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.568 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 33.3 mtp180 -144.5 144.95 31.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.643 -1.286 . . . . 0.0 110.645 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.1 mtm -135.34 110.42 8.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.915 -1.116 . . . . 0.0 109.149 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 339' ' ' LEU . 8.6 mt -130.49 145.96 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 110.001 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 41.8 mtt180 -135.9 160.88 37.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 110.76 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.528 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.2 128.58 34.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.6 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.39 174.4 33.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -174.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -57.52 151.55 16.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.949 -1.324 . . . . 0.0 108.357 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.066 HG21 HG11 ' A' ' 420' ' ' VAL . 61.2 t -57.69 -34.57 47.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.074 -1.017 . . . . 0.0 109.951 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.6 t70 -62.65 -46.59 87.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.702 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.24 -50.02 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.985 -1.072 . . . . 0.0 110.562 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.6 HD11 ' N ' ' A' ' 396' ' ' GLY . 32.2 mm -64.54 -43.82 96.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.656 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 6.1 ttt180 -59.87 -42.74 94.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 73.5 mtp180 -61.42 -36.16 79.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.572 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -67.33 -38.21 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 437' ' ' SER . 68.9 t -65.5 -47.56 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.573 -1.329 . . . . 0.0 110.138 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -35.02 78.91 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.783 -1.198 . . . . 0.0 110.354 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.0 -1.063 . . . . 0.0 109.949 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 22.0 m-80 -62.11 -27.11 68.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.24 19.16 31.3 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.04 -169.19 18.19 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.487 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.33 153.38 42.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.102 -1.234 . . . . 0.0 111.478 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.627 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 9.0 p90 -108.46 149.81 39.82 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.664 -0.647 . . . . 0.0 110.153 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.819 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.13 123.57 7.91 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.849 1.447 . . . . 0.0 110.465 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.27 -34.49 78.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.031 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.4 m-20 -60.63 -32.99 72.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.951 -1.093 . . . . 0.0 108.91 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.033 HG21 ' HA ' ' A' ' 325' ' ' ALA . 54.6 t -83.55 -42.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.001 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.574 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.6 m-20 -55.49 -36.8 67.03 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.659 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 98.9 mm-40 -63.79 -48.77 75.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.326 -1.484 . . . . 0.0 110.184 171.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.742 ' HD3' HD13 ' A' ' 323' ' ' ILE . 65.3 mttm -56.78 -34.99 68.16 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.661 -1.274 . . . . 0.0 110.309 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.066 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.33 -41.24 83.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.987 -1.07 . . . . 0.0 109.279 171.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.6 t0 -66.47 -36.14 82.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 83.6 mt-30 -66.93 -37.38 84.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 428' ' ' ALA . 54.0 t -60.53 -38.9 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 109.942 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.85 92.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.943 . . . . 0.0 110.366 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 2.6 mtp180 -64.16 -31.54 72.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.134 -0.979 . . . . 0.0 110.722 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 2.8 mt-30 -80.96 -5.14 57.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.61 40.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.631 ' HB1' ' O ' ' A' ' 445' ' ' LEU . . . -103.0 172.81 6.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -1.103 . . . . 0.0 109.855 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.912 ' HB ' HD12 ' A' ' 445' ' ' LEU . 14.4 m -114.37 106.55 52.55 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.96 -1.088 . . . . 0.0 109.99 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.571 ' HB2' HG22 ' A' ' 420' ' ' VAL . 48.3 Cg_endo -79.76 107.26 2.08 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.927 1.488 . . . . 0.0 110.498 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.92 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.8 mt -93.41 135.67 34.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.878 -1.139 . . . . 0.0 108.785 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 1.023 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.5 t -100.91 134.36 41.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 O-C-N 120.802 -1.186 . . . . 0.0 109.53 175.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 440' ' ' LEU . 54.1 t -115.54 137.23 49.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.043 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -118.14 159.96 18.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.374 -0.829 . . . . 0.0 109.635 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.557 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.85 131.92 33.88 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.19 -129.07 31.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.501 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.45 12.24 28.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.117 -1.226 . . . . 0.0 111.09 -179.241 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -126.09 170.88 11.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.598 -1.314 . . . . 0.0 109.938 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 434' ' ' VAL . 23.3 t -90.88 134.23 30.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.762 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.45 -22.28 18.38 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.793 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.97 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.61 177.15 38.86 Favored Glycine 0 N--CA 1.501 3.005 0 C-N-CA 118.857 -1.639 . . . . 0.0 111.085 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.033 HG21 HG23 ' A' ' 420' ' ' VAL . 51.5 t -107.84 142.69 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.049 -1.265 . . . . 0.0 109.964 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.767 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.2 mt -101.37 112.86 35.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.28 119.32 31.76 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.92 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.43 146.94 27.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 2.7 pttp . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.477 -1.389 . . . . 0.0 110.706 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.8 mt-30 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.078 0.466 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.75 ' CA ' HD23 ' A' ' 445' ' ' LEU . . . -61.43 137.95 58.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.995 . . . . 0.0 109.924 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.62 -38.35 2.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.7 mt-10 -153.57 149.55 27.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.928 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.067 ' CD1' HD21 ' A' ' 355' ' ' LEU . 7.7 p90 -136.02 158.77 43.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.023 -1.048 . . . . 0.0 111.569 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.721 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.2 mp -133.94 139.7 34.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.21 144.2 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.613 1.323 . . . . 0.0 111.619 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.084 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.51 151.35 43.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 108.791 164.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -58.86 129.19 40.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.686 -1.259 . . . . 0.0 110.098 -172.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.12 -2.33 40.71 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.8 t -135.99 139.1 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.715 -1.462 . . . . 0.0 110.785 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.5 m-20 -73.31 152.48 40.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.895 . . . . 0.0 110.203 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -63.41 -40.55 97.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 0.0 110.538 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.3 -43.12 92.63 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.687 -1.258 . . . . 0.0 109.543 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 328' ' ' VAL . 93.8 m -55.86 -43.72 77.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.834 173.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.969 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.3 tp -59.6 -39.03 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.996 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.68 -42.96 81.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.768 -176.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.87 -48.61 76.03 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.803 -1.186 . . . . 0.0 109.901 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.876 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.54 -31.98 72.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.891 -1.131 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.72 -35.47 66.16 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.211 -0.931 . . . . 0.0 109.127 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 29.9 mt-30 -73.64 -55.79 5.83 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 110.893 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.058 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.93 -34.68 77.97 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.929 -171.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.43 -21.07 65.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -0.991 . . . . 0.0 110.014 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.646 ' OG ' HG22 ' A' ' 353' ' ' VAL . 92.3 p -107.68 10.24 29.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.227 -0.921 . . . . 0.0 111.569 -174.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.8 mt -65.88 -44.78 84.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.581 -1.324 . . . . 0.0 109.68 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.77 0.42 46.86 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.841 -170.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.476 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.3 p30 -63.03 130.45 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.778 -1.201 . . . . 0.0 109.926 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.65 5.69 50.8 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.568 0.699 . . . . 0.0 109.857 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.6 p -77.18 150.81 80.92 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.559 -0.713 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -53.42 -38.47 82.86 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.686 1.361 . . . . 0.0 109.14 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.53 -28.48 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.543 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.83 -37.95 71.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 354' ' ' ILE . 95.3 mtt180 -77.32 -38.13 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -1.18 . . . . 0.0 110.593 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.532 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 11.4 m -61.2 -38.29 86.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.878 -1.139 . . . . 0.0 110.359 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.68 -48.94 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.058 -1.026 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.646 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.6 t -61.36 -32.72 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.043 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.995 HG22 ' OE1' ' A' ' 358' ' ' GLN . 34.0 mt -72.73 -33.57 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.752 -1.218 . . . . 0.0 110.678 171.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.067 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.53 -40.8 83.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.8 -1.187 . . . . 0.0 110.397 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.48 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.928 ' HB3' HD23 ' A' ' 362' ' ' LEU . 24.9 mtmt -72.24 -49.4 35.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.547 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.995 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.7 pt20 -71.52 -42.49 67.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.32 -0.862 . . . . 0.0 110.843 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.598 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 39.0 mmt180 -73.75 -45.33 52.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.084 -1.01 . . . . 0.0 111.23 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.671 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 86.8 m-85 -135.59 -37.66 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.329 -1.349 . . . . 0.0 112.117 -169.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.492 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.1 t-20 -160.57 105.9 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.627 -1.296 . . . . 0.0 111.492 -168.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.928 HD23 ' HB3' ' A' ' 357' ' ' LYS . 51.9 mt -57.63 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.0 109.349 172.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.3 tpt180 -128.08 164.16 23.03 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -137.91 -160.43 1.06 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 110.085 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.71 163.91 12.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.522 -0.736 . . . . 0.0 110.67 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -131.39 42.63 3.18 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.507 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.068 HG21 ' CE1' ' A' ' 374' ' ' PHE . 42.3 t -72.7 -46.36 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 110.259 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.83 -27.31 66.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 111.152 -175.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.02 -30.1 28.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.756 176.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.785 ' HB3' HD11 ' A' ' 388' ' ' ILE . 21.8 mt -102.47 -5.02 24.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.524 -0.735 . . . . 0.0 110.635 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.4 m-70 60.3 52.27 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 109.761 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.772 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.04 174.57 7.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.456 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.9 m -117.12 134.64 54.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 110.499 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.068 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.7 m-85 -89.23 145.17 25.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.443 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 43.9 t -119.04 101.15 50.24 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.633 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.6 Cg_endo -55.22 151.37 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.067 1.562 . . . . 0.0 110.548 -175.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 10.2 t80 -64.48 131.91 48.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.87 . . . . 0.0 110.078 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--N 1.302 -1.48 0 O-C-N 121.405 -0.81 . . . . 0.0 109.715 175.885 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 69.9 mtt85 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.503 0.668 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.671 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.5 ptp -159.46 167.96 27.4 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.934 0.873 . . . . 0.0 111.203 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 17.3 p -154.41 165.14 37.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.33 -165.8 34.11 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.988 -1.577 . . . . 0.0 110.521 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.716 HD11 HG22 ' A' ' 367' ' ' VAL . 4.8 tt -138.68 151.6 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.639 -0.918 . . . . 0.0 110.231 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -127.39 133.99 49.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 109.747 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.785 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -140.38 155.18 23.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.937 -1.102 . . . . 0.0 109.2 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.6 m-20 -21.91 -63.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.47 0.652 . . . . 0.0 112.555 170.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.459 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 44.3 t-20 -95.57 -7.58 37.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 111.911 -167.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.563 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.4 mtp180 -142.95 144.92 32.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.745 -1.222 . . . . 0.0 110.55 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -135.3 101.33 4.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.845 -1.159 . . . . 0.0 108.967 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.058 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -123.89 146.03 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 110.143 -172.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 33.7 mtt180 -135.85 160.42 38.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.905 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.651 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.53 131.25 39.55 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.551 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -157.01 174.01 34.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.4 m -56.91 150.17 17.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.941 -1.329 . . . . 0.0 108.441 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.088 HG21 HG11 ' A' ' 420' ' ' VAL . 16.9 t -54.54 -36.97 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.969 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.5 m-20 -63.8 -44.25 93.87 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.319 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.671 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.42 -51.53 42.79 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.951 -1.093 . . . . 0.0 110.574 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 432' ' ' VAL . 30.6 mm -64.64 -42.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.082 -1.011 . . . . 0.0 110.736 -176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.594 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.9 ttp180 -59.15 -43.74 92.06 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.8 mtp180 -61.62 -36.8 81.76 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.416 ' ND1' ' C ' ' A' ' 404' ' ' HIS . 2.3 t-80 -68.18 -36.68 79.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.301 -0.874 . . . . 0.0 111.367 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 437' ' ' SER . 54.4 t -66.24 -47.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.59 -1.319 . . . . 0.0 110.16 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -34.8 78.6 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.756 -1.215 . . . . 0.0 110.293 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.22 81.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.968 -1.082 . . . . 0.0 109.883 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.6 m120 -60.94 -28.24 68.81 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.509 -0.744 . . . . 0.0 109.084 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.4 19.8 26.82 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 -169.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -116.05 -168.84 15.32 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.37 153.88 41.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.213 -1.169 . . . . 0.0 111.149 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.7 p90 -107.98 150.68 40.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.589 -0.694 . . . . 0.0 110.061 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.857 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.56 127.4 12.42 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.891 1.469 . . . . 0.0 110.49 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.2 t -66.99 -34.93 78.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 111.024 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.5 m-20 -61.43 -33.73 74.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.817 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.084 HG21 ' HA ' ' A' ' 325' ' ' ALA . 54.7 t -83.5 -41.68 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.37 -38.51 68.92 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.347 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.38 -48.0 79.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.324 -1.485 . . . . 0.0 110.309 171.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.721 ' HD3' HG21 ' A' ' 323' ' ' ILE . 35.8 mttm -56.71 -34.87 67.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.668 -1.27 . . . . 0.0 110.512 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.088 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.7 -41.68 86.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.91 -1.119 . . . . 0.0 109.136 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -65.94 -36.18 82.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.915 0.864 . . . . 0.0 109.493 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.5 -38.18 80.73 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 110.886 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 428' ' ' ALA . 69.4 t -62.3 -37.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.975 -1.078 . . . . 0.0 109.945 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.42 87.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.219 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.05 -33.08 74.99 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.258 -0.901 . . . . 0.0 111.208 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -80.98 -4.38 54.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.012 -1.055 . . . . 0.0 109.456 174.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.24 30.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.661 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.42 170.91 7.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -1.141 . . . . 0.0 109.863 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.865 ' HB ' HD12 ' A' ' 445' ' ' LEU . 7.5 m -112.45 106.62 55.71 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.988 -1.07 . . . . 0.0 110.108 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' ' 420' ' ' VAL . 55.3 Cg_endo -80.05 107.23 2.03 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 O-C-N 123.864 1.454 . . . . 0.0 110.541 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.898 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -93.6 140.44 29.61 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.915 -1.116 . . . . 0.0 108.717 167.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.89 ' CG2' HG22 ' A' ' 398' ' ' VAL . 98.5 t -101.07 135.6 36.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.798 -1.189 . . . . 0.0 109.568 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.0 ' CG1' HD11 ' A' ' 440' ' ' LEU . 22.3 t -115.93 136.19 53.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 108.745 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.826 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -120.53 160.44 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.477 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -135.49 129.97 33.96 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.26 -131.3 29.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.614 ' O ' HG13 ' A' ' 405' ' ' VAL . 76.5 p -103.29 8.97 38.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.087 -1.243 . . . . 0.0 111.138 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -123.32 170.84 9.89 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.555 -1.34 . . . . 0.0 110.152 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.826 ' HA ' HG12 ' A' ' 434' ' ' VAL . 61.9 t -91.04 134.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.357 -0.84 . . . . 0.0 109.824 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.0 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -92.83 -22.49 19.27 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.48 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.969 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 169.22 177.42 39.89 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.048 -1.549 . . . . 0.0 110.871 170.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.044 HG21 HG23 ' A' ' 420' ' ' VAL . 60.0 t -107.72 143.91 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.109 -1.23 . . . . 0.0 109.82 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.597 HD13 HG23 ' A' ' 352' ' ' ILE . 81.3 mt -101.62 112.62 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.448 -0.783 . . . . 0.0 108.997 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.36 118.24 30.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.861 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.898 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.66 148.15 25.93 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -175.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 16.1 pttt . . . . . 0 C--N 1.297 -1.691 0 O-C-N 120.563 -1.335 . . . . 0.0 110.343 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.462 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 87.6 mt-30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.085 0.469 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.721 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -64.2 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.934 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.463 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -117.37 -33.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -169.95 151.03 3.96 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.008 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.017 ' CD1' HD21 ' A' ' 355' ' ' LEU . 11.4 p90 -136.0 145.87 46.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.774 -1.204 . . . . 0.0 111.814 -177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.453 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.4 mp -116.53 143.16 30.73 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.667 -0.646 . . . . 0.0 109.631 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.8 Cg_endo -72.37 143.71 39.56 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.69 1.363 . . . . 0.0 111.583 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.063 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.65 152.4 41.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 108.782 165.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -58.78 128.96 39.84 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.575 -1.328 . . . . 0.0 110.097 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.66 -1.8 42.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.5 t -136.43 138.84 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.463 . . . . 0.0 110.749 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.4 m-20 -73.5 152.32 40.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -61.98 -40.11 94.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.037 -1.039 . . . . 0.0 110.443 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.13 -43.44 91.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 109.568 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.519 HG21 HG13 ' A' ' 328' ' ' VAL . 95.1 m -56.36 -43.56 79.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.88 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 1.024 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.6 tp -59.23 -39.8 83.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.268 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.0 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.17 -41.75 85.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 110.774 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.5 -49.16 74.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.892 -1.13 . . . . 0.0 109.971 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.898 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.7 -31.67 71.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.994 -1.066 . . . . 0.0 109.776 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.79 -34.9 65.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.02 -55.79 5.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.516 -0.74 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.067 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.34 -35.96 78.85 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.885 -173.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.16 -20.81 65.8 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.06 -1.025 . . . . 0.0 110.015 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.5 p -107.43 8.93 29.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.129 -0.982 . . . . 0.0 111.504 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.3 mt -65.48 -44.71 86.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.655 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.612 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.61 1.45 48.8 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.9 -170.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.487 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.47 130.2 43.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.803 -1.186 . . . . 0.0 110.057 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.92 5.45 51.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.595 0.712 . . . . 0.0 109.906 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -77.05 153.36 82.61 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.27 -38.33 95.26 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.734 1.386 . . . . 0.0 109.149 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.4 mt-10 -64.53 -29.66 70.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.75 . . . . 0.0 110.477 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.12 -35.51 59.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.3 mtt180 -76.97 -38.04 54.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.143 -1.21 . . . . 0.0 110.521 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.9 m -60.85 -38.09 84.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.92 -1.113 . . . . 0.0 110.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 443' ' ' ILE . 80.0 mt -69.01 -49.24 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.019 -1.051 . . . . 0.0 110.627 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.618 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -61.54 -33.84 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.0 110.198 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.749 HG22 ' OE1' ' A' ' 358' ' ' GLN . 34.2 mt -72.45 -33.09 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.741 -1.225 . . . . 0.0 110.553 171.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.017 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -59.68 -40.29 87.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.931 -1.106 . . . . 0.0 110.59 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.52 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.78 -45.12 91.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.284 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.971 ' HB3' HD23 ' A' ' 362' ' ' LEU . 30.1 mtmt -71.61 -49.26 41.95 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.706 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.749 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.6 pt20 -71.08 -42.4 69.41 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.76 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 37.8 mmt180 -73.11 -46.52 50.79 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 111.218 -172.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 73.6 m-85 -136.44 -35.82 0.73 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.411 -169.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.508 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 56.3 t-20 -158.91 102.43 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.546 -1.346 . . . . 0.0 111.619 -168.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.971 HD23 ' HB3' ' A' ' 357' ' ' LYS . 34.3 mt -57.8 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.858 -1.152 . . . . 0.0 109.295 171.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.525 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.6 tpt85 -135.96 163.64 29.8 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.34 -0.85 . . . . 0.0 108.941 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.51 -155.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.951 -1.093 . . . . 0.0 110.32 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.7 ptt180 -95.19 163.03 13.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.478 0.656 . . . . 0.0 110.523 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -127.78 40.24 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 110.464 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.939 HG11 ' CE2' ' A' ' 374' ' ' PHE . 57.4 t -74.61 -47.94 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.449 -0.782 . . . . 0.0 110.28 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.77 -26.02 65.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 110.954 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.44 -29.93 27.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 109.818 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.988 ' HB3' HD11 ' A' ' 388' ' ' ILE . 18.6 mt -103.83 -3.88 24.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 110.718 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.9 m80 62.77 53.15 2.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.932 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.43 174.92 6.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.672 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.2 m -116.3 134.27 55.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.567 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.939 ' CE2' HG11 ' A' ' 367' ' ' VAL . 81.4 m-85 -88.29 149.02 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 50.6 t -122.26 101.12 41.48 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -54.81 153.36 25.02 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.09 1.574 . . . . 0.0 110.443 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.586 ' CE2' ' N ' ' A' ' 383' ' ' MET . 58.3 t80 -69.07 134.27 49.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.797 174.86 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 97.4 mtt180 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.44 0.638 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.963 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.4 ptp -165.03 170.41 15.17 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.839 0.828 . . . . 0.0 111.283 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.3 p -154.84 165.55 36.28 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.94 -165.7 34.27 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 118.771 -1.68 . . . . 0.0 110.821 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.7 tt -140.86 148.67 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.641 -0.917 . . . . 0.0 110.133 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.446 HD21 HG21 ' A' ' 375' ' ' VAL . 41.9 m-20 -127.72 135.06 49.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.869 -1.145 . . . . 0.0 109.724 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.988 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.55 154.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.861 -1.149 . . . . 0.0 109.446 171.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 89.3 m-20 -25.4 -62.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.299 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.454 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.2 t30 -92.03 -7.83 47.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 -168.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.7 mtp180 -144.03 144.97 31.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.699 -1.25 . . . . 0.0 110.574 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.71 109.94 8.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.833 -1.167 . . . . 0.0 109.02 169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.067 HD12 HD11 ' A' ' 339' ' ' LEU . 8.6 mt -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.047 -1.033 . . . . 0.0 110.052 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 25.0 mmt85 -134.54 160.47 37.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.449 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.514 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.03 126.83 32.75 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.568 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.71 173.7 31.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.6 t -58.21 150.76 20.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.901 -1.352 . . . . 0.0 108.554 170.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.044 HG21 HG11 ' A' ' 420' ' ' VAL . 53.5 t -55.63 -35.48 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.971 -1.08 . . . . 0.0 109.607 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.09 -46.45 89.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.165 -0.96 . . . . 0.0 110.366 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.963 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -69.17 -51.02 42.3 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.028 -1.045 . . . . 0.0 110.639 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.568 HD11 ' N ' ' A' ' 396' ' ' GLY . 28.7 mm -64.28 -41.62 92.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 110.816 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.594 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 34.8 ttt-85 -59.65 -45.17 92.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.3 mtp85 -62.59 -35.51 79.75 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.205 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 111.212 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.84 -48.95 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.501 -1.375 . . . . 0.0 110.109 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.4 -34.11 77.02 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 110.253 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.97 -36.19 79.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.941 -1.099 . . . . 0.0 109.923 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.6 m-80 -61.63 -27.49 68.7 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.511 -0.743 . . . . 0.0 109.228 173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.06 19.43 28.64 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -170.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.78 -170.34 16.49 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.66 153.59 41.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 111.098 -174.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.4 p90 -107.21 150.15 39.57 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.528 -0.733 . . . . 0.0 110.039 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.879 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -72.27 127.4 12.63 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.846 1.445 . . . . 0.0 110.42 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -67.0 -34.96 78.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 111.016 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 55.9 t0 -62.12 -33.05 73.74 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.865 -1.147 . . . . 0.0 108.823 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.063 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.8 t -83.52 -41.66 16.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.906 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.498 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.8 t0 -55.14 -38.17 67.88 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.455 171.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.66 -48.16 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.33 -1.481 . . . . 0.0 110.299 171.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 15.0 mmtt -56.2 -35.36 67.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.59 -1.319 . . . . 0.0 110.384 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.078 HG23 HG21 ' A' ' 442' ' ' VAL . 3.3 t -60.23 -41.31 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.963 -1.086 . . . . 0.0 109.435 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -65.83 -36.04 82.37 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.922 0.868 . . . . 0.0 109.398 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.24 -37.58 80.95 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.868 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 428' ' ' ALA . 66.9 t -63.05 -37.35 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.91 -1.119 . . . . 0.0 110.01 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.36 85.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.71 -30.03 67.57 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.352 -0.842 . . . . 0.0 110.892 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.37 -3.53 55.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.785 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.23 21.79 28.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.58 170.89 7.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -1.081 . . . . 0.0 109.47 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.664 ' O ' HD12 ' A' ' 445' ' ' LEU . 21.3 m -116.92 106.85 47.01 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 109.52 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.601 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.3 Cg_endo -74.59 107.43 2.46 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 O-C-N 123.965 1.508 . . . . 0.0 110.331 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.625 ' HG ' HD13 ' A' ' 445' ' ' LEU . 15.8 mt -92.57 132.67 36.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.913 -1.117 . . . . 0.0 108.38 167.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.969 ' CG2' HG22 ' A' ' 398' ' ' VAL . 60.6 t -100.75 136.43 32.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.834 -1.166 . . . . 0.0 109.681 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.847 ' CG1' HD11 ' A' ' 440' ' ' LEU . 41.8 t -115.25 138.17 46.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 108.991 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.7 159.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.461 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.56 133.78 40.62 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 170.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.44 -126.83 31.07 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -168.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.62 ' O ' HG13 ' A' ' 405' ' ' VAL . 71.7 p -108.14 8.08 27.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.021 -1.281 . . . . 0.0 111.228 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -123.98 171.03 10.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.542 -1.349 . . . . 0.0 110.147 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.82 ' HA ' HG12 ' A' ' 434' ' ' VAL . 60.5 t -88.94 134.62 27.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.933 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.847 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -92.71 -22.12 19.59 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.602 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 1.024 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 171.04 176.31 40.15 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 118.803 -1.665 . . . . 0.0 110.816 168.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.078 HG21 HG23 ' A' ' 420' ' ' VAL . 48.2 t -107.88 143.18 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.239 . . . . 0.0 109.616 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.671 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.7 mt -101.47 118.62 48.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.326 -0.858 . . . . 0.0 108.773 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -98.14 117.58 32.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -176.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 429' ' ' THR . 3.6 mp -112.24 145.28 40.21 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.014 -1.054 . . . . 0.0 109.781 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.491 1.578 0 O-C-N 120.728 -1.233 . . . . 0.0 111.199 -174.058 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 90.5 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.118 0.485 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 355' ' ' LEU . . . -59.3 137.56 57.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.02 . . . . 0.0 109.765 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.516 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.9 m -117.89 -44.02 2.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.1 -1.0 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 320' ' ' SER . 66.1 mt-10 -154.81 151.48 28.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -0.908 . . . . 0.0 110.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.993 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.6 p90 -136.0 140.43 43.9 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.918 -1.114 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.466 HG23 ' HD2' ' A' ' 324' ' ' PRO . 3.4 mt -112.67 143.84 29.79 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.784 -0.573 . . . . 0.0 109.708 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.76 142.55 35.81 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.678 1.357 . . . . 0.0 111.614 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.057 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.48 152.81 42.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 108.861 165.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -59.11 128.64 38.21 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.586 -1.321 . . . . 0.0 110.178 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.46 46.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.3 t -136.73 139.38 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.677 -1.484 . . . . 0.0 110.703 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.8 m-20 -74.32 152.37 39.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.9 tt0 -61.53 -40.28 94.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.038 -1.039 . . . . 0.0 110.278 -177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.5 -43.84 93.26 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.665 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.502 HG21 HG13 ' A' ' 328' ' ' VAL . 93.4 m -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.742 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 1.019 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.3 tp -59.21 -39.2 81.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.296 175.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.993 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.44 -41.4 84.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.991 -1.068 . . . . 0.0 110.729 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.543 ' O ' HD23 ' A' ' 339' ' ' LEU . 88.4 m-20 -63.28 -49.92 72.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.975 -1.078 . . . . 0.0 109.84 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.903 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.0 -31.98 72.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 109.901 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.822 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.26 -35.35 64.9 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.166 -0.959 . . . . 0.0 108.961 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.55 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.9 mt-30 -75.5 -55.89 5.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.564 -0.71 . . . . 0.0 110.971 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.014 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -62.36 -35.24 78.52 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.756 -172.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.428 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.07 -20.87 65.89 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.984 -1.072 . . . . 0.0 109.978 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.8 p -107.82 9.95 28.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.205 -0.934 . . . . 0.0 111.547 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.9 mt -66.36 -44.37 83.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.516 -1.365 . . . . 0.0 109.633 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.39 2.15 50.13 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.787 -170.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 14.0 p30 -64.17 130.08 42.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.739 -1.226 . . . . 0.0 110.015 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.42 4.44 53.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.508 0.671 . . . . 0.0 109.873 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.1 p -74.17 152.95 88.4 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 109.404 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.74 -40.05 87.01 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.737 1.388 . . . . 0.0 109.162 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.68 -27.56 69.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 0.0 110.481 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.22 -37.74 65.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.5 mtt180 -77.15 -37.83 53.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -1.223 . . . . 0.0 110.514 173.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.4 m -61.04 -38.06 84.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.613 HG23 HD13 ' A' ' 443' ' ' ILE . 90.6 mt -68.12 -49.61 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.613 HG22 ' OG ' ' A' ' 341' ' ' SER . 37.2 t -60.87 -33.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.014 . . . . 0.0 110.07 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.614 HG22 ' OE1' ' A' ' 358' ' ' GLN . 29.4 mt -72.92 -32.91 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.701 -1.25 . . . . 0.0 110.565 171.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.951 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.43 -40.17 85.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.809 -1.182 . . . . 0.0 110.545 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.407 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.51 -44.69 93.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.938 ' HB3' HD23 ' A' ' 362' ' ' LEU . 16.1 mtmt -71.46 -49.6 39.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.638 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.614 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.6 pt20 -71.51 -42.54 67.87 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 110.793 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.525 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.9 mmt180 -72.86 -45.7 56.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 111.24 -172.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.571 ' CE2' ' OE2' ' A' ' 330' ' ' GLU . 56.1 m-85 -135.76 -38.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.143 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.511 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.3 t30 -159.0 105.18 1.75 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.758 -1.214 . . . . 0.0 111.528 -168.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 357' ' ' LYS . 46.7 mt -57.45 89.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.842 -1.161 . . . . 0.0 109.163 171.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.535 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.1 tpt180 -131.14 164.49 25.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.236 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.4 mt-10 -136.88 -157.19 0.76 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.153 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 31.8 ptt-85 -94.65 162.52 13.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 88.4 m-20 -128.68 41.21 3.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.287 176.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.082 HG21 ' CE1' ' A' ' 374' ' ' PHE . 26.0 t -73.47 -45.73 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.45 -28.18 66.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 111.079 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.19 -29.87 28.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.037 -1.039 . . . . 0.0 109.763 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.771 ' HB3' HD11 ' A' ' 388' ' ' ILE . 26.0 mt -103.64 -4.63 23.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.494 -0.754 . . . . 0.0 110.613 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.1 m-70 60.64 52.49 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.842 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.781 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -95.09 174.39 7.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.409 -0.807 . . . . 0.0 110.638 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.3 m -117.35 135.68 53.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.082 ' CE1' HG21 ' A' ' 367' ' ' VAL . 74.2 m-85 -89.39 148.79 23.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.626 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 64.0 t -122.17 100.69 42.21 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.26 150.36 49.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.046 1.551 . . . . 0.0 110.512 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.9 t80 -62.99 131.79 49.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.797 . . . . 0.0 109.639 175.411 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 87.7 mtt180 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.53 0.681 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.867 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.4 ptp -160.05 169.07 24.15 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.895 0.855 . . . . 0.0 111.314 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.537 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.6 p -153.64 164.92 37.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.15 -167.11 35.6 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.643 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.843 HG21 ' HB2' ' A' ' 339' ' ' LEU . 4.0 tt -140.04 150.28 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.554 -0.968 . . . . 0.0 110.136 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.53 134.52 50.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.956 -1.09 . . . . 0.0 109.809 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.771 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -142.41 155.22 18.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.947 -1.096 . . . . 0.0 109.181 173.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 91.5 m-20 -22.41 -63.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.413 0.625 . . . . 0.0 112.582 171.306 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.46 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t30 -96.35 -6.01 38.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 111.776 -167.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.564 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.5 mtp180 -143.74 143.89 31.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.705 -1.247 . . . . 0.0 110.381 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -134.02 99.43 4.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.974 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.014 HD12 HD11 ' A' ' 339' ' ' LEU . 7.2 mt -121.29 145.96 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.036 -1.04 . . . . 0.0 110.103 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 31.4 mtt180 -133.83 159.68 39.9 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.08 -1.013 . . . . 0.0 110.689 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.489 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.19 127.23 31.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.344 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.567 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.23 174.07 32.7 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -173.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 35.7 m -56.99 151.51 14.75 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.854 -1.38 . . . . 0.0 108.572 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.052 HG21 HG11 ' A' ' 420' ' ' VAL . 57.7 t -57.02 -34.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.993 -1.067 . . . . 0.0 109.856 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.8 t0 -62.88 -46.54 87.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.218 -0.926 . . . . 0.0 110.414 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.867 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.9 -50.42 56.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.006 -1.059 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.567 HD11 ' N ' ' A' ' 396' ' ' GLY . 32.5 mm -65.38 -43.69 94.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 110.763 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.585 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.7 ttp85 -58.9 -43.57 91.04 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.348 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.0 mtp180 -61.92 -36.26 80.83 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 109.44 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 401' ' ' ILE . 2.3 t-80 -67.61 -37.03 81.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 111.277 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 437' ' ' SER . 55.9 t -66.03 -48.26 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.657 -1.277 . . . . 0.0 110.157 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.99 -34.2 77.46 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.845 -1.16 . . . . 0.0 110.395 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.67 -36.39 80.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.924 -1.11 . . . . 0.0 109.816 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.9 m120 -61.63 -27.62 68.79 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.22 173.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.02 20.35 28.43 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -168.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.44 -170.87 17.6 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.416 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.0 m-70 -143.96 153.79 42.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -1.221 . . . . 0.0 111.186 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.592 ' HB3' HG21 ' A' ' 439' ' ' VAL . 5.3 p90 -107.37 150.96 40.68 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.61 -0.681 . . . . 0.0 110.098 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.846 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -73.3 124.41 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.869 1.457 . . . . 0.0 110.202 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -65.99 -34.87 79.09 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 111.064 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 54.1 t0 -61.41 -33.05 73.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.949 -1.094 . . . . 0.0 108.859 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.057 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.2 t -83.7 -42.44 17.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 111.009 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.508 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 9.3 m-20 -55.46 -37.26 67.53 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.575 171.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.7 mt-30 -63.72 -48.96 74.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.29 -1.506 . . . . 0.0 110.205 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 72.6 mmtt -56.65 -34.79 67.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.717 -1.239 . . . . 0.0 110.373 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.07 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.73 -41.23 84.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.0 -1.062 . . . . 0.0 109.283 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -66.48 -36.25 82.29 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.03 -38.19 82.25 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.565 -0.709 . . . . 0.0 110.782 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.777 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.5 t -62.48 -37.56 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.902 -1.124 . . . . 0.0 110.016 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.3 87.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 110.192 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -65.9 -33.8 76.66 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.38 -0.825 . . . . 0.0 111.177 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -81.69 -4.2 55.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 175.055 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 22.56 28.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.777 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -103.23 165.31 11.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -1.115 . . . . 0.0 109.618 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.768 ' HB ' HD12 ' A' ' 445' ' ' LEU . 10.0 m -110.89 106.87 57.83 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.018 -1.051 . . . . 0.0 109.863 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.567 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.35 108.42 2.7 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.972 1.512 . . . . 0.0 110.64 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.861 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.7 mt -91.86 133.96 35.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.861 -1.149 . . . . 0.0 108.497 166.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.929 ' CG2' HG22 ' A' ' 398' ' ' VAL . 83.8 t -99.86 134.73 38.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 120.799 -1.188 . . . . 0.0 109.465 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.014 ' CG1' HD11 ' A' ' 440' ' ' LEU . 23.5 t -114.46 138.57 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.881 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.821 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -122.12 160.45 24.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.657 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.447 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.17 129.26 33.51 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.25 -129.33 28.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.496 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 5.4 p -104.96 10.18 34.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.105 -1.232 . . . . 0.0 111.089 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -121.85 170.83 9.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.574 -1.329 . . . . 0.0 110.128 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 434' ' ' VAL . 41.2 t -93.8 134.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.315 -0.866 . . . . 0.0 109.762 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.014 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -95.96 -20.5 18.69 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.805 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 1.019 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.54 176.5 38.88 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 118.719 -1.705 . . . . 0.0 110.981 168.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.07 HG21 HG23 ' A' ' 420' ' ' VAL . 47.3 t -107.96 142.13 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.091 -1.24 . . . . 0.0 109.938 173.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.822 HD11 ' HB1' ' A' ' 337' ' ' ALA . 81.8 mt -101.53 111.25 30.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.042 170.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.651 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.75 118.65 30.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.099 -1.0 . . . . 0.0 109.909 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.861 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -101.07 144.62 29.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.333 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 70.5 mttt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 111.153 -179.467 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 61.4 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.048 0.451 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.803 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.66 138.61 41.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 109.789 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.528 ' O ' ' CZ ' ' A' ' 359' ' ' ARG . 20.8 m -124.34 -40.04 2.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.988 . . . . 0.0 110.276 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 320' ' ' SER . 57.9 mt-10 -154.66 146.54 23.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.103 ' CD1' HD21 ' A' ' 355' ' ' LEU . 9.2 p90 -137.6 142.34 41.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.593 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.538 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.9 mt -116.11 145.82 35.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.758 -0.589 . . . . 0.0 109.827 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -73.42 143.03 34.13 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.778 1.409 . . . . 0.0 111.468 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.047 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.22 152.72 42.02 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 108.881 165.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 13.4 tp60 -57.82 128.43 37.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.74 -1.225 . . . . 0.0 110.058 -173.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.62 -2.61 39.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.7 t -136.74 140.34 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.667 -1.49 . . . . 0.0 110.809 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -74.08 152.98 39.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.07 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -62.18 -38.73 90.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.354 -176.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -60.92 -45.66 93.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.697 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 95.0 m -55.99 -43.73 77.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.674 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.2 tp -58.08 -40.55 81.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.014 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.15 -39.86 82.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.08 -1.013 . . . . 0.0 110.717 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.1 m-20 -62.82 -49.09 76.29 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 109.757 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.29 -31.49 70.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.884 -1.135 . . . . 0.0 109.73 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.667 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.28 -34.9 64.51 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 172.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 17.7 mt-30 -74.25 -55.6 5.85 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 110.827 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.002 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.05 -35.24 78.03 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.048 -172.76 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.66 -21.08 65.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 110.131 174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.569 ' OG ' HG22 ' A' ' 353' ' ' VAL . 89.3 p -107.52 10.04 29.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.0 111.508 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.5 mt -65.68 -45.51 82.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.622 -1.299 . . . . 0.0 109.793 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.5 0.85 48.28 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.865 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 341' ' ' SER . 10.7 p30 -64.25 130.57 44.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.817 -1.177 . . . . 0.0 110.023 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.83 5.61 50.89 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.566 0.698 . . . . 0.0 109.863 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.0 p -75.76 154.72 85.25 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.68 -39.5 90.71 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.786 1.414 . . . . 0.0 109.222 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.558 ' CD ' HD13 ' A' ' 445' ' ' LEU . 96.1 mt-10 -64.9 -27.46 68.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.47 -0.769 . . . . 0.0 110.634 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.61 -39.83 76.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -174.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -78.02 -36.81 48.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -1.182 . . . . 0.0 110.662 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.5 m -61.25 -38.97 88.6 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.928 -1.108 . . . . 0.0 110.4 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.537 HG23 HD13 ' A' ' 443' ' ' ILE . 87.4 mt -69.11 -48.33 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.708 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.569 HG22 ' OG ' ' A' ' 341' ' ' SER . 34.8 t -62.14 -34.52 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.846 -1.159 . . . . 0.0 110.204 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.6 mt -73.2 -32.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.686 -1.259 . . . . 0.0 110.632 171.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.103 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -58.19 -41.27 83.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.97 -1.081 . . . . 0.0 110.2 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.99 -44.07 93.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.556 -0.715 . . . . 0.0 110.618 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.99 ' HB3' HD23 ' A' ' 362' ' ' LEU . 74.6 mttt -69.8 -49.56 51.55 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.662 -173.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.7 pt20 -72.27 -42.85 65.11 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.644 -172.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.769 ' HE ' HD12 ' A' ' 355' ' ' LEU . 84.6 mtt-85 -78.89 -39.52 34.74 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 111.707 -171.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.669 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 76.3 m-85 -134.77 -38.64 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.462 -1.399 . . . . 0.0 112.088 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 48.6 t30 -160.57 99.79 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.585 -1.322 . . . . 0.0 111.649 -169.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.99 HD23 ' HB3' ' A' ' 357' ' ' LYS . 34.1 mt -57.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.865 -1.147 . . . . 0.0 109.329 171.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.541 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.4 tpt180 -141.58 164.04 31.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.169 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.7 mt-10 -130.23 -154.24 0.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.474 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.7 ptt-85 -94.11 162.97 13.66 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.686 -0.634 . . . . 0.0 110.576 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.3 p30 -125.49 39.09 4.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.943 HG11 ' CE2' ' A' ' 374' ' ' PHE . 61.6 t -74.53 -47.5 39.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.352 -0.843 . . . . 0.0 110.281 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.86 -26.26 65.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 111.004 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.77 -29.74 27.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.001 . . . . 0.0 109.724 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.997 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.9 mt -104.33 -3.63 23.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.449 -0.782 . . . . 0.0 110.711 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.3 m80 62.6 53.22 2.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -177.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.937 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.46 175.01 6.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 0.0 110.646 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.3 m -115.94 134.43 54.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.476 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.943 ' CE2' HG11 ' A' ' 367' ' ' VAL . 80.5 m-85 -88.32 149.04 23.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.434 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 25.6 t -121.56 101.11 43.62 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 109.735 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.9 Cg_endo -55.03 153.05 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 110.468 -176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.566 ' CE2' ' N ' ' A' ' 383' ' ' MET . 56.8 t80 -70.54 134.44 47.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.386 -0.821 . . . . 0.0 109.777 174.843 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.6 mtt180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.485 0.66 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.915 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.6 ptp -165.28 171.3 13.73 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.878 0.847 . . . . 0.0 111.237 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.535 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.8 p -155.79 165.43 36.54 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.8 -165.82 34.38 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.822 -1.656 . . . . 0.0 110.79 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.877 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.5 tt -140.52 149.2 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.623 -0.928 . . . . 0.0 110.143 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.416 HD21 HG21 ' A' ' 375' ' ' VAL . 44.0 m-20 -127.82 134.81 49.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 109.695 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.997 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -140.15 154.85 23.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.791 -1.193 . . . . 0.0 109.437 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 90.0 m-20 -25.37 -63.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.444 0.64 . . . . 0.0 112.277 172.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 34.1 t30 -91.94 -7.69 48.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.738 . . . . 0.0 111.828 -168.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.558 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.6 mtp180 -143.98 144.64 31.77 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.667 -1.271 . . . . 0.0 110.581 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.6 mtm -134.42 111.73 10.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 108.945 169.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.002 HD12 HD11 ' A' ' 339' ' ' LEU . 9.6 mt -131.66 146.16 33.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.0 109.978 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 26.2 mmt85 -134.41 159.32 41.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.069 -1.019 . . . . 0.0 110.356 175.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.525 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.06 127.21 33.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.661 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.12 174.23 31.88 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.635 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.2 m -56.0 150.56 13.36 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.958 -1.319 . . . . 0.0 108.551 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.001 HG21 HG11 ' A' ' 420' ' ' VAL . 20.4 t -54.84 -37.36 40.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.083 -1.011 . . . . 0.0 109.904 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.4 m-20 -64.23 -45.01 90.08 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.252 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.915 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.48 -48.98 65.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.972 -1.08 . . . . 0.0 110.655 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.661 HD11 ' N ' ' A' ' 396' ' ' GLY . 35.1 mm -65.98 -43.85 92.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.008 -1.057 . . . . 0.0 110.945 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.621 ' NE ' ' CZ ' ' A' ' 412' ' ' PHE . 4.0 ttt180 -60.29 -42.61 95.85 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.062 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 88.8 mtt-85 -61.28 -37.49 83.37 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.635 172.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -67.68 -36.21 80.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 111.289 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.71 -49.05 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.621 -1.3 . . . . 0.0 110.154 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -34.3 77.38 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.891 -1.13 . . . . 0.0 110.218 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.13 79.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.96 -1.088 . . . . 0.0 109.994 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.8 m120 -61.45 -27.71 68.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.174 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.93 19.81 27.87 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.84 -169.37 16.09 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.401 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.0 m-70 -144.39 153.62 42.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 111.435 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.621 ' CZ ' ' NE ' ' A' ' 402' ' ' ARG . 7.7 p90 -108.4 149.85 39.84 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.668 -0.645 . . . . 0.0 110.304 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.824 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.02 125.56 9.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.807 1.425 . . . . 0.0 110.52 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.25 -32.37 72.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -0.986 . . . . 0.0 111.075 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.479 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.5 m-20 -63.47 -31.67 72.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 108.848 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.047 HG21 ' HA ' ' A' ' 325' ' ' ALA . 46.0 t -83.58 -42.58 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.388 -0.82 . . . . 0.0 110.765 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.2 m-20 -55.22 -36.64 66.2 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.669 -1.212 . . . . 0.0 109.625 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.91 -49.75 71.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.337 -1.477 . . . . 0.0 109.662 173.082 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 79.2 mttt -56.8 -34.83 68.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.785 -1.197 . . . . 0.0 110.278 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.095 HG23 HG21 ' A' ' 442' ' ' VAL . 2.5 t -59.47 -40.98 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -66.09 -36.61 83.65 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.959 0.885 . . . . 0.0 109.255 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -66.75 -36.68 83.01 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 110.511 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 428' ' ' ALA . 68.3 t -63.11 -37.69 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.026 -1.047 . . . . 0.0 110.161 175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.05 81.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 110.286 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.75 -30.72 68.37 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.252 -0.905 . . . . 0.0 111.006 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.43 -3.32 57.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 109.777 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.05 22.1 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.74 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -105.68 160.92 14.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -1.052 . . . . 0.0 109.474 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.83 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.2 m -108.88 106.89 59.56 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.935 -1.103 . . . . 0.0 109.798 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.535 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.69 107.86 2.56 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.01 1.531 . . . . 0.0 110.769 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.899 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.9 mt -92.62 133.29 36.12 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.845 -1.16 . . . . 0.0 108.542 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.909 ' CG2' HG22 ' A' ' 398' ' ' VAL . 87.7 t -99.74 134.09 40.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.608 -1.308 . . . . 0.0 109.452 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.727 ' CG1' HD11 ' A' ' 440' ' ' LEU . 46.9 t -114.43 134.95 55.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.999 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.0 m -117.07 159.94 16.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.491 -0.755 . . . . 0.0 109.639 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.527 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -135.28 132.52 37.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.01 -129.15 32.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 -167.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.583 ' O ' HG13 ' A' ' 405' ' ' VAL . 75.6 p -106.46 8.02 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.125 -1.221 . . . . 0.0 111.13 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -120.11 170.73 9.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.643 -1.286 . . . . 0.0 109.977 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.827 ' HA ' HG12 ' A' ' 434' ' ' VAL . 26.1 t -91.82 133.85 32.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -96.14 -20.04 18.92 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.822 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.871 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 169.07 176.41 39.11 Favored Glycine 0 N--CA 1.501 2.976 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.03 168.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.095 HG21 HG23 ' A' ' 420' ' ' VAL . 45.1 t -107.86 141.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.234 -1.157 . . . . 0.0 109.802 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.667 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.4 mt -101.42 110.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 108.939 170.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.58 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.31 119.06 31.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.03 -1.044 . . . . 0.0 109.911 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.899 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -102.62 144.88 30.45 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.418 -0.802 . . . . 0.0 108.871 -175.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 320' ' ' SER . 37.8 mmtm . . . . . 0 C--N 1.3 -1.586 0 O-C-N 120.697 -1.252 . . . . 0.0 110.7 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.543 ' CA ' ' HB3' ' A' ' 351' ' ' SER . 92.5 mt-30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.099 0.476 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.69 137.5 57.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.065 -1.022 . . . . 0.0 109.889 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.52 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.45 -34.04 2.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.604 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -161.81 146.06 12.71 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.936 -1.105 . . . . 0.0 110.246 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.134 ' CD1' HD21 ' A' ' 355' ' ' LEU . 15.9 p90 -136.78 147.79 46.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.818 -1.176 . . . . 0.0 111.656 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 7.5 mt -119.96 142.5 33.42 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.737 -0.602 . . . . 0.0 109.674 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.559 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.69 143.86 42.86 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.667 1.351 . . . . 0.0 111.732 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.06 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.8 153.02 42.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 108.907 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -59.59 128.6 37.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.631 -1.293 . . . . 0.0 110.12 -172.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.46 0.6 50.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 440' ' ' LEU . 47.3 t -135.36 138.33 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.677 -1.484 . . . . 0.0 110.606 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.46 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.5 m-20 -73.58 149.97 41.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.372 -0.83 . . . . 0.0 110.148 176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -60.85 -37.22 81.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.983 -1.073 . . . . 0.0 110.025 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -59.53 -41.21 89.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.918 -1.114 . . . . 0.0 109.324 176.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.548 HG21 HG13 ' A' ' 328' ' ' VAL . 99.3 m -60.09 -42.95 95.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 110.031 173.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.968 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.5 tp -60.01 -39.01 84.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 110.531 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.983 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.31 -45.45 72.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 110.734 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.8 m-20 -63.48 -48.71 76.53 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.885 -1.134 . . . . 0.0 109.931 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.905 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.62 -31.51 71.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 109.815 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.684 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.44 -35.47 65.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 172.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.54 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 19.3 mt-30 -74.04 -55.52 6.02 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.545 -0.722 . . . . 0.0 111.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.026 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.31 -36.25 79.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.097 -172.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 395' ' ' LYS . . . -67.82 -18.94 65.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.834 174.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.62 ' OG ' HG22 ' A' ' 353' ' ' VAL . 90.2 p -107.95 8.57 28.5 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.244 -0.91 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.609 HD11 ' CB ' ' A' ' 365' ' ' ARG . 32.2 mt -65.37 -45.77 82.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.557 -1.339 . . . . 0.0 109.67 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.44 1.57 49.34 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.869 -170.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.484 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -62.58 130.36 44.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.683 -1.26 . . . . 0.0 109.905 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.16 5.17 52.54 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.585 0.707 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 346' ' ' THR . 2.9 p -75.53 151.1 85.01 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.561 -0.712 . . . . 0.0 109.385 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.1 -39.31 92.02 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.669 1.352 . . . . 0.0 109.152 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.09 -28.02 69.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -0.789 . . . . 0.0 110.412 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.43 -37.82 67.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.498 ' O ' HD12 ' A' ' 354' ' ' ILE . 96.3 mtt180 -76.63 -35.98 57.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.24 . . . . 0.0 110.466 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.543 ' HB3' ' CA ' ' A' ' 318' ' ' GLN . 3.7 m -61.66 -38.91 89.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.976 -1.078 . . . . 0.0 110.348 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 443' ' ' ILE . 79.6 mt -69.24 -48.89 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.029 -1.044 . . . . 0.0 110.494 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.697 HG12 ' HE3' ' A' ' 357' ' ' LYS . 21.8 t -60.64 -32.17 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.797 -1.189 . . . . 0.0 109.84 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.771 HG22 ' OE1' ' A' ' 358' ' ' GLN . 45.4 mt -72.98 -32.29 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.861 -1.149 . . . . 0.0 110.744 171.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.134 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.87 -42.51 89.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 110.053 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.71 93.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.817 . . . . 0.0 110.592 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 1.017 ' HB3' HD23 ' A' ' 362' ' ' LEU . 81.0 mttt -71.97 -51.11 23.55 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.691 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.771 ' OE1' HG22 ' A' ' 354' ' ' ILE . 20.0 pt20 -71.82 -42.54 66.89 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.7 mmt180 -73.09 -43.83 61.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 111.031 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 87.5 m-85 -134.88 -38.73 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 112.052 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 52.3 t30 -163.01 102.51 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.51 -1.369 . . . . 0.0 111.624 -167.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 1.017 HD23 ' HB3' ' A' ' 357' ' ' LYS . 25.5 mt -57.97 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.902 -1.124 . . . . 0.0 108.994 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.527 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.2 tpt180 -145.64 163.02 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.892 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 88.9 mt-10 -134.06 -171.26 2.7 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.04 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.769 ' NH2' HD13 ' A' ' 388' ' ' ILE . 1.2 tpt180 -100.47 155.67 17.7 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.175 -0.953 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.1 m-20 -104.68 48.42 0.84 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.196 -0.94 . . . . 0.0 110.968 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.983 ' CG2' HD11 ' A' ' 386' ' ' ILE . 78.0 t -66.79 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 176.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.59 -26.89 66.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 110.979 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -28.3 25.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.932 ' HB3' HD11 ' A' ' 388' ' ' ILE . 17.8 mt -104.13 -1.75 26.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 22.9 m80 64.29 53.49 1.72 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 110.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.885 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -97.12 175.03 6.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 110.758 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.8 m -115.42 132.18 56.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 110.375 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.914 ' CE2' HG11 ' A' ' 367' ' ' VAL . 70.6 m-85 -87.86 149.13 24.31 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.479 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 59.9 t -125.31 100.78 32.04 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.066 -1.021 . . . . 0.0 109.866 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.3 151.93 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.089 1.573 . . . . 0.0 110.404 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 12.8 t80 -62.19 131.75 50.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 110.118 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--N 1.301 -1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.553 175.633 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 94.1 mtt180 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.515 0.674 . . . . 0.0 109.691 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.677 ' CE ' ' HB1' ' A' ' 400' ' ' ALA . 2.0 ptp -160.92 172.91 16.11 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.155 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.518 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.3 p -154.43 165.04 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.65 -165.1 33.14 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.772 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.983 HD11 ' CG2' ' A' ' 367' ' ' VAL . 6.7 tt -142.51 148.31 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.956 . . . . 0.0 110.04 -175.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -128.28 135.15 49.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.803 -1.186 . . . . 0.0 109.912 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.932 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 109.421 169.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.257 88.3 m-20 -25.88 -63.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.444 0.64 . . . . 0.0 112.251 173.051 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.438 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 19.9 t-20 -91.45 -7.97 49.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.807 . . . . 0.0 111.723 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.557 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 26.4 mtp180 -143.23 145.53 32.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.669 -1.27 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.91 113.56 10.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.131 . . . . 0.0 109.033 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 339' ' ' LEU . 10.0 mt -131.8 146.08 33.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.043 -177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 26.9 mtt180 -135.52 160.74 37.53 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.613 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.647 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.87 138.69 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.485 -0.759 . . . . 0.0 109.185 174.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.625 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -165.36 174.55 41.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.6 m -57.34 150.97 17.04 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.024 -1.28 . . . . 0.0 108.654 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.036 HG21 HG11 ' A' ' 420' ' ' VAL . 19.7 t -53.72 -37.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.9 m-20 -64.11 -44.71 91.43 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.392 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.677 ' HB1' ' CE ' ' A' ' 383' ' ' MET . . . -68.44 -50.57 51.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.907 -1.12 . . . . 0.0 110.574 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.638 HD13 ' HE1' ' A' ' 383' ' ' MET . 25.9 mm -64.9 -43.56 96.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.027 -1.046 . . . . 0.0 110.847 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 14.0 ttp180 -59.39 -43.17 92.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 62.5 mtp180 -61.92 -36.09 80.32 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 109.433 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.23 -37.48 83.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.203 -0.935 . . . . 0.0 111.291 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 437' ' ' SER . 58.3 t -65.66 -47.86 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.538 -1.351 . . . . 0.0 110.246 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.4 -34.67 78.24 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.795 -1.19 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.27 80.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.901 -1.125 . . . . 0.0 109.962 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 15.6 m-80 -61.7 -27.27 68.58 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.244 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.48 19.41 30.04 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.52 -169.44 17.08 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.435 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.3 m-70 -143.88 153.92 42.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -1.214 . . . . 0.0 111.378 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.593 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.4 p90 -106.97 149.18 38.24 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.626 -0.671 . . . . 0.0 110.255 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.818 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.46 123.7 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.809 1.426 . . . . 0.0 110.433 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.33 -33.99 76.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.925 . . . . 0.0 111.053 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 90.7 m-20 -61.04 -32.99 72.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.9 -1.125 . . . . 0.0 108.841 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.06 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.8 t -84.1 -42.62 17.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 60.7 m-20 -54.2 -36.99 64.05 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.456 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.6 mm-40 -63.18 -48.82 76.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.254 -1.529 . . . . 0.0 110.228 170.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 16.5 mmtt -56.29 -35.38 67.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.751 -1.218 . . . . 0.0 110.412 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.042 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.79 -40.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 109.151 171.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.874 0.845 . . . . 0.0 109.346 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 94.7 mm-40 -66.83 -38.06 85.68 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.644 -0.66 . . . . 0.0 110.666 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 428' ' ' ALA . 65.5 t -63.09 -36.92 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.934 -1.104 . . . . 0.0 110.14 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.14 82.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -70.37 -30.67 67.65 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 111.108 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 423' ' ' VAL . 5.9 pt20 -82.15 -6.35 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.901 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 96.44 22.02 20.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 445' ' ' LEU . . . -110.19 170.99 7.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 110.026 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.945 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.7 m -113.44 107.02 53.84 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.075 -1.016 . . . . 0.0 110.078 -174.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.566 ' HB2' HG22 ' A' ' 420' ' ' VAL . 43.3 Cg_endo -77.38 108.59 2.62 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.7 mt -93.48 139.68 30.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.919 -1.113 . . . . 0.0 108.851 167.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.85 ' CG2' HG22 ' A' ' 398' ' ' VAL . 88.3 t -102.5 135.76 38.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.749 -1.219 . . . . 0.0 109.587 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.75 ' CG1' HD11 ' A' ' 440' ' ' LEU . 46.3 t -118.25 135.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 108.758 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -118.26 160.56 17.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.525 ' CB ' HD23 ' A' ' 440' ' ' LEU . 3.9 tt0 -136.67 133.64 36.4 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 171.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.82 -124.2 23.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 405' ' ' VAL . 1.9 p -114.19 12.48 17.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.269 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -127.19 171.36 11.5 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 109.843 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.828 ' HA ' HG12 ' A' ' 434' ' ' VAL . 47.4 t -88.17 136.19 23.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.089 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.6 pp -94.34 -22.33 18.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.46 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.968 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.17 177.44 39.34 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.976 169.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.042 HG21 HG23 ' A' ' 420' ' ' VAL . 52.3 t -107.66 142.88 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.178 -1.19 . . . . 0.0 109.811 172.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.684 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.1 mt -101.43 112.93 36.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.576 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.81 119.0 31.23 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 109.869 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.945 HD12 ' HB ' ' A' ' 429' ' ' THR . 0.8 OUTLIER -101.38 144.88 29.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.52 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 13.8 pttt . . . . . 0 C--N 1.299 -1.616 0 O-C-N 120.597 -1.314 . . . . 0.0 110.738 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.542 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.3 mt-30 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.12 0.486 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.691 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -62.03 137.87 58.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.842 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -122.98 -32.87 3.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.48 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.488 ' N ' HD11 ' A' ' 355' ' ' LEU . 46.2 tt0 -163.22 146.13 10.38 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.348 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.046 ' CD1' HD21 ' A' ' 355' ' ' LEU . 10.1 p90 -134.24 142.19 47.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.875 -1.141 . . . . 0.0 111.482 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.632 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.3 mp -113.53 139.71 23.64 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.612 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.0 143.14 44.11 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.713 1.375 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.072 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -69.06 153.87 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 108.724 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -57.83 128.26 36.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.68 -1.262 . . . . 0.0 110.378 -171.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 112.67 -22.27 17.23 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 440' ' ' LEU . 61.2 t -115.84 139.93 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.727 -1.455 . . . . 0.0 111.071 -172.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.6 m-20 -72.19 148.39 45.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -60.56 -39.28 87.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 110.496 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.476 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.4 ttmt -58.76 -43.6 90.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.713 -1.242 . . . . 0.0 109.641 175.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 93.1 m -56.75 -43.83 81.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.959 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -58.66 -39.7 81.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.016 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.81 -40.99 83.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.074 -1.016 . . . . 0.0 110.817 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -63.66 -50.02 70.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 109.823 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.904 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.18 -31.5 71.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 109.711 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.787 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.08 -35.4 64.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.954 . . . . 0.0 109.033 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 20.6 mt-30 -74.79 -55.86 5.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.535 -0.728 . . . . 0.0 110.882 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.15 -35.6 77.54 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.77 -172.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.407 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.53 -20.49 65.43 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.072 -1.018 . . . . 0.0 110.063 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.5 p -107.15 9.08 30.39 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.161 -0.962 . . . . 0.0 111.471 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.8 mt -66.2 -44.61 83.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.614 -1.304 . . . . 0.0 109.665 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.15 1.87 50.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.919 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.485 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.28 130.47 44.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.726 -1.234 . . . . 0.0 109.879 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.48 5.4 51.68 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.551 0.691 . . . . 0.0 109.926 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.5 152.04 83.25 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.643 -0.661 . . . . 0.0 109.478 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.07 -39.71 89.48 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.748 1.394 . . . . 0.0 109.144 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.44 -27.98 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 110.409 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.99 -37.26 62.25 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -175.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.527 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.72 -37.36 56.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -1.231 . . . . 0.0 110.513 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.542 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.9 m -61.28 -37.95 85.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.952 -1.092 . . . . 0.0 110.358 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.636 HG23 HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.78 -49.26 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.618 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.8 t -61.06 -33.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.93 HG22 ' OE1' ' A' ' 358' ' ' GLN . 33.2 mt -72.58 -33.62 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.698 -1.251 . . . . 0.0 110.652 171.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.046 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.01 -40.53 85.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.935 -1.103 . . . . 0.0 110.402 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.406 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.06 -45.15 90.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.916 ' HB3' HD23 ' A' ' 362' ' ' LEU . 40.7 mtmt -72.29 -49.51 34.17 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.616 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.93 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.8 pt20 -71.56 -42.77 67.42 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.891 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.5 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.5 mmt180 -72.67 -45.46 58.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.138 -0.976 . . . . 0.0 111.164 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.576 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 60.0 m-85 -135.83 -38.68 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.391 -1.323 . . . . 0.0 112.114 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.499 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 13.8 t-20 -159.99 106.17 1.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.698 -1.251 . . . . 0.0 111.542 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.916 HD23 ' HB3' ' A' ' 357' ' ' LYS . 52.6 mt -57.7 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 0.0 109.323 172.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.536 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.7 tpt180 -128.07 164.0 23.38 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.5 mt-10 -137.98 -159.58 0.97 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.592 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.3 ptt180 -95.98 162.86 13.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.523 -0.736 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -130.34 41.86 3.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 110.465 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.036 HG21 ' CE1' ' A' ' 374' ' ' PHE . 42.9 t -72.97 -45.65 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.191 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.29 -27.48 67.21 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.487 -0.758 . . . . 0.0 111.021 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -29.64 27.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.713 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.774 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.4 mt -103.36 -5.03 23.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 110.662 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 367' ' ' VAL . 73.5 m-70 60.57 51.73 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 0.0 109.752 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.755 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.99 174.62 7.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.81 . . . . 0.0 110.521 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.0 m -117.15 134.89 54.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.342 -0.849 . . . . 0.0 110.58 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.036 ' CE1' HG21 ' A' ' 367' ' ' VAL . 82.3 m-85 -88.58 147.47 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 60.7 t -120.43 100.98 46.91 Favored Pre-proline 0 C--N 1.299 -1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.2 Cg_endo -55.07 151.39 34.66 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.019 1.537 . . . . 0.0 110.529 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 16.4 t80 -66.44 131.87 47.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.732 175.593 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 81.4 mtm180 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.48 0.657 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.708 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.0 ptp -157.54 166.3 33.3 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.923 0.868 . . . . 0.0 111.357 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.93 165.0 37.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.63 -166.96 35.61 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 118.923 -1.608 . . . . 0.0 110.733 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.865 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.9 tt -139.45 149.58 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.556 -0.967 . . . . 0.0 110.178 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -127.16 134.84 50.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 0.0 109.798 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -141.51 155.21 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 90.4 m-20 -23.02 -63.04 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.406 0.622 . . . . 0.0 112.49 171.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 53.7 t30 -95.99 -5.7 40.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.788 . . . . 0.0 111.855 -167.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.554 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.1 mtp180 -144.13 143.96 31.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.741 -1.225 . . . . 0.0 110.434 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.9 mtm -134.72 102.26 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.896 -1.128 . . . . 0.0 109.071 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -124.31 146.03 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -172.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 39.9 mtt180 -134.37 159.98 39.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 0.0 110.872 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.65 127.96 32.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.692 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.502 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.33 173.83 32.8 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.319 -1.419 . . . . 0.0 109.566 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.2 m -55.82 149.26 15.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.757 -1.437 . . . . 0.0 108.343 168.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.067 HG22 HG23 ' A' ' 432' ' ' VAL . 61.3 t -58.24 -34.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.899 -1.126 . . . . 0.0 109.917 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.2 t0 -61.85 -45.32 94.3 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.708 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.84 -51.27 42.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.955 -1.09 . . . . 0.0 110.591 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.561 HD13 ' CE ' ' A' ' 383' ' ' MET . 31.0 mm -64.49 -42.93 96.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 110.742 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.8 ttp85 -59.31 -43.73 92.61 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 70.6 mtp180 -61.8 -36.57 81.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.403 173.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.544 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -68.45 -36.14 78.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 111.197 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 437' ' ' SER . 52.9 t -65.81 -49.29 78.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.587 -1.32 . . . . 0.0 110.127 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.73 -33.91 76.7 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.949 -1.095 . . . . 0.0 110.285 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.19 79.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.991 -1.068 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.545 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.2 m-80 -62.25 -27.17 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.69 19.46 29.41 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -169.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.73 -171.4 18.27 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -144.88 153.68 41.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 111.037 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.3 p90 -108.78 150.7 41.15 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.861 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.93 128.33 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.83 1.437 . . . . 0.0 110.388 -175.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.8 t -67.3 -35.57 79.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.251 -0.905 . . . . 0.0 110.992 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -61.52 -34.06 74.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.912 -1.118 . . . . 0.0 108.816 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.072 HG21 ' HA ' ' A' ' 325' ' ' ALA . 55.0 t -83.48 -42.6 17.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.956 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.67 -38.22 69.32 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.543 172.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.4 mm-40 -63.77 -47.93 78.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.343 -1.473 . . . . 0.0 110.295 171.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.632 ' CD ' HG21 ' A' ' 323' ' ' ILE . 66.2 mttm -56.76 -35.06 68.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.639 -1.288 . . . . 0.0 110.431 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.095 HG23 HG21 ' A' ' 442' ' ' VAL . 2.9 t -60.04 -41.36 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.879 -1.138 . . . . 0.0 109.371 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.0 -36.0 82.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.812 0.815 . . . . 0.0 109.418 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.52 -37.87 80.41 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.648 -0.658 . . . . 0.0 110.861 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.8 t -62.95 -37.56 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.092 . . . . 0.0 110.022 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -40.12 83.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.332 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -68.25 -31.16 70.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 110.972 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -80.87 -3.47 51.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.045 -1.035 . . . . 0.0 109.705 174.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.25 21.77 34.26 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.63 173.87 6.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.143 . . . . 0.0 109.827 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.985 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.4 m -115.89 106.72 49.34 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.978 -1.076 . . . . 0.0 110.03 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 398' ' ' VAL . 54.9 Cg_endo -79.85 107.47 2.1 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.91 1.479 . . . . 0.0 110.243 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -91.94 135.61 33.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.898 -1.126 . . . . 0.0 108.482 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 1.067 HG23 HG22 ' A' ' 398' ' ' VAL . 88.3 t -99.71 133.96 40.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.747 -1.22 . . . . 0.0 109.341 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.027 ' CG1' HD11 ' A' ' 440' ' ' LEU . 25.0 t -113.47 136.78 48.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.8 m -122.19 160.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 121.379 -0.825 . . . . 0.0 109.719 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.452 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.5 tt0 -135.14 130.98 36.27 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.84 -128.1 28.72 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.639 ' O ' HG13 ' A' ' 405' ' ' VAL . 84.8 p -106.33 8.7 31.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 111.132 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.477 ' NH1' ' HG3' ' A' ' 438' ' ' ARG . 35.2 ptt85 -122.87 174.23 7.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.59 -1.319 . . . . 0.0 110.257 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.804 ' HA ' HG12 ' A' ' 434' ' ' VAL . 52.9 t -94.49 134.5 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.027 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -93.88 -21.22 19.38 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.748 175.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.959 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 169.42 176.55 39.41 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 118.868 -1.634 . . . . 0.0 110.961 168.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.095 HG21 HG23 ' A' ' 420' ' ' VAL . 48.9 t -107.99 142.64 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.009 -1.289 . . . . 0.0 109.974 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.787 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.3 mt -101.38 112.36 34.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.352 -0.842 . . . . 0.0 109.104 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.28 119.44 31.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.793 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.985 HD12 ' HB ' ' A' ' 429' ' ' THR . 1.4 mt -102.59 146.33 28.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.579 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 1.4 ptpm? . . . . . 0 N--CA 1.491 1.576 0 O-C-N 120.575 -1.328 . . . . 0.0 110.777 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.8 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.168 0.509 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.76 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -55.59 139.35 44.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.074 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 39.8 m -123.34 -38.67 2.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.494 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.455 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.5 tt0 -163.03 148.97 12.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.149 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.023 ' CD1' HD21 ' A' ' 355' ' ' LEU . 16.1 p90 -134.54 143.57 47.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.759 -1.213 . . . . 0.0 111.802 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.531 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.6 mt -113.68 143.99 30.54 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.561 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.74 142.72 36.17 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.708 1.372 . . . . 0.0 111.569 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.035 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.98 151.72 43.02 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 108.876 165.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -57.79 129.04 40.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.684 -1.26 . . . . 0.0 109.983 -173.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.39 -1.8 46.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.676 HG13 HG21 ' A' ' 332' ' ' THR . 52.1 t -136.01 139.07 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.573 -1.545 . . . . 0.0 110.748 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 332' ' ' THR . 6.5 p-10 -73.52 151.89 40.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 110.158 176.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 83.5 tt0 -61.06 -34.7 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.108 -0.995 . . . . 0.0 109.658 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.517 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 109.473 177.235 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.676 HG21 HG13 ' A' ' 328' ' ' VAL . 3.2 m -62.98 -39.14 93.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 175.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.986 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.2 tp -59.83 -40.12 87.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.048 -1.033 . . . . 0.0 110.412 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.982 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.02 -43.96 77.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.953 -1.092 . . . . 0.0 110.711 -176.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.574 ' O ' HD23 ' A' ' 339' ' ' LEU . 57.5 t0 -63.15 -48.84 76.74 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.878 -1.139 . . . . 0.0 110.068 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.952 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.74 -31.05 69.83 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 109.918 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.8 -35.99 64.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.134 -0.979 . . . . 0.0 108.884 172.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.8 mt-30 -75.06 -55.76 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.663 -0.648 . . . . 0.0 111.06 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.046 HD11 HD12 ' A' ' 393' ' ' ILE . 0.2 OUTLIER -64.97 -32.92 74.87 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.136 -171.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.86 -1.15 . . . . 0.0 110.07 172.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.625 ' OG ' HG22 ' A' ' 353' ' ' VAL . 99.1 p -107.95 11.4 27.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.143 -0.973 . . . . 0.0 111.541 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 44.5 mt -66.74 -45.17 79.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.722 -1.236 . . . . 0.0 109.859 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.07 1.08 49.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.864 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.481 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -63.92 130.3 43.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.746 -1.221 . . . . 0.0 109.979 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 4.6 52.97 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.633 0.73 . . . . 0.0 109.85 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 346' ' ' THR . 3.1 p -74.13 152.69 88.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.434 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.75 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.757 1.399 . . . . 0.0 109.227 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.2 mt-10 -64.45 -28.44 69.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.41 -38.53 69.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.552 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.3 mtt85 -77.91 -37.2 48.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -1.157 . . . . 0.0 110.58 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 5.5 m -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 110.338 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.674 HG23 HD13 ' A' ' 443' ' ' ILE . 86.0 mt -68.66 -48.6 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.023 -1.048 . . . . 0.0 110.652 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.625 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.1 t -60.83 -32.77 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.9 mt -72.54 -32.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 110.719 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.023 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.84 -41.11 90.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.801 -1.187 . . . . 0.0 110.396 178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.23 -42.55 99.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.359 -0.838 . . . . 0.0 110.363 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 73.1 mttt -72.54 -51.54 19.46 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.711 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.547 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.1 pt20 -70.7 -42.4 70.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.547 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.5 mmm180 -74.59 -43.85 53.61 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 111.084 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.684 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 50.6 m-85 -135.2 -39.48 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.658 -1.276 . . . . 0.0 111.986 -169.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.524 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.5 t30 -161.03 105.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.716 -1.24 . . . . 0.0 111.588 -168.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 42.0 mt -57.57 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.899 -1.125 . . . . 0.0 109.075 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.512 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.7 tpt85 -135.09 163.73 29.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.006 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -134.03 -156.25 0.72 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.903 -1.123 . . . . 0.0 110.457 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 46.7 ptt85 -97.4 161.43 13.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.505 0.669 . . . . 0.0 110.717 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -128.08 41.77 3.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.305 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.946 HG21 ' CE1' ' A' ' 374' ' ' PHE . 88.5 t -73.49 -49.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.413 -0.804 . . . . 0.0 110.464 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -69.16 -23.87 64.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 111.073 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -31.94 31.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 109.691 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.989 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.2 mt -101.57 -3.61 28.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 110.554 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 367' ' ' VAL . 2.5 m-70 63.74 53.93 1.91 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.931 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -96.72 175.01 6.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.6 m -117.45 135.14 54.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.57 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.946 ' CE1' HG21 ' A' ' 367' ' ' VAL . 93.0 m-85 -90.28 143.11 27.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.653 HG21 HD21 ' A' ' 387' ' ' ASN . 19.8 t -116.68 101.23 53.66 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.973 . . . . 0.0 109.608 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.13 151.53 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.034 1.544 . . . . 0.0 110.603 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.1 t80 -64.43 132.0 48.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.84 . . . . 0.0 109.664 175.694 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 71.1 mtt85 . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.558 0.694 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.825 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.4 ptp -158.18 167.65 29.21 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.236 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.8 p -155.38 165.19 37.38 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.58 -165.55 33.83 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.618 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.774 HD11 HG22 ' A' ' 367' ' ' VAL . 1.5 tt -140.21 149.51 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.631 -0.923 . . . . 0.0 110.104 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.653 HD21 HG21 ' A' ' 375' ' ' VAL . 31.3 m-20 -127.23 134.62 50.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 109.756 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.989 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -139.82 154.87 24.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.875 -1.141 . . . . 0.0 109.381 171.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 89.8 m-20 -25.53 -63.09 0.06 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.407 0.622 . . . . 0.0 112.251 172.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.453 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 51.2 t30 -91.62 -7.76 49.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 111.692 -168.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.561 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.3 mtp180 -144.7 144.65 31.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.636 -1.29 . . . . 0.0 110.536 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.93 110.46 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.871 -1.143 . . . . 0.0 109.067 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 339' ' ' LEU . 8.7 mt -131.3 145.91 34.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 110.201 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 49.6 mtt-85 -134.94 160.95 36.66 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.834 175.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.521 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.52 128.74 33.93 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.582 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -157.03 174.31 34.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.4 m -57.27 151.09 16.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.934 -1.333 . . . . 0.0 108.597 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.12 HG21 HG11 ' A' ' 420' ' ' VAL . 60.1 t -56.62 -35.1 43.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.075 -1.016 . . . . 0.0 109.894 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.3 t70 -63.03 -46.13 89.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.306 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.825 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.82 -51.82 36.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.985 -1.072 . . . . 0.0 110.482 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.582 HD11 ' N ' ' A' ' 396' ' ' GLY . 36.7 mm -63.51 -42.77 97.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 121.126 -0.984 . . . . 0.0 110.64 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.624 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 9.1 ttt180 -60.24 -43.21 96.26 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 52.1 mtp85 -61.62 -35.86 79.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.052 -1.03 . . . . 0.0 109.562 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.505 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.45 -37.72 83.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.187 -0.945 . . . . 0.0 111.269 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.517 ' CG2' HG11 ' A' ' 434' ' ' VAL . 59.5 t -65.66 -47.7 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.558 -1.339 . . . . 0.0 110.16 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.1 -34.98 78.77 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.795 -1.19 . . . . 0.0 110.28 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -35.92 79.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.505 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.2 m-80 -61.53 -27.47 68.63 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.159 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.43 19.69 29.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.85 -169.38 16.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.445 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.8 m-70 -143.31 153.52 42.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.094 -1.239 . . . . 0.0 111.488 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.624 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 7.5 p90 -107.5 150.27 39.88 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.772 -0.58 . . . . 0.0 110.202 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.828 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.75 123.14 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.904 1.476 . . . . 0.0 110.495 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.82 -32.6 73.99 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.098 -1.002 . . . . 0.0 111.026 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.6 m-20 -61.96 -32.88 73.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.896 -1.128 . . . . 0.0 108.844 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.035 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.3 t -83.6 -42.4 17.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.999 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 67.9 m-20 -55.39 -37.13 67.17 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.616 171.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.0 mt-30 -63.75 -48.76 75.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.337 -1.477 . . . . 0.0 110.099 171.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.531 ' CD ' HG21 ' A' ' 323' ' ' ILE . 95.9 mttt -57.22 -34.7 68.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.68 -1.262 . . . . 0.0 110.355 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.12 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.5 -40.76 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 0.0 109.257 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -66.81 -36.74 83.07 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.873 0.844 . . . . 0.0 109.448 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 83.9 mt-30 -67.48 -36.66 81.56 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.622 -0.673 . . . . 0.0 110.472 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 428' ' ' ALA . 71.0 t -62.97 -37.89 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 110.029 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.86 -40.16 83.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.335 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -69.07 -31.06 69.54 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.287 -0.883 . . . . 0.0 110.942 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.25 -3.02 57.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.808 176.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.6 21.94 27.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.763 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.43 161.62 14.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -1.097 . . . . 0.0 109.478 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 445' ' ' LEU . 28.2 m -109.02 107.22 59.84 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.03 . . . . 0.0 109.703 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.546 ' CG ' HG13 ' A' ' 420' ' ' VAL . 39.0 Cg_endo -76.26 107.94 2.56 Favored 'Trans proline' 0 C--N 1.298 -2.09 0 O-C-N 123.924 1.486 . . . . 0.0 110.643 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.903 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.0 mt -93.04 134.43 35.19 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.825 -1.172 . . . . 0.0 108.677 167.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 1.009 ' CG2' HG22 ' A' ' 398' ' ' VAL . 91.3 t -100.74 134.93 39.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 120.72 -1.238 . . . . 0.0 109.504 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.741 ' CG1' HD11 ' A' ' 440' ' ' LEU . 45.2 t -115.38 137.02 50.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.8 m -117.56 159.59 17.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.373 -0.829 . . . . 0.0 109.676 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.553 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.17 132.45 35.98 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.28 -129.3 31.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.498 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.93 11.87 27.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -1.218 . . . . 0.0 110.945 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -126.18 170.89 11.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.697 -1.252 . . . . 0.0 109.908 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.837 ' HA ' HG12 ' A' ' 434' ' ' VAL . 22.7 t -90.3 134.77 28.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.342 -0.849 . . . . 0.0 109.874 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.77 -22.12 18.28 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.85 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.986 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.11 176.6 38.71 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.997 169.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.046 HG21 HG23 ' A' ' 420' ' ' VAL . 48.0 t -107.77 141.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.216 -1.167 . . . . 0.0 109.887 173.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.721 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.3 mt -101.31 111.71 31.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 108.987 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.531 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.22 119.39 31.8 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.85 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.903 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.25 143.22 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 10.5 mtmt . . . . . 0 C--N 1.3 -1.562 0 O-C-N 120.619 -1.301 . . . . 0.0 110.984 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 80.6 mt-30 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.179 0.514 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.721 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.66 136.63 57.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.957 -1.09 . . . . 0.0 109.889 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -121.24 -34.5 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.484 ' N ' HD11 ' A' ' 355' ' ' LEU . 46.5 tt0 -165.61 147.04 7.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.182 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.016 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 12.9 p90 -136.51 147.66 47.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.827 -1.17 . . . . 0.0 111.663 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.528 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -118.85 144.13 35.07 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.728 -0.607 . . . . 0.0 109.593 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.53 143.85 39.17 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.76 1.4 . . . . 0.0 111.521 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.041 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.39 152.48 42.0 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 108.818 165.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.407 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 10.8 tp60 -58.32 128.55 37.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.682 -1.261 . . . . 0.0 110.126 -172.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.98 -0.77 44.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.4 t -136.49 139.92 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.481 . . . . 0.0 110.73 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.459 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.0 m-20 -74.12 152.48 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 86.1 tt0 -62.61 -40.23 96.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.487 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -59.18 -43.29 92.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.57 -1.331 . . . . 0.0 109.63 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.525 HG21 HG13 ' A' ' 328' ' ' VAL . 94.1 m -55.73 -43.55 76.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.857 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 1.001 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.8 tp -59.71 -40.17 87.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.251 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.016 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -66.59 -40.79 89.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.92 -1.112 . . . . 0.0 110.917 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 82.3 m-20 -64.62 -50.2 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.895 -1.128 . . . . 0.0 109.766 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 1.012 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.7 -30.79 70.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.951 -1.093 . . . . 0.0 109.636 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.42 -35.54 65.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.103 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.561 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.3 mt-30 -73.43 -55.69 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.551 -0.718 . . . . 0.0 111.06 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.057 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.97 -35.72 81.1 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.559 -1.257 . . . . 0.0 109.894 -172.018 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.524 ' HB1' ' HG2' ' A' ' 395' ' ' LYS . . . -66.72 -20.73 66.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.088 -1.007 . . . . 0.0 110.053 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.649 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.2 p -107.03 8.84 30.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.121 -0.987 . . . . 0.0 111.579 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 41.4 mt -66.5 -44.47 82.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.531 -1.355 . . . . 0.0 109.584 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.76 1.0 50.36 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.478 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.67 130.53 44.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.714 -1.241 . . . . 0.0 109.979 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.62 5.61 51.03 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.511 0.672 . . . . 0.0 109.845 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.35 150.17 79.69 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.652 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -53.68 -38.21 84.37 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.678 1.357 . . . . 0.0 109.172 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.23 -28.55 69.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 110.393 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.82 -36.93 67.51 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.53 ' O ' HD12 ' A' ' 354' ' ' ILE . 42.2 mmt180 -76.65 -37.93 55.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.118 -1.225 . . . . 0.0 110.525 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.41 -38.17 86.14 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.962 -1.086 . . . . 0.0 110.372 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.5 HG23 HD13 ' A' ' 443' ' ' ILE . 86.0 mt -68.55 -49.42 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.005 -1.059 . . . . 0.0 110.594 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.649 HG22 ' OG ' ' A' ' 341' ' ' SER . 23.9 t -60.56 -33.67 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.1 mt -72.23 -33.3 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.689 -1.257 . . . . 0.0 110.68 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.003 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.57 -40.8 88.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -61.92 -43.1 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 110.273 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 83.3 mttt -69.64 -48.73 58.87 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.745 -174.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 18.3 pt20 -70.75 -43.46 68.78 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 110.499 -173.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.2 mmm180 -73.98 -46.09 45.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 111.312 -173.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 330' ' ' GLU . 27.8 m-85 -135.67 -35.97 0.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.666 -167.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.536 ' ND2' ' HD3' ' A' ' 363' ' ' ARG . 55.9 t-20 -158.59 93.89 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.512 -1.368 . . . . 0.0 111.808 -169.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -61.35 95.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.987 -1.07 . . . . 0.0 110.178 172.087 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.536 ' HD3' ' ND2' ' A' ' 361' ' ' ASN . 30.8 ptt85 -150.01 -179.06 6.86 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 363' ' ' ARG . 22.2 pt-20 -124.78 -157.39 0.77 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 110.531 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 40.9 ptt180 -90.62 165.59 13.65 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.743 -0.598 . . . . 0.0 110.492 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -123.99 38.63 4.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.422 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.022 HG21 ' CE1' ' A' ' 374' ' ' PHE . 43.9 t -74.34 -49.82 30.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 110.376 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -67.75 -25.1 65.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 111.039 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.08 -30.09 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.99 . . . . 0.0 109.8 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 1.0 ' HB3' HD11 ' A' ' 388' ' ' ILE . 19.3 mt -103.65 -4.19 24.12 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 110.672 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 31.1 m80 62.84 53.94 2.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.427 -0.796 . . . . 0.0 110.168 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.923 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.9 175.03 6.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 110.606 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.9 m -116.67 134.27 55.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.022 ' CE1' HG21 ' A' ' 367' ' ' VAL . 84.2 m-85 -88.89 147.96 24.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 25.9 t -122.93 100.97 39.61 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.13 -0.981 . . . . 0.0 109.604 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.64 151.15 40.39 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.983 1.518 . . . . 0.0 110.475 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.16 131.55 46.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 110.07 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 175.687 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.523 0.678 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.644 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.4 ptp -161.0 169.34 22.75 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.408 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 5.2 p -156.88 165.3 36.57 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.78 -165.18 33.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.859 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.3 tt -138.82 149.08 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.698 -0.884 . . . . 0.0 110.125 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.462 HD21 HG21 ' A' ' 375' ' ' VAL . 31.6 m-20 -127.79 135.15 49.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 109.654 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 1.0 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -140.06 154.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.875 -1.14 . . . . 0.0 109.389 171.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.6 -63.17 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.434 0.635 . . . . 0.0 112.242 172.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 40.8 t-20 -91.66 -7.89 48.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.51 -0.744 . . . . 0.0 111.755 -168.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 31.2 mtp180 -144.19 145.67 32.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.707 -1.246 . . . . 0.0 110.605 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.4 mtt -135.49 110.8 9.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.903 -1.123 . . . . 0.0 108.999 169.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.057 HD12 HD11 ' A' ' 339' ' ' LEU . 8.9 mt -130.35 146.13 34.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.989 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.519 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.4 mmt85 -134.13 159.69 40.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.109 -0.994 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.691 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -132.61 137.55 47.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.484 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -164.37 174.36 40.42 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.267 -1.444 . . . . 0.0 109.625 -173.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -56.94 149.93 17.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.278 . . . . 0.0 108.684 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.08 HG21 HG11 ' A' ' 420' ' ' VAL . 22.8 t -55.03 -37.62 43.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 109.975 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.7 m-20 -64.24 -44.35 92.12 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.221 -0.924 . . . . 0.0 110.343 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.644 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.21 -50.24 55.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.963 -1.085 . . . . 0.0 110.662 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.587 HD13 ' CE ' ' A' ' 383' ' ' MET . 30.9 mm -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.746 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.5 ttp85 -59.85 -42.92 94.68 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.1 mtt180 -61.47 -36.3 80.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.576 173.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.489 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.5 t-80 -66.61 -38.5 87.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 111.245 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.512 ' CG2' HG11 ' A' ' 434' ' ' VAL . 71.3 t -65.47 -47.28 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.623 -1.298 . . . . 0.0 110.268 178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.48 -34.8 78.56 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.785 -1.197 . . . . 0.0 110.436 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.933 -1.104 . . . . 0.0 109.951 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.489 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 27.1 m-80 -62.04 -27.1 68.65 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.26 18.93 31.94 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -169.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -111.58 -169.95 18.73 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.426 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.9 m-70 -144.1 153.69 42.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -1.223 . . . . 0.0 111.461 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.593 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 7.7 p90 -108.88 150.43 40.86 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.719 -0.613 . . . . 0.0 110.143 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.82 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.9 124.01 8.36 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.845 1.445 . . . . 0.0 110.488 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.32 -32.77 73.95 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.928 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.8 m-20 -61.65 -32.84 73.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.863 -1.148 . . . . 0.0 108.872 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.041 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.0 t -83.76 -42.55 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.391 -0.818 . . . . 0.0 110.975 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.581 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 68.8 m-20 -55.17 -37.2 66.72 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.584 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.8 mm-40 -63.94 -48.76 75.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.254 -1.529 . . . . 0.0 110.232 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.528 ' CD ' HG21 ' A' ' 323' ' ' ILE . 43.2 mttt -57.56 -34.27 69.02 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.638 -1.289 . . . . 0.0 110.416 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.08 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.21 -41.24 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.206 171.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -66.46 -36.22 82.22 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.921 0.867 . . . . 0.0 109.418 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.45 -37.63 83.25 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 110.798 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.8 t -63.31 -37.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.005 -1.059 . . . . 0.0 110.088 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.12 84.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.329 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -68.51 -31.18 70.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.394 -0.816 . . . . 0.0 110.889 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.507 ' NE2' ' HE2' ' A' ' 446' ' ' LYS . 2.0 tt0 -82.59 -3.01 55.42 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.852 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.85 27.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.67 163.18 13.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -1.064 . . . . 0.0 109.64 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.493 ' HB ' HD12 ' A' ' 445' ' ' LEU . 53.7 m -110.12 107.12 58.66 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.809 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.578 ' CG ' HG13 ' A' ' 420' ' ' VAL . 37.5 Cg_endo -75.82 108.22 2.64 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 123.979 1.515 . . . . 0.0 110.773 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.856 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.3 mt -92.71 135.05 34.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.854 -1.154 . . . . 0.0 108.599 166.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.968 ' CG2' HG22 ' A' ' 398' ' ' VAL . 97.9 t -100.08 136.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.651 -1.28 . . . . 0.0 109.568 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.705 ' CG1' HD11 ' A' ' 440' ' ' LEU . 44.5 t -117.33 136.96 52.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 108.992 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -117.75 160.03 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.532 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.07 132.08 35.7 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -128.65 31.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.503 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.11 11.36 27.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.185 -1.185 . . . . 0.0 110.968 -179.573 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -123.45 170.78 10.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.633 -1.292 . . . . 0.0 109.925 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 434' ' ' VAL . 22.5 t -91.39 134.03 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.7 pp -94.79 -21.71 18.54 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.862 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 1.001 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.99 177.02 38.97 Favored Glycine 0 N--CA 1.499 2.896 0 C-N-CA 118.847 -1.644 . . . . 0.0 110.985 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.045 HG21 HG23 ' A' ' 420' ' ' VAL . 47.1 t -107.78 142.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.183 -1.187 . . . . 0.0 109.819 173.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.652 HD11 ' CB ' ' A' ' 337' ' ' ALA . 80.1 mt -101.29 111.28 30.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 108.94 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.55 118.93 31.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.99 -1.069 . . . . 0.0 109.7 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.856 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -99.72 143.43 29.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.089 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.507 ' HE2' ' NE2' ' A' ' 426' ' ' GLN . 53.1 mttt . . . . . 0 C--N 1.3 -1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 111.146 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 14.4 pt20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.188 0.518 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 355' ' ' LEU . . . -60.75 137.59 58.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.636 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -118.49 -35.79 3.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.479 ' N ' HD11 ' A' ' 355' ' ' LEU . 49.6 tt0 -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 110.121 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.008 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.3 p90 -135.69 142.76 45.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.821 -1.174 . . . . 0.0 111.676 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.525 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.6 mp -114.38 144.59 32.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.725 -0.61 . . . . 0.0 109.706 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.72 143.49 37.64 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.738 1.388 . . . . 0.0 111.448 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.051 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.94 152.0 42.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.821 165.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 23.7 tp60 -57.59 128.61 37.9 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 110.11 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.17 -1.33 43.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.6 t -136.56 140.03 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.706 -1.467 . . . . 0.0 110.751 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.23 152.42 39.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 85.1 tt0 -62.3 -40.33 95.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.459 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.2 -43.33 92.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.6 -1.313 . . . . 0.0 109.639 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.519 HG21 HG13 ' A' ' 328' ' ' VAL . 93.7 m -55.97 -43.81 77.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 173.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 1.007 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.9 tp -59.21 -39.45 82.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.319 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.16 -41.31 86.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.11 . . . . 0.0 110.777 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.554 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.3 m-20 -63.87 -50.03 70.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.926 -1.109 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.49 -31.13 70.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.981 -1.074 . . . . 0.0 109.722 176.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.749 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.21 -35.66 65.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.912 172.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.569 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.6 mt-30 -74.77 -55.84 5.42 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.583 -0.698 . . . . 0.0 110.9 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -63.72 -34.46 77.93 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.846 -171.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.458 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.04 -21.4 65.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.934 -1.104 . . . . 0.0 110.076 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.707 ' OG ' HG22 ' A' ' 353' ' ' VAL . 77.3 p -107.27 10.4 29.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.16 -0.963 . . . . 0.0 111.538 -174.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.573 ' CG ' ' HA ' ' A' ' 339' ' ' LEU . 45.9 mt -66.34 -43.78 85.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.55 -1.344 . . . . 0.0 109.502 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.25 0.38 48.09 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.931 -170.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.3 p30 -62.37 130.44 45.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.742 -1.224 . . . . 0.0 109.872 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.54 5.39 51.66 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.6 0.714 . . . . 0.0 109.886 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.45 151.91 83.31 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.52 -0.737 . . . . 0.0 109.451 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.64 -39.53 90.54 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.643 1.338 . . . . 0.0 109.09 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.56 -27.83 69.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.503 -0.748 . . . . 0.0 110.436 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.66 -37.94 70.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.567 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.2 mtt-85 -76.14 -36.59 58.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.018 -1.284 . . . . 0.0 110.376 172.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 29.3 p -62.72 -37.22 85.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.957 -1.089 . . . . 0.0 110.377 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.607 HG23 HD13 ' A' ' 443' ' ' ILE . 87.6 mt -68.53 -49.48 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.536 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.707 HG22 ' OG ' ' A' ' 341' ' ' SER . 26.2 t -61.24 -33.61 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 0.0 110.148 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.9 mt -72.2 -32.9 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.601 -1.312 . . . . 0.0 110.523 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.947 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.43 -40.21 90.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.832 -1.168 . . . . 0.0 110.528 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.487 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.03 -43.18 99.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 77.3 mttt -71.65 -48.53 47.13 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.769 -175.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.549 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -70.26 -42.8 71.69 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.587 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.3 mmm180 -74.23 -46.51 41.25 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 111.214 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.548 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 76.4 m-85 -136.28 -34.45 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.252 -1.379 . . . . 0.0 112.564 -169.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.497 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 18.0 t-20 -160.11 98.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.441 -1.412 . . . . 0.0 111.763 -168.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.781 HD12 ' H ' ' A' ' 362' ' ' LEU . 5.5 mp -58.96 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.029 -1.045 . . . . 0.0 109.705 171.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.5 tpt180 -142.15 163.45 32.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.86 . . . . 0.0 109.344 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.0 mt-10 -127.37 -153.81 0.59 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.01 -1.056 . . . . 0.0 110.629 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.573 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.2 ptt-85 -95.51 163.58 13.16 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.638 -0.664 . . . . 0.0 110.733 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -128.19 40.71 3.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.553 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.927 HG11 ' CE2' ' A' ' 374' ' ' PHE . 61.6 t -73.47 -46.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.192 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.79 -26.6 66.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.465 -0.772 . . . . 0.0 111.11 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.44 -30.66 29.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.107 -0.995 . . . . 0.0 109.745 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.789 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.6 mt -101.41 -3.96 27.76 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.541 -0.724 . . . . 0.0 110.636 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 367' ' ' VAL . 50.7 m80 59.3 52.51 5.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.957 . . . . 0.0 109.795 -175.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.835 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.61 174.6 7.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 110.378 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.9 m -116.38 134.94 54.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 110.473 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.927 ' CE2' HG11 ' A' ' 367' ' ' VAL . 88.0 m-85 -89.73 147.39 23.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.441 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 40.1 t -120.33 101.18 46.96 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.5 Cg_endo -54.54 153.7 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.003 1.528 . . . . 0.0 110.545 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.556 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.7 t80 -70.68 134.8 47.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.829 . . . . 0.0 110.383 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.855 . . . . 0.0 109.832 174.454 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.515 0.674 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.891 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.9 ptp -165.45 170.98 13.86 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.795 0.807 . . . . 0.0 111.287 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.6 p -155.54 165.53 36.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.509 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.29 -164.28 31.6 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.756 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.723 HD11 HG22 ' A' ' 367' ' ' VAL . 2.2 tt -142.45 149.48 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.623 -0.928 . . . . 0.0 110.154 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.44 HD21 HG21 ' A' ' 375' ' ' VAL . 39.3 m-20 -127.29 136.32 51.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 109.755 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.789 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -140.8 155.24 22.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.993 -1.067 . . . . 0.0 109.221 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.5 m-20 -21.96 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.452 0.644 . . . . 0.0 112.62 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.9 t-20 -95.99 -7.01 37.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.449 -0.782 . . . . 0.0 111.858 -167.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.555 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 29.8 mtp180 -143.64 146.18 33.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.661 -1.275 . . . . 0.0 110.639 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -136.15 104.3 5.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.863 -1.148 . . . . 0.0 109.119 170.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 339' ' ' LEU . 8.0 mt -125.05 146.07 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.996 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 23.6 mmt85 -134.29 159.55 40.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.011 . . . . 0.0 110.324 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.563 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.43 126.03 30.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.684 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.42 174.33 31.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.9 m -56.21 151.33 12.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.973 -1.31 . . . . 0.0 108.646 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.041 HG21 HG11 ' A' ' 420' ' ' VAL . 23.0 t -54.57 -37.65 39.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.915 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.2 m-20 -64.62 -44.99 88.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.3 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.891 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.14 -48.95 66.52 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.944 -1.097 . . . . 0.0 110.635 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.684 HD11 ' N ' ' A' ' 396' ' ' GLY . 39.9 mm -66.53 -44.31 90.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.029 -1.045 . . . . 0.0 111.007 -176.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HD2' ' CZ ' ' A' ' 412' ' ' PHE . 9.3 ttp180 -59.52 -43.08 93.53 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 92.2 mtt180 -61.69 -37.05 82.68 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.04 -1.038 . . . . 0.0 109.579 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.2 t-80 -67.3 -36.47 81.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 111.273 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 437' ' ' SER . 54.7 t -65.54 -49.13 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.6 -1.313 . . . . 0.0 110.161 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.47 -34.34 77.55 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.943 -1.098 . . . . 0.0 110.371 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.74 78.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.111 . . . . 0.0 109.982 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 18.0 m-80 -62.08 -27.05 68.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.429 -0.794 . . . . 0.0 109.155 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.83 19.35 29.39 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.89 -169.66 16.88 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.434 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.7 m-70 -143.09 153.36 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.139 -1.212 . . . . 0.0 111.395 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.587 ' CZ ' ' HD2' ' A' ' 402' ' ' ARG . 7.9 p90 -108.17 149.32 39.04 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.635 -0.665 . . . . 0.0 110.182 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.815 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.1 125.14 9.06 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.873 1.459 . . . . 0.0 110.531 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.09 -32.32 72.55 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.478 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.6 m-20 -63.24 -31.81 73.06 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.878 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.051 HG21 ' HA ' ' A' ' 325' ' ' ALA . 46.6 t -83.57 -42.77 17.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.88 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.58 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 69.1 m-20 -55.08 -36.34 65.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.729 -1.232 . . . . 0.0 109.648 171.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.39 -50.13 68.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.434 -1.416 . . . . 0.0 109.639 173.209 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 85.9 mttt -56.83 -34.53 67.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.757 -1.215 . . . . 0.0 110.286 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.101 HG23 HG21 ' A' ' 442' ' ' VAL . 2.5 t -58.99 -41.6 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 171.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.07 -36.18 82.52 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.955 0.883 . . . . 0.0 109.409 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 95.5 mm-40 -67.25 -38.25 84.86 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.725 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.809 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.2 t -62.61 -37.13 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.074 . . . . 0.0 110.125 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.29 84.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -68.18 -32.38 72.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 0.0 110.983 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -82.73 -2.89 55.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.77 22.56 30.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.809 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.19 163.5 12.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -1.143 . . . . 0.0 109.538 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.772 ' HB ' HD12 ' A' ' 445' ' ' LEU . 18.5 m -110.5 107.0 58.26 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.058 -1.026 . . . . 0.0 109.855 -175.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.566 ' CG ' HG13 ' A' ' 420' ' ' VAL . 33.6 Cg_endo -74.82 107.93 2.59 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 O-C-N 123.984 1.518 . . . . 0.0 110.73 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.864 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.3 mt -92.69 132.76 36.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 108.509 166.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.904 ' CG2' HG22 ' A' ' 398' ' ' VAL . 99.8 t -100.04 134.98 37.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 O-C-N 120.746 -1.222 . . . . 0.0 109.512 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.822 ' CG1' HD11 ' A' ' 440' ' ' LEU . 40.8 t -114.73 138.46 44.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.116 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -119.56 160.55 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 109.655 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.477 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.34 129.64 33.74 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.2 -131.79 30.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -167.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.561 ' O ' HG13 ' A' ' 405' ' ' VAL . 79.6 p -102.93 7.75 39.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -1.23 . . . . 0.0 111.071 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -118.4 170.71 8.69 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.647 -1.283 . . . . 0.0 110.127 -175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 24.6 t -93.58 134.48 31.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.336 -0.853 . . . . 0.0 109.719 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -95.3 -21.72 18.23 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.772 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 1.007 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.7 176.77 39.16 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.003 169.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.101 HG21 HG23 ' A' ' 420' ' ' VAL . 44.4 t -107.74 141.45 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.153 -1.204 . . . . 0.0 109.923 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.749 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.7 mt -101.45 111.06 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 108.986 170.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.94 119.35 31.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.956 -1.09 . . . . 0.0 109.801 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.864 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -100.09 142.75 31.14 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.694 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.0 mttt . . . . . 0 C--N 1.298 -1.653 0 O-C-N 120.848 -1.158 . . . . 0.0 111.078 -178.199 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.558 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.9 tt0 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.136 0.493 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.79 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -57.05 139.76 51.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.1 -1.0 . . . . 0.0 109.946 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.512 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 74.5 m -122.69 -36.71 2.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.502 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.5 tt0 -165.7 150.82 8.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.054 -1.029 . . . . 0.0 110.184 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.038 ' CD1' HD21 ' A' ' 355' ' ' LEU . 13.4 p90 -135.13 158.26 44.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.839 -1.163 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.7 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.2 mp -134.17 139.04 31.85 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.552 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.11 144.82 53.32 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.65 1.342 . . . . 0.0 111.824 -171.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.045 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -69.32 152.47 44.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 108.768 165.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.404 ' H ' ' CB ' ' A' ' 413' ' ' PRO . 23.6 tp60 -57.79 128.99 39.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.658 -1.276 . . . . 0.0 110.269 -172.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 109.54 -21.39 26.12 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.943 HG21 ' HA ' ' A' ' 440' ' ' LEU . 53.3 t -114.0 138.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.393 . . . . 0.0 110.907 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.469 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.0 m-20 -72.21 145.08 48.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 109.891 173.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.565 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.3 tt0 -59.87 -34.01 72.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.917 -1.114 . . . . 0.0 109.868 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.51 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.51 -42.41 87.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 109.25 175.125 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 99.5 m -61.59 -42.76 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.3 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.961 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.28 -39.8 88.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.451 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.973 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.74 -43.3 80.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.083 . . . . 0.0 110.772 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.552 ' O ' HD23 ' A' ' 339' ' ' LEU . 47.8 t0 -63.41 -49.9 71.93 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.912 -1.117 . . . . 0.0 110.055 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.929 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.88 -31.02 70.53 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.762 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.8 -35.78 66.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.079 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.0 mt-30 -73.3 -55.75 5.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.565 -0.709 . . . . 0.0 110.996 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.075 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -65.1 -33.83 76.96 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.205 -171.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.52 -20.89 65.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.067 173.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.2 p -107.29 10.65 29.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.225 -0.922 . . . . 0.0 111.521 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.3 mt -66.66 -45.48 78.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.546 -1.346 . . . . 0.0 109.73 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.59 0.14 49.53 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.986 -171.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.473 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.0 p30 -62.93 130.66 45.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.214 . . . . 0.0 109.898 176.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.67 5.32 51.73 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.516 0.674 . . . . 0.0 109.864 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 346' ' ' THR . 2.8 p -76.05 150.87 83.69 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 109.467 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.51 -38.32 83.34 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.708 1.373 . . . . 0.0 109.132 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.53 -28.6 69.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.404 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.27 -37.83 75.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -77.29 -38.64 50.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.095 -1.238 . . . . 0.0 110.631 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.8 m -62.35 -37.8 87.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.919 -1.113 . . . . 0.0 110.466 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.695 HG23 HD13 ' A' ' 443' ' ' ILE . 87.9 mt -68.13 -48.66 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.936 -1.103 . . . . 0.0 110.492 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.635 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.4 t -60.62 -33.17 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.23 . . . . 0.0 109.772 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.498 HG22 ' OE1' ' A' ' 358' ' ' GLN . 38.7 mt -72.76 -31.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.79 -1.194 . . . . 0.0 110.722 171.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.038 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.9 -41.5 91.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.866 -1.146 . . . . 0.0 110.242 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.526 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.36 -43.18 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 110.422 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.953 ' HB3' HD23 ' A' ' 362' ' ' LEU . 78.8 mttt -72.08 -51.23 22.58 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.635 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -71.17 -42.61 68.86 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.508 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.552 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.5 mmt180 -73.66 -44.31 57.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 111.101 -172.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 81.6 m-85 -135.31 -37.57 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.623 -1.298 . . . . 0.0 112.159 -169.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.521 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 60.9 t-20 -162.68 105.38 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.489 -1.382 . . . . 0.0 111.55 -168.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.953 HD23 ' HB3' ' A' ' 357' ' ' LYS . 46.9 mt -57.56 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.858 -1.151 . . . . 0.0 109.056 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 335' ' ' ASP . 56.5 ttt180 -129.21 168.14 16.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.449 ' N ' ' HG2' ' A' ' 363' ' ' ARG . 87.5 mt-10 -139.69 -157.82 0.8 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.8 ptt-85 -98.1 165.45 11.89 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.627 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.814 ' O ' HD12 ' A' ' 370' ' ' LEU . 89.9 m-20 -131.47 42.47 3.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 110.56 175.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.081 HG21 ' CE1' ' A' ' 374' ' ' PHE . 47.6 t -72.19 -45.77 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 0.0 110.152 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.34 -23.91 64.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.862 . . . . 0.0 111.166 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -31.85 30.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.778 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 366' ' ' ASP . 9.3 mt -104.42 -2.77 24.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.536 -0.727 . . . . 0.0 110.624 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 367' ' ' VAL . 81.7 m-70 59.25 52.37 6.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.698 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.781 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -91.79 174.49 7.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 110.308 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.6 m -118.46 135.5 54.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.478 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.081 ' CE1' HG21 ' A' ' 367' ' ' VAL . 90.8 m-85 -90.36 145.22 25.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 9.1 t -118.45 101.36 51.04 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.776 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.8 Cg_endo -54.72 154.23 21.47 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.079 1.568 . . . . 0.0 110.524 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.58 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.1 t80 -69.66 134.64 48.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.37 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 174.841 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.505 0.669 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.936 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.1 ptp -165.15 171.26 13.96 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.822 0.82 . . . . 0.0 111.225 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 47.9 p -155.92 165.32 36.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.58 -165.57 34.3 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.704 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 367' ' ' VAL . 4.5 tt -139.82 152.57 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.902 . . . . 0.0 110.232 -175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -127.24 138.4 53.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.045 -1.034 . . . . 0.0 109.458 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.744 ' CD1' HD13 ' A' ' 370' ' ' LEU . 1.7 tt -140.85 154.36 21.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.842 -1.161 . . . . 0.0 109.362 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.267 89.0 m-20 -21.37 -61.83 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.438 0.637 . . . . 0.0 112.53 172.669 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 51.9 t-20 -98.99 -7.14 27.34 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.512 -0.742 . . . . 0.0 111.901 -166.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 15.9 mtp180 -142.91 147.97 36.18 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.681 -1.262 . . . . 0.0 110.573 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.6 mtm -134.98 111.07 9.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.942 -1.099 . . . . 0.0 108.995 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.075 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -129.52 146.09 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.557 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 31.2 mtt85 -136.76 161.92 34.63 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.16 -0.962 . . . . 0.0 111.035 176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.536 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.88 128.24 32.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.326 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.637 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.78 174.34 32.34 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 37.7 m -56.49 150.98 14.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.848 -1.384 . . . . 0.0 108.526 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.045 HG21 ' CG1' ' A' ' 420' ' ' VAL . 63.2 t -56.82 -35.33 46.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -0.999 . . . . 0.0 109.81 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.473 ' OD1' ' HD2' ' A' ' 403' ' ' ARG . 55.2 t0 -63.07 -46.75 85.97 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.315 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.936 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.18 -49.13 65.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.065 -1.022 . . . . 0.0 110.514 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.637 HD11 ' N ' ' A' ' 396' ' ' GLY . 41.7 mm -66.41 -43.84 90.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.099 -1.001 . . . . 0.0 110.931 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.595 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 7.8 ttp180 -59.86 -43.58 94.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.211 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.473 ' HD2' ' OD1' ' A' ' 399' ' ' ASP . 14.6 mtp-105 -61.8 -36.54 81.41 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.459 173.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.557 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 3.0 t-80 -68.69 -35.55 77.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.231 -0.918 . . . . 0.0 111.378 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 437' ' ' SER . 52.1 t -66.06 -50.42 69.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.533 -1.354 . . . . 0.0 110.171 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.966 -1.084 . . . . 0.0 110.37 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.26 76.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.924 -1.11 . . . . 0.0 110.085 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.547 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.9 m-80 -62.58 -26.81 68.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.132 174.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 98.12 17.83 28.56 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.43 -169.04 16.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.485 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.2 m-70 -142.87 153.62 43.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.112 -1.228 . . . . 0.0 111.351 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.595 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 9.5 p90 -105.82 147.64 35.1 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.272 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.85 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.95 123.95 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.808 1.425 . . . . 0.0 110.407 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.15 -32.73 74.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 111.033 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.9 m-20 -61.92 -33.04 73.53 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 0.0 108.963 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.045 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.8 t -83.63 -42.83 17.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.37 -0.832 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.4 m-20 -54.55 -37.46 65.46 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.76 -1.213 . . . . 0.0 109.507 171.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.5 mm-40 -63.38 -48.18 78.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.265 -1.522 . . . . 0.0 110.077 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.7 ' HD3' HG21 ' A' ' 323' ' ' ILE . 20.1 mttp -56.64 -35.24 68.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.072 HG23 HG21 ' A' ' 442' ' ' VAL . 2.4 t -59.78 -40.68 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.979 -1.075 . . . . 0.0 109.285 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.76 -36.25 82.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.842 0.829 . . . . 0.0 109.46 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -67.37 -36.81 82.1 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.63 -0.669 . . . . 0.0 110.62 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.769 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.0 t -62.88 -37.9 80.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.954 -1.091 . . . . 0.0 110.009 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.6 -40.01 84.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 0.0 110.385 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -68.11 -31.53 71.2 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.282 -0.886 . . . . 0.0 110.955 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.55 -3.11 55.47 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.783 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.51 22.14 29.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.769 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.34 163.48 12.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -1.079 . . . . 0.0 109.541 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.851 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.3 m -109.98 107.12 58.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.582 ' CG ' HG13 ' A' ' 420' ' ' VAL . 40.1 Cg_endo -75.79 108.28 2.65 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 123.97 1.511 . . . . 0.0 110.589 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.896 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.9 mt -92.81 134.77 34.74 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 108.598 167.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.953 ' CG2' HG22 ' A' ' 398' ' ' VAL . 96.8 t -100.7 134.27 41.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.754 -1.216 . . . . 0.0 109.428 176.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.771 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.5 t -114.82 137.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 176.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.1 m -118.09 160.27 17.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.413 -0.804 . . . . 0.0 109.721 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.483 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.39 130.77 35.39 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.07 -132.32 30.86 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 405' ' ' VAL . 82.9 p -102.75 7.52 39.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.081 -1.247 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -120.05 171.09 8.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.661 -1.275 . . . . 0.0 110.142 -175.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 26.0 t -92.25 133.4 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.418 -0.801 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.943 ' HA ' HG21 ' A' ' 328' ' ' VAL . 1.6 pp -92.93 -22.2 19.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.961 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.29 177.62 39.01 Favored Glycine 0 N--CA 1.5 2.939 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.987 169.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.072 HG21 HG23 ' A' ' 420' ' ' VAL . 51.2 t -107.81 142.95 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.22 -1.165 . . . . 0.0 110.075 174.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.762 HD11 ' HB1' ' A' ' 337' ' ' ALA . 75.8 mt -101.79 112.62 35.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 108.974 170.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.576 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -93.13 119.31 32.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.987 -1.071 . . . . 0.0 109.891 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.896 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -103.17 144.17 31.66 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.396 -0.815 . . . . 0.0 108.808 -175.451 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.512 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 16.2 mtmt . . . . . 0 C--N 1.3 -1.562 0 O-C-N 120.585 -1.322 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.2 mt-30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.113 0.482 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.773 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -59.93 138.64 57.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.07 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -122.31 -37.62 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 110.433 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.483 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.1 tt0 -162.84 148.32 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.187 -178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.078 ' CD1' HD21 ' A' ' 355' ' ' LEU . 14.1 p90 -133.95 142.88 47.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.803 -1.186 . . . . 0.0 111.704 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.568 HG21 ' CD ' ' A' ' 419' ' ' LYS . 4.4 mt -113.84 141.57 26.37 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.552 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.64 142.73 40.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.656 1.345 . . . . 0.0 111.528 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.062 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.83 151.13 45.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 108.856 165.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -57.46 128.88 39.28 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.744 -1.222 . . . . 0.0 110.098 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.66 -1.35 45.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.6 t -135.68 137.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.645 -1.503 . . . . 0.0 110.649 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.8 m-20 -72.74 150.44 42.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.4 tt0 -60.87 -38.04 84.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.0 OUTLIER -59.88 -40.3 88.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.929 -1.107 . . . . 0.0 109.224 177.376 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.546 HG21 HG13 ' A' ' 328' ' ' VAL . 98.9 m -60.51 -43.13 97.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 110.0 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.986 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.12 -38.43 83.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.373 -0.83 . . . . 0.0 110.502 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.971 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.75 -44.42 77.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.706 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.567 ' O ' HD23 ' A' ' 339' ' ' LEU . 89.9 m-20 -63.69 -48.74 75.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 110.017 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.921 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.61 -32.03 72.47 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.03 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.686 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.22 -36.0 65.5 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.011 172.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.2 mt-30 -74.1 -55.67 5.82 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.546 -0.721 . . . . 0.0 111.064 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.072 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.4 -33.96 77.07 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.066 -171.313 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.617 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.89 -20.31 65.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.982 -1.074 . . . . 0.0 109.991 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.594 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.3 p -107.62 10.42 29.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.134 -0.979 . . . . 0.0 111.502 -174.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.65 HD12 HD12 ' A' ' 386' ' ' ILE . 47.3 mt -66.53 -45.04 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.622 -1.299 . . . . 0.0 109.821 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.03 2.05 50.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.842 -170.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.485 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.9 p30 -65.09 130.29 42.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.798 -1.189 . . . . 0.0 110.061 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.7 4.47 52.97 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.574 0.702 . . . . 0.0 109.887 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 346' ' ' THR . 3.0 p -74.47 150.84 87.21 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.572 -0.705 . . . . 0.0 109.426 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.78 -40.74 78.96 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.723 1.381 . . . . 0.0 109.358 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.65 -28.07 69.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.1 -38.11 65.53 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.532 ' O ' HD12 ' A' ' 354' ' ' ILE . 68.5 mtt85 -77.4 -37.3 52.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.239 . . . . 0.0 110.501 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.2 m -61.36 -37.83 84.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.069 . . . . 0.0 110.324 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.664 HG23 HD13 ' A' ' 443' ' ' ILE . 83.1 mt -69.55 -49.38 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.631 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.594 HG22 ' OG ' ' A' ' 341' ' ' SER . 23.4 t -59.9 -32.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.865 -1.147 . . . . 0.0 109.813 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 350' ' ' ARG . 34.6 mt -72.74 -34.22 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 110.637 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.078 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.06 -40.25 80.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.817 -1.177 . . . . 0.0 110.239 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.02 -45.77 87.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 48.2 mtmt -72.02 -49.25 38.5 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.844 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.55 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 17.0 pt20 -70.87 -42.96 69.38 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.668 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 39.3 mmt180 -74.42 -45.36 47.04 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 111.145 -171.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 90.9 m-85 -135.57 -37.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.446 -1.301 . . . . 0.0 112.218 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.508 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 51.2 t30 -162.91 105.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.494 -1.379 . . . . 0.0 111.652 -168.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.5 OUTLIER -57.87 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.754 -1.216 . . . . 0.0 109.203 171.391 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.539 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.0 tpt180 -126.64 164.02 22.17 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 109.11 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 83.9 mt-10 -137.22 -159.38 0.95 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.933 -1.105 . . . . 0.0 110.369 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.8 ptt180 -97.69 163.82 12.66 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 110.586 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -130.87 42.13 3.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.366 -0.834 . . . . 0.0 110.544 175.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.022 HG21 ' CE1' ' A' ' 374' ' ' PHE . 64.8 t -73.52 -48.43 41.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.312 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.56 -26.09 66.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 111.067 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -30.14 27.91 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 176.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.985 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.6 mt -103.25 -4.0 24.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 110.731 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 367' ' ' VAL . 61.4 m-70 63.11 53.04 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.317 -0.864 . . . . 0.0 110.148 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.939 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.57 174.89 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.618 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.3 m -116.89 133.5 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.47 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.022 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.8 m-85 -87.67 143.42 27.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.472 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 387' ' ' ASN . 16.8 t -117.14 101.15 53.32 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 109.628 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.23 151.27 36.47 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.056 1.556 . . . . 0.0 110.55 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.7 t80 -62.32 130.86 47.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.038 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 176.859 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.9 mtt180 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.555 0.693 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.589 ' CE ' HD13 ' A' ' 401' ' ' ILE . 2.1 ptp -157.98 167.53 29.67 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.852 0.834 . . . . 0.0 111.174 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.65 165.26 36.49 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.8 -166.24 35.29 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.524 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.838 HD11 HG22 ' A' ' 367' ' ' VAL . 14.5 tt -139.51 150.75 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.634 -0.921 . . . . 0.0 110.176 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.64 HD21 HG21 ' A' ' 375' ' ' VAL . 37.8 m-20 -127.6 133.26 49.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 0.0 109.755 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.985 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -139.57 154.81 24.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.84 -1.162 . . . . 0.0 109.302 170.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 88.6 m-20 -25.62 -62.99 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.429 0.633 . . . . 0.0 112.266 172.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.461 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.0 t30 -90.96 -8.56 48.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 111.767 -168.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 35.7 mtp180 -143.38 143.93 31.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.643 -1.286 . . . . 0.0 110.627 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.7 mtm -134.08 107.47 7.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 108.909 168.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.072 HD12 HD11 ' A' ' 339' ' ' LEU . 7.4 mt -129.45 146.11 34.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.21 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 20.8 mtt-85 -135.64 162.12 33.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 110.995 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.516 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -135.22 127.79 30.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.221 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.557 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.7 174.05 33.04 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.7 m -57.28 150.73 17.35 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.978 -1.307 . . . . 0.0 108.601 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.055 HG21 HG11 ' A' ' 420' ' ' VAL . 20.0 t -54.82 -37.91 42.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.849 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.8 m-20 -63.72 -44.01 94.85 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.29 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 383' ' ' MET . . . -68.29 -52.14 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.876 -1.14 . . . . 0.0 110.535 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.614 HG21 HG12 ' A' ' 432' ' ' VAL . 27.6 mm -64.29 -42.22 94.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.106 -0.996 . . . . 0.0 110.828 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.2 ttp85 -59.94 -43.96 94.67 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.228 -0.92 . . . . 0.0 110.313 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 95.1 mtt180 -61.5 -37.16 82.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.515 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -68.21 -36.24 79.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.869 . . . . 0.0 111.319 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.65 -48.99 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.534 -1.354 . . . . 0.0 110.126 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.18 -34.33 77.4 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.914 -1.116 . . . . 0.0 110.145 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -36.23 80.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.952 -1.092 . . . . 0.0 109.958 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.0 m-80 -61.82 -27.33 68.69 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.202 173.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.79 19.46 29.17 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -169.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.49 -170.67 16.81 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -144.3 153.62 42.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -1.233 . . . . 0.0 111.231 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.595 ' HB3' HG21 ' A' ' 439' ' ' VAL . 9.8 p90 -108.85 149.97 40.25 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.475 -0.766 . . . . 0.0 110.068 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.865 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -73.02 126.31 11.11 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.877 1.462 . . . . 0.0 110.455 -175.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 414' ' ' THR . 1.3 t -67.18 -33.49 75.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 111.04 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.9 m-20 -63.36 -32.19 73.54 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.984 -1.072 . . . . 0.0 108.77 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.062 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.2 t -83.64 -41.69 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.395 -0.816 . . . . 0.0 110.824 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 56.4 t0 -54.9 -37.19 66.03 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 109.444 171.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.28 -50.99 65.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.447 -1.408 . . . . 0.0 109.635 172.673 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.568 ' CD ' HG21 ' A' ' 323' ' ' ILE . 45.0 mttm -55.77 -34.56 65.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.868 -1.145 . . . . 0.0 110.263 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.055 HG11 HG21 ' A' ' 398' ' ' VAL . 2.6 t -58.9 -42.5 86.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.172 170.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.5 -36.1 82.85 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 109.425 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.5 mm-40 -67.87 -37.13 81.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.697 -0.627 . . . . 0.0 110.65 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 428' ' ' ALA . 67.4 t -63.34 -37.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.025 . . . . 0.0 110.044 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.54 85.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -69.08 -30.38 68.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.296 -0.878 . . . . 0.0 110.888 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.75 -3.56 56.72 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.045 -1.034 . . . . 0.0 109.717 175.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.19 21.84 28.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.81 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.62 163.47 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -1.067 . . . . 0.0 109.626 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.468 ' HB ' HD12 ' A' ' 445' ' ' LEU . 22.1 m -109.75 107.2 59.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.989 -1.069 . . . . 0.0 109.731 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.562 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.2 Cg_endo -76.18 108.13 2.61 Favored 'Trans proline' 0 C--N 1.297 -2.158 0 O-C-N 123.878 1.462 . . . . 0.0 110.462 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.907 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.5 mt -92.29 136.31 33.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 0.0 108.64 167.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.879 ' CG2' HG22 ' A' ' 398' ' ' VAL . 94.6 t -99.93 135.06 37.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.675 -1.266 . . . . 0.0 109.462 175.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.904 ' CG1' HD11 ' A' ' 440' ' ' LEU . 27.3 t -115.83 137.76 48.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.291 -0.88 . . . . 0.0 108.831 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.84 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.7 m -120.45 160.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.272 -0.892 . . . . 0.0 109.734 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.494 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -134.37 132.9 40.0 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.18 -130.09 32.29 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.607 ' O ' HG13 ' A' ' 405' ' ' VAL . 74.1 p -105.64 8.71 33.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.034 -1.274 . . . . 0.0 111.129 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -122.12 170.64 9.67 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.588 -1.32 . . . . 0.0 110.107 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.84 ' HA ' HG12 ' A' ' 434' ' ' VAL . 47.0 t -89.48 133.86 30.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 109.95 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.904 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -92.22 -22.83 19.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.986 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.32 177.51 40.55 Favored Glycine 0 N--CA 1.5 2.943 0 C-N-CA 118.945 -1.598 . . . . 0.0 110.87 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.051 HG21 HG23 ' A' ' 420' ' ' VAL . 47.9 t -107.9 142.36 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.119 -1.224 . . . . 0.0 109.869 172.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.686 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.9 mt -101.3 112.02 32.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.416 -0.802 . . . . 0.0 108.941 170.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.09 119.38 31.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 109.837 -178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.907 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.29 142.82 32.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 320' ' ' SER . 28.9 mtmt . . . . . 0 C--N 1.299 -1.611 0 O-C-N 120.657 -1.277 . . . . 0.0 111.056 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.561 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.3 tt0 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.137 0.494 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.92 138.91 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.884 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.54 -44.34 2.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.07 -1.019 . . . . 0.0 110.278 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.1 mt-10 -154.44 152.34 30.04 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.427 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.008 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 16.5 p90 -137.22 143.15 42.15 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.731 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.525 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -114.93 144.66 32.44 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.747 -0.596 . . . . 0.0 109.657 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.7 143.71 38.15 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.758 1.399 . . . . 0.0 111.525 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.04 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.39 152.72 41.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 108.847 165.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.408 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 20.7 tp60 -57.87 128.43 37.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.654 -1.279 . . . . 0.0 110.081 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.67 -0.82 45.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.9 t -136.61 140.08 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.686 -1.479 . . . . 0.0 110.743 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.4 m-20 -74.15 152.67 39.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 85.0 tt0 -62.37 -40.76 97.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.985 -1.072 . . . . 0.0 110.471 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.25 -43.09 92.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.682 -1.261 . . . . 0.0 109.612 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 328' ' ' VAL . 93.3 m -55.53 -43.93 76.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.75 173.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 1.023 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -59.77 -39.24 84.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 110.285 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.0 -41.85 86.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.837 -1.164 . . . . 0.0 110.841 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.0 t0 -63.83 -49.83 71.3 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.832 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.918 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.27 -31.44 71.77 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.718 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.96 -35.09 66.33 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.142 172.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 18.0 mt-30 -73.85 -55.79 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.596 -0.69 . . . . 0.0 110.815 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.074 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.71 -34.7 76.24 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.894 -173.197 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.437 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.54 -20.43 65.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.927 174.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.626 ' OG ' HG22 ' A' ' 353' ' ' VAL . 97.1 p -108.91 9.75 26.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.199 -0.938 . . . . 0.0 111.631 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.708 HD22 ' HD2' ' A' ' 365' ' ' ARG . 35.5 mt -64.1 -45.78 87.14 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.652 -1.28 . . . . 0.0 109.806 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.7 -0.8 42.12 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.788 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 10.5 p30 -61.8 130.51 46.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.927 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.03 5.89 50.13 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.612 0.72 . . . . 0.0 109.951 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 346' ' ' THR . 2.5 p -77.56 154.59 81.42 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.579 -0.7 . . . . 0.0 109.45 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.15 -36.85 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.624 1.329 . . . . 0.0 109.128 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.3 -29.2 70.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.448 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -57.47 -38.54 87.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -77.33 -37.38 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -1.177 . . . . 0.0 110.629 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.561 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.0 m -61.68 -38.85 89.34 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.042 -1.036 . . . . 0.0 110.368 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.551 HG23 HD13 ' A' ' 443' ' ' ILE . 84.7 mt -69.18 -48.37 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.693 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.626 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -60.64 -34.54 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.06 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 350' ' ' ARG . 36.4 mt -72.54 -32.26 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.628 -1.295 . . . . 0.0 110.653 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.004 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.87 -41.06 90.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.937 -1.102 . . . . 0.0 110.394 179.09 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.79 -42.85 99.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 0.0 110.383 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.997 ' HB3' HD23 ' A' ' 362' ' ' LEU . 83.4 mttt -70.69 -50.55 35.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.913 -1.117 . . . . 0.0 110.772 -174.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.513 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.9 pt20 -71.0 -42.59 69.43 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 110.561 -173.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.595 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 40.1 mmt180 -73.06 -46.16 53.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 111.21 -173.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.647 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 79.3 m-85 -135.96 -36.03 0.76 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.542 -1.349 . . . . 0.0 112.39 -169.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.522 ' ND2' ' HD2' ' A' ' 363' ' ' ARG . 56.0 t-20 -158.59 98.55 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.557 -1.34 . . . . 0.0 111.7 -169.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.997 HD23 ' HB3' ' A' ' 357' ' ' LYS . 24.3 mt -58.38 91.17 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 0.0 109.509 171.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.522 ' HD2' ' ND2' ' A' ' 361' ' ' ASN . 13.8 ptm180 -145.6 -176.81 5.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.287 -0.883 . . . . 0.0 109.983 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.28 -158.53 0.9 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 110.329 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.708 ' HD2' HD22 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -97.96 166.81 11.27 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.661 -0.649 . . . . 0.0 110.558 -178.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.0 m-20 -121.02 41.1 3.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.009 HG11 ' CE2' ' A' ' 374' ' ' PHE . 43.0 t -70.45 -45.54 74.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 110.21 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -68.2 -29.02 67.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.159 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -29.66 27.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.07 -1.019 . . . . 0.0 109.767 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.811 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.6 mt -102.66 -3.22 26.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 110.777 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.1 m80 58.82 53.8 5.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 0.0 109.895 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.842 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.89 174.68 7.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 110.513 -177.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.1 m -114.79 134.02 55.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.357 -0.84 . . . . 0.0 110.396 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.009 ' CE2' HG11 ' A' ' 367' ' ' VAL . 72.4 m-85 -88.7 149.38 23.52 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 5.0 t -122.75 100.81 40.32 Favored Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -56.3 150.66 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.031 1.543 . . . . 0.0 110.473 -177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.6 t80 -66.91 131.75 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 110.141 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--N 1.302 -1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 109.639 175.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 73.2 mtt85 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.531 0.682 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.877 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.8 ptp -158.6 169.71 23.81 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.949 0.881 . . . . 0.0 111.339 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.524 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 31.1 p -154.84 165.22 37.33 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.15 -165.33 33.25 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.897 -1.621 . . . . 0.0 110.751 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.929 HG21 ' HB2' ' A' ' 339' ' ' LEU . 2.4 tt -142.28 149.38 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.63 -0.923 . . . . 0.0 110.054 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -127.91 136.0 50.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.957 -1.09 . . . . 0.0 109.911 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.45 155.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.859 -1.151 . . . . 0.0 109.22 171.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.498 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 91.2 m-20 -23.46 -63.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.398 0.618 . . . . 0.0 112.436 171.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 46.4 t-20 -95.82 -5.56 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.513 -0.742 . . . . 0.0 111.871 -167.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.562 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.6 mtp180 -143.98 143.8 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.66 -1.275 . . . . 0.0 110.375 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -134.02 112.25 11.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.822 -1.174 . . . . 0.0 108.913 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.074 HD12 HD11 ' A' ' 339' ' ' LEU . 9.6 mt -131.49 146.16 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 35.1 mtt180 -133.75 159.92 39.15 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.078 -1.014 . . . . 0.0 110.58 174.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.627 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.09 128.92 35.18 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.611 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.87 174.22 33.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -174.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.6 m -56.91 151.58 14.37 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.871 -1.37 . . . . 0.0 108.653 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.027 HG21 HG11 ' A' ' 420' ' ' VAL . 53.5 t -56.51 -34.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 109.942 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.516 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 46.2 t0 -63.26 -47.19 83.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.323 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.877 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.77 -50.05 59.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.523 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.611 HD11 ' N ' ' A' ' 396' ' ' GLY . 35.8 mm -64.97 -42.99 96.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.053 -1.029 . . . . 0.0 110.794 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.582 ' HD2' ' CZ ' ' A' ' 412' ' ' PHE . 9.5 ttp180 -59.36 -43.39 92.84 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.309 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.516 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 88.9 mtt180 -61.31 -37.16 82.25 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.517 173.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -67.5 -36.95 82.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 0.0 111.312 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.55 ' CG2' HG11 ' A' ' 434' ' ' VAL . 53.4 t -65.93 -48.35 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.5 -1.375 . . . . 0.0 110.206 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.6 -34.24 77.38 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.901 -1.124 . . . . 0.0 110.355 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.77 -36.26 80.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.939 -1.101 . . . . 0.0 109.886 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 4.8 m120 -61.03 -27.84 68.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 109.124 173.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.35 27.2 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -169.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.59 -169.05 15.59 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -144.36 153.66 42.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.131 -1.217 . . . . 0.0 111.404 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 6.7 p90 -108.22 150.35 40.39 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.769 -0.582 . . . . 0.0 110.258 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.817 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -75.0 125.53 9.39 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.812 1.427 . . . . 0.0 110.572 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -67.39 -33.82 75.98 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.172 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -62.12 -32.01 72.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.98 -1.075 . . . . 0.0 108.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.04 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.4 t -83.72 -42.69 17.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 110.942 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.585 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 66.8 m-20 -55.28 -36.22 65.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.629 171.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.88 -50.85 67.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.377 -1.452 . . . . 0.0 109.537 172.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 81.9 mttt -56.46 -34.36 66.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.338 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.05 HG23 HG21 ' A' ' 442' ' ' VAL . 2.4 t -58.86 -41.65 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.964 -1.085 . . . . 0.0 109.171 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -66.34 -36.51 83.08 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.936 0.874 . . . . 0.0 109.414 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.502 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 95.4 mm-40 -67.24 -37.28 83.28 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.586 -0.696 . . . . 0.0 110.703 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.745 HG13 ' HB3' ' A' ' 428' ' ' ALA . 77.0 t -62.39 -37.86 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 110.063 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.18 -37.97 86.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -66.26 -33.81 76.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.193 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -83.23 -1.82 54.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 176.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.05 22.54 32.44 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.745 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.12 162.47 13.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -1.084 . . . . 0.0 109.485 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.683 ' HB ' HD12 ' A' ' 445' ' ' LEU . 34.8 m -109.5 107.0 59.24 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 109.741 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.547 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.9 Cg_endo -74.98 108.09 2.64 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 O-C-N 124.05 1.553 . . . . 0.0 110.596 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.865 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -92.54 134.18 35.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.816 -1.177 . . . . 0.0 108.578 167.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.953 ' CG2' HG22 ' A' ' 398' ' ' VAL . 74.6 t -100.35 134.17 40.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.669 -1.269 . . . . 0.0 109.457 176.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.661 ' CG1' HD11 ' A' ' 440' ' ' LEU . 55.3 t -115.78 136.42 52.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.063 175.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -117.75 160.15 17.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.484 -0.76 . . . . 0.0 109.632 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.518 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.22 133.19 36.82 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.83 -123.57 22.24 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -168.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 405' ' ' VAL . 2.3 p -114.2 11.37 17.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.095 -1.238 . . . . 0.0 110.987 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -123.88 171.08 9.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.629 -1.294 . . . . 0.0 109.907 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 40.3 t -90.04 134.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.312 -0.867 . . . . 0.0 109.821 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.6 pp -94.33 -21.77 18.77 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 109.693 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 1.023 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.02 176.12 38.28 Favored Glycine 0 N--CA 1.499 2.883 0 C-N-CA 118.938 -1.601 . . . . 0.0 110.904 170.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.05 HG21 HG23 ' A' ' 420' ' ' VAL . 49.7 t -107.87 142.06 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.12 -1.224 . . . . 0.0 109.953 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.706 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.1 mt -101.32 110.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.424 -0.798 . . . . 0.0 108.961 170.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.625 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.36 118.18 30.67 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.031 -1.043 . . . . 0.0 109.864 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.865 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.08 144.32 30.81 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 19.9 mttt . . . . . 0 C--N 1.3 -1.583 0 O-C-N 120.675 -1.266 . . . . 0.0 110.905 179.586 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.468 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 50.9 tt0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.103 0.478 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.755 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -59.59 142.37 52.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.528 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -117.54 -34.17 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -0.981 . . . . 0.0 110.439 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -169.45 150.57 4.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 0.0 110.029 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.004 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 13.9 p90 -134.87 143.98 47.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.85 -1.156 . . . . 0.0 111.643 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.52 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.3 mt -114.49 144.03 31.02 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.611 -0.681 . . . . 0.0 109.666 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.88 143.78 37.49 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.767 1.404 . . . . 0.0 111.357 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.05 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.0 152.26 42.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 108.831 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -58.16 128.77 38.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.665 -1.272 . . . . 0.0 110.188 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.54 42.83 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.0 t -136.48 139.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.65 -1.5 . . . . 0.0 110.736 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.18 152.44 39.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.154 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.565 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -62.47 -40.13 95.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.993 . . . . 0.0 110.437 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.09 -43.15 91.81 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.701 -1.25 . . . . 0.0 109.62 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.531 HG21 HG13 ' A' ' 328' ' ' VAL . 94.3 m -56.11 -43.54 78.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.885 173.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 1.01 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.2 tp -59.68 -40.08 86.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.291 -0.881 . . . . 0.0 110.281 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.004 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -66.66 -41.21 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.914 -1.116 . . . . 0.0 110.742 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.546 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.3 t0 -64.22 -50.87 66.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.854 -1.153 . . . . 0.0 109.928 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.949 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.03 -30.62 69.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.909 -1.119 . . . . 0.0 109.779 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.91 65.29 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.133 -0.979 . . . . 0.0 109.028 171.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.574 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 17.3 mt-30 -74.25 -55.71 5.73 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.569 -0.707 . . . . 0.0 110.914 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.04 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -63.92 -33.78 76.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.908 -171.697 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.467 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -66.77 -21.48 66.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.986 -1.072 . . . . 0.0 110.045 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.609 ' OG ' HG22 ' A' ' 353' ' ' VAL . 97.5 p -107.65 10.79 28.95 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.04 -1.037 . . . . 0.0 111.598 -173.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 46.3 mt -67.15 -43.75 81.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.624 -1.297 . . . . 0.0 109.652 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.52 2.67 52.64 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.863 -171.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.515 ' OD2' ' CA ' ' A' ' 349' ' ' GLY . 18.3 p30 -65.0 130.0 41.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.773 -1.204 . . . . 0.0 110.088 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.72 4.43 52.98 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.573 0.701 . . . . 0.0 109.909 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.38 151.77 85.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.711 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -56.38 -39.4 91.53 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.702 1.369 . . . . 0.0 109.09 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.6 mt-10 -64.31 -29.63 70.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.484 -0.76 . . . . 0.0 110.367 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.31 -36.04 61.91 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 354' ' ' ILE . 65.9 mtt85 -77.18 -36.53 54.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 0.0 110.543 174.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.468 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 13.2 m -60.78 -39.08 87.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 443' ' ' ILE . 81.0 mt -68.19 -48.99 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.562 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.609 HG22 ' OG ' ' A' ' 341' ' ' SER . 27.5 t -62.18 -33.94 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.945 -1.097 . . . . 0.0 110.192 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 350' ' ' ARG . 31.7 mt -72.22 -31.98 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.597 -1.314 . . . . 0.0 110.576 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.997 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -60.61 -40.61 92.48 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 110.568 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.531 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.33 -42.93 99.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 0.0 110.274 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 70.4 mttt -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.73 -175.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.9 pt20 -70.09 -42.22 73.0 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 110.785 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.6 mmm180 -74.68 -46.24 39.18 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 111.189 -171.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.592 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 77.8 m-85 -136.22 -34.97 0.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.399 -1.321 . . . . 0.0 112.31 -170.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.516 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 53.5 t-20 -159.66 103.33 1.55 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.551 -1.343 . . . . 0.0 111.598 -169.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 37.0 mt -57.66 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.872 -1.142 . . . . 0.0 109.066 170.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 25.3 tpt180 -134.19 163.83 28.73 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.419 -0.8 . . . . 0.0 109.344 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.3 mt-10 -136.12 -158.05 0.84 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 46.3 ptt85 -97.66 163.69 12.72 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.661 -0.649 . . . . 0.0 110.841 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.9 m-20 -134.5 44.49 2.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.821 . . . . 0.0 110.554 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 1.017 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.0 t -72.41 -46.95 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.44 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -67.9 -26.15 65.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 111.264 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -31.18 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.057 . . . . 0.0 109.715 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 388' ' ' ILE . 19.8 mt -100.68 -4.09 28.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.498 -0.751 . . . . 0.0 110.606 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 46.8 m80 59.99 51.73 5.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -174.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.819 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.06 172.99 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.9 m -118.82 135.61 54.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 110.374 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 1.017 ' CE1' HG21 ' A' ' 367' ' ' VAL . 86.3 m-85 -90.01 145.16 25.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.651 175.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.441 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 47.9 t -118.73 100.99 50.92 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 174.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.16 150.75 38.24 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.068 1.562 . . . . 0.0 110.526 -175.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 8.4 t80 -63.27 131.35 48.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.357 -0.839 . . . . 0.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--N 1.301 -1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.706 176.124 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 88.7 mtt180 . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.519 0.676 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.79 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.6 ptp -158.75 168.48 26.73 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.26 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 12.2 p -155.39 165.16 37.49 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.6 -164.16 31.55 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.956 -1.592 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 367' ' ' VAL . 1.9 tt -141.96 149.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.665 -0.903 . . . . 0.0 110.173 -174.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -127.22 138.86 53.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -141.37 154.59 20.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.87 -1.144 . . . . 0.0 109.365 172.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.264 88.3 m-20 -21.4 -62.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.391 0.615 . . . . 0.0 112.608 171.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 24.8 t-20 -99.03 -6.78 27.89 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 111.819 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 18.3 mtp180 -142.97 145.86 33.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.746 -1.221 . . . . 0.0 110.553 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 89.9 mtp -134.16 113.27 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.909 -1.119 . . . . 0.0 109.08 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.04 HD12 HD11 ' A' ' 339' ' ' LEU . 9.3 mt -131.75 146.05 34.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.051 -1.031 . . . . 0.0 110.142 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 32.8 mtt180 -135.92 161.9 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.005 . . . . 0.0 110.779 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.643 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.45 134.23 41.34 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.531 -0.731 . . . . 0.0 109.11 174.132 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.504 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -159.76 174.06 36.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -58.51 153.0 16.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.921 -1.34 . . . . 0.0 108.438 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.031 HG21 HG11 ' A' ' 420' ' ' VAL . 20.8 t -54.87 -37.52 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.82 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.1 m-20 -64.25 -44.51 91.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.79 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.78 -51.84 36.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.923 -1.111 . . . . 0.0 110.503 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.504 HD11 ' N ' ' A' ' 396' ' ' GLY . 25.2 mm -63.82 -42.28 95.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.096 -1.003 . . . . 0.0 110.805 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.4 ttt180 -60.81 -43.29 98.38 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.299 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 89.8 mtt180 -61.15 -36.54 80.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.07 -1.019 . . . . 0.0 109.643 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -67.45 -38.15 84.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 111.33 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 437' ' ' SER . 63.7 t -66.07 -47.22 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.473 -1.392 . . . . 0.0 110.219 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.73 -34.63 78.3 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.738 -1.226 . . . . 0.0 110.337 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.47 -36.29 80.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.986 -1.071 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 5.3 m120 -61.15 -27.81 68.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.442 -0.786 . . . . 0.0 109.126 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.61 19.85 28.51 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.01 -170.26 16.3 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -144.61 153.98 42.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.247 . . . . 0.0 111.321 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.601 ' HB3' HG21 ' A' ' 439' ' ' VAL . 6.1 p90 -106.87 150.99 40.43 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.63 -0.669 . . . . 0.0 110.096 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.858 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.81 125.61 10.64 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.853 1.449 . . . . 0.0 110.237 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.2 t -66.69 -34.13 77.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 111.136 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.482 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.9 m-20 -62.97 -32.31 73.61 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.931 -1.106 . . . . 0.0 108.858 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.05 HG21 ' HA ' ' A' ' 325' ' ' ALA . 48.4 t -83.41 -42.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -0.846 . . . . 0.0 110.809 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 5.3 m-20 -55.58 -36.42 66.84 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.595 171.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.94 -50.16 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 0.0 109.686 172.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.52 ' CD ' HG21 ' A' ' 323' ' ' ILE . 35.7 mttt -56.65 -34.6 67.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.764 -1.21 . . . . 0.0 110.332 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.112 HG23 HG21 ' A' ' 442' ' ' VAL . 2.8 t -59.09 -41.78 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.932 -1.105 . . . . 0.0 109.369 170.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.66 -35.95 82.26 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.943 0.878 . . . . 0.0 109.296 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.39 -37.92 83.89 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.566 -0.709 . . . . 0.0 110.769 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 428' ' ' ALA . 64.5 t -63.44 -36.81 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.0 110.193 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.34 85.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -70.08 -28.95 65.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.326 -0.859 . . . . 0.0 110.599 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -80.36 -3.75 50.82 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.009 . . . . 0.0 109.74 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.7 21.96 35.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.733 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.74 175.96 5.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.722 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.657 ' O ' HD12 ' A' ' 445' ' ' LEU . 59.1 m -119.15 106.92 42.4 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.942 -1.099 . . . . 0.0 109.874 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.591 ' CG ' HG13 ' A' ' 420' ' ' VAL . 31.4 Cg_endo -74.06 106.78 2.28 Favored 'Trans proline' 0 C--N 1.296 -2.204 0 O-C-N 123.911 1.479 . . . . 0.0 110.354 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 445' ' ' LEU . 15.8 mt -93.08 131.79 37.78 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 167.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.81 ' CG2' HG22 ' A' ' 398' ' ' VAL . 72.6 t -100.57 137.54 27.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.823 -1.173 . . . . 0.0 109.777 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.775 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.7 t -116.2 137.74 48.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 108.928 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.851 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.05 159.98 20.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 121.351 -0.843 . . . . 0.0 109.757 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.48 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.11 132.77 36.52 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.41 -126.82 31.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -168.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.495 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -109.91 13.41 23.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.238 . . . . 0.0 111.123 -178.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -128.33 170.66 12.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.017 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.851 ' HA ' HG12 ' A' ' 434' ' ' VAL . 53.3 t -88.35 134.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 109.776 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.806 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.5 pp -92.3 -22.3 19.81 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.665 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 1.01 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.88 176.36 40.09 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.963 168.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.112 HG21 HG23 ' A' ' 420' ' ' VAL . 46.9 t -107.94 142.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.16 -1.2 . . . . 0.0 109.539 171.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.721 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.3 mt -101.67 119.24 49.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 169.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -99.0 117.49 33.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.744 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 3.6 mp -113.63 146.34 39.9 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.095 -1.003 . . . . 0.0 109.819 -173.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.528 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 O-C-N 120.749 -1.22 . . . . 0.0 110.773 -174.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.5 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.158 0.504 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.74 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.57 138.6 40.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 0.0 109.802 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 4.9 m -119.53 -44.7 2.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.086 -1.009 . . . . 0.0 110.197 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 320' ' ' SER . 69.7 mt-10 -154.59 152.33 29.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 0.0 110.448 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.009 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 16.9 p90 -136.12 141.82 44.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.755 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.643 HG21 ' CD ' ' A' ' 419' ' ' LYS . 4.3 mt -114.79 141.76 27.3 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.73 -0.607 . . . . 0.0 109.598 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -71.61 142.86 40.97 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.708 1.373 . . . . 0.0 111.55 -176.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 1.046 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.01 152.56 43.44 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 108.829 165.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -58.44 128.35 36.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.692 -1.255 . . . . 0.0 110.143 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.94 -0.75 44.76 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.8 t -136.13 139.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.716 -1.461 . . . . 0.0 110.727 177.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.93 152.07 40.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.163 177.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -62.17 -39.76 93.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.057 -1.027 . . . . 0.0 110.457 -176.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.3 ttmt -59.19 -43.38 92.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.806 -1.184 . . . . 0.0 109.56 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.529 HG21 HG13 ' A' ' 328' ' ' VAL . 95.8 m -56.15 -43.63 78.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.817 173.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.988 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -59.69 -39.64 85.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.009 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.37 -42.04 84.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.089 . . . . 0.0 110.757 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.4 m-20 -64.19 -49.48 71.88 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.118 . . . . 0.0 109.921 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.947 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.17 -31.3 70.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.937 -1.102 . . . . 0.0 109.664 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.751 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.19 -35.64 65.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.964 172.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.564 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 30.3 mt-30 -74.52 -55.81 5.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.989 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.38 -35.71 78.23 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.787 -172.435 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.89 66.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.592 ' OG ' HG22 ' A' ' 353' ' ' VAL . 95.9 p -108.4 10.15 27.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -174.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.581 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.2 mt -65.98 -44.95 83.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.657 -1.277 . . . . 0.0 109.802 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.54 0.72 47.94 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.821 -170.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.479 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.9 p30 -63.87 130.29 43.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.841 -1.162 . . . . 0.0 109.925 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.76 4.76 52.64 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.512 0.672 . . . . 0.0 109.886 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.3 152.88 86.03 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.592 -0.693 . . . . 0.0 109.443 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -56.0 -38.14 95.14 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.74 1.39 . . . . 0.0 109.132 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.19 -29.23 70.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.484 -0.76 . . . . 0.0 110.406 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.47 -38.56 80.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.531 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.9 mtt85 -78.2 -37.76 44.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.075 -1.25 . . . . 0.0 110.591 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.4 -38.02 85.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.932 -1.105 . . . . 0.0 110.352 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 443' ' ' ILE . 90.7 mt -68.92 -49.09 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 0.0 110.625 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.592 HG22 ' OG ' ' A' ' 341' ' ' SER . 38.4 t -60.87 -34.06 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.864 -1.147 . . . . 0.0 110.101 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.964 HG22 ' OE1' ' A' ' 358' ' ' GLN . 32.3 mt -72.62 -33.22 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.681 -1.262 . . . . 0.0 110.621 170.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.961 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.46 -40.35 86.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.938 -1.101 . . . . 0.0 110.489 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.27 88.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.47 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.872 ' HB3' HD23 ' A' ' 362' ' ' LEU . 18.0 mtmt -72.35 -49.48 33.82 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.743 -1.183 . . . . 0.0 110.6 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.964 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.7 pt20 -71.3 -42.43 68.69 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 110.814 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.58 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -72.63 -46.31 54.68 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.109 -0.995 . . . . 0.0 111.078 -172.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.58 ' CD2' ' HB3' ' A' ' 359' ' ' ARG . 84.0 m-85 -136.5 -36.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.205 -169.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.491 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 15.2 t-20 -160.02 106.64 1.6 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.605 -1.309 . . . . 0.0 111.508 -168.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.872 HD23 ' HB3' ' A' ' 357' ' ' LYS . 59.9 mt -57.56 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.368 172.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ARG . . . . . 0.534 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.7 tpt180 -125.64 164.39 20.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 109.325 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.4 mt-10 -140.06 -161.77 1.25 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.0 -1.062 . . . . 0.0 110.121 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.581 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.67 162.45 13.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.747 . . . . 0.0 110.521 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -130.3 41.74 3.36 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.381 175.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.947 HG11 ' CE2' ' A' ' 374' ' ' PHE . 59.4 t -74.16 -46.23 45.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.09 -27.46 66.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.344 -0.848 . . . . 0.0 111.122 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.78 -30.55 28.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.965 . . . . 0.0 109.656 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.781 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.9 mt -102.5 -3.66 26.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.557 -0.714 . . . . 0.0 110.674 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 367' ' ' VAL . 51.6 m80 59.11 52.57 6.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.753 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.55 174.67 7.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 110.51 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.1 m -116.45 134.62 54.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.396 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.947 ' CE2' HG11 ' A' ' 367' ' ' VAL . 83.6 m-85 -88.61 147.8 24.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 387' ' ' ASN . 87.2 t -120.34 101.12 46.99 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.616 175.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.22 150.36 40.68 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.077 1.567 . . . . 0.0 110.511 -175.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.2 t80 -65.47 131.41 46.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 109.695 176.183 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 74.0 mtt85 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.517 0.675 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.827 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.3 ptp -157.44 167.38 30.4 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.993 0.901 . . . . 0.0 111.4 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.9 p -154.43 165.36 36.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.503 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.8 -166.55 35.05 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.705 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.879 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.8 tt -140.92 149.84 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.995 . . . . 0.0 110.208 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.471 HD21 HG21 ' A' ' 375' ' ' VAL . 47.8 m-20 -127.25 134.73 50.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.045 . . . . 0.0 109.804 177.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' A' ' 370' ' ' LEU . 2.0 tt -140.73 155.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 109.211 171.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.0 m-20 -21.65 -63.03 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.388 0.614 . . . . 0.0 112.583 170.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.449 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 22.9 t-20 -96.49 -7.14 35.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 111.931 -167.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.571 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.9 mtp180 -141.86 145.84 35.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.594 -1.317 . . . . 0.0 110.503 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -136.22 100.93 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.132 . . . . 0.0 109.18 170.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 1.031 HD12 HD11 ' A' ' 339' ' ' LEU . 7.7 mt -122.96 146.18 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.04 -1.037 . . . . 0.0 110.092 -172.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.503 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 26.0 mmt85 -133.19 159.1 41.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.329 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.556 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.41 126.84 30.36 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.56 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.44 174.0 32.86 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.596 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.4 m -56.47 150.84 14.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.863 -1.375 . . . . 0.0 108.592 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.037 HG21 ' CG1' ' A' ' 420' ' ' VAL . 56.5 t -57.72 -34.6 48.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.887 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.4 t0 -62.55 -45.81 91.23 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.827 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.85 -51.07 44.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.93 -1.106 . . . . 0.0 110.61 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.56 HD11 ' N ' ' A' ' 396' ' ' GLY . 34.2 mm -63.98 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.063 -1.023 . . . . 0.0 110.59 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.0 ttp180 -58.47 -43.69 89.0 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.461 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 55.2 mtp85 -61.54 -36.12 79.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.061 -1.024 . . . . 0.0 109.459 173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.503 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.4 t-80 -67.65 -38.5 83.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 111.299 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.472 HG12 ' C ' ' A' ' 410' ' ' GLY . 66.7 t -65.91 -47.29 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.616 -1.302 . . . . 0.0 110.26 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.21 -34.21 77.57 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.814 -1.178 . . . . 0.0 110.362 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.65 -36.3 80.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.092 . . . . 0.0 109.895 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 26.7 m-80 -62.12 -27.09 68.68 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 109.225 173.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.86 19.56 31.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.24 -171.13 18.52 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.418 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.1 m-70 -144.81 153.85 42.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.168 -1.195 . . . . 0.0 111.07 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.64 ' HB3' HG21 ' A' ' 439' ' ' VAL . 8.5 p90 -109.51 151.92 42.46 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.54 -0.725 . . . . 0.0 109.978 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.857 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.15 124.76 10.27 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.913 1.48 . . . . 0.0 110.221 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.3 t -66.95 -33.21 75.08 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.3 m-20 -63.45 -32.48 73.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 108.853 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.046 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.3 t -83.64 -41.89 17.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.908 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.7 t0 -55.04 -37.55 66.83 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.404 171.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.66 -49.71 72.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.457 -1.402 . . . . 0.0 109.697 172.419 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.643 ' CD ' HG21 ' A' ' 323' ' ' ILE . 57.1 mttm -56.28 -34.79 66.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.802 -1.187 . . . . 0.0 110.444 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.088 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.32 -41.85 85.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.962 -1.086 . . . . 0.0 109.21 171.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.84 -36.26 82.97 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.906 0.86 . . . . 0.0 109.414 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.02 -37.89 81.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.609 -0.682 . . . . 0.0 110.74 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.765 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.2 t -62.28 -37.65 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.979 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.09 87.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 110.151 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -67.02 -33.43 75.54 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.285 -0.884 . . . . 0.0 111.229 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.1 OUTLIER -83.0 -3.4 57.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.012 -1.055 . . . . 0.0 109.597 176.256 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.33 29.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.765 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -103.72 163.34 12.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.651 ' HB ' HD12 ' A' ' 445' ' ' LEU . 70.5 m -109.65 107.02 59.1 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.081 -1.012 . . . . 0.0 109.744 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.56 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.6 Cg_endo -75.6 107.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.07 0 O-C-N 123.893 1.47 . . . . 0.0 110.52 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.867 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.5 mt -92.44 134.24 35.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.886 -1.134 . . . . 0.0 108.625 167.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.99 ' CG2' HG22 ' A' ' 398' ' ' VAL . 96.8 t -100.32 134.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.701 -1.25 . . . . 0.0 109.477 176.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.81 ' CG1' HD11 ' A' ' 440' ' ' LEU . 40.9 t -114.95 137.33 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.243 -0.91 . . . . 0.0 108.955 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.841 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.28 160.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.589 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.482 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.82 129.89 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.56 -128.42 29.84 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -168.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.53 15.41 23.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.052 -1.263 . . . . 0.0 111.171 -179.109 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -125.76 170.27 11.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.532 -1.355 . . . . 0.0 109.878 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.841 ' HA ' HG12 ' A' ' 434' ' ' VAL . 46.7 t -91.7 134.31 30.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.189 -0.945 . . . . 0.0 109.57 176.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.5 pp -94.36 -21.28 19.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.691 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.988 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.27 176.39 38.64 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 118.794 -1.669 . . . . 0.0 110.962 169.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.088 HG21 HG23 ' A' ' 420' ' ' VAL . 53.9 t -107.97 142.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 173.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.751 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.2 mt -101.32 110.91 29.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.99 118.12 30.47 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.863 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.867 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.28 30.54 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 59.3 mttt . . . . . 0 C--N 1.3 -1.578 0 O-C-N 120.612 -1.305 . . . . 0.0 111.121 -179.16 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.237 0.541 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.478 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 98.1 mtt180 -122.59 149.78 43.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.092 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.548 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 89.1 mm-40 -123.45 142.83 50.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.123 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -60.6 138.63 58.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.83 177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 9.4 m -122.16 -42.75 2.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.005 . . . . 0.0 110.217 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 320' ' ' SER . 68.3 mt-10 -154.17 150.81 28.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.475 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.0 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.9 p90 -137.46 141.85 41.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.957 -1.089 . . . . 0.0 111.709 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.694 HG21 ' HD3' ' A' ' 419' ' ' LYS . 3.7 mp -113.1 143.75 29.79 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.811 -0.555 . . . . 0.0 109.69 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.67 142.89 36.72 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.63 1.331 . . . . 0.0 111.605 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.036 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.72 152.65 42.6 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 108.862 165.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 23.6 tp60 -58.57 128.45 37.25 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.734 -1.229 . . . . 0.0 110.172 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.83 44.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.3 t -136.61 139.86 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.71 -1.465 . . . . 0.0 110.762 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.89 152.82 40.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.397 -0.815 . . . . 0.0 110.176 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.8 tt0 -62.16 -40.91 97.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.056 -1.027 . . . . 0.0 110.47 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.29 -43.33 92.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.694 -1.254 . . . . 0.0 109.678 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.516 HG21 HG13 ' A' ' 328' ' ' VAL . 92.7 m -55.51 -44.12 76.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.769 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 1.021 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -59.16 -39.01 81.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.0 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.3 -41.24 85.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.967 -1.083 . . . . 0.0 110.779 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.581 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.5 m-20 -63.26 -49.22 74.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.936 -1.102 . . . . 0.0 109.805 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.99 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.52 -31.37 70.57 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.982 -1.074 . . . . 0.0 109.888 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.714 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.28 64.62 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 108.834 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.5 mt-30 -74.54 -55.92 5.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.594 -0.691 . . . . 0.0 110.919 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.0 HD11 HD12 ' A' ' 393' ' ' ILE . 0.2 OUTLIER -65.77 -33.77 76.64 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.009 -171.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -66.34 -21.62 66.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.112 . . . . 0.0 110.109 172.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.609 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.4 p -107.58 10.59 29.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.142 -0.974 . . . . 0.0 111.536 -173.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.589 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 46.1 mt -66.98 -44.48 80.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.591 -1.318 . . . . 0.0 109.672 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.12 1.2 49.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.865 -170.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.483 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.81 130.45 44.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 109.942 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 5.4 51.58 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.532 0.682 . . . . 0.0 109.887 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.26 152.57 83.97 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.582 -0.699 . . . . 0.0 109.412 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -56.02 -38.49 94.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.689 1.363 . . . . 0.0 109.147 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.478 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.6 mt-10 -64.38 -28.31 69.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.548 -0.72 . . . . 0.0 110.395 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.23 -38.17 76.45 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.568 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.95 -36.73 56.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -1.209 . . . . 0.0 110.54 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 2.0 m -61.5 -39.25 90.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.605 HG23 HD13 ' A' ' 443' ' ' ILE . 85.4 mt -68.12 -48.33 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.537 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.609 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.3 t -61.46 -34.03 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.568 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.7 mt -72.43 -32.27 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.673 -1.267 . . . . 0.0 110.548 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.993 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.02 -40.58 89.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.96 -1.088 . . . . 0.0 110.444 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.542 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.76 -43.73 98.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.988 ' HB3' HD23 ' A' ' 362' ' ' LEU . 70.2 mttt -71.44 -49.83 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.614 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.55 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 1.8 pt20 -70.87 -42.54 69.94 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.704 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.7 mmt180 -73.62 -46.01 49.5 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 111.147 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.667 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 72.3 m-85 -135.93 -36.59 0.75 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.57 -1.331 . . . . 0.0 112.226 -169.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.0 t30 -159.57 103.16 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.549 -1.344 . . . . 0.0 111.682 -169.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.988 HD23 ' HB3' ' A' ' 357' ' ' LYS . 33.1 mt -57.78 89.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.893 -1.129 . . . . 0.0 109.113 171.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.543 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.0 tpt180 -135.43 164.71 27.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.436 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.9 mt-10 -135.8 -157.14 0.77 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.016 -1.052 . . . . 0.0 110.495 -177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 36.8 ptt180 -97.48 165.14 12.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.674 -0.641 . . . . 0.0 110.716 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.473 ' OD1' HD13 ' A' ' 388' ' ' ILE . 55.0 p30 -138.05 45.52 2.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.379 -0.826 . . . . 0.0 110.758 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.004 HG21 ' CE1' ' A' ' 374' ' ' PHE . 92.7 t -71.15 -42.38 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.334 -0.854 . . . . 0.0 110.341 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.78 -21.32 66.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 111.032 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -29.39 25.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.04 -1.038 . . . . 0.0 110.026 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 1.079 HD12 HD11 ' A' ' 388' ' ' ILE . 16.6 mt -105.38 -3.68 22.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.552 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 24.0 m80 62.11 53.33 2.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 109.649 -173.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.918 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.19 174.96 6.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.501 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.0 m -120.9 136.4 54.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.416 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.004 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.0 m-85 -90.62 145.1 25.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.668 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 21.5 t -118.6 101.32 50.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.11 155.18 19.88 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.105 1.582 . . . . 0.0 110.613 -175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.55 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 50.5 t80 -71.92 134.7 46.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 110.442 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 4.8 p -114.56 143.48 44.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.785 174.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.51 -25.08 59.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.646 -0.659 . . . . 0.0 110.357 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.81 -43.74 98.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 383' ' ' MET . 74.2 m -93.81 -14.41 26.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 110.164 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.7 mtt-85 57.45 48.21 15.01 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.617 -0.677 . . . . 0.0 109.646 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.898 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.1 ptp -165.34 171.23 13.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.781 0.8 . . . . 0.0 111.288 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.55 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 39.8 p -156.31 165.31 36.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.82 -165.96 34.11 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.025 -1.56 . . . . 0.0 110.637 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 367' ' ' VAL . 1.3 tt -143.34 147.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.935 . . . . 0.0 110.399 -174.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.493 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 56.1 m-20 -115.78 134.25 55.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.902 -1.124 . . . . 0.0 108.974 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 1.079 HD11 HD12 ' A' ' 370' ' ' LEU . 2.2 tt -142.63 154.41 17.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.9 -1.125 . . . . 0.0 109.611 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 88.7 m-20 -23.95 -62.02 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 112.298 173.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.478 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.5 t-20 -95.87 -5.45 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.539 -0.725 . . . . 0.0 111.801 -167.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.602 ' NH2' HD21 ' A' ' 339' ' ' LEU . 18.1 mtp180 -145.5 147.73 32.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.684 -1.26 . . . . 0.0 110.74 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.3 mtm -132.51 95.68 3.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.831 -1.168 . . . . 0.0 108.789 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 339' ' ' LEU . 7.6 mt -122.58 146.25 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.946 -1.096 . . . . 0.0 110.429 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 40.2 mtt180 -133.51 159.14 41.29 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 110.767 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.611 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.43 128.86 34.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.694 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.51 174.32 33.59 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.0 m -56.36 151.35 13.14 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.956 -1.32 . . . . 0.0 108.496 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.13 HG21 HG11 ' A' ' 420' ' ' VAL . 53.4 t -57.08 -34.28 44.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.027 -1.046 . . . . 0.0 109.887 -176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 19.7 t70 -62.86 -47.48 83.18 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.898 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.2 -49.12 62.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.042 -1.036 . . . . 0.0 110.652 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.694 HD11 ' N ' ' A' ' 396' ' ' GLY . 45.0 mm -65.06 -43.29 95.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.108 -0.995 . . . . 0.0 110.809 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.579 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 2.4 ttt180 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.0 mtt-85 -61.14 -37.75 83.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.979 -1.075 . . . . 0.0 109.607 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.413 ' ND1' ' C ' ' A' ' 404' ' ' HIS . 2.2 t-80 -67.62 -35.85 79.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 111.222 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.564 ' CG2' HG11 ' A' ' 434' ' ' VAL . 56.0 t -65.85 -48.98 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.673 -1.267 . . . . 0.0 110.187 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.2 -34.45 77.68 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.291 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.99 79.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.954 -1.091 . . . . 0.0 110.021 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.552 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.5 m120 -61.55 -27.67 68.79 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.491 -0.756 . . . . 0.0 109.114 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.13 19.77 27.53 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.1 -169.14 15.85 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.424 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.86 153.61 42.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -1.215 . . . . 0.0 111.328 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.582 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 8.3 p90 -108.01 149.66 39.39 Favored Pre-proline 0 N--CA 1.501 2.105 0 O-C-N 121.625 -0.672 . . . . 0.0 110.24 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.821 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.95 125.21 9.2 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.853 1.449 . . . . 0.0 110.573 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.79 -34.32 77.56 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.161 -0.962 . . . . 0.0 111.051 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.7 m-20 -60.84 -33.08 72.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 108.864 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.036 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.0 t -83.78 -42.57 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.017 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 71.9 m-20 -54.85 -37.29 66.01 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.48 171.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.4 mt-30 -63.31 -48.68 77.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.292 -1.505 . . . . 0.0 110.102 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.694 ' HD3' HG21 ' A' ' 323' ' ' ILE . 26.3 mttt -56.84 -34.85 68.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.704 -1.248 . . . . 0.0 110.392 177.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.13 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 109.171 171.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.9 t0 -66.62 -36.66 83.13 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.791 0.805 . . . . 0.0 109.517 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 84.8 mt-30 -67.04 -37.02 83.34 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.631 -0.668 . . . . 0.0 110.612 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.797 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.0 t -62.43 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.125 . . . . 0.0 110.005 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.68 -43.96 87.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -0.908 . . . . 0.0 110.435 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 6.0 mtp85 -64.98 -29.86 70.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 110.517 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.28 -3.87 53.84 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.683 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.52 22.1 38.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.797 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.39 164.26 12.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.395 -1.062 . . . . 0.0 109.727 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.451 ' HG1' HH11 ' A' ' 317' ' ' ARG . 28.4 m -109.57 107.04 59.19 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.585 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.0 Cg_endo -75.61 108.27 2.66 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 O-C-N 124.014 1.534 . . . . 0.0 110.62 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.854 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.1 mt -92.6 134.13 35.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.872 -1.142 . . . . 0.0 108.622 167.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.994 ' CG2' HG22 ' A' ' 398' ' ' VAL . 90.3 t -100.51 134.29 40.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.771 -1.205 . . . . 0.0 109.504 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.778 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.3 t -115.03 139.09 43.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.816 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -119.89 160.09 20.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.458 -0.776 . . . . 0.0 109.587 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.51 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -135.01 130.38 35.61 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.58 -129.22 27.74 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -167.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.559 ' O ' HG13 ' A' ' 405' ' ' VAL . 78.0 p -106.16 7.64 31.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.244 . . . . 0.0 111.082 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -118.99 170.43 9.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.588 -1.32 . . . . 0.0 110.048 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.816 ' HA ' HG12 ' A' ' 434' ' ' VAL . 24.3 t -92.67 134.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.857 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -96.68 -20.6 18.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.721 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 1.021 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.76 176.53 38.46 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 118.815 -1.659 . . . . 0.0 111.024 168.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.079 HG21 HG23 ' A' ' 420' ' ' VAL . 55.8 t -107.7 142.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.242 -1.152 . . . . 0.0 109.95 173.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.714 HD11 ' CB ' ' A' ' 337' ' ' ALA . 81.7 mt -101.32 110.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 109.023 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.626 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.7 118.31 30.54 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.047 -1.033 . . . . 0.0 109.831 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.854 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -101.67 141.67 34.18 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.564 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 11.0 mtmt -115.7 162.11 17.73 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.763 -1.211 . . . . 0.0 111.038 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -81.15 144.62 31.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.599 -0.688 . . . . 0.0 110.227 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 448' ' ' ILE . 10.6 tp -119.99 153.67 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 110.267 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.54 135.05 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.246 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -92.96 144.99 24.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 110.21 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.989 -1.45 . . . . 0.0 109.505 179.929 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.185 0.517 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.479 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 70.8 mtt85 -122.1 144.18 49.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.132 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.4 tt0 -122.5 130.75 53.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 110.354 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.786 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.72 138.62 41.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.992 -1.067 . . . . 0.0 109.815 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.508 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.41 -45.16 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.99 . . . . 0.0 110.339 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 320' ' ' SER . 72.4 mt-10 -154.53 154.59 33.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.228 -0.92 . . . . 0.0 110.511 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.06 ' CD1' HD21 ' A' ' 355' ' ' LEU . 15.6 p90 -135.51 151.5 50.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.956 -1.09 . . . . 0.0 111.572 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.692 HG21 ' HD3' ' A' ' 419' ' ' LYS . 3.4 mt -125.56 140.59 36.79 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.699 -0.625 . . . . 0.0 109.336 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.78 143.12 45.08 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.617 1.325 . . . . 0.0 111.64 -173.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.034 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.22 151.29 45.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.455 -0.778 . . . . 0.0 108.977 165.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -57.99 129.13 40.51 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.704 -1.247 . . . . 0.0 110.069 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.65 -0.35 49.25 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.5 t -135.36 138.05 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.578 -1.543 . . . . 0.0 110.759 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.6 m-20 -73.12 148.98 43.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.346 -0.846 . . . . 0.0 110.275 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.2 tt0 -60.59 -34.15 73.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.039 -1.038 . . . . 0.0 109.778 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -58.85 -43.73 90.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 109.139 175.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.547 HG21 HG13 ' A' ' 328' ' ' VAL . 88.9 m -61.17 -42.26 98.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.417 -0.802 . . . . 0.0 110.333 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.976 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.1 tp -60.48 -39.61 88.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.51 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.965 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.93 -44.04 77.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 110.69 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.562 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.9 m-20 -63.51 -48.07 79.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.912 -1.118 . . . . 0.0 110.063 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.959 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -69.17 -31.25 69.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.007 -1.058 . . . . 0.0 109.991 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.13 -35.55 64.81 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 0.0 108.915 172.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.8 mt-30 -74.3 -55.71 5.71 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.72 . . . . 0.0 111.023 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.055 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.9 -33.61 76.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.741 -1.183 . . . . 0.0 110.177 -172.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.72 -21.03 65.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.882 -1.136 . . . . 0.0 110.009 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.654 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.2 p -107.32 10.51 29.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.104 -0.997 . . . . 0.0 111.536 -174.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.587 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 43.6 mt -66.1 -45.18 82.09 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.612 -1.305 . . . . 0.0 109.758 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.05 0.73 49.13 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.976 -170.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.7 p30 -63.02 130.47 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.745 -1.222 . . . . 0.0 109.977 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.66 5.31 51.77 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.576 0.703 . . . . 0.0 109.923 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.05 152.87 84.52 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.666 -0.646 . . . . 0.0 109.443 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.58 -38.56 94.02 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.645 1.339 . . . . 0.0 109.117 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.479 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.7 mt-10 -64.32 -28.91 70.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.499 -0.751 . . . . 0.0 110.41 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.02 -37.49 71.41 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -76.92 -38.9 52.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -1.223 . . . . 0.0 110.598 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 4.8 m -62.13 -37.37 84.91 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 110.477 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.687 HG23 HD13 ' A' ' 443' ' ' ILE . 88.6 mt -68.55 -48.82 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.066 -1.021 . . . . 0.0 110.493 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.654 HG22 ' OG ' ' A' ' 341' ' ' SER . 22.0 t -60.9 -32.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.825 -1.172 . . . . 0.0 109.797 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.964 HG22 ' OE1' ' A' ' 358' ' ' GLN . 39.5 mt -72.8 -33.1 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 110.628 171.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.06 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.6 -41.08 84.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.866 -1.146 . . . . 0.0 110.274 178.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.508 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.27 -45.58 87.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.624 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.855 ' HB3' HD23 ' A' ' 362' ' ' LEU . 33.7 mtmt -72.36 -49.29 35.23 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.53 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.964 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.3 pt20 -72.23 -42.82 65.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.543 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -73.83 -43.75 57.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 111.227 -172.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.672 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 82.6 m-85 -135.42 -38.8 0.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.349 -1.341 . . . . 0.0 111.83 -168.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.5 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 16.7 t-20 -162.77 108.36 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.576 -1.328 . . . . 0.0 111.423 -167.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.855 HD23 ' HB3' ' A' ' 357' ' ' LYS . 68.6 mt -57.1 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.016 -1.053 . . . . 0.0 109.096 172.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.1 tpt180 -122.59 164.77 17.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.774 . . . . 0.0 109.408 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.502 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.1 mt-10 -141.21 -161.84 1.28 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.587 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 32.1 ptt-85 -97.6 163.67 12.74 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.638 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.479 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -129.67 41.8 3.38 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.331 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.056 HG21 ' CE1' ' A' ' 374' ' ' PHE . 41.3 t -73.02 -46.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.19 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 111.109 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.11 -30.12 28.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.692 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 388' ' ' ILE . 21.5 mt -102.69 -4.64 24.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.684 -177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 71.4 m-70 60.43 52.21 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.804 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.02 174.51 7.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.491 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 24.0 m -117.12 134.77 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.566 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.056 ' CE1' HG21 ' A' ' 367' ' ' VAL . 92.1 m-85 -90.13 145.91 24.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.438 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 6.5 t -119.11 101.22 49.99 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.649 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -54.54 153.71 22.41 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.073 1.565 . . . . 0.0 110.515 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.549 ' CE2' ' N ' ' A' ' 383' ' ' MET . 55.0 t80 -69.45 134.68 49.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 110.448 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 5.6 p -115.3 143.48 45.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.373 -0.829 . . . . 0.0 109.753 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.47 -24.8 59.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.689 -0.632 . . . . 0.0 110.418 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -61.55 -44.15 97.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 109.733 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 383' ' ' MET . 87.5 p -94.71 -13.57 25.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 110.183 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 57.75 48.09 14.46 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.606 -0.684 . . . . 0.0 109.803 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.889 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.2 ptp -165.44 171.55 13.21 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.779 0.799 . . . . 0.0 111.258 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.541 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 29.0 p -155.46 165.36 36.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.506 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.5 -165.73 34.09 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.048 -1.548 . . . . 0.0 110.694 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.722 HD11 HG22 ' A' ' 367' ' ' VAL . 4.5 tt -140.02 151.51 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.921 . . . . 0.0 110.208 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -127.54 135.55 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 109.693 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.794 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.93 155.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.816 -1.178 . . . . 0.0 109.174 172.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.502 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.5 m-20 -23.08 -63.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.389 0.614 . . . . 0.0 112.502 171.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.459 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 37.1 t30 -96.46 -5.1 40.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 111.808 -167.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.56 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.2 mtp180 -144.97 143.0 30.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.719 -1.238 . . . . 0.0 110.342 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -133.66 108.52 8.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 108.897 169.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.055 HD12 HD11 ' A' ' 339' ' ' LEU . 7.8 mt -128.65 146.03 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 0.0 109.931 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 25.1 mmt85 -134.43 159.7 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.295 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.1 OUTLIER -133.13 126.65 32.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.684 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.19 174.39 32.63 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -57.04 151.28 15.36 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.976 -1.308 . . . . 0.0 108.566 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.129 HG21 HG11 ' A' ' 420' ' ' VAL . 56.0 t -56.7 -35.01 44.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.851 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.85 -47.02 85.17 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.261 -0.9 . . . . 0.0 110.321 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.889 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.91 -49.18 63.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.963 -1.086 . . . . 0.0 110.59 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.684 HD11 ' N ' ' A' ' 396' ' ' GLY . 39.4 mm -65.59 -43.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.06 -1.025 . . . . 0.0 110.817 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.589 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.8 ttp180 -59.22 -43.26 92.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.243 -0.911 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.5 mtp180 -61.88 -36.37 81.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 173.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -67.93 -36.25 79.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.878 . . . . 0.0 111.236 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.62 -49.13 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.479 -1.388 . . . . 0.0 110.103 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -34.34 77.46 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.325 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.73 78.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.946 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.548 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 10.9 m-80 -61.8 -27.31 68.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.11 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.89 19.57 28.62 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.57 -169.02 16.17 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.448 ' C ' HG11 ' A' ' 405' ' ' VAL . 77.5 m80 -143.21 153.41 42.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.163 -1.198 . . . . 0.0 111.324 -174.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.5 p90 -108.39 149.75 39.71 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.642 -0.661 . . . . 0.0 110.182 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.828 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.71 124.0 8.45 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.879 1.463 . . . . 0.0 110.5 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.25 -34.22 77.51 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.986 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 91.1 m-20 -60.82 -33.03 72.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 108.836 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.034 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.7 t -83.52 -42.48 17.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.3 m-20 -54.8 -37.41 66.03 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.559 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.25 -48.32 78.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.17 -1.581 . . . . 0.0 110.104 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.692 ' HD3' HG21 ' A' ' 323' ' ' ILE . 19.1 mttp -56.58 -35.2 67.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.6 -1.313 . . . . 0.0 110.429 176.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.129 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.65 -40.98 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.885 -1.135 . . . . 0.0 109.208 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.76 -36.28 82.06 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.824 0.821 . . . . 0.0 109.581 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.67 -36.78 81.34 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.689 -0.632 . . . . 0.0 110.692 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.758 HG13 ' HB3' ' A' ' 428' ' ' ALA . 79.2 t -62.84 -37.95 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.005 -1.059 . . . . 0.0 110.043 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.13 85.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 110.406 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -67.91 -31.5 71.31 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 110.922 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.31 -3.47 55.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.724 175.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.92 22.04 29.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.758 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.99 164.09 12.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.562 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.61 ' HB ' HD12 ' A' ' 445' ' ' LEU . 93.9 m -109.89 107.29 58.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.077 -1.014 . . . . 0.0 109.691 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.581 ' HB2' HG22 ' A' ' 420' ' ' VAL . 39.7 Cg_endo -75.95 108.04 2.6 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 123.88 1.463 . . . . 0.0 110.613 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.894 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.4 mt -92.83 134.33 35.18 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.837 -1.164 . . . . 0.0 108.64 166.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.984 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.4 t -100.67 134.6 40.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 120.698 -1.251 . . . . 0.0 109.445 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.744 ' CG1' HD11 ' A' ' 440' ' ' LEU . 45.3 t -115.09 136.36 52.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.816 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.4 m -117.09 159.92 16.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.41 -0.806 . . . . 0.0 109.601 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.507 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.91 130.63 34.07 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.08 -133.17 31.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 405' ' ' VAL . 77.8 p -102.46 8.34 40.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.105 -1.232 . . . . 0.0 111.053 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -120.44 171.01 8.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.546 -1.346 . . . . 0.0 109.995 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.816 ' HA ' HG12 ' A' ' 434' ' ' VAL . 23.7 t -92.59 134.52 30.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.845 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.839 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.42 -22.13 18.49 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.308 -0.87 . . . . 0.0 109.793 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.976 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.47 176.95 38.64 Favored Glycine 0 N--CA 1.499 2.851 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.965 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.052 HG21 HG23 ' A' ' 420' ' ' VAL . 55.5 t -107.95 142.83 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.247 -1.149 . . . . 0.0 109.915 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.764 HD11 ' HB1' ' A' ' 337' ' ' ALA . 77.1 mt -101.49 111.42 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 108.907 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.615 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.85 118.58 30.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.917 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.894 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -113.47 162.02 16.64 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.759 -1.213 . . . . 0.0 110.974 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -73.63 144.73 45.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.638 -0.663 . . . . 0.0 110.207 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 448' ' ' ILE . 10.3 tp -120.69 153.46 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 110.227 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.21 135.44 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.27 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -90.59 145.39 24.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.187 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 117.937 -1.479 . . . . 0.0 109.501 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.228 0.537 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 97.3 mtt180 -122.85 146.69 47.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.893 . . . . 0.0 110.181 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.534 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.8 mt-30 -133.81 147.95 51.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.247 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.802 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -59.85 138.27 57.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 109.965 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 321' ' ' GLU . 46.6 m -122.13 -40.98 2.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.526 ' HG2' ' NH2' ' A' ' 359' ' ' ARG . 65.9 mt-10 -154.94 149.82 26.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.066 ' CD1' HD21 ' A' ' 355' ' ' LEU . 10.5 p90 -135.97 157.74 46.09 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.48 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.71 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.4 mt -134.84 140.16 34.38 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.604 -0.685 . . . . 0.0 109.397 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.561 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.54 144.82 50.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.644 1.339 . . . . 0.0 111.568 -172.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.058 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.74 151.52 43.5 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.134 -0.979 . . . . 0.0 108.829 164.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -58.86 129.4 41.95 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.658 -1.276 . . . . 0.0 110.095 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.09 -1.48 44.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.3 t -136.16 138.92 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.473 . . . . 0.0 110.647 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.3 m-20 -73.36 151.88 41.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.166 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -62.86 -39.81 95.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.023 -1.048 . . . . 0.0 110.362 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.92 -42.93 90.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.782 -1.198 . . . . 0.0 109.438 175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.515 HG21 HG13 ' A' ' 328' ' ' VAL . 94.4 m -56.9 -43.62 81.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.859 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 1.022 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -59.1 -40.58 85.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.33 -41.37 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.761 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -64.07 -49.73 71.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.914 -1.116 . . . . 0.0 109.92 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.892 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.98 -31.25 70.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.903 -1.123 . . . . 0.0 109.569 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.696 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.59 -35.23 65.59 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.324 -0.86 . . . . 0.0 108.985 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.7 mt-30 -74.25 -55.84 5.58 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.479 -0.763 . . . . 0.0 110.861 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.097 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.78 -36.14 80.22 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.681 -1.208 . . . . 0.0 109.807 -172.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.401 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -66.74 -20.67 66.01 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.055 173.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.2 p -107.35 9.18 29.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.215 -0.928 . . . . 0.0 111.552 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.4 -44.46 82.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.564 -1.335 . . . . 0.0 109.626 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.17 1.61 50.04 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.816 -170.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.478 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -64.34 130.6 44.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.732 -1.23 . . . . 0.0 109.944 175.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.72 5.44 51.39 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.58 0.705 . . . . 0.0 109.872 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.31 150.43 80.1 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.53 -0.731 . . . . 0.0 109.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.74 -38.14 84.75 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.651 1.342 . . . . 0.0 109.148 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.5 mt-10 -64.29 -28.58 69.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.496 -0.752 . . . . 0.0 110.377 176.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.33 -37.6 74.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -175.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 354' ' ' ILE . 96.1 mtt180 -77.32 -38.0 51.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.658 174.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.534 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 9.6 m -61.36 -37.97 85.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 110.365 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.542 HG23 HD13 ' A' ' 443' ' ' ILE . 88.8 mt -68.51 -49.31 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.069 -1.02 . . . . 0.0 110.602 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.619 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -61.17 -33.36 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.935 -1.103 . . . . 0.0 110.167 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.6 mt -72.84 -32.58 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.704 -1.248 . . . . 0.0 110.603 171.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.53 -40.82 88.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.964 -1.085 . . . . 0.0 110.414 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.26 -44.67 94.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.497 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.995 ' HB3' HD23 ' A' ' 362' ' ' LEU . 67.4 mttt -71.33 -47.37 56.96 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.743 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.545 ' CG ' ' HG3' ' A' ' 359' ' ' ARG . 20.5 pt20 -70.7 -42.58 70.45 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.667 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.545 ' HG3' ' CG ' ' A' ' 358' ' ' GLN . 40.8 mtp85 -79.89 -42.23 24.59 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 111.517 -170.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 85.5 m-85 -134.98 -35.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.437 -1.414 . . . . 0.0 112.097 -170.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 57.0 t-20 -161.86 101.87 1.15 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.632 -1.293 . . . . 0.0 111.669 -169.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.995 HD23 ' HB3' ' A' ' 357' ' ' LYS . 32.5 mt -57.47 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.816 -1.177 . . . . 0.0 108.908 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.542 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.9 tpt180 -134.34 164.31 27.69 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.416 -0.802 . . . . 0.0 109.241 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -135.74 -157.08 0.76 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.962 -1.086 . . . . 0.0 110.355 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 37.1 ptt180 -94.54 163.24 13.47 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.651 -0.655 . . . . 0.0 110.494 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.787 ' O ' HD12 ' A' ' 370' ' ' LEU . 88.3 m-20 -130.82 42.26 3.26 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.398 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.995 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.5 t -73.56 -45.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 110.345 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.78 -24.11 64.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.351 -0.843 . . . . 0.0 111.146 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.42 -32.85 32.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.013 -1.054 . . . . 0.0 109.719 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 366' ' ' ASP . 12.4 mt -104.73 -2.64 24.64 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.565 -0.709 . . . . 0.0 110.569 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 70.8 m-70 61.06 51.93 4.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 109.827 -176.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.758 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -92.78 174.64 7.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 0.0 110.533 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.8 m -119.18 136.22 54.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.478 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.995 ' CE1' HG21 ' A' ' 367' ' ' VAL . 73.4 m-85 -89.69 149.09 22.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.473 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 48.7 t -124.31 100.84 35.2 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.124 -0.985 . . . . 0.0 109.629 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -57.04 149.59 61.52 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.995 1.524 . . . . 0.0 110.251 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 21.4 t80 -63.61 129.95 42.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.87 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p -118.78 150.66 39.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.336 -0.853 . . . . 0.0 109.747 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.54 -4.26 47.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.584 -0.698 . . . . 0.0 109.985 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.55 -36.38 64.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.531 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 73.7 m -139.7 10.35 2.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 110.33 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 82.7 mtm180 58.1 52.77 7.28 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.311 -0.868 . . . . 0.0 109.735 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.832 ' HG2' ' HB1' ' A' ' 400' ' ' ALA . 0.7 OUTLIER -150.29 161.54 42.24 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.604 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 10.1 p -153.47 164.94 37.31 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 174.29 -164.94 36.26 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.881 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.901 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.6 tt -141.0 150.53 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.697 -0.884 . . . . 0.0 110.143 -176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -126.67 137.6 53.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.624 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.76 ' CD1' HD13 ' A' ' 370' ' ' LEU . 2.0 tt -141.53 154.7 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.352 172.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.506 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 88.9 m-20 -20.88 -62.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.48 0.657 . . . . 0.0 112.568 171.268 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.463 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t-20 -98.01 -7.49 29.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 111.934 -166.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.562 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 17.8 mtp180 -142.4 149.88 39.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.71 -1.244 . . . . 0.0 110.604 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -137.47 102.13 4.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 0.0 109.188 170.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.097 HD12 HD11 ' A' ' 339' ' ' LEU . 6.0 mt -121.64 146.09 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.097 -1.002 . . . . 0.0 110.007 -173.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.514 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 0.0 OUTLIER -136.77 155.32 49.98 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 110.261 177.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.608 ' HB3' HG22 ' A' ' 433' ' ' VAL . 43.7 pttt -129.23 145.82 51.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.17 173.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 401' ' ' ILE . . . -170.54 174.89 44.51 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 52.5 p -55.85 150.45 13.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.784 -1.421 . . . . 0.0 108.526 170.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.083 HG22 ' CG2' ' A' ' 432' ' ' VAL . 64.1 t -59.78 -34.96 57.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.064 -1.023 . . . . 0.0 109.977 -174.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.517 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 49.2 t0 -62.32 -45.89 91.21 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.196 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.832 ' HB1' ' HG2' ' A' ' 383' ' ' MET . . . -70.75 -52.01 23.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.085 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.769 HD13 ' CE ' ' A' ' 383' ' ' MET . 21.1 mm -62.98 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.998 -1.064 . . . . 0.0 110.505 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.595 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 13.4 ttp85 -59.46 -43.91 93.11 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.517 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 93.1 mtt180 -61.23 -36.99 81.46 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.448 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -66.9 -35.86 80.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -64.81 -49.72 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.455 -1.403 . . . . 0.0 110.152 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.63 -34.67 77.52 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.86 -1.15 . . . . 0.0 110.239 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.14 -35.76 78.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.995 -1.066 . . . . 0.0 109.971 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.7 m-80 -61.38 -27.38 68.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 109.134 173.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.87 19.59 28.62 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -169.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.42 -169.32 16.38 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -145.26 153.94 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -1.161 . . . . 0.0 111.232 -174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 439' ' ' VAL . 10.3 p90 -109.11 149.26 39.44 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.457 -0.777 . . . . 0.0 109.978 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.86 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.29 126.89 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.929 1.489 . . . . 0.0 110.401 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.3 t -66.92 -34.86 78.71 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.989 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.1 m-20 -62.01 -33.31 74.1 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.898 -1.126 . . . . 0.0 108.882 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.058 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.6 t -83.46 -41.77 17.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 110.987 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.33 -38.5 68.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.826 -1.171 . . . . 0.0 109.416 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.1 -47.92 80.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.374 -1.453 . . . . 0.0 110.264 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.71 ' HD3' HG21 ' A' ' 323' ' ' ILE . 66.9 mttm -56.39 -35.19 67.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.691 -1.256 . . . . 0.0 110.372 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.128 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -60.65 -40.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.405 172.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -65.85 -36.24 82.9 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 425' ' ' ARG . 94.9 mm-40 -68.38 -38.2 81.13 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 428' ' ' ALA . 63.0 t -61.0 -37.03 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.689 -1.257 . . . . 0.0 110.056 175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.0 82.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.969 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 422' ' ' GLN . 17.7 ptt180 -70.86 -28.68 64.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.721 -1.237 . . . . 0.0 111.097 -171.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 1.0 OUTLIER -82.62 -8.55 59.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.895 -1.128 . . . . 0.0 109.64 174.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.43 22.21 13.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.705 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -102.9 161.9 13.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -1.157 . . . . 0.0 109.323 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.873 ' HB ' HD12 ' A' ' 445' ' ' LEU . 2.0 m -109.16 106.94 59.49 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.062 . . . . 0.0 109.778 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 398' ' ' VAL . 44.5 Cg_endo -76.57 107.67 2.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 124.015 1.534 . . . . 0.0 110.452 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.86 ' HG ' HD11 ' A' ' 445' ' ' LEU . 10.3 mt -92.43 133.47 35.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.92 -1.112 . . . . 0.0 108.533 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 1.083 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.2 t -99.01 135.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.711 -1.243 . . . . 0.0 109.424 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.757 ' CG1' HD11 ' A' ' 440' ' ' LEU . 44.0 t -117.66 136.7 53.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 108.91 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -117.86 160.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.492 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.52 129.01 34.47 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.69 -131.6 28.98 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -167.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.608 ' O ' HG13 ' A' ' 405' ' ' VAL . 73.1 p -103.06 6.79 38.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.13 -1.218 . . . . 0.0 111.118 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -119.95 171.0 8.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.644 -1.285 . . . . 0.0 110.069 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.812 ' HA ' HG12 ' A' ' 434' ' ' VAL . 42.9 t -90.57 134.61 28.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.815 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -93.17 -22.6 18.96 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.672 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 1.022 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.33 176.87 39.04 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 118.883 -1.627 . . . . 0.0 110.721 170.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.128 HG21 HG23 ' A' ' 420' ' ' VAL . 56.6 t -107.94 142.84 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.161 -1.2 . . . . 0.0 109.994 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.8 mt -101.83 110.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 170.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.08 118.48 30.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.826 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.873 HD12 ' HB ' ' A' ' 429' ' ' THR . 0.9 OUTLIER -101.23 146.09 27.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.155 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 320' ' ' SER . 15.2 mmtp -107.61 150.38 26.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.566 -1.334 . . . . 0.0 110.58 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -101.13 148.16 25.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.708 -0.62 . . . . 0.0 110.255 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.5 tp -119.61 153.58 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 110.237 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.57 135.52 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.902 . . . . 0.0 110.329 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -90.75 145.6 24.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.22 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.561 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 75.9 mtt85 -123.05 150.29 43.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.254 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 351' ' ' SER . 93.4 mt-30 -125.31 147.83 48.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.863 . . . . 0.0 109.994 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.77 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -57.32 135.96 56.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.841 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.527 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 2.4 m -127.48 -37.21 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 110.385 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 320' ' ' SER . 65.2 mt-10 -153.58 148.07 26.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.958 . . . . 0.0 110.597 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.07 ' CD1' HD21 ' A' ' 355' ' ' LEU . 6.1 p90 -137.86 147.4 44.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.726 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.693 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.8 mt -119.96 141.83 32.16 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 109.625 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.54 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.02 143.23 40.06 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.735 1.387 . . . . 0.0 111.481 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.086 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.85 152.65 43.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.185 -0.947 . . . . 0.0 108.662 165.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -57.56 127.85 34.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.679 -1.263 . . . . 0.0 110.336 -172.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 115.68 -28.0 8.03 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 440' ' ' LEU . 42.4 t -115.0 140.49 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.738 -1.448 . . . . 0.0 110.943 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.03 150.13 44.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 109.788 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -61.35 -39.47 90.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 31.8 ttmt -60.51 -45.12 94.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.795 -1.191 . . . . 0.0 109.735 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 92.4 m -55.97 -43.92 78.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.698 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.616 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -58.03 -39.14 77.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.817 . . . . 0.0 110.233 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.022 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.92 -42.1 81.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 0.0 110.691 -176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -62.87 -48.35 79.4 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.924 -1.11 . . . . 0.0 109.832 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.899 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.02 -31.86 71.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.026 -1.046 . . . . 0.0 109.765 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.32 -35.25 64.93 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 172.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.543 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 20.6 mt-30 -74.67 -56.28 4.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.501 -0.749 . . . . 0.0 110.838 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.987 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -60.97 -35.39 76.67 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.756 -1.177 . . . . 0.0 109.772 -172.077 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -68.03 -19.52 64.91 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.088 -1.007 . . . . 0.0 109.782 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.1 p -108.23 9.41 28.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.206 -0.934 . . . . 0.0 111.639 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.722 HD22 ' HD2' ' A' ' 365' ' ' ARG . 36.8 mt -64.71 -44.84 88.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.551 -1.343 . . . . 0.0 109.705 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.49 1.72 46.94 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.707 -169.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.1 p30 -62.61 130.28 44.36 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.952 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.68 5.35 51.63 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.528 0.68 . . . . 0.0 109.891 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.56 152.4 83.3 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.607 -0.683 . . . . 0.0 109.432 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.95 -38.79 94.15 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.713 1.375 . . . . 0.0 109.08 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.7 mt-10 -64.35 -28.87 70.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.458 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.51 -37.26 66.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.494 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -76.69 -37.37 56.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.219 . . . . 0.0 110.553 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 318' ' ' GLN . 11.3 m -61.36 -38.44 86.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.001 -1.062 . . . . 0.0 110.42 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.628 HG23 HD13 ' A' ' 443' ' ' ILE . 83.7 mt -68.98 -48.84 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.051 . . . . 0.0 110.534 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.628 HG22 ' OG ' ' A' ' 341' ' ' SER . 30.4 t -61.67 -34.03 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.952 -1.092 . . . . 0.0 110.076 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.4 mt -72.89 -32.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.601 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.07 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.68 -40.91 89.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.39 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.93 99.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 82.7 mttt -71.26 -50.21 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.892 -1.13 . . . . 0.0 110.924 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.548 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.9 pt20 -70.36 -42.38 71.89 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.497 -174.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 30.6 mmt180 -74.16 -46.02 44.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 111.24 -172.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 78.3 m-85 -135.51 -35.5 0.81 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.437 -1.305 . . . . 0.0 112.437 -168.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.501 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 23.1 t-20 -160.52 97.85 1.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.484 -1.385 . . . . 0.0 111.677 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 362' ' ' LEU . 5.5 mp -58.77 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.933 -1.105 . . . . 0.0 109.59 171.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.8 tpt180 -147.84 163.08 37.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.387 -0.821 . . . . 0.0 109.618 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.7 mt-10 -125.97 -157.36 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.722 ' HD2' HD22 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -96.66 165.35 12.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.531 -0.73 . . . . 0.0 110.596 -178.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.475 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -121.0 38.08 4.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.428 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.966 ' CG2' HD11 ' A' ' 386' ' ' ILE . 71.0 t -69.28 -44.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.787 . . . . 0.0 110.307 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -67.43 -26.6 66.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.971 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -29.14 25.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.904 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.964 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.7 mt -103.45 -2.36 27.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.777 . . . . 0.0 110.837 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 27.2 m80 62.62 52.65 2.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.09 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.925 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -94.99 174.71 6.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.9 m -115.97 134.32 55.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 110.421 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.941 ' CE2' HG11 ' A' ' 367' ' ' VAL . 68.3 m-85 -89.19 149.26 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.541 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 24.1 t -122.71 100.97 40.29 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.9 Cg_endo -56.11 151.45 42.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.124 1.592 . . . . 0.0 110.486 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.51 131.63 46.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.096 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.1 p -120.71 152.94 37.62 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.44 -6.02 51.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.511 -0.743 . . . . 0.0 109.967 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.81 -32.86 66.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.872 . . . . 0.0 109.823 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 383' ' ' MET . 2.7 m -139.51 10.2 2.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 110.237 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 72.3 mtt85 56.91 51.06 11.2 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.868 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.3 ptp -158.69 168.61 26.41 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.948 0.88 . . . . 0.0 111.277 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 34.1 p -152.86 165.19 36.22 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -176.74 -165.89 32.96 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.04 -1.552 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.966 HD11 ' CG2' ' A' ' 367' ' ' VAL . 9.4 tt -144.1 150.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -1.03 . . . . 0.0 110.104 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 394' ' ' ARG . 43.0 m-20 -127.59 133.04 49.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.864 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.964 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.6 tt -139.28 155.03 25.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.75 -1.219 . . . . 0.0 109.165 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.504 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 90.7 m-20 -23.8 -62.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 172.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.445 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 49.5 t30 -92.36 -9.58 41.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 111.884 -167.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.587 ' H ' HG23 ' A' ' 388' ' ' ILE . 30.4 mtp180 -140.56 147.4 39.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.613 -1.304 . . . . 0.0 110.744 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.5 mtt -138.3 100.67 4.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.983 -1.073 . . . . 0.0 109.112 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.987 HD12 HD11 ' A' ' 339' ' ' LEU . 7.5 mt -122.66 146.47 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.934 -1.104 . . . . 0.0 110.296 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 387' ' ' ASN . 66.6 mmt-85 -130.49 156.84 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.142 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -132.91 125.46 29.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.458 -0.776 . . . . 0.0 108.97 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.529 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.85 173.94 32.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.717 -173.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.4 m -56.09 150.74 13.36 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.916 -1.343 . . . . 0.0 108.537 169.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.006 HG21 ' CG1' ' A' ' 420' ' ' VAL . 17.7 t -55.69 -37.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 109.932 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -64.04 -43.74 94.62 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.287 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.868 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.35 -51.2 47.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.555 HD13 ' HE1' ' A' ' 383' ' ' MET . 33.5 mm -64.96 -44.07 96.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 120.995 -1.066 . . . . 0.0 110.789 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.5 ttt180 -59.47 -42.94 93.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.192 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.9 mtp85 -61.65 -36.32 80.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.9 t-80 -67.49 -38.37 84.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 111.323 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.468 HG12 ' C ' ' A' ' 410' ' ' GLY . 67.9 t -65.88 -47.42 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.08 -34.25 77.6 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.859 -1.151 . . . . 0.0 110.33 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.34 80.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.093 . . . . 0.0 109.857 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 24.5 m-80 -62.01 -27.15 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.73 30.53 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -168.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.26 -170.67 18.37 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -146.9 153.92 40.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.173 -1.192 . . . . 0.0 111.111 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.628 ' HB3' HG21 ' A' ' 439' ' ' VAL . 6.8 p90 -108.99 151.9 42.15 Favored Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.456 -0.778 . . . . 0.0 110.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.874 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.4 125.99 11.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.909 1.478 . . . . 0.0 110.344 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.3 t -67.55 -32.74 73.71 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.7 m-20 -62.96 -33.6 75.73 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.895 -1.128 . . . . 0.0 108.808 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.086 HG21 ' HA ' ' A' ' 325' ' ' ALA . 51.1 t -83.71 -41.74 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.018 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.06 -38.37 67.94 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.8 -1.188 . . . . 0.0 109.475 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.3 mm-40 -63.48 -48.1 79.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 110.294 171.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.693 ' CD ' HG21 ' A' ' 323' ' ' ILE . 48.7 mttm -56.44 -35.25 67.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.611 -1.306 . . . . 0.0 110.411 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.034 HG23 HG21 ' A' ' 442' ' ' VAL . 2.9 t -60.14 -41.31 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.965 -1.084 . . . . 0.0 109.327 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.15 -35.91 81.74 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.852 0.835 . . . . 0.0 109.442 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -68.48 -37.62 80.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.582 -0.699 . . . . 0.0 110.886 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.696 HG13 ' HB3' ' A' ' 428' ' ' ALA . 70.9 t -62.85 -37.87 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.974 -1.079 . . . . 0.0 110.008 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.17 -40.38 82.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.945 . . . . 0.0 110.373 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.54 -31.22 70.3 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.252 -0.905 . . . . 0.0 110.931 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.46 -3.83 54.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.064 -1.023 . . . . 0.0 109.607 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 21.83 30.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.696 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.91 169.99 8.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 109.798 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.823 ' HB ' HD12 ' A' ' 445' ' ' LEU . 16.7 m -113.18 106.82 54.52 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.04 -1.037 . . . . 0.0 110.075 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.542 ' CG ' HG13 ' A' ' 420' ' ' VAL . 49.4 Cg_endo -79.39 107.38 2.16 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 O-C-N 123.898 1.473 . . . . 0.0 110.489 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.879 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.8 mt -93.09 137.95 31.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.883 -1.136 . . . . 0.0 108.625 167.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.912 ' CG2' HG22 ' A' ' 398' ' ' VAL . 92.4 t -101.56 134.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.678 -1.264 . . . . 0.0 109.613 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.812 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.7 t -114.52 134.53 57.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 108.824 174.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -118.4 160.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.501 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.52 130.15 32.04 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.88 -127.99 28.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.485 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.66 13.53 25.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -1.223 . . . . 0.0 111.233 -178.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -126.35 170.42 11.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 109.949 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.835 ' HA ' HG12 ' A' ' 434' ' ' VAL . 60.5 t -89.87 133.73 31.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.76 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -92.74 -21.36 20.0 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.323 -0.861 . . . . 0.0 109.574 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.825 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 168.93 176.86 39.36 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 118.909 -1.615 . . . . 0.0 111.093 169.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.034 HG21 HG23 ' A' ' 420' ' ' VAL . 56.4 t -107.88 142.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.071 -1.252 . . . . 0.0 109.777 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.701 HD11 ' HB1' ' A' ' 337' ' ' ALA . 77.5 mt -101.44 113.08 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.373 -0.83 . . . . 0.0 109.036 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.38 118.63 31.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.036 -1.04 . . . . 0.0 109.881 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.879 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.8 144.23 30.72 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.527 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.6 OUTLIER -137.4 168.32 19.87 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.574 -1.329 . . . . 0.0 110.986 -177.355 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -71.0 148.27 47.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.517 -0.739 . . . . 0.0 110.292 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.7 tp -117.27 154.31 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 110.117 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.25 136.36 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.336 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -142.17 147.48 36.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.011 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.547 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.241 0.543 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 94.5 mtt180 -123.22 144.1 49.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.1 mt-30 -130.37 148.81 52.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.081 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.707 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -57.79 136.83 56.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.97 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 3.4 m -118.98 -42.94 2.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 320' ' ' SER . 67.7 mt-10 -154.69 150.89 28.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.444 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.012 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 6.8 p90 -137.53 145.11 42.55 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.763 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.501 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.5 mp -118.26 144.42 34.96 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.596 -0.69 . . . . 0.0 109.775 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.554 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.6 143.62 38.39 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.764 1.402 . . . . 0.0 111.531 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.087 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.53 153.1 41.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 108.793 165.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -58.85 128.41 37.06 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.675 -1.266 . . . . 0.0 110.146 -172.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.86 -2.6 38.64 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.4 t -136.18 139.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.67 -1.488 . . . . 0.0 110.866 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.65 152.67 41.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.578 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.7 tt0 -62.01 -39.23 91.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.053 -1.029 . . . . 0.0 110.365 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -61.08 -45.21 95.67 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.816 -1.177 . . . . 0.0 109.765 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 92.2 m -55.8 -44.17 77.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.197 -0.94 . . . . 0.0 109.596 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.699 ' HA ' HD13 ' A' ' 440' ' ' LEU . 5.3 tp -57.99 -39.87 79.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.315 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.012 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.08 -1.013 . . . . 0.0 110.788 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.0 m-20 -63.44 -49.27 74.33 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.872 -1.143 . . . . 0.0 109.758 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.896 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.48 -31.67 71.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.821 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.656 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.69 -35.55 63.71 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.066 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.4 mt-30 -75.23 -55.79 5.36 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.506 -0.746 . . . . 0.0 110.999 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.039 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.28 -34.99 76.1 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.786 -172.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.414 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -66.89 -21.51 66.0 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.14 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.65 ' OG ' HG22 ' A' ' 353' ' ' VAL . 90.9 p -108.09 10.32 28.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.097 -1.002 . . . . 0.0 111.632 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.28 -44.67 82.92 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.696 -1.252 . . . . 0.0 109.694 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.26 1.43 49.62 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.885 -170.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.7 p30 -64.96 130.22 42.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.753 -1.217 . . . . 0.0 110.03 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.61 4.08 53.43 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.555 0.693 . . . . 0.0 109.863 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 346' ' ' THR . 3.2 p -73.79 152.62 89.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 109.38 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -55.94 -39.26 92.28 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.724 1.381 . . . . 0.0 109.149 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 97.8 mt-10 -65.05 -27.68 68.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.504 -0.747 . . . . 0.0 110.474 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.06 -39.24 79.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 354' ' ' ILE . 65.4 mtt85 -78.55 -35.78 45.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.6 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 6.3 m -60.98 -38.92 87.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.954 -1.091 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.616 HG23 HD13 ' A' ' 443' ' ' ILE . 88.2 mt -68.45 -49.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.062 . . . . 0.0 110.655 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.65 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.3 t -61.06 -34.57 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.988 -1.07 . . . . 0.0 110.124 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 350' ' ' ARG . 31.4 mt -72.52 -31.97 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 110.455 171.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.984 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.9 OUTLIER -60.12 -40.96 91.57 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.941 -1.099 . . . . 0.0 110.494 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.39 98.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 110.326 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 71.0 mttt -71.33 -49.09 45.99 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.68 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 11.7 pt20 -71.98 -43.26 65.42 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.73 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.594 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 78.7 mmt-85 -73.63 -44.44 56.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 111.435 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.594 ' CD2' ' HB3' ' A' ' 359' ' ' ARG . 60.3 m-85 -135.27 -38.72 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.522 -1.361 . . . . 0.0 112.125 -168.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.9 t30 -159.45 104.11 1.62 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.214 . . . . 0.0 111.58 -168.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 41.4 mt -57.42 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.875 -1.141 . . . . 0.0 108.912 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.492 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.7 tpt180 -131.42 164.06 26.56 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.477 -0.764 . . . . 0.0 109.25 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.9 mt-10 -138.13 -158.13 0.83 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.978 -1.076 . . . . 0.0 110.543 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.584 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.9 ptt85 -97.2 162.54 13.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 110.677 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 365' ' ' ARG . 89.2 m-20 -133.49 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.507 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.949 HG21 ' CE1' ' A' ' 374' ' ' PHE . 63.6 t -73.4 -47.61 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.491 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.02 -23.55 65.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -30.43 27.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.021 -1.05 . . . . 0.0 109.753 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.986 ' HB3' HD11 ' A' ' 388' ' ' ILE . 16.9 mt -103.53 -4.97 23.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.523 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 56.5 m-70 64.22 52.06 2.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.186 -176.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.912 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.86 174.91 6.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.631 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.4 m -117.98 136.03 53.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.949 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.1 m-85 -88.5 149.11 23.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.596 174.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 61.8 t -122.31 101.06 41.39 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.133 -0.979 . . . . 0.0 109.658 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.48 151.18 38.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.003 1.528 . . . . 0.0 110.413 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.632 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 15.1 t80 -65.02 132.31 48.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 110.048 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.4 p -120.67 151.96 38.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.354 -0.841 . . . . 0.0 109.611 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.43 -6.79 54.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.555 -0.716 . . . . 0.0 109.868 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -57.11 -32.87 66.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.768 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 6.8 p -138.4 9.61 2.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.331 -0.856 . . . . 0.0 110.353 174.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 79.9 mtm180 57.2 50.86 11.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.55 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.777 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.4 ptp -158.78 168.41 26.9 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.362 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.7 p -153.6 164.93 37.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.32 -166.68 35.54 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.714 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.847 HG21 ' HB2' ' A' ' 339' ' ' LEU . 4.2 tt -138.9 148.99 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.681 -0.894 . . . . 0.0 110.021 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -127.49 134.91 49.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.892 -1.13 . . . . 0.0 109.678 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.986 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -139.84 154.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.922 -1.111 . . . . 0.0 109.443 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.2 -62.99 0.06 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.48 0.657 . . . . 0.0 112.259 172.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 54.0 t30 -90.93 -10.21 43.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 111.686 -168.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.602 HH21 HD13 ' A' ' 339' ' ' LEU . 23.2 mtp180 -142.31 147.02 35.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.612 -1.305 . . . . 0.0 110.76 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.7 mtt -135.6 108.54 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.916 -1.115 . . . . 0.0 108.996 169.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.039 HD12 HD11 ' A' ' 339' ' ' LEU . 8.4 mt -128.17 145.9 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.008 -1.057 . . . . 0.0 110.058 -175.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 33.4 mtt180 -136.14 160.76 37.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 0.0 110.833 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.482 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.59 128.05 34.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.641 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.62 173.94 32.28 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 28.5 m -57.27 152.22 14.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.97 -1.312 . . . . 0.0 108.721 170.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.994 HG21 ' CG1' ' A' ' 420' ' ' VAL . 79.1 t -55.72 -35.99 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 109.783 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.6 t0 -63.25 -46.62 86.04 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.359 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.777 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.14 -50.57 53.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.497 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.641 HD11 ' N ' ' A' ' 396' ' ' GLY . 28.4 mm -64.59 -43.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.788 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.591 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.4 ttp180 -59.64 -43.71 93.76 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 67.2 mtp180 -61.93 -36.19 80.65 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.075 -1.015 . . . . 0.0 109.501 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.413 ' ND1' ' C ' ' A' ' 404' ' ' HIS . 2.3 t-80 -68.5 -36.46 78.94 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 111.353 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 437' ' ' SER . 55.8 t -65.97 -48.91 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.585 -1.322 . . . . 0.0 110.102 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.37 -34.21 77.22 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.2 79.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.074 . . . . 0.0 109.931 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.7 m120 -61.34 -27.7 68.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 109.153 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.12 19.8 27.45 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -169.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.63 -170.05 15.92 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -144.95 153.79 41.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.186 -1.185 . . . . 0.0 111.097 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.591 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.2 p90 -107.9 150.21 40.02 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.506 -0.746 . . . . 0.0 110.085 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.884 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.98 126.25 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.902 1.475 . . . . 0.0 110.291 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 2.0 t -67.64 -32.48 73.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.976 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 88.7 m-20 -63.43 -33.41 75.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.893 -1.13 . . . . 0.0 108.728 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.087 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.1 t -83.57 -40.99 16.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.938 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 52.4 t0 -55.19 -38.5 68.46 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.691 -1.204 . . . . 0.0 109.452 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.502 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.6 mt-30 -63.4 -48.62 77.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.433 -1.417 . . . . 0.0 110.285 171.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 50.1 mmtt -56.16 -35.15 66.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.667 -1.271 . . . . 0.0 110.488 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.052 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.65 -41.59 85.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 109.149 171.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -65.72 -35.81 81.82 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.896 0.855 . . . . 0.0 109.458 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.73 -36.94 81.49 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.556 -0.715 . . . . 0.0 110.724 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.751 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.7 t -62.94 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 110.046 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.82 85.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.307 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -69.42 -30.69 68.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.243 -0.91 . . . . 0.0 110.862 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.7 -3.57 56.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.7 21.89 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.751 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.42 166.41 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -1.139 . . . . 0.0 109.689 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.846 ' HB ' HD12 ' A' ' 445' ' ' LEU . 2.8 m -110.77 107.24 57.99 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.039 -1.038 . . . . 0.0 109.732 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 398' ' ' VAL . 40.8 Cg_endo -76.12 108.4 2.67 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 O-C-N 123.898 1.473 . . . . 0.0 110.431 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.855 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.5 mt -92.5 139.85 30.17 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.968 -1.083 . . . . 0.0 108.665 167.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.704 ' CG2' HG22 ' A' ' 398' ' ' VAL . 21.5 t -100.28 134.02 41.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.781 -1.199 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.937 ' CG1' HD11 ' A' ' 440' ' ' LEU . 13.9 t -115.13 132.89 63.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 108.591 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -119.33 160.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -175.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.2 tt0 -135.7 131.79 36.09 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.45 -128.41 30.16 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.582 ' O ' HG13 ' A' ' 405' ' ' VAL . 69.3 p -106.34 8.75 31.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.054 -1.262 . . . . 0.0 111.193 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -123.93 170.52 10.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.603 -1.31 . . . . 0.0 110.115 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.844 ' HA ' HG12 ' A' ' 434' ' ' VAL . 61.0 t -89.7 133.4 31.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.41 -0.806 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.937 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.7 pp -93.79 -19.9 20.6 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.498 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.87 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 170.34 176.72 40.03 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.846 -1.645 . . . . 0.0 110.894 167.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.052 HG21 HG23 ' A' ' 420' ' ' VAL . 55.1 t -107.82 143.0 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.121 -1.223 . . . . 0.0 109.86 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.656 HD11 ' HB1' ' A' ' 337' ' ' ALA . 75.8 mt -101.59 111.82 32.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 108.996 170.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.75 117.85 30.14 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.097 -1.002 . . . . 0.0 109.775 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.855 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -100.65 144.68 29.33 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -120.86 161.2 21.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.783 -1.198 . . . . 0.0 111.056 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -79.77 143.38 34.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.647 -0.658 . . . . 0.0 110.278 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 8.6 tt -112.65 152.77 14.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.344 -0.847 . . . . 0.0 110.36 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.5 t -103.65 136.28 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.311 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -90.87 145.94 24.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.243 0.544 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -122.65 141.8 51.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.4 mt-30 -134.97 152.81 52.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.171 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.707 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -61.06 139.32 58.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.803 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.522 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -123.37 -34.93 3.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.556 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.492 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.9 tt0 -163.79 149.41 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.36 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.073 ' CD1' HD21 ' A' ' 355' ' ' LEU . 16.4 p90 -135.74 145.45 46.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.847 -1.158 . . . . 0.0 111.725 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.742 HD13 ' HD3' ' A' ' 419' ' ' LYS . 11.4 mt -116.66 141.56 28.31 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.61 142.62 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.635 1.334 . . . . 0.0 111.712 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.033 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.41 151.66 44.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.348 -0.845 . . . . 0.0 108.86 165.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -58.08 129.21 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.735 -1.228 . . . . 0.0 110.09 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.44 -0.04 50.07 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 440' ' ' LEU . 53.5 t -135.28 138.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.74 -1.447 . . . . 0.0 110.764 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.7 m-20 -73.13 148.84 43.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.564 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.6 tt0 -60.22 -35.43 75.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.991 -1.068 . . . . 0.0 109.86 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.516 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.25 -43.44 87.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.001 -1.062 . . . . 0.0 109.297 176.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.528 HG21 HG13 ' A' ' 328' ' ' VAL . 92.7 m -60.81 -42.49 97.76 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.97 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.0 tp -60.49 -39.1 86.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.242 -0.911 . . . . 0.0 110.573 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.44 -44.2 79.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.061 . . . . 0.0 110.666 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.56 ' O ' HD23 ' A' ' 339' ' ' LEU . 89.4 m-20 -63.73 -49.05 74.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.908 -1.12 . . . . 0.0 110.056 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.937 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -69.03 -30.78 69.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.027 -1.046 . . . . 0.0 109.868 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.767 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.97 -35.69 64.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.125 -0.984 . . . . 0.0 108.953 171.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.574 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.68 -55.91 5.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.519 -0.738 . . . . 0.0 111.116 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.51 -33.86 76.89 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.033 -171.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.07 -21.48 65.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.965 -1.084 . . . . 0.0 110.147 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.731 ' OG ' HG22 ' A' ' 353' ' ' VAL . 78.5 p -106.46 10.57 31.36 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.188 -0.945 . . . . 0.0 111.473 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 50.6 mt -66.32 -44.68 82.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.562 -1.336 . . . . 0.0 109.672 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.74 2.79 52.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.997 -171.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.488 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 15.8 p30 -63.85 130.64 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.756 -1.215 . . . . 0.0 109.995 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.69 5.7 50.77 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.571 0.701 . . . . 0.0 109.949 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.4 p -77.11 149.78 80.02 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.614 -0.679 . . . . 0.0 109.541 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.85 -40.77 79.16 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.679 1.358 . . . . 0.0 109.255 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.16 -27.87 69.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.768 . . . . 0.0 110.382 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.92 -36.79 60.91 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.507 ' O ' HD12 ' A' ' 354' ' ' ILE . 94.4 mtt180 -75.91 -37.26 58.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.108 -1.23 . . . . 0.0 110.432 172.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.5 m -61.95 -38.04 87.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.049 -1.032 . . . . 0.0 110.418 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 443' ' ' ILE . 83.4 mt -68.6 -49.21 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.907 -1.121 . . . . 0.0 110.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.731 HG22 ' OG ' ' A' ' 341' ' ' SER . 21.5 t -61.2 -32.84 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.943 -1.098 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.672 HG22 ' OE1' ' A' ' 358' ' ' GLN . 42.4 mt -72.89 -31.76 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.771 -1.206 . . . . 0.0 110.808 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.073 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.73 -41.48 90.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.784 -1.198 . . . . 0.0 110.249 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.541 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.496 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.935 ' HB3' HD23 ' A' ' 362' ' ' LEU . 66.7 mttt -72.16 -51.07 23.01 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.672 ' OE1' HG22 ' A' ' 354' ' ' ILE . 20.2 pt20 -70.78 -42.73 70.0 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.706 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.9 mmm180 -74.94 -43.19 55.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 111.147 -172.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 55.2 m-85 -134.98 -39.48 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.675 -1.265 . . . . 0.0 112.012 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.514 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.5 t-20 -162.58 106.36 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.532 -167.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.935 HD23 ' HB3' ' A' ' 357' ' ' LYS . 54.1 mt -57.62 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.948 -1.095 . . . . 0.0 109.188 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.497 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.8 tpt180 -124.36 156.44 37.05 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.28 -0.888 . . . . 0.0 109.866 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 20.3 pt-20 -122.93 -167.66 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.023 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.586 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.5 ptt-85 -93.52 164.71 13.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 110.542 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.6 m-20 -129.43 40.84 3.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.965 HG21 ' CE1' ' A' ' 374' ' ' PHE . 93.8 t -73.75 -48.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.436 -0.79 . . . . 0.0 110.43 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.419 -0.801 . . . . 0.0 111.134 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -30.21 29.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 109.79 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.994 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.0 mt -102.83 -4.58 24.67 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 110.628 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.7 m-70 64.07 52.94 1.92 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.929 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.6 174.98 6.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 110.677 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.6 m -117.65 134.22 55.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.604 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.965 ' CE1' HG21 ' A' ' 367' ' ' VAL . 92.4 m-85 -89.71 143.55 26.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.577 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.458 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 41.9 t -118.2 101.22 51.58 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.9 Cg_endo -55.57 152.22 34.78 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.089 1.573 . . . . 0.0 110.343 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 19.2 t80 -63.4 132.31 51.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 0.0 110.174 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p -120.95 152.07 38.96 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.569 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.52 -6.96 55.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.547 -0.721 . . . . 0.0 109.864 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -57.17 -32.6 66.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 109.963 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 10.3 p -138.07 9.05 2.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.382 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 90.8 mtt-85 58.12 50.87 9.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.702 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.0 ptp -160.62 168.27 25.28 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.957 0.884 . . . . 0.0 111.328 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.0 p -153.59 164.88 37.49 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.44 -165.62 34.46 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 118.945 -1.597 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 367' ' ' VAL . 1.5 tt -139.11 148.51 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.663 -0.904 . . . . 0.0 109.989 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -127.24 135.33 50.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.676 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.994 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -139.87 154.87 24.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.867 -1.145 . . . . 0.0 109.363 171.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.492 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 89.7 m-20 -25.36 -63.16 0.06 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.447 0.641 . . . . 0.0 112.263 172.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.45 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 42.9 t-20 -92.14 -7.47 48.37 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.777 . . . . 0.0 111.804 -168.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.568 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 33.3 mtp180 -144.5 144.95 31.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.643 -1.286 . . . . 0.0 110.645 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.1 mtm -135.34 110.42 8.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.915 -1.116 . . . . 0.0 109.149 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 339' ' ' LEU . 8.6 mt -130.49 145.96 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 110.001 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 41.8 mtt180 -135.9 160.88 37.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 110.76 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.528 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.2 128.58 34.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.6 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.39 174.4 33.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -174.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -57.52 151.55 16.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.949 -1.324 . . . . 0.0 108.357 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.066 HG21 HG11 ' A' ' 420' ' ' VAL . 61.2 t -57.69 -34.57 47.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.074 -1.017 . . . . 0.0 109.951 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.6 t70 -62.65 -46.59 87.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.702 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.24 -50.02 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.985 -1.072 . . . . 0.0 110.562 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.6 HD11 ' N ' ' A' ' 396' ' ' GLY . 32.2 mm -64.54 -43.82 96.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.656 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 6.1 ttt180 -59.87 -42.74 94.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 73.5 mtp180 -61.42 -36.16 79.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.572 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -67.33 -38.21 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 437' ' ' SER . 68.9 t -65.5 -47.56 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.573 -1.329 . . . . 0.0 110.138 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -35.02 78.91 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.783 -1.198 . . . . 0.0 110.354 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.0 -1.063 . . . . 0.0 109.949 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 22.0 m-80 -62.11 -27.11 68.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.24 19.16 31.3 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.04 -169.19 18.19 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.487 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.33 153.38 42.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.102 -1.234 . . . . 0.0 111.478 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.627 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 9.0 p90 -108.46 149.81 39.82 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.664 -0.647 . . . . 0.0 110.153 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.819 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.13 123.57 7.91 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.849 1.447 . . . . 0.0 110.465 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.27 -34.49 78.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.031 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.4 m-20 -60.63 -32.99 72.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.951 -1.093 . . . . 0.0 108.91 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.033 HG21 ' HA ' ' A' ' 325' ' ' ALA . 54.6 t -83.55 -42.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.001 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.574 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.6 m-20 -55.49 -36.8 67.03 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.659 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 98.9 mm-40 -63.79 -48.77 75.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.326 -1.484 . . . . 0.0 110.184 171.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.742 ' HD3' HD13 ' A' ' 323' ' ' ILE . 65.3 mttm -56.78 -34.99 68.16 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.661 -1.274 . . . . 0.0 110.309 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.066 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.33 -41.24 83.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.987 -1.07 . . . . 0.0 109.279 171.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.6 t0 -66.47 -36.14 82.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 83.6 mt-30 -66.93 -37.38 84.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 428' ' ' ALA . 54.0 t -60.53 -38.9 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 109.942 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.85 92.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.943 . . . . 0.0 110.366 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 2.6 mtp180 -64.16 -31.54 72.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.134 -0.979 . . . . 0.0 110.722 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 2.8 mt-30 -80.96 -5.14 57.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.61 40.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.631 ' HB1' ' O ' ' A' ' 445' ' ' LEU . . . -103.0 172.81 6.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -1.103 . . . . 0.0 109.855 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.912 ' HB ' HD12 ' A' ' 445' ' ' LEU . 14.4 m -114.37 106.55 52.55 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.96 -1.088 . . . . 0.0 109.99 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.571 ' HB2' HG22 ' A' ' 420' ' ' VAL . 48.3 Cg_endo -79.76 107.26 2.08 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.927 1.488 . . . . 0.0 110.498 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.92 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.8 mt -93.41 135.67 34.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.878 -1.139 . . . . 0.0 108.785 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 1.023 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.5 t -100.91 134.36 41.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 O-C-N 120.802 -1.186 . . . . 0.0 109.53 175.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 440' ' ' LEU . 54.1 t -115.54 137.23 49.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.043 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -118.14 159.96 18.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.374 -0.829 . . . . 0.0 109.635 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.557 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.85 131.92 33.88 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.19 -129.07 31.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.501 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.45 12.24 28.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.117 -1.226 . . . . 0.0 111.09 -179.241 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -126.09 170.88 11.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.598 -1.314 . . . . 0.0 109.938 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 434' ' ' VAL . 23.3 t -90.88 134.23 30.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.762 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.45 -22.28 18.38 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.793 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.97 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.61 177.15 38.86 Favored Glycine 0 N--CA 1.501 3.005 0 C-N-CA 118.857 -1.639 . . . . 0.0 111.085 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.033 HG21 HG23 ' A' ' 420' ' ' VAL . 51.5 t -107.84 142.69 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.049 -1.265 . . . . 0.0 109.964 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.767 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.2 mt -101.37 112.86 35.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.28 119.32 31.76 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.92 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.43 146.94 27.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 2.7 pttp -138.22 166.6 23.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.477 -1.389 . . . . 0.0 110.706 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -79.03 144.72 34.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.528 -0.733 . . . . 0.0 110.147 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.6 tp -119.53 153.36 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 110.173 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.19 136.71 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -90.32 145.75 24.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 CA-C-O 118.045 -1.419 . . . . 0.0 109.61 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.463 ' O ' ' OD1' ' A' ' 316' ' ' ASN . 37.7 p-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.269 0.557 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 97.2 mtt180 -123.3 147.89 46.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.243 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.8 mt-30 -128.48 145.92 50.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.75 ' CA ' HD23 ' A' ' 445' ' ' LEU . . . -61.43 137.95 58.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.995 . . . . 0.0 109.924 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.62 -38.35 2.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.7 mt-10 -153.57 149.55 27.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.928 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.067 ' CD1' HD21 ' A' ' 355' ' ' LEU . 7.7 p90 -136.02 158.77 43.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.023 -1.048 . . . . 0.0 111.569 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.721 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.2 mp -133.94 139.7 34.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.21 144.2 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.613 1.323 . . . . 0.0 111.619 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.084 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.51 151.35 43.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 108.791 164.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -58.86 129.19 40.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.686 -1.259 . . . . 0.0 110.098 -172.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.12 -2.33 40.71 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.8 t -135.99 139.1 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.715 -1.462 . . . . 0.0 110.785 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.5 m-20 -73.31 152.48 40.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.895 . . . . 0.0 110.203 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -63.41 -40.55 97.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 0.0 110.538 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.3 -43.12 92.63 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.687 -1.258 . . . . 0.0 109.543 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 328' ' ' VAL . 93.8 m -55.86 -43.72 77.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.834 173.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.969 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.3 tp -59.6 -39.03 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.996 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.68 -42.96 81.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.768 -176.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.87 -48.61 76.03 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.803 -1.186 . . . . 0.0 109.901 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.876 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.54 -31.98 72.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.891 -1.131 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.72 -35.47 66.16 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.211 -0.931 . . . . 0.0 109.127 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 29.9 mt-30 -73.64 -55.79 5.83 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 110.893 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.058 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.93 -34.68 77.97 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.929 -171.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.43 -21.07 65.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -0.991 . . . . 0.0 110.014 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.646 ' OG ' HG22 ' A' ' 353' ' ' VAL . 92.3 p -107.68 10.24 29.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.227 -0.921 . . . . 0.0 111.569 -174.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.8 mt -65.88 -44.78 84.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.581 -1.324 . . . . 0.0 109.68 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.77 0.42 46.86 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.841 -170.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.476 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.3 p30 -63.03 130.45 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.778 -1.201 . . . . 0.0 109.926 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.65 5.69 50.8 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.568 0.699 . . . . 0.0 109.857 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.6 p -77.18 150.81 80.92 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.559 -0.713 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -53.42 -38.47 82.86 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.686 1.361 . . . . 0.0 109.14 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.9 mt-10 -64.53 -28.48 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.543 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.83 -37.95 71.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 354' ' ' ILE . 95.3 mtt180 -77.32 -38.13 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -1.18 . . . . 0.0 110.593 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.532 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 11.4 m -61.2 -38.29 86.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.878 -1.139 . . . . 0.0 110.359 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.68 -48.94 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.058 -1.026 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.646 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.6 t -61.36 -32.72 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.043 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.995 HG22 ' OE1' ' A' ' 358' ' ' GLN . 34.0 mt -72.73 -33.57 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.752 -1.218 . . . . 0.0 110.678 171.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.067 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.53 -40.8 83.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.8 -1.187 . . . . 0.0 110.397 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.48 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.928 ' HB3' HD23 ' A' ' 362' ' ' LEU . 24.9 mtmt -72.24 -49.4 35.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.547 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.995 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.7 pt20 -71.52 -42.49 67.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.32 -0.862 . . . . 0.0 110.843 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.598 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 39.0 mmt180 -73.75 -45.33 52.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.084 -1.01 . . . . 0.0 111.23 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.671 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 86.8 m-85 -135.59 -37.66 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.329 -1.349 . . . . 0.0 112.117 -169.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.492 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.1 t-20 -160.57 105.9 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.627 -1.296 . . . . 0.0 111.492 -168.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.928 HD23 ' HB3' ' A' ' 357' ' ' LYS . 51.9 mt -57.63 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.0 109.349 172.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.3 tpt180 -128.08 164.16 23.03 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -137.91 -160.43 1.06 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 110.085 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.71 163.91 12.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.522 -0.736 . . . . 0.0 110.67 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -131.39 42.63 3.18 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.507 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.068 HG21 ' CE1' ' A' ' 374' ' ' PHE . 42.3 t -72.7 -46.36 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 110.259 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.83 -27.31 66.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 111.152 -175.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.02 -30.1 28.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.756 176.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.785 ' HB3' HD11 ' A' ' 388' ' ' ILE . 21.8 mt -102.47 -5.02 24.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.524 -0.735 . . . . 0.0 110.635 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.4 m-70 60.3 52.27 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 109.761 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.772 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.04 174.57 7.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.456 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.9 m -117.12 134.64 54.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 110.499 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.068 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.7 m-85 -89.23 145.17 25.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.443 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 43.9 t -119.04 101.15 50.24 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.633 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.6 Cg_endo -55.22 151.37 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.067 1.562 . . . . 0.0 110.548 -175.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 10.2 t80 -64.48 131.91 48.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.87 . . . . 0.0 110.078 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.3 p -120.45 152.7 37.62 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.405 -0.81 . . . . 0.0 109.715 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.73 -6.54 54.34 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -56.97 -32.96 66.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.857 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.516 ' OG ' ' CG ' ' A' ' 383' ' ' MET . 4.9 p -138.86 9.79 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.335 -0.853 . . . . 0.0 110.375 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 69.9 mtt85 57.49 51.03 10.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.198 -0.939 . . . . 0.0 109.434 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.671 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.5 ptp -159.46 167.96 27.4 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.934 0.873 . . . . 0.0 111.203 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 17.3 p -154.41 165.14 37.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.33 -165.8 34.11 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.988 -1.577 . . . . 0.0 110.521 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.716 HD11 HG22 ' A' ' 367' ' ' VAL . 4.8 tt -138.68 151.6 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.639 -0.918 . . . . 0.0 110.231 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -127.39 133.99 49.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 109.747 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.785 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -140.38 155.18 23.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.937 -1.102 . . . . 0.0 109.2 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.6 m-20 -21.91 -63.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.47 0.652 . . . . 0.0 112.555 170.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.459 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 44.3 t-20 -95.57 -7.58 37.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 111.911 -167.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.563 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.4 mtp180 -142.95 144.92 32.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.745 -1.222 . . . . 0.0 110.55 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -135.3 101.33 4.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.845 -1.159 . . . . 0.0 108.967 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.058 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -123.89 146.03 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 110.143 -172.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 33.7 mtt180 -135.85 160.42 38.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.905 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.651 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.53 131.25 39.55 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.551 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -157.01 174.01 34.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.4 m -56.91 150.17 17.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.941 -1.329 . . . . 0.0 108.441 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.088 HG21 HG11 ' A' ' 420' ' ' VAL . 16.9 t -54.54 -36.97 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.969 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.5 m-20 -63.8 -44.25 93.87 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.319 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.671 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.42 -51.53 42.79 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.951 -1.093 . . . . 0.0 110.574 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 432' ' ' VAL . 30.6 mm -64.64 -42.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.082 -1.011 . . . . 0.0 110.736 -176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.594 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.9 ttp180 -59.15 -43.74 92.06 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.8 mtp180 -61.62 -36.8 81.76 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.416 ' ND1' ' C ' ' A' ' 404' ' ' HIS . 2.3 t-80 -68.18 -36.68 79.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.301 -0.874 . . . . 0.0 111.367 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 437' ' ' SER . 54.4 t -66.24 -47.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.59 -1.319 . . . . 0.0 110.16 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -34.8 78.6 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.756 -1.215 . . . . 0.0 110.293 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.22 81.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.968 -1.082 . . . . 0.0 109.883 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.6 m120 -60.94 -28.24 68.81 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.509 -0.744 . . . . 0.0 109.084 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.4 19.8 26.82 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 -169.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -116.05 -168.84 15.32 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.37 153.88 41.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.213 -1.169 . . . . 0.0 111.149 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.7 p90 -107.98 150.68 40.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.589 -0.694 . . . . 0.0 110.061 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.857 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.56 127.4 12.42 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.891 1.469 . . . . 0.0 110.49 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.2 t -66.99 -34.93 78.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 111.024 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.5 m-20 -61.43 -33.73 74.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.817 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.084 HG21 ' HA ' ' A' ' 325' ' ' ALA . 54.7 t -83.5 -41.68 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.37 -38.51 68.92 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.347 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.38 -48.0 79.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.324 -1.485 . . . . 0.0 110.309 171.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.721 ' HD3' HG21 ' A' ' 323' ' ' ILE . 35.8 mttm -56.71 -34.87 67.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.668 -1.27 . . . . 0.0 110.512 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.088 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.7 -41.68 86.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.91 -1.119 . . . . 0.0 109.136 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -65.94 -36.18 82.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.915 0.864 . . . . 0.0 109.493 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.5 -38.18 80.73 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 110.886 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 428' ' ' ALA . 69.4 t -62.3 -37.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.975 -1.078 . . . . 0.0 109.945 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.42 87.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.219 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.05 -33.08 74.99 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.258 -0.901 . . . . 0.0 111.208 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -80.98 -4.38 54.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.012 -1.055 . . . . 0.0 109.456 174.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.24 30.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.661 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.42 170.91 7.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -1.141 . . . . 0.0 109.863 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.865 ' HB ' HD12 ' A' ' 445' ' ' LEU . 7.5 m -112.45 106.62 55.71 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.988 -1.07 . . . . 0.0 110.108 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' ' 420' ' ' VAL . 55.3 Cg_endo -80.05 107.23 2.03 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 O-C-N 123.864 1.454 . . . . 0.0 110.541 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.898 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -93.6 140.44 29.61 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.915 -1.116 . . . . 0.0 108.717 167.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.89 ' CG2' HG22 ' A' ' 398' ' ' VAL . 98.5 t -101.07 135.6 36.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.798 -1.189 . . . . 0.0 109.568 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.0 ' CG1' HD11 ' A' ' 440' ' ' LEU . 22.3 t -115.93 136.19 53.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 108.745 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.826 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -120.53 160.44 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.477 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -135.49 129.97 33.96 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.26 -131.3 29.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.614 ' O ' HG13 ' A' ' 405' ' ' VAL . 76.5 p -103.29 8.97 38.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.087 -1.243 . . . . 0.0 111.138 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -123.32 170.84 9.89 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.555 -1.34 . . . . 0.0 110.152 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.826 ' HA ' HG12 ' A' ' 434' ' ' VAL . 61.9 t -91.04 134.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.357 -0.84 . . . . 0.0 109.824 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.0 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -92.83 -22.49 19.27 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.48 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.969 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 169.22 177.42 39.89 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.048 -1.549 . . . . 0.0 110.871 170.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.044 HG21 HG23 ' A' ' 420' ' ' VAL . 60.0 t -107.72 143.91 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.109 -1.23 . . . . 0.0 109.82 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.597 HD13 HG23 ' A' ' 352' ' ' ILE . 81.3 mt -101.62 112.62 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.448 -0.783 . . . . 0.0 108.997 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.36 118.24 30.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.861 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.898 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.66 148.15 25.93 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -175.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 16.1 pttt -125.62 165.09 19.17 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.563 -1.335 . . . . 0.0 110.343 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -78.52 139.26 38.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.395 -0.815 . . . . 0.0 110.473 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.2 tp -124.02 152.52 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.492 -0.755 . . . . 0.0 110.165 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.7 t -105.38 132.44 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.919 . . . . 0.0 110.354 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -93.63 145.63 24.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 110.208 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 117.932 -1.482 . . . . 0.0 109.539 179.843 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.303 0.573 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.499 ' NE ' ' OE2' ' A' ' 348' ' ' GLU . 85.2 mtm180 -123.38 143.95 49.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.462 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 87.6 mt-30 -133.69 145.99 50.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.224 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.721 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -64.2 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.934 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.463 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -117.37 -33.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -169.95 151.03 3.96 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.008 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.017 ' CD1' HD21 ' A' ' 355' ' ' LEU . 11.4 p90 -136.0 145.87 46.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.774 -1.204 . . . . 0.0 111.814 -177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.453 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.4 mp -116.53 143.16 30.73 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.667 -0.646 . . . . 0.0 109.631 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.8 Cg_endo -72.37 143.71 39.56 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.69 1.363 . . . . 0.0 111.583 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.063 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.65 152.4 41.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 108.782 165.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -58.78 128.96 39.84 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.575 -1.328 . . . . 0.0 110.097 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.66 -1.8 42.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.5 t -136.43 138.84 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.463 . . . . 0.0 110.749 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.4 m-20 -73.5 152.32 40.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -61.98 -40.11 94.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.037 -1.039 . . . . 0.0 110.443 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.13 -43.44 91.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 109.568 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.519 HG21 HG13 ' A' ' 328' ' ' VAL . 95.1 m -56.36 -43.56 79.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.88 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 1.024 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.6 tp -59.23 -39.8 83.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.268 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.0 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.17 -41.75 85.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 110.774 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.5 -49.16 74.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.892 -1.13 . . . . 0.0 109.971 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.898 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.7 -31.67 71.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.994 -1.066 . . . . 0.0 109.776 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.79 -34.9 65.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.02 -55.79 5.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.516 -0.74 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.067 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.34 -35.96 78.85 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.885 -173.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.16 -20.81 65.8 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.06 -1.025 . . . . 0.0 110.015 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.5 p -107.43 8.93 29.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.129 -0.982 . . . . 0.0 111.504 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.3 mt -65.48 -44.71 86.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.655 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.612 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.61 1.45 48.8 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.9 -170.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.487 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.47 130.2 43.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.803 -1.186 . . . . 0.0 110.057 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.92 5.45 51.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.595 0.712 . . . . 0.0 109.906 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -77.05 153.36 82.61 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.27 -38.33 95.26 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.734 1.386 . . . . 0.0 109.149 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.499 ' OE2' ' NE ' ' A' ' 317' ' ' ARG . 97.4 mt-10 -64.53 -29.66 70.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.75 . . . . 0.0 110.477 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.12 -35.51 59.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.3 mtt180 -76.97 -38.04 54.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.143 -1.21 . . . . 0.0 110.521 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.9 m -60.85 -38.09 84.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.92 -1.113 . . . . 0.0 110.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 443' ' ' ILE . 80.0 mt -69.01 -49.24 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.019 -1.051 . . . . 0.0 110.627 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.618 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -61.54 -33.84 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.0 110.198 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.749 HG22 ' OE1' ' A' ' 358' ' ' GLN . 34.2 mt -72.45 -33.09 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.741 -1.225 . . . . 0.0 110.553 171.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.017 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -59.68 -40.29 87.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.931 -1.106 . . . . 0.0 110.59 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.52 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.78 -45.12 91.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.284 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.971 ' HB3' HD23 ' A' ' 362' ' ' LEU . 30.1 mtmt -71.61 -49.26 41.95 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.706 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.749 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.6 pt20 -71.08 -42.4 69.41 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.76 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 37.8 mmt180 -73.11 -46.52 50.79 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 111.218 -172.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 73.6 m-85 -136.44 -35.82 0.73 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.411 -169.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.508 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 56.3 t-20 -158.91 102.43 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.546 -1.346 . . . . 0.0 111.619 -168.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.971 HD23 ' HB3' ' A' ' 357' ' ' LYS . 34.3 mt -57.8 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.858 -1.152 . . . . 0.0 109.295 171.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.525 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.6 tpt85 -135.96 163.64 29.8 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.34 -0.85 . . . . 0.0 108.941 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.51 -155.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.951 -1.093 . . . . 0.0 110.32 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.7 ptt180 -95.19 163.03 13.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.478 0.656 . . . . 0.0 110.523 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -127.78 40.24 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 110.464 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.939 HG11 ' CE2' ' A' ' 374' ' ' PHE . 57.4 t -74.61 -47.94 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.449 -0.782 . . . . 0.0 110.28 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.77 -26.02 65.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 110.954 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.44 -29.93 27.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 109.818 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.988 ' HB3' HD11 ' A' ' 388' ' ' ILE . 18.6 mt -103.83 -3.88 24.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 110.718 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.9 m80 62.77 53.15 2.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.932 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.43 174.92 6.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.672 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.2 m -116.3 134.27 55.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.567 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.939 ' CE2' HG11 ' A' ' 367' ' ' VAL . 81.4 m-85 -88.29 149.02 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 50.6 t -122.26 101.12 41.48 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -54.81 153.36 25.02 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.09 1.574 . . . . 0.0 110.443 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.586 ' CE2' ' N ' ' A' ' 383' ' ' MET . 58.3 t80 -69.07 134.27 49.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 11.0 p -115.14 144.24 43.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.797 174.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.03 -21.74 58.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.668 -0.645 . . . . 0.0 110.356 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.07 -45.21 94.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 109.729 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 383' ' ' MET . 66.6 m -95.64 -12.75 25.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 110.25 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 97.4 mtt180 57.83 49.74 11.6 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.6 -0.688 . . . . 0.0 109.627 -174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.963 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.4 ptp -165.03 170.41 15.17 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.839 0.828 . . . . 0.0 111.283 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.3 p -154.84 165.55 36.28 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.94 -165.7 34.27 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 118.771 -1.68 . . . . 0.0 110.821 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.7 tt -140.86 148.67 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.641 -0.917 . . . . 0.0 110.133 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.446 HD21 HG21 ' A' ' 375' ' ' VAL . 41.9 m-20 -127.72 135.06 49.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.869 -1.145 . . . . 0.0 109.724 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.988 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.55 154.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.861 -1.149 . . . . 0.0 109.446 171.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 89.3 m-20 -25.4 -62.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.299 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.454 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.2 t30 -92.03 -7.83 47.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 -168.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.7 mtp180 -144.03 144.97 31.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.699 -1.25 . . . . 0.0 110.574 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.71 109.94 8.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.833 -1.167 . . . . 0.0 109.02 169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.067 HD12 HD11 ' A' ' 339' ' ' LEU . 8.6 mt -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.047 -1.033 . . . . 0.0 110.052 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 25.0 mmt85 -134.54 160.47 37.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.449 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.514 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.03 126.83 32.75 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.568 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.71 173.7 31.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.6 t -58.21 150.76 20.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.901 -1.352 . . . . 0.0 108.554 170.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.044 HG21 HG11 ' A' ' 420' ' ' VAL . 53.5 t -55.63 -35.48 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.971 -1.08 . . . . 0.0 109.607 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.09 -46.45 89.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.165 -0.96 . . . . 0.0 110.366 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.963 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -69.17 -51.02 42.3 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.028 -1.045 . . . . 0.0 110.639 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.568 HD11 ' N ' ' A' ' 396' ' ' GLY . 28.7 mm -64.28 -41.62 92.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 110.816 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.594 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 34.8 ttt-85 -59.65 -45.17 92.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.3 mtp85 -62.59 -35.51 79.75 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.205 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 111.212 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.84 -48.95 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.501 -1.375 . . . . 0.0 110.109 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.4 -34.11 77.02 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 110.253 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.97 -36.19 79.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.941 -1.099 . . . . 0.0 109.923 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.6 m-80 -61.63 -27.49 68.7 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.511 -0.743 . . . . 0.0 109.228 173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.06 19.43 28.64 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -170.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.78 -170.34 16.49 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.66 153.59 41.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 111.098 -174.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.4 p90 -107.21 150.15 39.57 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.528 -0.733 . . . . 0.0 110.039 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.879 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -72.27 127.4 12.63 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.846 1.445 . . . . 0.0 110.42 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -67.0 -34.96 78.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 111.016 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 55.9 t0 -62.12 -33.05 73.74 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.865 -1.147 . . . . 0.0 108.823 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.063 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.8 t -83.52 -41.66 16.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.906 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.498 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.8 t0 -55.14 -38.17 67.88 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.455 171.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.66 -48.16 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.33 -1.481 . . . . 0.0 110.299 171.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 15.0 mmtt -56.2 -35.36 67.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.59 -1.319 . . . . 0.0 110.384 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.078 HG23 HG21 ' A' ' 442' ' ' VAL . 3.3 t -60.23 -41.31 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.963 -1.086 . . . . 0.0 109.435 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -65.83 -36.04 82.37 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.922 0.868 . . . . 0.0 109.398 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.24 -37.58 80.95 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.868 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 428' ' ' ALA . 66.9 t -63.05 -37.35 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.91 -1.119 . . . . 0.0 110.01 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.36 85.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.71 -30.03 67.57 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.352 -0.842 . . . . 0.0 110.892 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.37 -3.53 55.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.785 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.23 21.79 28.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.58 170.89 7.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -1.081 . . . . 0.0 109.47 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.664 ' O ' HD12 ' A' ' 445' ' ' LEU . 21.3 m -116.92 106.85 47.01 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 109.52 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.601 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.3 Cg_endo -74.59 107.43 2.46 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 O-C-N 123.965 1.508 . . . . 0.0 110.331 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.625 ' HG ' HD13 ' A' ' 445' ' ' LEU . 15.8 mt -92.57 132.67 36.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.913 -1.117 . . . . 0.0 108.38 167.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.969 ' CG2' HG22 ' A' ' 398' ' ' VAL . 60.6 t -100.75 136.43 32.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.834 -1.166 . . . . 0.0 109.681 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.847 ' CG1' HD11 ' A' ' 440' ' ' LEU . 41.8 t -115.25 138.17 46.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 108.991 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.7 159.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.461 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.56 133.78 40.62 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 170.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.44 -126.83 31.07 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -168.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.62 ' O ' HG13 ' A' ' 405' ' ' VAL . 71.7 p -108.14 8.08 27.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.021 -1.281 . . . . 0.0 111.228 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -123.98 171.03 10.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.542 -1.349 . . . . 0.0 110.147 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.82 ' HA ' HG12 ' A' ' 434' ' ' VAL . 60.5 t -88.94 134.62 27.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.933 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.847 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -92.71 -22.12 19.59 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.602 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 1.024 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 171.04 176.31 40.15 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 118.803 -1.665 . . . . 0.0 110.816 168.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.078 HG21 HG23 ' A' ' 420' ' ' VAL . 48.2 t -107.88 143.18 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.239 . . . . 0.0 109.616 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.671 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.7 mt -101.47 118.62 48.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.326 -0.858 . . . . 0.0 108.773 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -98.14 117.58 32.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -176.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 429' ' ' THR . 3.6 mp -112.24 145.28 40.21 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.014 -1.054 . . . . 0.0 109.781 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -110.92 159.86 17.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.728 -1.233 . . . . 0.0 111.199 -174.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -93.72 148.52 22.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.769 -0.582 . . . . 0.0 110.085 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.6 tp -117.57 152.92 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.231 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.1 136.31 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.867 . . . . 0.0 110.365 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -91.89 144.32 25.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 110.177 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.533 -179.881 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.27 0.557 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 89.9 mtt180 -122.28 149.56 43.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.127 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 90.5 mt-30 -126.02 146.67 49.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.213 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 355' ' ' LEU . . . -59.3 137.56 57.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.02 . . . . 0.0 109.765 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.516 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.9 m -117.89 -44.02 2.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.1 -1.0 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 320' ' ' SER . 66.1 mt-10 -154.81 151.48 28.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -0.908 . . . . 0.0 110.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.993 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.6 p90 -136.0 140.43 43.9 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.918 -1.114 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.466 HG23 ' HD2' ' A' ' 324' ' ' PRO . 3.4 mt -112.67 143.84 29.79 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.784 -0.573 . . . . 0.0 109.708 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.76 142.55 35.81 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.678 1.357 . . . . 0.0 111.614 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.057 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.48 152.81 42.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 108.861 165.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -59.11 128.64 38.21 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.586 -1.321 . . . . 0.0 110.178 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.46 46.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.3 t -136.73 139.38 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.677 -1.484 . . . . 0.0 110.703 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.8 m-20 -74.32 152.37 39.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.9 tt0 -61.53 -40.28 94.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.038 -1.039 . . . . 0.0 110.278 -177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.5 -43.84 93.26 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.665 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.502 HG21 HG13 ' A' ' 328' ' ' VAL . 93.4 m -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.742 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 1.019 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.3 tp -59.21 -39.2 81.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.296 175.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.993 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.44 -41.4 84.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.991 -1.068 . . . . 0.0 110.729 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.543 ' O ' HD23 ' A' ' 339' ' ' LEU . 88.4 m-20 -63.28 -49.92 72.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.975 -1.078 . . . . 0.0 109.84 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.903 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.0 -31.98 72.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 109.901 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.822 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.26 -35.35 64.9 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.166 -0.959 . . . . 0.0 108.961 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.55 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.9 mt-30 -75.5 -55.89 5.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.564 -0.71 . . . . 0.0 110.971 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.014 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -62.36 -35.24 78.52 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.756 -172.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.428 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.07 -20.87 65.89 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.984 -1.072 . . . . 0.0 109.978 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.8 p -107.82 9.95 28.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.205 -0.934 . . . . 0.0 111.547 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.9 mt -66.36 -44.37 83.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.516 -1.365 . . . . 0.0 109.633 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.39 2.15 50.13 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.787 -170.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 14.0 p30 -64.17 130.08 42.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.739 -1.226 . . . . 0.0 110.015 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.42 4.44 53.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.508 0.671 . . . . 0.0 109.873 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.1 p -74.17 152.95 88.4 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 109.404 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.74 -40.05 87.01 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.737 1.388 . . . . 0.0 109.162 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 99.0 mt-10 -64.68 -27.56 69.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 0.0 110.481 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.22 -37.74 65.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.5 mtt180 -77.15 -37.83 53.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -1.223 . . . . 0.0 110.514 173.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.4 m -61.04 -38.06 84.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.613 HG23 HD13 ' A' ' 443' ' ' ILE . 90.6 mt -68.12 -49.61 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.613 HG22 ' OG ' ' A' ' 341' ' ' SER . 37.2 t -60.87 -33.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.014 . . . . 0.0 110.07 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.614 HG22 ' OE1' ' A' ' 358' ' ' GLN . 29.4 mt -72.92 -32.91 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.701 -1.25 . . . . 0.0 110.565 171.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.951 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.43 -40.17 85.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.809 -1.182 . . . . 0.0 110.545 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.407 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.51 -44.69 93.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.938 ' HB3' HD23 ' A' ' 362' ' ' LEU . 16.1 mtmt -71.46 -49.6 39.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.638 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.614 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.6 pt20 -71.51 -42.54 67.87 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 110.793 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.525 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.9 mmt180 -72.86 -45.7 56.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 111.24 -172.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.571 ' CE2' ' OE2' ' A' ' 330' ' ' GLU . 56.1 m-85 -135.76 -38.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.143 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.511 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.3 t30 -159.0 105.18 1.75 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.758 -1.214 . . . . 0.0 111.528 -168.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 357' ' ' LYS . 46.7 mt -57.45 89.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.842 -1.161 . . . . 0.0 109.163 171.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.535 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.1 tpt180 -131.14 164.49 25.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.236 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.4 mt-10 -136.88 -157.19 0.76 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.153 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 31.8 ptt-85 -94.65 162.52 13.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 88.4 m-20 -128.68 41.21 3.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.287 176.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.082 HG21 ' CE1' ' A' ' 374' ' ' PHE . 26.0 t -73.47 -45.73 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.45 -28.18 66.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 111.079 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.19 -29.87 28.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.037 -1.039 . . . . 0.0 109.763 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.771 ' HB3' HD11 ' A' ' 388' ' ' ILE . 26.0 mt -103.64 -4.63 23.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.494 -0.754 . . . . 0.0 110.613 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.1 m-70 60.64 52.49 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.842 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.781 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -95.09 174.39 7.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.409 -0.807 . . . . 0.0 110.638 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.3 m -117.35 135.68 53.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.082 ' CE1' HG21 ' A' ' 367' ' ' VAL . 74.2 m-85 -89.39 148.79 23.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.626 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 64.0 t -122.17 100.69 42.21 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.26 150.36 49.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.046 1.551 . . . . 0.0 110.512 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.9 t80 -62.99 131.79 49.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p -121.23 152.95 38.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.797 . . . . 0.0 109.639 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.31 -5.81 50.89 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.545 -0.722 . . . . 0.0 109.936 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.1 -32.75 66.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.873 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 383' ' ' MET . 1.4 m -139.48 9.97 2.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.295 175.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 87.7 mtt180 57.6 51.15 9.91 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 109.465 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.867 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.4 ptp -160.05 169.07 24.15 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.895 0.855 . . . . 0.0 111.314 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.537 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.6 p -153.64 164.92 37.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.15 -167.11 35.6 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.643 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.843 HG21 ' HB2' ' A' ' 339' ' ' LEU . 4.0 tt -140.04 150.28 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.554 -0.968 . . . . 0.0 110.136 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.53 134.52 50.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.956 -1.09 . . . . 0.0 109.809 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.771 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -142.41 155.22 18.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.947 -1.096 . . . . 0.0 109.181 173.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 91.5 m-20 -22.41 -63.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.413 0.625 . . . . 0.0 112.582 171.306 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.46 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t30 -96.35 -6.01 38.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 111.776 -167.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.564 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.5 mtp180 -143.74 143.89 31.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.705 -1.247 . . . . 0.0 110.381 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -134.02 99.43 4.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.974 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.014 HD12 HD11 ' A' ' 339' ' ' LEU . 7.2 mt -121.29 145.96 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.036 -1.04 . . . . 0.0 110.103 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 31.4 mtt180 -133.83 159.68 39.9 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.08 -1.013 . . . . 0.0 110.689 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.489 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.19 127.23 31.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.344 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.567 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.23 174.07 32.7 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -173.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 35.7 m -56.99 151.51 14.75 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.854 -1.38 . . . . 0.0 108.572 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.052 HG21 HG11 ' A' ' 420' ' ' VAL . 57.7 t -57.02 -34.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.993 -1.067 . . . . 0.0 109.856 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.8 t0 -62.88 -46.54 87.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.218 -0.926 . . . . 0.0 110.414 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.867 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.9 -50.42 56.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.006 -1.059 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.567 HD11 ' N ' ' A' ' 396' ' ' GLY . 32.5 mm -65.38 -43.69 94.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 110.763 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.585 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.7 ttp85 -58.9 -43.57 91.04 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.348 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.0 mtp180 -61.92 -36.26 80.83 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 109.44 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 401' ' ' ILE . 2.3 t-80 -67.61 -37.03 81.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 111.277 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 437' ' ' SER . 55.9 t -66.03 -48.26 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.657 -1.277 . . . . 0.0 110.157 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.99 -34.2 77.46 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.845 -1.16 . . . . 0.0 110.395 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.67 -36.39 80.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.924 -1.11 . . . . 0.0 109.816 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.9 m120 -61.63 -27.62 68.79 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.22 173.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.02 20.35 28.43 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -168.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.44 -170.87 17.6 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.416 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.0 m-70 -143.96 153.79 42.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -1.221 . . . . 0.0 111.186 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.592 ' HB3' HG21 ' A' ' 439' ' ' VAL . 5.3 p90 -107.37 150.96 40.68 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.61 -0.681 . . . . 0.0 110.098 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.846 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -73.3 124.41 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.869 1.457 . . . . 0.0 110.202 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -65.99 -34.87 79.09 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 111.064 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 54.1 t0 -61.41 -33.05 73.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.949 -1.094 . . . . 0.0 108.859 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.057 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.2 t -83.7 -42.44 17.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 111.009 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.508 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 9.3 m-20 -55.46 -37.26 67.53 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.575 171.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.7 mt-30 -63.72 -48.96 74.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.29 -1.506 . . . . 0.0 110.205 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 72.6 mmtt -56.65 -34.79 67.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.717 -1.239 . . . . 0.0 110.373 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.07 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.73 -41.23 84.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.0 -1.062 . . . . 0.0 109.283 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -66.48 -36.25 82.29 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.03 -38.19 82.25 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.565 -0.709 . . . . 0.0 110.782 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.777 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.5 t -62.48 -37.56 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.902 -1.124 . . . . 0.0 110.016 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.3 87.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 110.192 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -65.9 -33.8 76.66 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.38 -0.825 . . . . 0.0 111.177 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -81.69 -4.2 55.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 175.055 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 22.56 28.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.777 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -103.23 165.31 11.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -1.115 . . . . 0.0 109.618 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.768 ' HB ' HD12 ' A' ' 445' ' ' LEU . 10.0 m -110.89 106.87 57.83 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.018 -1.051 . . . . 0.0 109.863 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.567 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.35 108.42 2.7 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.972 1.512 . . . . 0.0 110.64 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.861 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.7 mt -91.86 133.96 35.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.861 -1.149 . . . . 0.0 108.497 166.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.929 ' CG2' HG22 ' A' ' 398' ' ' VAL . 83.8 t -99.86 134.73 38.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 120.799 -1.188 . . . . 0.0 109.465 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.014 ' CG1' HD11 ' A' ' 440' ' ' LEU . 23.5 t -114.46 138.57 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.881 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.821 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -122.12 160.45 24.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.657 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.447 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.17 129.26 33.51 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.25 -129.33 28.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.496 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 5.4 p -104.96 10.18 34.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.105 -1.232 . . . . 0.0 111.089 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -121.85 170.83 9.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.574 -1.329 . . . . 0.0 110.128 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 434' ' ' VAL . 41.2 t -93.8 134.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.315 -0.866 . . . . 0.0 109.762 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.014 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -95.96 -20.5 18.69 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.805 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 1.019 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.54 176.5 38.88 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 118.719 -1.705 . . . . 0.0 110.981 168.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.07 HG21 HG23 ' A' ' 420' ' ' VAL . 47.3 t -107.96 142.13 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.091 -1.24 . . . . 0.0 109.938 173.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.822 HD11 ' HB1' ' A' ' 337' ' ' ALA . 81.8 mt -101.53 111.25 30.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.042 170.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.651 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.75 118.65 30.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.099 -1.0 . . . . 0.0 109.909 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.861 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -101.07 144.62 29.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.333 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -121.59 160.49 24.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 111.153 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -100.14 143.32 30.48 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.23 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 8.3 tp -123.78 151.93 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 110.335 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 55.3 t -136.99 135.9 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -145.12 146.21 31.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 CA-C-O 117.987 -1.452 . . . . 0.0 109.567 179.706 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.286 0.565 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.542 ' NH1' HG21 ' A' ' 429' ' ' THR . 84.7 mtm180 -123.36 140.64 52.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 110.221 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 61.4 tt0 -126.69 131.01 51.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.264 -0.898 . . . . 0.0 110.354 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.803 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.66 138.61 41.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 109.789 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.528 ' O ' ' CZ ' ' A' ' 359' ' ' ARG . 20.8 m -124.34 -40.04 2.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.988 . . . . 0.0 110.276 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 320' ' ' SER . 57.9 mt-10 -154.66 146.54 23.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.103 ' CD1' HD21 ' A' ' 355' ' ' LEU . 9.2 p90 -137.6 142.34 41.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.593 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.538 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.9 mt -116.11 145.82 35.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.758 -0.589 . . . . 0.0 109.827 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -73.42 143.03 34.13 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.778 1.409 . . . . 0.0 111.468 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.047 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.22 152.72 42.02 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 108.881 165.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 13.4 tp60 -57.82 128.43 37.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.74 -1.225 . . . . 0.0 110.058 -173.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.62 -2.61 39.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.7 t -136.74 140.34 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.667 -1.49 . . . . 0.0 110.809 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -74.08 152.98 39.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.07 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -62.18 -38.73 90.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.354 -176.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -60.92 -45.66 93.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.697 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 95.0 m -55.99 -43.73 77.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.674 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.2 tp -58.08 -40.55 81.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.014 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.15 -39.86 82.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.08 -1.013 . . . . 0.0 110.717 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.1 m-20 -62.82 -49.09 76.29 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 109.757 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.29 -31.49 70.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.884 -1.135 . . . . 0.0 109.73 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.667 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.28 -34.9 64.51 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 172.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 17.7 mt-30 -74.25 -55.6 5.85 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 110.827 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.002 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.05 -35.24 78.03 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.048 -172.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.66 -21.08 65.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 110.131 174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.569 ' OG ' HG22 ' A' ' 353' ' ' VAL . 89.3 p -107.52 10.04 29.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.0 111.508 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.5 mt -65.68 -45.51 82.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.622 -1.299 . . . . 0.0 109.793 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.5 0.85 48.28 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.865 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 341' ' ' SER . 10.7 p30 -64.25 130.57 44.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.817 -1.177 . . . . 0.0 110.023 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.83 5.61 50.89 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.566 0.698 . . . . 0.0 109.863 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.0 p -75.76 154.72 85.25 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.68 -39.5 90.71 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.786 1.414 . . . . 0.0 109.222 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.558 ' CD ' HD13 ' A' ' 445' ' ' LEU . 96.1 mt-10 -64.9 -27.46 68.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.47 -0.769 . . . . 0.0 110.634 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.61 -39.83 76.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -174.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -78.02 -36.81 48.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -1.182 . . . . 0.0 110.662 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.5 m -61.25 -38.97 88.6 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.928 -1.108 . . . . 0.0 110.4 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.537 HG23 HD13 ' A' ' 443' ' ' ILE . 87.4 mt -69.11 -48.33 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.708 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.569 HG22 ' OG ' ' A' ' 341' ' ' SER . 34.8 t -62.14 -34.52 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.846 -1.159 . . . . 0.0 110.204 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.6 mt -73.2 -32.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.686 -1.259 . . . . 0.0 110.632 171.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.103 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -58.19 -41.27 83.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.97 -1.081 . . . . 0.0 110.2 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.99 -44.07 93.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.556 -0.715 . . . . 0.0 110.618 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.99 ' HB3' HD23 ' A' ' 362' ' ' LEU . 74.6 mttt -69.8 -49.56 51.55 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.662 -173.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.7 pt20 -72.27 -42.85 65.11 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.644 -172.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.769 ' HE ' HD12 ' A' ' 355' ' ' LEU . 84.6 mtt-85 -78.89 -39.52 34.74 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 111.707 -171.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.669 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 76.3 m-85 -134.77 -38.64 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.462 -1.399 . . . . 0.0 112.088 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 48.6 t30 -160.57 99.79 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.585 -1.322 . . . . 0.0 111.649 -169.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.99 HD23 ' HB3' ' A' ' 357' ' ' LYS . 34.1 mt -57.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.865 -1.147 . . . . 0.0 109.329 171.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.541 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.4 tpt180 -141.58 164.04 31.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.169 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.7 mt-10 -130.23 -154.24 0.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.474 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.7 ptt-85 -94.11 162.97 13.66 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.686 -0.634 . . . . 0.0 110.576 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.3 p30 -125.49 39.09 4.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.943 HG11 ' CE2' ' A' ' 374' ' ' PHE . 61.6 t -74.53 -47.5 39.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.352 -0.843 . . . . 0.0 110.281 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.86 -26.26 65.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 111.004 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.77 -29.74 27.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.001 . . . . 0.0 109.724 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.997 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.9 mt -104.33 -3.63 23.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.449 -0.782 . . . . 0.0 110.711 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.3 m80 62.6 53.22 2.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -177.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.937 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.46 175.01 6.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 0.0 110.646 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.3 m -115.94 134.43 54.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.476 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.943 ' CE2' HG11 ' A' ' 367' ' ' VAL . 80.5 m-85 -88.32 149.04 23.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.434 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 25.6 t -121.56 101.11 43.62 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 109.735 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.9 Cg_endo -55.03 153.05 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 110.468 -176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.566 ' CE2' ' N ' ' A' ' 383' ' ' MET . 56.8 t80 -70.54 134.44 47.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.6 p -115.62 143.57 45.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.386 -0.821 . . . . 0.0 109.777 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.18 -23.65 59.26 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.365 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -61.5 -44.62 96.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.138 -0.976 . . . . 0.0 109.731 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 383' ' ' MET . 74.6 m -94.85 -13.54 25.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 110.146 176.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.6 mtt180 57.53 48.41 14.43 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.563 -0.71 . . . . 0.0 109.578 -175.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.915 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.6 ptp -165.28 171.3 13.73 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.878 0.847 . . . . 0.0 111.237 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.535 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.8 p -155.79 165.43 36.54 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.8 -165.82 34.38 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.822 -1.656 . . . . 0.0 110.79 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.877 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.5 tt -140.52 149.2 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.623 -0.928 . . . . 0.0 110.143 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.416 HD21 HG21 ' A' ' 375' ' ' VAL . 44.0 m-20 -127.82 134.81 49.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 109.695 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.997 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -140.15 154.85 23.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.791 -1.193 . . . . 0.0 109.437 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 90.0 m-20 -25.37 -63.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.444 0.64 . . . . 0.0 112.277 172.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 34.1 t30 -91.94 -7.69 48.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.738 . . . . 0.0 111.828 -168.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.558 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.6 mtp180 -143.98 144.64 31.77 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.667 -1.271 . . . . 0.0 110.581 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.6 mtm -134.42 111.73 10.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 108.945 169.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.002 HD12 HD11 ' A' ' 339' ' ' LEU . 9.6 mt -131.66 146.16 33.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.0 109.978 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 26.2 mmt85 -134.41 159.32 41.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.069 -1.019 . . . . 0.0 110.356 175.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.525 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.06 127.21 33.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.661 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.12 174.23 31.88 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.635 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.2 m -56.0 150.56 13.36 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.958 -1.319 . . . . 0.0 108.551 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.001 HG21 HG11 ' A' ' 420' ' ' VAL . 20.4 t -54.84 -37.36 40.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.083 -1.011 . . . . 0.0 109.904 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.4 m-20 -64.23 -45.01 90.08 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.252 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.915 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.48 -48.98 65.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.972 -1.08 . . . . 0.0 110.655 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.661 HD11 ' N ' ' A' ' 396' ' ' GLY . 35.1 mm -65.98 -43.85 92.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.008 -1.057 . . . . 0.0 110.945 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.621 ' NE ' ' CZ ' ' A' ' 412' ' ' PHE . 4.0 ttt180 -60.29 -42.61 95.85 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.062 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 88.8 mtt-85 -61.28 -37.49 83.37 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.635 172.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -67.68 -36.21 80.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 111.289 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.71 -49.05 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.621 -1.3 . . . . 0.0 110.154 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -34.3 77.38 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.891 -1.13 . . . . 0.0 110.218 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.13 79.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.96 -1.088 . . . . 0.0 109.994 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 4.8 m120 -61.45 -27.71 68.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.174 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.93 19.81 27.87 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.84 -169.37 16.09 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.401 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.0 m-70 -144.39 153.62 42.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 111.435 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.621 ' CZ ' ' NE ' ' A' ' 402' ' ' ARG . 7.7 p90 -108.4 149.85 39.84 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.668 -0.645 . . . . 0.0 110.304 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.824 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.02 125.56 9.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.807 1.425 . . . . 0.0 110.52 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.25 -32.37 72.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -0.986 . . . . 0.0 111.075 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.479 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.5 m-20 -63.47 -31.67 72.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 108.848 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.047 HG21 ' HA ' ' A' ' 325' ' ' ALA . 46.0 t -83.58 -42.58 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.388 -0.82 . . . . 0.0 110.765 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.2 m-20 -55.22 -36.64 66.2 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.669 -1.212 . . . . 0.0 109.625 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.91 -49.75 71.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.337 -1.477 . . . . 0.0 109.662 173.082 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 79.2 mttt -56.8 -34.83 68.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.785 -1.197 . . . . 0.0 110.278 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.095 HG23 HG21 ' A' ' 442' ' ' VAL . 2.5 t -59.47 -40.98 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -66.09 -36.61 83.65 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.959 0.885 . . . . 0.0 109.255 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -66.75 -36.68 83.01 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 110.511 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 428' ' ' ALA . 68.3 t -63.11 -37.69 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.026 -1.047 . . . . 0.0 110.161 175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.05 81.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 110.286 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.75 -30.72 68.37 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.252 -0.905 . . . . 0.0 111.006 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.43 -3.32 57.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 109.777 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.05 22.1 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.74 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -105.68 160.92 14.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -1.052 . . . . 0.0 109.474 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.83 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.2 m -108.88 106.89 59.56 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.935 -1.103 . . . . 0.0 109.798 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.535 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.69 107.86 2.56 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.01 1.531 . . . . 0.0 110.769 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.899 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.9 mt -92.62 133.29 36.12 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.845 -1.16 . . . . 0.0 108.542 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.909 ' CG2' HG22 ' A' ' 398' ' ' VAL . 87.7 t -99.74 134.09 40.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.608 -1.308 . . . . 0.0 109.452 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.727 ' CG1' HD11 ' A' ' 440' ' ' LEU . 46.9 t -114.43 134.95 55.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.999 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.0 m -117.07 159.94 16.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.491 -0.755 . . . . 0.0 109.639 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.527 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -135.28 132.52 37.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.01 -129.15 32.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 -167.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.583 ' O ' HG13 ' A' ' 405' ' ' VAL . 75.6 p -106.46 8.02 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.125 -1.221 . . . . 0.0 111.13 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -120.11 170.73 9.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.643 -1.286 . . . . 0.0 109.977 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.827 ' HA ' HG12 ' A' ' 434' ' ' VAL . 26.1 t -91.82 133.85 32.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -96.14 -20.04 18.92 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.822 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.871 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 169.07 176.41 39.11 Favored Glycine 0 N--CA 1.501 2.976 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.03 168.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.095 HG21 HG23 ' A' ' 420' ' ' VAL . 45.1 t -107.86 141.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.234 -1.157 . . . . 0.0 109.802 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.667 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.4 mt -101.42 110.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 108.939 170.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.58 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.31 119.06 31.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.03 -1.044 . . . . 0.0 109.911 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.899 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -102.62 144.88 30.45 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.418 -0.802 . . . . 0.0 108.871 -175.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 320' ' ' SER . 37.8 mmtm -105.97 151.24 24.86 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.697 -1.252 . . . . 0.0 110.7 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -83.86 145.43 28.63 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.353 0.597 . . . . 0.0 110.175 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.418 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.5 tp -119.45 152.84 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.7 t -136.36 136.75 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -92.65 145.06 24.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 110.193 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 118.037 -1.424 . . . . 0.0 109.555 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.289 0.566 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -123.54 146.55 48.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.288 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.543 ' CA ' ' HB3' ' A' ' 351' ' ' SER . 92.5 mt-30 -131.12 152.66 50.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.155 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.69 137.5 57.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.065 -1.022 . . . . 0.0 109.889 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.52 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.45 -34.04 2.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.604 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -161.81 146.06 12.71 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.936 -1.105 . . . . 0.0 110.246 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.134 ' CD1' HD21 ' A' ' 355' ' ' LEU . 15.9 p90 -136.78 147.79 46.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.818 -1.176 . . . . 0.0 111.656 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 7.5 mt -119.96 142.5 33.42 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.737 -0.602 . . . . 0.0 109.674 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.559 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.69 143.86 42.86 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.667 1.351 . . . . 0.0 111.732 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.06 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.8 153.02 42.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 108.907 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -59.59 128.6 37.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.631 -1.293 . . . . 0.0 110.12 -172.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.46 0.6 50.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 440' ' ' LEU . 47.3 t -135.36 138.33 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.677 -1.484 . . . . 0.0 110.606 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.46 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.5 m-20 -73.58 149.97 41.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.372 -0.83 . . . . 0.0 110.148 176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -60.85 -37.22 81.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.983 -1.073 . . . . 0.0 110.025 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -59.53 -41.21 89.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.918 -1.114 . . . . 0.0 109.324 176.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.548 HG21 HG13 ' A' ' 328' ' ' VAL . 99.3 m -60.09 -42.95 95.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 110.031 173.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.968 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.5 tp -60.01 -39.01 84.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 110.531 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.983 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.31 -45.45 72.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 110.734 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.8 m-20 -63.48 -48.71 76.53 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.885 -1.134 . . . . 0.0 109.931 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.905 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.62 -31.51 71.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 109.815 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.684 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.44 -35.47 65.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 172.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.54 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 19.3 mt-30 -74.04 -55.52 6.02 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.545 -0.722 . . . . 0.0 111.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.026 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.31 -36.25 79.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.097 -172.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 395' ' ' LYS . . . -67.82 -18.94 65.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.834 174.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.62 ' OG ' HG22 ' A' ' 353' ' ' VAL . 90.2 p -107.95 8.57 28.5 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.244 -0.91 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.609 HD11 ' CB ' ' A' ' 365' ' ' ARG . 32.2 mt -65.37 -45.77 82.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.557 -1.339 . . . . 0.0 109.67 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.44 1.57 49.34 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.869 -170.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.484 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -62.58 130.36 44.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.683 -1.26 . . . . 0.0 109.905 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.16 5.17 52.54 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.585 0.707 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 346' ' ' THR . 2.9 p -75.53 151.1 85.01 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.561 -0.712 . . . . 0.0 109.385 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.1 -39.31 92.02 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.669 1.352 . . . . 0.0 109.152 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.09 -28.02 69.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -0.789 . . . . 0.0 110.412 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.43 -37.82 67.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.498 ' O ' HD12 ' A' ' 354' ' ' ILE . 96.3 mtt180 -76.63 -35.98 57.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.24 . . . . 0.0 110.466 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.543 ' HB3' ' CA ' ' A' ' 318' ' ' GLN . 3.7 m -61.66 -38.91 89.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.976 -1.078 . . . . 0.0 110.348 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 443' ' ' ILE . 79.6 mt -69.24 -48.89 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.029 -1.044 . . . . 0.0 110.494 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.697 HG12 ' HE3' ' A' ' 357' ' ' LYS . 21.8 t -60.64 -32.17 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.797 -1.189 . . . . 0.0 109.84 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.771 HG22 ' OE1' ' A' ' 358' ' ' GLN . 45.4 mt -72.98 -32.29 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.861 -1.149 . . . . 0.0 110.744 171.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.134 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.87 -42.51 89.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 110.053 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.71 93.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.817 . . . . 0.0 110.592 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 1.017 ' HB3' HD23 ' A' ' 362' ' ' LEU . 81.0 mttt -71.97 -51.11 23.55 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.691 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.771 ' OE1' HG22 ' A' ' 354' ' ' ILE . 20.0 pt20 -71.82 -42.54 66.89 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.7 mmt180 -73.09 -43.83 61.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 111.031 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 87.5 m-85 -134.88 -38.73 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 112.052 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 52.3 t30 -163.01 102.51 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.51 -1.369 . . . . 0.0 111.624 -167.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 1.017 HD23 ' HB3' ' A' ' 357' ' ' LYS . 25.5 mt -57.97 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.902 -1.124 . . . . 0.0 108.994 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.527 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.2 tpt180 -145.64 163.02 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.892 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 88.9 mt-10 -134.06 -171.26 2.7 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.04 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.769 ' NH2' HD13 ' A' ' 388' ' ' ILE . 1.2 tpt180 -100.47 155.67 17.7 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.175 -0.953 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.1 m-20 -104.68 48.42 0.84 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.196 -0.94 . . . . 0.0 110.968 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.983 ' CG2' HD11 ' A' ' 386' ' ' ILE . 78.0 t -66.79 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 176.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.59 -26.89 66.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 110.979 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -28.3 25.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.932 ' HB3' HD11 ' A' ' 388' ' ' ILE . 17.8 mt -104.13 -1.75 26.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 22.9 m80 64.29 53.49 1.72 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 110.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.885 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -97.12 175.03 6.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 110.758 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.8 m -115.42 132.18 56.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 110.375 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.914 ' CE2' HG11 ' A' ' 367' ' ' VAL . 70.6 m-85 -87.86 149.13 24.31 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.479 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 59.9 t -125.31 100.78 32.04 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.066 -1.021 . . . . 0.0 109.866 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.3 151.93 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.089 1.573 . . . . 0.0 110.404 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 12.8 t80 -62.19 131.75 50.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 110.118 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.8 p -120.7 153.37 37.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.553 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.12 -4.89 49.68 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.882 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -56.65 -33.56 66.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.821 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.535 ' HB2' ' CG ' ' A' ' 383' ' ' MET . 5.3 m -139.77 9.77 2.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.841 . . . . 0.0 110.372 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 94.1 mtt180 58.51 51.89 7.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.329 -0.857 . . . . 0.0 109.691 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.677 ' CE ' ' HB1' ' A' ' 400' ' ' ALA . 2.0 ptp -160.92 172.91 16.11 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.155 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.518 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.3 p -154.43 165.04 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.65 -165.1 33.14 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.772 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.983 HD11 ' CG2' ' A' ' 367' ' ' VAL . 6.7 tt -142.51 148.31 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.956 . . . . 0.0 110.04 -175.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -128.28 135.15 49.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.803 -1.186 . . . . 0.0 109.912 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.932 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 109.421 169.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.257 88.3 m-20 -25.88 -63.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.444 0.64 . . . . 0.0 112.251 173.051 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.438 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 19.9 t-20 -91.45 -7.97 49.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.807 . . . . 0.0 111.723 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.557 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 26.4 mtp180 -143.23 145.53 32.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.669 -1.27 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.91 113.56 10.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.131 . . . . 0.0 109.033 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 339' ' ' LEU . 10.0 mt -131.8 146.08 33.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.043 -177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 26.9 mtt180 -135.52 160.74 37.53 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.613 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.647 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.87 138.69 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.485 -0.759 . . . . 0.0 109.185 174.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.625 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -165.36 174.55 41.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.6 m -57.34 150.97 17.04 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.024 -1.28 . . . . 0.0 108.654 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.036 HG21 HG11 ' A' ' 420' ' ' VAL . 19.7 t -53.72 -37.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.9 m-20 -64.11 -44.71 91.43 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.392 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.677 ' HB1' ' CE ' ' A' ' 383' ' ' MET . . . -68.44 -50.57 51.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.907 -1.12 . . . . 0.0 110.574 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.638 HD13 ' HE1' ' A' ' 383' ' ' MET . 25.9 mm -64.9 -43.56 96.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.027 -1.046 . . . . 0.0 110.847 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 14.0 ttp180 -59.39 -43.17 92.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 62.5 mtp180 -61.92 -36.09 80.32 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 109.433 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.23 -37.48 83.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.203 -0.935 . . . . 0.0 111.291 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 437' ' ' SER . 58.3 t -65.66 -47.86 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.538 -1.351 . . . . 0.0 110.246 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.4 -34.67 78.24 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.795 -1.19 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.27 80.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.901 -1.125 . . . . 0.0 109.962 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 15.6 m-80 -61.7 -27.27 68.58 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.244 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.48 19.41 30.04 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.52 -169.44 17.08 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.435 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.3 m-70 -143.88 153.92 42.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -1.214 . . . . 0.0 111.378 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.593 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.4 p90 -106.97 149.18 38.24 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.626 -0.671 . . . . 0.0 110.255 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.818 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.46 123.7 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.809 1.426 . . . . 0.0 110.433 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.33 -33.99 76.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.925 . . . . 0.0 111.053 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 90.7 m-20 -61.04 -32.99 72.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.9 -1.125 . . . . 0.0 108.841 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.06 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.8 t -84.1 -42.62 17.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 60.7 m-20 -54.2 -36.99 64.05 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.456 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.6 mm-40 -63.18 -48.82 76.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.254 -1.529 . . . . 0.0 110.228 170.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 16.5 mmtt -56.29 -35.38 67.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.751 -1.218 . . . . 0.0 110.412 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.042 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.79 -40.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 109.151 171.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.874 0.845 . . . . 0.0 109.346 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 94.7 mm-40 -66.83 -38.06 85.68 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.644 -0.66 . . . . 0.0 110.666 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 428' ' ' ALA . 65.5 t -63.09 -36.92 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.934 -1.104 . . . . 0.0 110.14 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.14 82.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -70.37 -30.67 67.65 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 111.108 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 423' ' ' VAL . 5.9 pt20 -82.15 -6.35 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.901 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 96.44 22.02 20.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 445' ' ' LEU . . . -110.19 170.99 7.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 110.026 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.945 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.7 m -113.44 107.02 53.84 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.075 -1.016 . . . . 0.0 110.078 -174.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.566 ' HB2' HG22 ' A' ' 420' ' ' VAL . 43.3 Cg_endo -77.38 108.59 2.62 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.7 mt -93.48 139.68 30.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.919 -1.113 . . . . 0.0 108.851 167.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.85 ' CG2' HG22 ' A' ' 398' ' ' VAL . 88.3 t -102.5 135.76 38.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.749 -1.219 . . . . 0.0 109.587 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.75 ' CG1' HD11 ' A' ' 440' ' ' LEU . 46.3 t -118.25 135.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 108.758 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -118.26 160.56 17.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.525 ' CB ' HD23 ' A' ' 440' ' ' LEU . 3.9 tt0 -136.67 133.64 36.4 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 171.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.82 -124.2 23.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 405' ' ' VAL . 1.9 p -114.19 12.48 17.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.269 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -127.19 171.36 11.5 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 109.843 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.828 ' HA ' HG12 ' A' ' 434' ' ' VAL . 47.4 t -88.17 136.19 23.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.089 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.6 pp -94.34 -22.33 18.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.46 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.968 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.17 177.44 39.34 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.976 169.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.042 HG21 HG23 ' A' ' 420' ' ' VAL . 52.3 t -107.66 142.88 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.178 -1.19 . . . . 0.0 109.811 172.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.684 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.1 mt -101.43 112.93 36.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.576 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.81 119.0 31.23 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 109.869 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.945 HD12 ' HB ' ' A' ' 429' ' ' THR . 0.8 OUTLIER -101.38 144.88 29.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.52 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 13.8 pttt -141.01 171.08 14.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.597 -1.314 . . . . 0.0 110.738 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -71.38 144.88 49.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.737 . . . . 0.0 110.17 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 9.3 tp -119.63 152.84 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 110.283 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.07 134.01 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 110.303 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -93.12 144.08 25.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.183 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.54 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.248 0.547 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -122.61 146.1 47.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.221 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.542 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.3 mt-30 -131.33 151.31 51.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.25 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.691 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -62.03 137.87 58.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.842 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -122.98 -32.87 3.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.48 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.488 ' N ' HD11 ' A' ' 355' ' ' LEU . 46.2 tt0 -163.22 146.13 10.38 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.348 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.046 ' CD1' HD21 ' A' ' 355' ' ' LEU . 10.1 p90 -134.24 142.19 47.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.875 -1.141 . . . . 0.0 111.482 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.632 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.3 mp -113.53 139.71 23.64 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.612 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.0 143.14 44.11 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.713 1.375 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.072 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -69.06 153.87 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 108.724 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -57.83 128.26 36.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.68 -1.262 . . . . 0.0 110.378 -171.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 112.67 -22.27 17.23 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 440' ' ' LEU . 61.2 t -115.84 139.93 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.727 -1.455 . . . . 0.0 111.071 -172.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.6 m-20 -72.19 148.39 45.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -60.56 -39.28 87.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 110.496 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.476 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.4 ttmt -58.76 -43.6 90.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.713 -1.242 . . . . 0.0 109.641 175.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 93.1 m -56.75 -43.83 81.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.959 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -58.66 -39.7 81.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.016 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.81 -40.99 83.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.074 -1.016 . . . . 0.0 110.817 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -63.66 -50.02 70.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 109.823 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.904 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.18 -31.5 71.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 109.711 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.787 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.08 -35.4 64.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.954 . . . . 0.0 109.033 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 20.6 mt-30 -74.79 -55.86 5.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.535 -0.728 . . . . 0.0 110.882 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.15 -35.6 77.54 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.77 -172.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.407 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.53 -20.49 65.43 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.072 -1.018 . . . . 0.0 110.063 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.5 p -107.15 9.08 30.39 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.161 -0.962 . . . . 0.0 111.471 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.8 mt -66.2 -44.61 83.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.614 -1.304 . . . . 0.0 109.665 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.15 1.87 50.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.919 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.485 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.28 130.47 44.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.726 -1.234 . . . . 0.0 109.879 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.48 5.4 51.68 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.551 0.691 . . . . 0.0 109.926 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.5 152.04 83.25 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.643 -0.661 . . . . 0.0 109.478 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.07 -39.71 89.48 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.748 1.394 . . . . 0.0 109.144 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.44 -27.98 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 110.409 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.99 -37.26 62.25 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -175.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.527 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.72 -37.36 56.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -1.231 . . . . 0.0 110.513 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.542 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.9 m -61.28 -37.95 85.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.952 -1.092 . . . . 0.0 110.358 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.636 HG23 HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.78 -49.26 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.618 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.8 t -61.06 -33.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.93 HG22 ' OE1' ' A' ' 358' ' ' GLN . 33.2 mt -72.58 -33.62 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.698 -1.251 . . . . 0.0 110.652 171.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.046 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.01 -40.53 85.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.935 -1.103 . . . . 0.0 110.402 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.406 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.06 -45.15 90.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.916 ' HB3' HD23 ' A' ' 362' ' ' LEU . 40.7 mtmt -72.29 -49.51 34.17 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.616 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.93 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.8 pt20 -71.56 -42.77 67.42 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.891 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.5 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.5 mmt180 -72.67 -45.46 58.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.138 -0.976 . . . . 0.0 111.164 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.576 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 60.0 m-85 -135.83 -38.68 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.391 -1.323 . . . . 0.0 112.114 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.499 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 13.8 t-20 -159.99 106.17 1.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.698 -1.251 . . . . 0.0 111.542 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.916 HD23 ' HB3' ' A' ' 357' ' ' LYS . 52.6 mt -57.7 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 0.0 109.323 172.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.536 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.7 tpt180 -128.07 164.0 23.38 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.5 mt-10 -137.98 -159.58 0.97 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.592 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.3 ptt180 -95.98 162.86 13.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.523 -0.736 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -130.34 41.86 3.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 110.465 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.036 HG21 ' CE1' ' A' ' 374' ' ' PHE . 42.9 t -72.97 -45.65 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.191 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.29 -27.48 67.21 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.487 -0.758 . . . . 0.0 111.021 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -29.64 27.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.713 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.774 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.4 mt -103.36 -5.03 23.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 110.662 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 367' ' ' VAL . 73.5 m-70 60.57 51.73 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 0.0 109.752 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.755 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.99 174.62 7.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.81 . . . . 0.0 110.521 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.0 m -117.15 134.89 54.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.342 -0.849 . . . . 0.0 110.58 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.036 ' CE1' HG21 ' A' ' 367' ' ' VAL . 82.3 m-85 -88.58 147.47 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 60.7 t -120.43 100.98 46.91 Favored Pre-proline 0 C--N 1.299 -1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.2 Cg_endo -55.07 151.39 34.66 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.019 1.537 . . . . 0.0 110.529 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 16.4 t80 -66.44 131.87 47.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.5 p -120.01 151.76 38.51 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.732 175.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.39 -6.63 54.08 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.536 -0.727 . . . . 0.0 109.881 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -56.89 -32.97 66.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.862 . . . . 0.0 109.838 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.545 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 15.1 m -138.82 9.93 2.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.412 -0.805 . . . . 0.0 110.299 174.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 81.4 mtm180 56.79 50.98 11.51 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.185 -0.947 . . . . 0.0 109.424 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.708 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.0 ptp -157.54 166.3 33.3 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.923 0.868 . . . . 0.0 111.357 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.93 165.0 37.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.63 -166.96 35.61 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 118.923 -1.608 . . . . 0.0 110.733 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.865 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.9 tt -139.45 149.58 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.556 -0.967 . . . . 0.0 110.178 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -127.16 134.84 50.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 0.0 109.798 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -141.51 155.21 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 90.4 m-20 -23.02 -63.04 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.406 0.622 . . . . 0.0 112.49 171.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 53.7 t30 -95.99 -5.7 40.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.788 . . . . 0.0 111.855 -167.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.554 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.1 mtp180 -144.13 143.96 31.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.741 -1.225 . . . . 0.0 110.434 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.9 mtm -134.72 102.26 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.896 -1.128 . . . . 0.0 109.071 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -124.31 146.03 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -172.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 39.9 mtt180 -134.37 159.98 39.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 0.0 110.872 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.65 127.96 32.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.692 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.502 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.33 173.83 32.8 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.319 -1.419 . . . . 0.0 109.566 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.2 m -55.82 149.26 15.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.757 -1.437 . . . . 0.0 108.343 168.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.067 HG22 HG23 ' A' ' 432' ' ' VAL . 61.3 t -58.24 -34.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.899 -1.126 . . . . 0.0 109.917 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.2 t0 -61.85 -45.32 94.3 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.708 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.84 -51.27 42.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.955 -1.09 . . . . 0.0 110.591 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.561 HD13 ' CE ' ' A' ' 383' ' ' MET . 31.0 mm -64.49 -42.93 96.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 110.742 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.8 ttp85 -59.31 -43.73 92.61 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 70.6 mtp180 -61.8 -36.57 81.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.403 173.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.544 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -68.45 -36.14 78.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 111.197 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 437' ' ' SER . 52.9 t -65.81 -49.29 78.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.587 -1.32 . . . . 0.0 110.127 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.73 -33.91 76.7 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.949 -1.095 . . . . 0.0 110.285 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.19 79.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.991 -1.068 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.545 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.2 m-80 -62.25 -27.17 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.69 19.46 29.41 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -169.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.73 -171.4 18.27 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -144.88 153.68 41.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 111.037 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.3 p90 -108.78 150.7 41.15 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.861 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.93 128.33 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.83 1.437 . . . . 0.0 110.388 -175.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.8 t -67.3 -35.57 79.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.251 -0.905 . . . . 0.0 110.992 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -61.52 -34.06 74.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.912 -1.118 . . . . 0.0 108.816 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.072 HG21 ' HA ' ' A' ' 325' ' ' ALA . 55.0 t -83.48 -42.6 17.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.956 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.67 -38.22 69.32 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.543 172.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.4 mm-40 -63.77 -47.93 78.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.343 -1.473 . . . . 0.0 110.295 171.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.632 ' CD ' HG21 ' A' ' 323' ' ' ILE . 66.2 mttm -56.76 -35.06 68.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.639 -1.288 . . . . 0.0 110.431 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.095 HG23 HG21 ' A' ' 442' ' ' VAL . 2.9 t -60.04 -41.36 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.879 -1.138 . . . . 0.0 109.371 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.0 -36.0 82.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.812 0.815 . . . . 0.0 109.418 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.52 -37.87 80.41 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.648 -0.658 . . . . 0.0 110.861 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.8 t -62.95 -37.56 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.092 . . . . 0.0 110.022 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -40.12 83.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.332 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -68.25 -31.16 70.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 110.972 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -80.87 -3.47 51.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.045 -1.035 . . . . 0.0 109.705 174.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.25 21.77 34.26 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.63 173.87 6.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.143 . . . . 0.0 109.827 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.985 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.4 m -115.89 106.72 49.34 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.978 -1.076 . . . . 0.0 110.03 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 398' ' ' VAL . 54.9 Cg_endo -79.85 107.47 2.1 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.91 1.479 . . . . 0.0 110.243 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -91.94 135.61 33.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.898 -1.126 . . . . 0.0 108.482 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 1.067 HG23 HG22 ' A' ' 398' ' ' VAL . 88.3 t -99.71 133.96 40.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.747 -1.22 . . . . 0.0 109.341 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.027 ' CG1' HD11 ' A' ' 440' ' ' LEU . 25.0 t -113.47 136.78 48.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.8 m -122.19 160.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 121.379 -0.825 . . . . 0.0 109.719 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.452 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.5 tt0 -135.14 130.98 36.27 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.84 -128.1 28.72 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.639 ' O ' HG13 ' A' ' 405' ' ' VAL . 84.8 p -106.33 8.7 31.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 111.132 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.477 ' NH1' ' HG3' ' A' ' 438' ' ' ARG . 35.2 ptt85 -122.87 174.23 7.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.59 -1.319 . . . . 0.0 110.257 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.804 ' HA ' HG12 ' A' ' 434' ' ' VAL . 52.9 t -94.49 134.5 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.027 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -93.88 -21.22 19.38 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.748 175.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.959 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 169.42 176.55 39.41 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 118.868 -1.634 . . . . 0.0 110.961 168.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.095 HG21 HG23 ' A' ' 420' ' ' VAL . 48.9 t -107.99 142.64 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.009 -1.289 . . . . 0.0 109.974 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.787 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.3 mt -101.38 112.36 34.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.352 -0.842 . . . . 0.0 109.104 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.28 119.44 31.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.793 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.985 HD12 ' HB ' ' A' ' 429' ' ' THR . 1.4 mt -102.59 146.33 28.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.579 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 1.4 ptpm? -134.64 164.88 26.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.575 -1.328 . . . . 0.0 110.777 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -83.79 146.02 28.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.547 -0.721 . . . . 0.0 110.14 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.7 tp -119.02 153.09 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.853 . . . . 0.0 110.333 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.91 136.53 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.287 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -89.73 145.52 25.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 110.188 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 CA-C-O 118.005 -1.441 . . . . 0.0 109.561 -179.904 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.264 0.554 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.519 ' NE ' ' OE2' ' A' ' 348' ' ' GLU . 87.5 mtm-85 -122.96 145.03 48.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.895 . . . . 0.0 110.215 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.8 tt0 -120.37 133.59 55.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.372 -0.83 . . . . 0.0 110.089 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.76 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -55.59 139.35 44.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.074 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 39.8 m -123.34 -38.67 2.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.494 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.455 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.5 tt0 -163.03 148.97 12.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.149 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.023 ' CD1' HD21 ' A' ' 355' ' ' LEU . 16.1 p90 -134.54 143.57 47.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.759 -1.213 . . . . 0.0 111.802 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.531 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.6 mt -113.68 143.99 30.54 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.561 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.74 142.72 36.17 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.708 1.372 . . . . 0.0 111.569 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.035 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.98 151.72 43.02 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 108.876 165.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -57.79 129.04 40.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.684 -1.26 . . . . 0.0 109.983 -173.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.39 -1.8 46.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.676 HG13 HG21 ' A' ' 332' ' ' THR . 52.1 t -136.01 139.07 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.573 -1.545 . . . . 0.0 110.748 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 332' ' ' THR . 6.5 p-10 -73.52 151.89 40.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 110.158 176.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 83.5 tt0 -61.06 -34.7 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.108 -0.995 . . . . 0.0 109.658 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.517 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 109.473 177.235 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.676 HG21 HG13 ' A' ' 328' ' ' VAL . 3.2 m -62.98 -39.14 93.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 175.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.986 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.2 tp -59.83 -40.12 87.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.048 -1.033 . . . . 0.0 110.412 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.982 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.02 -43.96 77.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.953 -1.092 . . . . 0.0 110.711 -176.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.574 ' O ' HD23 ' A' ' 339' ' ' LEU . 57.5 t0 -63.15 -48.84 76.74 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.878 -1.139 . . . . 0.0 110.068 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.952 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.74 -31.05 69.83 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 109.918 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.8 -35.99 64.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.134 -0.979 . . . . 0.0 108.884 172.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.8 mt-30 -75.06 -55.76 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.663 -0.648 . . . . 0.0 111.06 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.046 HD11 HD12 ' A' ' 393' ' ' ILE . 0.2 OUTLIER -64.97 -32.92 74.87 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.136 -171.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.86 -1.15 . . . . 0.0 110.07 172.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.625 ' OG ' HG22 ' A' ' 353' ' ' VAL . 99.1 p -107.95 11.4 27.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.143 -0.973 . . . . 0.0 111.541 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 44.5 mt -66.74 -45.17 79.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.722 -1.236 . . . . 0.0 109.859 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.07 1.08 49.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.864 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.481 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -63.92 130.3 43.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.746 -1.221 . . . . 0.0 109.979 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 4.6 52.97 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.633 0.73 . . . . 0.0 109.85 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 346' ' ' THR . 3.1 p -74.13 152.69 88.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.434 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.75 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.757 1.399 . . . . 0.0 109.227 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.519 ' OE2' ' NE ' ' A' ' 317' ' ' ARG . 99.2 mt-10 -64.45 -28.44 69.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.41 -38.53 69.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.552 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.3 mtt85 -77.91 -37.2 48.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -1.157 . . . . 0.0 110.58 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 5.5 m -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 110.338 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.674 HG23 HD13 ' A' ' 443' ' ' ILE . 86.0 mt -68.66 -48.6 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.023 -1.048 . . . . 0.0 110.652 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.625 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.1 t -60.83 -32.77 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.9 mt -72.54 -32.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 110.719 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.023 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.84 -41.11 90.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.801 -1.187 . . . . 0.0 110.396 178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.23 -42.55 99.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.359 -0.838 . . . . 0.0 110.363 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 73.1 mttt -72.54 -51.54 19.46 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.711 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.547 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.1 pt20 -70.7 -42.4 70.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.547 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.5 mmm180 -74.59 -43.85 53.61 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 111.084 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.684 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 50.6 m-85 -135.2 -39.48 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.658 -1.276 . . . . 0.0 111.986 -169.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.524 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.5 t30 -161.03 105.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.716 -1.24 . . . . 0.0 111.588 -168.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 42.0 mt -57.57 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.899 -1.125 . . . . 0.0 109.075 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.512 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.7 tpt85 -135.09 163.73 29.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.006 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -134.03 -156.25 0.72 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.903 -1.123 . . . . 0.0 110.457 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 46.7 ptt85 -97.4 161.43 13.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.505 0.669 . . . . 0.0 110.717 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -128.08 41.77 3.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.305 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.946 HG21 ' CE1' ' A' ' 374' ' ' PHE . 88.5 t -73.49 -49.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.413 -0.804 . . . . 0.0 110.464 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -69.16 -23.87 64.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 111.073 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -31.94 31.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 109.691 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.989 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.2 mt -101.57 -3.61 28.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 110.554 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 367' ' ' VAL . 2.5 m-70 63.74 53.93 1.91 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.931 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -96.72 175.01 6.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.6 m -117.45 135.14 54.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.57 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.946 ' CE1' HG21 ' A' ' 367' ' ' VAL . 93.0 m-85 -90.28 143.11 27.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.653 HG21 HD21 ' A' ' 387' ' ' ASN . 19.8 t -116.68 101.23 53.66 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.973 . . . . 0.0 109.608 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.13 151.53 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.034 1.544 . . . . 0.0 110.603 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.1 t80 -64.43 132.0 48.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.1 p -120.43 152.37 38.05 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.84 . . . . 0.0 109.664 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.63 -6.63 54.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.504 -0.747 . . . . 0.0 109.918 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.86 -32.84 66.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.843 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 3.3 m -139.05 9.97 2.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.371 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 71.1 mtt85 56.93 51.27 10.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.203 -0.936 . . . . 0.0 109.485 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.825 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.4 ptp -158.18 167.65 29.21 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.236 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.8 p -155.38 165.19 37.38 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.58 -165.55 33.83 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.618 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.774 HD11 HG22 ' A' ' 367' ' ' VAL . 1.5 tt -140.21 149.51 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.631 -0.923 . . . . 0.0 110.104 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.653 HD21 HG21 ' A' ' 375' ' ' VAL . 31.3 m-20 -127.23 134.62 50.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 109.756 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.989 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -139.82 154.87 24.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.875 -1.141 . . . . 0.0 109.381 171.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 89.8 m-20 -25.53 -63.09 0.06 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.407 0.622 . . . . 0.0 112.251 172.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.453 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 51.2 t30 -91.62 -7.76 49.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 111.692 -168.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.561 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.3 mtp180 -144.7 144.65 31.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.636 -1.29 . . . . 0.0 110.536 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.93 110.46 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.871 -1.143 . . . . 0.0 109.067 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 339' ' ' LEU . 8.7 mt -131.3 145.91 34.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 110.201 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 49.6 mtt-85 -134.94 160.95 36.66 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.834 175.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.521 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.52 128.74 33.93 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.582 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -157.03 174.31 34.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.4 m -57.27 151.09 16.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.934 -1.333 . . . . 0.0 108.597 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.12 HG21 HG11 ' A' ' 420' ' ' VAL . 60.1 t -56.62 -35.1 43.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.075 -1.016 . . . . 0.0 109.894 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.3 t70 -63.03 -46.13 89.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.306 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.825 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.82 -51.82 36.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.985 -1.072 . . . . 0.0 110.482 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.582 HD11 ' N ' ' A' ' 396' ' ' GLY . 36.7 mm -63.51 -42.77 97.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 121.126 -0.984 . . . . 0.0 110.64 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.624 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 9.1 ttt180 -60.24 -43.21 96.26 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 52.1 mtp85 -61.62 -35.86 79.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.052 -1.03 . . . . 0.0 109.562 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.505 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.45 -37.72 83.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.187 -0.945 . . . . 0.0 111.269 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.517 ' CG2' HG11 ' A' ' 434' ' ' VAL . 59.5 t -65.66 -47.7 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.558 -1.339 . . . . 0.0 110.16 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.1 -34.98 78.77 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.795 -1.19 . . . . 0.0 110.28 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -35.92 79.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.505 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.2 m-80 -61.53 -27.47 68.63 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.159 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.43 19.69 29.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.85 -169.38 16.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.445 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.8 m-70 -143.31 153.52 42.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.094 -1.239 . . . . 0.0 111.488 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.624 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 7.5 p90 -107.5 150.27 39.88 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.772 -0.58 . . . . 0.0 110.202 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.828 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.75 123.14 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.904 1.476 . . . . 0.0 110.495 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.82 -32.6 73.99 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.098 -1.002 . . . . 0.0 111.026 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.6 m-20 -61.96 -32.88 73.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.896 -1.128 . . . . 0.0 108.844 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.035 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.3 t -83.6 -42.4 17.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.999 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 67.9 m-20 -55.39 -37.13 67.17 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.616 171.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.0 mt-30 -63.75 -48.76 75.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.337 -1.477 . . . . 0.0 110.099 171.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.531 ' CD ' HG21 ' A' ' 323' ' ' ILE . 95.9 mttt -57.22 -34.7 68.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.68 -1.262 . . . . 0.0 110.355 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.12 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.5 -40.76 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 0.0 109.257 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -66.81 -36.74 83.07 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.873 0.844 . . . . 0.0 109.448 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 83.9 mt-30 -67.48 -36.66 81.56 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.622 -0.673 . . . . 0.0 110.472 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 428' ' ' ALA . 71.0 t -62.97 -37.89 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 110.029 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.86 -40.16 83.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.335 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -69.07 -31.06 69.54 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.287 -0.883 . . . . 0.0 110.942 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.25 -3.02 57.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.808 176.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.6 21.94 27.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.763 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.43 161.62 14.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -1.097 . . . . 0.0 109.478 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 445' ' ' LEU . 28.2 m -109.02 107.22 59.84 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.03 . . . . 0.0 109.703 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.546 ' CG ' HG13 ' A' ' 420' ' ' VAL . 39.0 Cg_endo -76.26 107.94 2.56 Favored 'Trans proline' 0 C--N 1.298 -2.09 0 O-C-N 123.924 1.486 . . . . 0.0 110.643 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.903 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.0 mt -93.04 134.43 35.19 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.825 -1.172 . . . . 0.0 108.677 167.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 1.009 ' CG2' HG22 ' A' ' 398' ' ' VAL . 91.3 t -100.74 134.93 39.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 120.72 -1.238 . . . . 0.0 109.504 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.741 ' CG1' HD11 ' A' ' 440' ' ' LEU . 45.2 t -115.38 137.02 50.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.8 m -117.56 159.59 17.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.373 -0.829 . . . . 0.0 109.676 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.553 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.17 132.45 35.98 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.28 -129.3 31.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.498 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.93 11.87 27.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -1.218 . . . . 0.0 110.945 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -126.18 170.89 11.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.697 -1.252 . . . . 0.0 109.908 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.837 ' HA ' HG12 ' A' ' 434' ' ' VAL . 22.7 t -90.3 134.77 28.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.342 -0.849 . . . . 0.0 109.874 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.77 -22.12 18.28 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.85 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.986 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.11 176.6 38.71 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.997 169.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.046 HG21 HG23 ' A' ' 420' ' ' VAL . 48.0 t -107.77 141.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.216 -1.167 . . . . 0.0 109.887 173.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.721 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.3 mt -101.31 111.71 31.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 108.987 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.531 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.22 119.39 31.8 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.85 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.903 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.25 143.22 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 10.5 mtmt -106.73 157.99 17.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.619 -1.301 . . . . 0.0 110.984 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -91.08 146.07 24.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.71 . . . . 0.0 110.35 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.8 tp -119.18 155.64 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.85 . . . . 0.0 110.117 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.1 t -101.34 134.52 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.148 -0.97 . . . . 0.0 110.294 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 451' ' ' GLY . 57.0 mtpt -93.88 145.53 24.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.9 . . . . 0.0 110.234 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 450' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.292 0.567 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 90.9 mtm-85 -122.91 145.96 48.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 110.183 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 80.6 mt-30 -131.97 148.6 52.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.721 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.66 136.63 57.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.957 -1.09 . . . . 0.0 109.889 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -121.24 -34.5 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.484 ' N ' HD11 ' A' ' 355' ' ' LEU . 46.5 tt0 -165.61 147.04 7.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.182 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.016 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 12.9 p90 -136.51 147.66 47.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.827 -1.17 . . . . 0.0 111.663 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.528 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -118.85 144.13 35.07 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.728 -0.607 . . . . 0.0 109.593 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.53 143.85 39.17 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.76 1.4 . . . . 0.0 111.521 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.041 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.39 152.48 42.0 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 108.818 165.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.407 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 10.8 tp60 -58.32 128.55 37.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.682 -1.261 . . . . 0.0 110.126 -172.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.98 -0.77 44.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.4 t -136.49 139.92 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.481 . . . . 0.0 110.73 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.459 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.0 m-20 -74.12 152.48 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 86.1 tt0 -62.61 -40.23 96.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.487 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -59.18 -43.29 92.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.57 -1.331 . . . . 0.0 109.63 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.525 HG21 HG13 ' A' ' 328' ' ' VAL . 94.1 m -55.73 -43.55 76.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.857 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 1.001 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.8 tp -59.71 -40.17 87.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.251 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.016 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -66.59 -40.79 89.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.92 -1.112 . . . . 0.0 110.917 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 82.3 m-20 -64.62 -50.2 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.895 -1.128 . . . . 0.0 109.766 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 1.012 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.7 -30.79 70.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.951 -1.093 . . . . 0.0 109.636 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.42 -35.54 65.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.103 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.561 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.3 mt-30 -73.43 -55.69 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.551 -0.718 . . . . 0.0 111.06 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.057 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.97 -35.72 81.1 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.559 -1.257 . . . . 0.0 109.894 -172.018 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.524 ' HB1' ' HG2' ' A' ' 395' ' ' LYS . . . -66.72 -20.73 66.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.088 -1.007 . . . . 0.0 110.053 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.649 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.2 p -107.03 8.84 30.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.121 -0.987 . . . . 0.0 111.579 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 41.4 mt -66.5 -44.47 82.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.531 -1.355 . . . . 0.0 109.584 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.76 1.0 50.36 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.478 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.67 130.53 44.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.714 -1.241 . . . . 0.0 109.979 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.62 5.61 51.03 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.511 0.672 . . . . 0.0 109.845 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.35 150.17 79.69 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.652 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -53.68 -38.21 84.37 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.678 1.357 . . . . 0.0 109.172 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.7 mt-10 -64.23 -28.55 69.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 110.393 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.82 -36.93 67.51 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.53 ' O ' HD12 ' A' ' 354' ' ' ILE . 42.2 mmt180 -76.65 -37.93 55.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.118 -1.225 . . . . 0.0 110.525 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.41 -38.17 86.14 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.962 -1.086 . . . . 0.0 110.372 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.5 HG23 HD13 ' A' ' 443' ' ' ILE . 86.0 mt -68.55 -49.42 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.005 -1.059 . . . . 0.0 110.594 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.649 HG22 ' OG ' ' A' ' 341' ' ' SER . 23.9 t -60.56 -33.67 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.1 mt -72.23 -33.3 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.689 -1.257 . . . . 0.0 110.68 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.003 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.57 -40.8 88.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -61.92 -43.1 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 110.273 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 83.3 mttt -69.64 -48.73 58.87 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.745 -174.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 18.3 pt20 -70.75 -43.46 68.78 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 110.499 -173.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.2 mmm180 -73.98 -46.09 45.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 111.312 -173.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 330' ' ' GLU . 27.8 m-85 -135.67 -35.97 0.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.666 -167.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.536 ' ND2' ' HD3' ' A' ' 363' ' ' ARG . 55.9 t-20 -158.59 93.89 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.512 -1.368 . . . . 0.0 111.808 -169.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -61.35 95.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.987 -1.07 . . . . 0.0 110.178 172.087 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.536 ' HD3' ' ND2' ' A' ' 361' ' ' ASN . 30.8 ptt85 -150.01 -179.06 6.86 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 363' ' ' ARG . 22.2 pt-20 -124.78 -157.39 0.77 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 110.531 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 40.9 ptt180 -90.62 165.59 13.65 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.743 -0.598 . . . . 0.0 110.492 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -123.99 38.63 4.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.422 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.022 HG21 ' CE1' ' A' ' 374' ' ' PHE . 43.9 t -74.34 -49.82 30.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 110.376 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -67.75 -25.1 65.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 111.039 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.08 -30.09 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.99 . . . . 0.0 109.8 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 1.0 ' HB3' HD11 ' A' ' 388' ' ' ILE . 19.3 mt -103.65 -4.19 24.12 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 110.672 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 31.1 m80 62.84 53.94 2.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.427 -0.796 . . . . 0.0 110.168 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.923 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.9 175.03 6.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 110.606 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.9 m -116.67 134.27 55.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.022 ' CE1' HG21 ' A' ' 367' ' ' VAL . 84.2 m-85 -88.89 147.96 24.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 25.9 t -122.93 100.97 39.61 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.13 -0.981 . . . . 0.0 109.604 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.64 151.15 40.39 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.983 1.518 . . . . 0.0 110.475 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.16 131.55 46.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 110.07 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.8 p -120.77 152.89 37.76 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.99 -6.12 53.45 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.526 -0.734 . . . . 0.0 109.936 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -57.01 -33.04 66.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.804 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 383' ' ' MET . 0.5 OUTLIER -138.26 9.39 2.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 110.315 174.489 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 57.88 51.14 9.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.542 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.644 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.4 ptp -161.0 169.34 22.75 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.408 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 5.2 p -156.88 165.3 36.57 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.78 -165.18 33.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.859 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.3 tt -138.82 149.08 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.698 -0.884 . . . . 0.0 110.125 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.462 HD21 HG21 ' A' ' 375' ' ' VAL . 31.6 m-20 -127.79 135.15 49.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 109.654 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 1.0 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -140.06 154.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.875 -1.14 . . . . 0.0 109.389 171.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.6 -63.17 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.434 0.635 . . . . 0.0 112.242 172.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 40.8 t-20 -91.66 -7.89 48.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.51 -0.744 . . . . 0.0 111.755 -168.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 31.2 mtp180 -144.19 145.67 32.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.707 -1.246 . . . . 0.0 110.605 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.4 mtt -135.49 110.8 9.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.903 -1.123 . . . . 0.0 108.999 169.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.057 HD12 HD11 ' A' ' 339' ' ' LEU . 8.9 mt -130.35 146.13 34.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.989 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.519 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.4 mmt85 -134.13 159.69 40.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.109 -0.994 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.691 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -132.61 137.55 47.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.484 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -164.37 174.36 40.42 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.267 -1.444 . . . . 0.0 109.625 -173.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -56.94 149.93 17.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.278 . . . . 0.0 108.684 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.08 HG21 HG11 ' A' ' 420' ' ' VAL . 22.8 t -55.03 -37.62 43.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 109.975 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.7 m-20 -64.24 -44.35 92.12 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.221 -0.924 . . . . 0.0 110.343 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.644 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.21 -50.24 55.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.963 -1.085 . . . . 0.0 110.662 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.587 HD13 ' CE ' ' A' ' 383' ' ' MET . 30.9 mm -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.746 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.5 ttp85 -59.85 -42.92 94.68 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.1 mtt180 -61.47 -36.3 80.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.576 173.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.489 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.5 t-80 -66.61 -38.5 87.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 111.245 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.512 ' CG2' HG11 ' A' ' 434' ' ' VAL . 71.3 t -65.47 -47.28 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.623 -1.298 . . . . 0.0 110.268 178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.48 -34.8 78.56 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.785 -1.197 . . . . 0.0 110.436 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.933 -1.104 . . . . 0.0 109.951 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.489 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 27.1 m-80 -62.04 -27.1 68.65 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.26 18.93 31.94 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -169.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -111.58 -169.95 18.73 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.426 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.9 m-70 -144.1 153.69 42.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -1.223 . . . . 0.0 111.461 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.593 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 7.7 p90 -108.88 150.43 40.86 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.719 -0.613 . . . . 0.0 110.143 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.82 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.9 124.01 8.36 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.845 1.445 . . . . 0.0 110.488 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.32 -32.77 73.95 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.928 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.8 m-20 -61.65 -32.84 73.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.863 -1.148 . . . . 0.0 108.872 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.041 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.0 t -83.76 -42.55 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.391 -0.818 . . . . 0.0 110.975 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.581 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 68.8 m-20 -55.17 -37.2 66.72 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.584 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.8 mm-40 -63.94 -48.76 75.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.254 -1.529 . . . . 0.0 110.232 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.528 ' CD ' HG21 ' A' ' 323' ' ' ILE . 43.2 mttt -57.56 -34.27 69.02 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.638 -1.289 . . . . 0.0 110.416 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.08 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.21 -41.24 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.206 171.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -66.46 -36.22 82.22 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.921 0.867 . . . . 0.0 109.418 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.45 -37.63 83.25 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 110.798 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.8 t -63.31 -37.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.005 -1.059 . . . . 0.0 110.088 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.12 84.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.329 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -68.51 -31.18 70.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.394 -0.816 . . . . 0.0 110.889 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.507 ' NE2' ' HE2' ' A' ' 446' ' ' LYS . 2.0 tt0 -82.59 -3.01 55.42 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.852 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.85 27.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.67 163.18 13.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -1.064 . . . . 0.0 109.64 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.493 ' HB ' HD12 ' A' ' 445' ' ' LEU . 53.7 m -110.12 107.12 58.66 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.809 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.578 ' CG ' HG13 ' A' ' 420' ' ' VAL . 37.5 Cg_endo -75.82 108.22 2.64 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 123.979 1.515 . . . . 0.0 110.773 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.856 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.3 mt -92.71 135.05 34.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.854 -1.154 . . . . 0.0 108.599 166.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.968 ' CG2' HG22 ' A' ' 398' ' ' VAL . 97.9 t -100.08 136.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.651 -1.28 . . . . 0.0 109.568 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.705 ' CG1' HD11 ' A' ' 440' ' ' LEU . 44.5 t -117.33 136.96 52.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 108.992 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -117.75 160.03 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.532 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.07 132.08 35.7 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -128.65 31.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.503 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.11 11.36 27.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.185 -1.185 . . . . 0.0 110.968 -179.573 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -123.45 170.78 10.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.633 -1.292 . . . . 0.0 109.925 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 434' ' ' VAL . 22.5 t -91.39 134.03 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.7 pp -94.79 -21.71 18.54 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.862 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 1.001 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.99 177.02 38.97 Favored Glycine 0 N--CA 1.499 2.896 0 C-N-CA 118.847 -1.644 . . . . 0.0 110.985 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.045 HG21 HG23 ' A' ' 420' ' ' VAL . 47.1 t -107.78 142.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.183 -1.187 . . . . 0.0 109.819 173.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.652 HD11 ' CB ' ' A' ' 337' ' ' ALA . 80.1 mt -101.29 111.28 30.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 108.94 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.55 118.93 31.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.99 -1.069 . . . . 0.0 109.7 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.856 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -99.72 143.43 29.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.089 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.507 ' HE2' ' NE2' ' A' ' 426' ' ' GLN . 53.1 mttt -120.37 161.15 21.68 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 111.146 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.91 143.46 34.23 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.385 0.612 . . . . 0.0 110.216 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 12.1 tt -112.04 153.79 13.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 110.242 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.81 134.52 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.182 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -91.74 145.54 24.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.202 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.227 0.537 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -65.69 145.96 55.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.191 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 14.4 pt20 -143.33 155.8 44.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.0 110.273 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 355' ' ' LEU . . . -60.75 137.59 58.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.636 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -118.49 -35.79 3.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.479 ' N ' HD11 ' A' ' 355' ' ' LEU . 49.6 tt0 -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 110.121 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.008 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.3 p90 -135.69 142.76 45.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.821 -1.174 . . . . 0.0 111.676 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.525 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.6 mp -114.38 144.59 32.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.725 -0.61 . . . . 0.0 109.706 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.72 143.49 37.64 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.738 1.388 . . . . 0.0 111.448 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.051 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.94 152.0 42.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.821 165.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 23.7 tp60 -57.59 128.61 37.9 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 110.11 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.17 -1.33 43.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.6 t -136.56 140.03 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.706 -1.467 . . . . 0.0 110.751 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.23 152.42 39.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 85.1 tt0 -62.3 -40.33 95.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.459 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.2 -43.33 92.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.6 -1.313 . . . . 0.0 109.639 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.519 HG21 HG13 ' A' ' 328' ' ' VAL . 93.7 m -55.97 -43.81 77.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 173.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 1.007 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.9 tp -59.21 -39.45 82.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.319 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.16 -41.31 86.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.11 . . . . 0.0 110.777 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.554 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.3 m-20 -63.87 -50.03 70.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.926 -1.109 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.49 -31.13 70.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.981 -1.074 . . . . 0.0 109.722 176.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.749 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.21 -35.66 65.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.912 172.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.569 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.6 mt-30 -74.77 -55.84 5.42 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.583 -0.698 . . . . 0.0 110.9 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -63.72 -34.46 77.93 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.846 -171.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.458 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.04 -21.4 65.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.934 -1.104 . . . . 0.0 110.076 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.707 ' OG ' HG22 ' A' ' 353' ' ' VAL . 77.3 p -107.27 10.4 29.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.16 -0.963 . . . . 0.0 111.538 -174.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.573 ' CG ' ' HA ' ' A' ' 339' ' ' LEU . 45.9 mt -66.34 -43.78 85.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.55 -1.344 . . . . 0.0 109.502 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.25 0.38 48.09 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.931 -170.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.3 p30 -62.37 130.44 45.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.742 -1.224 . . . . 0.0 109.872 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.54 5.39 51.66 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.6 0.714 . . . . 0.0 109.886 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.45 151.91 83.31 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.52 -0.737 . . . . 0.0 109.451 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.64 -39.53 90.54 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.643 1.338 . . . . 0.0 109.09 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.56 -27.83 69.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.503 -0.748 . . . . 0.0 110.436 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.66 -37.94 70.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.567 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.2 mtt-85 -76.14 -36.59 58.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.018 -1.284 . . . . 0.0 110.376 172.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 29.3 p -62.72 -37.22 85.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.957 -1.089 . . . . 0.0 110.377 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.607 HG23 HD13 ' A' ' 443' ' ' ILE . 87.6 mt -68.53 -49.48 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.536 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.707 HG22 ' OG ' ' A' ' 341' ' ' SER . 26.2 t -61.24 -33.61 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 0.0 110.148 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.9 mt -72.2 -32.9 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.601 -1.312 . . . . 0.0 110.523 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.947 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.43 -40.21 90.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.832 -1.168 . . . . 0.0 110.528 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.487 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.03 -43.18 99.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 77.3 mttt -71.65 -48.53 47.13 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.769 -175.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.549 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -70.26 -42.8 71.69 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.587 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.3 mmm180 -74.23 -46.51 41.25 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 111.214 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.548 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 76.4 m-85 -136.28 -34.45 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.252 -1.379 . . . . 0.0 112.564 -169.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.497 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 18.0 t-20 -160.11 98.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.441 -1.412 . . . . 0.0 111.763 -168.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.781 HD12 ' H ' ' A' ' 362' ' ' LEU . 5.5 mp -58.96 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.029 -1.045 . . . . 0.0 109.705 171.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.5 tpt180 -142.15 163.45 32.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.86 . . . . 0.0 109.344 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.0 mt-10 -127.37 -153.81 0.59 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.01 -1.056 . . . . 0.0 110.629 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.573 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.2 ptt-85 -95.51 163.58 13.16 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.638 -0.664 . . . . 0.0 110.733 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -128.19 40.71 3.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.553 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.927 HG11 ' CE2' ' A' ' 374' ' ' PHE . 61.6 t -73.47 -46.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.192 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.79 -26.6 66.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.465 -0.772 . . . . 0.0 111.11 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.44 -30.66 29.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.107 -0.995 . . . . 0.0 109.745 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.789 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.6 mt -101.41 -3.96 27.76 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.541 -0.724 . . . . 0.0 110.636 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 367' ' ' VAL . 50.7 m80 59.3 52.51 5.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.957 . . . . 0.0 109.795 -175.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.835 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.61 174.6 7.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 110.378 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.9 m -116.38 134.94 54.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 110.473 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.927 ' CE2' HG11 ' A' ' 367' ' ' VAL . 88.0 m-85 -89.73 147.39 23.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.441 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 40.1 t -120.33 101.18 46.96 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.5 Cg_endo -54.54 153.7 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.003 1.528 . . . . 0.0 110.545 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.556 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.7 t80 -70.68 134.8 47.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.829 . . . . 0.0 110.383 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 6.4 p -115.64 143.42 45.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.855 . . . . 0.0 109.832 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.29 -24.4 59.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.656 -0.652 . . . . 0.0 110.341 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.84 -45.49 94.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.714 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.489 ' OG ' ' HG3' ' A' ' 383' ' ' MET . 97.1 p -94.31 -12.76 27.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.256 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 57.16 47.9 16.3 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.592 -0.692 . . . . 0.0 109.67 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.891 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.9 ptp -165.45 170.98 13.86 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.795 0.807 . . . . 0.0 111.287 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.6 p -155.54 165.53 36.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.509 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.29 -164.28 31.6 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.756 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.723 HD11 HG22 ' A' ' 367' ' ' VAL . 2.2 tt -142.45 149.48 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.623 -0.928 . . . . 0.0 110.154 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.44 HD21 HG21 ' A' ' 375' ' ' VAL . 39.3 m-20 -127.29 136.32 51.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 109.755 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.789 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -140.8 155.24 22.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.993 -1.067 . . . . 0.0 109.221 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.5 m-20 -21.96 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.452 0.644 . . . . 0.0 112.62 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.9 t-20 -95.99 -7.01 37.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.449 -0.782 . . . . 0.0 111.858 -167.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.555 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 29.8 mtp180 -143.64 146.18 33.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.661 -1.275 . . . . 0.0 110.639 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -136.15 104.3 5.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.863 -1.148 . . . . 0.0 109.119 170.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 339' ' ' LEU . 8.0 mt -125.05 146.07 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.996 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 23.6 mmt85 -134.29 159.55 40.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.011 . . . . 0.0 110.324 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.563 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.43 126.03 30.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.684 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.42 174.33 31.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.9 m -56.21 151.33 12.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.973 -1.31 . . . . 0.0 108.646 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.041 HG21 HG11 ' A' ' 420' ' ' VAL . 23.0 t -54.57 -37.65 39.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.915 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.2 m-20 -64.62 -44.99 88.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.3 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.891 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.14 -48.95 66.52 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.944 -1.097 . . . . 0.0 110.635 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.684 HD11 ' N ' ' A' ' 396' ' ' GLY . 39.9 mm -66.53 -44.31 90.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.029 -1.045 . . . . 0.0 111.007 -176.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HD2' ' CZ ' ' A' ' 412' ' ' PHE . 9.3 ttp180 -59.52 -43.08 93.53 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 92.2 mtt180 -61.69 -37.05 82.68 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.04 -1.038 . . . . 0.0 109.579 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.2 t-80 -67.3 -36.47 81.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 111.273 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 437' ' ' SER . 54.7 t -65.54 -49.13 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.6 -1.313 . . . . 0.0 110.161 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.47 -34.34 77.55 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.943 -1.098 . . . . 0.0 110.371 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.74 78.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.111 . . . . 0.0 109.982 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 18.0 m-80 -62.08 -27.05 68.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.429 -0.794 . . . . 0.0 109.155 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.83 19.35 29.39 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.89 -169.66 16.88 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.434 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.7 m-70 -143.09 153.36 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.139 -1.212 . . . . 0.0 111.395 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.587 ' CZ ' ' HD2' ' A' ' 402' ' ' ARG . 7.9 p90 -108.17 149.32 39.04 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.635 -0.665 . . . . 0.0 110.182 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.815 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.1 125.14 9.06 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.873 1.459 . . . . 0.0 110.531 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.09 -32.32 72.55 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.478 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.6 m-20 -63.24 -31.81 73.06 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.878 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.051 HG21 ' HA ' ' A' ' 325' ' ' ALA . 46.6 t -83.57 -42.77 17.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.88 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.58 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 69.1 m-20 -55.08 -36.34 65.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.729 -1.232 . . . . 0.0 109.648 171.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.39 -50.13 68.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.434 -1.416 . . . . 0.0 109.639 173.209 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 85.9 mttt -56.83 -34.53 67.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.757 -1.215 . . . . 0.0 110.286 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.101 HG23 HG21 ' A' ' 442' ' ' VAL . 2.5 t -58.99 -41.6 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 171.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.07 -36.18 82.52 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.955 0.883 . . . . 0.0 109.409 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 95.5 mm-40 -67.25 -38.25 84.86 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.725 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.809 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.2 t -62.61 -37.13 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.074 . . . . 0.0 110.125 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.29 84.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -68.18 -32.38 72.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 0.0 110.983 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -82.73 -2.89 55.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.77 22.56 30.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.809 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.19 163.5 12.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -1.143 . . . . 0.0 109.538 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.772 ' HB ' HD12 ' A' ' 445' ' ' LEU . 18.5 m -110.5 107.0 58.26 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.058 -1.026 . . . . 0.0 109.855 -175.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.566 ' CG ' HG13 ' A' ' 420' ' ' VAL . 33.6 Cg_endo -74.82 107.93 2.59 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 O-C-N 123.984 1.518 . . . . 0.0 110.73 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.864 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.3 mt -92.69 132.76 36.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 108.509 166.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.904 ' CG2' HG22 ' A' ' 398' ' ' VAL . 99.8 t -100.04 134.98 37.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 O-C-N 120.746 -1.222 . . . . 0.0 109.512 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.822 ' CG1' HD11 ' A' ' 440' ' ' LEU . 40.8 t -114.73 138.46 44.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.116 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -119.56 160.55 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 109.655 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.477 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.34 129.64 33.74 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.2 -131.79 30.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -167.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.561 ' O ' HG13 ' A' ' 405' ' ' VAL . 79.6 p -102.93 7.75 39.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -1.23 . . . . 0.0 111.071 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -118.4 170.71 8.69 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.647 -1.283 . . . . 0.0 110.127 -175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 24.6 t -93.58 134.48 31.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.336 -0.853 . . . . 0.0 109.719 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -95.3 -21.72 18.23 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.772 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 1.007 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.7 176.77 39.16 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.003 169.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.101 HG21 HG23 ' A' ' 420' ' ' VAL . 44.4 t -107.74 141.45 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.153 -1.204 . . . . 0.0 109.923 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.749 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.7 mt -101.45 111.06 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 108.986 170.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.94 119.35 31.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.956 -1.09 . . . . 0.0 109.801 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.864 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -100.09 142.75 31.14 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -122.35 161.18 23.88 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.848 -1.158 . . . . 0.0 111.078 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -87.07 141.39 28.7 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.375 0.607 . . . . 0.0 110.105 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 448' ' ' ILE . 10.3 tp -122.65 152.19 26.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.331 -0.855 . . . . 0.0 110.311 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.6 t -105.21 134.55 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.28 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -92.68 144.47 25.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.224 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.187 0.518 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.485 ' HD3' ' OG1' ' A' ' 429' ' ' THR . 62.4 mtt85 -123.07 146.67 47.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.558 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.9 tt0 -124.21 132.72 53.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.492 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.79 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -57.05 139.76 51.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.1 -1.0 . . . . 0.0 109.946 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.512 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 74.5 m -122.69 -36.71 2.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.502 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.5 tt0 -165.7 150.82 8.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.054 -1.029 . . . . 0.0 110.184 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.038 ' CD1' HD21 ' A' ' 355' ' ' LEU . 13.4 p90 -135.13 158.26 44.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.839 -1.163 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.7 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.2 mp -134.17 139.04 31.85 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.552 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.11 144.82 53.32 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.65 1.342 . . . . 0.0 111.824 -171.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.045 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -69.32 152.47 44.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 108.768 165.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.404 ' H ' ' CB ' ' A' ' 413' ' ' PRO . 23.6 tp60 -57.79 128.99 39.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.658 -1.276 . . . . 0.0 110.269 -172.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 109.54 -21.39 26.12 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.943 HG21 ' HA ' ' A' ' 440' ' ' LEU . 53.3 t -114.0 138.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.393 . . . . 0.0 110.907 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.469 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.0 m-20 -72.21 145.08 48.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 109.891 173.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.565 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.3 tt0 -59.87 -34.01 72.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.917 -1.114 . . . . 0.0 109.868 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.51 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.51 -42.41 87.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 109.25 175.125 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 99.5 m -61.59 -42.76 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.3 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.961 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.28 -39.8 88.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.451 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.973 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.74 -43.3 80.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.083 . . . . 0.0 110.772 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.552 ' O ' HD23 ' A' ' 339' ' ' LEU . 47.8 t0 -63.41 -49.9 71.93 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.912 -1.117 . . . . 0.0 110.055 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.929 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.88 -31.02 70.53 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.762 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.8 -35.78 66.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.079 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.0 mt-30 -73.3 -55.75 5.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.565 -0.709 . . . . 0.0 110.996 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.075 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -65.1 -33.83 76.96 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.205 -171.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.52 -20.89 65.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.067 173.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.2 p -107.29 10.65 29.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.225 -0.922 . . . . 0.0 111.521 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.3 mt -66.66 -45.48 78.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.546 -1.346 . . . . 0.0 109.73 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.59 0.14 49.53 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.986 -171.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.473 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.0 p30 -62.93 130.66 45.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.214 . . . . 0.0 109.898 176.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.67 5.32 51.73 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.516 0.674 . . . . 0.0 109.864 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 346' ' ' THR . 2.8 p -76.05 150.87 83.69 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 109.467 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.51 -38.32 83.34 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.708 1.373 . . . . 0.0 109.132 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.482 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.3 mt-10 -64.53 -28.6 69.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.404 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.27 -37.83 75.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -77.29 -38.64 50.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.095 -1.238 . . . . 0.0 110.631 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.8 m -62.35 -37.8 87.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.919 -1.113 . . . . 0.0 110.466 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.695 HG23 HD13 ' A' ' 443' ' ' ILE . 87.9 mt -68.13 -48.66 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.936 -1.103 . . . . 0.0 110.492 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.635 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.4 t -60.62 -33.17 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.23 . . . . 0.0 109.772 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.498 HG22 ' OE1' ' A' ' 358' ' ' GLN . 38.7 mt -72.76 -31.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.79 -1.194 . . . . 0.0 110.722 171.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.038 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.9 -41.5 91.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.866 -1.146 . . . . 0.0 110.242 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.526 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.36 -43.18 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 110.422 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.953 ' HB3' HD23 ' A' ' 362' ' ' LEU . 78.8 mttt -72.08 -51.23 22.58 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.635 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -71.17 -42.61 68.86 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.508 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.552 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.5 mmt180 -73.66 -44.31 57.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 111.101 -172.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 81.6 m-85 -135.31 -37.57 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.623 -1.298 . . . . 0.0 112.159 -169.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.521 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 60.9 t-20 -162.68 105.38 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.489 -1.382 . . . . 0.0 111.55 -168.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.953 HD23 ' HB3' ' A' ' 357' ' ' LYS . 46.9 mt -57.56 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.858 -1.151 . . . . 0.0 109.056 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 335' ' ' ASP . 56.5 ttt180 -129.21 168.14 16.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.449 ' N ' ' HG2' ' A' ' 363' ' ' ARG . 87.5 mt-10 -139.69 -157.82 0.8 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.8 ptt-85 -98.1 165.45 11.89 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.627 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.814 ' O ' HD12 ' A' ' 370' ' ' LEU . 89.9 m-20 -131.47 42.47 3.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 110.56 175.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.081 HG21 ' CE1' ' A' ' 374' ' ' PHE . 47.6 t -72.19 -45.77 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 0.0 110.152 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.34 -23.91 64.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.862 . . . . 0.0 111.166 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -31.85 30.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.778 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 366' ' ' ASP . 9.3 mt -104.42 -2.77 24.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.536 -0.727 . . . . 0.0 110.624 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 367' ' ' VAL . 81.7 m-70 59.25 52.37 6.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.698 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.781 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -91.79 174.49 7.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 110.308 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.6 m -118.46 135.5 54.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.478 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.081 ' CE1' HG21 ' A' ' 367' ' ' VAL . 90.8 m-85 -90.36 145.22 25.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 9.1 t -118.45 101.36 51.04 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.776 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.8 Cg_endo -54.72 154.23 21.47 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.079 1.568 . . . . 0.0 110.524 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.58 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.1 t80 -69.66 134.64 48.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.37 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 15.8 p -115.37 144.86 43.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.6 -19.88 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.641 -0.662 . . . . 0.0 110.355 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -62.34 -46.02 90.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.99 . . . . 0.0 109.695 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 383' ' ' MET . 70.9 m -95.97 -12.29 25.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 110.28 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 58.02 49.89 10.98 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.597 -0.689 . . . . 0.0 109.629 -174.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.936 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.1 ptp -165.15 171.26 13.96 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.822 0.82 . . . . 0.0 111.225 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 47.9 p -155.92 165.32 36.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.58 -165.57 34.3 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.704 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 367' ' ' VAL . 4.5 tt -139.82 152.57 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.902 . . . . 0.0 110.232 -175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -127.24 138.4 53.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.045 -1.034 . . . . 0.0 109.458 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.744 ' CD1' HD13 ' A' ' 370' ' ' LEU . 1.7 tt -140.85 154.36 21.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.842 -1.161 . . . . 0.0 109.362 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.267 89.0 m-20 -21.37 -61.83 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.438 0.637 . . . . 0.0 112.53 172.669 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 51.9 t-20 -98.99 -7.14 27.34 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.512 -0.742 . . . . 0.0 111.901 -166.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 15.9 mtp180 -142.91 147.97 36.18 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.681 -1.262 . . . . 0.0 110.573 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.6 mtm -134.98 111.07 9.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.942 -1.099 . . . . 0.0 108.995 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.075 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -129.52 146.09 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.557 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 31.2 mtt85 -136.76 161.92 34.63 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.16 -0.962 . . . . 0.0 111.035 176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.536 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.88 128.24 32.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.326 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.637 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.78 174.34 32.34 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 37.7 m -56.49 150.98 14.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.848 -1.384 . . . . 0.0 108.526 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.045 HG21 ' CG1' ' A' ' 420' ' ' VAL . 63.2 t -56.82 -35.33 46.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -0.999 . . . . 0.0 109.81 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.473 ' OD1' ' HD2' ' A' ' 403' ' ' ARG . 55.2 t0 -63.07 -46.75 85.97 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.315 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.936 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.18 -49.13 65.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.065 -1.022 . . . . 0.0 110.514 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.637 HD11 ' N ' ' A' ' 396' ' ' GLY . 41.7 mm -66.41 -43.84 90.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.099 -1.001 . . . . 0.0 110.931 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.595 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 7.8 ttp180 -59.86 -43.58 94.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.211 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.473 ' HD2' ' OD1' ' A' ' 399' ' ' ASP . 14.6 mtp-105 -61.8 -36.54 81.41 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.459 173.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.557 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 3.0 t-80 -68.69 -35.55 77.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.231 -0.918 . . . . 0.0 111.378 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 437' ' ' SER . 52.1 t -66.06 -50.42 69.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.533 -1.354 . . . . 0.0 110.171 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.966 -1.084 . . . . 0.0 110.37 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.26 76.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.924 -1.11 . . . . 0.0 110.085 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.547 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.9 m-80 -62.58 -26.81 68.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.132 174.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 98.12 17.83 28.56 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.43 -169.04 16.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.485 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.2 m-70 -142.87 153.62 43.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.112 -1.228 . . . . 0.0 111.351 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.595 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 9.5 p90 -105.82 147.64 35.1 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.272 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.85 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.95 123.95 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.808 1.425 . . . . 0.0 110.407 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.15 -32.73 74.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 111.033 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.9 m-20 -61.92 -33.04 73.53 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 0.0 108.963 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.045 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.8 t -83.63 -42.83 17.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.37 -0.832 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.4 m-20 -54.55 -37.46 65.46 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.76 -1.213 . . . . 0.0 109.507 171.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.5 mm-40 -63.38 -48.18 78.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.265 -1.522 . . . . 0.0 110.077 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.7 ' HD3' HG21 ' A' ' 323' ' ' ILE . 20.1 mttp -56.64 -35.24 68.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.072 HG23 HG21 ' A' ' 442' ' ' VAL . 2.4 t -59.78 -40.68 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.979 -1.075 . . . . 0.0 109.285 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.76 -36.25 82.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.842 0.829 . . . . 0.0 109.46 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -67.37 -36.81 82.1 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.63 -0.669 . . . . 0.0 110.62 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.769 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.0 t -62.88 -37.9 80.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.954 -1.091 . . . . 0.0 110.009 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.6 -40.01 84.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 0.0 110.385 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -68.11 -31.53 71.2 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.282 -0.886 . . . . 0.0 110.955 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.55 -3.11 55.47 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.783 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.51 22.14 29.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.769 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.34 163.48 12.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -1.079 . . . . 0.0 109.541 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.851 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.3 m -109.98 107.12 58.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.582 ' CG ' HG13 ' A' ' 420' ' ' VAL . 40.1 Cg_endo -75.79 108.28 2.65 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 123.97 1.511 . . . . 0.0 110.589 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.896 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.9 mt -92.81 134.77 34.74 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 108.598 167.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.953 ' CG2' HG22 ' A' ' 398' ' ' VAL . 96.8 t -100.7 134.27 41.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.754 -1.216 . . . . 0.0 109.428 176.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.771 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.5 t -114.82 137.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 176.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.1 m -118.09 160.27 17.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.413 -0.804 . . . . 0.0 109.721 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.483 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.39 130.77 35.39 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.07 -132.32 30.86 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 405' ' ' VAL . 82.9 p -102.75 7.52 39.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.081 -1.247 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -120.05 171.09 8.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.661 -1.275 . . . . 0.0 110.142 -175.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 26.0 t -92.25 133.4 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.418 -0.801 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.943 ' HA ' HG21 ' A' ' 328' ' ' VAL . 1.6 pp -92.93 -22.2 19.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.961 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.29 177.62 39.01 Favored Glycine 0 N--CA 1.5 2.939 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.987 169.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.072 HG21 HG23 ' A' ' 420' ' ' VAL . 51.2 t -107.81 142.95 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.22 -1.165 . . . . 0.0 110.075 174.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.762 HD11 ' HB1' ' A' ' 337' ' ' ALA . 75.8 mt -101.79 112.62 35.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 108.974 170.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.576 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -93.13 119.31 32.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.987 -1.071 . . . . 0.0 109.891 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.896 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -103.17 144.17 31.66 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.396 -0.815 . . . . 0.0 108.808 -175.451 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.512 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 16.2 mtmt -105.72 156.87 17.87 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.585 -1.322 . . . . 0.0 110.833 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -104.25 148.17 26.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.653 -0.654 . . . . 0.0 110.366 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 9.0 tp -119.31 153.16 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 110.11 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.9 t -104.16 135.18 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.97 . . . . 0.0 110.319 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -144.58 145.86 32.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 0.0 110.197 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.971 -1.461 . . . . 0.0 109.529 -179.899 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.223 0.535 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 66.7 mtt85 -122.04 148.85 44.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.2 mt-30 -124.91 144.96 50.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.154 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.773 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -59.93 138.64 57.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.07 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -122.31 -37.62 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 110.433 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.483 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.1 tt0 -162.84 148.32 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.187 -178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.078 ' CD1' HD21 ' A' ' 355' ' ' LEU . 14.1 p90 -133.95 142.88 47.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.803 -1.186 . . . . 0.0 111.704 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.568 HG21 ' CD ' ' A' ' 419' ' ' LYS . 4.4 mt -113.84 141.57 26.37 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.552 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.64 142.73 40.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.656 1.345 . . . . 0.0 111.528 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.062 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.83 151.13 45.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 108.856 165.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -57.46 128.88 39.28 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.744 -1.222 . . . . 0.0 110.098 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.66 -1.35 45.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.6 t -135.68 137.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.645 -1.503 . . . . 0.0 110.649 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.8 m-20 -72.74 150.44 42.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.4 tt0 -60.87 -38.04 84.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.0 OUTLIER -59.88 -40.3 88.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.929 -1.107 . . . . 0.0 109.224 177.376 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.546 HG21 HG13 ' A' ' 328' ' ' VAL . 98.9 m -60.51 -43.13 97.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 110.0 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.986 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.12 -38.43 83.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.373 -0.83 . . . . 0.0 110.502 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.971 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.75 -44.42 77.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.706 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.567 ' O ' HD23 ' A' ' 339' ' ' LEU . 89.9 m-20 -63.69 -48.74 75.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 110.017 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.921 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.61 -32.03 72.47 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.03 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.686 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.22 -36.0 65.5 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.011 172.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.2 mt-30 -74.1 -55.67 5.82 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.546 -0.721 . . . . 0.0 111.064 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.072 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.4 -33.96 77.07 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.066 -171.313 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.617 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.89 -20.31 65.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.982 -1.074 . . . . 0.0 109.991 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.594 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.3 p -107.62 10.42 29.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.134 -0.979 . . . . 0.0 111.502 -174.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.65 HD12 HD12 ' A' ' 386' ' ' ILE . 47.3 mt -66.53 -45.04 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.622 -1.299 . . . . 0.0 109.821 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.03 2.05 50.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.842 -170.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.485 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.9 p30 -65.09 130.29 42.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.798 -1.189 . . . . 0.0 110.061 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.7 4.47 52.97 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.574 0.702 . . . . 0.0 109.887 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 346' ' ' THR . 3.0 p -74.47 150.84 87.21 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.572 -0.705 . . . . 0.0 109.426 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.78 -40.74 78.96 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.723 1.381 . . . . 0.0 109.358 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.6 mt-10 -64.65 -28.07 69.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.1 -38.11 65.53 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.532 ' O ' HD12 ' A' ' 354' ' ' ILE . 68.5 mtt85 -77.4 -37.3 52.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.239 . . . . 0.0 110.501 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.2 m -61.36 -37.83 84.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.069 . . . . 0.0 110.324 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.664 HG23 HD13 ' A' ' 443' ' ' ILE . 83.1 mt -69.55 -49.38 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.631 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.594 HG22 ' OG ' ' A' ' 341' ' ' SER . 23.4 t -59.9 -32.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.865 -1.147 . . . . 0.0 109.813 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 350' ' ' ARG . 34.6 mt -72.74 -34.22 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 110.637 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.078 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.06 -40.25 80.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.817 -1.177 . . . . 0.0 110.239 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.02 -45.77 87.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 48.2 mtmt -72.02 -49.25 38.5 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.844 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.55 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 17.0 pt20 -70.87 -42.96 69.38 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.668 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 39.3 mmt180 -74.42 -45.36 47.04 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 111.145 -171.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 90.9 m-85 -135.57 -37.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.446 -1.301 . . . . 0.0 112.218 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.508 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 51.2 t30 -162.91 105.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.494 -1.379 . . . . 0.0 111.652 -168.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.5 OUTLIER -57.87 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.754 -1.216 . . . . 0.0 109.203 171.391 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.539 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.0 tpt180 -126.64 164.02 22.17 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 109.11 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 83.9 mt-10 -137.22 -159.38 0.95 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.933 -1.105 . . . . 0.0 110.369 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.8 ptt180 -97.69 163.82 12.66 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 110.586 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -130.87 42.13 3.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.366 -0.834 . . . . 0.0 110.544 175.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.022 HG21 ' CE1' ' A' ' 374' ' ' PHE . 64.8 t -73.52 -48.43 41.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.312 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.56 -26.09 66.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 111.067 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -30.14 27.91 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 176.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.985 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.6 mt -103.25 -4.0 24.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 110.731 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 367' ' ' VAL . 61.4 m-70 63.11 53.04 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.317 -0.864 . . . . 0.0 110.148 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.939 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.57 174.89 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.618 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.3 m -116.89 133.5 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.47 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.022 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.8 m-85 -87.67 143.42 27.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.472 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 387' ' ' ASN . 16.8 t -117.14 101.15 53.32 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 109.628 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.23 151.27 36.47 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.056 1.556 . . . . 0.0 110.55 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.7 t80 -62.32 130.86 47.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.038 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.3 p -120.23 153.7 35.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.07 -4.95 49.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.517 -0.739 . . . . 0.0 109.948 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.42 -33.2 65.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.762 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 400' ' ' ALA . 22.5 m -141.49 10.85 2.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.361 -0.837 . . . . 0.0 110.374 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.9 mtt180 57.55 51.8 9.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.589 ' CE ' HD13 ' A' ' 401' ' ' ILE . 2.1 ptp -157.98 167.53 29.67 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.852 0.834 . . . . 0.0 111.174 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.65 165.26 36.49 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.8 -166.24 35.29 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.524 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.838 HD11 HG22 ' A' ' 367' ' ' VAL . 14.5 tt -139.51 150.75 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.634 -0.921 . . . . 0.0 110.176 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.64 HD21 HG21 ' A' ' 375' ' ' VAL . 37.8 m-20 -127.6 133.26 49.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 0.0 109.755 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.985 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -139.57 154.81 24.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.84 -1.162 . . . . 0.0 109.302 170.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 88.6 m-20 -25.62 -62.99 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.429 0.633 . . . . 0.0 112.266 172.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.461 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.0 t30 -90.96 -8.56 48.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 111.767 -168.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 35.7 mtp180 -143.38 143.93 31.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.643 -1.286 . . . . 0.0 110.627 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.7 mtm -134.08 107.47 7.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 108.909 168.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.072 HD12 HD11 ' A' ' 339' ' ' LEU . 7.4 mt -129.45 146.11 34.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.21 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 20.8 mtt-85 -135.64 162.12 33.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 110.995 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.516 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -135.22 127.79 30.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.221 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.557 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.7 174.05 33.04 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.7 m -57.28 150.73 17.35 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.978 -1.307 . . . . 0.0 108.601 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.055 HG21 HG11 ' A' ' 420' ' ' VAL . 20.0 t -54.82 -37.91 42.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.849 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.8 m-20 -63.72 -44.01 94.85 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.29 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 383' ' ' MET . . . -68.29 -52.14 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.876 -1.14 . . . . 0.0 110.535 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.614 HG21 HG12 ' A' ' 432' ' ' VAL . 27.6 mm -64.29 -42.22 94.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.106 -0.996 . . . . 0.0 110.828 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.2 ttp85 -59.94 -43.96 94.67 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.228 -0.92 . . . . 0.0 110.313 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 95.1 mtt180 -61.5 -37.16 82.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.515 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -68.21 -36.24 79.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.869 . . . . 0.0 111.319 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.65 -48.99 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.534 -1.354 . . . . 0.0 110.126 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.18 -34.33 77.4 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.914 -1.116 . . . . 0.0 110.145 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -36.23 80.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.952 -1.092 . . . . 0.0 109.958 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.0 m-80 -61.82 -27.33 68.69 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.202 173.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.79 19.46 29.17 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -169.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.49 -170.67 16.81 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -144.3 153.62 42.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -1.233 . . . . 0.0 111.231 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.595 ' HB3' HG21 ' A' ' 439' ' ' VAL . 9.8 p90 -108.85 149.97 40.25 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.475 -0.766 . . . . 0.0 110.068 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.865 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -73.02 126.31 11.11 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.877 1.462 . . . . 0.0 110.455 -175.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 414' ' ' THR . 1.3 t -67.18 -33.49 75.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 111.04 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.9 m-20 -63.36 -32.19 73.54 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.984 -1.072 . . . . 0.0 108.77 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.062 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.2 t -83.64 -41.69 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.395 -0.816 . . . . 0.0 110.824 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 56.4 t0 -54.9 -37.19 66.03 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 109.444 171.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.28 -50.99 65.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.447 -1.408 . . . . 0.0 109.635 172.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.568 ' CD ' HG21 ' A' ' 323' ' ' ILE . 45.0 mttm -55.77 -34.56 65.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.868 -1.145 . . . . 0.0 110.263 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.055 HG11 HG21 ' A' ' 398' ' ' VAL . 2.6 t -58.9 -42.5 86.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.172 170.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.5 -36.1 82.85 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 109.425 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.5 mm-40 -67.87 -37.13 81.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.697 -0.627 . . . . 0.0 110.65 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 428' ' ' ALA . 67.4 t -63.34 -37.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.025 . . . . 0.0 110.044 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.54 85.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -69.08 -30.38 68.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.296 -0.878 . . . . 0.0 110.888 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.75 -3.56 56.72 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.045 -1.034 . . . . 0.0 109.717 175.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.19 21.84 28.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.81 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.62 163.47 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -1.067 . . . . 0.0 109.626 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.468 ' HB ' HD12 ' A' ' 445' ' ' LEU . 22.1 m -109.75 107.2 59.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.989 -1.069 . . . . 0.0 109.731 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.562 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.2 Cg_endo -76.18 108.13 2.61 Favored 'Trans proline' 0 C--N 1.297 -2.158 0 O-C-N 123.878 1.462 . . . . 0.0 110.462 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.907 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.5 mt -92.29 136.31 33.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 0.0 108.64 167.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.879 ' CG2' HG22 ' A' ' 398' ' ' VAL . 94.6 t -99.93 135.06 37.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.675 -1.266 . . . . 0.0 109.462 175.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.904 ' CG1' HD11 ' A' ' 440' ' ' LEU . 27.3 t -115.83 137.76 48.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.291 -0.88 . . . . 0.0 108.831 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.84 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.7 m -120.45 160.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.272 -0.892 . . . . 0.0 109.734 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.494 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -134.37 132.9 40.0 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.18 -130.09 32.29 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.607 ' O ' HG13 ' A' ' 405' ' ' VAL . 74.1 p -105.64 8.71 33.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.034 -1.274 . . . . 0.0 111.129 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -122.12 170.64 9.67 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.588 -1.32 . . . . 0.0 110.107 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.84 ' HA ' HG12 ' A' ' 434' ' ' VAL . 47.0 t -89.48 133.86 30.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 109.95 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.904 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -92.22 -22.83 19.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.986 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.32 177.51 40.55 Favored Glycine 0 N--CA 1.5 2.943 0 C-N-CA 118.945 -1.598 . . . . 0.0 110.87 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.051 HG21 HG23 ' A' ' 420' ' ' VAL . 47.9 t -107.9 142.36 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.119 -1.224 . . . . 0.0 109.869 172.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.686 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.9 mt -101.3 112.02 32.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.416 -0.802 . . . . 0.0 108.941 170.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.09 119.38 31.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 109.837 -178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.907 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.29 142.82 32.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 320' ' ' SER . 28.9 mtmt -111.08 158.23 19.08 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.657 -1.277 . . . . 0.0 111.056 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -87.93 146.79 25.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.671 -0.643 . . . . 0.0 110.319 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 448' ' ' ILE . 10.7 tp -117.78 154.7 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.854 . . . . 0.0 110.169 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.0 t -102.58 134.11 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.258 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -93.67 146.0 24.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.232 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 118.011 -1.439 . . . . 0.0 109.526 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.302 0.573 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.482 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 74.9 mtt85 -122.72 143.31 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.153 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.561 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.3 tt0 -124.82 131.8 53.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.266 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.92 138.91 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.884 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.54 -44.34 2.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.07 -1.019 . . . . 0.0 110.278 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.1 mt-10 -154.44 152.34 30.04 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.427 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.008 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 16.5 p90 -137.22 143.15 42.15 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.731 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.525 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -114.93 144.66 32.44 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.747 -0.596 . . . . 0.0 109.657 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.7 143.71 38.15 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.758 1.399 . . . . 0.0 111.525 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.04 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.39 152.72 41.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 108.847 165.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.408 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 20.7 tp60 -57.87 128.43 37.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.654 -1.279 . . . . 0.0 110.081 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.67 -0.82 45.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.9 t -136.61 140.08 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.686 -1.479 . . . . 0.0 110.743 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.4 m-20 -74.15 152.67 39.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 85.0 tt0 -62.37 -40.76 97.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.985 -1.072 . . . . 0.0 110.471 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.25 -43.09 92.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.682 -1.261 . . . . 0.0 109.612 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 328' ' ' VAL . 93.3 m -55.53 -43.93 76.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.75 173.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 1.023 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -59.77 -39.24 84.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 110.285 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.0 -41.85 86.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.837 -1.164 . . . . 0.0 110.841 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.0 t0 -63.83 -49.83 71.3 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.832 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.918 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.27 -31.44 71.77 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.718 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.96 -35.09 66.33 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.142 172.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 18.0 mt-30 -73.85 -55.79 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.596 -0.69 . . . . 0.0 110.815 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.074 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.71 -34.7 76.24 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.894 -173.197 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.437 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.54 -20.43 65.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.927 174.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.626 ' OG ' HG22 ' A' ' 353' ' ' VAL . 97.1 p -108.91 9.75 26.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.199 -0.938 . . . . 0.0 111.631 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.708 HD22 ' HD2' ' A' ' 365' ' ' ARG . 35.5 mt -64.1 -45.78 87.14 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.652 -1.28 . . . . 0.0 109.806 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.7 -0.8 42.12 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.788 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 10.5 p30 -61.8 130.51 46.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.927 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.03 5.89 50.13 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.612 0.72 . . . . 0.0 109.951 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 346' ' ' THR . 2.5 p -77.56 154.59 81.42 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.579 -0.7 . . . . 0.0 109.45 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.15 -36.85 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.624 1.329 . . . . 0.0 109.128 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.482 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.3 mt-10 -64.3 -29.2 70.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.448 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -57.47 -38.54 87.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -77.33 -37.38 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -1.177 . . . . 0.0 110.629 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.561 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.0 m -61.68 -38.85 89.34 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.042 -1.036 . . . . 0.0 110.368 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.551 HG23 HD13 ' A' ' 443' ' ' ILE . 84.7 mt -69.18 -48.37 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.693 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.626 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -60.64 -34.54 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.06 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 350' ' ' ARG . 36.4 mt -72.54 -32.26 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.628 -1.295 . . . . 0.0 110.653 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.004 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.87 -41.06 90.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.937 -1.102 . . . . 0.0 110.394 179.09 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.79 -42.85 99.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 0.0 110.383 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.997 ' HB3' HD23 ' A' ' 362' ' ' LEU . 83.4 mttt -70.69 -50.55 35.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.913 -1.117 . . . . 0.0 110.772 -174.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.513 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.9 pt20 -71.0 -42.59 69.43 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 110.561 -173.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.595 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 40.1 mmt180 -73.06 -46.16 53.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 111.21 -173.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.647 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 79.3 m-85 -135.96 -36.03 0.76 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.542 -1.349 . . . . 0.0 112.39 -169.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.522 ' ND2' ' HD2' ' A' ' 363' ' ' ARG . 56.0 t-20 -158.59 98.55 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.557 -1.34 . . . . 0.0 111.7 -169.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.997 HD23 ' HB3' ' A' ' 357' ' ' LYS . 24.3 mt -58.38 91.17 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 0.0 109.509 171.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.522 ' HD2' ' ND2' ' A' ' 361' ' ' ASN . 13.8 ptm180 -145.6 -176.81 5.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.287 -0.883 . . . . 0.0 109.983 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.28 -158.53 0.9 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 110.329 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.708 ' HD2' HD22 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -97.96 166.81 11.27 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.661 -0.649 . . . . 0.0 110.558 -178.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.0 m-20 -121.02 41.1 3.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.009 HG11 ' CE2' ' A' ' 374' ' ' PHE . 43.0 t -70.45 -45.54 74.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 110.21 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -68.2 -29.02 67.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.159 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -29.66 27.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.07 -1.019 . . . . 0.0 109.767 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.811 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.6 mt -102.66 -3.22 26.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 110.777 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.1 m80 58.82 53.8 5.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 0.0 109.895 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.842 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.89 174.68 7.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 110.513 -177.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.1 m -114.79 134.02 55.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.357 -0.84 . . . . 0.0 110.396 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.009 ' CE2' HG11 ' A' ' 367' ' ' VAL . 72.4 m-85 -88.7 149.38 23.52 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 5.0 t -122.75 100.81 40.32 Favored Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -56.3 150.66 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.031 1.543 . . . . 0.0 110.473 -177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.6 t80 -66.91 131.75 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 110.141 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p -121.3 153.13 38.11 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 109.639 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.56 -6.35 53.38 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.606 -0.684 . . . . 0.0 109.897 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -54.77 -34.48 62.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 109.685 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 383' ' ' MET . 1.8 m -139.11 10.27 2.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 110.241 175.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 73.2 mtt85 57.21 50.97 10.83 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.877 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.8 ptp -158.6 169.71 23.81 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.949 0.881 . . . . 0.0 111.339 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.524 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 31.1 p -154.84 165.22 37.33 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.15 -165.33 33.25 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.897 -1.621 . . . . 0.0 110.751 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.929 HG21 ' HB2' ' A' ' 339' ' ' LEU . 2.4 tt -142.28 149.38 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.63 -0.923 . . . . 0.0 110.054 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -127.91 136.0 50.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.957 -1.09 . . . . 0.0 109.911 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.45 155.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.859 -1.151 . . . . 0.0 109.22 171.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.498 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 91.2 m-20 -23.46 -63.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.398 0.618 . . . . 0.0 112.436 171.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 46.4 t-20 -95.82 -5.56 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.513 -0.742 . . . . 0.0 111.871 -167.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.562 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.6 mtp180 -143.98 143.8 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.66 -1.275 . . . . 0.0 110.375 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -134.02 112.25 11.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.822 -1.174 . . . . 0.0 108.913 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.074 HD12 HD11 ' A' ' 339' ' ' LEU . 9.6 mt -131.49 146.16 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 35.1 mtt180 -133.75 159.92 39.15 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.078 -1.014 . . . . 0.0 110.58 174.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.627 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.09 128.92 35.18 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.611 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.87 174.22 33.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -174.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.6 m -56.91 151.58 14.37 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.871 -1.37 . . . . 0.0 108.653 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.027 HG21 HG11 ' A' ' 420' ' ' VAL . 53.5 t -56.51 -34.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 109.942 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.516 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 46.2 t0 -63.26 -47.19 83.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.323 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.877 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.77 -50.05 59.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.523 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.611 HD11 ' N ' ' A' ' 396' ' ' GLY . 35.8 mm -64.97 -42.99 96.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.053 -1.029 . . . . 0.0 110.794 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.582 ' HD2' ' CZ ' ' A' ' 412' ' ' PHE . 9.5 ttp180 -59.36 -43.39 92.84 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.309 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.516 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 88.9 mtt180 -61.31 -37.16 82.25 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.517 173.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -67.5 -36.95 82.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 0.0 111.312 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.55 ' CG2' HG11 ' A' ' 434' ' ' VAL . 53.4 t -65.93 -48.35 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.5 -1.375 . . . . 0.0 110.206 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.6 -34.24 77.38 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.901 -1.124 . . . . 0.0 110.355 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.77 -36.26 80.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.939 -1.101 . . . . 0.0 109.886 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 4.8 m120 -61.03 -27.84 68.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 109.124 173.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.35 27.2 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -169.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.59 -169.05 15.59 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -144.36 153.66 42.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.131 -1.217 . . . . 0.0 111.404 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 6.7 p90 -108.22 150.35 40.39 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.769 -0.582 . . . . 0.0 110.258 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.817 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -75.0 125.53 9.39 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.812 1.427 . . . . 0.0 110.572 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -67.39 -33.82 75.98 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.172 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -62.12 -32.01 72.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.98 -1.075 . . . . 0.0 108.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.04 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.4 t -83.72 -42.69 17.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 110.942 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.585 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 66.8 m-20 -55.28 -36.22 65.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.629 171.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.88 -50.85 67.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.377 -1.452 . . . . 0.0 109.537 172.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 81.9 mttt -56.46 -34.36 66.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.338 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.05 HG23 HG21 ' A' ' 442' ' ' VAL . 2.4 t -58.86 -41.65 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.964 -1.085 . . . . 0.0 109.171 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -66.34 -36.51 83.08 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.936 0.874 . . . . 0.0 109.414 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.502 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 95.4 mm-40 -67.24 -37.28 83.28 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.586 -0.696 . . . . 0.0 110.703 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.745 HG13 ' HB3' ' A' ' 428' ' ' ALA . 77.0 t -62.39 -37.86 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 110.063 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.18 -37.97 86.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -66.26 -33.81 76.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.193 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -83.23 -1.82 54.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 176.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.05 22.54 32.44 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.745 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.12 162.47 13.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -1.084 . . . . 0.0 109.485 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.683 ' HB ' HD12 ' A' ' 445' ' ' LEU . 34.8 m -109.5 107.0 59.24 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 109.741 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.547 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.9 Cg_endo -74.98 108.09 2.64 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 O-C-N 124.05 1.553 . . . . 0.0 110.596 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.865 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -92.54 134.18 35.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.816 -1.177 . . . . 0.0 108.578 167.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.953 ' CG2' HG22 ' A' ' 398' ' ' VAL . 74.6 t -100.35 134.17 40.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.669 -1.269 . . . . 0.0 109.457 176.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.661 ' CG1' HD11 ' A' ' 440' ' ' LEU . 55.3 t -115.78 136.42 52.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.063 175.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -117.75 160.15 17.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.484 -0.76 . . . . 0.0 109.632 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.518 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.22 133.19 36.82 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.83 -123.57 22.24 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -168.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 405' ' ' VAL . 2.3 p -114.2 11.37 17.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.095 -1.238 . . . . 0.0 110.987 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -123.88 171.08 9.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.629 -1.294 . . . . 0.0 109.907 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 40.3 t -90.04 134.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.312 -0.867 . . . . 0.0 109.821 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.6 pp -94.33 -21.77 18.77 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 109.693 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 1.023 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.02 176.12 38.28 Favored Glycine 0 N--CA 1.499 2.883 0 C-N-CA 118.938 -1.601 . . . . 0.0 110.904 170.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.05 HG21 HG23 ' A' ' 420' ' ' VAL . 49.7 t -107.87 142.06 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.12 -1.224 . . . . 0.0 109.953 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.706 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.1 mt -101.32 110.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.424 -0.798 . . . . 0.0 108.961 170.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.625 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.36 118.18 30.67 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.031 -1.043 . . . . 0.0 109.864 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.865 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.08 144.32 30.81 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -109.37 159.38 17.04 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.675 -1.266 . . . . 0.0 110.905 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -83.23 140.69 32.38 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.433 0.635 . . . . 0.0 110.332 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 7.4 tt -115.07 152.42 16.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 110.278 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.2 t -104.53 135.47 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.369 -0.832 . . . . 0.0 110.308 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -92.23 144.56 25.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 CA-C-O 118.02 -1.433 . . . . 0.0 109.548 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.25 0.547 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 97.3 mtt180 -123.02 149.66 44.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.245 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.468 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 50.9 tt0 -122.73 137.96 54.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.877 . . . . 0.0 110.076 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.755 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -59.59 142.37 52.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.528 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -117.54 -34.17 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -0.981 . . . . 0.0 110.439 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -169.45 150.57 4.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 0.0 110.029 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.004 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 13.9 p90 -134.87 143.98 47.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.85 -1.156 . . . . 0.0 111.643 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.52 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.3 mt -114.49 144.03 31.02 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.611 -0.681 . . . . 0.0 109.666 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.88 143.78 37.49 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.767 1.404 . . . . 0.0 111.357 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.05 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.0 152.26 42.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 108.831 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -58.16 128.77 38.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.665 -1.272 . . . . 0.0 110.188 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.54 42.83 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.0 t -136.48 139.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.65 -1.5 . . . . 0.0 110.736 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.18 152.44 39.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.154 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.565 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -62.47 -40.13 95.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.993 . . . . 0.0 110.437 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.09 -43.15 91.81 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.701 -1.25 . . . . 0.0 109.62 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.531 HG21 HG13 ' A' ' 328' ' ' VAL . 94.3 m -56.11 -43.54 78.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.885 173.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 1.01 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.2 tp -59.68 -40.08 86.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.291 -0.881 . . . . 0.0 110.281 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.004 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -66.66 -41.21 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.914 -1.116 . . . . 0.0 110.742 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.546 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.3 t0 -64.22 -50.87 66.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.854 -1.153 . . . . 0.0 109.928 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.949 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.03 -30.62 69.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.909 -1.119 . . . . 0.0 109.779 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.91 65.29 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.133 -0.979 . . . . 0.0 109.028 171.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.574 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 17.3 mt-30 -74.25 -55.71 5.73 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.569 -0.707 . . . . 0.0 110.914 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.04 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -63.92 -33.78 76.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.908 -171.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.467 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -66.77 -21.48 66.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.986 -1.072 . . . . 0.0 110.045 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.609 ' OG ' HG22 ' A' ' 353' ' ' VAL . 97.5 p -107.65 10.79 28.95 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.04 -1.037 . . . . 0.0 111.598 -173.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 46.3 mt -67.15 -43.75 81.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.624 -1.297 . . . . 0.0 109.652 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.52 2.67 52.64 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.863 -171.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.515 ' OD2' ' CA ' ' A' ' 349' ' ' GLY . 18.3 p30 -65.0 130.0 41.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.773 -1.204 . . . . 0.0 110.088 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.72 4.43 52.98 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.573 0.701 . . . . 0.0 109.909 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.38 151.77 85.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.711 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -56.38 -39.4 91.53 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.702 1.369 . . . . 0.0 109.09 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 97.6 mt-10 -64.31 -29.63 70.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.484 -0.76 . . . . 0.0 110.367 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.31 -36.04 61.91 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 354' ' ' ILE . 65.9 mtt85 -77.18 -36.53 54.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 0.0 110.543 174.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.468 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 13.2 m -60.78 -39.08 87.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 443' ' ' ILE . 81.0 mt -68.19 -48.99 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.562 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.609 HG22 ' OG ' ' A' ' 341' ' ' SER . 27.5 t -62.18 -33.94 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.945 -1.097 . . . . 0.0 110.192 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 350' ' ' ARG . 31.7 mt -72.22 -31.98 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.597 -1.314 . . . . 0.0 110.576 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.997 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -60.61 -40.61 92.48 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 110.568 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.531 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.33 -42.93 99.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 0.0 110.274 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 70.4 mttt -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.73 -175.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.9 pt20 -70.09 -42.22 73.0 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 110.785 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.6 mmm180 -74.68 -46.24 39.18 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 111.189 -171.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.592 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 77.8 m-85 -136.22 -34.97 0.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.399 -1.321 . . . . 0.0 112.31 -170.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.516 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 53.5 t-20 -159.66 103.33 1.55 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.551 -1.343 . . . . 0.0 111.598 -169.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 37.0 mt -57.66 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.872 -1.142 . . . . 0.0 109.066 170.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 25.3 tpt180 -134.19 163.83 28.73 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.419 -0.8 . . . . 0.0 109.344 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.3 mt-10 -136.12 -158.05 0.84 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 46.3 ptt85 -97.66 163.69 12.72 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.661 -0.649 . . . . 0.0 110.841 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.9 m-20 -134.5 44.49 2.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.821 . . . . 0.0 110.554 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 1.017 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.0 t -72.41 -46.95 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.44 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -67.9 -26.15 65.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 111.264 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -31.18 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.057 . . . . 0.0 109.715 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 388' ' ' ILE . 19.8 mt -100.68 -4.09 28.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.498 -0.751 . . . . 0.0 110.606 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 46.8 m80 59.99 51.73 5.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -174.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.819 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.06 172.99 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.9 m -118.82 135.61 54.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 110.374 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 1.017 ' CE1' HG21 ' A' ' 367' ' ' VAL . 86.3 m-85 -90.01 145.16 25.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.651 175.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.441 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 47.9 t -118.73 100.99 50.92 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 174.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.16 150.75 38.24 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.068 1.562 . . . . 0.0 110.526 -175.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 8.4 t80 -63.27 131.35 48.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.357 -0.839 . . . . 0.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.7 p -120.5 153.0 37.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.706 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.69 -5.86 51.94 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.919 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.7 -33.18 66.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -0.867 . . . . 0.0 109.836 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 383' ' ' MET . 1.8 m -139.47 10.25 2.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 110.293 174.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 88.7 mtt180 57.08 51.01 10.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.79 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.6 ptp -158.75 168.48 26.73 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.26 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 12.2 p -155.39 165.16 37.49 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.6 -164.16 31.55 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.956 -1.592 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 367' ' ' VAL . 1.9 tt -141.96 149.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.665 -0.903 . . . . 0.0 110.173 -174.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -127.22 138.86 53.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -141.37 154.59 20.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.87 -1.144 . . . . 0.0 109.365 172.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.264 88.3 m-20 -21.4 -62.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.391 0.615 . . . . 0.0 112.608 171.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 24.8 t-20 -99.03 -6.78 27.89 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 111.819 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 18.3 mtp180 -142.97 145.86 33.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.746 -1.221 . . . . 0.0 110.553 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 89.9 mtp -134.16 113.27 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.909 -1.119 . . . . 0.0 109.08 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.04 HD12 HD11 ' A' ' 339' ' ' LEU . 9.3 mt -131.75 146.05 34.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.051 -1.031 . . . . 0.0 110.142 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 32.8 mtt180 -135.92 161.9 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.005 . . . . 0.0 110.779 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.643 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.45 134.23 41.34 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.531 -0.731 . . . . 0.0 109.11 174.132 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.504 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -159.76 174.06 36.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -58.51 153.0 16.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.921 -1.34 . . . . 0.0 108.438 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.031 HG21 HG11 ' A' ' 420' ' ' VAL . 20.8 t -54.87 -37.52 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.82 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.1 m-20 -64.25 -44.51 91.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.79 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.78 -51.84 36.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.923 -1.111 . . . . 0.0 110.503 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.504 HD11 ' N ' ' A' ' 396' ' ' GLY . 25.2 mm -63.82 -42.28 95.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.096 -1.003 . . . . 0.0 110.805 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.4 ttt180 -60.81 -43.29 98.38 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.299 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 89.8 mtt180 -61.15 -36.54 80.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.07 -1.019 . . . . 0.0 109.643 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -67.45 -38.15 84.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 111.33 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 437' ' ' SER . 63.7 t -66.07 -47.22 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.473 -1.392 . . . . 0.0 110.219 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.73 -34.63 78.3 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.738 -1.226 . . . . 0.0 110.337 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.47 -36.29 80.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.986 -1.071 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 5.3 m120 -61.15 -27.81 68.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.442 -0.786 . . . . 0.0 109.126 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.61 19.85 28.51 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.01 -170.26 16.3 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -144.61 153.98 42.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.247 . . . . 0.0 111.321 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.601 ' HB3' HG21 ' A' ' 439' ' ' VAL . 6.1 p90 -106.87 150.99 40.43 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.63 -0.669 . . . . 0.0 110.096 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.858 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.81 125.61 10.64 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.853 1.449 . . . . 0.0 110.237 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.2 t -66.69 -34.13 77.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 111.136 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.482 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.9 m-20 -62.97 -32.31 73.61 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.931 -1.106 . . . . 0.0 108.858 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.05 HG21 ' HA ' ' A' ' 325' ' ' ALA . 48.4 t -83.41 -42.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -0.846 . . . . 0.0 110.809 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 5.3 m-20 -55.58 -36.42 66.84 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.595 171.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.94 -50.16 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 0.0 109.686 172.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.52 ' CD ' HG21 ' A' ' 323' ' ' ILE . 35.7 mttt -56.65 -34.6 67.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.764 -1.21 . . . . 0.0 110.332 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.112 HG23 HG21 ' A' ' 442' ' ' VAL . 2.8 t -59.09 -41.78 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.932 -1.105 . . . . 0.0 109.369 170.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.66 -35.95 82.26 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.943 0.878 . . . . 0.0 109.296 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.39 -37.92 83.89 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.566 -0.709 . . . . 0.0 110.769 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 428' ' ' ALA . 64.5 t -63.44 -36.81 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.0 110.193 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.34 85.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -70.08 -28.95 65.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.326 -0.859 . . . . 0.0 110.599 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -80.36 -3.75 50.82 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.009 . . . . 0.0 109.74 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.7 21.96 35.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.733 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.74 175.96 5.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.722 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.657 ' O ' HD12 ' A' ' 445' ' ' LEU . 59.1 m -119.15 106.92 42.4 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.942 -1.099 . . . . 0.0 109.874 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.591 ' CG ' HG13 ' A' ' 420' ' ' VAL . 31.4 Cg_endo -74.06 106.78 2.28 Favored 'Trans proline' 0 C--N 1.296 -2.204 0 O-C-N 123.911 1.479 . . . . 0.0 110.354 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 445' ' ' LEU . 15.8 mt -93.08 131.79 37.78 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 167.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.81 ' CG2' HG22 ' A' ' 398' ' ' VAL . 72.6 t -100.57 137.54 27.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.823 -1.173 . . . . 0.0 109.777 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.775 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.7 t -116.2 137.74 48.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 108.928 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.851 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.05 159.98 20.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 121.351 -0.843 . . . . 0.0 109.757 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.48 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.11 132.77 36.52 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.41 -126.82 31.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -168.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.495 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -109.91 13.41 23.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.238 . . . . 0.0 111.123 -178.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -128.33 170.66 12.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.017 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.851 ' HA ' HG12 ' A' ' 434' ' ' VAL . 53.3 t -88.35 134.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 109.776 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.806 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.5 pp -92.3 -22.3 19.81 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.665 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 1.01 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.88 176.36 40.09 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.963 168.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.112 HG21 HG23 ' A' ' 420' ' ' VAL . 46.9 t -107.94 142.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.16 -1.2 . . . . 0.0 109.539 171.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.721 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.3 mt -101.67 119.24 49.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 169.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -99.0 117.49 33.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.744 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 3.6 mp -113.63 146.34 39.9 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.095 -1.003 . . . . 0.0 109.819 -173.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.528 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.7 OUTLIER -134.53 170.28 16.02 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.749 -1.22 . . . . 0.0 110.773 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -71.16 145.59 49.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 110.113 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.423 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.5 tp -119.72 153.49 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.246 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.24 135.6 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.197 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -92.49 144.73 25.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.231 0.539 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.48 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 97.7 mtt180 -122.45 147.53 46.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 110.181 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.5 tt0 -121.53 133.05 55.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.239 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.74 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.57 138.6 40.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 0.0 109.802 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 4.9 m -119.53 -44.7 2.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.086 -1.009 . . . . 0.0 110.197 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 320' ' ' SER . 69.7 mt-10 -154.59 152.33 29.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 0.0 110.448 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.009 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 16.9 p90 -136.12 141.82 44.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.755 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.643 HG21 ' CD ' ' A' ' 419' ' ' LYS . 4.3 mt -114.79 141.76 27.3 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.73 -0.607 . . . . 0.0 109.598 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -71.61 142.86 40.97 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.708 1.373 . . . . 0.0 111.55 -176.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.046 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.01 152.56 43.44 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 108.829 165.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -58.44 128.35 36.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.692 -1.255 . . . . 0.0 110.143 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.94 -0.75 44.76 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.8 t -136.13 139.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.716 -1.461 . . . . 0.0 110.727 177.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.93 152.07 40.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.163 177.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -62.17 -39.76 93.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.057 -1.027 . . . . 0.0 110.457 -176.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.3 ttmt -59.19 -43.38 92.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.806 -1.184 . . . . 0.0 109.56 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.529 HG21 HG13 ' A' ' 328' ' ' VAL . 95.8 m -56.15 -43.63 78.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.817 173.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.988 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -59.69 -39.64 85.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.009 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.37 -42.04 84.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.089 . . . . 0.0 110.757 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.4 m-20 -64.19 -49.48 71.88 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.118 . . . . 0.0 109.921 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.947 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.17 -31.3 70.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.937 -1.102 . . . . 0.0 109.664 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.751 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.19 -35.64 65.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.964 172.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.564 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 30.3 mt-30 -74.52 -55.81 5.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.989 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.38 -35.71 78.23 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.787 -172.435 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.89 66.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.592 ' OG ' HG22 ' A' ' 353' ' ' VAL . 95.9 p -108.4 10.15 27.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -174.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.581 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.2 mt -65.98 -44.95 83.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.657 -1.277 . . . . 0.0 109.802 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.54 0.72 47.94 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.821 -170.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.479 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.9 p30 -63.87 130.29 43.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.841 -1.162 . . . . 0.0 109.925 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.76 4.76 52.64 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.512 0.672 . . . . 0.0 109.886 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.3 152.88 86.03 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.592 -0.693 . . . . 0.0 109.443 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -56.0 -38.14 95.14 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.74 1.39 . . . . 0.0 109.132 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.48 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.3 mt-10 -64.19 -29.23 70.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.484 -0.76 . . . . 0.0 110.406 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.47 -38.56 80.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.531 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.9 mtt85 -78.2 -37.76 44.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.075 -1.25 . . . . 0.0 110.591 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.4 -38.02 85.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.932 -1.105 . . . . 0.0 110.352 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 443' ' ' ILE . 90.7 mt -68.92 -49.09 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 0.0 110.625 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.592 HG22 ' OG ' ' A' ' 341' ' ' SER . 38.4 t -60.87 -34.06 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.864 -1.147 . . . . 0.0 110.101 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.964 HG22 ' OE1' ' A' ' 358' ' ' GLN . 32.3 mt -72.62 -33.22 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.681 -1.262 . . . . 0.0 110.621 170.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.961 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.46 -40.35 86.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.938 -1.101 . . . . 0.0 110.489 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.27 88.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.47 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.872 ' HB3' HD23 ' A' ' 362' ' ' LEU . 18.0 mtmt -72.35 -49.48 33.82 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.743 -1.183 . . . . 0.0 110.6 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.964 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.7 pt20 -71.3 -42.43 68.69 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 110.814 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.58 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -72.63 -46.31 54.68 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.109 -0.995 . . . . 0.0 111.078 -172.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.58 ' CD2' ' HB3' ' A' ' 359' ' ' ARG . 84.0 m-85 -136.5 -36.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.205 -169.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.491 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 15.2 t-20 -160.02 106.64 1.6 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.605 -1.309 . . . . 0.0 111.508 -168.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.872 HD23 ' HB3' ' A' ' 357' ' ' LYS . 59.9 mt -57.56 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.368 172.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.534 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.7 tpt180 -125.64 164.39 20.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 109.325 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.4 mt-10 -140.06 -161.77 1.25 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.0 -1.062 . . . . 0.0 110.121 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.581 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.67 162.45 13.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.747 . . . . 0.0 110.521 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -130.3 41.74 3.36 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.381 175.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.947 HG11 ' CE2' ' A' ' 374' ' ' PHE . 59.4 t -74.16 -46.23 45.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.09 -27.46 66.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.344 -0.848 . . . . 0.0 111.122 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.78 -30.55 28.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.965 . . . . 0.0 109.656 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.781 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.9 mt -102.5 -3.66 26.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.557 -0.714 . . . . 0.0 110.674 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 367' ' ' VAL . 51.6 m80 59.11 52.57 6.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.753 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.55 174.67 7.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 110.51 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.1 m -116.45 134.62 54.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.396 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.947 ' CE2' HG11 ' A' ' 367' ' ' VAL . 83.6 m-85 -88.61 147.8 24.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 387' ' ' ASN . 87.2 t -120.34 101.12 46.99 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.616 175.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.22 150.36 40.68 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.077 1.567 . . . . 0.0 110.511 -175.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.2 t80 -65.47 131.41 46.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p -120.3 152.79 37.31 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 109.695 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.74 -5.82 51.9 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.91 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.78 -33.15 66.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.843 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 3.2 m -139.54 10.27 2.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 110.278 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 74.0 mtt85 57.0 51.19 10.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.233 -0.917 . . . . 0.0 109.363 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.827 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.3 ptp -157.44 167.38 30.4 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.993 0.901 . . . . 0.0 111.4 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.9 p -154.43 165.36 36.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.503 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.8 -166.55 35.05 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.705 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.879 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.8 tt -140.92 149.84 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.995 . . . . 0.0 110.208 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.471 HD21 HG21 ' A' ' 375' ' ' VAL . 47.8 m-20 -127.25 134.73 50.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.045 . . . . 0.0 109.804 177.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' A' ' 370' ' ' LEU . 2.0 tt -140.73 155.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 109.211 171.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.0 m-20 -21.65 -63.03 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.388 0.614 . . . . 0.0 112.583 170.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.449 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 22.9 t-20 -96.49 -7.14 35.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 111.931 -167.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.571 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.9 mtp180 -141.86 145.84 35.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.594 -1.317 . . . . 0.0 110.503 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -136.22 100.93 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.132 . . . . 0.0 109.18 170.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.031 HD12 HD11 ' A' ' 339' ' ' LEU . 7.7 mt -122.96 146.18 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.04 -1.037 . . . . 0.0 110.092 -172.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.503 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 26.0 mmt85 -133.19 159.1 41.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.329 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.556 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.41 126.84 30.36 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.56 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.44 174.0 32.86 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.596 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.4 m -56.47 150.84 14.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.863 -1.375 . . . . 0.0 108.592 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.037 HG21 ' CG1' ' A' ' 420' ' ' VAL . 56.5 t -57.72 -34.6 48.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.887 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.4 t0 -62.55 -45.81 91.23 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.827 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.85 -51.07 44.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.93 -1.106 . . . . 0.0 110.61 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.56 HD11 ' N ' ' A' ' 396' ' ' GLY . 34.2 mm -63.98 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.063 -1.023 . . . . 0.0 110.59 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.0 ttp180 -58.47 -43.69 89.0 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.461 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 55.2 mtp85 -61.54 -36.12 79.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.061 -1.024 . . . . 0.0 109.459 173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.503 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.4 t-80 -67.65 -38.5 83.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 111.299 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.472 HG12 ' C ' ' A' ' 410' ' ' GLY . 66.7 t -65.91 -47.29 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.616 -1.302 . . . . 0.0 110.26 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.21 -34.21 77.57 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.814 -1.178 . . . . 0.0 110.362 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.65 -36.3 80.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.092 . . . . 0.0 109.895 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 26.7 m-80 -62.12 -27.09 68.68 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 109.225 173.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.86 19.56 31.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.24 -171.13 18.52 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.418 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.1 m-70 -144.81 153.85 42.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.168 -1.195 . . . . 0.0 111.07 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.64 ' HB3' HG21 ' A' ' 439' ' ' VAL . 8.5 p90 -109.51 151.92 42.46 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.54 -0.725 . . . . 0.0 109.978 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.857 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.15 124.76 10.27 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.913 1.48 . . . . 0.0 110.221 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.3 t -66.95 -33.21 75.08 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.3 m-20 -63.45 -32.48 73.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 108.853 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.046 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.3 t -83.64 -41.89 17.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.908 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.7 t0 -55.04 -37.55 66.83 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.404 171.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.66 -49.71 72.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.457 -1.402 . . . . 0.0 109.697 172.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.643 ' CD ' HG21 ' A' ' 323' ' ' ILE . 57.1 mttm -56.28 -34.79 66.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.802 -1.187 . . . . 0.0 110.444 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.088 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.32 -41.85 85.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.962 -1.086 . . . . 0.0 109.21 171.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.84 -36.26 82.97 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.906 0.86 . . . . 0.0 109.414 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.02 -37.89 81.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.609 -0.682 . . . . 0.0 110.74 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.765 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.2 t -62.28 -37.65 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.979 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.09 87.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 110.151 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -67.02 -33.43 75.54 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.285 -0.884 . . . . 0.0 111.229 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.1 OUTLIER -83.0 -3.4 57.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.012 -1.055 . . . . 0.0 109.597 176.256 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.33 29.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.765 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -103.72 163.34 12.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.651 ' HB ' HD12 ' A' ' 445' ' ' LEU . 70.5 m -109.65 107.02 59.1 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.081 -1.012 . . . . 0.0 109.744 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.56 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.6 Cg_endo -75.6 107.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.07 0 O-C-N 123.893 1.47 . . . . 0.0 110.52 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.867 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.5 mt -92.44 134.24 35.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.886 -1.134 . . . . 0.0 108.625 167.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.99 ' CG2' HG22 ' A' ' 398' ' ' VAL . 96.8 t -100.32 134.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.701 -1.25 . . . . 0.0 109.477 176.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.81 ' CG1' HD11 ' A' ' 440' ' ' LEU . 40.9 t -114.95 137.33 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.243 -0.91 . . . . 0.0 108.955 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.841 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.28 160.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.589 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.482 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.82 129.89 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.56 -128.42 29.84 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -168.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.53 15.41 23.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.052 -1.263 . . . . 0.0 111.171 -179.109 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -125.76 170.27 11.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.532 -1.355 . . . . 0.0 109.878 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.841 ' HA ' HG12 ' A' ' 434' ' ' VAL . 46.7 t -91.7 134.31 30.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.189 -0.945 . . . . 0.0 109.57 176.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.5 pp -94.36 -21.28 19.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.691 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.988 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.27 176.39 38.64 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 118.794 -1.669 . . . . 0.0 110.962 169.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.088 HG21 HG23 ' A' ' 420' ' ' VAL . 53.9 t -107.97 142.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 173.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.751 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.2 mt -101.32 110.91 29.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.99 118.12 30.47 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.863 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.867 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.28 30.54 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -114.63 159.87 19.98 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.612 -1.305 . . . . 0.0 111.121 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -83.97 144.71 28.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.722 -0.611 . . . . 0.0 110.223 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.831 HD13 ' N ' ' A' ' 449' ' ' VAL . 0.0 OUTLIER -121.29 150.73 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.831 ' N ' HD13 ' A' ' 448' ' ' ILE . 46.7 t -136.26 136.1 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.161 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -92.87 144.8 24.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.237 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.548 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 89.1 mm-40 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.129 0.49 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -60.6 138.63 58.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.83 177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 9.4 m -122.16 -42.75 2.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.005 . . . . 0.0 110.217 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 320' ' ' SER . 68.3 mt-10 -154.17 150.81 28.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.475 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.0 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.9 p90 -137.46 141.85 41.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.957 -1.089 . . . . 0.0 111.709 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.694 HG21 ' HD3' ' A' ' 419' ' ' LYS . 3.7 mp -113.1 143.75 29.79 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.811 -0.555 . . . . 0.0 109.69 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.67 142.89 36.72 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.63 1.331 . . . . 0.0 111.605 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.036 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.72 152.65 42.6 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 108.862 165.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 1.7 tp-100 -58.57 128.45 37.25 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.734 -1.229 . . . . 0.0 110.172 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.83 44.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.3 t -136.61 139.86 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.71 -1.465 . . . . 0.0 110.762 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.89 152.82 40.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.397 -0.815 . . . . 0.0 110.176 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.8 tt0 -62.16 -40.91 97.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.056 -1.027 . . . . 0.0 110.47 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.29 -43.33 92.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.694 -1.254 . . . . 0.0 109.678 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.516 HG21 HG13 ' A' ' 328' ' ' VAL . 92.7 m -55.51 -44.12 76.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.769 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 1.021 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -59.16 -39.01 81.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.0 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.3 -41.24 85.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.967 -1.083 . . . . 0.0 110.779 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.581 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.5 m-20 -63.26 -49.22 74.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.936 -1.102 . . . . 0.0 109.805 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.99 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.52 -31.37 70.57 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.982 -1.074 . . . . 0.0 109.888 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.714 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.28 64.62 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 108.834 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.5 mt-30 -74.54 -55.92 5.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.594 -0.691 . . . . 0.0 110.919 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.0 HD11 HD12 ' A' ' 393' ' ' ILE . 0.2 OUTLIER -65.77 -33.77 76.64 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.009 -171.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -66.34 -21.62 66.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.112 . . . . 0.0 110.109 172.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.609 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.4 p -107.58 10.59 29.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.142 -0.974 . . . . 0.0 111.536 -173.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.589 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 46.1 mt -66.98 -44.48 80.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.591 -1.318 . . . . 0.0 109.672 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.12 1.2 49.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.865 -170.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.483 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.81 130.45 44.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 109.942 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 5.4 51.58 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.532 0.682 . . . . 0.0 109.887 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.26 152.57 83.97 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.582 -0.699 . . . . 0.0 109.412 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -56.02 -38.49 94.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.689 1.363 . . . . 0.0 109.147 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.38 -28.31 69.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.548 -0.72 . . . . 0.0 110.395 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.23 -38.17 76.45 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.568 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.95 -36.73 56.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -1.209 . . . . 0.0 110.54 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 2.0 m -61.5 -39.25 90.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.605 HG23 HD13 ' A' ' 443' ' ' ILE . 85.4 mt -68.12 -48.33 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.537 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.609 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.3 t -61.46 -34.03 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.568 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.7 mt -72.43 -32.27 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.673 -1.267 . . . . 0.0 110.548 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.993 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.02 -40.58 89.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.96 -1.088 . . . . 0.0 110.444 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.542 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.76 -43.73 98.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.988 ' HB3' HD23 ' A' ' 362' ' ' LEU . 70.2 mttt -71.44 -49.83 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.614 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.55 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 1.8 pt20 -70.87 -42.54 69.94 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.704 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.7 mmt180 -73.62 -46.01 49.5 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 111.147 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.667 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 72.3 m-85 -135.93 -36.59 0.75 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.57 -1.331 . . . . 0.0 112.226 -169.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.0 t30 -159.57 103.16 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.549 -1.344 . . . . 0.0 111.682 -169.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.988 HD23 ' HB3' ' A' ' 357' ' ' LYS . 33.1 mt -57.78 89.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.893 -1.129 . . . . 0.0 109.113 171.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.543 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.0 tpt180 -135.43 164.71 27.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.436 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.9 mt-10 -135.8 -157.14 0.77 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.016 -1.052 . . . . 0.0 110.495 -177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 36.8 ptt180 -97.48 165.14 12.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.674 -0.641 . . . . 0.0 110.716 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.473 ' OD1' HD13 ' A' ' 388' ' ' ILE . 55.0 p30 -138.05 45.52 2.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.379 -0.826 . . . . 0.0 110.758 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.004 HG21 ' CE1' ' A' ' 374' ' ' PHE . 92.7 t -71.15 -42.38 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.334 -0.854 . . . . 0.0 110.341 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.78 -21.32 66.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 111.032 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -29.39 25.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.04 -1.038 . . . . 0.0 110.026 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 1.079 HD12 HD11 ' A' ' 388' ' ' ILE . 16.6 mt -105.38 -3.68 22.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.552 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 24.0 m80 62.11 53.33 2.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 109.649 -173.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.918 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.19 174.96 6.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.501 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.0 m -120.9 136.4 54.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.416 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.004 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.0 m-85 -90.62 145.1 25.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.668 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 21.5 t -118.6 101.32 50.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.11 155.18 19.88 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.105 1.582 . . . . 0.0 110.613 -175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.55 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 50.5 t80 -71.92 134.7 46.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 110.442 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.785 174.322 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.7 mtt-85 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.497 0.665 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.898 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.1 ptp -165.34 171.23 13.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.781 0.8 . . . . 0.0 111.288 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.55 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 39.8 p -156.31 165.31 36.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.82 -165.96 34.11 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.025 -1.56 . . . . 0.0 110.637 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 367' ' ' VAL . 1.3 tt -143.34 147.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.935 . . . . 0.0 110.399 -174.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.493 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 56.1 m-20 -115.78 134.25 55.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.902 -1.124 . . . . 0.0 108.974 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 1.079 HD11 HD12 ' A' ' 370' ' ' LEU . 2.2 tt -142.63 154.41 17.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.9 -1.125 . . . . 0.0 109.611 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 88.7 m-20 -23.95 -62.02 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 112.298 173.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.478 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.5 t-20 -95.87 -5.45 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.539 -0.725 . . . . 0.0 111.801 -167.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.602 ' NH2' HD21 ' A' ' 339' ' ' LEU . 18.1 mtp180 -145.5 147.73 32.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.684 -1.26 . . . . 0.0 110.74 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.3 mtm -132.51 95.68 3.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.831 -1.168 . . . . 0.0 108.789 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 339' ' ' LEU . 7.6 mt -122.58 146.25 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.946 -1.096 . . . . 0.0 110.429 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 40.2 mtt180 -133.51 159.14 41.29 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 110.767 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.611 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.43 128.86 34.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.694 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.51 174.32 33.59 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.0 m -56.36 151.35 13.14 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.956 -1.32 . . . . 0.0 108.496 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.13 HG21 HG11 ' A' ' 420' ' ' VAL . 53.4 t -57.08 -34.28 44.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.027 -1.046 . . . . 0.0 109.887 -176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 19.7 t70 -62.86 -47.48 83.18 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.898 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.2 -49.12 62.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.042 -1.036 . . . . 0.0 110.652 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.694 HD11 ' N ' ' A' ' 396' ' ' GLY . 45.0 mm -65.06 -43.29 95.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.108 -0.995 . . . . 0.0 110.809 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.579 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 2.4 ttt180 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.0 mtt-85 -61.14 -37.75 83.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.979 -1.075 . . . . 0.0 109.607 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.517 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.2 t-80 -67.62 -35.85 79.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 111.222 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.564 ' CG2' HG11 ' A' ' 434' ' ' VAL . 56.0 t -65.85 -48.98 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.673 -1.267 . . . . 0.0 110.187 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.2 -34.45 77.68 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.291 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.99 79.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.954 -1.091 . . . . 0.0 110.021 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.552 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 6.3 m-80 -61.55 -27.67 68.79 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.491 -0.756 . . . . 0.0 109.114 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.13 19.77 27.53 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.1 -169.14 15.85 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.424 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.86 153.61 42.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -1.215 . . . . 0.0 111.328 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.582 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 8.3 p90 -108.01 149.66 39.39 Favored Pre-proline 0 N--CA 1.501 2.105 0 O-C-N 121.625 -0.672 . . . . 0.0 110.24 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.821 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.95 125.21 9.2 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.853 1.449 . . . . 0.0 110.573 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.79 -34.32 77.56 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.161 -0.962 . . . . 0.0 111.051 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.7 m-20 -60.84 -33.08 72.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 108.864 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.036 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.0 t -83.78 -42.57 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.017 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 71.9 m-20 -54.85 -37.29 66.01 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.48 171.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.4 mt-30 -63.31 -48.68 77.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.292 -1.505 . . . . 0.0 110.102 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.694 ' HD3' HG21 ' A' ' 323' ' ' ILE . 26.3 mttt -56.84 -34.85 68.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.704 -1.248 . . . . 0.0 110.392 177.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.13 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 109.171 171.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.9 t0 -66.62 -36.66 83.13 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.791 0.805 . . . . 0.0 109.517 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 84.8 mt-30 -67.04 -37.02 83.34 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.631 -0.668 . . . . 0.0 110.612 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.797 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.0 t -62.43 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.125 . . . . 0.0 110.005 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.68 -43.96 87.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -0.908 . . . . 0.0 110.435 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 6.0 mtp85 -64.98 -29.86 70.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 110.517 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.28 -3.87 53.84 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.683 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.52 22.1 38.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.797 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.39 164.26 12.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.395 -1.062 . . . . 0.0 109.727 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.437 ' HB ' HD12 ' A' ' 445' ' ' LEU . 28.4 m -109.57 107.04 59.19 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.585 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.0 Cg_endo -75.61 108.27 2.66 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 O-C-N 124.014 1.534 . . . . 0.0 110.62 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.854 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.1 mt -92.6 134.13 35.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.872 -1.142 . . . . 0.0 108.622 167.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.994 ' CG2' HG22 ' A' ' 398' ' ' VAL . 90.3 t -100.51 134.29 40.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.771 -1.205 . . . . 0.0 109.504 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.778 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.3 t -115.03 139.09 43.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.816 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -119.89 160.09 20.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.458 -0.776 . . . . 0.0 109.587 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.51 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -135.01 130.38 35.61 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.58 -129.22 27.74 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -167.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.559 ' O ' HG13 ' A' ' 405' ' ' VAL . 78.0 p -106.16 7.64 31.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.244 . . . . 0.0 111.082 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -118.99 170.43 9.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.588 -1.32 . . . . 0.0 110.048 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.816 ' HA ' HG12 ' A' ' 434' ' ' VAL . 24.3 t -92.67 134.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.857 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -96.68 -20.6 18.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.721 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 1.021 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.76 176.53 38.46 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 118.815 -1.659 . . . . 0.0 111.024 168.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.079 HG21 HG23 ' A' ' 420' ' ' VAL . 55.8 t -107.7 142.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.242 -1.152 . . . . 0.0 109.95 173.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.714 HD11 ' CB ' ' A' ' 337' ' ' ALA . 81.7 mt -101.32 110.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 109.023 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.626 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.7 118.31 30.54 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.047 -1.033 . . . . 0.0 109.831 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.854 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -101.67 141.67 34.18 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.564 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 11.0 mtmt . . . . . 0 C--N 1.299 -1.612 0 O-C-N 120.763 -1.211 . . . . 0.0 111.038 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.4 tt0 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.133 0.492 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.786 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.72 138.62 41.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.992 -1.067 . . . . 0.0 109.815 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.508 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.41 -45.16 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.99 . . . . 0.0 110.339 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 320' ' ' SER . 72.4 mt-10 -154.53 154.59 33.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.228 -0.92 . . . . 0.0 110.511 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.06 ' CD1' HD21 ' A' ' 355' ' ' LEU . 15.6 p90 -135.51 151.5 50.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.956 -1.09 . . . . 0.0 111.572 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.692 HG21 ' HD3' ' A' ' 419' ' ' LYS . 3.4 mt -125.56 140.59 36.79 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.699 -0.625 . . . . 0.0 109.336 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.78 143.12 45.08 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.617 1.325 . . . . 0.0 111.64 -173.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.034 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.22 151.29 45.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.455 -0.778 . . . . 0.0 108.977 165.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.99 129.13 40.51 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.704 -1.247 . . . . 0.0 110.069 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.65 -0.35 49.25 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.5 t -135.36 138.05 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.578 -1.543 . . . . 0.0 110.759 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.6 m-20 -73.12 148.98 43.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.346 -0.846 . . . . 0.0 110.275 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.2 tt0 -60.59 -34.15 73.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.039 -1.038 . . . . 0.0 109.778 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -58.85 -43.73 90.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 109.139 175.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.547 HG21 HG13 ' A' ' 328' ' ' VAL . 88.9 m -61.17 -42.26 98.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.417 -0.802 . . . . 0.0 110.333 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.976 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.1 tp -60.48 -39.61 88.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.51 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.965 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.93 -44.04 77.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 110.69 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.562 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.9 m-20 -63.51 -48.07 79.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.912 -1.118 . . . . 0.0 110.063 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.959 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -69.17 -31.25 69.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.007 -1.058 . . . . 0.0 109.991 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.13 -35.55 64.81 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 0.0 108.915 172.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.8 mt-30 -74.3 -55.71 5.71 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.72 . . . . 0.0 111.023 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.055 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.9 -33.61 76.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.741 -1.183 . . . . 0.0 110.177 -172.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.72 -21.03 65.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.882 -1.136 . . . . 0.0 110.009 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.654 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.2 p -107.32 10.51 29.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.104 -0.997 . . . . 0.0 111.536 -174.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.587 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 43.6 mt -66.1 -45.18 82.09 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.612 -1.305 . . . . 0.0 109.758 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.05 0.73 49.13 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.976 -170.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.7 p30 -63.02 130.47 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.745 -1.222 . . . . 0.0 109.977 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.66 5.31 51.77 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.576 0.703 . . . . 0.0 109.923 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.05 152.87 84.52 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.666 -0.646 . . . . 0.0 109.443 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.58 -38.56 94.02 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.645 1.339 . . . . 0.0 109.117 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.32 -28.91 70.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.499 -0.751 . . . . 0.0 110.41 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.02 -37.49 71.41 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -76.92 -38.9 52.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -1.223 . . . . 0.0 110.598 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 4.8 m -62.13 -37.37 84.91 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 110.477 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.687 HG23 HD13 ' A' ' 443' ' ' ILE . 88.6 mt -68.55 -48.82 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.066 -1.021 . . . . 0.0 110.493 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.654 HG22 ' OG ' ' A' ' 341' ' ' SER . 22.0 t -60.9 -32.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.825 -1.172 . . . . 0.0 109.797 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.964 HG22 ' OE1' ' A' ' 358' ' ' GLN . 39.5 mt -72.8 -33.1 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 110.628 171.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.06 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.6 -41.08 84.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.866 -1.146 . . . . 0.0 110.274 178.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.508 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.27 -45.58 87.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.624 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.855 ' HB3' HD23 ' A' ' 362' ' ' LEU . 33.7 mtmt -72.36 -49.29 35.23 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.53 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.964 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.3 pt20 -72.23 -42.82 65.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.543 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -73.83 -43.75 57.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 111.227 -172.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.672 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 82.6 m-85 -135.42 -38.8 0.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.349 -1.341 . . . . 0.0 111.83 -168.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.5 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 16.7 t-20 -162.77 108.36 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.576 -1.328 . . . . 0.0 111.423 -167.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.855 HD23 ' HB3' ' A' ' 357' ' ' LYS . 68.6 mt -57.1 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.016 -1.053 . . . . 0.0 109.096 172.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.1 tpt180 -122.59 164.77 17.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.774 . . . . 0.0 109.408 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.502 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.1 mt-10 -141.21 -161.84 1.28 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.587 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 32.1 ptt-85 -97.6 163.67 12.74 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.638 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.479 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -129.67 41.8 3.38 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.331 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.056 HG21 ' CE1' ' A' ' 374' ' ' PHE . 41.3 t -73.02 -46.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.19 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 111.109 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.11 -30.12 28.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.692 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 388' ' ' ILE . 21.5 mt -102.69 -4.64 24.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.684 -177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 71.4 m-70 60.43 52.21 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.804 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.02 174.51 7.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.491 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 24.0 m -117.12 134.77 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.566 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.056 ' CE1' HG21 ' A' ' 367' ' ' VAL . 92.1 m-85 -90.13 145.91 24.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.438 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 6.5 t -119.11 101.22 49.99 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.649 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -54.54 153.71 22.41 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.073 1.565 . . . . 0.0 110.515 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.549 ' CE2' ' N ' ' A' ' 383' ' ' MET . 55.0 t80 -69.45 134.68 49.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 110.448 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.373 -0.829 . . . . 0.0 109.753 174.638 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.48 0.657 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.889 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.2 ptp -165.44 171.55 13.21 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.779 0.799 . . . . 0.0 111.258 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.541 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 29.0 p -155.46 165.36 36.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.506 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.5 -165.73 34.09 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.048 -1.548 . . . . 0.0 110.694 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.722 HD11 HG22 ' A' ' 367' ' ' VAL . 4.5 tt -140.02 151.51 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.921 . . . . 0.0 110.208 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -127.54 135.55 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 109.693 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.794 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.93 155.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.816 -1.178 . . . . 0.0 109.174 172.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.502 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.5 m-20 -23.08 -63.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.389 0.614 . . . . 0.0 112.502 171.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.459 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 37.1 t30 -96.46 -5.1 40.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 111.808 -167.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.56 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.2 mtp180 -144.97 143.0 30.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.719 -1.238 . . . . 0.0 110.342 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -133.66 108.52 8.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 108.897 169.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.055 HD12 HD11 ' A' ' 339' ' ' LEU . 7.8 mt -128.65 146.03 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 0.0 109.931 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 25.1 mmt85 -134.43 159.7 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.295 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.1 OUTLIER -133.13 126.65 32.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.684 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.19 174.39 32.63 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -57.04 151.28 15.36 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.976 -1.308 . . . . 0.0 108.566 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.129 HG21 HG11 ' A' ' 420' ' ' VAL . 56.0 t -56.7 -35.01 44.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.851 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.85 -47.02 85.17 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.261 -0.9 . . . . 0.0 110.321 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.889 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.91 -49.18 63.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.963 -1.086 . . . . 0.0 110.59 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.684 HD11 ' N ' ' A' ' 396' ' ' GLY . 39.4 mm -65.59 -43.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.06 -1.025 . . . . 0.0 110.817 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.589 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.8 ttp180 -59.22 -43.26 92.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.243 -0.911 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.5 mtp180 -61.88 -36.37 81.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 173.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -67.93 -36.25 79.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.878 . . . . 0.0 111.236 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.62 -49.13 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.479 -1.388 . . . . 0.0 110.103 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -34.34 77.46 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.325 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.73 78.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.946 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.548 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 10.9 m-80 -61.8 -27.31 68.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.11 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.89 19.57 28.62 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.57 -169.02 16.17 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.448 ' C ' HG11 ' A' ' 405' ' ' VAL . 77.5 m80 -143.21 153.41 42.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.163 -1.198 . . . . 0.0 111.324 -174.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.5 p90 -108.39 149.75 39.71 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.642 -0.661 . . . . 0.0 110.182 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.828 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.71 124.0 8.45 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.879 1.463 . . . . 0.0 110.5 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.25 -34.22 77.51 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.986 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 91.1 m-20 -60.82 -33.03 72.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 108.836 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.034 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.7 t -83.52 -42.48 17.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.3 m-20 -54.8 -37.41 66.03 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.559 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.25 -48.32 78.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.17 -1.581 . . . . 0.0 110.104 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.692 ' HD3' HG21 ' A' ' 323' ' ' ILE . 19.1 mttp -56.58 -35.2 67.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.6 -1.313 . . . . 0.0 110.429 176.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.129 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.65 -40.98 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.885 -1.135 . . . . 0.0 109.208 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.76 -36.28 82.06 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.824 0.821 . . . . 0.0 109.581 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.67 -36.78 81.34 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.689 -0.632 . . . . 0.0 110.692 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.758 HG13 ' HB3' ' A' ' 428' ' ' ALA . 79.2 t -62.84 -37.95 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.005 -1.059 . . . . 0.0 110.043 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.13 85.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 110.406 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -67.91 -31.5 71.31 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 110.922 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.31 -3.47 55.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.724 175.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.92 22.04 29.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.758 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.99 164.09 12.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.562 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.61 ' HB ' HD12 ' A' ' 445' ' ' LEU . 93.9 m -109.89 107.29 58.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.077 -1.014 . . . . 0.0 109.691 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.581 ' HB2' HG22 ' A' ' 420' ' ' VAL . 39.7 Cg_endo -75.95 108.04 2.6 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 123.88 1.463 . . . . 0.0 110.613 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.894 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.4 mt -92.83 134.33 35.18 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.837 -1.164 . . . . 0.0 108.64 166.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.984 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.4 t -100.67 134.6 40.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 120.698 -1.251 . . . . 0.0 109.445 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.744 ' CG1' HD11 ' A' ' 440' ' ' LEU . 45.3 t -115.09 136.36 52.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.816 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.4 m -117.09 159.92 16.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.41 -0.806 . . . . 0.0 109.601 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.507 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.91 130.63 34.07 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.08 -133.17 31.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 405' ' ' VAL . 77.8 p -102.46 8.34 40.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.105 -1.232 . . . . 0.0 111.053 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -120.44 171.01 8.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.546 -1.346 . . . . 0.0 109.995 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.816 ' HA ' HG12 ' A' ' 434' ' ' VAL . 23.7 t -92.59 134.52 30.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.845 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.839 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.42 -22.13 18.49 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.308 -0.87 . . . . 0.0 109.793 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.976 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.47 176.95 38.64 Favored Glycine 0 N--CA 1.499 2.851 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.965 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.052 HG21 HG23 ' A' ' 420' ' ' VAL . 55.5 t -107.95 142.83 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.247 -1.149 . . . . 0.0 109.915 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.764 HD11 ' HB1' ' A' ' 337' ' ' ALA . 77.1 mt -101.49 111.42 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 108.907 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.615 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.85 118.58 30.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.917 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.894 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 26.9 mttt . . . . . 0 C--N 1.299 -1.614 0 O-C-N 120.759 -1.213 . . . . 0.0 110.974 -178.864 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.534 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.8 mt-30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.122 0.487 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.802 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -59.85 138.27 57.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 109.965 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 321' ' ' GLU . 46.6 m -122.13 -40.98 2.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.526 ' HG2' ' NH2' ' A' ' 359' ' ' ARG . 65.9 mt-10 -154.94 149.82 26.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.066 ' CD1' HD21 ' A' ' 355' ' ' LEU . 10.5 p90 -135.97 157.74 46.09 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.48 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.71 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.4 mt -134.84 140.16 34.38 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.604 -0.685 . . . . 0.0 109.397 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.561 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.54 144.82 50.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.644 1.339 . . . . 0.0 111.568 -172.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.058 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.74 151.52 43.5 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.134 -0.979 . . . . 0.0 108.829 164.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.86 129.4 41.95 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.658 -1.276 . . . . 0.0 110.095 -172.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.09 -1.48 44.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.3 t -136.16 138.92 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.473 . . . . 0.0 110.647 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.3 m-20 -73.36 151.88 41.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.166 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -62.86 -39.81 95.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.023 -1.048 . . . . 0.0 110.362 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.92 -42.93 90.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.782 -1.198 . . . . 0.0 109.438 175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.515 HG21 HG13 ' A' ' 328' ' ' VAL . 94.4 m -56.9 -43.62 81.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.859 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 1.022 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -59.1 -40.58 85.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.33 -41.37 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.761 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -64.07 -49.73 71.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.914 -1.116 . . . . 0.0 109.92 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.892 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.98 -31.25 70.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.903 -1.123 . . . . 0.0 109.569 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.696 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.59 -35.23 65.59 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.324 -0.86 . . . . 0.0 108.985 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.7 mt-30 -74.25 -55.84 5.58 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.479 -0.763 . . . . 0.0 110.861 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.097 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.78 -36.14 80.22 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.681 -1.208 . . . . 0.0 109.807 -172.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.401 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -66.74 -20.67 66.01 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.055 173.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.2 p -107.35 9.18 29.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.215 -0.928 . . . . 0.0 111.552 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.4 -44.46 82.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.564 -1.335 . . . . 0.0 109.626 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.17 1.61 50.04 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.816 -170.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.478 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -64.34 130.6 44.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.732 -1.23 . . . . 0.0 109.944 175.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.72 5.44 51.39 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.58 0.705 . . . . 0.0 109.872 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.31 150.43 80.1 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.53 -0.731 . . . . 0.0 109.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.74 -38.14 84.75 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.651 1.342 . . . . 0.0 109.148 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.29 -28.58 69.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.496 -0.752 . . . . 0.0 110.377 176.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.33 -37.6 74.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -175.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 354' ' ' ILE . 96.1 mtt180 -77.32 -38.0 51.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.658 174.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.534 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 9.6 m -61.36 -37.97 85.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 110.365 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.542 HG23 HD13 ' A' ' 443' ' ' ILE . 88.8 mt -68.51 -49.31 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.069 -1.02 . . . . 0.0 110.602 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.619 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -61.17 -33.36 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.935 -1.103 . . . . 0.0 110.167 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.6 mt -72.84 -32.58 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.704 -1.248 . . . . 0.0 110.603 171.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.53 -40.82 88.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.964 -1.085 . . . . 0.0 110.414 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.26 -44.67 94.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.497 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.995 ' HB3' HD23 ' A' ' 362' ' ' LEU . 67.4 mttt -71.33 -47.37 56.96 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.743 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.545 ' CG ' ' HG3' ' A' ' 359' ' ' ARG . 20.5 pt20 -70.7 -42.58 70.45 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.667 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.545 ' HG3' ' CG ' ' A' ' 358' ' ' GLN . 40.8 mtp85 -79.89 -42.23 24.59 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 111.517 -170.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 85.5 m-85 -134.98 -35.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.437 -1.414 . . . . 0.0 112.097 -170.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 57.0 t-20 -161.86 101.87 1.15 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.632 -1.293 . . . . 0.0 111.669 -169.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.995 HD23 ' HB3' ' A' ' 357' ' ' LYS . 32.5 mt -57.47 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.816 -1.177 . . . . 0.0 108.908 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.542 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.9 tpt180 -134.34 164.31 27.69 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.416 -0.802 . . . . 0.0 109.241 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -135.74 -157.08 0.76 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.962 -1.086 . . . . 0.0 110.355 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 37.1 ptt180 -94.54 163.24 13.47 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.651 -0.655 . . . . 0.0 110.494 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.787 ' O ' HD12 ' A' ' 370' ' ' LEU . 88.3 m-20 -130.82 42.26 3.26 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.398 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.995 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.5 t -73.56 -45.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 110.345 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.78 -24.11 64.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.351 -0.843 . . . . 0.0 111.146 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.42 -32.85 32.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.013 -1.054 . . . . 0.0 109.719 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 366' ' ' ASP . 12.4 mt -104.73 -2.64 24.64 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.565 -0.709 . . . . 0.0 110.569 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 70.8 m-70 61.06 51.93 4.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 109.827 -176.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.758 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -92.78 174.64 7.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 0.0 110.533 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.8 m -119.18 136.22 54.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.478 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.995 ' CE1' HG21 ' A' ' 367' ' ' VAL . 73.4 m-85 -89.69 149.09 22.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.473 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 48.7 t -124.31 100.84 35.2 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.124 -0.985 . . . . 0.0 109.629 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -57.04 149.59 61.52 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.995 1.524 . . . . 0.0 110.251 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 21.4 t80 -63.61 129.95 42.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.87 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.336 -0.853 . . . . 0.0 109.747 176.621 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 82.7 mtm180 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.308 0.575 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.832 ' HG2' ' HB1' ' A' ' 400' ' ' ALA . 0.7 OUTLIER -150.29 161.54 42.24 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.604 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 10.1 p -153.47 164.94 37.31 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 174.29 -164.94 36.26 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.881 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.901 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.6 tt -141.0 150.53 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.697 -0.884 . . . . 0.0 110.143 -176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -126.67 137.6 53.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.624 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.76 ' CD1' HD13 ' A' ' 370' ' ' LEU . 2.0 tt -141.53 154.7 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.352 172.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.506 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 88.9 m-20 -20.88 -62.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.48 0.657 . . . . 0.0 112.568 171.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.463 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t-20 -98.01 -7.49 29.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 111.934 -166.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.562 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 17.8 mtp180 -142.4 149.88 39.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.71 -1.244 . . . . 0.0 110.604 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -137.47 102.13 4.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 0.0 109.188 170.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.097 HD12 HD11 ' A' ' 339' ' ' LEU . 6.0 mt -121.64 146.09 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.097 -1.002 . . . . 0.0 110.007 -173.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.514 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 0.0 OUTLIER -136.77 155.32 49.98 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 110.261 177.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.608 ' HB3' HG22 ' A' ' 433' ' ' VAL . 43.7 pttt -129.23 145.82 51.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.17 173.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 401' ' ' ILE . . . -170.54 174.89 44.51 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 52.5 p -55.85 150.45 13.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.784 -1.421 . . . . 0.0 108.526 170.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.083 HG22 ' CG2' ' A' ' 432' ' ' VAL . 64.1 t -59.78 -34.96 57.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.064 -1.023 . . . . 0.0 109.977 -174.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.517 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 49.2 t0 -62.32 -45.89 91.21 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.196 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.832 ' HB1' ' HG2' ' A' ' 383' ' ' MET . . . -70.75 -52.01 23.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.085 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.769 HD13 ' CE ' ' A' ' 383' ' ' MET . 21.1 mm -62.98 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.998 -1.064 . . . . 0.0 110.505 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.595 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 13.4 ttp85 -59.46 -43.91 93.11 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.517 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 93.1 mtt180 -61.23 -36.99 81.46 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.448 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -66.9 -35.86 80.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -64.81 -49.72 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.455 -1.403 . . . . 0.0 110.152 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.63 -34.67 77.52 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.86 -1.15 . . . . 0.0 110.239 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.14 -35.76 78.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.995 -1.066 . . . . 0.0 109.971 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.7 m-80 -61.38 -27.38 68.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 109.134 173.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.87 19.59 28.62 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -169.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.42 -169.32 16.38 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -145.26 153.94 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -1.161 . . . . 0.0 111.232 -174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 439' ' ' VAL . 10.3 p90 -109.11 149.26 39.44 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.457 -0.777 . . . . 0.0 109.978 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.86 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.29 126.89 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.929 1.489 . . . . 0.0 110.401 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.3 t -66.92 -34.86 78.71 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.989 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.1 m-20 -62.01 -33.31 74.1 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.898 -1.126 . . . . 0.0 108.882 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.058 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.6 t -83.46 -41.77 17.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 110.987 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.33 -38.5 68.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.826 -1.171 . . . . 0.0 109.416 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.1 -47.92 80.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.374 -1.453 . . . . 0.0 110.264 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.71 ' HD3' HG21 ' A' ' 323' ' ' ILE . 66.9 mttm -56.39 -35.19 67.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.691 -1.256 . . . . 0.0 110.372 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.128 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -60.65 -40.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.405 172.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -65.85 -36.24 82.9 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 425' ' ' ARG . 94.9 mm-40 -68.38 -38.2 81.13 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 428' ' ' ALA . 63.0 t -61.0 -37.03 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.689 -1.257 . . . . 0.0 110.056 175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.0 82.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.969 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 422' ' ' GLN . 17.7 ptt180 -70.86 -28.68 64.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.721 -1.237 . . . . 0.0 111.097 -171.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 1.0 OUTLIER -82.62 -8.55 59.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.895 -1.128 . . . . 0.0 109.64 174.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.43 22.21 13.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.705 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -102.9 161.9 13.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -1.157 . . . . 0.0 109.323 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.873 ' HB ' HD12 ' A' ' 445' ' ' LEU . 2.0 m -109.16 106.94 59.49 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.062 . . . . 0.0 109.778 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 398' ' ' VAL . 44.5 Cg_endo -76.57 107.67 2.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 124.015 1.534 . . . . 0.0 110.452 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.86 ' HG ' HD11 ' A' ' 445' ' ' LEU . 10.3 mt -92.43 133.47 35.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.92 -1.112 . . . . 0.0 108.533 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 1.083 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.2 t -99.01 135.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.711 -1.243 . . . . 0.0 109.424 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.757 ' CG1' HD11 ' A' ' 440' ' ' LEU . 44.0 t -117.66 136.7 53.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 108.91 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -117.86 160.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.492 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.52 129.01 34.47 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.69 -131.6 28.98 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -167.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.608 ' O ' HG13 ' A' ' 405' ' ' VAL . 73.1 p -103.06 6.79 38.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.13 -1.218 . . . . 0.0 111.118 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -119.95 171.0 8.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.644 -1.285 . . . . 0.0 110.069 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.812 ' HA ' HG12 ' A' ' 434' ' ' VAL . 42.9 t -90.57 134.61 28.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.815 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -93.17 -22.6 18.96 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.672 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 1.022 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.33 176.87 39.04 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 118.883 -1.627 . . . . 0.0 110.721 170.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.128 HG21 HG23 ' A' ' 420' ' ' VAL . 56.6 t -107.94 142.84 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.161 -1.2 . . . . 0.0 109.994 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.8 mt -101.83 110.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 170.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.08 118.48 30.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.826 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.873 HD12 ' HB ' ' A' ' 429' ' ' THR . 0.9 OUTLIER -101.23 146.09 27.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 320' ' ' SER . 15.2 mmtp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 120.566 -1.334 . . . . 0.0 110.58 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 351' ' ' SER . 93.4 mt-30 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.126 0.489 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.77 ' CA ' HD23 ' A' ' 445' ' ' LEU . . . -57.32 135.96 56.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.841 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.527 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 2.4 m -127.48 -37.21 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 110.385 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 320' ' ' SER . 65.2 mt-10 -153.58 148.07 26.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.958 . . . . 0.0 110.597 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.07 ' CD1' HD21 ' A' ' 355' ' ' LEU . 6.1 p90 -137.86 147.4 44.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.726 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.693 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.8 mt -119.96 141.83 32.16 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 109.625 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.54 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.02 143.23 40.06 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.735 1.387 . . . . 0.0 111.481 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.086 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.85 152.65 43.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.185 -0.947 . . . . 0.0 108.662 165.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -57.56 127.85 34.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.679 -1.263 . . . . 0.0 110.336 -172.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 115.68 -28.0 8.03 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 440' ' ' LEU . 42.4 t -115.0 140.49 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.738 -1.448 . . . . 0.0 110.943 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.03 150.13 44.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 109.788 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -61.35 -39.47 90.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 31.8 ttmt -60.51 -45.12 94.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.795 -1.191 . . . . 0.0 109.735 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 92.4 m -55.97 -43.92 78.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.698 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.616 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -58.03 -39.14 77.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.817 . . . . 0.0 110.233 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.022 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.92 -42.1 81.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 0.0 110.691 -176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -62.87 -48.35 79.4 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.924 -1.11 . . . . 0.0 109.832 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.899 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.02 -31.86 71.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.026 -1.046 . . . . 0.0 109.765 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.32 -35.25 64.93 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 172.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.543 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 20.6 mt-30 -74.67 -56.28 4.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.501 -0.749 . . . . 0.0 110.838 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.987 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -60.97 -35.39 76.67 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.756 -1.177 . . . . 0.0 109.772 -172.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -68.03 -19.52 64.91 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.088 -1.007 . . . . 0.0 109.782 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.1 p -108.23 9.41 28.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.206 -0.934 . . . . 0.0 111.639 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.722 HD22 ' HD2' ' A' ' 365' ' ' ARG . 36.8 mt -64.71 -44.84 88.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.551 -1.343 . . . . 0.0 109.705 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.49 1.72 46.94 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.707 -169.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.1 p30 -62.61 130.28 44.36 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.952 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.68 5.35 51.63 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.528 0.68 . . . . 0.0 109.891 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.56 152.4 83.3 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.607 -0.683 . . . . 0.0 109.432 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.95 -38.79 94.15 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.713 1.375 . . . . 0.0 109.08 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.35 -28.87 70.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.458 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.51 -37.26 66.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.494 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -76.69 -37.37 56.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.219 . . . . 0.0 110.553 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 318' ' ' GLN . 11.3 m -61.36 -38.44 86.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.001 -1.062 . . . . 0.0 110.42 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.628 HG23 HD13 ' A' ' 443' ' ' ILE . 83.7 mt -68.98 -48.84 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.051 . . . . 0.0 110.534 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.628 HG22 ' OG ' ' A' ' 341' ' ' SER . 30.4 t -61.67 -34.03 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.952 -1.092 . . . . 0.0 110.076 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.4 mt -72.89 -32.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.601 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.07 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.68 -40.91 89.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.39 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.93 99.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 82.7 mttt -71.26 -50.21 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.892 -1.13 . . . . 0.0 110.924 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.548 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.9 pt20 -70.36 -42.38 71.89 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.497 -174.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 30.6 mmt180 -74.16 -46.02 44.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 111.24 -172.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 78.3 m-85 -135.51 -35.5 0.81 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.437 -1.305 . . . . 0.0 112.437 -168.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.501 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 23.1 t-20 -160.52 97.85 1.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.484 -1.385 . . . . 0.0 111.677 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 362' ' ' LEU . 5.5 mp -58.77 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.933 -1.105 . . . . 0.0 109.59 171.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.8 tpt180 -147.84 163.08 37.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.387 -0.821 . . . . 0.0 109.618 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.7 mt-10 -125.97 -157.36 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.722 ' HD2' HD22 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -96.66 165.35 12.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.531 -0.73 . . . . 0.0 110.596 -178.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.475 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -121.0 38.08 4.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.428 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.966 ' CG2' HD11 ' A' ' 386' ' ' ILE . 71.0 t -69.28 -44.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.787 . . . . 0.0 110.307 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -67.43 -26.6 66.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.971 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -29.14 25.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.904 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.964 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.7 mt -103.45 -2.36 27.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.777 . . . . 0.0 110.837 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 27.2 m80 62.62 52.65 2.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.09 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.925 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -94.99 174.71 6.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.9 m -115.97 134.32 55.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 110.421 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.941 ' CE2' HG11 ' A' ' 367' ' ' VAL . 68.3 m-85 -89.19 149.26 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.541 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 24.1 t -122.71 100.97 40.29 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.9 Cg_endo -56.11 151.45 42.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.124 1.592 . . . . 0.0 110.486 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.51 131.63 46.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.096 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 175.813 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 72.3 mtt85 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.542 0.687 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.868 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.3 ptp -158.69 168.61 26.41 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.948 0.88 . . . . 0.0 111.277 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 34.1 p -152.86 165.19 36.22 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -176.74 -165.89 32.96 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.04 -1.552 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.966 HD11 ' CG2' ' A' ' 367' ' ' VAL . 9.4 tt -144.1 150.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -1.03 . . . . 0.0 110.104 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 394' ' ' ARG . 43.0 m-20 -127.59 133.04 49.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.864 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.964 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.6 tt -139.28 155.03 25.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.75 -1.219 . . . . 0.0 109.165 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.504 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 90.7 m-20 -23.8 -62.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 172.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.445 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 49.5 t30 -92.36 -9.58 41.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 111.884 -167.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.587 ' H ' HG23 ' A' ' 388' ' ' ILE . 30.4 mtp180 -140.56 147.4 39.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.613 -1.304 . . . . 0.0 110.744 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.5 mtt -138.3 100.67 4.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.983 -1.073 . . . . 0.0 109.112 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.987 HD12 HD11 ' A' ' 339' ' ' LEU . 7.5 mt -122.66 146.47 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.934 -1.104 . . . . 0.0 110.296 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 387' ' ' ASN . 66.6 mmt-85 -130.49 156.84 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.142 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -132.91 125.46 29.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.458 -0.776 . . . . 0.0 108.97 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.529 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.85 173.94 32.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.717 -173.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.4 m -56.09 150.74 13.36 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.916 -1.343 . . . . 0.0 108.537 169.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.006 HG21 ' CG1' ' A' ' 420' ' ' VAL . 17.7 t -55.69 -37.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 109.932 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -64.04 -43.74 94.62 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.287 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.868 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.35 -51.2 47.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.555 HD13 ' HE1' ' A' ' 383' ' ' MET . 33.5 mm -64.96 -44.07 96.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 120.995 -1.066 . . . . 0.0 110.789 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.5 ttt180 -59.47 -42.94 93.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.192 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.9 mtp85 -61.65 -36.32 80.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.9 t-80 -67.49 -38.37 84.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 111.323 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.468 HG12 ' C ' ' A' ' 410' ' ' GLY . 67.9 t -65.88 -47.42 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.08 -34.25 77.6 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.859 -1.151 . . . . 0.0 110.33 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.34 80.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.093 . . . . 0.0 109.857 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 24.5 m-80 -62.01 -27.15 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.73 30.53 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -168.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.26 -170.67 18.37 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -146.9 153.92 40.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.173 -1.192 . . . . 0.0 111.111 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.628 ' HB3' HG21 ' A' ' 439' ' ' VAL . 6.8 p90 -108.99 151.9 42.15 Favored Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.456 -0.778 . . . . 0.0 110.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.874 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.4 125.99 11.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.909 1.478 . . . . 0.0 110.344 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.3 t -67.55 -32.74 73.71 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.7 m-20 -62.96 -33.6 75.73 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.895 -1.128 . . . . 0.0 108.808 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.086 HG21 ' HA ' ' A' ' 325' ' ' ALA . 51.1 t -83.71 -41.74 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.018 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.06 -38.37 67.94 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.8 -1.188 . . . . 0.0 109.475 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.3 mm-40 -63.48 -48.1 79.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 110.294 171.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.693 ' CD ' HG21 ' A' ' 323' ' ' ILE . 48.7 mttm -56.44 -35.25 67.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.611 -1.306 . . . . 0.0 110.411 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.034 HG23 HG21 ' A' ' 442' ' ' VAL . 2.9 t -60.14 -41.31 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.965 -1.084 . . . . 0.0 109.327 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.15 -35.91 81.74 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.852 0.835 . . . . 0.0 109.442 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -68.48 -37.62 80.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.582 -0.699 . . . . 0.0 110.886 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.696 HG13 ' HB3' ' A' ' 428' ' ' ALA . 70.9 t -62.85 -37.87 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.974 -1.079 . . . . 0.0 110.008 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.17 -40.38 82.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.945 . . . . 0.0 110.373 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.54 -31.22 70.3 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.252 -0.905 . . . . 0.0 110.931 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.46 -3.83 54.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.064 -1.023 . . . . 0.0 109.607 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 21.83 30.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.696 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.91 169.99 8.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 109.798 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.823 ' HB ' HD12 ' A' ' 445' ' ' LEU . 16.7 m -113.18 106.82 54.52 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.04 -1.037 . . . . 0.0 110.075 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.542 ' CG ' HG13 ' A' ' 420' ' ' VAL . 49.4 Cg_endo -79.39 107.38 2.16 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 O-C-N 123.898 1.473 . . . . 0.0 110.489 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.879 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.8 mt -93.09 137.95 31.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.883 -1.136 . . . . 0.0 108.625 167.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.912 ' CG2' HG22 ' A' ' 398' ' ' VAL . 92.4 t -101.56 134.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.678 -1.264 . . . . 0.0 109.613 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.812 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.7 t -114.52 134.53 57.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 108.824 174.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -118.4 160.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.501 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.52 130.15 32.04 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.88 -127.99 28.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.485 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.66 13.53 25.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -1.223 . . . . 0.0 111.233 -178.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -126.35 170.42 11.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 109.949 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.835 ' HA ' HG12 ' A' ' 434' ' ' VAL . 60.5 t -89.87 133.73 31.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.76 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -92.74 -21.36 20.0 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.323 -0.861 . . . . 0.0 109.574 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.825 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 168.93 176.86 39.36 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 118.909 -1.615 . . . . 0.0 111.093 169.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.034 HG21 HG23 ' A' ' 420' ' ' VAL . 56.4 t -107.88 142.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.071 -1.252 . . . . 0.0 109.777 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.701 HD11 ' HB1' ' A' ' 337' ' ' ALA . 77.5 mt -101.44 113.08 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.373 -0.83 . . . . 0.0 109.036 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.38 118.63 31.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.036 -1.04 . . . . 0.0 109.881 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.879 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.8 144.23 30.72 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.527 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.67 0 O-C-N 120.574 -1.329 . . . . 0.0 110.986 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.1 mt-30 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.118 0.485 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.707 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -57.79 136.83 56.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.97 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 3.4 m -118.98 -42.94 2.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 320' ' ' SER . 67.7 mt-10 -154.69 150.89 28.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.444 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.012 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 6.8 p90 -137.53 145.11 42.55 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.763 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.501 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.5 mp -118.26 144.42 34.96 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.596 -0.69 . . . . 0.0 109.775 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.554 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.6 143.62 38.39 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.764 1.402 . . . . 0.0 111.531 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.087 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.53 153.1 41.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 108.793 165.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.85 128.41 37.06 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.675 -1.266 . . . . 0.0 110.146 -172.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.86 -2.6 38.64 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.4 t -136.18 139.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.67 -1.488 . . . . 0.0 110.866 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.65 152.67 41.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.578 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.7 tt0 -62.01 -39.23 91.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.053 -1.029 . . . . 0.0 110.365 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -61.08 -45.21 95.67 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.816 -1.177 . . . . 0.0 109.765 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 92.2 m -55.8 -44.17 77.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.197 -0.94 . . . . 0.0 109.596 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.699 ' HA ' HD13 ' A' ' 440' ' ' LEU . 5.3 tp -57.99 -39.87 79.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.315 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.012 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.08 -1.013 . . . . 0.0 110.788 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.0 m-20 -63.44 -49.27 74.33 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.872 -1.143 . . . . 0.0 109.758 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.896 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.48 -31.67 71.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.821 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.656 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.69 -35.55 63.71 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.066 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.4 mt-30 -75.23 -55.79 5.36 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.506 -0.746 . . . . 0.0 110.999 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.039 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.28 -34.99 76.1 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.786 -172.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.414 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -66.89 -21.51 66.0 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.14 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.65 ' OG ' HG22 ' A' ' 353' ' ' VAL . 90.9 p -108.09 10.32 28.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.097 -1.002 . . . . 0.0 111.632 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.28 -44.67 82.92 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.696 -1.252 . . . . 0.0 109.694 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.26 1.43 49.62 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.885 -170.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.7 p30 -64.96 130.22 42.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.753 -1.217 . . . . 0.0 110.03 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.61 4.08 53.43 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.555 0.693 . . . . 0.0 109.863 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 346' ' ' THR . 3.2 p -73.79 152.62 89.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 109.38 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -55.94 -39.26 92.28 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.724 1.381 . . . . 0.0 109.149 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.8 mt-10 -65.05 -27.68 68.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.504 -0.747 . . . . 0.0 110.474 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.06 -39.24 79.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 354' ' ' ILE . 65.4 mtt85 -78.55 -35.78 45.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.6 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 6.3 m -60.98 -38.92 87.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.954 -1.091 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.616 HG23 HD13 ' A' ' 443' ' ' ILE . 88.2 mt -68.45 -49.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.062 . . . . 0.0 110.655 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.65 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.3 t -61.06 -34.57 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.988 -1.07 . . . . 0.0 110.124 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 350' ' ' ARG . 31.4 mt -72.52 -31.97 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 110.455 171.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.984 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.9 OUTLIER -60.12 -40.96 91.57 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.941 -1.099 . . . . 0.0 110.494 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.39 98.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 110.326 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 71.0 mttt -71.33 -49.09 45.99 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.68 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 11.7 pt20 -71.98 -43.26 65.42 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.73 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.594 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 78.7 mmt-85 -73.63 -44.44 56.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 111.435 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.594 ' CD2' ' HB3' ' A' ' 359' ' ' ARG . 60.3 m-85 -135.27 -38.72 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.522 -1.361 . . . . 0.0 112.125 -168.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.9 t30 -159.45 104.11 1.62 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.214 . . . . 0.0 111.58 -168.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 41.4 mt -57.42 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.875 -1.141 . . . . 0.0 108.912 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.492 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.7 tpt180 -131.42 164.06 26.56 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.477 -0.764 . . . . 0.0 109.25 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.9 mt-10 -138.13 -158.13 0.83 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.978 -1.076 . . . . 0.0 110.543 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.584 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.9 ptt85 -97.2 162.54 13.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 110.677 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 365' ' ' ARG . 89.2 m-20 -133.49 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.507 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.949 HG21 ' CE1' ' A' ' 374' ' ' PHE . 63.6 t -73.4 -47.61 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.491 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.02 -23.55 65.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -30.43 27.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.021 -1.05 . . . . 0.0 109.753 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.986 ' HB3' HD11 ' A' ' 388' ' ' ILE . 16.9 mt -103.53 -4.97 23.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.523 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 56.5 m-70 64.22 52.06 2.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.186 -176.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.912 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.86 174.91 6.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.631 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.4 m -117.98 136.03 53.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.949 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.1 m-85 -88.5 149.11 23.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.596 174.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.685 HG21 HD21 ' A' ' 387' ' ' ASN . 61.8 t -122.31 101.06 41.39 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.133 -0.979 . . . . 0.0 109.658 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.48 151.18 38.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.003 1.528 . . . . 0.0 110.413 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.632 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 15.1 t80 -65.02 132.31 48.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 110.048 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.303 -1.436 0 O-C-N 121.354 -0.841 . . . . 0.0 109.611 175.359 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 79.9 mtm180 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.44 0.638 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.777 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.4 ptp -158.78 168.41 26.9 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.362 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.7 p -153.6 164.93 37.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.32 -166.68 35.54 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.714 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.847 HG21 ' HB2' ' A' ' 339' ' ' LEU . 4.2 tt -138.9 148.99 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.681 -0.894 . . . . 0.0 110.021 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.685 HD21 HG21 ' A' ' 375' ' ' VAL . 32.4 m-20 -127.49 134.91 49.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.892 -1.13 . . . . 0.0 109.678 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.986 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -139.84 154.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.922 -1.111 . . . . 0.0 109.443 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.2 -62.99 0.06 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.48 0.657 . . . . 0.0 112.259 172.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 54.0 t30 -90.93 -10.21 43.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 111.686 -168.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.602 HH21 HD13 ' A' ' 339' ' ' LEU . 23.2 mtp180 -142.31 147.02 35.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.612 -1.305 . . . . 0.0 110.76 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.7 mtt -135.6 108.54 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.916 -1.115 . . . . 0.0 108.996 169.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.039 HD12 HD11 ' A' ' 339' ' ' LEU . 8.4 mt -128.17 145.9 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.008 -1.057 . . . . 0.0 110.058 -175.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 33.4 mtt180 -136.14 160.76 37.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 0.0 110.833 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.482 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.59 128.05 34.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.641 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.62 173.94 32.28 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 28.5 m -57.27 152.22 14.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.97 -1.312 . . . . 0.0 108.721 170.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.994 HG21 ' CG1' ' A' ' 420' ' ' VAL . 79.1 t -55.72 -35.99 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 109.783 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.6 t0 -63.25 -46.62 86.04 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.359 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.777 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.14 -50.57 53.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.497 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.641 HD11 ' N ' ' A' ' 396' ' ' GLY . 28.4 mm -64.59 -43.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.788 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.591 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.4 ttp180 -59.64 -43.71 93.76 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 67.2 mtp180 -61.93 -36.19 80.65 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.075 -1.015 . . . . 0.0 109.501 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -68.5 -36.46 78.94 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 111.353 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 437' ' ' SER . 55.8 t -65.97 -48.91 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.585 -1.322 . . . . 0.0 110.102 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.37 -34.21 77.22 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.2 79.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.074 . . . . 0.0 109.931 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.6 m-80 -61.34 -27.7 68.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 109.153 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.12 19.8 27.45 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -169.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.63 -170.05 15.92 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -144.95 153.79 41.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.186 -1.185 . . . . 0.0 111.097 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.591 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.2 p90 -107.9 150.21 40.02 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.506 -0.746 . . . . 0.0 110.085 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.884 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.98 126.25 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.902 1.475 . . . . 0.0 110.291 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 2.0 t -67.64 -32.48 73.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.976 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 88.7 m-20 -63.43 -33.41 75.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.893 -1.13 . . . . 0.0 108.728 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.087 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.1 t -83.57 -40.99 16.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.938 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 52.4 t0 -55.19 -38.5 68.46 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.691 -1.204 . . . . 0.0 109.452 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.502 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.6 mt-30 -63.4 -48.62 77.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.433 -1.417 . . . . 0.0 110.285 171.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 50.1 mmtt -56.16 -35.15 66.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.667 -1.271 . . . . 0.0 110.488 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.052 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.65 -41.59 85.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 109.149 171.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -65.72 -35.81 81.82 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.896 0.855 . . . . 0.0 109.458 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.73 -36.94 81.49 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.556 -0.715 . . . . 0.0 110.724 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.751 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.7 t -62.94 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 110.046 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.82 85.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.307 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -69.42 -30.69 68.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.243 -0.91 . . . . 0.0 110.862 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.7 -3.57 56.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.7 21.89 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.751 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.42 166.41 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -1.139 . . . . 0.0 109.689 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.846 ' HB ' HD12 ' A' ' 445' ' ' LEU . 2.8 m -110.77 107.24 57.99 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.039 -1.038 . . . . 0.0 109.732 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 398' ' ' VAL . 40.8 Cg_endo -76.12 108.4 2.67 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 O-C-N 123.898 1.473 . . . . 0.0 110.431 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.855 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.5 mt -92.5 139.85 30.17 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.968 -1.083 . . . . 0.0 108.665 167.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.704 ' CG2' HG22 ' A' ' 398' ' ' VAL . 21.5 t -100.28 134.02 41.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.781 -1.199 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.937 ' CG1' HD11 ' A' ' 440' ' ' LEU . 13.9 t -115.13 132.89 63.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 108.591 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -119.33 160.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -175.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.2 tt0 -135.7 131.79 36.09 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.45 -128.41 30.16 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.582 ' O ' HG13 ' A' ' 405' ' ' VAL . 69.3 p -106.34 8.75 31.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.054 -1.262 . . . . 0.0 111.193 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -123.93 170.52 10.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.603 -1.31 . . . . 0.0 110.115 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.844 ' HA ' HG12 ' A' ' 434' ' ' VAL . 61.0 t -89.7 133.4 31.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.41 -0.806 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.937 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.7 pp -93.79 -19.9 20.6 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.498 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.87 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 170.34 176.72 40.03 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.846 -1.645 . . . . 0.0 110.894 167.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.052 HG21 HG23 ' A' ' 420' ' ' VAL . 55.1 t -107.82 143.0 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.121 -1.223 . . . . 0.0 109.86 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.656 HD11 ' HB1' ' A' ' 337' ' ' ALA . 75.8 mt -101.59 111.82 32.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 108.996 170.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.75 117.85 30.14 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.097 -1.002 . . . . 0.0 109.775 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.855 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -100.65 144.68 29.33 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 32.3 mttp . . . . . 0 N--CA 1.491 1.61 0 O-C-N 120.783 -1.198 . . . . 0.0 111.056 -178.674 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.4 mt-30 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.088 0.47 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.707 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -61.06 139.32 58.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.803 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.522 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -123.37 -34.93 3.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.556 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.492 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.9 tt0 -163.79 149.41 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.36 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.073 ' CD1' HD21 ' A' ' 355' ' ' LEU . 16.4 p90 -135.74 145.45 46.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.847 -1.158 . . . . 0.0 111.725 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.742 HD13 ' HD3' ' A' ' 419' ' ' LYS . 11.4 mt -116.66 141.56 28.31 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.61 142.62 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.635 1.334 . . . . 0.0 111.712 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.033 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.41 151.66 44.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.348 -0.845 . . . . 0.0 108.86 165.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -58.08 129.21 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.735 -1.228 . . . . 0.0 110.09 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.44 -0.04 50.07 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 440' ' ' LEU . 53.5 t -135.28 138.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.74 -1.447 . . . . 0.0 110.764 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.7 m-20 -73.13 148.84 43.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.564 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.6 tt0 -60.22 -35.43 75.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.991 -1.068 . . . . 0.0 109.86 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.516 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.25 -43.44 87.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.001 -1.062 . . . . 0.0 109.297 176.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.528 HG21 HG13 ' A' ' 328' ' ' VAL . 92.7 m -60.81 -42.49 97.76 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.97 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.0 tp -60.49 -39.1 86.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.242 -0.911 . . . . 0.0 110.573 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.44 -44.2 79.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.061 . . . . 0.0 110.666 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.56 ' O ' HD23 ' A' ' 339' ' ' LEU . 89.4 m-20 -63.73 -49.05 74.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.908 -1.12 . . . . 0.0 110.056 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.937 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -69.03 -30.78 69.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.027 -1.046 . . . . 0.0 109.868 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.767 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.97 -35.69 64.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.125 -0.984 . . . . 0.0 108.953 171.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.574 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.68 -55.91 5.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.519 -0.738 . . . . 0.0 111.116 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.51 -33.86 76.89 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.033 -171.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.07 -21.48 65.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.965 -1.084 . . . . 0.0 110.147 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.731 ' OG ' HG22 ' A' ' 353' ' ' VAL . 78.5 p -106.46 10.57 31.36 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.188 -0.945 . . . . 0.0 111.473 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 50.6 mt -66.32 -44.68 82.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.562 -1.336 . . . . 0.0 109.672 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.74 2.79 52.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.997 -171.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.488 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 15.8 p30 -63.85 130.64 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.756 -1.215 . . . . 0.0 109.995 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.69 5.7 50.77 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.571 0.701 . . . . 0.0 109.949 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.4 p -77.11 149.78 80.02 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.614 -0.679 . . . . 0.0 109.541 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.85 -40.77 79.16 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.679 1.358 . . . . 0.0 109.255 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.16 -27.87 69.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.768 . . . . 0.0 110.382 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.92 -36.79 60.91 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.507 ' O ' HD12 ' A' ' 354' ' ' ILE . 94.4 mtt180 -75.91 -37.26 58.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.108 -1.23 . . . . 0.0 110.432 172.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.5 m -61.95 -38.04 87.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.049 -1.032 . . . . 0.0 110.418 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 443' ' ' ILE . 83.4 mt -68.6 -49.21 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.907 -1.121 . . . . 0.0 110.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.731 HG22 ' OG ' ' A' ' 341' ' ' SER . 21.5 t -61.2 -32.84 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.943 -1.098 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.672 HG22 ' OE1' ' A' ' 358' ' ' GLN . 42.4 mt -72.89 -31.76 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.771 -1.206 . . . . 0.0 110.808 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.073 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.73 -41.48 90.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.784 -1.198 . . . . 0.0 110.249 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.541 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.496 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.935 ' HB3' HD23 ' A' ' 362' ' ' LEU . 66.7 mttt -72.16 -51.07 23.01 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.672 ' OE1' HG22 ' A' ' 354' ' ' ILE . 20.2 pt20 -70.78 -42.73 70.0 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.706 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.9 mmm180 -74.94 -43.19 55.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 111.147 -172.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 55.2 m-85 -134.98 -39.48 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.675 -1.265 . . . . 0.0 112.012 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.514 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.5 t-20 -162.58 106.36 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.532 -167.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.935 HD23 ' HB3' ' A' ' 357' ' ' LYS . 54.1 mt -57.62 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.948 -1.095 . . . . 0.0 109.188 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.497 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.8 tpt180 -124.36 156.44 37.05 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.28 -0.888 . . . . 0.0 109.866 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 20.3 pt-20 -122.93 -167.66 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.023 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.586 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.5 ptt-85 -93.52 164.71 13.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 110.542 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.6 m-20 -129.43 40.84 3.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.965 HG21 ' CE1' ' A' ' 374' ' ' PHE . 93.8 t -73.75 -48.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.436 -0.79 . . . . 0.0 110.43 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.419 -0.801 . . . . 0.0 111.134 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -30.21 29.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 109.79 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.994 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.0 mt -102.83 -4.58 24.67 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 110.628 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.7 m-70 64.07 52.94 1.92 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.929 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.6 174.98 6.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 110.677 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.6 m -117.65 134.22 55.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.604 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.965 ' CE1' HG21 ' A' ' 367' ' ' VAL . 92.4 m-85 -89.71 143.55 26.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.577 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.487 HG21 HD21 ' A' ' 387' ' ' ASN . 41.9 t -118.2 101.22 51.58 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.9 Cg_endo -55.57 152.22 34.78 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.089 1.573 . . . . 0.0 110.343 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 19.2 t80 -63.4 132.31 51.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 0.0 110.174 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.569 174.898 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 90.8 mtt-85 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.468 0.652 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.702 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.0 ptp -160.62 168.27 25.28 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.957 0.884 . . . . 0.0 111.328 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.0 p -153.59 164.88 37.49 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.44 -165.62 34.46 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 118.945 -1.597 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 367' ' ' VAL . 1.5 tt -139.11 148.51 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.663 -0.904 . . . . 0.0 109.989 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.487 HD21 HG21 ' A' ' 375' ' ' VAL . 28.1 m-20 -127.24 135.33 50.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.676 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.994 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -139.87 154.87 24.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.867 -1.145 . . . . 0.0 109.363 171.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.492 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 89.7 m-20 -25.36 -63.16 0.06 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.447 0.641 . . . . 0.0 112.263 172.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.45 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 42.9 t-20 -92.14 -7.47 48.37 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.777 . . . . 0.0 111.804 -168.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.568 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 33.3 mtp180 -144.5 144.95 31.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.643 -1.286 . . . . 0.0 110.645 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.1 mtm -135.34 110.42 8.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.915 -1.116 . . . . 0.0 109.149 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 339' ' ' LEU . 8.6 mt -130.49 145.96 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 110.001 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 41.8 mtt180 -135.9 160.88 37.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 110.76 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.528 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.2 128.58 34.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.6 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.39 174.4 33.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -174.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -57.52 151.55 16.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.949 -1.324 . . . . 0.0 108.357 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.066 HG21 HG11 ' A' ' 420' ' ' VAL . 61.2 t -57.69 -34.57 47.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.074 -1.017 . . . . 0.0 109.951 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.6 t70 -62.65 -46.59 87.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.702 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.24 -50.02 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.985 -1.072 . . . . 0.0 110.562 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.6 HD11 ' N ' ' A' ' 396' ' ' GLY . 32.2 mm -64.54 -43.82 96.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.656 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 6.1 ttt180 -59.87 -42.74 94.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 73.5 mtp180 -61.42 -36.16 79.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.572 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -67.33 -38.21 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 437' ' ' SER . 68.9 t -65.5 -47.56 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.573 -1.329 . . . . 0.0 110.138 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -35.02 78.91 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.783 -1.198 . . . . 0.0 110.354 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.0 -1.063 . . . . 0.0 109.949 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 22.0 m-80 -62.11 -27.11 68.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.24 19.16 31.3 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.04 -169.19 18.19 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.487 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.33 153.38 42.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.102 -1.234 . . . . 0.0 111.478 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.627 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 9.0 p90 -108.46 149.81 39.82 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.664 -0.647 . . . . 0.0 110.153 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.819 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.13 123.57 7.91 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.849 1.447 . . . . 0.0 110.465 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.27 -34.49 78.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.031 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.4 m-20 -60.63 -32.99 72.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.951 -1.093 . . . . 0.0 108.91 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.033 HG21 ' HA ' ' A' ' 325' ' ' ALA . 54.6 t -83.55 -42.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.001 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.574 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.6 m-20 -55.49 -36.8 67.03 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.659 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 98.9 mm-40 -63.79 -48.77 75.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.326 -1.484 . . . . 0.0 110.184 171.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.742 ' HD3' HD13 ' A' ' 323' ' ' ILE . 65.3 mttm -56.78 -34.99 68.16 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.661 -1.274 . . . . 0.0 110.309 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.066 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.33 -41.24 83.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.987 -1.07 . . . . 0.0 109.279 171.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.6 t0 -66.47 -36.14 82.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 83.6 mt-30 -66.93 -37.38 84.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 428' ' ' ALA . 54.0 t -60.53 -38.9 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 109.942 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.85 92.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.943 . . . . 0.0 110.366 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 2.6 mtp180 -64.16 -31.54 72.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.134 -0.979 . . . . 0.0 110.722 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 2.8 mt-30 -80.96 -5.14 57.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.61 40.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.631 ' HB1' ' O ' ' A' ' 445' ' ' LEU . . . -103.0 172.81 6.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -1.103 . . . . 0.0 109.855 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.912 ' HB ' HD12 ' A' ' 445' ' ' LEU . 14.4 m -114.37 106.55 52.55 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.96 -1.088 . . . . 0.0 109.99 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.571 ' HB2' HG22 ' A' ' 420' ' ' VAL . 48.3 Cg_endo -79.76 107.26 2.08 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.927 1.488 . . . . 0.0 110.498 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.92 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.8 mt -93.41 135.67 34.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.878 -1.139 . . . . 0.0 108.785 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 1.023 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.5 t -100.91 134.36 41.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 O-C-N 120.802 -1.186 . . . . 0.0 109.53 175.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 440' ' ' LEU . 54.1 t -115.54 137.23 49.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.043 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -118.14 159.96 18.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.374 -0.829 . . . . 0.0 109.635 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.557 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.85 131.92 33.88 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.19 -129.07 31.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.501 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.45 12.24 28.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.117 -1.226 . . . . 0.0 111.09 -179.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -126.09 170.88 11.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.598 -1.314 . . . . 0.0 109.938 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 434' ' ' VAL . 23.3 t -90.88 134.23 30.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.762 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.45 -22.28 18.38 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.793 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.97 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.61 177.15 38.86 Favored Glycine 0 N--CA 1.501 3.005 0 C-N-CA 118.857 -1.639 . . . . 0.0 111.085 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.033 HG21 HG23 ' A' ' 420' ' ' VAL . 51.5 t -107.84 142.69 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.049 -1.265 . . . . 0.0 109.964 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.767 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.2 mt -101.37 112.86 35.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.28 119.32 31.76 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.92 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.43 146.94 27.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 2.7 pttp . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.477 -1.389 . . . . 0.0 110.706 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.8 mt-30 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.078 0.466 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.75 ' CA ' HD23 ' A' ' 445' ' ' LEU . . . -61.43 137.95 58.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.995 . . . . 0.0 109.924 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.62 -38.35 2.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.7 mt-10 -153.57 149.55 27.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.928 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.067 ' CD1' HD21 ' A' ' 355' ' ' LEU . 7.7 p90 -136.02 158.77 43.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.023 -1.048 . . . . 0.0 111.569 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.721 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.2 mp -133.94 139.7 34.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.21 144.2 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.613 1.323 . . . . 0.0 111.619 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.084 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.51 151.35 43.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 108.791 164.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.86 129.19 40.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.686 -1.259 . . . . 0.0 110.098 -172.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.12 -2.33 40.71 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.8 t -135.99 139.1 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.715 -1.462 . . . . 0.0 110.785 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.5 m-20 -73.31 152.48 40.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.895 . . . . 0.0 110.203 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -63.41 -40.55 97.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 0.0 110.538 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.3 -43.12 92.63 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.687 -1.258 . . . . 0.0 109.543 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 328' ' ' VAL . 93.8 m -55.86 -43.72 77.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.834 173.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.969 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.3 tp -59.6 -39.03 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.996 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.68 -42.96 81.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.768 -176.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.87 -48.61 76.03 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.803 -1.186 . . . . 0.0 109.901 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.876 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.54 -31.98 72.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.891 -1.131 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.72 -35.47 66.16 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.211 -0.931 . . . . 0.0 109.127 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 29.9 mt-30 -73.64 -55.79 5.83 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 110.893 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.058 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.93 -34.68 77.97 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.929 -171.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.43 -21.07 65.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -0.991 . . . . 0.0 110.014 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.646 ' OG ' HG22 ' A' ' 353' ' ' VAL . 92.3 p -107.68 10.24 29.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.227 -0.921 . . . . 0.0 111.569 -174.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.8 mt -65.88 -44.78 84.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.581 -1.324 . . . . 0.0 109.68 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.77 0.42 46.86 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.841 -170.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.476 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.3 p30 -63.03 130.45 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.778 -1.201 . . . . 0.0 109.926 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.65 5.69 50.8 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.568 0.699 . . . . 0.0 109.857 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.6 p -77.18 150.81 80.92 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.559 -0.713 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -53.42 -38.47 82.86 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.686 1.361 . . . . 0.0 109.14 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.53 -28.48 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.543 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.83 -37.95 71.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 354' ' ' ILE . 95.3 mtt180 -77.32 -38.13 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -1.18 . . . . 0.0 110.593 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.532 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 11.4 m -61.2 -38.29 86.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.878 -1.139 . . . . 0.0 110.359 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.68 -48.94 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.058 -1.026 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.646 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.6 t -61.36 -32.72 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.043 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.995 HG22 ' OE1' ' A' ' 358' ' ' GLN . 34.0 mt -72.73 -33.57 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.752 -1.218 . . . . 0.0 110.678 171.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.067 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.53 -40.8 83.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.8 -1.187 . . . . 0.0 110.397 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.48 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.928 ' HB3' HD23 ' A' ' 362' ' ' LEU . 24.9 mtmt -72.24 -49.4 35.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.547 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.995 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.7 pt20 -71.52 -42.49 67.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.32 -0.862 . . . . 0.0 110.843 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.598 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 39.0 mmt180 -73.75 -45.33 52.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.084 -1.01 . . . . 0.0 111.23 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.671 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 86.8 m-85 -135.59 -37.66 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.329 -1.349 . . . . 0.0 112.117 -169.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.492 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.1 t-20 -160.57 105.9 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.627 -1.296 . . . . 0.0 111.492 -168.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.928 HD23 ' HB3' ' A' ' 357' ' ' LYS . 51.9 mt -57.63 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.0 109.349 172.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.3 tpt180 -128.08 164.16 23.03 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -137.91 -160.43 1.06 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 110.085 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.71 163.91 12.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.522 -0.736 . . . . 0.0 110.67 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -131.39 42.63 3.18 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.507 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.068 HG21 ' CE1' ' A' ' 374' ' ' PHE . 42.3 t -72.7 -46.36 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 110.259 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.83 -27.31 66.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 111.152 -175.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.02 -30.1 28.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.756 176.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.785 ' HB3' HD11 ' A' ' 388' ' ' ILE . 21.8 mt -102.47 -5.02 24.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.524 -0.735 . . . . 0.0 110.635 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.4 m-70 60.3 52.27 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 109.761 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.772 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.04 174.57 7.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.456 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.9 m -117.12 134.64 54.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 110.499 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.068 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.7 m-85 -89.23 145.17 25.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 387' ' ' ASN . 43.9 t -119.04 101.15 50.24 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.633 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.6 Cg_endo -55.22 151.37 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.067 1.562 . . . . 0.0 110.548 -175.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 10.2 t80 -64.48 131.91 48.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.87 . . . . 0.0 110.078 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--N 1.302 -1.48 0 O-C-N 121.405 -0.81 . . . . 0.0 109.715 175.885 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 69.9 mtt85 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.503 0.668 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.671 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.5 ptp -159.46 167.96 27.4 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.934 0.873 . . . . 0.0 111.203 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 17.3 p -154.41 165.14 37.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.33 -165.8 34.11 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.988 -1.577 . . . . 0.0 110.521 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.716 HD11 HG22 ' A' ' 367' ' ' VAL . 4.8 tt -138.68 151.6 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.639 -0.918 . . . . 0.0 110.231 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.544 HD21 HG21 ' A' ' 375' ' ' VAL . 46.4 m-20 -127.39 133.99 49.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 109.747 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.785 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -140.38 155.18 23.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.937 -1.102 . . . . 0.0 109.2 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.6 m-20 -21.91 -63.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.47 0.652 . . . . 0.0 112.555 170.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.459 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 44.3 t-20 -95.57 -7.58 37.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 111.911 -167.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.563 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.4 mtp180 -142.95 144.92 32.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.745 -1.222 . . . . 0.0 110.55 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -135.3 101.33 4.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.845 -1.159 . . . . 0.0 108.967 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.058 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -123.89 146.03 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 110.143 -172.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 33.7 mtt180 -135.85 160.42 38.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.905 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.651 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.53 131.25 39.55 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.551 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -157.01 174.01 34.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.4 m -56.91 150.17 17.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.941 -1.329 . . . . 0.0 108.441 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.088 HG21 HG11 ' A' ' 420' ' ' VAL . 16.9 t -54.54 -36.97 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.969 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.5 m-20 -63.8 -44.25 93.87 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.319 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.671 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.42 -51.53 42.79 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.951 -1.093 . . . . 0.0 110.574 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 432' ' ' VAL . 30.6 mm -64.64 -42.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.082 -1.011 . . . . 0.0 110.736 -176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.594 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.9 ttp180 -59.15 -43.74 92.06 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.8 mtp180 -61.62 -36.8 81.76 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.506 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -68.18 -36.68 79.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.301 -0.874 . . . . 0.0 111.367 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 437' ' ' SER . 54.4 t -66.24 -47.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.59 -1.319 . . . . 0.0 110.16 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -34.8 78.6 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.756 -1.215 . . . . 0.0 110.293 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.22 81.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.968 -1.082 . . . . 0.0 109.883 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 5.3 m-80 -60.94 -28.24 68.81 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.509 -0.744 . . . . 0.0 109.084 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.4 19.8 26.82 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 -169.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -116.05 -168.84 15.32 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.37 153.88 41.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.213 -1.169 . . . . 0.0 111.149 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.7 p90 -107.98 150.68 40.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.589 -0.694 . . . . 0.0 110.061 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.857 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.56 127.4 12.42 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.891 1.469 . . . . 0.0 110.49 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.2 t -66.99 -34.93 78.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 111.024 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.5 m-20 -61.43 -33.73 74.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.817 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.084 HG21 ' HA ' ' A' ' 325' ' ' ALA . 54.7 t -83.5 -41.68 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.37 -38.51 68.92 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.347 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.38 -48.0 79.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.324 -1.485 . . . . 0.0 110.309 171.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.721 ' HD3' HG21 ' A' ' 323' ' ' ILE . 35.8 mttm -56.71 -34.87 67.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.668 -1.27 . . . . 0.0 110.512 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.088 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.7 -41.68 86.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.91 -1.119 . . . . 0.0 109.136 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -65.94 -36.18 82.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.915 0.864 . . . . 0.0 109.493 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.5 -38.18 80.73 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 110.886 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 428' ' ' ALA . 69.4 t -62.3 -37.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.975 -1.078 . . . . 0.0 109.945 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.42 87.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.219 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.05 -33.08 74.99 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.258 -0.901 . . . . 0.0 111.208 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -80.98 -4.38 54.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.012 -1.055 . . . . 0.0 109.456 174.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.24 30.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.661 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.42 170.91 7.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -1.141 . . . . 0.0 109.863 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.865 ' HB ' HD12 ' A' ' 445' ' ' LEU . 7.5 m -112.45 106.62 55.71 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.988 -1.07 . . . . 0.0 110.108 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' ' 420' ' ' VAL . 55.3 Cg_endo -80.05 107.23 2.03 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 O-C-N 123.864 1.454 . . . . 0.0 110.541 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.898 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -93.6 140.44 29.61 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.915 -1.116 . . . . 0.0 108.717 167.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.89 ' CG2' HG22 ' A' ' 398' ' ' VAL . 98.5 t -101.07 135.6 36.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.798 -1.189 . . . . 0.0 109.568 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.0 ' CG1' HD11 ' A' ' 440' ' ' LEU . 22.3 t -115.93 136.19 53.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 108.745 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.826 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -120.53 160.44 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.477 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -135.49 129.97 33.96 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.26 -131.3 29.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.614 ' O ' HG13 ' A' ' 405' ' ' VAL . 76.5 p -103.29 8.97 38.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.087 -1.243 . . . . 0.0 111.138 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -123.32 170.84 9.89 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.555 -1.34 . . . . 0.0 110.152 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.826 ' HA ' HG12 ' A' ' 434' ' ' VAL . 61.9 t -91.04 134.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.357 -0.84 . . . . 0.0 109.824 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.0 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -92.83 -22.49 19.27 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.48 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.969 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 169.22 177.42 39.89 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.048 -1.549 . . . . 0.0 110.871 170.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.044 HG21 HG23 ' A' ' 420' ' ' VAL . 60.0 t -107.72 143.91 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.109 -1.23 . . . . 0.0 109.82 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.597 HD13 HG23 ' A' ' 352' ' ' ILE . 81.3 mt -101.62 112.62 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.448 -0.783 . . . . 0.0 108.997 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.36 118.24 30.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.861 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.898 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.66 148.15 25.93 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -175.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 16.1 pttt . . . . . 0 C--N 1.297 -1.691 0 O-C-N 120.563 -1.335 . . . . 0.0 110.343 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.462 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 87.6 mt-30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.085 0.469 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.721 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -64.2 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.934 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.463 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -117.37 -33.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -169.95 151.03 3.96 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.008 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.017 ' CD1' HD21 ' A' ' 355' ' ' LEU . 11.4 p90 -136.0 145.87 46.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.774 -1.204 . . . . 0.0 111.814 -177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.453 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.4 mp -116.53 143.16 30.73 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.667 -0.646 . . . . 0.0 109.631 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.8 Cg_endo -72.37 143.71 39.56 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.69 1.363 . . . . 0.0 111.583 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.063 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.65 152.4 41.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 108.782 165.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.78 128.96 39.84 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.575 -1.328 . . . . 0.0 110.097 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.66 -1.8 42.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.5 t -136.43 138.84 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.463 . . . . 0.0 110.749 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.4 m-20 -73.5 152.32 40.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -61.98 -40.11 94.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.037 -1.039 . . . . 0.0 110.443 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.13 -43.44 91.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 109.568 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.519 HG21 HG13 ' A' ' 328' ' ' VAL . 95.1 m -56.36 -43.56 79.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.88 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 1.024 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.6 tp -59.23 -39.8 83.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.268 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.0 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.17 -41.75 85.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 110.774 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.5 -49.16 74.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.892 -1.13 . . . . 0.0 109.971 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.898 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.7 -31.67 71.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.994 -1.066 . . . . 0.0 109.776 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.79 -34.9 65.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.02 -55.79 5.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.516 -0.74 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.067 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.34 -35.96 78.85 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.885 -173.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.16 -20.81 65.8 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.06 -1.025 . . . . 0.0 110.015 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.5 p -107.43 8.93 29.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.129 -0.982 . . . . 0.0 111.504 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.3 mt -65.48 -44.71 86.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.655 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.612 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.61 1.45 48.8 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.9 -170.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.487 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.47 130.2 43.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.803 -1.186 . . . . 0.0 110.057 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.92 5.45 51.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.595 0.712 . . . . 0.0 109.906 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -77.05 153.36 82.61 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.27 -38.33 95.26 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.734 1.386 . . . . 0.0 109.149 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.4 mt-10 -64.53 -29.66 70.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.75 . . . . 0.0 110.477 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.12 -35.51 59.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.3 mtt180 -76.97 -38.04 54.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.143 -1.21 . . . . 0.0 110.521 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.9 m -60.85 -38.09 84.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.92 -1.113 . . . . 0.0 110.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 443' ' ' ILE . 80.0 mt -69.01 -49.24 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.019 -1.051 . . . . 0.0 110.627 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.618 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -61.54 -33.84 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.0 110.198 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.749 HG22 ' OE1' ' A' ' 358' ' ' GLN . 34.2 mt -72.45 -33.09 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.741 -1.225 . . . . 0.0 110.553 171.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.017 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -59.68 -40.29 87.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.931 -1.106 . . . . 0.0 110.59 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.52 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.78 -45.12 91.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.284 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.971 ' HB3' HD23 ' A' ' 362' ' ' LEU . 30.1 mtmt -71.61 -49.26 41.95 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.706 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.749 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.6 pt20 -71.08 -42.4 69.41 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.76 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 37.8 mmt180 -73.11 -46.52 50.79 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 111.218 -172.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 73.6 m-85 -136.44 -35.82 0.73 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.411 -169.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.508 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 56.3 t-20 -158.91 102.43 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.546 -1.346 . . . . 0.0 111.619 -168.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.971 HD23 ' HB3' ' A' ' 357' ' ' LYS . 34.3 mt -57.8 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.858 -1.152 . . . . 0.0 109.295 171.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.525 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.6 tpt85 -135.96 163.64 29.8 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.34 -0.85 . . . . 0.0 108.941 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.51 -155.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.951 -1.093 . . . . 0.0 110.32 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.7 ptt180 -95.19 163.03 13.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.478 0.656 . . . . 0.0 110.523 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -127.78 40.24 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 110.464 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.939 HG11 ' CE2' ' A' ' 374' ' ' PHE . 57.4 t -74.61 -47.94 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.449 -0.782 . . . . 0.0 110.28 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.77 -26.02 65.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 110.954 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.44 -29.93 27.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 109.818 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.988 ' HB3' HD11 ' A' ' 388' ' ' ILE . 18.6 mt -103.83 -3.88 24.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 110.718 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.9 m80 62.77 53.15 2.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.932 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.43 174.92 6.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.672 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.2 m -116.3 134.27 55.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.567 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.939 ' CE2' HG11 ' A' ' 367' ' ' VAL . 81.4 m-85 -88.29 149.02 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 50.6 t -122.26 101.12 41.48 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -54.81 153.36 25.02 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.09 1.574 . . . . 0.0 110.443 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.586 ' CE2' ' N ' ' A' ' 383' ' ' MET . 58.3 t80 -69.07 134.27 49.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.797 174.86 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 97.4 mtt180 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.44 0.638 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.963 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.4 ptp -165.03 170.41 15.17 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.839 0.828 . . . . 0.0 111.283 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.3 p -154.84 165.55 36.28 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.94 -165.7 34.27 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 118.771 -1.68 . . . . 0.0 110.821 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.7 tt -140.86 148.67 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.641 -0.917 . . . . 0.0 110.133 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.446 HD21 HG21 ' A' ' 375' ' ' VAL . 41.9 m-20 -127.72 135.06 49.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.869 -1.145 . . . . 0.0 109.724 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.988 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.55 154.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.861 -1.149 . . . . 0.0 109.446 171.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 89.3 m-20 -25.4 -62.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.299 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.454 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.2 t30 -92.03 -7.83 47.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 -168.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.7 mtp180 -144.03 144.97 31.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.699 -1.25 . . . . 0.0 110.574 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.71 109.94 8.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.833 -1.167 . . . . 0.0 109.02 169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.067 HD12 HD11 ' A' ' 339' ' ' LEU . 8.6 mt -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.047 -1.033 . . . . 0.0 110.052 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 25.0 mmt85 -134.54 160.47 37.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.449 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.514 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.03 126.83 32.75 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.568 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.71 173.7 31.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.6 t -58.21 150.76 20.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.901 -1.352 . . . . 0.0 108.554 170.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.044 HG21 HG11 ' A' ' 420' ' ' VAL . 53.5 t -55.63 -35.48 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.971 -1.08 . . . . 0.0 109.607 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.09 -46.45 89.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.165 -0.96 . . . . 0.0 110.366 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.963 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -69.17 -51.02 42.3 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.028 -1.045 . . . . 0.0 110.639 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.568 HD11 ' N ' ' A' ' 396' ' ' GLY . 28.7 mm -64.28 -41.62 92.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 110.816 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.594 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 34.8 ttt-85 -59.65 -45.17 92.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.3 mtp85 -62.59 -35.51 79.75 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.205 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 111.212 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.84 -48.95 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.501 -1.375 . . . . 0.0 110.109 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.4 -34.11 77.02 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 110.253 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.97 -36.19 79.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.941 -1.099 . . . . 0.0 109.923 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.6 m-80 -61.63 -27.49 68.7 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.511 -0.743 . . . . 0.0 109.228 173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.06 19.43 28.64 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -170.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.78 -170.34 16.49 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.66 153.59 41.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 111.098 -174.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.4 p90 -107.21 150.15 39.57 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.528 -0.733 . . . . 0.0 110.039 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.879 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -72.27 127.4 12.63 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.846 1.445 . . . . 0.0 110.42 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -67.0 -34.96 78.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 111.016 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 55.9 t0 -62.12 -33.05 73.74 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.865 -1.147 . . . . 0.0 108.823 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.063 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.8 t -83.52 -41.66 16.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.906 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.498 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.8 t0 -55.14 -38.17 67.88 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.455 171.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.66 -48.16 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.33 -1.481 . . . . 0.0 110.299 171.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 15.0 mmtt -56.2 -35.36 67.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.59 -1.319 . . . . 0.0 110.384 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.078 HG23 HG21 ' A' ' 442' ' ' VAL . 3.3 t -60.23 -41.31 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.963 -1.086 . . . . 0.0 109.435 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -65.83 -36.04 82.37 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.922 0.868 . . . . 0.0 109.398 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.24 -37.58 80.95 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.868 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 428' ' ' ALA . 66.9 t -63.05 -37.35 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.91 -1.119 . . . . 0.0 110.01 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.36 85.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.71 -30.03 67.57 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.352 -0.842 . . . . 0.0 110.892 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.37 -3.53 55.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.785 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.23 21.79 28.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.58 170.89 7.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -1.081 . . . . 0.0 109.47 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.664 ' O ' HD12 ' A' ' 445' ' ' LEU . 21.3 m -116.92 106.85 47.01 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 109.52 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.601 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.3 Cg_endo -74.59 107.43 2.46 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 O-C-N 123.965 1.508 . . . . 0.0 110.331 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.625 ' HG ' HD13 ' A' ' 445' ' ' LEU . 15.8 mt -92.57 132.67 36.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.913 -1.117 . . . . 0.0 108.38 167.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.969 ' CG2' HG22 ' A' ' 398' ' ' VAL . 60.6 t -100.75 136.43 32.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.834 -1.166 . . . . 0.0 109.681 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.847 ' CG1' HD11 ' A' ' 440' ' ' LEU . 41.8 t -115.25 138.17 46.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 108.991 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.7 159.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.461 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.56 133.78 40.62 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 170.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.44 -126.83 31.07 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -168.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.62 ' O ' HG13 ' A' ' 405' ' ' VAL . 71.7 p -108.14 8.08 27.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.021 -1.281 . . . . 0.0 111.228 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -123.98 171.03 10.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.542 -1.349 . . . . 0.0 110.147 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.82 ' HA ' HG12 ' A' ' 434' ' ' VAL . 60.5 t -88.94 134.62 27.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.933 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.847 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -92.71 -22.12 19.59 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.602 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 1.024 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 171.04 176.31 40.15 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 118.803 -1.665 . . . . 0.0 110.816 168.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.078 HG21 HG23 ' A' ' 420' ' ' VAL . 48.2 t -107.88 143.18 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.239 . . . . 0.0 109.616 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.671 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.7 mt -101.47 118.62 48.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.326 -0.858 . . . . 0.0 108.773 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -98.14 117.58 32.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -176.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 429' ' ' THR . 3.6 mp -112.24 145.28 40.21 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.014 -1.054 . . . . 0.0 109.781 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.491 1.578 0 O-C-N 120.728 -1.233 . . . . 0.0 111.199 -174.058 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 90.5 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.118 0.485 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 355' ' ' LEU . . . -59.3 137.56 57.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.02 . . . . 0.0 109.765 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.516 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.9 m -117.89 -44.02 2.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.1 -1.0 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 320' ' ' SER . 66.1 mt-10 -154.81 151.48 28.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -0.908 . . . . 0.0 110.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.993 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.6 p90 -136.0 140.43 43.9 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.918 -1.114 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.466 HG23 ' HD2' ' A' ' 324' ' ' PRO . 3.4 mt -112.67 143.84 29.79 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.784 -0.573 . . . . 0.0 109.708 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.76 142.55 35.81 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.678 1.357 . . . . 0.0 111.614 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.057 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.48 152.81 42.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 108.861 165.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.11 128.64 38.21 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.586 -1.321 . . . . 0.0 110.178 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.46 46.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.3 t -136.73 139.38 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.677 -1.484 . . . . 0.0 110.703 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.8 m-20 -74.32 152.37 39.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.9 tt0 -61.53 -40.28 94.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.038 -1.039 . . . . 0.0 110.278 -177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.5 -43.84 93.26 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.665 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.502 HG21 HG13 ' A' ' 328' ' ' VAL . 93.4 m -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.742 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 1.019 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.3 tp -59.21 -39.2 81.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.296 175.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.993 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.44 -41.4 84.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.991 -1.068 . . . . 0.0 110.729 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.543 ' O ' HD23 ' A' ' 339' ' ' LEU . 88.4 m-20 -63.28 -49.92 72.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.975 -1.078 . . . . 0.0 109.84 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.903 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.0 -31.98 72.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 109.901 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.822 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.26 -35.35 64.9 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.166 -0.959 . . . . 0.0 108.961 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.55 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.9 mt-30 -75.5 -55.89 5.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.564 -0.71 . . . . 0.0 110.971 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.014 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -62.36 -35.24 78.52 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.756 -172.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.428 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.07 -20.87 65.89 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.984 -1.072 . . . . 0.0 109.978 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.8 p -107.82 9.95 28.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.205 -0.934 . . . . 0.0 111.547 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.9 mt -66.36 -44.37 83.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.516 -1.365 . . . . 0.0 109.633 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.39 2.15 50.13 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.787 -170.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 14.0 p30 -64.17 130.08 42.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.739 -1.226 . . . . 0.0 110.015 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.42 4.44 53.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.508 0.671 . . . . 0.0 109.873 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.1 p -74.17 152.95 88.4 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 109.404 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.74 -40.05 87.01 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.737 1.388 . . . . 0.0 109.162 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.68 -27.56 69.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 0.0 110.481 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.22 -37.74 65.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.5 mtt180 -77.15 -37.83 53.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -1.223 . . . . 0.0 110.514 173.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.4 m -61.04 -38.06 84.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.613 HG23 HD13 ' A' ' 443' ' ' ILE . 90.6 mt -68.12 -49.61 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.613 HG22 ' OG ' ' A' ' 341' ' ' SER . 37.2 t -60.87 -33.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.014 . . . . 0.0 110.07 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.614 HG22 ' OE1' ' A' ' 358' ' ' GLN . 29.4 mt -72.92 -32.91 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.701 -1.25 . . . . 0.0 110.565 171.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.951 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.43 -40.17 85.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.809 -1.182 . . . . 0.0 110.545 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.407 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.51 -44.69 93.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.938 ' HB3' HD23 ' A' ' 362' ' ' LEU . 16.1 mtmt -71.46 -49.6 39.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.638 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.614 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.6 pt20 -71.51 -42.54 67.87 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 110.793 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.525 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.9 mmt180 -72.86 -45.7 56.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 111.24 -172.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.571 ' CE2' ' OE2' ' A' ' 330' ' ' GLU . 56.1 m-85 -135.76 -38.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.143 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.511 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.3 t30 -159.0 105.18 1.75 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.758 -1.214 . . . . 0.0 111.528 -168.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 357' ' ' LYS . 46.7 mt -57.45 89.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.842 -1.161 . . . . 0.0 109.163 171.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.535 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.1 tpt180 -131.14 164.49 25.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.236 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.4 mt-10 -136.88 -157.19 0.76 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.153 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 31.8 ptt-85 -94.65 162.52 13.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 88.4 m-20 -128.68 41.21 3.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.287 176.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.082 HG21 ' CE1' ' A' ' 374' ' ' PHE . 26.0 t -73.47 -45.73 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.45 -28.18 66.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 111.079 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.19 -29.87 28.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.037 -1.039 . . . . 0.0 109.763 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.771 ' HB3' HD11 ' A' ' 388' ' ' ILE . 26.0 mt -103.64 -4.63 23.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.494 -0.754 . . . . 0.0 110.613 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.1 m-70 60.64 52.49 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.842 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.781 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -95.09 174.39 7.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.409 -0.807 . . . . 0.0 110.638 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.3 m -117.35 135.68 53.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.082 ' CE1' HG21 ' A' ' 367' ' ' VAL . 74.2 m-85 -89.39 148.79 23.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.626 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.463 HG21 HD21 ' A' ' 387' ' ' ASN . 64.0 t -122.17 100.69 42.21 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.26 150.36 49.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.046 1.551 . . . . 0.0 110.512 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.9 t80 -62.99 131.79 49.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.797 . . . . 0.0 109.639 175.411 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 87.7 mtt180 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.53 0.681 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.867 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.4 ptp -160.05 169.07 24.15 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.895 0.855 . . . . 0.0 111.314 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.537 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.6 p -153.64 164.92 37.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.15 -167.11 35.6 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.643 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.843 HG21 ' HB2' ' A' ' 339' ' ' LEU . 4.0 tt -140.04 150.28 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.554 -0.968 . . . . 0.0 110.136 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.463 HD21 HG21 ' A' ' 375' ' ' VAL . 47.6 m-20 -126.53 134.52 50.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.956 -1.09 . . . . 0.0 109.809 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.771 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -142.41 155.22 18.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.947 -1.096 . . . . 0.0 109.181 173.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 91.5 m-20 -22.41 -63.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.413 0.625 . . . . 0.0 112.582 171.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.46 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t30 -96.35 -6.01 38.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 111.776 -167.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.564 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.5 mtp180 -143.74 143.89 31.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.705 -1.247 . . . . 0.0 110.381 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -134.02 99.43 4.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.974 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.014 HD12 HD11 ' A' ' 339' ' ' LEU . 7.2 mt -121.29 145.96 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.036 -1.04 . . . . 0.0 110.103 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 31.4 mtt180 -133.83 159.68 39.9 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.08 -1.013 . . . . 0.0 110.689 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.489 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.19 127.23 31.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.344 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.567 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.23 174.07 32.7 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -173.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 35.7 m -56.99 151.51 14.75 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.854 -1.38 . . . . 0.0 108.572 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.052 HG21 HG11 ' A' ' 420' ' ' VAL . 57.7 t -57.02 -34.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.993 -1.067 . . . . 0.0 109.856 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.8 t0 -62.88 -46.54 87.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.218 -0.926 . . . . 0.0 110.414 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.867 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.9 -50.42 56.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.006 -1.059 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.567 HD11 ' N ' ' A' ' 396' ' ' GLY . 32.5 mm -65.38 -43.69 94.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 110.763 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.585 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.7 ttp85 -58.9 -43.57 91.04 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.348 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.0 mtp180 -61.92 -36.26 80.83 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 109.44 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.534 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -67.61 -37.03 81.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 111.277 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 437' ' ' SER . 55.9 t -66.03 -48.26 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.657 -1.277 . . . . 0.0 110.157 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.99 -34.2 77.46 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.845 -1.16 . . . . 0.0 110.395 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.67 -36.39 80.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.924 -1.11 . . . . 0.0 109.816 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.534 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.1 m-80 -61.63 -27.62 68.79 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.22 173.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.02 20.35 28.43 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -168.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.44 -170.87 17.6 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.416 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.0 m-70 -143.96 153.79 42.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -1.221 . . . . 0.0 111.186 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.592 ' HB3' HG21 ' A' ' 439' ' ' VAL . 5.3 p90 -107.37 150.96 40.68 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.61 -0.681 . . . . 0.0 110.098 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.846 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -73.3 124.41 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.869 1.457 . . . . 0.0 110.202 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -65.99 -34.87 79.09 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 111.064 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 54.1 t0 -61.41 -33.05 73.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.949 -1.094 . . . . 0.0 108.859 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.057 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.2 t -83.7 -42.44 17.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 111.009 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.508 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 9.3 m-20 -55.46 -37.26 67.53 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.575 171.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.7 mt-30 -63.72 -48.96 74.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.29 -1.506 . . . . 0.0 110.205 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 72.6 mmtt -56.65 -34.79 67.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.717 -1.239 . . . . 0.0 110.373 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.07 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.73 -41.23 84.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.0 -1.062 . . . . 0.0 109.283 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -66.48 -36.25 82.29 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.03 -38.19 82.25 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.565 -0.709 . . . . 0.0 110.782 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.777 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.5 t -62.48 -37.56 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.902 -1.124 . . . . 0.0 110.016 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.3 87.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 110.192 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -65.9 -33.8 76.66 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.38 -0.825 . . . . 0.0 111.177 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -81.69 -4.2 55.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 175.055 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 22.56 28.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.777 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -103.23 165.31 11.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -1.115 . . . . 0.0 109.618 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.768 ' HB ' HD12 ' A' ' 445' ' ' LEU . 10.0 m -110.89 106.87 57.83 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.018 -1.051 . . . . 0.0 109.863 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.567 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.35 108.42 2.7 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.972 1.512 . . . . 0.0 110.64 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.861 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.7 mt -91.86 133.96 35.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.861 -1.149 . . . . 0.0 108.497 166.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.929 ' CG2' HG22 ' A' ' 398' ' ' VAL . 83.8 t -99.86 134.73 38.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 120.799 -1.188 . . . . 0.0 109.465 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.014 ' CG1' HD11 ' A' ' 440' ' ' LEU . 23.5 t -114.46 138.57 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.881 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.821 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -122.12 160.45 24.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.657 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.447 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.17 129.26 33.51 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.25 -129.33 28.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.496 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 5.4 p -104.96 10.18 34.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.105 -1.232 . . . . 0.0 111.089 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -121.85 170.83 9.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.574 -1.329 . . . . 0.0 110.128 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 434' ' ' VAL . 41.2 t -93.8 134.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.315 -0.866 . . . . 0.0 109.762 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.014 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -95.96 -20.5 18.69 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.805 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 1.019 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.54 176.5 38.88 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 118.719 -1.705 . . . . 0.0 110.981 168.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.07 HG21 HG23 ' A' ' 420' ' ' VAL . 47.3 t -107.96 142.13 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.091 -1.24 . . . . 0.0 109.938 173.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.822 HD11 ' HB1' ' A' ' 337' ' ' ALA . 81.8 mt -101.53 111.25 30.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.042 170.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.651 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.75 118.65 30.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.099 -1.0 . . . . 0.0 109.909 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.861 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -101.07 144.62 29.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 70.5 mttt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 111.153 -179.467 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 61.4 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.048 0.451 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.803 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.66 138.61 41.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 109.789 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.528 ' O ' ' CZ ' ' A' ' 359' ' ' ARG . 20.8 m -124.34 -40.04 2.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.988 . . . . 0.0 110.276 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 320' ' ' SER . 57.9 mt-10 -154.66 146.54 23.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.103 ' CD1' HD21 ' A' ' 355' ' ' LEU . 9.2 p90 -137.6 142.34 41.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.593 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.538 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.9 mt -116.11 145.82 35.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.758 -0.589 . . . . 0.0 109.827 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -73.42 143.03 34.13 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.778 1.409 . . . . 0.0 111.468 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.047 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.22 152.72 42.02 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 108.881 165.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 0.8 OUTLIER -57.82 128.43 37.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.74 -1.225 . . . . 0.0 110.058 -173.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.62 -2.61 39.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.7 t -136.74 140.34 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.667 -1.49 . . . . 0.0 110.809 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -74.08 152.98 39.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.07 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -62.18 -38.73 90.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.354 -176.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -60.92 -45.66 93.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.697 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 95.0 m -55.99 -43.73 77.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.674 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.2 tp -58.08 -40.55 81.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.014 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.15 -39.86 82.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.08 -1.013 . . . . 0.0 110.717 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.1 m-20 -62.82 -49.09 76.29 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 109.757 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.29 -31.49 70.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.884 -1.135 . . . . 0.0 109.73 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.667 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.28 -34.9 64.51 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 172.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 17.7 mt-30 -74.25 -55.6 5.85 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 110.827 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.002 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.05 -35.24 78.03 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.048 -172.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.66 -21.08 65.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 110.131 174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.569 ' OG ' HG22 ' A' ' 353' ' ' VAL . 89.3 p -107.52 10.04 29.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.0 111.508 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.5 mt -65.68 -45.51 82.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.622 -1.299 . . . . 0.0 109.793 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.5 0.85 48.28 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.865 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 341' ' ' SER . 10.7 p30 -64.25 130.57 44.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.817 -1.177 . . . . 0.0 110.023 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.83 5.61 50.89 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.566 0.698 . . . . 0.0 109.863 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.0 p -75.76 154.72 85.25 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.68 -39.5 90.71 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.786 1.414 . . . . 0.0 109.222 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.558 ' CD ' HD13 ' A' ' 445' ' ' LEU . 96.1 mt-10 -64.9 -27.46 68.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.47 -0.769 . . . . 0.0 110.634 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.61 -39.83 76.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -174.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -78.02 -36.81 48.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -1.182 . . . . 0.0 110.662 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.5 m -61.25 -38.97 88.6 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.928 -1.108 . . . . 0.0 110.4 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.537 HG23 HD13 ' A' ' 443' ' ' ILE . 87.4 mt -69.11 -48.33 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.708 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.569 HG22 ' OG ' ' A' ' 341' ' ' SER . 34.8 t -62.14 -34.52 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.846 -1.159 . . . . 0.0 110.204 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.6 mt -73.2 -32.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.686 -1.259 . . . . 0.0 110.632 171.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.103 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -58.19 -41.27 83.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.97 -1.081 . . . . 0.0 110.2 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.99 -44.07 93.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.556 -0.715 . . . . 0.0 110.618 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.99 ' HB3' HD23 ' A' ' 362' ' ' LEU . 74.6 mttt -69.8 -49.56 51.55 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.662 -173.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.7 pt20 -72.27 -42.85 65.11 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.644 -172.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.769 ' HE ' HD12 ' A' ' 355' ' ' LEU . 84.6 mtt-85 -78.89 -39.52 34.74 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 111.707 -171.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.669 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 76.3 m-85 -134.77 -38.64 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.462 -1.399 . . . . 0.0 112.088 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 48.6 t30 -160.57 99.79 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.585 -1.322 . . . . 0.0 111.649 -169.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.99 HD23 ' HB3' ' A' ' 357' ' ' LYS . 34.1 mt -57.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.865 -1.147 . . . . 0.0 109.329 171.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.541 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.4 tpt180 -141.58 164.04 31.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.169 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.7 mt-10 -130.23 -154.24 0.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.474 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.7 ptt-85 -94.11 162.97 13.66 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.686 -0.634 . . . . 0.0 110.576 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.3 p30 -125.49 39.09 4.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.943 HG11 ' CE2' ' A' ' 374' ' ' PHE . 61.6 t -74.53 -47.5 39.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.352 -0.843 . . . . 0.0 110.281 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.86 -26.26 65.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 111.004 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.77 -29.74 27.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.001 . . . . 0.0 109.724 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.997 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.9 mt -104.33 -3.63 23.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.449 -0.782 . . . . 0.0 110.711 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.3 m80 62.6 53.22 2.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -177.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.937 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.46 175.01 6.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 0.0 110.646 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.3 m -115.94 134.43 54.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.476 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.943 ' CE2' HG11 ' A' ' 367' ' ' VAL . 80.5 m-85 -88.32 149.04 23.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.434 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 25.6 t -121.56 101.11 43.62 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 109.735 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.9 Cg_endo -55.03 153.05 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 110.468 -176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.566 ' CE2' ' N ' ' A' ' 383' ' ' MET . 56.8 t80 -70.54 134.44 47.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.386 -0.821 . . . . 0.0 109.777 174.843 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.6 mtt180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.485 0.66 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.915 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.6 ptp -165.28 171.3 13.73 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.878 0.847 . . . . 0.0 111.237 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.535 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.8 p -155.79 165.43 36.54 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.8 -165.82 34.38 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.822 -1.656 . . . . 0.0 110.79 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.877 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.5 tt -140.52 149.2 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.623 -0.928 . . . . 0.0 110.143 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.416 HD21 HG21 ' A' ' 375' ' ' VAL . 44.0 m-20 -127.82 134.81 49.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 109.695 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.997 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -140.15 154.85 23.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.791 -1.193 . . . . 0.0 109.437 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 90.0 m-20 -25.37 -63.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.444 0.64 . . . . 0.0 112.277 172.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 34.1 t30 -91.94 -7.69 48.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.738 . . . . 0.0 111.828 -168.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.558 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.6 mtp180 -143.98 144.64 31.77 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.667 -1.271 . . . . 0.0 110.581 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.6 mtm -134.42 111.73 10.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 108.945 169.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.002 HD12 HD11 ' A' ' 339' ' ' LEU . 9.6 mt -131.66 146.16 33.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.0 109.978 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 26.2 mmt85 -134.41 159.32 41.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.069 -1.019 . . . . 0.0 110.356 175.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.525 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.06 127.21 33.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.661 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.12 174.23 31.88 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.635 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.2 m -56.0 150.56 13.36 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.958 -1.319 . . . . 0.0 108.551 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.001 HG21 HG11 ' A' ' 420' ' ' VAL . 20.4 t -54.84 -37.36 40.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.083 -1.011 . . . . 0.0 109.904 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.4 m-20 -64.23 -45.01 90.08 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.252 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.915 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.48 -48.98 65.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.972 -1.08 . . . . 0.0 110.655 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.661 HD11 ' N ' ' A' ' 396' ' ' GLY . 35.1 mm -65.98 -43.85 92.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.008 -1.057 . . . . 0.0 110.945 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.621 ' NE ' ' CZ ' ' A' ' 412' ' ' PHE . 4.0 ttt180 -60.29 -42.61 95.85 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.062 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 88.8 mtt-85 -61.28 -37.49 83.37 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.635 172.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.4 t-80 -67.68 -36.21 80.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 111.289 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.71 -49.05 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.621 -1.3 . . . . 0.0 110.154 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -34.3 77.38 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.891 -1.13 . . . . 0.0 110.218 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.13 79.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.96 -1.088 . . . . 0.0 109.994 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 8.0 m-80 -61.45 -27.71 68.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.174 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.93 19.81 27.87 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.84 -169.37 16.09 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.401 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.0 m-70 -144.39 153.62 42.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 111.435 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.621 ' CZ ' ' NE ' ' A' ' 402' ' ' ARG . 7.7 p90 -108.4 149.85 39.84 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.668 -0.645 . . . . 0.0 110.304 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.824 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.02 125.56 9.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.807 1.425 . . . . 0.0 110.52 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.25 -32.37 72.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -0.986 . . . . 0.0 111.075 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.479 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.5 m-20 -63.47 -31.67 72.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 108.848 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.047 HG21 ' HA ' ' A' ' 325' ' ' ALA . 46.0 t -83.58 -42.58 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.388 -0.82 . . . . 0.0 110.765 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.2 m-20 -55.22 -36.64 66.2 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.669 -1.212 . . . . 0.0 109.625 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.91 -49.75 71.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.337 -1.477 . . . . 0.0 109.662 173.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 79.2 mttt -56.8 -34.83 68.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.785 -1.197 . . . . 0.0 110.278 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.095 HG23 HG21 ' A' ' 442' ' ' VAL . 2.5 t -59.47 -40.98 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -66.09 -36.61 83.65 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.959 0.885 . . . . 0.0 109.255 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -66.75 -36.68 83.01 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 110.511 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 428' ' ' ALA . 68.3 t -63.11 -37.69 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.026 -1.047 . . . . 0.0 110.161 175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.05 81.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 110.286 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.75 -30.72 68.37 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.252 -0.905 . . . . 0.0 111.006 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.43 -3.32 57.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 109.777 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.05 22.1 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.74 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -105.68 160.92 14.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -1.052 . . . . 0.0 109.474 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.83 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.2 m -108.88 106.89 59.56 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.935 -1.103 . . . . 0.0 109.798 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.535 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.69 107.86 2.56 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.01 1.531 . . . . 0.0 110.769 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.899 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.9 mt -92.62 133.29 36.12 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.845 -1.16 . . . . 0.0 108.542 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.909 ' CG2' HG22 ' A' ' 398' ' ' VAL . 87.7 t -99.74 134.09 40.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.608 -1.308 . . . . 0.0 109.452 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.727 ' CG1' HD11 ' A' ' 440' ' ' LEU . 46.9 t -114.43 134.95 55.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.999 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.0 m -117.07 159.94 16.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.491 -0.755 . . . . 0.0 109.639 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.527 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -135.28 132.52 37.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.01 -129.15 32.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 -167.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.583 ' O ' HG13 ' A' ' 405' ' ' VAL . 75.6 p -106.46 8.02 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.125 -1.221 . . . . 0.0 111.13 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -120.11 170.73 9.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.643 -1.286 . . . . 0.0 109.977 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.827 ' HA ' HG12 ' A' ' 434' ' ' VAL . 26.1 t -91.82 133.85 32.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -96.14 -20.04 18.92 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.822 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.871 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 169.07 176.41 39.11 Favored Glycine 0 N--CA 1.501 2.976 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.03 168.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.095 HG21 HG23 ' A' ' 420' ' ' VAL . 45.1 t -107.86 141.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.234 -1.157 . . . . 0.0 109.802 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.667 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.4 mt -101.42 110.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 108.939 170.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.58 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.31 119.06 31.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.03 -1.044 . . . . 0.0 109.911 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.899 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -102.62 144.88 30.45 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.418 -0.802 . . . . 0.0 108.871 -175.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 320' ' ' SER . 37.8 mmtm . . . . . 0 C--N 1.3 -1.586 0 O-C-N 120.697 -1.252 . . . . 0.0 110.7 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.543 ' CA ' ' HB3' ' A' ' 351' ' ' SER . 92.5 mt-30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.099 0.476 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.69 137.5 57.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.065 -1.022 . . . . 0.0 109.889 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.52 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.45 -34.04 2.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.604 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -161.81 146.06 12.71 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.936 -1.105 . . . . 0.0 110.246 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.134 ' CD1' HD21 ' A' ' 355' ' ' LEU . 15.9 p90 -136.78 147.79 46.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.818 -1.176 . . . . 0.0 111.656 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 7.5 mt -119.96 142.5 33.42 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.737 -0.602 . . . . 0.0 109.674 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.559 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.69 143.86 42.86 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.667 1.351 . . . . 0.0 111.732 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.06 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.8 153.02 42.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 108.907 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.59 128.6 37.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.631 -1.293 . . . . 0.0 110.12 -172.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.46 0.6 50.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 440' ' ' LEU . 47.3 t -135.36 138.33 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.677 -1.484 . . . . 0.0 110.606 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.46 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.5 m-20 -73.58 149.97 41.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.372 -0.83 . . . . 0.0 110.148 176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -60.85 -37.22 81.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.983 -1.073 . . . . 0.0 110.025 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -59.53 -41.21 89.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.918 -1.114 . . . . 0.0 109.324 176.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.548 HG21 HG13 ' A' ' 328' ' ' VAL . 99.3 m -60.09 -42.95 95.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 110.031 173.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.968 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.5 tp -60.01 -39.01 84.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 110.531 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.983 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.31 -45.45 72.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 110.734 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.8 m-20 -63.48 -48.71 76.53 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.885 -1.134 . . . . 0.0 109.931 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.905 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.62 -31.51 71.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 109.815 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.684 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.44 -35.47 65.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 172.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.54 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 19.3 mt-30 -74.04 -55.52 6.02 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.545 -0.722 . . . . 0.0 111.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.026 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.31 -36.25 79.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.097 -172.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 395' ' ' LYS . . . -67.82 -18.94 65.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.834 174.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.62 ' OG ' HG22 ' A' ' 353' ' ' VAL . 90.2 p -107.95 8.57 28.5 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.244 -0.91 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.609 HD11 ' CB ' ' A' ' 365' ' ' ARG . 32.2 mt -65.37 -45.77 82.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.557 -1.339 . . . . 0.0 109.67 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.44 1.57 49.34 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.869 -170.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.484 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -62.58 130.36 44.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.683 -1.26 . . . . 0.0 109.905 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.16 5.17 52.54 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.585 0.707 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 346' ' ' THR . 2.9 p -75.53 151.1 85.01 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.561 -0.712 . . . . 0.0 109.385 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.1 -39.31 92.02 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.669 1.352 . . . . 0.0 109.152 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.09 -28.02 69.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -0.789 . . . . 0.0 110.412 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.43 -37.82 67.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.498 ' O ' HD12 ' A' ' 354' ' ' ILE . 96.3 mtt180 -76.63 -35.98 57.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.24 . . . . 0.0 110.466 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.543 ' HB3' ' CA ' ' A' ' 318' ' ' GLN . 3.7 m -61.66 -38.91 89.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.976 -1.078 . . . . 0.0 110.348 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 443' ' ' ILE . 79.6 mt -69.24 -48.89 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.029 -1.044 . . . . 0.0 110.494 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.697 HG12 ' HE3' ' A' ' 357' ' ' LYS . 21.8 t -60.64 -32.17 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.797 -1.189 . . . . 0.0 109.84 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.771 HG22 ' OE1' ' A' ' 358' ' ' GLN . 45.4 mt -72.98 -32.29 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.861 -1.149 . . . . 0.0 110.744 171.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.134 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.87 -42.51 89.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 110.053 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.71 93.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.817 . . . . 0.0 110.592 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 1.017 ' HB3' HD23 ' A' ' 362' ' ' LEU . 81.0 mttt -71.97 -51.11 23.55 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.691 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.771 ' OE1' HG22 ' A' ' 354' ' ' ILE . 20.0 pt20 -71.82 -42.54 66.89 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.7 mmt180 -73.09 -43.83 61.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 111.031 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 87.5 m-85 -134.88 -38.73 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 112.052 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 52.3 t30 -163.01 102.51 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.51 -1.369 . . . . 0.0 111.624 -167.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 1.017 HD23 ' HB3' ' A' ' 357' ' ' LYS . 25.5 mt -57.97 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.902 -1.124 . . . . 0.0 108.994 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.527 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.2 tpt180 -145.64 163.02 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.892 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 88.9 mt-10 -134.06 -171.26 2.7 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.04 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.769 ' NH2' HD13 ' A' ' 388' ' ' ILE . 1.2 tpt180 -100.47 155.67 17.7 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.175 -0.953 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.1 m-20 -104.68 48.42 0.84 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.196 -0.94 . . . . 0.0 110.968 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.983 ' CG2' HD11 ' A' ' 386' ' ' ILE . 78.0 t -66.79 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 176.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.59 -26.89 66.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 110.979 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -28.3 25.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.932 ' HB3' HD11 ' A' ' 388' ' ' ILE . 17.8 mt -104.13 -1.75 26.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 22.9 m80 64.29 53.49 1.72 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 110.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.885 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -97.12 175.03 6.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 110.758 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.8 m -115.42 132.18 56.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 110.375 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.914 ' CE2' HG11 ' A' ' 367' ' ' VAL . 70.6 m-85 -87.86 149.13 24.31 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.479 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 59.9 t -125.31 100.78 32.04 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.066 -1.021 . . . . 0.0 109.866 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.3 151.93 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.089 1.573 . . . . 0.0 110.404 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 12.8 t80 -62.19 131.75 50.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 110.118 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--N 1.301 -1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.553 175.633 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 94.1 mtt180 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.515 0.674 . . . . 0.0 109.691 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.677 ' CE ' ' HB1' ' A' ' 400' ' ' ALA . 2.0 ptp -160.92 172.91 16.11 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.155 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.518 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.3 p -154.43 165.04 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.65 -165.1 33.14 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.772 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.983 HD11 ' CG2' ' A' ' 367' ' ' VAL . 6.7 tt -142.51 148.31 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.956 . . . . 0.0 110.04 -175.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -128.28 135.15 49.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.803 -1.186 . . . . 0.0 109.912 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.932 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 109.421 169.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.257 88.3 m-20 -25.88 -63.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.444 0.64 . . . . 0.0 112.251 173.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.438 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 19.9 t-20 -91.45 -7.97 49.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.807 . . . . 0.0 111.723 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.557 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 26.4 mtp180 -143.23 145.53 32.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.669 -1.27 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.91 113.56 10.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.131 . . . . 0.0 109.033 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 339' ' ' LEU . 10.0 mt -131.8 146.08 33.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.043 -177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 26.9 mtt180 -135.52 160.74 37.53 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.613 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.647 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.87 138.69 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.485 -0.759 . . . . 0.0 109.185 174.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.625 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -165.36 174.55 41.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.6 m -57.34 150.97 17.04 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.024 -1.28 . . . . 0.0 108.654 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.036 HG21 HG11 ' A' ' 420' ' ' VAL . 19.7 t -53.72 -37.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.9 m-20 -64.11 -44.71 91.43 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.392 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.677 ' HB1' ' CE ' ' A' ' 383' ' ' MET . . . -68.44 -50.57 51.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.907 -1.12 . . . . 0.0 110.574 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.638 HD13 ' HE1' ' A' ' 383' ' ' MET . 25.9 mm -64.9 -43.56 96.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.027 -1.046 . . . . 0.0 110.847 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 14.0 ttp180 -59.39 -43.17 92.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 62.5 mtp180 -61.92 -36.09 80.32 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 109.433 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.23 -37.48 83.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.203 -0.935 . . . . 0.0 111.291 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 437' ' ' SER . 58.3 t -65.66 -47.86 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.538 -1.351 . . . . 0.0 110.246 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.4 -34.67 78.24 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.795 -1.19 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.27 80.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.901 -1.125 . . . . 0.0 109.962 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 15.6 m-80 -61.7 -27.27 68.58 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.244 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.48 19.41 30.04 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.52 -169.44 17.08 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.435 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.3 m-70 -143.88 153.92 42.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -1.214 . . . . 0.0 111.378 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.593 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.4 p90 -106.97 149.18 38.24 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.626 -0.671 . . . . 0.0 110.255 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.818 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.46 123.7 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.809 1.426 . . . . 0.0 110.433 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.33 -33.99 76.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.925 . . . . 0.0 111.053 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 90.7 m-20 -61.04 -32.99 72.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.9 -1.125 . . . . 0.0 108.841 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.06 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.8 t -84.1 -42.62 17.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 60.7 m-20 -54.2 -36.99 64.05 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.456 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.6 mm-40 -63.18 -48.82 76.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.254 -1.529 . . . . 0.0 110.228 170.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 16.5 mmtt -56.29 -35.38 67.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.751 -1.218 . . . . 0.0 110.412 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.042 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.79 -40.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 109.151 171.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.874 0.845 . . . . 0.0 109.346 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 94.7 mm-40 -66.83 -38.06 85.68 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.644 -0.66 . . . . 0.0 110.666 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 428' ' ' ALA . 65.5 t -63.09 -36.92 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.934 -1.104 . . . . 0.0 110.14 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.14 82.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -70.37 -30.67 67.65 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 111.108 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 423' ' ' VAL . 5.9 pt20 -82.15 -6.35 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.901 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 96.44 22.02 20.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 445' ' ' LEU . . . -110.19 170.99 7.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 110.026 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.945 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.7 m -113.44 107.02 53.84 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.075 -1.016 . . . . 0.0 110.078 -174.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.566 ' HB2' HG22 ' A' ' 420' ' ' VAL . 43.3 Cg_endo -77.38 108.59 2.62 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.7 mt -93.48 139.68 30.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.919 -1.113 . . . . 0.0 108.851 167.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.85 ' CG2' HG22 ' A' ' 398' ' ' VAL . 88.3 t -102.5 135.76 38.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.749 -1.219 . . . . 0.0 109.587 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.75 ' CG1' HD11 ' A' ' 440' ' ' LEU . 46.3 t -118.25 135.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 108.758 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -118.26 160.56 17.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.525 ' CB ' HD23 ' A' ' 440' ' ' LEU . 3.9 tt0 -136.67 133.64 36.4 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 171.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.82 -124.2 23.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 405' ' ' VAL . 1.9 p -114.19 12.48 17.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.269 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -127.19 171.36 11.5 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 109.843 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.828 ' HA ' HG12 ' A' ' 434' ' ' VAL . 47.4 t -88.17 136.19 23.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.089 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.6 pp -94.34 -22.33 18.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.46 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.968 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.17 177.44 39.34 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.976 169.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.042 HG21 HG23 ' A' ' 420' ' ' VAL . 52.3 t -107.66 142.88 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.178 -1.19 . . . . 0.0 109.811 172.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.684 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.1 mt -101.43 112.93 36.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.576 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.81 119.0 31.23 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 109.869 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.945 HD12 ' HB ' ' A' ' 429' ' ' THR . 0.8 OUTLIER -101.38 144.88 29.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.52 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 13.8 pttt . . . . . 0 C--N 1.299 -1.616 0 O-C-N 120.597 -1.314 . . . . 0.0 110.738 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.542 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.3 mt-30 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.12 0.486 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.691 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -62.03 137.87 58.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.842 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -122.98 -32.87 3.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.48 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.488 ' N ' HD11 ' A' ' 355' ' ' LEU . 46.2 tt0 -163.22 146.13 10.38 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.348 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.046 ' CD1' HD21 ' A' ' 355' ' ' LEU . 10.1 p90 -134.24 142.19 47.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.875 -1.141 . . . . 0.0 111.482 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.632 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.3 mp -113.53 139.71 23.64 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.612 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.0 143.14 44.11 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.713 1.375 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.072 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -69.06 153.87 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 108.724 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.83 128.26 36.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.68 -1.262 . . . . 0.0 110.378 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 112.67 -22.27 17.23 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 440' ' ' LEU . 61.2 t -115.84 139.93 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.727 -1.455 . . . . 0.0 111.071 -172.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.6 m-20 -72.19 148.39 45.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -60.56 -39.28 87.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 110.496 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.476 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.4 ttmt -58.76 -43.6 90.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.713 -1.242 . . . . 0.0 109.641 175.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 93.1 m -56.75 -43.83 81.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.959 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -58.66 -39.7 81.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.016 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.81 -40.99 83.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.074 -1.016 . . . . 0.0 110.817 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -63.66 -50.02 70.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 109.823 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.904 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.18 -31.5 71.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 109.711 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.787 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.08 -35.4 64.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.954 . . . . 0.0 109.033 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 20.6 mt-30 -74.79 -55.86 5.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.535 -0.728 . . . . 0.0 110.882 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.15 -35.6 77.54 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.77 -172.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.407 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.53 -20.49 65.43 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.072 -1.018 . . . . 0.0 110.063 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.5 p -107.15 9.08 30.39 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.161 -0.962 . . . . 0.0 111.471 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.8 mt -66.2 -44.61 83.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.614 -1.304 . . . . 0.0 109.665 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.15 1.87 50.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.919 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.485 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.28 130.47 44.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.726 -1.234 . . . . 0.0 109.879 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.48 5.4 51.68 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.551 0.691 . . . . 0.0 109.926 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.5 152.04 83.25 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.643 -0.661 . . . . 0.0 109.478 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.07 -39.71 89.48 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.748 1.394 . . . . 0.0 109.144 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.44 -27.98 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 110.409 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.99 -37.26 62.25 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -175.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.527 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.72 -37.36 56.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -1.231 . . . . 0.0 110.513 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.542 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.9 m -61.28 -37.95 85.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.952 -1.092 . . . . 0.0 110.358 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.636 HG23 HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.78 -49.26 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.618 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.8 t -61.06 -33.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.93 HG22 ' OE1' ' A' ' 358' ' ' GLN . 33.2 mt -72.58 -33.62 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.698 -1.251 . . . . 0.0 110.652 171.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.046 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.01 -40.53 85.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.935 -1.103 . . . . 0.0 110.402 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.406 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.06 -45.15 90.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.916 ' HB3' HD23 ' A' ' 362' ' ' LEU . 40.7 mtmt -72.29 -49.51 34.17 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.616 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.93 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.8 pt20 -71.56 -42.77 67.42 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.891 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.5 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.5 mmt180 -72.67 -45.46 58.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.138 -0.976 . . . . 0.0 111.164 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.576 ' CZ ' ' OE2' ' A' ' 330' ' ' GLU . 60.0 m-85 -135.83 -38.68 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.391 -1.323 . . . . 0.0 112.114 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.499 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 13.8 t-20 -159.99 106.17 1.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.698 -1.251 . . . . 0.0 111.542 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.916 HD23 ' HB3' ' A' ' 357' ' ' LYS . 52.6 mt -57.7 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 0.0 109.323 172.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.536 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.7 tpt180 -128.07 164.0 23.38 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.5 mt-10 -137.98 -159.58 0.97 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.592 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.3 ptt180 -95.98 162.86 13.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.523 -0.736 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -130.34 41.86 3.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 110.465 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.036 HG21 ' CE1' ' A' ' 374' ' ' PHE . 42.9 t -72.97 -45.65 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.191 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.29 -27.48 67.21 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.487 -0.758 . . . . 0.0 111.021 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -29.64 27.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.713 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.774 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.4 mt -103.36 -5.03 23.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 110.662 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 367' ' ' VAL . 73.5 m-70 60.57 51.73 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 0.0 109.752 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.755 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.99 174.62 7.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.81 . . . . 0.0 110.521 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.0 m -117.15 134.89 54.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.342 -0.849 . . . . 0.0 110.58 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.036 ' CE1' HG21 ' A' ' 367' ' ' VAL . 82.3 m-85 -88.58 147.47 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 387' ' ' ASN . 60.7 t -120.43 100.98 46.91 Favored Pre-proline 0 C--N 1.299 -1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.2 Cg_endo -55.07 151.39 34.66 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.019 1.537 . . . . 0.0 110.529 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 16.4 t80 -66.44 131.87 47.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.732 175.593 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 81.4 mtm180 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.48 0.657 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.708 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.0 ptp -157.54 166.3 33.3 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.923 0.868 . . . . 0.0 111.357 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.93 165.0 37.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.63 -166.96 35.61 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 118.923 -1.608 . . . . 0.0 110.733 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.865 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.9 tt -139.45 149.58 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.556 -0.967 . . . . 0.0 110.178 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.522 HD21 HG21 ' A' ' 375' ' ' VAL . 47.3 m-20 -127.16 134.84 50.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 0.0 109.798 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -141.51 155.21 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 90.4 m-20 -23.02 -63.04 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.406 0.622 . . . . 0.0 112.49 171.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 53.7 t30 -95.99 -5.7 40.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.788 . . . . 0.0 111.855 -167.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.554 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.1 mtp180 -144.13 143.96 31.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.741 -1.225 . . . . 0.0 110.434 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.9 mtm -134.72 102.26 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.896 -1.128 . . . . 0.0 109.071 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -124.31 146.03 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -172.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 39.9 mtt180 -134.37 159.98 39.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 0.0 110.872 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.65 127.96 32.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.502 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.33 173.83 32.8 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.319 -1.419 . . . . 0.0 109.566 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.2 m -55.82 149.26 15.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.757 -1.437 . . . . 0.0 108.343 168.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.067 HG22 HG23 ' A' ' 432' ' ' VAL . 61.3 t -58.24 -34.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.899 -1.126 . . . . 0.0 109.917 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.2 t0 -61.85 -45.32 94.3 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.708 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.84 -51.27 42.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.955 -1.09 . . . . 0.0 110.591 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.561 HD13 ' CE ' ' A' ' 383' ' ' MET . 31.0 mm -64.49 -42.93 96.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 110.742 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.8 ttp85 -59.31 -43.73 92.61 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 70.6 mtp180 -61.8 -36.57 81.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.403 173.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.544 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -68.45 -36.14 78.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 111.197 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 437' ' ' SER . 52.9 t -65.81 -49.29 78.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.587 -1.32 . . . . 0.0 110.127 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.73 -33.91 76.7 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.949 -1.095 . . . . 0.0 110.285 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.19 79.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.991 -1.068 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.545 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.2 m-80 -62.25 -27.17 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.69 19.46 29.41 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -169.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.73 -171.4 18.27 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -144.88 153.68 41.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 111.037 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.3 p90 -108.78 150.7 41.15 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.861 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.93 128.33 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.83 1.437 . . . . 0.0 110.388 -175.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.8 t -67.3 -35.57 79.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.251 -0.905 . . . . 0.0 110.992 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -61.52 -34.06 74.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.912 -1.118 . . . . 0.0 108.816 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.072 HG21 ' HA ' ' A' ' 325' ' ' ALA . 55.0 t -83.48 -42.6 17.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.956 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.67 -38.22 69.32 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.543 172.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.4 mm-40 -63.77 -47.93 78.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.343 -1.473 . . . . 0.0 110.295 171.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.632 ' CD ' HG21 ' A' ' 323' ' ' ILE . 66.2 mttm -56.76 -35.06 68.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.639 -1.288 . . . . 0.0 110.431 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.095 HG23 HG21 ' A' ' 442' ' ' VAL . 2.9 t -60.04 -41.36 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.879 -1.138 . . . . 0.0 109.371 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.0 -36.0 82.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.812 0.815 . . . . 0.0 109.418 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.52 -37.87 80.41 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.648 -0.658 . . . . 0.0 110.861 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.8 t -62.95 -37.56 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.092 . . . . 0.0 110.022 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -40.12 83.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.332 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -68.25 -31.16 70.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 110.972 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -80.87 -3.47 51.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.045 -1.035 . . . . 0.0 109.705 174.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.25 21.77 34.26 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.63 173.87 6.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.143 . . . . 0.0 109.827 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.985 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.4 m -115.89 106.72 49.34 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.978 -1.076 . . . . 0.0 110.03 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 398' ' ' VAL . 54.9 Cg_endo -79.85 107.47 2.1 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.91 1.479 . . . . 0.0 110.243 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -91.94 135.61 33.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.898 -1.126 . . . . 0.0 108.482 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 1.067 HG23 HG22 ' A' ' 398' ' ' VAL . 88.3 t -99.71 133.96 40.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.747 -1.22 . . . . 0.0 109.341 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.027 ' CG1' HD11 ' A' ' 440' ' ' LEU . 25.0 t -113.47 136.78 48.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.8 m -122.19 160.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 121.379 -0.825 . . . . 0.0 109.719 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.452 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.5 tt0 -135.14 130.98 36.27 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.84 -128.1 28.72 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.639 ' O ' HG13 ' A' ' 405' ' ' VAL . 84.8 p -106.33 8.7 31.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 111.132 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.477 ' NH1' ' HG3' ' A' ' 438' ' ' ARG . 35.2 ptt85 -122.87 174.23 7.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.59 -1.319 . . . . 0.0 110.257 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.804 ' HA ' HG12 ' A' ' 434' ' ' VAL . 52.9 t -94.49 134.5 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.027 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -93.88 -21.22 19.38 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.748 175.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.959 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 169.42 176.55 39.41 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 118.868 -1.634 . . . . 0.0 110.961 168.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.095 HG21 HG23 ' A' ' 420' ' ' VAL . 48.9 t -107.99 142.64 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.009 -1.289 . . . . 0.0 109.974 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.787 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.3 mt -101.38 112.36 34.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.352 -0.842 . . . . 0.0 109.104 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.28 119.44 31.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.793 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.985 HD12 ' HB ' ' A' ' 429' ' ' THR . 1.4 mt -102.59 146.33 28.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.579 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 1.4 ptpm? . . . . . 0 N--CA 1.491 1.576 0 O-C-N 120.575 -1.328 . . . . 0.0 110.777 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.8 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.168 0.509 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.76 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -55.59 139.35 44.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.074 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 39.8 m -123.34 -38.67 2.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.494 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.455 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.5 tt0 -163.03 148.97 12.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.149 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.023 ' CD1' HD21 ' A' ' 355' ' ' LEU . 16.1 p90 -134.54 143.57 47.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.759 -1.213 . . . . 0.0 111.802 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.531 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.6 mt -113.68 143.99 30.54 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.561 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.74 142.72 36.17 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.708 1.372 . . . . 0.0 111.569 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.035 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.98 151.72 43.02 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 108.876 165.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.79 129.04 40.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.684 -1.26 . . . . 0.0 109.983 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.39 -1.8 46.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.676 HG13 HG21 ' A' ' 332' ' ' THR . 52.1 t -136.01 139.07 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.573 -1.545 . . . . 0.0 110.748 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 332' ' ' THR . 6.5 p-10 -73.52 151.89 40.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 110.158 176.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 83.5 tt0 -61.06 -34.7 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.108 -0.995 . . . . 0.0 109.658 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.517 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 109.473 177.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.676 HG21 HG13 ' A' ' 328' ' ' VAL . 3.2 m -62.98 -39.14 93.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 175.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.986 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.2 tp -59.83 -40.12 87.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.048 -1.033 . . . . 0.0 110.412 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.982 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.02 -43.96 77.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.953 -1.092 . . . . 0.0 110.711 -176.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.574 ' O ' HD23 ' A' ' 339' ' ' LEU . 57.5 t0 -63.15 -48.84 76.74 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.878 -1.139 . . . . 0.0 110.068 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.952 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.74 -31.05 69.83 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 109.918 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.8 -35.99 64.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.134 -0.979 . . . . 0.0 108.884 172.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.8 mt-30 -75.06 -55.76 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.663 -0.648 . . . . 0.0 111.06 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.046 HD11 HD12 ' A' ' 393' ' ' ILE . 0.2 OUTLIER -64.97 -32.92 74.87 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.136 -171.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.86 -1.15 . . . . 0.0 110.07 172.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.625 ' OG ' HG22 ' A' ' 353' ' ' VAL . 99.1 p -107.95 11.4 27.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.143 -0.973 . . . . 0.0 111.541 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 44.5 mt -66.74 -45.17 79.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.722 -1.236 . . . . 0.0 109.859 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.07 1.08 49.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.864 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.481 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -63.92 130.3 43.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.746 -1.221 . . . . 0.0 109.979 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 4.6 52.97 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.633 0.73 . . . . 0.0 109.85 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 346' ' ' THR . 3.1 p -74.13 152.69 88.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.434 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.75 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.757 1.399 . . . . 0.0 109.227 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.2 mt-10 -64.45 -28.44 69.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.41 -38.53 69.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.552 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.3 mtt85 -77.91 -37.2 48.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -1.157 . . . . 0.0 110.58 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 5.5 m -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 110.338 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.674 HG23 HD13 ' A' ' 443' ' ' ILE . 86.0 mt -68.66 -48.6 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.023 -1.048 . . . . 0.0 110.652 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.625 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.1 t -60.83 -32.77 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.9 mt -72.54 -32.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 110.719 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.023 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.84 -41.11 90.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.801 -1.187 . . . . 0.0 110.396 178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.23 -42.55 99.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.359 -0.838 . . . . 0.0 110.363 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 73.1 mttt -72.54 -51.54 19.46 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.711 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.547 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.1 pt20 -70.7 -42.4 70.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.547 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.5 mmm180 -74.59 -43.85 53.61 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 111.084 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.684 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 50.6 m-85 -135.2 -39.48 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.658 -1.276 . . . . 0.0 111.986 -169.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.524 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.5 t30 -161.03 105.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.716 -1.24 . . . . 0.0 111.588 -168.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 42.0 mt -57.57 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.899 -1.125 . . . . 0.0 109.075 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.512 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.7 tpt85 -135.09 163.73 29.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.006 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -134.03 -156.25 0.72 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.903 -1.123 . . . . 0.0 110.457 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 46.7 ptt85 -97.4 161.43 13.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.505 0.669 . . . . 0.0 110.717 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -128.08 41.77 3.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.305 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.946 HG21 ' CE1' ' A' ' 374' ' ' PHE . 88.5 t -73.49 -49.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.413 -0.804 . . . . 0.0 110.464 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -69.16 -23.87 64.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 111.073 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -31.94 31.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 109.691 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.989 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.2 mt -101.57 -3.61 28.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 110.554 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 371' ' ' HIS . 8.6 m170 63.74 53.93 1.91 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.931 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -96.72 175.01 6.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.6 m -117.45 135.14 54.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.57 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.946 ' CE1' HG21 ' A' ' 367' ' ' VAL . 93.0 m-85 -90.28 143.11 27.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.653 HG21 HD21 ' A' ' 387' ' ' ASN . 19.8 t -116.68 101.23 53.66 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.973 . . . . 0.0 109.608 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.13 151.53 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.034 1.544 . . . . 0.0 110.603 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.1 t80 -64.43 132.0 48.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.84 . . . . 0.0 109.664 175.694 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 71.1 mtt85 . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.558 0.694 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.825 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.4 ptp -158.18 167.65 29.21 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.236 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.8 p -155.38 165.19 37.38 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.58 -165.55 33.83 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.618 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.774 HD11 HG22 ' A' ' 367' ' ' VAL . 1.5 tt -140.21 149.51 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.631 -0.923 . . . . 0.0 110.104 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.653 HD21 HG21 ' A' ' 375' ' ' VAL . 31.3 m-20 -127.23 134.62 50.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 109.756 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.989 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -139.82 154.87 24.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.875 -1.141 . . . . 0.0 109.381 171.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 89.8 m-20 -25.53 -63.09 0.06 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.407 0.622 . . . . 0.0 112.251 172.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.453 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 51.2 t30 -91.62 -7.76 49.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 111.692 -168.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.561 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.3 mtp180 -144.7 144.65 31.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.636 -1.29 . . . . 0.0 110.536 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.93 110.46 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.871 -1.143 . . . . 0.0 109.067 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 339' ' ' LEU . 8.7 mt -131.3 145.91 34.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 110.201 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 49.6 mtt-85 -134.94 160.95 36.66 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.834 175.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.521 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.52 128.74 33.93 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.582 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -157.03 174.31 34.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.4 m -57.27 151.09 16.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.934 -1.333 . . . . 0.0 108.597 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.12 HG21 HG11 ' A' ' 420' ' ' VAL . 60.1 t -56.62 -35.1 43.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.075 -1.016 . . . . 0.0 109.894 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.3 t70 -63.03 -46.13 89.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.306 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.825 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.82 -51.82 36.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.985 -1.072 . . . . 0.0 110.482 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.582 HD11 ' N ' ' A' ' 396' ' ' GLY . 36.7 mm -63.51 -42.77 97.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 121.126 -0.984 . . . . 0.0 110.64 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.624 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 9.1 ttt180 -60.24 -43.21 96.26 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 52.1 mtp85 -61.62 -35.86 79.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.052 -1.03 . . . . 0.0 109.562 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.505 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.45 -37.72 83.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.187 -0.945 . . . . 0.0 111.269 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.517 ' CG2' HG11 ' A' ' 434' ' ' VAL . 59.5 t -65.66 -47.7 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.558 -1.339 . . . . 0.0 110.16 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.1 -34.98 78.77 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.795 -1.19 . . . . 0.0 110.28 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -35.92 79.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.505 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.2 m-80 -61.53 -27.47 68.63 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.159 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.43 19.69 29.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.85 -169.38 16.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.445 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.8 m-70 -143.31 153.52 42.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.094 -1.239 . . . . 0.0 111.488 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.624 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 7.5 p90 -107.5 150.27 39.88 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.772 -0.58 . . . . 0.0 110.202 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.828 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.75 123.14 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.904 1.476 . . . . 0.0 110.495 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.82 -32.6 73.99 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.098 -1.002 . . . . 0.0 111.026 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.6 m-20 -61.96 -32.88 73.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.896 -1.128 . . . . 0.0 108.844 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.035 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.3 t -83.6 -42.4 17.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.999 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 67.9 m-20 -55.39 -37.13 67.17 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.616 171.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.0 mt-30 -63.75 -48.76 75.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.337 -1.477 . . . . 0.0 110.099 171.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.531 ' CD ' HG21 ' A' ' 323' ' ' ILE . 95.9 mttt -57.22 -34.7 68.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.68 -1.262 . . . . 0.0 110.355 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.12 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.5 -40.76 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 0.0 109.257 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -66.81 -36.74 83.07 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.873 0.844 . . . . 0.0 109.448 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 83.9 mt-30 -67.48 -36.66 81.56 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.622 -0.673 . . . . 0.0 110.472 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 428' ' ' ALA . 71.0 t -62.97 -37.89 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 110.029 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.86 -40.16 83.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.335 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -69.07 -31.06 69.54 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.287 -0.883 . . . . 0.0 110.942 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.25 -3.02 57.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.808 176.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.6 21.94 27.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.763 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.43 161.62 14.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -1.097 . . . . 0.0 109.478 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 445' ' ' LEU . 28.2 m -109.02 107.22 59.84 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.03 . . . . 0.0 109.703 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.546 ' CG ' HG13 ' A' ' 420' ' ' VAL . 39.0 Cg_endo -76.26 107.94 2.56 Favored 'Trans proline' 0 C--N 1.298 -2.09 0 O-C-N 123.924 1.486 . . . . 0.0 110.643 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.903 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.0 mt -93.04 134.43 35.19 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.825 -1.172 . . . . 0.0 108.677 167.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 1.009 ' CG2' HG22 ' A' ' 398' ' ' VAL . 91.3 t -100.74 134.93 39.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 120.72 -1.238 . . . . 0.0 109.504 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.741 ' CG1' HD11 ' A' ' 440' ' ' LEU . 45.2 t -115.38 137.02 50.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.8 m -117.56 159.59 17.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.373 -0.829 . . . . 0.0 109.676 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.553 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.17 132.45 35.98 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.28 -129.3 31.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.498 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.93 11.87 27.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -1.218 . . . . 0.0 110.945 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -126.18 170.89 11.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.697 -1.252 . . . . 0.0 109.908 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.837 ' HA ' HG12 ' A' ' 434' ' ' VAL . 22.7 t -90.3 134.77 28.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.342 -0.849 . . . . 0.0 109.874 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.77 -22.12 18.28 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.85 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.986 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.11 176.6 38.71 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.997 169.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.046 HG21 HG23 ' A' ' 420' ' ' VAL . 48.0 t -107.77 141.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.216 -1.167 . . . . 0.0 109.887 173.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.721 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.3 mt -101.31 111.71 31.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 108.987 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.531 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.22 119.39 31.8 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.85 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.903 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.25 143.22 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 10.5 mtmt . . . . . 0 C--N 1.3 -1.562 0 O-C-N 120.619 -1.301 . . . . 0.0 110.984 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 24.9 mt-30 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.179 0.514 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.721 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.66 136.63 57.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.957 -1.09 . . . . 0.0 109.889 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -121.24 -34.5 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.484 ' N ' HD11 ' A' ' 355' ' ' LEU . 46.5 tt0 -165.61 147.04 7.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.182 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.016 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 12.9 p90 -136.51 147.66 47.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.827 -1.17 . . . . 0.0 111.663 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.528 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -118.85 144.13 35.07 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.728 -0.607 . . . . 0.0 109.593 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.53 143.85 39.17 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.76 1.4 . . . . 0.0 111.521 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.041 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.39 152.48 42.0 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 108.818 165.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.407 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 0.6 OUTLIER -58.32 128.55 37.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.682 -1.261 . . . . 0.0 110.126 -172.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.98 -0.77 44.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.4 t -136.49 139.92 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.481 . . . . 0.0 110.73 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.459 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.0 m-20 -74.12 152.48 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 86.1 tt0 -62.61 -40.23 96.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.487 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -59.18 -43.29 92.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.57 -1.331 . . . . 0.0 109.63 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.525 HG21 HG13 ' A' ' 328' ' ' VAL . 94.1 m -55.73 -43.55 76.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.857 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 1.001 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.8 tp -59.71 -40.17 87.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.251 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.016 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -66.59 -40.79 89.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.92 -1.112 . . . . 0.0 110.917 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 82.3 m-20 -64.62 -50.2 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.895 -1.128 . . . . 0.0 109.766 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 1.012 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.7 -30.79 70.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.951 -1.093 . . . . 0.0 109.636 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.42 -35.54 65.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.103 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.561 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.3 mt-30 -73.43 -55.69 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.551 -0.718 . . . . 0.0 111.06 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.057 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.97 -35.72 81.1 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.559 -1.257 . . . . 0.0 109.894 -172.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.524 ' HB1' ' HG2' ' A' ' 395' ' ' LYS . . . -66.72 -20.73 66.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.088 -1.007 . . . . 0.0 110.053 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.649 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.2 p -107.03 8.84 30.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.121 -0.987 . . . . 0.0 111.579 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 41.4 mt -66.5 -44.47 82.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.531 -1.355 . . . . 0.0 109.584 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.76 1.0 50.36 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.478 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.67 130.53 44.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.714 -1.241 . . . . 0.0 109.979 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.62 5.61 51.03 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.511 0.672 . . . . 0.0 109.845 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.35 150.17 79.69 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.652 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -53.68 -38.21 84.37 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.678 1.357 . . . . 0.0 109.172 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.7 mt-10 -64.23 -28.55 69.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 110.393 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.82 -36.93 67.51 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.53 ' O ' HD12 ' A' ' 354' ' ' ILE . 42.2 mmt180 -76.65 -37.93 55.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.118 -1.225 . . . . 0.0 110.525 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.41 -38.17 86.14 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.962 -1.086 . . . . 0.0 110.372 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.5 HG23 HD13 ' A' ' 443' ' ' ILE . 86.0 mt -68.55 -49.42 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.005 -1.059 . . . . 0.0 110.594 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.649 HG22 ' OG ' ' A' ' 341' ' ' SER . 23.9 t -60.56 -33.67 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.1 mt -72.23 -33.3 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.689 -1.257 . . . . 0.0 110.68 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.003 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.57 -40.8 88.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -61.92 -43.1 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 110.273 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 83.3 mttt -69.64 -48.73 58.87 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.745 -174.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 10.2 pt20 -70.75 -43.46 68.78 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 110.499 -173.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.2 mmm180 -73.98 -46.09 45.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 111.312 -173.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 330' ' ' GLU . 27.8 m-85 -135.67 -35.97 0.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.666 -167.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.536 ' ND2' ' HD3' ' A' ' 363' ' ' ARG . 55.9 t-20 -158.59 93.89 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.512 -1.368 . . . . 0.0 111.808 -169.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -61.35 95.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.987 -1.07 . . . . 0.0 110.178 172.087 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.536 ' HD3' ' ND2' ' A' ' 361' ' ' ASN . 30.8 ptt85 -150.01 -179.06 6.86 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 363' ' ' ARG . 22.2 pt-20 -124.78 -157.39 0.77 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 110.531 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 40.9 ptt180 -90.62 165.59 13.65 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.743 -0.598 . . . . 0.0 110.492 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -123.99 38.63 4.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.422 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.022 HG21 ' CE1' ' A' ' 374' ' ' PHE . 43.9 t -74.34 -49.82 30.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 110.376 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -67.75 -25.1 65.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 111.039 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.08 -30.09 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.99 . . . . 0.0 109.8 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 1.0 ' HB3' HD11 ' A' ' 388' ' ' ILE . 19.3 mt -103.65 -4.19 24.12 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 110.672 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 31.1 m80 62.84 53.94 2.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.427 -0.796 . . . . 0.0 110.168 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.923 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.9 175.03 6.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 110.606 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.9 m -116.67 134.27 55.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.022 ' CE1' HG21 ' A' ' 367' ' ' VAL . 84.2 m-85 -88.89 147.96 24.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 25.9 t -122.93 100.97 39.61 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.13 -0.981 . . . . 0.0 109.604 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.64 151.15 40.39 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.983 1.518 . . . . 0.0 110.475 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.16 131.55 46.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 110.07 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 175.687 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.523 0.678 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.644 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.4 ptp -161.0 169.34 22.75 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.408 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 5.2 p -156.88 165.3 36.57 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.78 -165.18 33.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.859 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.3 tt -138.82 149.08 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.698 -0.884 . . . . 0.0 110.125 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.462 HD21 HG21 ' A' ' 375' ' ' VAL . 31.6 m-20 -127.79 135.15 49.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 109.654 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 1.0 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -140.06 154.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.875 -1.14 . . . . 0.0 109.389 171.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.6 -63.17 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.434 0.635 . . . . 0.0 112.242 172.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 40.8 t-20 -91.66 -7.89 48.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.51 -0.744 . . . . 0.0 111.755 -168.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 31.2 mtp180 -144.19 145.67 32.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.707 -1.246 . . . . 0.0 110.605 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.4 mtt -135.49 110.8 9.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.903 -1.123 . . . . 0.0 108.999 169.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.057 HD12 HD11 ' A' ' 339' ' ' LEU . 8.9 mt -130.35 146.13 34.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.989 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.519 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.4 mmt85 -134.13 159.69 40.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.109 -0.994 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.691 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -132.61 137.55 47.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.484 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -164.37 174.36 40.42 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.267 -1.444 . . . . 0.0 109.625 -173.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -56.94 149.93 17.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.278 . . . . 0.0 108.684 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.08 HG21 HG11 ' A' ' 420' ' ' VAL . 22.8 t -55.03 -37.62 43.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 109.975 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.7 m-20 -64.24 -44.35 92.12 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.221 -0.924 . . . . 0.0 110.343 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.644 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.21 -50.24 55.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.963 -1.085 . . . . 0.0 110.662 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.587 HD13 ' CE ' ' A' ' 383' ' ' MET . 30.9 mm -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.746 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.5 ttp85 -59.85 -42.92 94.68 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.1 mtt180 -61.47 -36.3 80.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.576 173.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.489 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.5 t-80 -66.61 -38.5 87.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 111.245 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.512 ' CG2' HG11 ' A' ' 434' ' ' VAL . 71.3 t -65.47 -47.28 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.623 -1.298 . . . . 0.0 110.268 178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.48 -34.8 78.56 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.785 -1.197 . . . . 0.0 110.436 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.933 -1.104 . . . . 0.0 109.951 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.489 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 27.1 m-80 -62.04 -27.1 68.65 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.26 18.93 31.94 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -169.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -111.58 -169.95 18.73 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.426 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.9 m-70 -144.1 153.69 42.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -1.223 . . . . 0.0 111.461 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.593 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 7.7 p90 -108.88 150.43 40.86 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.719 -0.613 . . . . 0.0 110.143 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.82 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.9 124.01 8.36 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.845 1.445 . . . . 0.0 110.488 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.32 -32.77 73.95 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.928 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.8 m-20 -61.65 -32.84 73.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.863 -1.148 . . . . 0.0 108.872 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.041 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.0 t -83.76 -42.55 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.391 -0.818 . . . . 0.0 110.975 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.581 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 68.8 m-20 -55.17 -37.2 66.72 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.584 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.8 mm-40 -63.94 -48.76 75.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.254 -1.529 . . . . 0.0 110.232 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.528 ' CD ' HG21 ' A' ' 323' ' ' ILE . 43.2 mttt -57.56 -34.27 69.02 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.638 -1.289 . . . . 0.0 110.416 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.08 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.21 -41.24 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.206 171.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -66.46 -36.22 82.22 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.921 0.867 . . . . 0.0 109.418 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.45 -37.63 83.25 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 110.798 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.8 t -63.31 -37.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.005 -1.059 . . . . 0.0 110.088 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.12 84.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.329 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -68.51 -31.18 70.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.394 -0.816 . . . . 0.0 110.889 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.507 ' NE2' ' HE2' ' A' ' 446' ' ' LYS . 2.0 tt0 -82.59 -3.01 55.42 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.852 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.85 27.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.67 163.18 13.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -1.064 . . . . 0.0 109.64 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.493 ' HB ' HD12 ' A' ' 445' ' ' LEU . 53.7 m -110.12 107.12 58.66 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.809 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.578 ' CG ' HG13 ' A' ' 420' ' ' VAL . 37.5 Cg_endo -75.82 108.22 2.64 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 123.979 1.515 . . . . 0.0 110.773 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.856 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.3 mt -92.71 135.05 34.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.854 -1.154 . . . . 0.0 108.599 166.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.968 ' CG2' HG22 ' A' ' 398' ' ' VAL . 97.9 t -100.08 136.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.651 -1.28 . . . . 0.0 109.568 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.705 ' CG1' HD11 ' A' ' 440' ' ' LEU . 44.5 t -117.33 136.96 52.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 108.992 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -117.75 160.03 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.532 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.07 132.08 35.7 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -128.65 31.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.503 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.11 11.36 27.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.185 -1.185 . . . . 0.0 110.968 -179.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -123.45 170.78 10.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.633 -1.292 . . . . 0.0 109.925 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 434' ' ' VAL . 22.5 t -91.39 134.03 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.7 pp -94.79 -21.71 18.54 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.862 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 1.001 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.99 177.02 38.97 Favored Glycine 0 N--CA 1.499 2.896 0 C-N-CA 118.847 -1.644 . . . . 0.0 110.985 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.045 HG21 HG23 ' A' ' 420' ' ' VAL . 47.1 t -107.78 142.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.183 -1.187 . . . . 0.0 109.819 173.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.652 HD11 ' CB ' ' A' ' 337' ' ' ALA . 80.1 mt -101.29 111.28 30.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 108.94 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.55 118.93 31.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.99 -1.069 . . . . 0.0 109.7 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.856 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -99.72 143.43 29.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.507 ' HE2' ' NE2' ' A' ' 426' ' ' GLN . 53.1 mttt . . . . . 0 C--N 1.3 -1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 111.146 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 14.4 pt20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.188 0.518 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 355' ' ' LEU . . . -60.75 137.59 58.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.636 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -118.49 -35.79 3.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.479 ' N ' HD11 ' A' ' 355' ' ' LEU . 49.6 tt0 -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 110.121 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.008 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.3 p90 -135.69 142.76 45.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.821 -1.174 . . . . 0.0 111.676 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.525 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.6 mp -114.38 144.59 32.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.725 -0.61 . . . . 0.0 109.706 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.72 143.49 37.64 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.738 1.388 . . . . 0.0 111.448 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.051 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.94 152.0 42.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.821 165.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 1.7 tp-100 -57.59 128.61 37.9 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 110.11 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.17 -1.33 43.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.6 t -136.56 140.03 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.706 -1.467 . . . . 0.0 110.751 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.23 152.42 39.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 85.1 tt0 -62.3 -40.33 95.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.459 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.2 -43.33 92.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.6 -1.313 . . . . 0.0 109.639 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.519 HG21 HG13 ' A' ' 328' ' ' VAL . 93.7 m -55.97 -43.81 77.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 173.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 1.007 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.9 tp -59.21 -39.45 82.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.319 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.16 -41.31 86.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.11 . . . . 0.0 110.777 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.554 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.3 m-20 -63.87 -50.03 70.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.926 -1.109 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.49 -31.13 70.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.981 -1.074 . . . . 0.0 109.722 176.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.749 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.21 -35.66 65.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.912 172.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.569 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.6 mt-30 -74.77 -55.84 5.42 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.583 -0.698 . . . . 0.0 110.9 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -63.72 -34.46 77.93 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.846 -171.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.458 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.04 -21.4 65.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.934 -1.104 . . . . 0.0 110.076 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.707 ' OG ' HG22 ' A' ' 353' ' ' VAL . 77.3 p -107.27 10.4 29.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.16 -0.963 . . . . 0.0 111.538 -174.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.573 ' CG ' ' HA ' ' A' ' 339' ' ' LEU . 45.9 mt -66.34 -43.78 85.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.55 -1.344 . . . . 0.0 109.502 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.25 0.38 48.09 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.931 -170.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.3 p30 -62.37 130.44 45.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.742 -1.224 . . . . 0.0 109.872 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.54 5.39 51.66 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.6 0.714 . . . . 0.0 109.886 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.45 151.91 83.31 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.52 -0.737 . . . . 0.0 109.451 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.64 -39.53 90.54 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.643 1.338 . . . . 0.0 109.09 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.56 -27.83 69.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.503 -0.748 . . . . 0.0 110.436 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.66 -37.94 70.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.567 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.2 mtt-85 -76.14 -36.59 58.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.018 -1.284 . . . . 0.0 110.376 172.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 29.3 p -62.72 -37.22 85.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.957 -1.089 . . . . 0.0 110.377 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.607 HG23 HD13 ' A' ' 443' ' ' ILE . 87.6 mt -68.53 -49.48 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.536 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.707 HG22 ' OG ' ' A' ' 341' ' ' SER . 26.2 t -61.24 -33.61 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 0.0 110.148 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.9 mt -72.2 -32.9 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.601 -1.312 . . . . 0.0 110.523 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.947 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.43 -40.21 90.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.832 -1.168 . . . . 0.0 110.528 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.487 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.03 -43.18 99.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 77.3 mttt -71.65 -48.53 47.13 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.769 -175.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.549 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -70.26 -42.8 71.69 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.587 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.3 mmm180 -74.23 -46.51 41.25 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 111.214 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.548 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 76.4 m-85 -136.28 -34.45 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.252 -1.379 . . . . 0.0 112.564 -169.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.497 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 18.0 t-20 -160.11 98.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.441 -1.412 . . . . 0.0 111.763 -168.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.781 HD12 ' H ' ' A' ' 362' ' ' LEU . 5.5 mp -58.96 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.029 -1.045 . . . . 0.0 109.705 171.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.5 tpt180 -142.15 163.45 32.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.86 . . . . 0.0 109.344 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.0 mt-10 -127.37 -153.81 0.59 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.01 -1.056 . . . . 0.0 110.629 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.573 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.2 ptt-85 -95.51 163.58 13.16 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.638 -0.664 . . . . 0.0 110.733 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -128.19 40.71 3.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.553 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.927 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.6 t -73.47 -46.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.192 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.79 -26.6 66.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.465 -0.772 . . . . 0.0 111.11 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.44 -30.66 29.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.107 -0.995 . . . . 0.0 109.745 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.789 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.6 mt -101.41 -3.96 27.76 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.541 -0.724 . . . . 0.0 110.636 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 367' ' ' VAL . 50.7 m80 59.3 52.51 5.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.957 . . . . 0.0 109.795 -175.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.835 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.61 174.6 7.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 110.378 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.9 m -116.38 134.94 54.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 110.473 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.927 ' CE1' HG21 ' A' ' 367' ' ' VAL . 88.0 m-85 -89.73 147.39 23.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.441 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 40.1 t -120.33 101.18 46.96 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.5 Cg_endo -54.54 153.7 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.003 1.528 . . . . 0.0 110.545 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.556 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.7 t80 -70.68 134.8 47.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.829 . . . . 0.0 110.383 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.855 . . . . 0.0 109.832 174.454 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.515 0.674 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.891 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.9 ptp -165.45 170.98 13.86 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.795 0.807 . . . . 0.0 111.287 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.6 p -155.54 165.53 36.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.509 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.29 -164.28 31.6 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.756 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.723 HD11 HG22 ' A' ' 367' ' ' VAL . 2.2 tt -142.45 149.48 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.623 -0.928 . . . . 0.0 110.154 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.44 HD21 HG21 ' A' ' 375' ' ' VAL . 39.3 m-20 -127.29 136.32 51.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 109.755 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.789 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -140.8 155.24 22.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.993 -1.067 . . . . 0.0 109.221 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.5 m-20 -21.96 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.452 0.644 . . . . 0.0 112.62 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.9 t-20 -95.99 -7.01 37.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.449 -0.782 . . . . 0.0 111.858 -167.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.555 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 29.8 mtp180 -143.64 146.18 33.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.661 -1.275 . . . . 0.0 110.639 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -136.15 104.3 5.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.863 -1.148 . . . . 0.0 109.119 170.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 339' ' ' LEU . 8.0 mt -125.05 146.07 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.996 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 23.6 mmt85 -134.29 159.55 40.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.011 . . . . 0.0 110.324 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.563 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.43 126.03 30.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.684 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.42 174.33 31.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.9 m -56.21 151.33 12.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.973 -1.31 . . . . 0.0 108.646 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.041 HG21 HG11 ' A' ' 420' ' ' VAL . 23.0 t -54.57 -37.65 39.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.915 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.2 m-20 -64.62 -44.99 88.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.3 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.891 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.14 -48.95 66.52 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.944 -1.097 . . . . 0.0 110.635 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.684 HD11 ' N ' ' A' ' 396' ' ' GLY . 39.9 mm -66.53 -44.31 90.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.029 -1.045 . . . . 0.0 111.007 -176.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HD2' ' CZ ' ' A' ' 412' ' ' PHE . 9.3 ttp180 -59.52 -43.08 93.53 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 92.2 mtt180 -61.69 -37.05 82.68 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.04 -1.038 . . . . 0.0 109.579 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.2 t-80 -67.3 -36.47 81.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 111.273 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 437' ' ' SER . 54.7 t -65.54 -49.13 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.6 -1.313 . . . . 0.0 110.161 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.47 -34.34 77.55 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.943 -1.098 . . . . 0.0 110.371 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.74 78.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.111 . . . . 0.0 109.982 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 18.0 m-80 -62.08 -27.05 68.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.429 -0.794 . . . . 0.0 109.155 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.83 19.35 29.39 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.89 -169.66 16.88 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.434 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.7 m-70 -143.09 153.36 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.139 -1.212 . . . . 0.0 111.395 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.587 ' CZ ' ' HD2' ' A' ' 402' ' ' ARG . 7.9 p90 -108.17 149.32 39.04 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.635 -0.665 . . . . 0.0 110.182 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.815 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.1 125.14 9.06 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.873 1.459 . . . . 0.0 110.531 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.09 -32.32 72.55 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.478 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.6 m-20 -63.24 -31.81 73.06 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.878 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.051 HG21 ' HA ' ' A' ' 325' ' ' ALA . 46.6 t -83.57 -42.77 17.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.88 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.58 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 69.1 m-20 -55.08 -36.34 65.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.729 -1.232 . . . . 0.0 109.648 171.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.39 -50.13 68.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.434 -1.416 . . . . 0.0 109.639 173.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 85.9 mttt -56.83 -34.53 67.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.757 -1.215 . . . . 0.0 110.286 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.101 HG23 HG21 ' A' ' 442' ' ' VAL . 2.5 t -58.99 -41.6 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 171.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.07 -36.18 82.52 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.955 0.883 . . . . 0.0 109.409 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 95.5 mm-40 -67.25 -38.25 84.86 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.725 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.809 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.2 t -62.61 -37.13 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.074 . . . . 0.0 110.125 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.29 84.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -68.18 -32.38 72.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 0.0 110.983 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -82.73 -2.89 55.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.77 22.56 30.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.809 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.19 163.5 12.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -1.143 . . . . 0.0 109.538 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.772 ' HB ' HD12 ' A' ' 445' ' ' LEU . 18.5 m -110.5 107.0 58.26 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.058 -1.026 . . . . 0.0 109.855 -175.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.566 ' CG ' HG13 ' A' ' 420' ' ' VAL . 33.6 Cg_endo -74.82 107.93 2.59 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 O-C-N 123.984 1.518 . . . . 0.0 110.73 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.864 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.3 mt -92.69 132.76 36.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 108.509 166.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.904 ' CG2' HG22 ' A' ' 398' ' ' VAL . 99.8 t -100.04 134.98 37.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 O-C-N 120.746 -1.222 . . . . 0.0 109.512 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.822 ' CG1' HD11 ' A' ' 440' ' ' LEU . 40.8 t -114.73 138.46 44.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.116 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -119.56 160.55 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 109.655 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.477 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.34 129.64 33.74 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.2 -131.79 30.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -167.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.561 ' O ' HG13 ' A' ' 405' ' ' VAL . 79.6 p -102.93 7.75 39.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -1.23 . . . . 0.0 111.071 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -118.4 170.71 8.69 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.647 -1.283 . . . . 0.0 110.127 -175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 24.6 t -93.58 134.48 31.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.336 -0.853 . . . . 0.0 109.719 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -95.3 -21.72 18.23 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.772 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 1.007 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.7 176.77 39.16 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.003 169.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.101 HG21 HG23 ' A' ' 420' ' ' VAL . 44.4 t -107.74 141.45 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.153 -1.204 . . . . 0.0 109.923 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.749 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.7 mt -101.45 111.06 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 108.986 170.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.94 119.35 31.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.956 -1.09 . . . . 0.0 109.801 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.864 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -100.09 142.75 31.14 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.0 mttt . . . . . 0 C--N 1.298 -1.653 0 O-C-N 120.848 -1.158 . . . . 0.0 111.078 -178.199 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.558 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.9 tt0 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.136 0.493 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.79 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -57.05 139.76 51.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.1 -1.0 . . . . 0.0 109.946 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.512 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 74.5 m -122.69 -36.71 2.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.502 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.5 tt0 -165.7 150.82 8.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.054 -1.029 . . . . 0.0 110.184 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.038 ' CD1' HD21 ' A' ' 355' ' ' LEU . 13.4 p90 -135.13 158.26 44.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.839 -1.163 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.7 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.2 mp -134.17 139.04 31.85 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.552 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.11 144.82 53.32 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.65 1.342 . . . . 0.0 111.824 -171.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.045 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -69.32 152.47 44.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 108.768 165.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.404 ' H ' ' CB ' ' A' ' 413' ' ' PRO . 1.7 tp-100 -57.79 128.99 39.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.658 -1.276 . . . . 0.0 110.269 -172.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 109.54 -21.39 26.12 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.943 HG21 ' HA ' ' A' ' 440' ' ' LEU . 53.3 t -114.0 138.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.393 . . . . 0.0 110.907 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.469 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.0 m-20 -72.21 145.08 48.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 109.891 173.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.565 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.3 tt0 -59.87 -34.01 72.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.917 -1.114 . . . . 0.0 109.868 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.51 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.51 -42.41 87.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 109.25 175.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 99.5 m -61.59 -42.76 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.3 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.961 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.28 -39.8 88.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.451 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.973 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.74 -43.3 80.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.083 . . . . 0.0 110.772 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.552 ' O ' HD23 ' A' ' 339' ' ' LEU . 47.8 t0 -63.41 -49.9 71.93 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.912 -1.117 . . . . 0.0 110.055 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.929 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.88 -31.02 70.53 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.762 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.8 -35.78 66.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.079 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.0 mt-30 -73.3 -55.75 5.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.565 -0.709 . . . . 0.0 110.996 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.075 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -65.1 -33.83 76.96 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.205 -171.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.52 -20.89 65.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.067 173.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.2 p -107.29 10.65 29.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.225 -0.922 . . . . 0.0 111.521 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.3 mt -66.66 -45.48 78.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.546 -1.346 . . . . 0.0 109.73 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.59 0.14 49.53 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.986 -171.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.473 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.0 p30 -62.93 130.66 45.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.214 . . . . 0.0 109.898 176.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.67 5.32 51.73 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.516 0.674 . . . . 0.0 109.864 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 346' ' ' THR . 2.8 p -76.05 150.87 83.69 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 109.467 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.51 -38.32 83.34 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.708 1.373 . . . . 0.0 109.132 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.53 -28.6 69.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.404 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.27 -37.83 75.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -77.29 -38.64 50.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.095 -1.238 . . . . 0.0 110.631 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.8 m -62.35 -37.8 87.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.919 -1.113 . . . . 0.0 110.466 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.695 HG23 HD13 ' A' ' 443' ' ' ILE . 87.9 mt -68.13 -48.66 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.936 -1.103 . . . . 0.0 110.492 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.635 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.4 t -60.62 -33.17 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.23 . . . . 0.0 109.772 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.498 HG22 ' OE1' ' A' ' 358' ' ' GLN . 38.7 mt -72.76 -31.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.79 -1.194 . . . . 0.0 110.722 171.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.038 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.9 -41.5 91.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.866 -1.146 . . . . 0.0 110.242 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.526 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.36 -43.18 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 110.422 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.953 ' HB3' HD23 ' A' ' 362' ' ' LEU . 78.8 mttt -72.08 -51.23 22.58 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.635 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -71.17 -42.61 68.86 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.508 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.552 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.5 mmt180 -73.66 -44.31 57.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 111.101 -172.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 81.6 m-85 -135.31 -37.57 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.623 -1.298 . . . . 0.0 112.159 -169.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.521 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 60.9 t-20 -162.68 105.38 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.489 -1.382 . . . . 0.0 111.55 -168.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.953 HD23 ' HB3' ' A' ' 357' ' ' LYS . 46.9 mt -57.56 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.858 -1.151 . . . . 0.0 109.056 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 335' ' ' ASP . 56.5 ttt180 -129.21 168.14 16.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.449 ' N ' ' HG2' ' A' ' 363' ' ' ARG . 87.5 mt-10 -139.69 -157.82 0.8 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.8 ptt-85 -98.1 165.45 11.89 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.627 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.814 ' O ' HD12 ' A' ' 370' ' ' LEU . 89.9 m-20 -131.47 42.47 3.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 110.56 175.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.081 HG21 ' CE1' ' A' ' 374' ' ' PHE . 47.6 t -72.19 -45.77 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 0.0 110.152 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.34 -23.91 64.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.862 . . . . 0.0 111.166 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -31.85 30.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.778 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 366' ' ' ASP . 9.3 mt -104.42 -2.77 24.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.536 -0.727 . . . . 0.0 110.624 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 367' ' ' VAL . 81.7 m-70 59.25 52.37 6.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.698 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.781 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -91.79 174.49 7.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 110.308 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.6 m -118.46 135.5 54.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.478 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.081 ' CE1' HG21 ' A' ' 367' ' ' VAL . 90.8 m-85 -90.36 145.22 25.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 9.1 t -118.45 101.36 51.04 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.776 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.8 Cg_endo -54.72 154.23 21.47 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.079 1.568 . . . . 0.0 110.524 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.58 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.1 t80 -69.66 134.64 48.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.37 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 174.841 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.505 0.669 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.936 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.1 ptp -165.15 171.26 13.96 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.822 0.82 . . . . 0.0 111.225 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 47.9 p -155.92 165.32 36.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.58 -165.57 34.3 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.704 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 367' ' ' VAL . 4.5 tt -139.82 152.57 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.902 . . . . 0.0 110.232 -175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -127.24 138.4 53.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.045 -1.034 . . . . 0.0 109.458 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.744 ' CD1' HD13 ' A' ' 370' ' ' LEU . 1.7 tt -140.85 154.36 21.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.842 -1.161 . . . . 0.0 109.362 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.267 89.0 m-20 -21.37 -61.83 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.438 0.637 . . . . 0.0 112.53 172.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 51.9 t-20 -98.99 -7.14 27.34 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.512 -0.742 . . . . 0.0 111.901 -166.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 15.9 mtp180 -142.91 147.97 36.18 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.681 -1.262 . . . . 0.0 110.573 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.6 mtm -134.98 111.07 9.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.942 -1.099 . . . . 0.0 108.995 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.075 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -129.52 146.09 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.557 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 31.2 mtt85 -136.76 161.92 34.63 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.16 -0.962 . . . . 0.0 111.035 176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.536 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.88 128.24 32.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.637 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.78 174.34 32.34 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 37.7 m -56.49 150.98 14.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.848 -1.384 . . . . 0.0 108.526 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.045 HG21 ' CG1' ' A' ' 420' ' ' VAL . 63.2 t -56.82 -35.33 46.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -0.999 . . . . 0.0 109.81 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.473 ' OD1' ' HD2' ' A' ' 403' ' ' ARG . 55.2 t0 -63.07 -46.75 85.97 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.315 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.936 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.18 -49.13 65.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.065 -1.022 . . . . 0.0 110.514 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.637 HD11 ' N ' ' A' ' 396' ' ' GLY . 41.7 mm -66.41 -43.84 90.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.099 -1.001 . . . . 0.0 110.931 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.595 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 7.8 ttp180 -59.86 -43.58 94.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.211 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.473 ' HD2' ' OD1' ' A' ' 399' ' ' ASP . 14.6 mtp-105 -61.8 -36.54 81.41 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.459 173.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.557 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 3.0 t-80 -68.69 -35.55 77.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.231 -0.918 . . . . 0.0 111.378 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 437' ' ' SER . 52.1 t -66.06 -50.42 69.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.533 -1.354 . . . . 0.0 110.171 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.966 -1.084 . . . . 0.0 110.37 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.26 76.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.924 -1.11 . . . . 0.0 110.085 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.547 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.9 m-80 -62.58 -26.81 68.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.132 174.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 98.12 17.83 28.56 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.43 -169.04 16.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.485 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.2 m-70 -142.87 153.62 43.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.112 -1.228 . . . . 0.0 111.351 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.595 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 9.5 p90 -105.82 147.64 35.1 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.272 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.85 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.95 123.95 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.808 1.425 . . . . 0.0 110.407 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.15 -32.73 74.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 111.033 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.9 m-20 -61.92 -33.04 73.53 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 0.0 108.963 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.045 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.8 t -83.63 -42.83 17.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.37 -0.832 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.4 m-20 -54.55 -37.46 65.46 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.76 -1.213 . . . . 0.0 109.507 171.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.5 mm-40 -63.38 -48.18 78.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.265 -1.522 . . . . 0.0 110.077 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.7 ' HD3' HG21 ' A' ' 323' ' ' ILE . 20.1 mttp -56.64 -35.24 68.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.072 HG23 HG21 ' A' ' 442' ' ' VAL . 2.4 t -59.78 -40.68 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.979 -1.075 . . . . 0.0 109.285 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.76 -36.25 82.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.842 0.829 . . . . 0.0 109.46 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -67.37 -36.81 82.1 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.63 -0.669 . . . . 0.0 110.62 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.769 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.0 t -62.88 -37.9 80.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.954 -1.091 . . . . 0.0 110.009 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.6 -40.01 84.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 0.0 110.385 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -68.11 -31.53 71.2 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.282 -0.886 . . . . 0.0 110.955 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.55 -3.11 55.47 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.783 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.51 22.14 29.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.769 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.34 163.48 12.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -1.079 . . . . 0.0 109.541 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.851 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.3 m -109.98 107.12 58.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.582 ' CG ' HG13 ' A' ' 420' ' ' VAL . 40.1 Cg_endo -75.79 108.28 2.65 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 123.97 1.511 . . . . 0.0 110.589 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.896 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.9 mt -92.81 134.77 34.74 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 108.598 167.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.953 ' CG2' HG22 ' A' ' 398' ' ' VAL . 96.8 t -100.7 134.27 41.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.754 -1.216 . . . . 0.0 109.428 176.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.771 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.5 t -114.82 137.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 176.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.1 m -118.09 160.27 17.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.413 -0.804 . . . . 0.0 109.721 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.483 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.39 130.77 35.39 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.07 -132.32 30.86 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 405' ' ' VAL . 82.9 p -102.75 7.52 39.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.081 -1.247 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -120.05 171.09 8.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.661 -1.275 . . . . 0.0 110.142 -175.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 26.0 t -92.25 133.4 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.418 -0.801 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.943 ' HA ' HG21 ' A' ' 328' ' ' VAL . 1.6 pp -92.93 -22.2 19.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.961 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.29 177.62 39.01 Favored Glycine 0 N--CA 1.5 2.939 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.987 169.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.072 HG21 HG23 ' A' ' 420' ' ' VAL . 51.2 t -107.81 142.95 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.22 -1.165 . . . . 0.0 110.075 174.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.762 HD11 ' HB1' ' A' ' 337' ' ' ALA . 75.8 mt -101.79 112.62 35.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 108.974 170.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.576 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -93.13 119.31 32.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.987 -1.071 . . . . 0.0 109.891 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.896 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -103.17 144.17 31.66 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.396 -0.815 . . . . 0.0 108.808 -175.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.512 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 16.2 mtmt . . . . . 0 C--N 1.3 -1.562 0 O-C-N 120.585 -1.322 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.2 mt-30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.113 0.482 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.773 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -59.93 138.64 57.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.07 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -122.31 -37.62 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 110.433 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.483 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.1 tt0 -162.84 148.32 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.187 -178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.078 ' CD1' HD21 ' A' ' 355' ' ' LEU . 14.1 p90 -133.95 142.88 47.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.803 -1.186 . . . . 0.0 111.704 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.568 HG21 ' CD ' ' A' ' 419' ' ' LYS . 4.4 mt -113.84 141.57 26.37 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.552 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.64 142.73 40.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.656 1.345 . . . . 0.0 111.528 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.062 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.83 151.13 45.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 108.856 165.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.46 128.88 39.28 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.744 -1.222 . . . . 0.0 110.098 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.66 -1.35 45.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.6 t -135.68 137.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.645 -1.503 . . . . 0.0 110.649 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.8 m-20 -72.74 150.44 42.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.4 tt0 -60.87 -38.04 84.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.0 OUTLIER -59.88 -40.3 88.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.929 -1.107 . . . . 0.0 109.224 177.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.546 HG21 HG13 ' A' ' 328' ' ' VAL . 98.9 m -60.51 -43.13 97.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 110.0 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.986 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.12 -38.43 83.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.373 -0.83 . . . . 0.0 110.502 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.971 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.75 -44.42 77.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.706 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.567 ' O ' HD23 ' A' ' 339' ' ' LEU . 89.9 m-20 -63.69 -48.74 75.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 110.017 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.921 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.61 -32.03 72.47 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.03 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.686 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.22 -36.0 65.5 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.011 172.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.2 mt-30 -74.1 -55.67 5.82 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.546 -0.721 . . . . 0.0 111.064 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.072 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.4 -33.96 77.07 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.066 -171.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.617 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.89 -20.31 65.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.982 -1.074 . . . . 0.0 109.991 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.594 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.3 p -107.62 10.42 29.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.134 -0.979 . . . . 0.0 111.502 -174.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.65 HD12 HD12 ' A' ' 386' ' ' ILE . 47.3 mt -66.53 -45.04 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.622 -1.299 . . . . 0.0 109.821 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.03 2.05 50.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.842 -170.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.485 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.9 p30 -65.09 130.29 42.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.798 -1.189 . . . . 0.0 110.061 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.7 4.47 52.97 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.574 0.702 . . . . 0.0 109.887 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 346' ' ' THR . 3.0 p -74.47 150.84 87.21 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.572 -0.705 . . . . 0.0 109.426 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.78 -40.74 78.96 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.723 1.381 . . . . 0.0 109.358 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.46 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.65 -28.07 69.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.1 -38.11 65.53 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.532 ' O ' HD12 ' A' ' 354' ' ' ILE . 68.5 mtt85 -77.4 -37.3 52.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.239 . . . . 0.0 110.501 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.2 m -61.36 -37.83 84.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.069 . . . . 0.0 110.324 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.664 HG23 HD13 ' A' ' 443' ' ' ILE . 83.1 mt -69.55 -49.38 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.631 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.594 HG22 ' OG ' ' A' ' 341' ' ' SER . 23.4 t -59.9 -32.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.865 -1.147 . . . . 0.0 109.813 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.536 HG22 ' NE2' ' A' ' 358' ' ' GLN . 34.6 mt -72.74 -34.22 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 110.637 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.078 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.06 -40.25 80.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.817 -1.177 . . . . 0.0 110.239 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.02 -45.77 87.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 48.2 mtmt -72.02 -49.25 38.5 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.844 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.55 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 10.6 pt20 -70.87 -42.96 69.38 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.668 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 39.3 mmt180 -74.42 -45.36 47.04 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 111.145 -171.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 90.9 m-85 -135.57 -37.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.446 -1.301 . . . . 0.0 112.218 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.508 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 51.2 t30 -162.91 105.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.494 -1.379 . . . . 0.0 111.652 -168.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.5 OUTLIER -57.87 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.754 -1.216 . . . . 0.0 109.203 171.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.539 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.0 tpt180 -126.64 164.02 22.17 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 109.11 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 83.9 mt-10 -137.22 -159.38 0.95 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.933 -1.105 . . . . 0.0 110.369 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.8 ptt180 -97.69 163.82 12.66 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 110.586 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -130.87 42.13 3.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.366 -0.834 . . . . 0.0 110.544 175.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.022 HG21 ' CE1' ' A' ' 374' ' ' PHE . 64.8 t -73.52 -48.43 41.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.312 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.56 -26.09 66.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 111.067 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -30.14 27.91 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 176.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.985 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.6 mt -103.25 -4.0 24.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 110.731 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 367' ' ' VAL . 61.4 m-70 63.11 53.04 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.317 -0.864 . . . . 0.0 110.148 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.939 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.57 174.89 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.618 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.3 m -116.89 133.5 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.47 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.022 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.8 m-85 -87.67 143.42 27.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.472 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 387' ' ' ASN . 16.8 t -117.14 101.15 53.32 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 109.628 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.23 151.27 36.47 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.056 1.556 . . . . 0.0 110.55 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.7 t80 -62.32 130.86 47.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.038 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 176.859 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.9 mtt180 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.555 0.693 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.589 ' CE ' HD13 ' A' ' 401' ' ' ILE . 2.1 ptp -157.98 167.53 29.67 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.852 0.834 . . . . 0.0 111.174 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.65 165.26 36.49 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.8 -166.24 35.29 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.524 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.838 HD11 HG22 ' A' ' 367' ' ' VAL . 14.5 tt -139.51 150.75 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.634 -0.921 . . . . 0.0 110.176 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.64 HD21 HG21 ' A' ' 375' ' ' VAL . 37.8 m-20 -127.6 133.26 49.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 0.0 109.755 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.985 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -139.57 154.81 24.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.84 -1.162 . . . . 0.0 109.302 170.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 88.6 m-20 -25.62 -62.99 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.429 0.633 . . . . 0.0 112.266 172.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.461 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.0 t30 -90.96 -8.56 48.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 111.767 -168.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 35.7 mtp180 -143.38 143.93 31.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.643 -1.286 . . . . 0.0 110.627 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.7 mtm -134.08 107.47 7.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 108.909 168.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.072 HD12 HD11 ' A' ' 339' ' ' LEU . 7.4 mt -129.45 146.11 34.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.21 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 20.8 mtt-85 -135.64 162.12 33.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 110.995 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.516 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -135.22 127.79 30.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.557 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.7 174.05 33.04 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.7 m -57.28 150.73 17.35 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.978 -1.307 . . . . 0.0 108.601 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.055 HG21 HG11 ' A' ' 420' ' ' VAL . 20.0 t -54.82 -37.91 42.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.849 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.8 m-20 -63.72 -44.01 94.85 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.29 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 383' ' ' MET . . . -68.29 -52.14 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.876 -1.14 . . . . 0.0 110.535 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.614 HG21 HG12 ' A' ' 432' ' ' VAL . 27.6 mm -64.29 -42.22 94.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.106 -0.996 . . . . 0.0 110.828 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.2 ttp85 -59.94 -43.96 94.67 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.228 -0.92 . . . . 0.0 110.313 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 95.1 mtt180 -61.5 -37.16 82.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.515 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -68.21 -36.24 79.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.869 . . . . 0.0 111.319 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.65 -48.99 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.534 -1.354 . . . . 0.0 110.126 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.18 -34.33 77.4 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.914 -1.116 . . . . 0.0 110.145 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -36.23 80.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.952 -1.092 . . . . 0.0 109.958 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.0 m-80 -61.82 -27.33 68.69 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.202 173.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.79 19.46 29.17 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -169.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.49 -170.67 16.81 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -144.3 153.62 42.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -1.233 . . . . 0.0 111.231 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.595 ' HB3' HG21 ' A' ' 439' ' ' VAL . 9.8 p90 -108.85 149.97 40.25 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.475 -0.766 . . . . 0.0 110.068 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.865 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -73.02 126.31 11.11 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.877 1.462 . . . . 0.0 110.455 -175.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 414' ' ' THR . 1.3 t -67.18 -33.49 75.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 111.04 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.9 m-20 -63.36 -32.19 73.54 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.984 -1.072 . . . . 0.0 108.77 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.062 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.2 t -83.64 -41.69 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.395 -0.816 . . . . 0.0 110.824 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 56.4 t0 -54.9 -37.19 66.03 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 109.444 171.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.28 -50.99 65.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.447 -1.408 . . . . 0.0 109.635 172.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.568 ' CD ' HG21 ' A' ' 323' ' ' ILE . 45.0 mttm -55.77 -34.56 65.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.868 -1.145 . . . . 0.0 110.263 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.055 HG11 HG21 ' A' ' 398' ' ' VAL . 2.6 t -58.9 -42.5 86.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.172 170.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.5 -36.1 82.85 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 109.425 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.5 mm-40 -67.87 -37.13 81.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.697 -0.627 . . . . 0.0 110.65 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 428' ' ' ALA . 67.4 t -63.34 -37.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.025 . . . . 0.0 110.044 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.54 85.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -69.08 -30.38 68.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.296 -0.878 . . . . 0.0 110.888 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.75 -3.56 56.72 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.045 -1.034 . . . . 0.0 109.717 175.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.19 21.84 28.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.81 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.62 163.47 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -1.067 . . . . 0.0 109.626 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.468 ' HB ' HD12 ' A' ' 445' ' ' LEU . 22.1 m -109.75 107.2 59.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.989 -1.069 . . . . 0.0 109.731 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.562 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.2 Cg_endo -76.18 108.13 2.61 Favored 'Trans proline' 0 C--N 1.297 -2.158 0 O-C-N 123.878 1.462 . . . . 0.0 110.462 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.907 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.5 mt -92.29 136.31 33.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 0.0 108.64 167.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.879 ' CG2' HG22 ' A' ' 398' ' ' VAL . 94.6 t -99.93 135.06 37.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.675 -1.266 . . . . 0.0 109.462 175.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.904 ' CG1' HD11 ' A' ' 440' ' ' LEU . 27.3 t -115.83 137.76 48.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.291 -0.88 . . . . 0.0 108.831 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.84 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.7 m -120.45 160.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.272 -0.892 . . . . 0.0 109.734 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.494 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -134.37 132.9 40.0 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.18 -130.09 32.29 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.607 ' O ' HG13 ' A' ' 405' ' ' VAL . 74.1 p -105.64 8.71 33.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.034 -1.274 . . . . 0.0 111.129 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -122.12 170.64 9.67 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.588 -1.32 . . . . 0.0 110.107 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.84 ' HA ' HG12 ' A' ' 434' ' ' VAL . 47.0 t -89.48 133.86 30.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 109.95 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.904 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -92.22 -22.83 19.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.986 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.32 177.51 40.55 Favored Glycine 0 N--CA 1.5 2.943 0 C-N-CA 118.945 -1.598 . . . . 0.0 110.87 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.051 HG21 HG23 ' A' ' 420' ' ' VAL . 47.9 t -107.9 142.36 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.119 -1.224 . . . . 0.0 109.869 172.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.686 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.9 mt -101.3 112.02 32.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.416 -0.802 . . . . 0.0 108.941 170.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.09 119.38 31.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 109.837 -178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.907 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.29 142.82 32.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 320' ' ' SER . 28.9 mtmt . . . . . 0 C--N 1.299 -1.611 0 O-C-N 120.657 -1.277 . . . . 0.0 111.056 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.561 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.3 tt0 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.137 0.494 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.92 138.91 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.884 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.54 -44.34 2.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.07 -1.019 . . . . 0.0 110.278 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.1 mt-10 -154.44 152.34 30.04 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.427 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.008 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 16.5 p90 -137.22 143.15 42.15 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.731 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.525 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -114.93 144.66 32.44 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.747 -0.596 . . . . 0.0 109.657 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.7 143.71 38.15 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.758 1.399 . . . . 0.0 111.525 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.04 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.39 152.72 41.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 108.847 165.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.408 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 1.4 tp-100 -57.87 128.43 37.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.654 -1.279 . . . . 0.0 110.081 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.67 -0.82 45.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.9 t -136.61 140.08 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.686 -1.479 . . . . 0.0 110.743 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.4 m-20 -74.15 152.67 39.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 85.0 tt0 -62.37 -40.76 97.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.985 -1.072 . . . . 0.0 110.471 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.25 -43.09 92.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.682 -1.261 . . . . 0.0 109.612 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 328' ' ' VAL . 93.3 m -55.53 -43.93 76.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.75 173.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 1.023 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -59.77 -39.24 84.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 110.285 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.0 -41.85 86.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.837 -1.164 . . . . 0.0 110.841 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.0 t0 -63.83 -49.83 71.3 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.832 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.918 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.27 -31.44 71.77 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.718 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.96 -35.09 66.33 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.142 172.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 18.0 mt-30 -73.85 -55.79 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.596 -0.69 . . . . 0.0 110.815 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.074 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.71 -34.7 76.24 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.894 -173.197 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.437 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.54 -20.43 65.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.927 174.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.626 ' OG ' HG22 ' A' ' 353' ' ' VAL . 97.1 p -108.91 9.75 26.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.199 -0.938 . . . . 0.0 111.631 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.708 HD22 ' HD2' ' A' ' 365' ' ' ARG . 35.5 mt -64.1 -45.78 87.14 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.652 -1.28 . . . . 0.0 109.806 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.7 -0.8 42.12 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.788 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 10.5 p30 -61.8 130.51 46.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.927 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.03 5.89 50.13 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.612 0.72 . . . . 0.0 109.951 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 346' ' ' THR . 2.5 p -77.56 154.59 81.42 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.579 -0.7 . . . . 0.0 109.45 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.15 -36.85 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.624 1.329 . . . . 0.0 109.128 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.3 -29.2 70.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.448 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -57.47 -38.54 87.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -77.33 -37.38 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -1.177 . . . . 0.0 110.629 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.561 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.0 m -61.68 -38.85 89.34 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.042 -1.036 . . . . 0.0 110.368 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.551 HG23 HD13 ' A' ' 443' ' ' ILE . 84.7 mt -69.18 -48.37 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.693 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.626 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -60.64 -34.54 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.06 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 350' ' ' ARG . 36.4 mt -72.54 -32.26 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.628 -1.295 . . . . 0.0 110.653 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.004 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.87 -41.06 90.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.937 -1.102 . . . . 0.0 110.394 179.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.79 -42.85 99.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 0.0 110.383 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.997 ' HB3' HD23 ' A' ' 362' ' ' LEU . 83.4 mttt -70.69 -50.55 35.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.913 -1.117 . . . . 0.0 110.772 -174.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.513 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.9 pt20 -71.0 -42.59 69.43 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 110.561 -173.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.595 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 40.1 mmt180 -73.06 -46.16 53.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 111.21 -173.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.647 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 79.3 m-85 -135.96 -36.03 0.76 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.542 -1.349 . . . . 0.0 112.39 -169.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.522 ' ND2' ' HD2' ' A' ' 363' ' ' ARG . 56.0 t-20 -158.59 98.55 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.557 -1.34 . . . . 0.0 111.7 -169.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.997 HD23 ' HB3' ' A' ' 357' ' ' LYS . 24.3 mt -58.38 91.17 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 0.0 109.509 171.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.522 ' HD2' ' ND2' ' A' ' 361' ' ' ASN . 13.8 ptm180 -145.6 -176.81 5.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.287 -0.883 . . . . 0.0 109.983 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.28 -158.53 0.9 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 110.329 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.708 ' HD2' HD22 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -97.96 166.81 11.27 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.661 -0.649 . . . . 0.0 110.558 -178.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.0 m-20 -121.02 41.1 3.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.009 HG11 ' CE2' ' A' ' 374' ' ' PHE . 43.0 t -70.45 -45.54 74.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 110.21 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -68.2 -29.02 67.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.159 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -29.66 27.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.07 -1.019 . . . . 0.0 109.767 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.811 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.6 mt -102.66 -3.22 26.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 110.777 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.1 m80 58.82 53.8 5.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 0.0 109.895 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.842 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.89 174.68 7.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 110.513 -177.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.1 m -114.79 134.02 55.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.357 -0.84 . . . . 0.0 110.396 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.009 ' CE2' HG11 ' A' ' 367' ' ' VAL . 72.4 m-85 -88.7 149.38 23.52 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 5.0 t -122.75 100.81 40.32 Favored Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -56.3 150.66 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.031 1.543 . . . . 0.0 110.473 -177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.6 t80 -66.91 131.75 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 110.141 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--N 1.302 -1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 109.639 175.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 73.2 mtt85 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.531 0.682 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.877 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.8 ptp -158.6 169.71 23.81 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.949 0.881 . . . . 0.0 111.339 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.524 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 31.1 p -154.84 165.22 37.33 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.15 -165.33 33.25 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.897 -1.621 . . . . 0.0 110.751 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.929 HG21 ' HB2' ' A' ' 339' ' ' LEU . 2.4 tt -142.28 149.38 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.63 -0.923 . . . . 0.0 110.054 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -127.91 136.0 50.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.957 -1.09 . . . . 0.0 109.911 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.45 155.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.859 -1.151 . . . . 0.0 109.22 171.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.498 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 91.2 m-20 -23.46 -63.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.398 0.618 . . . . 0.0 112.436 171.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 46.4 t-20 -95.82 -5.56 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.513 -0.742 . . . . 0.0 111.871 -167.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.562 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.6 mtp180 -143.98 143.8 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.66 -1.275 . . . . 0.0 110.375 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -134.02 112.25 11.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.822 -1.174 . . . . 0.0 108.913 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.074 HD12 HD11 ' A' ' 339' ' ' LEU . 9.6 mt -131.49 146.16 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 35.1 mtt180 -133.75 159.92 39.15 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.078 -1.014 . . . . 0.0 110.58 174.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.627 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.09 128.92 35.18 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.611 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.87 174.22 33.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -174.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.6 m -56.91 151.58 14.37 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.871 -1.37 . . . . 0.0 108.653 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.027 HG21 HG11 ' A' ' 420' ' ' VAL . 53.5 t -56.51 -34.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 109.942 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.516 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 46.2 t0 -63.26 -47.19 83.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.323 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.877 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.77 -50.05 59.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.523 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.611 HD11 ' N ' ' A' ' 396' ' ' GLY . 35.8 mm -64.97 -42.99 96.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.053 -1.029 . . . . 0.0 110.794 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.582 ' HD2' ' CZ ' ' A' ' 412' ' ' PHE . 9.5 ttp180 -59.36 -43.39 92.84 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.309 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.516 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 88.9 mtt180 -61.31 -37.16 82.25 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.517 173.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.4 t-80 -67.5 -36.95 82.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 0.0 111.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.55 ' CG2' HG11 ' A' ' 434' ' ' VAL . 53.4 t -65.93 -48.35 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.5 -1.375 . . . . 0.0 110.206 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.6 -34.24 77.38 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.901 -1.124 . . . . 0.0 110.355 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.77 -36.26 80.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.939 -1.101 . . . . 0.0 109.886 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 9.4 m-80 -61.03 -27.84 68.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 109.124 173.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.35 27.2 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -169.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.59 -169.05 15.59 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -144.36 153.66 42.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.131 -1.217 . . . . 0.0 111.404 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 6.7 p90 -108.22 150.35 40.39 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.769 -0.582 . . . . 0.0 110.258 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.817 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -75.0 125.53 9.39 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.812 1.427 . . . . 0.0 110.572 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -67.39 -33.82 75.98 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.172 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -62.12 -32.01 72.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.98 -1.075 . . . . 0.0 108.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.04 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.4 t -83.72 -42.69 17.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 110.942 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.585 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 66.8 m-20 -55.28 -36.22 65.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.629 171.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.88 -50.85 67.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.377 -1.452 . . . . 0.0 109.537 172.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 81.9 mttt -56.46 -34.36 66.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.338 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.05 HG23 HG21 ' A' ' 442' ' ' VAL . 2.4 t -58.86 -41.65 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.964 -1.085 . . . . 0.0 109.171 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -66.34 -36.51 83.08 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.936 0.874 . . . . 0.0 109.414 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.502 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 95.4 mm-40 -67.24 -37.28 83.28 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.586 -0.696 . . . . 0.0 110.703 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.745 HG13 ' HB3' ' A' ' 428' ' ' ALA . 77.0 t -62.39 -37.86 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 110.063 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.18 -37.97 86.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -66.26 -33.81 76.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.193 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -83.23 -1.82 54.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 176.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.05 22.54 32.44 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.745 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.12 162.47 13.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -1.084 . . . . 0.0 109.485 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.683 ' HB ' HD12 ' A' ' 445' ' ' LEU . 34.8 m -109.5 107.0 59.24 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 109.741 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.547 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.9 Cg_endo -74.98 108.09 2.64 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 O-C-N 124.05 1.553 . . . . 0.0 110.596 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.865 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -92.54 134.18 35.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.816 -1.177 . . . . 0.0 108.578 167.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.953 ' CG2' HG22 ' A' ' 398' ' ' VAL . 74.6 t -100.35 134.17 40.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.669 -1.269 . . . . 0.0 109.457 176.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.661 ' CG1' HD11 ' A' ' 440' ' ' LEU . 55.3 t -115.78 136.42 52.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.063 175.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -117.75 160.15 17.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.484 -0.76 . . . . 0.0 109.632 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.518 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.22 133.19 36.82 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.83 -123.57 22.24 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -168.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 405' ' ' VAL . 2.3 p -114.2 11.37 17.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.095 -1.238 . . . . 0.0 110.987 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -123.88 171.08 9.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.629 -1.294 . . . . 0.0 109.907 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 40.3 t -90.04 134.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.312 -0.867 . . . . 0.0 109.821 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.6 pp -94.33 -21.77 18.77 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 109.693 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 1.023 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.02 176.12 38.28 Favored Glycine 0 N--CA 1.499 2.883 0 C-N-CA 118.938 -1.601 . . . . 0.0 110.904 170.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.05 HG21 HG23 ' A' ' 420' ' ' VAL . 49.7 t -107.87 142.06 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.12 -1.224 . . . . 0.0 109.953 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.706 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.1 mt -101.32 110.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.424 -0.798 . . . . 0.0 108.961 170.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.625 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.36 118.18 30.67 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.031 -1.043 . . . . 0.0 109.864 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.865 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.08 144.32 30.81 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 19.9 mttt . . . . . 0 C--N 1.3 -1.583 0 O-C-N 120.675 -1.266 . . . . 0.0 110.905 179.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.468 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 50.9 tt0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.103 0.478 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.755 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -59.59 142.37 52.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.528 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -117.54 -34.17 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -0.981 . . . . 0.0 110.439 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -169.45 150.57 4.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 0.0 110.029 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.004 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 13.9 p90 -134.87 143.98 47.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.85 -1.156 . . . . 0.0 111.643 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.52 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.3 mt -114.49 144.03 31.02 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.611 -0.681 . . . . 0.0 109.666 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.88 143.78 37.49 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.767 1.404 . . . . 0.0 111.357 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.05 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.0 152.26 42.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 108.831 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.16 128.77 38.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.665 -1.272 . . . . 0.0 110.188 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.54 42.83 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.0 t -136.48 139.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.65 -1.5 . . . . 0.0 110.736 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.18 152.44 39.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.154 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.565 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -62.47 -40.13 95.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.993 . . . . 0.0 110.437 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.09 -43.15 91.81 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.701 -1.25 . . . . 0.0 109.62 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.531 HG21 HG13 ' A' ' 328' ' ' VAL . 94.3 m -56.11 -43.54 78.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.885 173.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 1.01 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.2 tp -59.68 -40.08 86.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.291 -0.881 . . . . 0.0 110.281 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.004 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -66.66 -41.21 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.914 -1.116 . . . . 0.0 110.742 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.546 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.3 t0 -64.22 -50.87 66.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.854 -1.153 . . . . 0.0 109.928 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.949 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.03 -30.62 69.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.909 -1.119 . . . . 0.0 109.779 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.91 65.29 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.133 -0.979 . . . . 0.0 109.028 171.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.574 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 17.3 mt-30 -74.25 -55.71 5.73 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.569 -0.707 . . . . 0.0 110.914 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.04 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -63.92 -33.78 76.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.908 -171.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.467 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -66.77 -21.48 66.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.986 -1.072 . . . . 0.0 110.045 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.609 ' OG ' HG22 ' A' ' 353' ' ' VAL . 97.5 p -107.65 10.79 28.95 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.04 -1.037 . . . . 0.0 111.598 -173.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 46.3 mt -67.15 -43.75 81.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.624 -1.297 . . . . 0.0 109.652 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.52 2.67 52.64 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.863 -171.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.515 ' OD2' ' CA ' ' A' ' 349' ' ' GLY . 18.3 p30 -65.0 130.0 41.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.773 -1.204 . . . . 0.0 110.088 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.72 4.43 52.98 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.573 0.701 . . . . 0.0 109.909 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.38 151.77 85.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.711 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -56.38 -39.4 91.53 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.702 1.369 . . . . 0.0 109.09 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 352' ' ' ILE . 97.6 mt-10 -64.31 -29.63 70.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.484 -0.76 . . . . 0.0 110.367 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.31 -36.04 61.91 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 354' ' ' ILE . 65.9 mtt85 -77.18 -36.53 54.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 0.0 110.543 174.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.468 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 13.2 m -60.78 -39.08 87.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 443' ' ' ILE . 81.0 mt -68.19 -48.99 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.562 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.609 HG22 ' OG ' ' A' ' 341' ' ' SER . 27.5 t -62.18 -33.94 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.945 -1.097 . . . . 0.0 110.192 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 350' ' ' ARG . 31.7 mt -72.22 -31.98 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.597 -1.314 . . . . 0.0 110.576 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.997 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -60.61 -40.61 92.48 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 110.568 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.531 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.33 -42.93 99.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 0.0 110.274 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 70.4 mttt -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.73 -175.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.9 pt20 -70.09 -42.22 73.0 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 110.785 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.6 mmm180 -74.68 -46.24 39.18 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 111.189 -171.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.592 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 77.8 m-85 -136.22 -34.97 0.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.399 -1.321 . . . . 0.0 112.31 -170.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.516 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 53.5 t-20 -159.66 103.33 1.55 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.551 -1.343 . . . . 0.0 111.598 -169.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 37.0 mt -57.66 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.872 -1.142 . . . . 0.0 109.066 170.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 25.3 tpt180 -134.19 163.83 28.73 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.419 -0.8 . . . . 0.0 109.344 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.3 mt-10 -136.12 -158.05 0.84 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 46.3 ptt85 -97.66 163.69 12.72 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.661 -0.649 . . . . 0.0 110.841 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.9 m-20 -134.5 44.49 2.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.821 . . . . 0.0 110.554 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 1.017 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.0 t -72.41 -46.95 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.44 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -67.9 -26.15 65.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 111.264 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -31.18 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.057 . . . . 0.0 109.715 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 388' ' ' ILE . 19.8 mt -100.68 -4.09 28.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.498 -0.751 . . . . 0.0 110.606 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 46.8 m80 59.99 51.73 5.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -174.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.819 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.06 172.99 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.9 m -118.82 135.61 54.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 110.374 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 1.017 ' CE1' HG21 ' A' ' 367' ' ' VAL . 86.3 m-85 -90.01 145.16 25.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.651 175.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.6 HG21 HD21 ' A' ' 387' ' ' ASN . 47.9 t -118.73 100.99 50.92 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 174.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.16 150.75 38.24 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.068 1.562 . . . . 0.0 110.526 -175.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 8.4 t80 -63.27 131.35 48.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.357 -0.839 . . . . 0.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--N 1.301 -1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.706 176.124 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 88.7 mtt180 . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.519 0.676 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.79 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.6 ptp -158.75 168.48 26.73 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.26 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 12.2 p -155.39 165.16 37.49 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.6 -164.16 31.55 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.956 -1.592 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 367' ' ' VAL . 1.9 tt -141.96 149.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.665 -0.903 . . . . 0.0 110.173 -174.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.6 HD21 HG21 ' A' ' 375' ' ' VAL . 26.5 m-20 -127.22 138.86 53.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 176.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -141.37 154.59 20.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.87 -1.144 . . . . 0.0 109.365 172.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.264 88.3 m-20 -21.4 -62.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.391 0.615 . . . . 0.0 112.608 171.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 24.8 t-20 -99.03 -6.78 27.89 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 111.819 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 18.3 mtp180 -142.97 145.86 33.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.746 -1.221 . . . . 0.0 110.553 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 89.9 mtp -134.16 113.27 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.909 -1.119 . . . . 0.0 109.08 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.04 HD12 HD11 ' A' ' 339' ' ' LEU . 9.3 mt -131.75 146.05 34.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.051 -1.031 . . . . 0.0 110.142 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 32.8 mtt180 -135.92 161.9 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.005 . . . . 0.0 110.779 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.643 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.45 134.23 41.34 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.531 -0.731 . . . . 0.0 109.11 174.132 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.504 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -159.76 174.06 36.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -58.51 153.0 16.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.921 -1.34 . . . . 0.0 108.438 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.031 HG21 HG11 ' A' ' 420' ' ' VAL . 20.8 t -54.87 -37.52 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.82 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.1 m-20 -64.25 -44.51 91.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.79 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.78 -51.84 36.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.923 -1.111 . . . . 0.0 110.503 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.504 HD11 ' N ' ' A' ' 396' ' ' GLY . 25.2 mm -63.82 -42.28 95.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.096 -1.003 . . . . 0.0 110.805 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.4 ttt180 -60.81 -43.29 98.38 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.299 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 89.8 mtt180 -61.15 -36.54 80.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.07 -1.019 . . . . 0.0 109.643 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.511 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -67.45 -38.15 84.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 111.33 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 437' ' ' SER . 63.7 t -66.07 -47.22 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.473 -1.392 . . . . 0.0 110.219 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.73 -34.63 78.3 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.738 -1.226 . . . . 0.0 110.337 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.47 -36.29 80.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.986 -1.071 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.511 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.1 m-80 -61.15 -27.81 68.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.442 -0.786 . . . . 0.0 109.126 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.61 19.85 28.51 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.01 -170.26 16.3 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -144.61 153.98 42.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.247 . . . . 0.0 111.321 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.601 ' HB3' HG21 ' A' ' 439' ' ' VAL . 6.1 p90 -106.87 150.99 40.43 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.63 -0.669 . . . . 0.0 110.096 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.858 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.81 125.61 10.64 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.853 1.449 . . . . 0.0 110.237 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.2 t -66.69 -34.13 77.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 111.136 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.482 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.9 m-20 -62.97 -32.31 73.61 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.931 -1.106 . . . . 0.0 108.858 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.05 HG21 ' HA ' ' A' ' 325' ' ' ALA . 48.4 t -83.41 -42.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -0.846 . . . . 0.0 110.809 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 5.3 m-20 -55.58 -36.42 66.84 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.595 171.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.94 -50.16 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 0.0 109.686 172.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.52 ' CD ' HG21 ' A' ' 323' ' ' ILE . 35.7 mttt -56.65 -34.6 67.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.764 -1.21 . . . . 0.0 110.332 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.112 HG23 HG21 ' A' ' 442' ' ' VAL . 2.8 t -59.09 -41.78 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.932 -1.105 . . . . 0.0 109.369 170.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.66 -35.95 82.26 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.943 0.878 . . . . 0.0 109.296 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.39 -37.92 83.89 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.566 -0.709 . . . . 0.0 110.769 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 428' ' ' ALA . 64.5 t -63.44 -36.81 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.0 110.193 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.34 85.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -70.08 -28.95 65.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.326 -0.859 . . . . 0.0 110.599 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -80.36 -3.75 50.82 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.009 . . . . 0.0 109.74 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.7 21.96 35.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.733 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.74 175.96 5.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.722 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.657 ' O ' HD12 ' A' ' 445' ' ' LEU . 59.1 m -119.15 106.92 42.4 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.942 -1.099 . . . . 0.0 109.874 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.591 ' CG ' HG13 ' A' ' 420' ' ' VAL . 31.4 Cg_endo -74.06 106.78 2.28 Favored 'Trans proline' 0 C--N 1.296 -2.204 0 O-C-N 123.911 1.479 . . . . 0.0 110.354 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 445' ' ' LEU . 15.8 mt -93.08 131.79 37.78 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 167.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.81 ' CG2' HG22 ' A' ' 398' ' ' VAL . 72.6 t -100.57 137.54 27.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.823 -1.173 . . . . 0.0 109.777 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.775 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.7 t -116.2 137.74 48.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 108.928 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.851 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.05 159.98 20.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 121.351 -0.843 . . . . 0.0 109.757 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.48 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.11 132.77 36.52 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.41 -126.82 31.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -168.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.495 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -109.91 13.41 23.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.238 . . . . 0.0 111.123 -178.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -128.33 170.66 12.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.017 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.851 ' HA ' HG12 ' A' ' 434' ' ' VAL . 53.3 t -88.35 134.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 109.776 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.806 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.5 pp -92.3 -22.3 19.81 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.665 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 1.01 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.88 176.36 40.09 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.963 168.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.112 HG21 HG23 ' A' ' 420' ' ' VAL . 46.9 t -107.94 142.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.16 -1.2 . . . . 0.0 109.539 171.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.721 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.3 mt -101.67 119.24 49.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 169.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -99.0 117.49 33.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.744 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 3.6 mp -113.63 146.34 39.9 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.095 -1.003 . . . . 0.0 109.819 -173.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.528 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 O-C-N 120.749 -1.22 . . . . 0.0 110.773 -174.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.5 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.158 0.504 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.74 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.57 138.6 40.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 0.0 109.802 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 4.9 m -119.53 -44.7 2.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.086 -1.009 . . . . 0.0 110.197 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 320' ' ' SER . 69.7 mt-10 -154.59 152.33 29.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 0.0 110.448 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.009 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 16.9 p90 -136.12 141.82 44.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.755 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.643 HG21 ' CD ' ' A' ' 419' ' ' LYS . 4.3 mt -114.79 141.76 27.3 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.73 -0.607 . . . . 0.0 109.598 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -71.61 142.86 40.97 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.708 1.373 . . . . 0.0 111.55 -176.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 1.046 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.01 152.56 43.44 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 108.829 165.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.44 128.35 36.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.692 -1.255 . . . . 0.0 110.143 -172.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.94 -0.75 44.76 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.8 t -136.13 139.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.716 -1.461 . . . . 0.0 110.727 177.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.93 152.07 40.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.163 177.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -62.17 -39.76 93.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.057 -1.027 . . . . 0.0 110.457 -176.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.3 ttmt -59.19 -43.38 92.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.806 -1.184 . . . . 0.0 109.56 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.529 HG21 HG13 ' A' ' 328' ' ' VAL . 95.8 m -56.15 -43.63 78.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.817 173.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.988 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -59.69 -39.64 85.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.009 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.37 -42.04 84.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.089 . . . . 0.0 110.757 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.4 m-20 -64.19 -49.48 71.88 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.118 . . . . 0.0 109.921 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.947 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.17 -31.3 70.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.937 -1.102 . . . . 0.0 109.664 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.751 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.19 -35.64 65.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.964 172.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.564 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 30.3 mt-30 -74.52 -55.81 5.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.989 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.38 -35.71 78.23 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.787 -172.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.89 66.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.592 ' OG ' HG22 ' A' ' 353' ' ' VAL . 95.9 p -108.4 10.15 27.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -174.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.581 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.2 mt -65.98 -44.95 83.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.657 -1.277 . . . . 0.0 109.802 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.54 0.72 47.94 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.821 -170.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.479 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.9 p30 -63.87 130.29 43.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.841 -1.162 . . . . 0.0 109.925 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.76 4.76 52.64 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.512 0.672 . . . . 0.0 109.886 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.3 152.88 86.03 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.592 -0.693 . . . . 0.0 109.443 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -56.0 -38.14 95.14 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.74 1.39 . . . . 0.0 109.132 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.3 mt-10 -64.19 -29.23 70.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.484 -0.76 . . . . 0.0 110.406 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.47 -38.56 80.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.531 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.9 mtt85 -78.2 -37.76 44.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.075 -1.25 . . . . 0.0 110.591 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.4 -38.02 85.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.932 -1.105 . . . . 0.0 110.352 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 443' ' ' ILE . 90.7 mt -68.92 -49.09 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 0.0 110.625 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.592 HG22 ' OG ' ' A' ' 341' ' ' SER . 38.4 t -60.87 -34.06 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.864 -1.147 . . . . 0.0 110.101 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.964 HG22 ' OE1' ' A' ' 358' ' ' GLN . 32.3 mt -72.62 -33.22 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.681 -1.262 . . . . 0.0 110.621 170.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.961 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.46 -40.35 86.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.938 -1.101 . . . . 0.0 110.489 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.27 88.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.47 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.872 ' HB3' HD23 ' A' ' 362' ' ' LEU . 18.0 mtmt -72.35 -49.48 33.82 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.743 -1.183 . . . . 0.0 110.6 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.964 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.7 pt20 -71.3 -42.43 68.69 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 110.814 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.58 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -72.63 -46.31 54.68 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.109 -0.995 . . . . 0.0 111.078 -172.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.58 ' CD2' ' HB3' ' A' ' 359' ' ' ARG . 84.0 m-85 -136.5 -36.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.205 -169.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.491 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 15.2 t-20 -160.02 106.64 1.6 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.605 -1.309 . . . . 0.0 111.508 -168.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.872 HD23 ' HB3' ' A' ' 357' ' ' LYS . 59.9 mt -57.56 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.368 172.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . 0.534 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.7 tpt180 -125.64 164.39 20.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 109.325 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.4 mt-10 -140.06 -161.77 1.25 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.0 -1.062 . . . . 0.0 110.121 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.581 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.67 162.45 13.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.747 . . . . 0.0 110.521 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -130.3 41.74 3.36 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.381 175.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.947 HG11 ' CE2' ' A' ' 374' ' ' PHE . 59.4 t -74.16 -46.23 45.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.09 -27.46 66.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.344 -0.848 . . . . 0.0 111.122 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.78 -30.55 28.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.965 . . . . 0.0 109.656 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.781 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.9 mt -102.5 -3.66 26.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.557 -0.714 . . . . 0.0 110.674 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 367' ' ' VAL . 51.6 m80 59.11 52.57 6.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.753 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.55 174.67 7.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 110.51 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.1 m -116.45 134.62 54.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.396 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.947 ' CE2' HG11 ' A' ' 367' ' ' VAL . 83.6 m-85 -88.61 147.8 24.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 387' ' ' ASN . 87.2 t -120.34 101.12 46.99 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.616 175.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.22 150.36 40.68 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.077 1.567 . . . . 0.0 110.511 -175.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.2 t80 -65.47 131.41 46.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 109.695 176.183 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 74.0 mtt85 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.517 0.675 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.827 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.3 ptp -157.44 167.38 30.4 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.993 0.901 . . . . 0.0 111.4 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.9 p -154.43 165.36 36.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.503 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.8 -166.55 35.05 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.705 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.879 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.8 tt -140.92 149.84 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.995 . . . . 0.0 110.208 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.471 HD21 HG21 ' A' ' 375' ' ' VAL . 47.8 m-20 -127.25 134.73 50.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.045 . . . . 0.0 109.804 177.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' A' ' 370' ' ' LEU . 2.0 tt -140.73 155.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 109.211 171.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.0 m-20 -21.65 -63.03 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.388 0.614 . . . . 0.0 112.583 170.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.449 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 22.9 t-20 -96.49 -7.14 35.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 111.931 -167.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.571 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.9 mtp180 -141.86 145.84 35.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.594 -1.317 . . . . 0.0 110.503 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -136.22 100.93 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.132 . . . . 0.0 109.18 170.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 1.031 HD12 HD11 ' A' ' 339' ' ' LEU . 7.7 mt -122.96 146.18 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.04 -1.037 . . . . 0.0 110.092 -172.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.503 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 26.0 mmt85 -133.19 159.1 41.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.329 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.556 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.41 126.84 30.36 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.56 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.44 174.0 32.86 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.596 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.4 m -56.47 150.84 14.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.863 -1.375 . . . . 0.0 108.592 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.037 HG21 ' CG1' ' A' ' 420' ' ' VAL . 56.5 t -57.72 -34.6 48.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.887 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.4 t0 -62.55 -45.81 91.23 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.827 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.85 -51.07 44.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.93 -1.106 . . . . 0.0 110.61 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.56 HD11 ' N ' ' A' ' 396' ' ' GLY . 34.2 mm -63.98 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.063 -1.023 . . . . 0.0 110.59 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.0 ttp180 -58.47 -43.69 89.0 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.461 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 55.2 mtp85 -61.54 -36.12 79.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.061 -1.024 . . . . 0.0 109.459 173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.503 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.4 t-80 -67.65 -38.5 83.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 111.299 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.472 HG12 ' C ' ' A' ' 410' ' ' GLY . 66.7 t -65.91 -47.29 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.616 -1.302 . . . . 0.0 110.26 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.21 -34.21 77.57 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.814 -1.178 . . . . 0.0 110.362 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.65 -36.3 80.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.092 . . . . 0.0 109.895 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 26.7 m-80 -62.12 -27.09 68.68 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 109.225 173.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.86 19.56 31.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.24 -171.13 18.52 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.418 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.1 m-70 -144.81 153.85 42.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.168 -1.195 . . . . 0.0 111.07 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.64 ' HB3' HG21 ' A' ' 439' ' ' VAL . 8.5 p90 -109.51 151.92 42.46 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.54 -0.725 . . . . 0.0 109.978 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.857 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.15 124.76 10.27 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.913 1.48 . . . . 0.0 110.221 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.3 t -66.95 -33.21 75.08 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.3 m-20 -63.45 -32.48 73.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 108.853 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.046 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.3 t -83.64 -41.89 17.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.908 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.7 t0 -55.04 -37.55 66.83 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.404 171.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.66 -49.71 72.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.457 -1.402 . . . . 0.0 109.697 172.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.643 ' CD ' HG21 ' A' ' 323' ' ' ILE . 57.1 mttm -56.28 -34.79 66.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.802 -1.187 . . . . 0.0 110.444 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.088 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.32 -41.85 85.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.962 -1.086 . . . . 0.0 109.21 171.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.84 -36.26 82.97 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.906 0.86 . . . . 0.0 109.414 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.02 -37.89 81.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.609 -0.682 . . . . 0.0 110.74 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.765 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.2 t -62.28 -37.65 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.979 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.09 87.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 110.151 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -67.02 -33.43 75.54 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.285 -0.884 . . . . 0.0 111.229 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.1 OUTLIER -83.0 -3.4 57.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.012 -1.055 . . . . 0.0 109.597 176.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.33 29.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.765 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -103.72 163.34 12.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.651 ' HB ' HD12 ' A' ' 445' ' ' LEU . 70.5 m -109.65 107.02 59.1 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.081 -1.012 . . . . 0.0 109.744 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.56 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.6 Cg_endo -75.6 107.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.07 0 O-C-N 123.893 1.47 . . . . 0.0 110.52 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.867 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.5 mt -92.44 134.24 35.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.886 -1.134 . . . . 0.0 108.625 167.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.99 ' CG2' HG22 ' A' ' 398' ' ' VAL . 96.8 t -100.32 134.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.701 -1.25 . . . . 0.0 109.477 176.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.81 ' CG1' HD11 ' A' ' 440' ' ' LEU . 40.9 t -114.95 137.33 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.243 -0.91 . . . . 0.0 108.955 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.841 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.28 160.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.589 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.482 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.82 129.89 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.56 -128.42 29.84 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -168.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.53 15.41 23.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.052 -1.263 . . . . 0.0 111.171 -179.109 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -125.76 170.27 11.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.532 -1.355 . . . . 0.0 109.878 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.841 ' HA ' HG12 ' A' ' 434' ' ' VAL . 46.7 t -91.7 134.31 30.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.189 -0.945 . . . . 0.0 109.57 176.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.5 pp -94.36 -21.28 19.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.691 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.988 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.27 176.39 38.64 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 118.794 -1.669 . . . . 0.0 110.962 169.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.088 HG21 HG23 ' A' ' 420' ' ' VAL . 53.9 t -107.97 142.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 173.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.751 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.2 mt -101.32 110.91 29.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.99 118.12 30.47 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.863 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.867 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.28 30.54 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 59.3 mttt . . . . . 0 C--N 1.3 -1.578 0 O-C-N 120.612 -1.305 . . . . 0.0 111.121 -179.16 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.237 0.541 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.478 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 98.1 mtt180 -122.59 149.78 43.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.092 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.548 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 89.1 mm-40 -123.45 142.83 50.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.123 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -60.6 138.63 58.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.83 177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 9.4 m -122.16 -42.75 2.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.091 -1.005 . . . . 0.0 110.217 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 320' ' ' SER . 68.3 mt-10 -154.17 150.81 28.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.475 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.0 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.9 p90 -137.46 141.85 41.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.957 -1.089 . . . . 0.0 111.709 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.694 HG21 ' HD3' ' A' ' 419' ' ' LYS . 3.7 mp -113.1 143.75 29.79 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.811 -0.555 . . . . 0.0 109.69 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.67 142.89 36.72 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.63 1.331 . . . . 0.0 111.605 -177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.036 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.72 152.65 42.6 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 108.862 165.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 1.7 tp-100 -58.57 128.45 37.25 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.734 -1.229 . . . . 0.0 110.172 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.89 -0.83 44.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.3 t -136.61 139.86 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.71 -1.465 . . . . 0.0 110.762 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.89 152.82 40.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.397 -0.815 . . . . 0.0 110.176 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.8 tt0 -62.16 -40.91 97.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.056 -1.027 . . . . 0.0 110.47 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.29 -43.33 92.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.694 -1.254 . . . . 0.0 109.678 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.516 HG21 HG13 ' A' ' 328' ' ' VAL . 92.7 m -55.51 -44.12 76.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.769 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 1.021 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -59.16 -39.01 81.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.0 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.3 -41.24 85.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.967 -1.083 . . . . 0.0 110.779 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.581 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.5 m-20 -63.26 -49.22 74.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.936 -1.102 . . . . 0.0 109.805 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.99 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.52 -31.37 70.57 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.982 -1.074 . . . . 0.0 109.888 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.714 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.28 64.62 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 108.834 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.5 mt-30 -74.54 -55.92 5.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.594 -0.691 . . . . 0.0 110.919 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.0 HD11 HD12 ' A' ' 393' ' ' ILE . 0.2 OUTLIER -65.77 -33.77 76.64 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.009 -171.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -66.34 -21.62 66.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.112 . . . . 0.0 110.109 172.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.609 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.4 p -107.58 10.59 29.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.142 -0.974 . . . . 0.0 111.536 -173.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.589 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 46.1 mt -66.98 -44.48 80.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.591 -1.318 . . . . 0.0 109.672 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.12 1.2 49.66 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.865 -170.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.483 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.81 130.45 44.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 109.942 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 5.4 51.58 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.532 0.682 . . . . 0.0 109.887 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.26 152.57 83.97 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.582 -0.699 . . . . 0.0 109.412 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -56.02 -38.49 94.66 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.689 1.363 . . . . 0.0 109.147 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.478 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.6 mt-10 -64.38 -28.31 69.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.548 -0.72 . . . . 0.0 110.395 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.23 -38.17 76.45 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.568 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.95 -36.73 56.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.145 -1.209 . . . . 0.0 110.54 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 2.0 m -61.5 -39.25 90.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.605 HG23 HD13 ' A' ' 443' ' ' ILE . 85.4 mt -68.12 -48.33 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.537 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.609 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.3 t -61.46 -34.03 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.568 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.7 mt -72.43 -32.27 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.673 -1.267 . . . . 0.0 110.548 170.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.993 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.02 -40.58 89.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.96 -1.088 . . . . 0.0 110.444 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.542 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.76 -43.73 98.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.988 ' HB3' HD23 ' A' ' 362' ' ' LEU . 70.2 mttt -71.44 -49.83 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.614 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.55 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 1.8 pt20 -70.87 -42.54 69.94 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.704 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.7 mmt180 -73.62 -46.01 49.5 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 111.147 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.667 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 72.3 m-85 -135.93 -36.59 0.75 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.57 -1.331 . . . . 0.0 112.226 -169.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.0 t30 -159.57 103.16 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.549 -1.344 . . . . 0.0 111.682 -169.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.988 HD23 ' HB3' ' A' ' 357' ' ' LYS . 33.1 mt -57.78 89.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.893 -1.129 . . . . 0.0 109.113 171.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.543 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.0 tpt180 -135.43 164.71 27.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.436 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.9 mt-10 -135.8 -157.14 0.77 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.016 -1.052 . . . . 0.0 110.495 -177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 36.8 ptt180 -97.48 165.14 12.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.674 -0.641 . . . . 0.0 110.716 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.473 ' OD1' HD13 ' A' ' 388' ' ' ILE . 55.0 p30 -138.05 45.52 2.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.379 -0.826 . . . . 0.0 110.758 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.004 HG21 ' CE1' ' A' ' 374' ' ' PHE . 92.7 t -71.15 -42.38 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.334 -0.854 . . . . 0.0 110.341 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.78 -21.32 66.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 111.032 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -29.39 25.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.04 -1.038 . . . . 0.0 110.026 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 1.079 HD12 HD11 ' A' ' 388' ' ' ILE . 16.6 mt -105.38 -3.68 22.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.552 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 24.0 m80 62.11 53.33 2.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 109.649 -173.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.918 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.19 174.96 6.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.501 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.0 m -120.9 136.4 54.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.416 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.004 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.0 m-85 -90.62 145.1 25.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.668 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 21.5 t -118.6 101.32 50.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.11 155.18 19.88 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.105 1.582 . . . . 0.0 110.613 -175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.55 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 50.5 t80 -71.92 134.7 46.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.393 -0.817 . . . . 0.0 110.442 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 4.8 p -114.56 143.48 44.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.785 174.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.51 -25.08 59.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.646 -0.659 . . . . 0.0 110.357 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.81 -43.74 98.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 383' ' ' MET . 74.2 m -93.81 -14.41 26.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 110.164 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.7 mtt-85 57.45 48.21 15.01 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.617 -0.677 . . . . 0.0 109.646 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.898 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.1 ptp -165.34 171.23 13.73 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.781 0.8 . . . . 0.0 111.288 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.55 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 39.8 p -156.31 165.31 36.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.82 -165.96 34.11 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.025 -1.56 . . . . 0.0 110.637 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 367' ' ' VAL . 1.3 tt -143.34 147.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.61 -0.935 . . . . 0.0 110.399 -174.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.493 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 56.1 m-20 -115.78 134.25 55.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.902 -1.124 . . . . 0.0 108.974 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 1.079 HD11 HD12 ' A' ' 370' ' ' LEU . 2.2 tt -142.63 154.41 17.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.9 -1.125 . . . . 0.0 109.611 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 88.7 m-20 -23.95 -62.02 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 112.298 173.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.478 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.5 t-20 -95.87 -5.45 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.539 -0.725 . . . . 0.0 111.801 -167.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.602 ' NH2' HD21 ' A' ' 339' ' ' LEU . 18.1 mtp180 -145.5 147.73 32.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.684 -1.26 . . . . 0.0 110.74 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.3 mtm -132.51 95.68 3.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.831 -1.168 . . . . 0.0 108.789 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 339' ' ' LEU . 7.6 mt -122.58 146.25 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.946 -1.096 . . . . 0.0 110.429 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 40.2 mtt180 -133.51 159.14 41.29 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 110.767 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.611 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.43 128.86 34.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.694 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.51 174.32 33.59 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.0 m -56.36 151.35 13.14 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.956 -1.32 . . . . 0.0 108.496 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.13 HG21 HG11 ' A' ' 420' ' ' VAL . 53.4 t -57.08 -34.28 44.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.027 -1.046 . . . . 0.0 109.887 -176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 19.7 t70 -62.86 -47.48 83.18 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.898 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.2 -49.12 62.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.042 -1.036 . . . . 0.0 110.652 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.694 HD11 ' N ' ' A' ' 396' ' ' GLY . 45.0 mm -65.06 -43.29 95.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.108 -0.995 . . . . 0.0 110.809 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.579 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 2.4 ttt180 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.0 mtt-85 -61.14 -37.75 83.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.979 -1.075 . . . . 0.0 109.607 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.517 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.2 t-80 -67.62 -35.85 79.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 111.222 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.564 ' CG2' HG11 ' A' ' 434' ' ' VAL . 56.0 t -65.85 -48.98 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.673 -1.267 . . . . 0.0 110.187 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.2 -34.45 77.68 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.291 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.99 79.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.954 -1.091 . . . . 0.0 110.021 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.552 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 6.3 m-80 -61.55 -27.67 68.79 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.491 -0.756 . . . . 0.0 109.114 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.13 19.77 27.53 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.1 -169.14 15.85 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.424 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.86 153.61 42.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -1.215 . . . . 0.0 111.328 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.582 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 8.3 p90 -108.01 149.66 39.39 Favored Pre-proline 0 N--CA 1.501 2.105 0 O-C-N 121.625 -0.672 . . . . 0.0 110.24 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.821 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.95 125.21 9.2 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.853 1.449 . . . . 0.0 110.573 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.79 -34.32 77.56 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.161 -0.962 . . . . 0.0 111.051 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.7 m-20 -60.84 -33.08 72.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 108.864 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.036 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.0 t -83.78 -42.57 17.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.017 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 71.9 m-20 -54.85 -37.29 66.01 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.48 171.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.4 mt-30 -63.31 -48.68 77.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.292 -1.505 . . . . 0.0 110.102 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.694 ' HD3' HG21 ' A' ' 323' ' ' ILE . 26.3 mttt -56.84 -34.85 68.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.704 -1.248 . . . . 0.0 110.392 177.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.13 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 109.171 171.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.9 t0 -66.62 -36.66 83.13 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.791 0.805 . . . . 0.0 109.517 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 84.8 mt-30 -67.04 -37.02 83.34 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.631 -0.668 . . . . 0.0 110.612 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.797 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.0 t -62.43 -36.94 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.125 . . . . 0.0 110.005 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.68 -43.96 87.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -0.908 . . . . 0.0 110.435 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 6.0 mtp85 -64.98 -29.86 70.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 110.517 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.28 -3.87 53.84 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.683 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.52 22.1 38.28 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.797 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.39 164.26 12.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.395 -1.062 . . . . 0.0 109.727 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.451 ' HG1' HH11 ' A' ' 317' ' ' ARG . 28.4 m -109.57 107.04 59.19 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.045 -1.035 . . . . 0.0 109.748 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.585 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.0 Cg_endo -75.61 108.27 2.66 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 O-C-N 124.014 1.534 . . . . 0.0 110.62 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.854 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.1 mt -92.6 134.13 35.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.872 -1.142 . . . . 0.0 108.622 167.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.994 ' CG2' HG22 ' A' ' 398' ' ' VAL . 90.3 t -100.51 134.29 40.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.771 -1.205 . . . . 0.0 109.504 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.778 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.3 t -115.03 139.09 43.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.816 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -119.89 160.09 20.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.458 -0.776 . . . . 0.0 109.587 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.51 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -135.01 130.38 35.61 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.58 -129.22 27.74 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -167.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.559 ' O ' HG13 ' A' ' 405' ' ' VAL . 78.0 p -106.16 7.64 31.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.244 . . . . 0.0 111.082 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -118.99 170.43 9.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.588 -1.32 . . . . 0.0 110.048 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.816 ' HA ' HG12 ' A' ' 434' ' ' VAL . 24.3 t -92.67 134.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.857 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -96.68 -20.6 18.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.721 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 1.021 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.76 176.53 38.46 Favored Glycine 0 N--CA 1.5 2.926 0 C-N-CA 118.815 -1.659 . . . . 0.0 111.024 168.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.079 HG21 HG23 ' A' ' 420' ' ' VAL . 55.8 t -107.7 142.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.242 -1.152 . . . . 0.0 109.95 173.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.714 HD11 ' CB ' ' A' ' 337' ' ' ALA . 81.7 mt -101.32 110.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 109.023 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.626 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.7 118.31 30.54 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.047 -1.033 . . . . 0.0 109.831 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.854 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -101.67 141.67 34.18 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.564 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 11.0 mtmt -115.7 162.11 17.73 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.763 -1.211 . . . . 0.0 111.038 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -81.15 144.62 31.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.599 -0.688 . . . . 0.0 110.227 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 448' ' ' ILE . 10.6 tp -119.99 153.67 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 110.267 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.54 135.05 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.246 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -92.96 144.99 24.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 110.21 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.989 -1.45 . . . . 0.0 109.505 179.929 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.185 0.517 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.479 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 70.8 mtt85 -122.1 144.18 49.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.132 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.4 tt0 -122.5 130.75 53.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 110.354 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.786 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.72 138.62 41.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.992 -1.067 . . . . 0.0 109.815 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.508 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.41 -45.16 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.99 . . . . 0.0 110.339 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 320' ' ' SER . 72.4 mt-10 -154.53 154.59 33.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.228 -0.92 . . . . 0.0 110.511 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.06 ' CD1' HD21 ' A' ' 355' ' ' LEU . 15.6 p90 -135.51 151.5 50.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.956 -1.09 . . . . 0.0 111.572 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.692 HG21 ' HD3' ' A' ' 419' ' ' LYS . 3.4 mt -125.56 140.59 36.79 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.699 -0.625 . . . . 0.0 109.336 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.78 143.12 45.08 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.617 1.325 . . . . 0.0 111.64 -173.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.034 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.22 151.29 45.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.455 -0.778 . . . . 0.0 108.977 165.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.99 129.13 40.51 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.704 -1.247 . . . . 0.0 110.069 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.65 -0.35 49.25 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.5 t -135.36 138.05 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.578 -1.543 . . . . 0.0 110.759 177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.6 m-20 -73.12 148.98 43.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.346 -0.846 . . . . 0.0 110.275 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.2 tt0 -60.59 -34.15 73.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.039 -1.038 . . . . 0.0 109.778 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -58.85 -43.73 90.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 109.139 175.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.547 HG21 HG13 ' A' ' 328' ' ' VAL . 88.9 m -61.17 -42.26 98.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.417 -0.802 . . . . 0.0 110.333 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.976 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.1 tp -60.48 -39.61 88.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.51 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.965 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.93 -44.04 77.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 110.69 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.562 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.9 m-20 -63.51 -48.07 79.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.912 -1.118 . . . . 0.0 110.063 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.959 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -69.17 -31.25 69.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.007 -1.058 . . . . 0.0 109.991 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.13 -35.55 64.81 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 0.0 108.915 172.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.8 mt-30 -74.3 -55.71 5.71 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.72 . . . . 0.0 111.023 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.055 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.9 -33.61 76.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.741 -1.183 . . . . 0.0 110.177 -172.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.72 -21.03 65.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.882 -1.136 . . . . 0.0 110.009 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.654 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.2 p -107.32 10.51 29.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.104 -0.997 . . . . 0.0 111.536 -174.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.587 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 43.6 mt -66.1 -45.18 82.09 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.612 -1.305 . . . . 0.0 109.758 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.05 0.73 49.13 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.976 -170.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.7 p30 -63.02 130.47 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.745 -1.222 . . . . 0.0 109.977 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.66 5.31 51.77 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.576 0.703 . . . . 0.0 109.923 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -76.05 152.87 84.52 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.666 -0.646 . . . . 0.0 109.443 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.58 -38.56 94.02 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.645 1.339 . . . . 0.0 109.117 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.479 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.7 mt-10 -64.32 -28.91 70.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.499 -0.751 . . . . 0.0 110.41 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.02 -37.49 71.41 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -76.92 -38.9 52.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -1.223 . . . . 0.0 110.598 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 4.8 m -62.13 -37.37 84.91 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 110.477 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.687 HG23 HD13 ' A' ' 443' ' ' ILE . 88.6 mt -68.55 -48.82 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.066 -1.021 . . . . 0.0 110.493 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.654 HG22 ' OG ' ' A' ' 341' ' ' SER . 22.0 t -60.9 -32.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.825 -1.172 . . . . 0.0 109.797 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.964 HG22 ' OE1' ' A' ' 358' ' ' GLN . 39.5 mt -72.8 -33.1 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 110.628 171.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.06 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.6 -41.08 84.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.866 -1.146 . . . . 0.0 110.274 178.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.508 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.27 -45.58 87.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.624 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.855 ' HB3' HD23 ' A' ' 362' ' ' LEU . 33.7 mtmt -72.36 -49.29 35.23 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.53 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.964 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.3 pt20 -72.23 -42.82 65.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.543 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -73.83 -43.75 57.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 111.227 -172.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.672 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 82.6 m-85 -135.42 -38.8 0.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.349 -1.341 . . . . 0.0 111.83 -168.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.5 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 16.7 t-20 -162.77 108.36 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.576 -1.328 . . . . 0.0 111.423 -167.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.855 HD23 ' HB3' ' A' ' 357' ' ' LYS . 68.6 mt -57.1 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.016 -1.053 . . . . 0.0 109.096 172.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.1 tpt180 -122.59 164.77 17.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.774 . . . . 0.0 109.408 -178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.502 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.1 mt-10 -141.21 -161.84 1.28 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.587 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 32.1 ptt-85 -97.6 163.67 12.74 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 110.638 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.479 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -129.67 41.8 3.38 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.331 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.056 HG21 ' CE1' ' A' ' 374' ' ' PHE . 41.3 t -73.02 -46.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.19 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 111.109 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.11 -30.12 28.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.692 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 388' ' ' ILE . 21.5 mt -102.69 -4.64 24.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 110.684 -177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 71.4 m-70 60.43 52.21 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 109.853 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.804 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.02 174.51 7.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.491 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 24.0 m -117.12 134.77 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.566 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.056 ' CE1' HG21 ' A' ' 367' ' ' VAL . 92.1 m-85 -90.13 145.91 24.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.438 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 6.5 t -119.11 101.22 49.99 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.649 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -54.54 153.71 22.41 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.073 1.565 . . . . 0.0 110.515 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.549 ' CE2' ' N ' ' A' ' 383' ' ' MET . 55.0 t80 -69.45 134.68 49.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 110.448 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 5.6 p -115.3 143.48 45.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.373 -0.829 . . . . 0.0 109.753 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.47 -24.8 59.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.689 -0.632 . . . . 0.0 110.418 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -61.55 -44.15 97.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 109.733 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 383' ' ' MET . 87.5 p -94.71 -13.57 25.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 110.183 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 57.75 48.09 14.46 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.606 -0.684 . . . . 0.0 109.803 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.889 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.2 ptp -165.44 171.55 13.21 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.779 0.799 . . . . 0.0 111.258 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.541 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 29.0 p -155.46 165.36 36.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.506 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.5 -165.73 34.09 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.048 -1.548 . . . . 0.0 110.694 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.722 HD11 HG22 ' A' ' 367' ' ' VAL . 4.5 tt -140.02 151.51 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.921 . . . . 0.0 110.208 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -127.54 135.55 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 109.693 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.794 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.93 155.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.816 -1.178 . . . . 0.0 109.174 172.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.502 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.5 m-20 -23.08 -63.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.389 0.614 . . . . 0.0 112.502 171.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.459 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 37.1 t30 -96.46 -5.1 40.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 111.808 -167.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.56 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.2 mtp180 -144.97 143.0 30.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.719 -1.238 . . . . 0.0 110.342 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -133.66 108.52 8.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 108.897 169.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.055 HD12 HD11 ' A' ' 339' ' ' LEU . 7.8 mt -128.65 146.03 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 0.0 109.931 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 25.1 mmt85 -134.43 159.7 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.295 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.1 OUTLIER -133.13 126.65 32.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.684 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.19 174.39 32.63 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -57.04 151.28 15.36 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.976 -1.308 . . . . 0.0 108.566 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.129 HG21 HG11 ' A' ' 420' ' ' VAL . 56.0 t -56.7 -35.01 44.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.851 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.85 -47.02 85.17 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.261 -0.9 . . . . 0.0 110.321 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.889 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.91 -49.18 63.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.963 -1.086 . . . . 0.0 110.59 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.684 HD11 ' N ' ' A' ' 396' ' ' GLY . 39.4 mm -65.59 -43.8 93.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.06 -1.025 . . . . 0.0 110.817 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.589 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 9.8 ttp180 -59.22 -43.26 92.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.243 -0.911 . . . . 0.0 110.34 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.5 mtp180 -61.88 -36.37 81.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 173.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -67.93 -36.25 79.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.878 . . . . 0.0 111.236 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.62 -49.13 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.479 -1.388 . . . . 0.0 110.103 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -34.34 77.46 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.325 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.73 78.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.946 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.548 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 10.9 m-80 -61.8 -27.31 68.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.11 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.89 19.57 28.62 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.57 -169.02 16.17 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.448 ' C ' HG11 ' A' ' 405' ' ' VAL . 77.5 m80 -143.21 153.41 42.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.163 -1.198 . . . . 0.0 111.324 -174.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.5 p90 -108.39 149.75 39.71 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.642 -0.661 . . . . 0.0 110.182 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.828 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.71 124.0 8.45 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.879 1.463 . . . . 0.0 110.5 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.25 -34.22 77.51 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 110.986 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 91.1 m-20 -60.82 -33.03 72.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 108.836 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.034 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.7 t -83.52 -42.48 17.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.582 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.3 m-20 -54.8 -37.41 66.03 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.559 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.25 -48.32 78.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.17 -1.581 . . . . 0.0 110.104 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.692 ' HD3' HG21 ' A' ' 323' ' ' ILE . 19.1 mttp -56.58 -35.2 67.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.6 -1.313 . . . . 0.0 110.429 176.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.129 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.65 -40.98 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.885 -1.135 . . . . 0.0 109.208 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.76 -36.28 82.06 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.824 0.821 . . . . 0.0 109.581 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.67 -36.78 81.34 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.689 -0.632 . . . . 0.0 110.692 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.758 HG13 ' HB3' ' A' ' 428' ' ' ALA . 79.2 t -62.84 -37.95 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.005 -1.059 . . . . 0.0 110.043 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.13 85.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 110.406 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -67.91 -31.5 71.31 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 110.922 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.31 -3.47 55.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.724 175.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.92 22.04 29.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.758 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.99 164.09 12.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -1.1 . . . . 0.0 109.562 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.61 ' HB ' HD12 ' A' ' 445' ' ' LEU . 93.9 m -109.89 107.29 58.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.077 -1.014 . . . . 0.0 109.691 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.581 ' HB2' HG22 ' A' ' 420' ' ' VAL . 39.7 Cg_endo -75.95 108.04 2.6 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 123.88 1.463 . . . . 0.0 110.613 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.894 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.4 mt -92.83 134.33 35.18 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.837 -1.164 . . . . 0.0 108.64 166.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.984 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.4 t -100.67 134.6 40.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 120.698 -1.251 . . . . 0.0 109.445 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.744 ' CG1' HD11 ' A' ' 440' ' ' LEU . 45.3 t -115.09 136.36 52.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.816 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.4 m -117.09 159.92 16.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.41 -0.806 . . . . 0.0 109.601 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.507 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.91 130.63 34.07 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.08 -133.17 31.17 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 405' ' ' VAL . 77.8 p -102.46 8.34 40.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.105 -1.232 . . . . 0.0 111.053 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -120.44 171.01 8.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.546 -1.346 . . . . 0.0 109.995 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.816 ' HA ' HG12 ' A' ' 434' ' ' VAL . 23.7 t -92.59 134.52 30.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.845 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.839 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.42 -22.13 18.49 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.308 -0.87 . . . . 0.0 109.793 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.976 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.47 176.95 38.64 Favored Glycine 0 N--CA 1.499 2.851 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.965 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.052 HG21 HG23 ' A' ' 420' ' ' VAL . 55.5 t -107.95 142.83 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.247 -1.149 . . . . 0.0 109.915 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.764 HD11 ' HB1' ' A' ' 337' ' ' ALA . 77.1 mt -101.49 111.42 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 108.907 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.615 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.85 118.58 30.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.917 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.894 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -113.47 162.02 16.64 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.759 -1.213 . . . . 0.0 110.974 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -73.63 144.73 45.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.638 -0.663 . . . . 0.0 110.207 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 448' ' ' ILE . 10.3 tp -120.69 153.46 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 110.227 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.21 135.44 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.27 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -90.59 145.39 24.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.187 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 117.937 -1.479 . . . . 0.0 109.501 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.228 0.537 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 97.3 mtt180 -122.85 146.69 47.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.893 . . . . 0.0 110.181 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.534 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.8 mt-30 -133.81 147.95 51.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.247 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.802 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -59.85 138.27 57.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 109.965 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 321' ' ' GLU . 46.6 m -122.13 -40.98 2.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.526 ' HG2' ' NH2' ' A' ' 359' ' ' ARG . 65.9 mt-10 -154.94 149.82 26.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.066 ' CD1' HD21 ' A' ' 355' ' ' LEU . 10.5 p90 -135.97 157.74 46.09 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.48 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.71 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.4 mt -134.84 140.16 34.38 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.604 -0.685 . . . . 0.0 109.397 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.561 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.54 144.82 50.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.644 1.339 . . . . 0.0 111.568 -172.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.058 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.74 151.52 43.5 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.134 -0.979 . . . . 0.0 108.829 164.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.86 129.4 41.95 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.658 -1.276 . . . . 0.0 110.095 -172.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.09 -1.48 44.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.3 t -136.16 138.92 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.473 . . . . 0.0 110.647 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.3 m-20 -73.36 151.88 41.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.166 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -62.86 -39.81 95.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.023 -1.048 . . . . 0.0 110.362 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.92 -42.93 90.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.782 -1.198 . . . . 0.0 109.438 175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.515 HG21 HG13 ' A' ' 328' ' ' VAL . 94.4 m -56.9 -43.62 81.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.859 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 1.022 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -59.1 -40.58 85.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.33 -41.37 85.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.761 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -64.07 -49.73 71.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.914 -1.116 . . . . 0.0 109.92 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.892 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.98 -31.25 70.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.903 -1.123 . . . . 0.0 109.569 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.696 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.59 -35.23 65.59 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.324 -0.86 . . . . 0.0 108.985 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.7 mt-30 -74.25 -55.84 5.58 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.479 -0.763 . . . . 0.0 110.861 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.097 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.78 -36.14 80.22 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.681 -1.208 . . . . 0.0 109.807 -172.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.401 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -66.74 -20.67 66.01 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.055 173.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.2 p -107.35 9.18 29.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.215 -0.928 . . . . 0.0 111.552 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.4 -44.46 82.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.564 -1.335 . . . . 0.0 109.626 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.17 1.61 50.04 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.816 -170.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.478 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -64.34 130.6 44.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.732 -1.23 . . . . 0.0 109.944 175.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.72 5.44 51.39 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.58 0.705 . . . . 0.0 109.872 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.31 150.43 80.1 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.53 -0.731 . . . . 0.0 109.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.74 -38.14 84.75 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.651 1.342 . . . . 0.0 109.148 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.5 mt-10 -64.29 -28.58 69.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.496 -0.752 . . . . 0.0 110.377 176.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.33 -37.6 74.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -175.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 354' ' ' ILE . 96.1 mtt180 -77.32 -38.0 51.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.658 174.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.534 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 9.6 m -61.36 -37.97 85.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 110.365 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.542 HG23 HD13 ' A' ' 443' ' ' ILE . 88.8 mt -68.51 -49.31 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.069 -1.02 . . . . 0.0 110.602 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.619 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -61.17 -33.36 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.935 -1.103 . . . . 0.0 110.167 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.6 mt -72.84 -32.58 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.704 -1.248 . . . . 0.0 110.603 171.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.066 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.53 -40.82 88.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.964 -1.085 . . . . 0.0 110.414 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.26 -44.67 94.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.497 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.995 ' HB3' HD23 ' A' ' 362' ' ' LEU . 67.4 mttt -71.33 -47.37 56.96 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.743 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.545 ' CG ' ' HG3' ' A' ' 359' ' ' ARG . 20.5 pt20 -70.7 -42.58 70.45 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.667 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.545 ' HG3' ' CG ' ' A' ' 358' ' ' GLN . 40.8 mtp85 -79.89 -42.23 24.59 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 111.517 -170.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 85.5 m-85 -134.98 -35.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.437 -1.414 . . . . 0.0 112.097 -170.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 57.0 t-20 -161.86 101.87 1.15 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.632 -1.293 . . . . 0.0 111.669 -169.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.995 HD23 ' HB3' ' A' ' 357' ' ' LYS . 32.5 mt -57.47 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.816 -1.177 . . . . 0.0 108.908 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.542 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.9 tpt180 -134.34 164.31 27.69 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.416 -0.802 . . . . 0.0 109.241 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -135.74 -157.08 0.76 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.962 -1.086 . . . . 0.0 110.355 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 37.1 ptt180 -94.54 163.24 13.47 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.651 -0.655 . . . . 0.0 110.494 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.787 ' O ' HD12 ' A' ' 370' ' ' LEU . 88.3 m-20 -130.82 42.26 3.26 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.398 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.995 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.5 t -73.56 -45.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.502 -0.749 . . . . 0.0 110.345 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.78 -24.11 64.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.351 -0.843 . . . . 0.0 111.146 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.42 -32.85 32.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.013 -1.054 . . . . 0.0 109.719 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 366' ' ' ASP . 12.4 mt -104.73 -2.64 24.64 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.565 -0.709 . . . . 0.0 110.569 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 70.8 m-70 61.06 51.93 4.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.0 109.827 -176.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.758 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -92.78 174.64 7.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 0.0 110.533 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 21.8 m -119.18 136.22 54.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.478 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.995 ' CE1' HG21 ' A' ' 367' ' ' VAL . 73.4 m-85 -89.69 149.09 22.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.473 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 48.7 t -124.31 100.84 35.2 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.124 -0.985 . . . . 0.0 109.629 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -57.04 149.59 61.52 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.995 1.524 . . . . 0.0 110.251 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 21.4 t80 -63.61 129.95 42.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.87 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p -118.78 150.66 39.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.336 -0.853 . . . . 0.0 109.747 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.54 -4.26 47.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.584 -0.698 . . . . 0.0 109.985 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.55 -36.38 64.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.531 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 73.7 m -139.7 10.35 2.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 110.33 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 82.7 mtm180 58.1 52.77 7.28 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.311 -0.868 . . . . 0.0 109.735 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.832 ' HG2' ' HB1' ' A' ' 400' ' ' ALA . 0.7 OUTLIER -150.29 161.54 42.24 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.604 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 10.1 p -153.47 164.94 37.31 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 174.29 -164.94 36.26 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.881 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.901 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.6 tt -141.0 150.53 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.697 -0.884 . . . . 0.0 110.143 -176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -126.67 137.6 53.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.624 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.76 ' CD1' HD13 ' A' ' 370' ' ' LEU . 2.0 tt -141.53 154.7 20.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.941 -1.099 . . . . 0.0 109.352 172.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.506 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 88.9 m-20 -20.88 -62.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.48 0.657 . . . . 0.0 112.568 171.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.463 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t-20 -98.01 -7.49 29.79 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 111.934 -166.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.562 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 17.8 mtp180 -142.4 149.88 39.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.71 -1.244 . . . . 0.0 110.604 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -137.47 102.13 4.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 0.0 109.188 170.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.097 HD12 HD11 ' A' ' 339' ' ' LEU . 6.0 mt -121.64 146.09 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.097 -1.002 . . . . 0.0 110.007 -173.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.514 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 0.0 OUTLIER -136.77 155.32 49.98 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 110.261 177.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.608 ' HB3' HG22 ' A' ' 433' ' ' VAL . 43.7 pttt -129.23 145.82 51.26 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.17 173.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 401' ' ' ILE . . . -170.54 174.89 44.51 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 52.5 p -55.85 150.45 13.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.784 -1.421 . . . . 0.0 108.526 170.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.083 HG22 ' CG2' ' A' ' 432' ' ' VAL . 64.1 t -59.78 -34.96 57.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.064 -1.023 . . . . 0.0 109.977 -174.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.517 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 49.2 t0 -62.32 -45.89 91.21 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.196 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.832 ' HB1' ' HG2' ' A' ' 383' ' ' MET . . . -70.75 -52.01 23.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.085 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.769 HD13 ' CE ' ' A' ' 383' ' ' MET . 21.1 mm -62.98 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.998 -1.064 . . . . 0.0 110.505 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.595 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 13.4 ttp85 -59.46 -43.91 93.11 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.517 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 93.1 mtt180 -61.23 -36.99 81.46 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.448 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -66.9 -35.86 80.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -64.81 -49.72 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.455 -1.403 . . . . 0.0 110.152 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.63 -34.67 77.52 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.86 -1.15 . . . . 0.0 110.239 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.14 -35.76 78.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.995 -1.066 . . . . 0.0 109.971 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.7 m-80 -61.38 -27.38 68.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 109.134 173.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.87 19.59 28.62 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -169.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.42 -169.32 16.38 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -145.26 153.94 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -1.161 . . . . 0.0 111.232 -174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 439' ' ' VAL . 10.3 p90 -109.11 149.26 39.44 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.457 -0.777 . . . . 0.0 109.978 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.86 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.29 126.89 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.929 1.489 . . . . 0.0 110.401 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.3 t -66.92 -34.86 78.71 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.989 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.1 m-20 -62.01 -33.31 74.1 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.898 -1.126 . . . . 0.0 108.882 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.058 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.6 t -83.46 -41.77 17.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 110.987 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.33 -38.5 68.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.826 -1.171 . . . . 0.0 109.416 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.1 -47.92 80.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.374 -1.453 . . . . 0.0 110.264 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.71 ' HD3' HG21 ' A' ' 323' ' ' ILE . 66.9 mttm -56.39 -35.19 67.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.691 -1.256 . . . . 0.0 110.372 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.128 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -60.65 -40.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.405 172.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -65.85 -36.24 82.9 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 425' ' ' ARG . 94.9 mm-40 -68.38 -38.2 81.13 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 428' ' ' ALA . 63.0 t -61.0 -37.03 76.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.689 -1.257 . . . . 0.0 110.056 175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.0 82.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.969 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 422' ' ' GLN . 17.7 ptt180 -70.86 -28.68 64.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.721 -1.237 . . . . 0.0 111.097 -171.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 1.0 OUTLIER -82.62 -8.55 59.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.895 -1.128 . . . . 0.0 109.64 174.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.43 22.21 13.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.705 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -102.9 161.9 13.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -1.157 . . . . 0.0 109.323 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.873 ' HB ' HD12 ' A' ' 445' ' ' LEU . 2.0 m -109.16 106.94 59.49 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.062 . . . . 0.0 109.778 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 398' ' ' VAL . 44.5 Cg_endo -76.57 107.67 2.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 124.015 1.534 . . . . 0.0 110.452 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.86 ' HG ' HD11 ' A' ' 445' ' ' LEU . 10.3 mt -92.43 133.47 35.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.92 -1.112 . . . . 0.0 108.533 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 1.083 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.2 t -99.01 135.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 O-C-N 120.711 -1.243 . . . . 0.0 109.424 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.757 ' CG1' HD11 ' A' ' 440' ' ' LEU . 44.0 t -117.66 136.7 53.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 108.91 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.3 m -117.86 160.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.492 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.52 129.01 34.47 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.69 -131.6 28.98 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -167.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.608 ' O ' HG13 ' A' ' 405' ' ' VAL . 73.1 p -103.06 6.79 38.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.13 -1.218 . . . . 0.0 111.118 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -119.95 171.0 8.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.644 -1.285 . . . . 0.0 110.069 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.812 ' HA ' HG12 ' A' ' 434' ' ' VAL . 42.9 t -90.57 134.61 28.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.815 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -93.17 -22.6 18.96 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.672 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 1.022 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.33 176.87 39.04 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 118.883 -1.627 . . . . 0.0 110.721 170.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.128 HG21 HG23 ' A' ' 420' ' ' VAL . 56.6 t -107.94 142.84 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.161 -1.2 . . . . 0.0 109.994 174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.8 mt -101.83 110.9 29.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 170.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.08 118.48 30.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.826 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.873 HD12 ' HB ' ' A' ' 429' ' ' THR . 0.9 OUTLIER -101.23 146.09 27.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 320' ' ' SER . 15.2 mmtp -107.61 150.38 26.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.566 -1.334 . . . . 0.0 110.58 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -101.13 148.16 25.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.708 -0.62 . . . . 0.0 110.255 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.5 tp -119.61 153.58 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 110.237 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.57 135.52 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.902 . . . . 0.0 110.329 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -90.75 145.6 24.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.22 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.561 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 75.9 mtt85 -123.05 150.29 43.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.254 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 351' ' ' SER . 93.4 mt-30 -125.31 147.83 48.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.863 . . . . 0.0 109.994 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.77 ' CA ' HD23 ' A' ' 445' ' ' LEU . . . -57.32 135.96 56.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.841 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.527 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 2.4 m -127.48 -37.21 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 110.385 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 320' ' ' SER . 65.2 mt-10 -153.58 148.07 26.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.958 . . . . 0.0 110.597 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.07 ' CD1' HD21 ' A' ' 355' ' ' LEU . 6.1 p90 -137.86 147.4 44.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.726 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.693 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.8 mt -119.96 141.83 32.16 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 109.625 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.54 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.02 143.23 40.06 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.735 1.387 . . . . 0.0 111.481 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.086 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.85 152.65 43.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.185 -0.947 . . . . 0.0 108.662 165.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -57.56 127.85 34.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.679 -1.263 . . . . 0.0 110.336 -172.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 115.68 -28.0 8.03 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 440' ' ' LEU . 42.4 t -115.0 140.49 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.738 -1.448 . . . . 0.0 110.943 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.03 150.13 44.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 109.788 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -61.35 -39.47 90.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 31.8 ttmt -60.51 -45.12 94.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.795 -1.191 . . . . 0.0 109.735 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 92.4 m -55.97 -43.92 78.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.698 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.616 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -58.03 -39.14 77.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.817 . . . . 0.0 110.233 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.022 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.92 -42.1 81.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 0.0 110.691 -176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -62.87 -48.35 79.4 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.924 -1.11 . . . . 0.0 109.832 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.899 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.02 -31.86 71.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.026 -1.046 . . . . 0.0 109.765 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.32 -35.25 64.93 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 172.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.543 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 20.6 mt-30 -74.67 -56.28 4.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.501 -0.749 . . . . 0.0 110.838 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.987 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -60.97 -35.39 76.67 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.756 -1.177 . . . . 0.0 109.772 -172.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 395' ' ' LYS . . . -68.03 -19.52 64.91 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.088 -1.007 . . . . 0.0 109.782 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.1 p -108.23 9.41 28.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.206 -0.934 . . . . 0.0 111.639 -175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.722 HD22 ' HD2' ' A' ' 365' ' ' ARG . 36.8 mt -64.71 -44.84 88.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.551 -1.343 . . . . 0.0 109.705 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.49 1.72 46.94 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.707 -169.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.1 p30 -62.61 130.28 44.36 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.952 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.68 5.35 51.63 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.528 0.68 . . . . 0.0 109.891 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.56 152.4 83.3 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.607 -0.683 . . . . 0.0 109.432 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.95 -38.79 94.15 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.713 1.375 . . . . 0.0 109.08 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.7 mt-10 -64.35 -28.87 70.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.458 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.51 -37.26 66.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.494 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -76.69 -37.37 56.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.219 . . . . 0.0 110.553 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 318' ' ' GLN . 11.3 m -61.36 -38.44 86.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.001 -1.062 . . . . 0.0 110.42 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.628 HG23 HD13 ' A' ' 443' ' ' ILE . 83.7 mt -68.98 -48.84 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.051 . . . . 0.0 110.534 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.628 HG22 ' OG ' ' A' ' 341' ' ' SER . 30.4 t -61.67 -34.03 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.952 -1.092 . . . . 0.0 110.076 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.4 mt -72.89 -32.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.601 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.07 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.68 -40.91 89.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.39 178.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.93 99.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 82.7 mttt -71.26 -50.21 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.892 -1.13 . . . . 0.0 110.924 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.548 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.9 pt20 -70.36 -42.38 71.89 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.497 -174.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 30.6 mmt180 -74.16 -46.02 44.95 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 111.24 -172.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 78.3 m-85 -135.51 -35.5 0.81 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.437 -1.305 . . . . 0.0 112.437 -168.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.501 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 23.1 t-20 -160.52 97.85 1.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.484 -1.385 . . . . 0.0 111.677 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 362' ' ' LEU . 5.5 mp -58.77 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.933 -1.105 . . . . 0.0 109.59 171.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.524 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.8 tpt180 -147.84 163.08 37.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.387 -0.821 . . . . 0.0 109.618 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.7 mt-10 -125.97 -157.36 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.722 ' HD2' HD22 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -96.66 165.35 12.18 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.531 -0.73 . . . . 0.0 110.596 -178.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.475 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -121.0 38.08 4.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.428 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.966 ' CG2' HD11 ' A' ' 386' ' ' ILE . 71.0 t -69.28 -44.95 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.787 . . . . 0.0 110.307 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -67.43 -26.6 66.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.971 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -29.14 25.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.904 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.964 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.7 mt -103.45 -2.36 27.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.777 . . . . 0.0 110.837 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 27.2 m80 62.62 52.65 2.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.09 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.925 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -94.99 174.71 6.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.9 m -115.97 134.32 55.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 110.421 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.941 ' CE2' HG11 ' A' ' 367' ' ' VAL . 68.3 m-85 -89.19 149.26 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.541 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 24.1 t -122.71 100.97 40.29 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.9 Cg_endo -56.11 151.45 42.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.124 1.592 . . . . 0.0 110.486 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.51 131.63 46.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.096 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.1 p -120.71 152.94 37.62 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.44 -6.02 51.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.511 -0.743 . . . . 0.0 109.967 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.81 -32.86 66.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.872 . . . . 0.0 109.823 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 383' ' ' MET . 2.7 m -139.51 10.2 2.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 110.237 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 72.3 mtt85 56.91 51.06 11.2 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.868 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.3 ptp -158.69 168.61 26.41 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.948 0.88 . . . . 0.0 111.277 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 395' ' ' LYS . 34.1 p -152.86 165.19 36.22 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -176.74 -165.89 32.96 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.04 -1.552 . . . . 0.0 110.527 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.966 HD11 ' CG2' ' A' ' 367' ' ' VAL . 9.4 tt -144.1 150.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -1.03 . . . . 0.0 110.104 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 394' ' ' ARG . 43.0 m-20 -127.59 133.04 49.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.003 -1.061 . . . . 0.0 109.864 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.964 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.6 tt -139.28 155.03 25.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 120.75 -1.219 . . . . 0.0 109.165 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.504 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 90.7 m-20 -23.8 -62.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 172.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.445 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 49.5 t30 -92.36 -9.58 41.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 111.884 -167.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.587 ' H ' HG23 ' A' ' 388' ' ' ILE . 30.4 mtp180 -140.56 147.4 39.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.613 -1.304 . . . . 0.0 110.744 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.5 mtt -138.3 100.67 4.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.983 -1.073 . . . . 0.0 109.112 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.987 HD12 HD11 ' A' ' 339' ' ' LEU . 7.5 mt -122.66 146.47 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.934 -1.104 . . . . 0.0 110.296 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 387' ' ' ASN . 66.6 mmt-85 -130.49 156.84 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.142 174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -132.91 125.46 29.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.458 -0.776 . . . . 0.0 108.97 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.529 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.85 173.94 32.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.717 -173.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.4 m -56.09 150.74 13.36 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.916 -1.343 . . . . 0.0 108.537 169.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.006 HG21 ' CG1' ' A' ' 420' ' ' VAL . 17.7 t -55.69 -37.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 109.932 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -64.04 -43.74 94.62 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.287 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.868 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.35 -51.2 47.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.555 HD13 ' HE1' ' A' ' 383' ' ' MET . 33.5 mm -64.96 -44.07 96.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 120.995 -1.066 . . . . 0.0 110.789 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.5 ttt180 -59.47 -42.94 93.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.192 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.9 mtp85 -61.65 -36.32 80.47 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.041 -1.037 . . . . 0.0 109.546 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.9 t-80 -67.49 -38.37 84.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 111.323 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.468 HG12 ' C ' ' A' ' 410' ' ' GLY . 67.9 t -65.88 -47.42 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.08 -34.25 77.6 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.859 -1.151 . . . . 0.0 110.33 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.34 80.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.093 . . . . 0.0 109.857 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 24.5 m-80 -62.01 -27.15 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.73 30.53 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -168.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.26 -170.67 18.37 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -146.9 153.92 40.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.173 -1.192 . . . . 0.0 111.111 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.628 ' HB3' HG21 ' A' ' 439' ' ' VAL . 6.8 p90 -108.99 151.9 42.15 Favored Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.456 -0.778 . . . . 0.0 110.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.874 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.4 125.99 11.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.909 1.478 . . . . 0.0 110.344 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.3 t -67.55 -32.74 73.71 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.7 m-20 -62.96 -33.6 75.73 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.895 -1.128 . . . . 0.0 108.808 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.086 HG21 ' HA ' ' A' ' 325' ' ' ALA . 51.1 t -83.71 -41.74 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.018 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.06 -38.37 67.94 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.8 -1.188 . . . . 0.0 109.475 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.3 mm-40 -63.48 -48.1 79.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 110.294 171.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.693 ' CD ' HG21 ' A' ' 323' ' ' ILE . 48.7 mttm -56.44 -35.25 67.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.611 -1.306 . . . . 0.0 110.411 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.034 HG23 HG21 ' A' ' 442' ' ' VAL . 2.9 t -60.14 -41.31 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.965 -1.084 . . . . 0.0 109.327 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.15 -35.91 81.74 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.852 0.835 . . . . 0.0 109.442 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -68.48 -37.62 80.3 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.582 -0.699 . . . . 0.0 110.886 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.696 HG13 ' HB3' ' A' ' 428' ' ' ALA . 70.9 t -62.85 -37.87 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.974 -1.079 . . . . 0.0 110.008 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.17 -40.38 82.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.945 . . . . 0.0 110.373 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.54 -31.22 70.3 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.252 -0.905 . . . . 0.0 110.931 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -81.46 -3.83 54.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.064 -1.023 . . . . 0.0 109.607 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 21.83 30.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.696 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.91 169.99 8.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 109.798 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.823 ' HB ' HD12 ' A' ' 445' ' ' LEU . 16.7 m -113.18 106.82 54.52 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.04 -1.037 . . . . 0.0 110.075 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.542 ' CG ' HG13 ' A' ' 420' ' ' VAL . 49.4 Cg_endo -79.39 107.38 2.16 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 O-C-N 123.898 1.473 . . . . 0.0 110.489 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.879 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.8 mt -93.09 137.95 31.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.883 -1.136 . . . . 0.0 108.625 167.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.912 ' CG2' HG22 ' A' ' 398' ' ' VAL . 92.4 t -101.56 134.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.678 -1.264 . . . . 0.0 109.613 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.812 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.7 t -114.52 134.53 57.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 108.824 174.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -118.4 160.13 18.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.501 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.52 130.15 32.04 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 171.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.88 -127.99 28.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.485 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.66 13.53 25.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -1.223 . . . . 0.0 111.233 -178.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -126.35 170.42 11.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 109.949 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.835 ' HA ' HG12 ' A' ' 434' ' ' VAL . 60.5 t -89.87 133.73 31.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.76 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -92.74 -21.36 20.0 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.323 -0.861 . . . . 0.0 109.574 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.825 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 168.93 176.86 39.36 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 118.909 -1.615 . . . . 0.0 111.093 169.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.034 HG21 HG23 ' A' ' 420' ' ' VAL . 56.4 t -107.88 142.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.071 -1.252 . . . . 0.0 109.777 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.701 HD11 ' HB1' ' A' ' 337' ' ' ALA . 77.5 mt -101.44 113.08 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.373 -0.83 . . . . 0.0 109.036 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.38 118.63 31.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.036 -1.04 . . . . 0.0 109.881 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.879 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.8 144.23 30.72 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.527 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.6 OUTLIER -137.4 168.32 19.87 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.574 -1.329 . . . . 0.0 110.986 -177.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -71.0 148.27 47.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.517 -0.739 . . . . 0.0 110.292 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.7 tp -117.27 154.31 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 110.117 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.25 136.36 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.336 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -142.17 147.48 36.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.011 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.547 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.241 0.543 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 94.5 mtt180 -123.22 144.1 49.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.1 mt-30 -130.37 148.81 52.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.081 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.707 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -57.79 136.83 56.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.97 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 3.4 m -118.98 -42.94 2.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 320' ' ' SER . 67.7 mt-10 -154.69 150.89 28.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.444 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.012 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 6.8 p90 -137.53 145.11 42.55 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.763 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.501 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.5 mp -118.26 144.42 34.96 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.596 -0.69 . . . . 0.0 109.775 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.554 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.6 143.62 38.39 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.764 1.402 . . . . 0.0 111.531 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.087 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.53 153.1 41.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 108.793 165.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.85 128.41 37.06 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.675 -1.266 . . . . 0.0 110.146 -172.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.86 -2.6 38.64 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.4 t -136.18 139.45 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.67 -1.488 . . . . 0.0 110.866 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.65 152.67 41.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.578 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.7 tt0 -62.01 -39.23 91.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.053 -1.029 . . . . 0.0 110.365 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -61.08 -45.21 95.67 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.816 -1.177 . . . . 0.0 109.765 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 92.2 m -55.8 -44.17 77.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.197 -0.94 . . . . 0.0 109.596 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.699 ' HA ' HD13 ' A' ' 440' ' ' LEU . 5.3 tp -57.99 -39.87 79.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.315 174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.012 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.27 -40.68 81.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.08 -1.013 . . . . 0.0 110.788 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.0 m-20 -63.44 -49.27 74.33 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.872 -1.143 . . . . 0.0 109.758 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.896 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.48 -31.67 71.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.821 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.656 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.69 -35.55 63.71 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.066 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 22.4 mt-30 -75.23 -55.79 5.36 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.506 -0.746 . . . . 0.0 110.999 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.039 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.28 -34.99 76.1 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.786 -172.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.414 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -66.89 -21.51 66.0 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.14 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.65 ' OG ' HG22 ' A' ' 353' ' ' VAL . 90.9 p -108.09 10.32 28.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.097 -1.002 . . . . 0.0 111.632 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.7 mt -66.28 -44.67 82.92 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.696 -1.252 . . . . 0.0 109.694 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.26 1.43 49.62 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.885 -170.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.7 p30 -64.96 130.22 42.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.753 -1.217 . . . . 0.0 110.03 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.61 4.08 53.43 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.555 0.693 . . . . 0.0 109.863 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 346' ' ' THR . 3.2 p -73.79 152.62 89.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 109.38 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -55.94 -39.26 92.28 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.724 1.381 . . . . 0.0 109.149 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 97.8 mt-10 -65.05 -27.68 68.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.504 -0.747 . . . . 0.0 110.474 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.06 -39.24 79.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 354' ' ' ILE . 65.4 mtt85 -78.55 -35.78 45.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.6 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 6.3 m -60.98 -38.92 87.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.954 -1.091 . . . . 0.0 110.351 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.616 HG23 HD13 ' A' ' 443' ' ' ILE . 88.2 mt -68.45 -49.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.062 . . . . 0.0 110.655 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.65 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.3 t -61.06 -34.57 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.988 -1.07 . . . . 0.0 110.124 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 350' ' ' ARG . 31.4 mt -72.52 -31.97 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 110.455 171.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.984 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.9 OUTLIER -60.12 -40.96 91.57 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.941 -1.099 . . . . 0.0 110.494 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.39 98.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 110.326 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 71.0 mttt -71.33 -49.09 45.99 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.68 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 11.7 pt20 -71.98 -43.26 65.42 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.73 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.594 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 78.7 mmt-85 -73.63 -44.44 56.94 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 111.435 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.594 ' CD2' ' HB3' ' A' ' 359' ' ' ARG . 60.3 m-85 -135.27 -38.72 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.522 -1.361 . . . . 0.0 112.125 -168.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 50.9 t30 -159.45 104.11 1.62 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.214 . . . . 0.0 111.58 -168.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 41.4 mt -57.42 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.875 -1.141 . . . . 0.0 108.912 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.492 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.7 tpt180 -131.42 164.06 26.56 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.477 -0.764 . . . . 0.0 109.25 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.9 mt-10 -138.13 -158.13 0.83 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.978 -1.076 . . . . 0.0 110.543 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.584 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 46.9 ptt85 -97.2 162.54 13.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.647 -0.658 . . . . 0.0 110.677 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 365' ' ' ARG . 89.2 m-20 -133.49 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.507 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.949 HG21 ' CE1' ' A' ' 374' ' ' PHE . 63.6 t -73.4 -47.61 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.491 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.02 -23.55 65.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -30.43 27.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.021 -1.05 . . . . 0.0 109.753 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.986 ' HB3' HD11 ' A' ' 388' ' ' ILE . 16.9 mt -103.53 -4.97 23.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.523 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 56.5 m-70 64.22 52.06 2.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.305 -0.872 . . . . 0.0 110.186 -176.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.912 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.86 174.91 6.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.631 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.4 m -117.98 136.03 53.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.949 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.1 m-85 -88.5 149.11 23.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.596 174.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.685 HG21 HD21 ' A' ' 387' ' ' ASN . 61.8 t -122.31 101.06 41.39 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.133 -0.979 . . . . 0.0 109.658 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.48 151.18 38.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.003 1.528 . . . . 0.0 110.413 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.632 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 15.1 t80 -65.02 132.31 48.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 110.048 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.4 p -120.67 151.96 38.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.354 -0.841 . . . . 0.0 109.611 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.43 -6.79 54.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.555 -0.716 . . . . 0.0 109.868 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -57.11 -32.87 66.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.768 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 6.8 p -138.4 9.61 2.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.331 -0.856 . . . . 0.0 110.353 174.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 79.9 mtm180 57.2 50.86 11.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.55 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.777 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.4 ptp -158.78 168.41 26.9 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.362 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.7 p -153.6 164.93 37.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.32 -166.68 35.54 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.714 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.847 HG21 ' HB2' ' A' ' 339' ' ' LEU . 4.2 tt -138.9 148.99 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.681 -0.894 . . . . 0.0 110.021 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.685 HD21 HG21 ' A' ' 375' ' ' VAL . 32.4 m-20 -127.49 134.91 49.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.892 -1.13 . . . . 0.0 109.678 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.986 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -139.84 154.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.922 -1.111 . . . . 0.0 109.443 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.2 -62.99 0.06 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.48 0.657 . . . . 0.0 112.259 172.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 54.0 t30 -90.93 -10.21 43.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 111.686 -168.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.602 HH21 HD13 ' A' ' 339' ' ' LEU . 23.2 mtp180 -142.31 147.02 35.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.612 -1.305 . . . . 0.0 110.76 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.7 mtt -135.6 108.54 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.916 -1.115 . . . . 0.0 108.996 169.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.039 HD12 HD11 ' A' ' 339' ' ' LEU . 8.4 mt -128.17 145.9 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.008 -1.057 . . . . 0.0 110.058 -175.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 33.4 mtt180 -136.14 160.76 37.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 0.0 110.833 176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.482 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.59 128.05 34.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.641 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.62 173.94 32.28 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 28.5 m -57.27 152.22 14.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.97 -1.312 . . . . 0.0 108.721 170.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.994 HG21 ' CG1' ' A' ' 420' ' ' VAL . 79.1 t -55.72 -35.99 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 109.783 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.6 t0 -63.25 -46.62 86.04 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.359 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.777 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.14 -50.57 53.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.497 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.641 HD11 ' N ' ' A' ' 396' ' ' GLY . 28.4 mm -64.59 -43.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.788 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.591 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.4 ttp180 -59.64 -43.71 93.76 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 67.2 mtp180 -61.93 -36.19 80.65 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.075 -1.015 . . . . 0.0 109.501 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -68.5 -36.46 78.94 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 111.353 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 437' ' ' SER . 55.8 t -65.97 -48.91 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.585 -1.322 . . . . 0.0 110.102 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.37 -34.21 77.22 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.2 79.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.074 . . . . 0.0 109.931 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 7.6 m-80 -61.34 -27.7 68.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 109.153 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.12 19.8 27.45 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -169.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.63 -170.05 15.92 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -144.95 153.79 41.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.186 -1.185 . . . . 0.0 111.097 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.591 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.2 p90 -107.9 150.21 40.02 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.506 -0.746 . . . . 0.0 110.085 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.884 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.98 126.25 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.902 1.475 . . . . 0.0 110.291 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 2.0 t -67.64 -32.48 73.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 110.976 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 88.7 m-20 -63.43 -33.41 75.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.893 -1.13 . . . . 0.0 108.728 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.087 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.1 t -83.57 -40.99 16.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.938 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 52.4 t0 -55.19 -38.5 68.46 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.691 -1.204 . . . . 0.0 109.452 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.502 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.6 mt-30 -63.4 -48.62 77.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.433 -1.417 . . . . 0.0 110.285 171.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 50.1 mmtt -56.16 -35.15 66.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.667 -1.271 . . . . 0.0 110.488 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.052 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.65 -41.59 85.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 109.149 171.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -65.72 -35.81 81.82 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.896 0.855 . . . . 0.0 109.458 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.73 -36.94 81.49 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.556 -0.715 . . . . 0.0 110.724 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.751 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.7 t -62.94 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 110.046 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.82 85.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.307 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -69.42 -30.69 68.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.243 -0.91 . . . . 0.0 110.862 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.7 -3.57 56.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.7 21.89 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.751 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.42 166.41 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -1.139 . . . . 0.0 109.689 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.846 ' HB ' HD12 ' A' ' 445' ' ' LEU . 2.8 m -110.77 107.24 57.99 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.039 -1.038 . . . . 0.0 109.732 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 398' ' ' VAL . 40.8 Cg_endo -76.12 108.4 2.67 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 O-C-N 123.898 1.473 . . . . 0.0 110.431 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.855 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.5 mt -92.5 139.85 30.17 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.968 -1.083 . . . . 0.0 108.665 167.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.704 ' CG2' HG22 ' A' ' 398' ' ' VAL . 21.5 t -100.28 134.02 41.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.781 -1.199 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.937 ' CG1' HD11 ' A' ' 440' ' ' LEU . 13.9 t -115.13 132.89 63.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 108.591 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -119.33 160.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.316 -0.865 . . . . 0.0 109.729 -175.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.46 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.2 tt0 -135.7 131.79 36.09 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.45 -128.41 30.16 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.582 ' O ' HG13 ' A' ' 405' ' ' VAL . 69.3 p -106.34 8.75 31.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.054 -1.262 . . . . 0.0 111.193 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -123.93 170.52 10.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.603 -1.31 . . . . 0.0 110.115 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.844 ' HA ' HG12 ' A' ' 434' ' ' VAL . 61.0 t -89.7 133.4 31.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.41 -0.806 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.937 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.7 pp -93.79 -19.9 20.6 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.498 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.87 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 170.34 176.72 40.03 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.846 -1.645 . . . . 0.0 110.894 167.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.052 HG21 HG23 ' A' ' 420' ' ' VAL . 55.1 t -107.82 143.0 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.121 -1.223 . . . . 0.0 109.86 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.656 HD11 ' HB1' ' A' ' 337' ' ' ALA . 75.8 mt -101.59 111.82 32.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.324 -0.86 . . . . 0.0 108.996 170.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.75 117.85 30.14 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.097 -1.002 . . . . 0.0 109.775 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.855 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.9 OUTLIER -100.65 144.68 29.33 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -120.86 161.2 21.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.783 -1.198 . . . . 0.0 111.056 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -79.77 143.38 34.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.647 -0.658 . . . . 0.0 110.278 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 8.6 tt -112.65 152.77 14.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.344 -0.847 . . . . 0.0 110.36 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.5 t -103.65 136.28 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.311 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -90.87 145.94 24.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.243 0.544 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -122.65 141.8 51.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.4 mt-30 -134.97 152.81 52.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.171 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.707 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -61.06 139.32 58.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.803 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.522 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -123.37 -34.93 3.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 110.556 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.492 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.9 tt0 -163.79 149.41 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.36 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.073 ' CD1' HD21 ' A' ' 355' ' ' LEU . 16.4 p90 -135.74 145.45 46.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.847 -1.158 . . . . 0.0 111.725 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.742 HD13 ' HD3' ' A' ' 419' ' ' LYS . 11.4 mt -116.66 141.56 28.31 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.61 142.62 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.635 1.334 . . . . 0.0 111.712 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.033 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.41 151.66 44.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.348 -0.845 . . . . 0.0 108.86 165.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -58.08 129.21 40.91 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.735 -1.228 . . . . 0.0 110.09 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.44 -0.04 50.07 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 440' ' ' LEU . 53.5 t -135.28 138.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.74 -1.447 . . . . 0.0 110.764 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.7 m-20 -73.13 148.84 43.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.564 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.6 tt0 -60.22 -35.43 75.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.991 -1.068 . . . . 0.0 109.86 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.516 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.25 -43.44 87.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.001 -1.062 . . . . 0.0 109.297 176.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.528 HG21 HG13 ' A' ' 328' ' ' VAL . 92.7 m -60.81 -42.49 97.76 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.97 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.0 tp -60.49 -39.1 86.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.242 -0.911 . . . . 0.0 110.573 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.44 -44.2 79.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.061 . . . . 0.0 110.666 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.56 ' O ' HD23 ' A' ' 339' ' ' LEU . 89.4 m-20 -63.73 -49.05 74.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.908 -1.12 . . . . 0.0 110.056 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.937 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -69.03 -30.78 69.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.027 -1.046 . . . . 0.0 109.868 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.767 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.97 -35.69 64.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.125 -0.984 . . . . 0.0 108.953 171.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.574 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.68 -55.91 5.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.519 -0.738 . . . . 0.0 111.116 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.51 -33.86 76.89 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.033 -171.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.07 -21.48 65.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.965 -1.084 . . . . 0.0 110.147 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.731 ' OG ' HG22 ' A' ' 353' ' ' VAL . 78.5 p -106.46 10.57 31.36 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.188 -0.945 . . . . 0.0 111.473 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 50.6 mt -66.32 -44.68 82.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.562 -1.336 . . . . 0.0 109.672 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.74 2.79 52.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.997 -171.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.488 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 15.8 p30 -63.85 130.64 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.756 -1.215 . . . . 0.0 109.995 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.69 5.7 50.77 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.571 0.701 . . . . 0.0 109.949 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.4 p -77.11 149.78 80.02 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.614 -0.679 . . . . 0.0 109.541 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.85 -40.77 79.16 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.679 1.358 . . . . 0.0 109.255 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.6 mt-10 -64.16 -27.87 69.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.768 . . . . 0.0 110.382 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.92 -36.79 60.91 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.507 ' O ' HD12 ' A' ' 354' ' ' ILE . 94.4 mtt180 -75.91 -37.26 58.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.108 -1.23 . . . . 0.0 110.432 172.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.5 m -61.95 -38.04 87.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.049 -1.032 . . . . 0.0 110.418 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 443' ' ' ILE . 83.4 mt -68.6 -49.21 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.907 -1.121 . . . . 0.0 110.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.731 HG22 ' OG ' ' A' ' 341' ' ' SER . 21.5 t -61.2 -32.84 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.943 -1.098 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.672 HG22 ' OE1' ' A' ' 358' ' ' GLN . 42.4 mt -72.89 -31.76 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.771 -1.206 . . . . 0.0 110.808 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.073 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.73 -41.48 90.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.784 -1.198 . . . . 0.0 110.249 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.541 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.496 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.935 ' HB3' HD23 ' A' ' 362' ' ' LEU . 66.7 mttt -72.16 -51.07 23.01 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.672 ' OE1' HG22 ' A' ' 354' ' ' ILE . 20.2 pt20 -70.78 -42.73 70.0 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.706 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.9 mmm180 -74.94 -43.19 55.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 111.147 -172.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 55.2 m-85 -134.98 -39.48 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.675 -1.265 . . . . 0.0 112.012 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.514 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.5 t-20 -162.58 106.36 1.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.532 -167.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.935 HD23 ' HB3' ' A' ' 357' ' ' LYS . 54.1 mt -57.62 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.948 -1.095 . . . . 0.0 109.188 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.497 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 14.8 tpt180 -124.36 156.44 37.05 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.28 -0.888 . . . . 0.0 109.866 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 20.3 pt-20 -122.93 -167.66 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.023 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.586 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.5 ptt-85 -93.52 164.71 13.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 110.542 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.6 m-20 -129.43 40.84 3.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.965 HG21 ' CE1' ' A' ' 374' ' ' PHE . 93.8 t -73.75 -48.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.436 -0.79 . . . . 0.0 110.43 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.419 -0.801 . . . . 0.0 111.134 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -30.21 29.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 109.79 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.994 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.0 mt -102.83 -4.58 24.67 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 110.628 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.7 m-70 64.07 52.94 1.92 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.929 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.6 174.98 6.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 110.677 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.6 m -117.65 134.22 55.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.604 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.965 ' CE1' HG21 ' A' ' 367' ' ' VAL . 92.4 m-85 -89.71 143.55 26.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.577 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.487 HG21 HD21 ' A' ' 387' ' ' ASN . 41.9 t -118.2 101.22 51.58 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.9 Cg_endo -55.57 152.22 34.78 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.089 1.573 . . . . 0.0 110.343 -175.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 19.2 t80 -63.4 132.31 51.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 0.0 110.174 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p -120.95 152.07 38.96 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.569 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.52 -6.96 55.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.547 -0.721 . . . . 0.0 109.864 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -57.17 -32.6 66.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 109.963 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 10.3 p -138.07 9.05 2.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.382 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 90.8 mtt-85 58.12 50.87 9.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.702 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.0 ptp -160.62 168.27 25.28 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.957 0.884 . . . . 0.0 111.328 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.0 p -153.59 164.88 37.49 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.44 -165.62 34.46 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 118.945 -1.597 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 367' ' ' VAL . 1.5 tt -139.11 148.51 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.663 -0.904 . . . . 0.0 109.989 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.487 HD21 HG21 ' A' ' 375' ' ' VAL . 28.1 m-20 -127.24 135.33 50.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.676 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.994 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -139.87 154.87 24.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.867 -1.145 . . . . 0.0 109.363 171.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.492 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 89.7 m-20 -25.36 -63.16 0.06 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.447 0.641 . . . . 0.0 112.263 172.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.45 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 42.9 t-20 -92.14 -7.47 48.37 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.777 . . . . 0.0 111.804 -168.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.568 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 33.3 mtp180 -144.5 144.95 31.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.643 -1.286 . . . . 0.0 110.645 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.1 mtm -135.34 110.42 8.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.915 -1.116 . . . . 0.0 109.149 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 339' ' ' LEU . 8.6 mt -130.49 145.96 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 110.001 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 41.8 mtt180 -135.9 160.88 37.23 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 110.76 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.528 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.2 128.58 34.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.6 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.39 174.4 33.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -174.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -57.52 151.55 16.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.949 -1.324 . . . . 0.0 108.357 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.066 HG21 HG11 ' A' ' 420' ' ' VAL . 61.2 t -57.69 -34.57 47.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.074 -1.017 . . . . 0.0 109.951 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.6 t70 -62.65 -46.59 87.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.702 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.24 -50.02 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.985 -1.072 . . . . 0.0 110.562 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.6 HD11 ' N ' ' A' ' 396' ' ' GLY . 32.2 mm -64.54 -43.82 96.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.656 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 6.1 ttt180 -59.87 -42.74 94.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 73.5 mtp180 -61.42 -36.16 79.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.572 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.512 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -67.33 -38.21 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 437' ' ' SER . 68.9 t -65.5 -47.56 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.573 -1.329 . . . . 0.0 110.138 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -35.02 78.91 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.783 -1.198 . . . . 0.0 110.354 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.0 -1.063 . . . . 0.0 109.949 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.512 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 22.0 m-80 -62.11 -27.11 68.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.258 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.24 19.16 31.3 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.04 -169.19 18.19 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.487 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.9 m-70 -143.33 153.38 42.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.102 -1.234 . . . . 0.0 111.478 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.627 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 9.0 p90 -108.46 149.81 39.82 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.664 -0.647 . . . . 0.0 110.153 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.819 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.13 123.57 7.91 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.849 1.447 . . . . 0.0 110.465 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.27 -34.49 78.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.031 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.4 m-20 -60.63 -32.99 72.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.951 -1.093 . . . . 0.0 108.91 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.033 HG21 ' HA ' ' A' ' 325' ' ' ALA . 54.6 t -83.55 -42.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.001 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.574 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.6 m-20 -55.49 -36.8 67.03 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.659 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 98.9 mm-40 -63.79 -48.77 75.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.326 -1.484 . . . . 0.0 110.184 171.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.742 ' HD3' HD13 ' A' ' 323' ' ' ILE . 65.3 mttm -56.78 -34.99 68.16 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.661 -1.274 . . . . 0.0 110.309 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.066 HG11 HG21 ' A' ' 398' ' ' VAL . 2.4 t -59.33 -41.24 83.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.987 -1.07 . . . . 0.0 109.279 171.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 48.6 t0 -66.47 -36.14 82.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 83.6 mt-30 -66.93 -37.38 84.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.574 -0.704 . . . . 0.0 110.615 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 428' ' ' ALA . 54.0 t -60.53 -38.9 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 109.942 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.85 92.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.943 . . . . 0.0 110.366 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 2.6 mtp180 -64.16 -31.54 72.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.134 -0.979 . . . . 0.0 110.722 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 2.8 mt-30 -80.96 -5.14 57.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.61 40.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.631 ' HB1' ' O ' ' A' ' 445' ' ' LEU . . . -103.0 172.81 6.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -1.103 . . . . 0.0 109.855 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.912 ' HB ' HD12 ' A' ' 445' ' ' LEU . 14.4 m -114.37 106.55 52.55 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.96 -1.088 . . . . 0.0 109.99 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.571 ' HB2' HG22 ' A' ' 420' ' ' VAL . 48.3 Cg_endo -79.76 107.26 2.08 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.927 1.488 . . . . 0.0 110.498 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.92 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.8 mt -93.41 135.67 34.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.878 -1.139 . . . . 0.0 108.785 167.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 1.023 ' CG2' HG22 ' A' ' 398' ' ' VAL . 89.5 t -100.91 134.36 41.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 O-C-N 120.802 -1.186 . . . . 0.0 109.53 175.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 440' ' ' LEU . 54.1 t -115.54 137.23 49.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.043 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -118.14 159.96 18.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.374 -0.829 . . . . 0.0 109.635 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.557 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -136.85 131.92 33.88 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.19 -129.07 31.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.501 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.45 12.24 28.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.117 -1.226 . . . . 0.0 111.09 -179.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -126.09 170.88 11.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.598 -1.314 . . . . 0.0 109.938 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 434' ' ' VAL . 23.3 t -90.88 134.23 30.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.762 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.45 -22.28 18.38 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.793 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.97 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.61 177.15 38.86 Favored Glycine 0 N--CA 1.501 3.005 0 C-N-CA 118.857 -1.639 . . . . 0.0 111.085 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.033 HG21 HG23 ' A' ' 420' ' ' VAL . 51.5 t -107.84 142.69 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.049 -1.265 . . . . 0.0 109.964 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.767 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.2 mt -101.37 112.86 35.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.28 119.32 31.76 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.92 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.43 146.94 27.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -176.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.522 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 2.7 pttp -138.22 166.6 23.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.477 -1.389 . . . . 0.0 110.706 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -79.03 144.72 34.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.528 -0.733 . . . . 0.0 110.147 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.6 tp -119.53 153.36 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 110.173 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.19 136.71 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -90.32 145.75 24.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 CA-C-O 118.045 -1.419 . . . . 0.0 109.61 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.463 ' O ' ' OD1' ' A' ' 316' ' ' ASN . 37.7 p-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.269 0.557 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 97.2 mtt180 -123.3 147.89 46.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.243 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.8 mt-30 -128.48 145.92 50.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.75 ' CA ' HD23 ' A' ' 445' ' ' LEU . . . -61.43 137.95 58.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.995 . . . . 0.0 109.924 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.524 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.62 -38.35 2.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.7 mt-10 -153.57 149.55 27.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.928 . . . . 0.0 110.724 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.067 ' CD1' HD21 ' A' ' 355' ' ' LEU . 7.7 p90 -136.02 158.77 43.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.023 -1.048 . . . . 0.0 111.569 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.721 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.2 mp -133.94 139.7 34.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -70.21 144.2 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.613 1.323 . . . . 0.0 111.619 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.084 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.51 151.35 43.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 108.791 164.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.86 129.19 40.96 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.686 -1.259 . . . . 0.0 110.098 -172.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.12 -2.33 40.71 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.8 t -135.99 139.1 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.715 -1.462 . . . . 0.0 110.785 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.5 m-20 -73.31 152.48 40.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.895 . . . . 0.0 110.203 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -63.41 -40.55 97.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 0.0 110.538 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.3 -43.12 92.63 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.687 -1.258 . . . . 0.0 109.543 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 328' ' ' VAL . 93.8 m -55.86 -43.72 77.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.834 173.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.969 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.3 tp -59.6 -39.03 82.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.996 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.68 -42.96 81.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.045 . . . . 0.0 110.768 -176.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.87 -48.61 76.03 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.803 -1.186 . . . . 0.0 109.901 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.876 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.54 -31.98 72.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.891 -1.131 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.72 -35.47 66.16 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.211 -0.931 . . . . 0.0 109.127 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 29.9 mt-30 -73.64 -55.79 5.83 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 110.893 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.058 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.93 -34.68 77.97 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.929 -171.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.43 -21.07 65.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -0.991 . . . . 0.0 110.014 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.646 ' OG ' HG22 ' A' ' 353' ' ' VAL . 92.3 p -107.68 10.24 29.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.227 -0.921 . . . . 0.0 111.569 -174.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.8 mt -65.88 -44.78 84.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.581 -1.324 . . . . 0.0 109.68 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.77 0.42 46.86 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.841 -170.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.476 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.3 p30 -63.03 130.45 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.778 -1.201 . . . . 0.0 109.926 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.65 5.69 50.8 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.568 0.699 . . . . 0.0 109.857 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.6 p -77.18 150.81 80.92 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.559 -0.713 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -53.42 -38.47 82.86 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.686 1.361 . . . . 0.0 109.14 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.9 mt-10 -64.53 -28.48 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.543 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.83 -37.95 71.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 354' ' ' ILE . 95.3 mtt180 -77.32 -38.13 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -1.18 . . . . 0.0 110.593 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.532 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 11.4 m -61.2 -38.29 86.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.878 -1.139 . . . . 0.0 110.359 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.68 -48.94 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.058 -1.026 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.646 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.6 t -61.36 -32.72 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.043 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.995 HG22 ' OE1' ' A' ' 358' ' ' GLN . 34.0 mt -72.73 -33.57 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.752 -1.218 . . . . 0.0 110.678 171.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.067 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.53 -40.8 83.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.8 -1.187 . . . . 0.0 110.397 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.48 87.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.928 ' HB3' HD23 ' A' ' 362' ' ' LEU . 24.9 mtmt -72.24 -49.4 35.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.547 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.995 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.7 pt20 -71.52 -42.49 67.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.32 -0.862 . . . . 0.0 110.843 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.598 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 39.0 mmt180 -73.75 -45.33 52.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.084 -1.01 . . . . 0.0 111.23 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.671 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 86.8 m-85 -135.59 -37.66 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.329 -1.349 . . . . 0.0 112.117 -169.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.492 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 14.1 t-20 -160.57 105.9 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.627 -1.296 . . . . 0.0 111.492 -168.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.928 HD23 ' HB3' ' A' ' 357' ' ' LYS . 51.9 mt -57.63 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.0 109.349 172.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 19.3 tpt180 -128.08 164.16 23.03 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.6 mt-10 -137.91 -160.43 1.06 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 110.085 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.71 163.91 12.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.522 -0.736 . . . . 0.0 110.67 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -131.39 42.63 3.18 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.507 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.068 HG21 ' CE1' ' A' ' 374' ' ' PHE . 42.3 t -72.7 -46.36 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 110.259 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.83 -27.31 66.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 111.152 -175.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.02 -30.1 28.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.756 176.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.785 ' HB3' HD11 ' A' ' 388' ' ' ILE . 21.8 mt -102.47 -5.02 24.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.524 -0.735 . . . . 0.0 110.635 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.4 m-70 60.3 52.27 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 109.761 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.772 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.04 174.57 7.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.456 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.9 m -117.12 134.64 54.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 110.499 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.068 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.7 m-85 -89.23 145.17 25.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 387' ' ' ASN . 43.9 t -119.04 101.15 50.24 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.633 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.6 Cg_endo -55.22 151.37 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.067 1.562 . . . . 0.0 110.548 -175.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 10.2 t80 -64.48 131.91 48.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.87 . . . . 0.0 110.078 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.3 p -120.45 152.7 37.62 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.405 -0.81 . . . . 0.0 109.715 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.73 -6.54 54.34 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -56.97 -32.96 66.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.857 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.516 ' OG ' ' CG ' ' A' ' 383' ' ' MET . 4.9 p -138.86 9.79 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.335 -0.853 . . . . 0.0 110.375 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 69.9 mtt85 57.49 51.03 10.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.198 -0.939 . . . . 0.0 109.434 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.671 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.5 ptp -159.46 167.96 27.4 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.934 0.873 . . . . 0.0 111.203 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 17.3 p -154.41 165.14 37.32 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.33 -165.8 34.11 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.988 -1.577 . . . . 0.0 110.521 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.716 HD11 HG22 ' A' ' 367' ' ' VAL . 4.8 tt -138.68 151.6 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.639 -0.918 . . . . 0.0 110.231 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.544 HD21 HG21 ' A' ' 375' ' ' VAL . 46.4 m-20 -127.39 133.99 49.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 109.747 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.785 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -140.38 155.18 23.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 120.937 -1.102 . . . . 0.0 109.2 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.6 m-20 -21.91 -63.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.47 0.652 . . . . 0.0 112.555 170.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.459 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 44.3 t-20 -95.57 -7.58 37.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 111.911 -167.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.563 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.4 mtp180 -142.95 144.92 32.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.745 -1.222 . . . . 0.0 110.55 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -135.3 101.33 4.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.845 -1.159 . . . . 0.0 108.967 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.058 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -123.89 146.03 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 110.143 -172.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 33.7 mtt180 -135.85 160.42 38.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.905 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.651 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.53 131.25 39.55 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.551 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -157.01 174.01 34.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.4 m -56.91 150.17 17.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.941 -1.329 . . . . 0.0 108.441 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.088 HG21 HG11 ' A' ' 420' ' ' VAL . 16.9 t -54.54 -36.97 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.969 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.5 m-20 -63.8 -44.25 93.87 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.319 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.671 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.42 -51.53 42.79 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.951 -1.093 . . . . 0.0 110.574 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 432' ' ' VAL . 30.6 mm -64.64 -42.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.082 -1.011 . . . . 0.0 110.736 -176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.594 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 11.9 ttp180 -59.15 -43.74 92.06 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.8 mtp180 -61.62 -36.8 81.76 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.506 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -68.18 -36.68 79.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.301 -0.874 . . . . 0.0 111.367 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 437' ' ' SER . 54.4 t -66.24 -47.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.59 -1.319 . . . . 0.0 110.16 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -34.8 78.6 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.756 -1.215 . . . . 0.0 110.293 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.22 81.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.968 -1.082 . . . . 0.0 109.883 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 5.3 m-80 -60.94 -28.24 68.81 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.509 -0.744 . . . . 0.0 109.084 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.4 19.8 26.82 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 -169.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -116.05 -168.84 15.32 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.37 153.88 41.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.213 -1.169 . . . . 0.0 111.149 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.7 p90 -107.98 150.68 40.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.589 -0.694 . . . . 0.0 110.061 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.857 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.56 127.4 12.42 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.891 1.469 . . . . 0.0 110.49 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.2 t -66.99 -34.93 78.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 111.024 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.5 m-20 -61.43 -33.73 74.21 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.817 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.084 HG21 ' HA ' ' A' ' 325' ' ' ALA . 54.7 t -83.5 -41.68 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.1 t0 -55.37 -38.51 68.92 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.347 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 99.5 mm-40 -63.38 -48.0 79.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.324 -1.485 . . . . 0.0 110.309 171.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.721 ' HD3' HG21 ' A' ' 323' ' ' ILE . 35.8 mttm -56.71 -34.87 67.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.668 -1.27 . . . . 0.0 110.512 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.088 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.7 -41.68 86.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.91 -1.119 . . . . 0.0 109.136 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -65.94 -36.18 82.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.915 0.864 . . . . 0.0 109.493 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.5 -38.18 80.73 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 110.886 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 428' ' ' ALA . 69.4 t -62.3 -37.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.975 -1.078 . . . . 0.0 109.945 175.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.42 87.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.219 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.05 -33.08 74.99 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.258 -0.901 . . . . 0.0 111.208 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -80.98 -4.38 54.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.012 -1.055 . . . . 0.0 109.456 174.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.24 30.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.661 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.42 170.91 7.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -1.141 . . . . 0.0 109.863 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.865 ' HB ' HD12 ' A' ' 445' ' ' LEU . 7.5 m -112.45 106.62 55.71 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.988 -1.07 . . . . 0.0 110.108 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' ' 420' ' ' VAL . 55.3 Cg_endo -80.05 107.23 2.03 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 O-C-N 123.864 1.454 . . . . 0.0 110.541 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.898 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -93.6 140.44 29.61 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.915 -1.116 . . . . 0.0 108.717 167.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.89 ' CG2' HG22 ' A' ' 398' ' ' VAL . 98.5 t -101.07 135.6 36.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.798 -1.189 . . . . 0.0 109.568 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.0 ' CG1' HD11 ' A' ' 440' ' ' LEU . 22.3 t -115.93 136.19 53.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 108.745 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.826 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -120.53 160.44 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.477 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -135.49 129.97 33.96 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.26 -131.3 29.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -168.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.614 ' O ' HG13 ' A' ' 405' ' ' VAL . 76.5 p -103.29 8.97 38.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.087 -1.243 . . . . 0.0 111.138 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -123.32 170.84 9.89 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.555 -1.34 . . . . 0.0 110.152 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.826 ' HA ' HG12 ' A' ' 434' ' ' VAL . 61.9 t -91.04 134.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.357 -0.84 . . . . 0.0 109.824 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.0 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -92.83 -22.49 19.27 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.48 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.969 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 169.22 177.42 39.89 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.048 -1.549 . . . . 0.0 110.871 170.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.044 HG21 HG23 ' A' ' 420' ' ' VAL . 60.0 t -107.72 143.91 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.109 -1.23 . . . . 0.0 109.82 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.597 HD13 HG23 ' A' ' 352' ' ' ILE . 81.3 mt -101.62 112.62 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.448 -0.783 . . . . 0.0 108.997 171.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.36 118.24 30.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.861 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.898 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.66 148.15 25.93 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -175.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.524 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 16.1 pttt -125.62 165.09 19.17 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.563 -1.335 . . . . 0.0 110.343 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -78.52 139.26 38.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.395 -0.815 . . . . 0.0 110.473 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.2 tp -124.02 152.52 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.492 -0.755 . . . . 0.0 110.165 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.7 t -105.38 132.44 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.919 . . . . 0.0 110.354 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -93.63 145.63 24.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 110.208 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 117.932 -1.482 . . . . 0.0 109.539 179.843 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.303 0.573 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.499 ' NE ' ' OE2' ' A' ' 348' ' ' GLU . 85.2 mtm180 -123.38 143.95 49.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.462 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 87.6 mt-30 -133.69 145.99 50.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.224 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.721 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -64.2 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.934 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.463 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -117.37 -33.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -169.95 151.03 3.96 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.008 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.017 ' CD1' HD21 ' A' ' 355' ' ' LEU . 11.4 p90 -136.0 145.87 46.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.774 -1.204 . . . . 0.0 111.814 -177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.453 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.4 mp -116.53 143.16 30.73 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.667 -0.646 . . . . 0.0 109.631 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.8 Cg_endo -72.37 143.71 39.56 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.69 1.363 . . . . 0.0 111.583 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.063 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.65 152.4 41.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 108.782 165.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.78 128.96 39.84 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.575 -1.328 . . . . 0.0 110.097 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.66 -1.8 42.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.5 t -136.43 138.84 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.463 . . . . 0.0 110.749 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.4 m-20 -73.5 152.32 40.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -61.98 -40.11 94.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.037 -1.039 . . . . 0.0 110.443 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.13 -43.44 91.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 109.568 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.519 HG21 HG13 ' A' ' 328' ' ' VAL . 95.1 m -56.36 -43.56 79.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.88 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 1.024 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.6 tp -59.23 -39.8 83.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.268 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.0 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.17 -41.75 85.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 110.774 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.5 m-20 -63.5 -49.16 74.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.892 -1.13 . . . . 0.0 109.971 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.898 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.7 -31.67 71.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.994 -1.066 . . . . 0.0 109.776 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.79 -34.9 65.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 16.2 mt-30 -74.02 -55.79 5.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.516 -0.74 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.067 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.34 -35.96 78.85 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.885 -173.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.16 -20.81 65.8 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.06 -1.025 . . . . 0.0 110.015 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.5 p -107.43 8.93 29.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.129 -0.982 . . . . 0.0 111.504 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.3 mt -65.48 -44.71 86.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.655 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.612 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.61 1.45 48.8 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.9 -170.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.487 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.47 130.2 43.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.803 -1.186 . . . . 0.0 110.057 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.92 5.45 51.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.595 0.712 . . . . 0.0 109.906 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -77.05 153.36 82.61 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.27 -38.33 95.26 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.734 1.386 . . . . 0.0 109.149 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.499 ' OE2' ' NE ' ' A' ' 317' ' ' ARG . 97.4 mt-10 -64.53 -29.66 70.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.75 . . . . 0.0 110.477 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.12 -35.51 59.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.3 mtt180 -76.97 -38.04 54.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.143 -1.21 . . . . 0.0 110.521 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.9 m -60.85 -38.09 84.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.92 -1.113 . . . . 0.0 110.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 443' ' ' ILE . 80.0 mt -69.01 -49.24 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.019 -1.051 . . . . 0.0 110.627 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.618 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -61.54 -33.84 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.0 110.198 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.749 HG22 ' OE1' ' A' ' 358' ' ' GLN . 34.2 mt -72.45 -33.09 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.741 -1.225 . . . . 0.0 110.553 171.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.017 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -59.68 -40.29 87.32 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.931 -1.106 . . . . 0.0 110.59 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.52 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.78 -45.12 91.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.284 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.971 ' HB3' HD23 ' A' ' 362' ' ' LEU . 30.1 mtmt -71.61 -49.26 41.95 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.706 -175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.749 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.6 pt20 -71.08 -42.4 69.41 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 110.76 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 37.8 mmt180 -73.11 -46.52 50.79 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 111.218 -172.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 73.6 m-85 -136.44 -35.82 0.73 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.411 -169.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.508 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 56.3 t-20 -158.91 102.43 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.546 -1.346 . . . . 0.0 111.619 -168.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.971 HD23 ' HB3' ' A' ' 357' ' ' LYS . 34.3 mt -57.8 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.858 -1.152 . . . . 0.0 109.295 171.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.525 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.6 tpt85 -135.96 163.64 29.8 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.34 -0.85 . . . . 0.0 108.941 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.51 -155.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.951 -1.093 . . . . 0.0 110.32 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.7 ptt180 -95.19 163.03 13.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.478 0.656 . . . . 0.0 110.523 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -127.78 40.24 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 110.464 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.939 HG11 ' CE2' ' A' ' 374' ' ' PHE . 57.4 t -74.61 -47.94 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.449 -0.782 . . . . 0.0 110.28 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.77 -26.02 65.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.376 -0.827 . . . . 0.0 110.954 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.44 -29.93 27.68 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 109.818 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.988 ' HB3' HD11 ' A' ' 388' ' ' ILE . 18.6 mt -103.83 -3.88 24.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 0.0 110.718 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.9 m80 62.77 53.15 2.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.932 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.43 174.92 6.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.672 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.2 m -116.3 134.27 55.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.567 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.939 ' CE2' HG11 ' A' ' 367' ' ' VAL . 81.4 m-85 -88.29 149.02 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 50.6 t -122.26 101.12 41.48 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.172 -0.955 . . . . 0.0 109.64 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -54.81 153.36 25.02 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.09 1.574 . . . . 0.0 110.443 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.586 ' CE2' ' N ' ' A' ' 383' ' ' MET . 58.3 t80 -69.07 134.27 49.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 11.0 p -115.14 144.24 43.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.797 174.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.03 -21.74 58.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.668 -0.645 . . . . 0.0 110.356 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.07 -45.21 94.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 109.729 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 383' ' ' MET . 66.6 m -95.64 -12.75 25.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 110.25 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 97.4 mtt180 57.83 49.74 11.6 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.6 -0.688 . . . . 0.0 109.627 -174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.963 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.4 ptp -165.03 170.41 15.17 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.839 0.828 . . . . 0.0 111.283 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.3 p -154.84 165.55 36.28 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.94 -165.7 34.27 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 118.771 -1.68 . . . . 0.0 110.821 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.7 tt -140.86 148.67 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.641 -0.917 . . . . 0.0 110.133 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.446 HD21 HG21 ' A' ' 375' ' ' VAL . 41.9 m-20 -127.72 135.06 49.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.869 -1.145 . . . . 0.0 109.724 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.988 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.55 154.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.861 -1.149 . . . . 0.0 109.446 171.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 89.3 m-20 -25.4 -62.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.299 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.454 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.2 t30 -92.03 -7.83 47.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 -168.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.7 mtp180 -144.03 144.97 31.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.699 -1.25 . . . . 0.0 110.574 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.71 109.94 8.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.833 -1.167 . . . . 0.0 109.02 169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.067 HD12 HD11 ' A' ' 339' ' ' LEU . 8.6 mt -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.047 -1.033 . . . . 0.0 110.052 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 25.0 mmt85 -134.54 160.47 37.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.449 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.514 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -133.03 126.83 32.75 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.568 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.71 173.7 31.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.6 t -58.21 150.76 20.78 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.901 -1.352 . . . . 0.0 108.554 170.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.044 HG21 HG11 ' A' ' 420' ' ' VAL . 53.5 t -55.63 -35.48 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.971 -1.08 . . . . 0.0 109.607 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.6 t0 -62.09 -46.45 89.01 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.165 -0.96 . . . . 0.0 110.366 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.963 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -69.17 -51.02 42.3 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.028 -1.045 . . . . 0.0 110.639 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.568 HD11 ' N ' ' A' ' 396' ' ' GLY . 28.7 mm -64.28 -41.62 92.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 110.816 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.594 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 34.8 ttt-85 -59.65 -45.17 92.83 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 59.3 mtp85 -62.59 -35.51 79.75 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.205 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.7 t-80 -68.39 -36.7 79.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 111.212 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.84 -48.95 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.501 -1.375 . . . . 0.0 110.109 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.4 -34.11 77.02 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 110.253 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.97 -36.19 79.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.941 -1.099 . . . . 0.0 109.923 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.6 m-80 -61.63 -27.49 68.7 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.511 -0.743 . . . . 0.0 109.228 173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.06 19.43 28.64 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -170.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.78 -170.34 16.49 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.66 153.59 41.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 111.098 -174.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.4 p90 -107.21 150.15 39.57 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.528 -0.733 . . . . 0.0 110.039 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.879 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -72.27 127.4 12.63 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.846 1.445 . . . . 0.0 110.42 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -67.0 -34.96 78.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 111.016 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 55.9 t0 -62.12 -33.05 73.74 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.865 -1.147 . . . . 0.0 108.823 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.063 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.8 t -83.52 -41.66 16.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.906 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.498 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.8 t0 -55.14 -38.17 67.88 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.455 171.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 96.5 mt-30 -63.66 -48.16 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.33 -1.481 . . . . 0.0 110.299 171.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 15.0 mmtt -56.2 -35.36 67.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.59 -1.319 . . . . 0.0 110.384 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.078 HG23 HG21 ' A' ' 442' ' ' VAL . 3.3 t -60.23 -41.31 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.963 -1.086 . . . . 0.0 109.435 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -65.83 -36.04 82.37 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.922 0.868 . . . . 0.0 109.398 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.24 -37.58 80.95 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.868 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 428' ' ' ALA . 66.9 t -63.05 -37.35 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.91 -1.119 . . . . 0.0 110.01 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.36 85.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.71 -30.03 67.57 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.352 -0.842 . . . . 0.0 110.892 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -82.37 -3.53 55.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.785 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.23 21.79 28.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.58 170.89 7.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -1.081 . . . . 0.0 109.47 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.664 ' O ' HD12 ' A' ' 445' ' ' LEU . 21.3 m -116.92 106.85 47.01 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 109.52 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.601 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.3 Cg_endo -74.59 107.43 2.46 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 O-C-N 123.965 1.508 . . . . 0.0 110.331 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.625 ' HG ' HD13 ' A' ' 445' ' ' LEU . 15.8 mt -92.57 132.67 36.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.913 -1.117 . . . . 0.0 108.38 167.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.969 ' CG2' HG22 ' A' ' 398' ' ' VAL . 60.6 t -100.75 136.43 32.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.834 -1.166 . . . . 0.0 109.681 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.847 ' CG1' HD11 ' A' ' 440' ' ' LEU . 41.8 t -115.25 138.17 46.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 108.991 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.7 159.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.461 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -134.56 133.78 40.62 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 170.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.44 -126.83 31.07 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -168.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.62 ' O ' HG13 ' A' ' 405' ' ' VAL . 71.7 p -108.14 8.08 27.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.021 -1.281 . . . . 0.0 111.228 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -123.98 171.03 10.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.542 -1.349 . . . . 0.0 110.147 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.82 ' HA ' HG12 ' A' ' 434' ' ' VAL . 60.5 t -88.94 134.62 27.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.933 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.847 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -92.71 -22.12 19.59 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.602 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 1.024 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 171.04 176.31 40.15 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 118.803 -1.665 . . . . 0.0 110.816 168.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.078 HG21 HG23 ' A' ' 420' ' ' VAL . 48.2 t -107.88 143.18 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.239 . . . . 0.0 109.616 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.671 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.7 mt -101.47 118.62 48.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.326 -0.858 . . . . 0.0 108.773 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -98.14 117.58 32.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.503 -176.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 429' ' ' THR . 3.6 mp -112.24 145.28 40.21 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.014 -1.054 . . . . 0.0 109.781 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -110.92 159.86 17.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.728 -1.233 . . . . 0.0 111.199 -174.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -93.72 148.52 22.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.769 -0.582 . . . . 0.0 110.085 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.6 tp -117.57 152.92 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.231 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.1 136.31 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.867 . . . . 0.0 110.365 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -91.89 144.32 25.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 110.177 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.533 -179.881 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.27 0.557 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 89.9 mtt180 -122.28 149.56 43.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.127 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 90.5 mt-30 -126.02 146.67 49.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.213 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' A' ' 355' ' ' LEU . . . -59.3 137.56 57.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.02 . . . . 0.0 109.765 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.516 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.9 m -117.89 -44.02 2.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.1 -1.0 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 320' ' ' SER . 66.1 mt-10 -154.81 151.48 28.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -0.908 . . . . 0.0 110.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.993 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.6 p90 -136.0 140.43 43.9 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.918 -1.114 . . . . 0.0 111.586 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.466 HG23 ' HD2' ' A' ' 324' ' ' PRO . 3.4 mt -112.67 143.84 29.79 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.784 -0.573 . . . . 0.0 109.708 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.76 142.55 35.81 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.678 1.357 . . . . 0.0 111.614 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.057 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.48 152.81 42.72 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 108.861 165.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.11 128.64 38.21 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.586 -1.321 . . . . 0.0 110.178 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.46 46.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.3 t -136.73 139.38 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.677 -1.484 . . . . 0.0 110.703 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.8 m-20 -74.32 152.37 39.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CE2' ' A' ' 360' ' ' PHE . 84.9 tt0 -61.53 -40.28 94.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.038 -1.039 . . . . 0.0 110.278 -177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.5 -43.84 93.26 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.665 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.502 HG21 HG13 ' A' ' 328' ' ' VAL . 93.4 m -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.742 173.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 1.019 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.3 tp -59.21 -39.2 81.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.296 175.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.993 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.44 -41.4 84.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.991 -1.068 . . . . 0.0 110.729 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.543 ' O ' HD23 ' A' ' 339' ' ' LEU . 88.4 m-20 -63.28 -49.92 72.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.975 -1.078 . . . . 0.0 109.84 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.903 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.0 -31.98 72.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 109.901 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.822 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.26 -35.35 64.9 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.166 -0.959 . . . . 0.0 108.961 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.55 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.9 mt-30 -75.5 -55.89 5.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.564 -0.71 . . . . 0.0 110.971 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.014 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -62.36 -35.24 78.52 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.756 -172.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.428 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.07 -20.87 65.89 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.984 -1.072 . . . . 0.0 109.978 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.8 p -107.82 9.95 28.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.205 -0.934 . . . . 0.0 111.547 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.595 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.9 mt -66.36 -44.37 83.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.516 -1.365 . . . . 0.0 109.633 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.39 2.15 50.13 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.787 -170.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 14.0 p30 -64.17 130.08 42.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.739 -1.226 . . . . 0.0 110.015 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.42 4.44 53.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.508 0.671 . . . . 0.0 109.873 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.1 p -74.17 152.95 88.4 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 109.404 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.74 -40.05 87.01 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.737 1.388 . . . . 0.0 109.162 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 99.0 mt-10 -64.68 -27.56 69.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.74 . . . . 0.0 110.481 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.22 -37.74 65.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.5 mtt180 -77.15 -37.83 53.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -1.223 . . . . 0.0 110.514 173.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.4 m -61.04 -38.06 84.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.613 HG23 HD13 ' A' ' 443' ' ' ILE . 90.6 mt -68.12 -49.61 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.613 HG22 ' OG ' ' A' ' 341' ' ' SER . 37.2 t -60.87 -33.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.014 . . . . 0.0 110.07 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.614 HG22 ' OE1' ' A' ' 358' ' ' GLN . 29.4 mt -72.92 -32.91 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.701 -1.25 . . . . 0.0 110.565 171.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.951 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.43 -40.17 85.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.809 -1.182 . . . . 0.0 110.545 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.407 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.51 -44.69 93.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.938 ' HB3' HD23 ' A' ' 362' ' ' LEU . 16.1 mtmt -71.46 -49.6 39.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.638 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.614 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.6 pt20 -71.51 -42.54 67.87 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 110.793 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.525 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.9 mmt180 -72.86 -45.7 56.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 111.24 -172.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.571 ' CE2' ' OE2' ' A' ' 330' ' ' GLU . 56.1 m-85 -135.76 -38.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.143 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.511 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.3 t30 -159.0 105.18 1.75 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.758 -1.214 . . . . 0.0 111.528 -168.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 357' ' ' LYS . 46.7 mt -57.45 89.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.842 -1.161 . . . . 0.0 109.163 171.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.535 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.1 tpt180 -131.14 164.49 25.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.236 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 86.4 mt-10 -136.88 -157.19 0.76 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.153 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.595 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 31.8 ptt-85 -94.65 162.52 13.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 88.4 m-20 -128.68 41.21 3.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.287 176.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.082 HG21 ' CE1' ' A' ' 374' ' ' PHE . 26.0 t -73.47 -45.73 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -68.45 -28.18 66.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.848 . . . . 0.0 111.079 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.19 -29.87 28.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.037 -1.039 . . . . 0.0 109.763 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.771 ' HB3' HD11 ' A' ' 388' ' ' ILE . 26.0 mt -103.64 -4.63 23.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.494 -0.754 . . . . 0.0 110.613 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 367' ' ' VAL . 72.1 m-70 60.64 52.49 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.842 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.781 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -95.09 174.39 7.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.409 -0.807 . . . . 0.0 110.638 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.3 m -117.35 135.68 53.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.082 ' CE1' HG21 ' A' ' 367' ' ' VAL . 74.2 m-85 -89.39 148.79 23.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.626 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.463 HG21 HD21 ' A' ' 387' ' ' ASN . 64.0 t -122.17 100.69 42.21 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.26 150.36 49.84 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.046 1.551 . . . . 0.0 110.512 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.9 t80 -62.99 131.79 49.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p -121.23 152.95 38.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.424 -0.797 . . . . 0.0 109.639 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.31 -5.81 50.89 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.545 -0.722 . . . . 0.0 109.936 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.1 -32.75 66.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.873 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 383' ' ' MET . 1.4 m -139.48 9.97 2.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.295 175.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 87.7 mtt180 57.6 51.15 9.91 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 109.465 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.867 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.4 ptp -160.05 169.07 24.15 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.895 0.855 . . . . 0.0 111.314 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.537 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.6 p -153.64 164.92 37.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.15 -167.11 35.6 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.643 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.843 HG21 ' HB2' ' A' ' 339' ' ' LEU . 4.0 tt -140.04 150.28 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.554 -0.968 . . . . 0.0 110.136 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.463 HD21 HG21 ' A' ' 375' ' ' VAL . 47.6 m-20 -126.53 134.52 50.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.956 -1.09 . . . . 0.0 109.809 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.771 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -142.41 155.22 18.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.947 -1.096 . . . . 0.0 109.181 173.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 91.5 m-20 -22.41 -63.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.413 0.625 . . . . 0.0 112.582 171.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.46 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 48.3 t30 -96.35 -6.01 38.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 111.776 -167.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.564 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.5 mtp180 -143.74 143.89 31.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.705 -1.247 . . . . 0.0 110.381 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -134.02 99.43 4.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.974 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.014 HD12 HD11 ' A' ' 339' ' ' LEU . 7.2 mt -121.29 145.96 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.036 -1.04 . . . . 0.0 110.103 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 31.4 mtt180 -133.83 159.68 39.9 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.08 -1.013 . . . . 0.0 110.689 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.489 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.19 127.23 31.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.344 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.567 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.23 174.07 32.7 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -173.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 35.7 m -56.99 151.51 14.75 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.854 -1.38 . . . . 0.0 108.572 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.052 HG21 HG11 ' A' ' 420' ' ' VAL . 57.7 t -57.02 -34.75 45.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.993 -1.067 . . . . 0.0 109.856 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.8 t0 -62.88 -46.54 87.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.218 -0.926 . . . . 0.0 110.414 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.867 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.9 -50.42 56.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.006 -1.059 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.567 HD11 ' N ' ' A' ' 396' ' ' GLY . 32.5 mm -65.38 -43.69 94.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 110.763 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.585 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.7 ttp85 -58.9 -43.57 91.04 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.348 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 76.0 mtp180 -61.92 -36.26 80.83 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 109.44 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.534 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -67.61 -37.03 81.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 111.277 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 437' ' ' SER . 55.9 t -66.03 -48.26 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.657 -1.277 . . . . 0.0 110.157 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.99 -34.2 77.46 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.845 -1.16 . . . . 0.0 110.395 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.67 -36.39 80.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.924 -1.11 . . . . 0.0 109.816 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.534 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.1 m-80 -61.63 -27.62 68.79 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.486 -0.759 . . . . 0.0 109.22 173.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.02 20.35 28.43 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -168.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.44 -170.87 17.6 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.416 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.0 m-70 -143.96 153.79 42.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.124 -1.221 . . . . 0.0 111.186 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.592 ' HB3' HG21 ' A' ' 439' ' ' VAL . 5.3 p90 -107.37 150.96 40.68 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.61 -0.681 . . . . 0.0 110.098 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.846 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -73.3 124.41 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.869 1.457 . . . . 0.0 110.202 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -65.99 -34.87 79.09 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 111.064 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 54.1 t0 -61.41 -33.05 73.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.949 -1.094 . . . . 0.0 108.859 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.057 HG21 ' HA ' ' A' ' 325' ' ' ALA . 53.2 t -83.7 -42.44 17.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 111.009 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.508 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 9.3 m-20 -55.46 -37.26 67.53 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.575 171.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.7 mt-30 -63.72 -48.96 74.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.29 -1.506 . . . . 0.0 110.205 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 72.6 mmtt -56.65 -34.79 67.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.717 -1.239 . . . . 0.0 110.373 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.07 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.73 -41.23 84.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.0 -1.062 . . . . 0.0 109.283 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -66.48 -36.25 82.29 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.0 mm-40 -68.03 -38.19 82.25 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.565 -0.709 . . . . 0.0 110.782 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.777 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.5 t -62.48 -37.56 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.902 -1.124 . . . . 0.0 110.016 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.3 87.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 110.192 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -65.9 -33.8 76.66 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.38 -0.825 . . . . 0.0 111.177 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.8 OUTLIER -81.69 -4.2 55.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 175.055 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.48 22.56 28.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.777 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -103.23 165.31 11.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -1.115 . . . . 0.0 109.618 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.768 ' HB ' HD12 ' A' ' 445' ' ' LEU . 10.0 m -110.89 106.87 57.83 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.018 -1.051 . . . . 0.0 109.863 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.567 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.35 108.42 2.7 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.972 1.512 . . . . 0.0 110.64 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.861 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.7 mt -91.86 133.96 35.19 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.861 -1.149 . . . . 0.0 108.497 166.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.929 ' CG2' HG22 ' A' ' 398' ' ' VAL . 83.8 t -99.86 134.73 38.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 120.799 -1.188 . . . . 0.0 109.465 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.014 ' CG1' HD11 ' A' ' 440' ' ' LEU . 23.5 t -114.46 138.57 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.881 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.821 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -122.12 160.45 24.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.657 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.447 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.3 tt0 -135.17 129.26 33.51 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.25 -129.33 28.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.496 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 5.4 p -104.96 10.18 34.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.105 -1.232 . . . . 0.0 111.089 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -121.85 170.83 9.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.574 -1.329 . . . . 0.0 110.128 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 434' ' ' VAL . 41.2 t -93.8 134.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.315 -0.866 . . . . 0.0 109.762 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.014 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.3 pp -95.96 -20.5 18.69 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.805 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 1.019 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.54 176.5 38.88 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 118.719 -1.705 . . . . 0.0 110.981 168.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.07 HG21 HG23 ' A' ' 420' ' ' VAL . 47.3 t -107.96 142.13 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.091 -1.24 . . . . 0.0 109.938 173.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.822 HD11 ' HB1' ' A' ' 337' ' ' ALA . 81.8 mt -101.53 111.25 30.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.042 170.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.651 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.75 118.65 30.88 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.099 -1.0 . . . . 0.0 109.909 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.861 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -101.07 144.62 29.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -121.59 160.49 24.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 111.153 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -100.14 143.32 30.48 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.23 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 8.3 tp -123.78 151.93 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 110.335 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 55.3 t -136.99 135.9 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -145.12 146.21 31.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 CA-C-O 117.987 -1.452 . . . . 0.0 109.567 179.706 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.286 0.565 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.542 ' NH1' HG21 ' A' ' 429' ' ' THR . 84.7 mtm180 -123.36 140.64 52.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 110.221 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 61.4 tt0 -126.69 131.01 51.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.264 -0.898 . . . . 0.0 110.354 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.803 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.66 138.61 41.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 109.789 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.528 ' O ' ' CZ ' ' A' ' 359' ' ' ARG . 20.8 m -124.34 -40.04 2.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.988 . . . . 0.0 110.276 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 320' ' ' SER . 57.9 mt-10 -154.66 146.54 23.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.103 ' CD1' HD21 ' A' ' 355' ' ' LEU . 9.2 p90 -137.6 142.34 41.27 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.593 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.538 HG23 ' HD2' ' A' ' 324' ' ' PRO . 1.9 mt -116.11 145.82 35.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.758 -0.589 . . . . 0.0 109.827 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -73.42 143.03 34.13 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.778 1.409 . . . . 0.0 111.468 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.047 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.22 152.72 42.02 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 108.881 165.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 0.8 OUTLIER -57.82 128.43 37.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.74 -1.225 . . . . 0.0 110.058 -173.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 105.62 -2.61 39.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.7 t -136.74 140.34 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.667 -1.49 . . . . 0.0 110.809 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -74.08 152.98 39.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.07 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -62.18 -38.73 90.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.354 -176.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -60.92 -45.66 93.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.697 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 95.0 m -55.99 -43.73 77.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.674 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.2 tp -58.08 -40.55 81.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.014 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.15 -39.86 82.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.08 -1.013 . . . . 0.0 110.717 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 91.1 m-20 -62.82 -49.09 76.29 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 109.757 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.29 -31.49 70.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.884 -1.135 . . . . 0.0 109.73 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.667 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.28 -34.9 64.51 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 172.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 17.7 mt-30 -74.25 -55.6 5.85 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 110.827 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.002 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.05 -35.24 78.03 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.048 -172.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.66 -21.08 65.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.189 -0.944 . . . . 0.0 110.131 174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.569 ' OG ' HG22 ' A' ' 353' ' ' VAL . 89.3 p -107.52 10.04 29.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.0 111.508 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.5 mt -65.68 -45.51 82.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.622 -1.299 . . . . 0.0 109.793 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.5 0.85 48.28 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.865 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 341' ' ' SER . 10.7 p30 -64.25 130.57 44.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.817 -1.177 . . . . 0.0 110.023 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.83 5.61 50.89 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.566 0.698 . . . . 0.0 109.863 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 3.0 p -75.76 154.72 85.25 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.68 -39.5 90.71 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.786 1.414 . . . . 0.0 109.222 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.558 ' CD ' HD13 ' A' ' 445' ' ' LEU . 96.1 mt-10 -64.9 -27.46 68.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.47 -0.769 . . . . 0.0 110.634 176.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.61 -39.83 76.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -174.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -78.02 -36.81 48.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -1.182 . . . . 0.0 110.662 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 8.5 m -61.25 -38.97 88.6 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.928 -1.108 . . . . 0.0 110.4 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.537 HG23 HD13 ' A' ' 443' ' ' ILE . 87.4 mt -69.11 -48.33 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.708 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.569 HG22 ' OG ' ' A' ' 341' ' ' SER . 34.8 t -62.14 -34.52 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.846 -1.159 . . . . 0.0 110.204 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 350' ' ' ARG . 37.6 mt -73.2 -32.86 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.686 -1.259 . . . . 0.0 110.632 171.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.103 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -58.19 -41.27 83.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.97 -1.081 . . . . 0.0 110.2 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -63.99 -44.07 93.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.556 -0.715 . . . . 0.0 110.618 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.99 ' HB3' HD23 ' A' ' 362' ' ' LEU . 74.6 mttt -69.8 -49.56 51.55 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.662 -173.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.7 pt20 -72.27 -42.85 65.11 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.644 -172.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.769 ' HE ' HD12 ' A' ' 355' ' ' LEU . 84.6 mtt-85 -78.89 -39.52 34.74 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 111.707 -171.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.669 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 76.3 m-85 -134.77 -38.64 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.462 -1.399 . . . . 0.0 112.088 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.517 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 48.6 t30 -160.57 99.79 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.585 -1.322 . . . . 0.0 111.649 -169.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.99 HD23 ' HB3' ' A' ' 357' ' ' LYS . 34.1 mt -57.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.865 -1.147 . . . . 0.0 109.329 171.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.541 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.4 tpt180 -141.58 164.04 31.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.169 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.7 mt-10 -130.23 -154.24 0.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.474 -176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.588 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.7 ptt-85 -94.11 162.97 13.66 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.686 -0.634 . . . . 0.0 110.576 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.3 p30 -125.49 39.09 4.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.943 HG11 ' CE2' ' A' ' 374' ' ' PHE . 61.6 t -74.53 -47.5 39.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.352 -0.843 . . . . 0.0 110.281 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.86 -26.26 65.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 111.004 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.77 -29.74 27.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.001 . . . . 0.0 109.724 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.997 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.9 mt -104.33 -3.63 23.94 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.449 -0.782 . . . . 0.0 110.711 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 367' ' ' VAL . 28.3 m80 62.6 53.22 2.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -177.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.937 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.46 175.01 6.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 0.0 110.646 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.3 m -115.94 134.43 54.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.476 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.943 ' CE2' HG11 ' A' ' 367' ' ' VAL . 80.5 m-85 -88.32 149.04 23.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.434 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 25.6 t -121.56 101.11 43.62 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 109.735 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.9 Cg_endo -55.03 153.05 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 110.468 -176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.566 ' CE2' ' N ' ' A' ' 383' ' ' MET . 56.8 t80 -70.54 134.44 47.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.331 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.6 p -115.62 143.57 45.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.386 -0.821 . . . . 0.0 109.777 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.18 -23.65 59.26 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.365 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -61.5 -44.62 96.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.138 -0.976 . . . . 0.0 109.731 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 383' ' ' MET . 74.6 m -94.85 -13.54 25.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 110.146 176.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.6 mtt180 57.53 48.41 14.43 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.563 -0.71 . . . . 0.0 109.578 -175.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.915 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.6 ptp -165.28 171.3 13.73 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.878 0.847 . . . . 0.0 111.237 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.535 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.8 p -155.79 165.43 36.54 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.8 -165.82 34.38 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.822 -1.656 . . . . 0.0 110.79 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.877 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.5 tt -140.52 149.2 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.623 -0.928 . . . . 0.0 110.143 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.416 HD21 HG21 ' A' ' 375' ' ' VAL . 44.0 m-20 -127.82 134.81 49.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 109.695 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.997 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -140.15 154.85 23.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.791 -1.193 . . . . 0.0 109.437 171.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.259 90.0 m-20 -25.37 -63.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.444 0.64 . . . . 0.0 112.277 172.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 34.1 t30 -91.94 -7.69 48.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.738 . . . . 0.0 111.828 -168.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.558 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.6 mtp180 -143.98 144.64 31.77 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.667 -1.271 . . . . 0.0 110.581 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.6 mtm -134.42 111.73 10.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 108.945 169.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.002 HD12 HD11 ' A' ' 339' ' ' LEU . 9.6 mt -131.66 146.16 33.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.0 109.978 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 26.2 mmt85 -134.41 159.32 41.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.069 -1.019 . . . . 0.0 110.356 175.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.525 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.06 127.21 33.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.661 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.12 174.23 31.88 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.635 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.2 m -56.0 150.56 13.36 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.958 -1.319 . . . . 0.0 108.551 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.001 HG21 HG11 ' A' ' 420' ' ' VAL . 20.4 t -54.84 -37.36 40.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.083 -1.011 . . . . 0.0 109.904 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.4 m-20 -64.23 -45.01 90.08 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.252 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.915 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.48 -48.98 65.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.972 -1.08 . . . . 0.0 110.655 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.661 HD11 ' N ' ' A' ' 396' ' ' GLY . 35.1 mm -65.98 -43.85 92.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.008 -1.057 . . . . 0.0 110.945 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.621 ' NE ' ' CZ ' ' A' ' 412' ' ' PHE . 4.0 ttt180 -60.29 -42.61 95.85 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.062 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 88.8 mtt-85 -61.28 -37.49 83.37 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.635 172.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.521 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.4 t-80 -67.68 -36.21 80.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 111.289 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 437' ' ' SER . 56.0 t -65.71 -49.05 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.621 -1.3 . . . . 0.0 110.154 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.25 -34.3 77.38 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.891 -1.13 . . . . 0.0 110.218 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.87 -36.13 79.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.96 -1.088 . . . . 0.0 109.994 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 8.0 m-80 -61.45 -27.71 68.76 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.174 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.93 19.81 27.87 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.84 -169.37 16.09 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.401 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.0 m-70 -144.39 153.62 42.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.238 . . . . 0.0 111.435 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.621 ' CZ ' ' NE ' ' A' ' 402' ' ' ARG . 7.7 p90 -108.4 149.85 39.84 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.668 -0.645 . . . . 0.0 110.304 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.824 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.02 125.56 9.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.807 1.425 . . . . 0.0 110.52 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.25 -32.37 72.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -0.986 . . . . 0.0 111.075 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.479 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.5 m-20 -63.47 -31.67 72.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 108.848 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.047 HG21 ' HA ' ' A' ' 325' ' ' ALA . 46.0 t -83.58 -42.58 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.388 -0.82 . . . . 0.0 110.765 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 70.2 m-20 -55.22 -36.64 66.2 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.669 -1.212 . . . . 0.0 109.625 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.91 -49.75 71.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.337 -1.477 . . . . 0.0 109.662 173.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 79.2 mttt -56.8 -34.83 68.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.785 -1.197 . . . . 0.0 110.278 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.095 HG23 HG21 ' A' ' 442' ' ' VAL . 2.5 t -59.47 -40.98 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.932 -1.105 . . . . 0.0 109.377 171.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -66.09 -36.61 83.65 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.959 0.885 . . . . 0.0 109.255 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -66.75 -36.68 83.01 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 110.511 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 428' ' ' ALA . 68.3 t -63.11 -37.69 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.026 -1.047 . . . . 0.0 110.161 175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.05 81.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 110.286 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.75 -30.72 68.37 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.252 -0.905 . . . . 0.0 111.006 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.43 -3.32 57.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.115 -0.99 . . . . 0.0 109.777 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.05 22.1 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.74 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -105.68 160.92 14.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -1.052 . . . . 0.0 109.474 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.83 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.2 m -108.88 106.89 59.56 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.935 -1.103 . . . . 0.0 109.798 -176.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.535 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.8 Cg_endo -75.69 107.86 2.56 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.01 1.531 . . . . 0.0 110.769 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.899 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.9 mt -92.62 133.29 36.12 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.845 -1.16 . . . . 0.0 108.542 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.909 ' CG2' HG22 ' A' ' 398' ' ' VAL . 87.7 t -99.74 134.09 40.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.608 -1.308 . . . . 0.0 109.452 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.727 ' CG1' HD11 ' A' ' 440' ' ' LEU . 46.9 t -114.43 134.95 55.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.999 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.0 m -117.07 159.94 16.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.491 -0.755 . . . . 0.0 109.639 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.527 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.1 tt0 -135.28 132.52 37.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.01 -129.15 32.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 -167.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.583 ' O ' HG13 ' A' ' 405' ' ' VAL . 75.6 p -106.46 8.02 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.125 -1.221 . . . . 0.0 111.13 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -120.11 170.73 9.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.643 -1.286 . . . . 0.0 109.977 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.827 ' HA ' HG12 ' A' ' 434' ' ' VAL . 26.1 t -91.82 133.85 32.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.867 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -96.14 -20.04 18.92 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.822 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.871 ' N ' HD12 ' A' ' 440' ' ' LEU . . . 169.07 176.41 39.11 Favored Glycine 0 N--CA 1.501 2.976 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.03 168.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.095 HG21 HG23 ' A' ' 420' ' ' VAL . 45.1 t -107.86 141.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.234 -1.157 . . . . 0.0 109.802 172.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.667 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.4 mt -101.42 110.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 108.939 170.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.58 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.31 119.06 31.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.03 -1.044 . . . . 0.0 109.911 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.899 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -102.62 144.88 30.45 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.418 -0.802 . . . . 0.0 108.871 -175.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 320' ' ' SER . 37.8 mmtm -105.97 151.24 24.86 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.697 -1.252 . . . . 0.0 110.7 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -83.86 145.43 28.63 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.353 0.597 . . . . 0.0 110.175 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.418 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.5 tp -119.45 152.84 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.7 t -136.36 136.75 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -92.65 145.06 24.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 110.193 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 118.037 -1.424 . . . . 0.0 109.555 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.289 0.566 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -123.54 146.55 48.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.288 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.543 ' CA ' ' HB3' ' A' ' 351' ' ' SER . 92.5 mt-30 -131.12 152.66 50.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.155 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.69 137.5 57.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.065 -1.022 . . . . 0.0 109.889 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.52 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -125.45 -34.04 2.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.604 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -161.81 146.06 12.71 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.936 -1.105 . . . . 0.0 110.246 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.134 ' CD1' HD21 ' A' ' 355' ' ' LEU . 15.9 p90 -136.78 147.79 46.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.818 -1.176 . . . . 0.0 111.656 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 7.5 mt -119.96 142.5 33.42 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.737 -0.602 . . . . 0.0 109.674 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.559 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.69 143.86 42.86 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.667 1.351 . . . . 0.0 111.732 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.06 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.8 153.02 42.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 108.907 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.59 128.6 37.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.631 -1.293 . . . . 0.0 110.12 -172.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.46 0.6 50.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 440' ' ' LEU . 47.3 t -135.36 138.33 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.677 -1.484 . . . . 0.0 110.606 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.46 ' O ' ' HB ' ' A' ' 332' ' ' THR . 91.5 m-20 -73.58 149.97 41.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.372 -0.83 . . . . 0.0 110.148 176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.1 tt0 -60.85 -37.22 81.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.983 -1.073 . . . . 0.0 110.025 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.1 OUTLIER -59.53 -41.21 89.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.918 -1.114 . . . . 0.0 109.324 176.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.548 HG21 HG13 ' A' ' 328' ' ' VAL . 99.3 m -60.09 -42.95 95.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 110.031 173.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.968 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.5 tp -60.01 -39.01 84.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 110.531 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.983 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.31 -45.45 72.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 110.734 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.8 m-20 -63.48 -48.71 76.53 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.885 -1.134 . . . . 0.0 109.931 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.905 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.62 -31.51 71.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 109.815 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.684 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.44 -35.47 65.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 109.096 172.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.54 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 19.3 mt-30 -74.04 -55.52 6.02 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.545 -0.722 . . . . 0.0 111.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.026 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.31 -36.25 79.62 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.097 -172.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 395' ' ' LYS . . . -67.82 -18.94 65.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.834 174.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.62 ' OG ' HG22 ' A' ' 353' ' ' VAL . 90.2 p -107.95 8.57 28.5 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.244 -0.91 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.609 HD11 ' CB ' ' A' ' 365' ' ' ARG . 32.2 mt -65.37 -45.77 82.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.557 -1.339 . . . . 0.0 109.67 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.44 1.57 49.34 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.869 -170.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.484 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -62.58 130.36 44.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.683 -1.26 . . . . 0.0 109.905 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.16 5.17 52.54 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.585 0.707 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 346' ' ' THR . 2.9 p -75.53 151.1 85.01 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.561 -0.712 . . . . 0.0 109.385 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.1 -39.31 92.02 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.669 1.352 . . . . 0.0 109.152 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 352' ' ' ILE . 99.0 mt-10 -64.09 -28.02 69.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.437 -0.789 . . . . 0.0 110.412 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.43 -37.82 67.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.498 ' O ' HD12 ' A' ' 354' ' ' ILE . 96.3 mtt180 -76.63 -35.98 57.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.24 . . . . 0.0 110.466 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.543 ' HB3' ' CA ' ' A' ' 318' ' ' GLN . 3.7 m -61.66 -38.91 89.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.976 -1.078 . . . . 0.0 110.348 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 443' ' ' ILE . 79.6 mt -69.24 -48.89 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.029 -1.044 . . . . 0.0 110.494 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.697 HG12 ' HE3' ' A' ' 357' ' ' LYS . 21.8 t -60.64 -32.17 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.797 -1.189 . . . . 0.0 109.84 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.771 HG22 ' OE1' ' A' ' 358' ' ' GLN . 45.4 mt -72.98 -32.29 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.861 -1.149 . . . . 0.0 110.744 171.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.134 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.87 -42.51 89.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 110.053 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.71 93.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.817 . . . . 0.0 110.592 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 1.017 ' HB3' HD23 ' A' ' 362' ' ' LEU . 81.0 mttt -71.97 -51.11 23.55 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.691 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.771 ' OE1' HG22 ' A' ' 354' ' ' ILE . 20.0 pt20 -71.82 -42.54 66.89 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.7 mmt180 -73.09 -43.83 61.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 111.031 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 87.5 m-85 -134.88 -38.73 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 112.052 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 52.3 t30 -163.01 102.51 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.51 -1.369 . . . . 0.0 111.624 -167.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 1.017 HD23 ' HB3' ' A' ' 357' ' ' LYS . 25.5 mt -57.97 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.902 -1.124 . . . . 0.0 108.994 172.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.527 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.2 tpt180 -145.64 163.02 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.892 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 88.9 mt-10 -134.06 -171.26 2.7 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.04 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.769 ' NH2' HD13 ' A' ' 388' ' ' ILE . 1.2 tpt180 -100.47 155.67 17.7 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.175 -0.953 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.1 m-20 -104.68 48.42 0.84 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.196 -0.94 . . . . 0.0 110.968 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.983 ' CG2' HD11 ' A' ' 386' ' ' ILE . 78.0 t -66.79 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 176.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.59 -26.89 66.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 110.979 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -28.3 25.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.932 ' HB3' HD11 ' A' ' 388' ' ' ILE . 17.8 mt -104.13 -1.75 26.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 22.9 m80 64.29 53.49 1.72 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 110.215 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.885 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -97.12 175.03 6.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 110.758 -176.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.8 m -115.42 132.18 56.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 110.375 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.914 ' CE2' HG11 ' A' ' 367' ' ' VAL . 70.6 m-85 -87.86 149.13 24.31 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.479 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 59.9 t -125.31 100.78 32.04 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.066 -1.021 . . . . 0.0 109.866 175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.3 Cg_endo -56.3 151.93 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.089 1.573 . . . . 0.0 110.404 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 12.8 t80 -62.19 131.75 50.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 110.118 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.8 p -120.7 153.37 37.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.553 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.12 -4.89 49.68 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.882 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -56.65 -33.56 66.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.821 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.535 ' HB2' ' CG ' ' A' ' 383' ' ' MET . 5.3 m -139.77 9.77 2.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.841 . . . . 0.0 110.372 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 94.1 mtt180 58.51 51.89 7.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.329 -0.857 . . . . 0.0 109.691 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.677 ' CE ' ' HB1' ' A' ' 400' ' ' ALA . 2.0 ptp -160.92 172.91 16.11 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.155 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.518 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.3 p -154.43 165.04 37.66 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.65 -165.1 33.14 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.772 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.983 HD11 ' CG2' ' A' ' 367' ' ' VAL . 6.7 tt -142.51 148.31 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.956 . . . . 0.0 110.04 -175.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -128.28 135.15 49.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.803 -1.186 . . . . 0.0 109.912 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.932 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.691 -1.255 . . . . 0.0 109.421 169.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.257 88.3 m-20 -25.88 -63.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.444 0.64 . . . . 0.0 112.251 173.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.438 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 19.9 t-20 -91.45 -7.97 49.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.807 . . . . 0.0 111.723 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.557 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 26.4 mtp180 -143.23 145.53 32.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.669 -1.27 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.0 mtm -135.91 113.56 10.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.131 . . . . 0.0 109.033 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 339' ' ' LEU . 10.0 mt -131.8 146.08 33.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.043 -177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 26.9 mtt180 -135.52 160.74 37.53 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.613 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.647 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.87 138.69 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.485 -0.759 . . . . 0.0 109.185 174.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.625 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -165.36 174.55 41.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 44.6 m -57.34 150.97 17.04 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.024 -1.28 . . . . 0.0 108.654 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.036 HG21 HG11 ' A' ' 420' ' ' VAL . 19.7 t -53.72 -37.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.9 m-20 -64.11 -44.71 91.43 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.392 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.677 ' HB1' ' CE ' ' A' ' 383' ' ' MET . . . -68.44 -50.57 51.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.907 -1.12 . . . . 0.0 110.574 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.638 HD13 ' HE1' ' A' ' 383' ' ' MET . 25.9 mm -64.9 -43.56 96.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.027 -1.046 . . . . 0.0 110.847 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 14.0 ttp180 -59.39 -43.17 92.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 62.5 mtp180 -61.92 -36.09 80.32 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 109.433 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.23 -37.48 83.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.203 -0.935 . . . . 0.0 111.291 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 437' ' ' SER . 58.3 t -65.66 -47.86 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.538 -1.351 . . . . 0.0 110.246 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.4 -34.67 78.24 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.795 -1.19 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.27 80.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.901 -1.125 . . . . 0.0 109.962 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 15.6 m-80 -61.7 -27.27 68.58 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.244 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.48 19.41 30.04 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.52 -169.44 17.08 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.435 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.3 m-70 -143.88 153.92 42.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -1.214 . . . . 0.0 111.378 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.593 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 6.4 p90 -106.97 149.18 38.24 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.626 -0.671 . . . . 0.0 110.255 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.818 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.46 123.7 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.809 1.426 . . . . 0.0 110.433 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -66.33 -33.99 76.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.925 . . . . 0.0 111.053 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 419' ' ' LYS . 90.7 m-20 -61.04 -32.99 72.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.9 -1.125 . . . . 0.0 108.841 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.06 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.8 t -84.1 -42.62 17.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 60.7 m-20 -54.2 -36.99 64.05 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.456 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.6 mm-40 -63.18 -48.82 76.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.254 -1.529 . . . . 0.0 110.228 170.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 415' ' ' ASP . 16.5 mmtt -56.29 -35.38 67.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.751 -1.218 . . . . 0.0 110.412 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.042 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.79 -40.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 109.151 171.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.874 0.845 . . . . 0.0 109.346 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 94.7 mm-40 -66.83 -38.06 85.68 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.644 -0.66 . . . . 0.0 110.666 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 428' ' ' ALA . 65.5 t -63.09 -36.92 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.934 -1.104 . . . . 0.0 110.14 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.14 82.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.017 -1.052 . . . . 0.0 110.103 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -70.37 -30.67 67.65 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 111.108 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 423' ' ' VAL . 5.9 pt20 -82.15 -6.35 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 0.0 109.901 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 96.44 22.02 20.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 445' ' ' LEU . . . -110.19 170.99 7.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 110.026 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.945 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.7 m -113.44 107.02 53.84 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.075 -1.016 . . . . 0.0 110.078 -174.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.566 ' HB2' HG22 ' A' ' 420' ' ' VAL . 43.3 Cg_endo -77.38 108.59 2.62 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.7 mt -93.48 139.68 30.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.919 -1.113 . . . . 0.0 108.851 167.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.85 ' CG2' HG22 ' A' ' 398' ' ' VAL . 88.3 t -102.5 135.76 38.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.749 -1.219 . . . . 0.0 109.587 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.75 ' CG1' HD11 ' A' ' 440' ' ' LEU . 46.3 t -118.25 135.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 108.758 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -118.26 160.56 17.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.525 ' CB ' HD23 ' A' ' 440' ' ' LEU . 3.9 tt0 -136.67 133.64 36.4 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 171.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.82 -124.2 23.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 405' ' ' VAL . 1.9 p -114.19 12.48 17.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.269 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -127.19 171.36 11.5 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 109.843 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.828 ' HA ' HG12 ' A' ' 434' ' ' VAL . 47.4 t -88.17 136.19 23.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.089 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.6 pp -94.34 -22.33 18.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.46 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.968 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.17 177.44 39.34 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.976 169.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.042 HG21 HG23 ' A' ' 420' ' ' VAL . 52.3 t -107.66 142.88 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.178 -1.19 . . . . 0.0 109.811 172.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.684 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.1 mt -101.43 112.93 36.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 171.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.576 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.81 119.0 31.23 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 109.869 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.945 HD12 ' HB ' ' A' ' 429' ' ' THR . 0.8 OUTLIER -101.38 144.88 29.66 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.52 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 13.8 pttt -141.01 171.08 14.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.597 -1.314 . . . . 0.0 110.738 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -71.38 144.88 49.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.737 . . . . 0.0 110.17 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 9.3 tp -119.63 152.84 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 110.283 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.07 134.01 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 110.303 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -93.12 144.08 25.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.183 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.54 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.248 0.547 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -122.61 146.1 47.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.221 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.542 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.3 mt-30 -131.33 151.31 51.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.25 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.691 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -62.03 137.87 58.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.842 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -122.98 -32.87 3.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.48 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.488 ' N ' HD11 ' A' ' 355' ' ' LEU . 46.2 tt0 -163.22 146.13 10.38 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.348 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.046 ' CD1' HD21 ' A' ' 355' ' ' LEU . 10.1 p90 -134.24 142.19 47.26 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.875 -1.141 . . . . 0.0 111.482 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.632 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.3 mp -113.53 139.71 23.64 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.612 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -71.0 143.14 44.11 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.713 1.375 . . . . 0.0 111.359 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.072 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -69.06 153.87 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 108.724 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.83 128.26 36.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.68 -1.262 . . . . 0.0 110.378 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 112.67 -22.27 17.23 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 440' ' ' LEU . 61.2 t -115.84 139.93 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.727 -1.455 . . . . 0.0 111.071 -172.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.6 m-20 -72.19 148.39 45.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.139 -0.976 . . . . 0.0 109.66 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.576 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.5 tt0 -60.56 -39.28 87.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 110.496 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.476 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.4 ttmt -58.76 -43.6 90.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.713 -1.242 . . . . 0.0 109.641 175.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 93.1 m -56.75 -43.83 81.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.959 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -58.66 -39.7 81.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.016 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.81 -40.99 83.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.074 -1.016 . . . . 0.0 110.817 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.2 m-20 -63.66 -50.02 70.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 109.823 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.904 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.18 -31.5 71.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 109.711 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.787 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.08 -35.4 64.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.954 . . . . 0.0 109.033 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 20.6 mt-30 -74.79 -55.86 5.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.535 -0.728 . . . . 0.0 110.882 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.15 -35.6 77.54 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.77 -172.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.407 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.53 -20.49 65.43 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.072 -1.018 . . . . 0.0 110.063 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 353' ' ' VAL . 93.5 p -107.15 9.08 30.39 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.161 -0.962 . . . . 0.0 111.471 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 38.8 mt -66.2 -44.61 83.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.614 -1.304 . . . . 0.0 109.665 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.15 1.87 50.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.919 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.485 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.4 p30 -63.28 130.47 44.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.726 -1.234 . . . . 0.0 109.879 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.48 5.4 51.68 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.551 0.691 . . . . 0.0 109.926 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.5 152.04 83.25 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.643 -0.661 . . . . 0.0 109.478 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.07 -39.71 89.48 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.748 1.394 . . . . 0.0 109.144 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.9 mt-10 -64.44 -27.98 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 110.409 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.99 -37.26 62.25 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -175.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.527 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.0 mtt-85 -76.72 -37.36 56.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -1.231 . . . . 0.0 110.513 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.542 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.9 m -61.28 -37.95 85.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.952 -1.092 . . . . 0.0 110.358 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.636 HG23 HD13 ' A' ' 443' ' ' ILE . 85.2 mt -68.78 -49.26 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.618 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.8 t -61.06 -33.61 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.93 HG22 ' OE1' ' A' ' 358' ' ' GLN . 33.2 mt -72.58 -33.62 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.698 -1.251 . . . . 0.0 110.652 171.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.046 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.01 -40.53 85.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.935 -1.103 . . . . 0.0 110.402 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.406 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.06 -45.15 90.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.444 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.916 ' HB3' HD23 ' A' ' 362' ' ' LEU . 40.7 mtmt -72.29 -49.51 34.17 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.616 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.93 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.8 pt20 -71.56 -42.77 67.42 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.891 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.5 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 38.5 mmt180 -72.67 -45.46 58.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.138 -0.976 . . . . 0.0 111.164 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.576 ' CZ ' ' OE2' ' A' ' 330' ' ' GLU . 60.0 m-85 -135.83 -38.68 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.391 -1.323 . . . . 0.0 112.114 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.499 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 13.8 t-20 -159.99 106.17 1.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.698 -1.251 . . . . 0.0 111.542 -168.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.916 HD23 ' HB3' ' A' ' 357' ' ' LYS . 52.6 mt -57.7 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 0.0 109.323 172.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.536 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 15.7 tpt180 -128.07 164.0 23.38 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.5 mt-10 -137.98 -159.58 0.97 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.041 -1.037 . . . . 0.0 110.167 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.592 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.3 ptt180 -95.98 162.86 13.38 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.523 -0.736 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -130.34 41.86 3.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 110.465 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.036 HG21 ' CE1' ' A' ' 374' ' ' PHE . 42.9 t -72.97 -45.65 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.191 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -67.29 -27.48 67.21 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.487 -0.758 . . . . 0.0 111.021 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -29.64 27.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.713 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.774 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.4 mt -103.36 -5.03 23.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 110.662 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 367' ' ' VAL . 73.5 m-70 60.57 51.73 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.116 -0.99 . . . . 0.0 109.752 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.755 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.99 174.62 7.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.81 . . . . 0.0 110.521 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.0 m -117.15 134.89 54.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.342 -0.849 . . . . 0.0 110.58 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.036 ' CE1' HG21 ' A' ' 367' ' ' VAL . 82.3 m-85 -88.58 147.47 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 387' ' ' ASN . 60.7 t -120.43 100.98 46.91 Favored Pre-proline 0 C--N 1.299 -1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.2 Cg_endo -55.07 151.39 34.66 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.019 1.537 . . . . 0.0 110.529 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 16.4 t80 -66.44 131.87 47.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.5 p -120.01 151.76 38.51 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.732 175.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.39 -6.63 54.08 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.536 -0.727 . . . . 0.0 109.881 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -56.89 -32.97 66.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.862 . . . . 0.0 109.838 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.545 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 15.1 m -138.82 9.93 2.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.412 -0.805 . . . . 0.0 110.299 174.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 81.4 mtm180 56.79 50.98 11.51 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.185 -0.947 . . . . 0.0 109.424 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.708 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.0 ptp -157.54 166.3 33.3 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.923 0.868 . . . . 0.0 111.357 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.93 165.0 37.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -178.63 -166.96 35.61 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 118.923 -1.608 . . . . 0.0 110.733 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.865 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.9 tt -139.45 149.58 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.556 -0.967 . . . . 0.0 110.178 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.522 HD21 HG21 ' A' ' 375' ' ' VAL . 47.3 m-20 -127.16 134.84 50.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.018 -1.051 . . . . 0.0 109.798 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -141.51 155.21 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.268 90.4 m-20 -23.02 -63.04 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.406 0.622 . . . . 0.0 112.49 171.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 53.7 t30 -95.99 -5.7 40.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.788 . . . . 0.0 111.855 -167.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.554 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.1 mtp180 -144.13 143.96 31.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.741 -1.225 . . . . 0.0 110.434 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.9 mtm -134.72 102.26 5.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.896 -1.128 . . . . 0.0 109.071 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -124.31 146.03 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -172.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 39.9 mtt180 -134.37 159.98 39.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 0.0 110.872 176.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.505 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.65 127.96 32.15 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.502 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.33 173.83 32.8 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.319 -1.419 . . . . 0.0 109.566 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.2 m -55.82 149.26 15.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.757 -1.437 . . . . 0.0 108.343 168.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.067 HG22 HG23 ' A' ' 432' ' ' VAL . 61.3 t -58.24 -34.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.899 -1.126 . . . . 0.0 109.917 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.2 t0 -61.85 -45.32 94.3 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.708 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.84 -51.27 42.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.955 -1.09 . . . . 0.0 110.591 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.561 HD13 ' CE ' ' A' ' 383' ' ' MET . 31.0 mm -64.49 -42.93 96.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.097 -1.002 . . . . 0.0 110.742 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.8 ttp85 -59.31 -43.73 92.61 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 70.6 mtp180 -61.8 -36.57 81.5 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.403 173.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.544 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -68.45 -36.14 78.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 111.197 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 437' ' ' SER . 52.9 t -65.81 -49.29 78.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.587 -1.32 . . . . 0.0 110.127 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.73 -33.91 76.7 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.949 -1.095 . . . . 0.0 110.285 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.19 79.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.991 -1.068 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.545 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.2 m-80 -62.25 -27.17 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.69 19.46 29.41 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -169.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.73 -171.4 18.27 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -144.88 153.68 41.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 111.037 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.3 p90 -108.78 150.7 41.15 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.861 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -71.93 128.33 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.83 1.437 . . . . 0.0 110.388 -175.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 2.8 t -67.3 -35.57 79.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.251 -0.905 . . . . 0.0 110.992 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -61.52 -34.06 74.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.912 -1.118 . . . . 0.0 108.816 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.072 HG21 ' HA ' ' A' ' 325' ' ' ALA . 55.0 t -83.48 -42.6 17.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.956 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.5 t0 -55.67 -38.22 69.32 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.543 172.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.4 mm-40 -63.77 -47.93 78.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.343 -1.473 . . . . 0.0 110.295 171.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.632 ' CD ' HG21 ' A' ' 323' ' ' ILE . 66.2 mttm -56.76 -35.06 68.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.639 -1.288 . . . . 0.0 110.431 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.095 HG23 HG21 ' A' ' 442' ' ' VAL . 2.9 t -60.04 -41.36 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.879 -1.138 . . . . 0.0 109.371 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.0 -36.0 82.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.812 0.815 . . . . 0.0 109.418 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.52 -37.87 80.41 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.648 -0.658 . . . . 0.0 110.861 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.8 t -62.95 -37.56 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.092 . . . . 0.0 110.022 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -40.12 83.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.332 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -68.25 -31.16 70.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 110.972 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -80.87 -3.47 51.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.045 -1.035 . . . . 0.0 109.705 174.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.25 21.77 34.26 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.63 173.87 6.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.143 . . . . 0.0 109.827 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.985 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.4 m -115.89 106.72 49.34 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.978 -1.076 . . . . 0.0 110.03 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 398' ' ' VAL . 54.9 Cg_endo -79.85 107.47 2.1 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.91 1.479 . . . . 0.0 110.243 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -91.94 135.61 33.8 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.898 -1.126 . . . . 0.0 108.482 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 1.067 HG23 HG22 ' A' ' 398' ' ' VAL . 88.3 t -99.71 133.96 40.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.747 -1.22 . . . . 0.0 109.341 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.027 ' CG1' HD11 ' A' ' 440' ' ' LEU . 25.0 t -113.47 136.78 48.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.8 m -122.19 160.92 23.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 121.379 -0.825 . . . . 0.0 109.719 -177.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.452 ' HA ' HG12 ' A' ' 393' ' ' ILE . 4.5 tt0 -135.14 130.98 36.27 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 170.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.84 -128.1 28.72 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.639 ' O ' HG13 ' A' ' 405' ' ' VAL . 84.8 p -106.33 8.7 31.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 111.132 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.477 ' NH1' ' HG3' ' A' ' 438' ' ' ARG . 35.2 ptt85 -122.87 174.23 7.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.59 -1.319 . . . . 0.0 110.257 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.804 ' HA ' HG12 ' A' ' 434' ' ' VAL . 52.9 t -94.49 134.5 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.027 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -93.88 -21.22 19.38 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.748 175.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.959 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 169.42 176.55 39.41 Favored Glycine 0 N--CA 1.5 2.945 0 C-N-CA 118.868 -1.634 . . . . 0.0 110.961 168.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.095 HG21 HG23 ' A' ' 420' ' ' VAL . 48.9 t -107.99 142.64 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.009 -1.289 . . . . 0.0 109.974 173.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.787 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.3 mt -101.38 112.36 34.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.352 -0.842 . . . . 0.0 109.104 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.28 119.44 31.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.793 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.985 HD12 ' HB ' ' A' ' 429' ' ' THR . 1.4 mt -102.59 146.33 28.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.579 ' CE ' ' CB ' ' A' ' 320' ' ' SER . 1.4 ptpm? -134.64 164.88 26.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.575 -1.328 . . . . 0.0 110.777 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -83.79 146.02 28.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.547 -0.721 . . . . 0.0 110.14 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.7 tp -119.02 153.09 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.853 . . . . 0.0 110.333 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.91 136.53 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.287 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -89.73 145.52 25.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 110.188 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 CA-C-O 118.005 -1.441 . . . . 0.0 109.561 -179.904 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.264 0.554 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.519 ' NE ' ' OE2' ' A' ' 348' ' ' GLU . 87.5 mtm-85 -122.96 145.03 48.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.895 . . . . 0.0 110.215 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 63.8 tt0 -120.37 133.59 55.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.372 -0.83 . . . . 0.0 110.089 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.76 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -55.59 139.35 44.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.074 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 39.8 m -123.34 -38.67 2.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.494 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.455 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.5 tt0 -163.03 148.97 12.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.149 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.023 ' CD1' HD21 ' A' ' 355' ' ' LEU . 16.1 p90 -134.54 143.57 47.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.759 -1.213 . . . . 0.0 111.802 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.531 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.6 mt -113.68 143.99 30.54 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.561 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.74 142.72 36.17 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.708 1.372 . . . . 0.0 111.569 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.035 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.98 151.72 43.02 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 108.876 165.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.79 129.04 40.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.684 -1.26 . . . . 0.0 109.983 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.39 -1.8 46.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.676 HG13 HG21 ' A' ' 332' ' ' THR . 52.1 t -136.01 139.07 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.573 -1.545 . . . . 0.0 110.748 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 332' ' ' THR . 6.5 p-10 -73.52 151.89 40.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 110.158 176.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 83.5 tt0 -61.06 -34.7 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.108 -0.995 . . . . 0.0 109.658 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.517 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -59.75 -44.22 93.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 109.473 177.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.676 HG21 HG13 ' A' ' 328' ' ' VAL . 3.2 m -62.98 -39.14 93.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 175.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.986 HD22 ' HA3' ' A' ' 441' ' ' GLY . 6.2 tp -59.83 -40.12 87.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.048 -1.033 . . . . 0.0 110.412 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.982 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -68.02 -43.96 77.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.953 -1.092 . . . . 0.0 110.711 -176.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.574 ' O ' HD23 ' A' ' 339' ' ' LEU . 57.5 t0 -63.15 -48.84 76.74 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.878 -1.139 . . . . 0.0 110.068 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.952 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.74 -31.05 69.83 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 109.918 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -54.8 -35.99 64.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.134 -0.979 . . . . 0.0 108.884 172.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 13.8 mt-30 -75.06 -55.76 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.663 -0.648 . . . . 0.0 111.06 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.046 HD11 HD12 ' A' ' 393' ' ' ILE . 0.2 OUTLIER -64.97 -32.92 74.87 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.136 -171.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.86 -1.15 . . . . 0.0 110.07 172.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.625 ' OG ' HG22 ' A' ' 353' ' ' VAL . 99.1 p -107.95 11.4 27.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.143 -0.973 . . . . 0.0 111.541 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 44.5 mt -66.74 -45.17 79.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.722 -1.236 . . . . 0.0 109.859 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.07 1.08 49.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.864 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.481 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.2 p30 -63.92 130.3 43.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.746 -1.221 . . . . 0.0 109.979 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.59 4.6 52.97 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.633 0.73 . . . . 0.0 109.85 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 346' ' ' THR . 3.1 p -74.13 152.69 88.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.434 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.75 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.757 1.399 . . . . 0.0 109.227 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.519 ' OE2' ' NE ' ' A' ' 317' ' ' ARG . 99.2 mt-10 -64.45 -28.44 69.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.41 -38.53 69.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.552 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.3 mtt85 -77.91 -37.2 48.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -1.157 . . . . 0.0 110.58 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 5.5 m -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 110.338 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.674 HG23 HD13 ' A' ' 443' ' ' ILE . 86.0 mt -68.66 -48.6 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.023 -1.048 . . . . 0.0 110.652 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.625 HG22 ' OG ' ' A' ' 341' ' ' SER . 25.1 t -60.83 -32.77 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.9 mt -72.54 -32.14 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 110.719 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.023 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.4 OUTLIER -59.84 -41.11 90.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.801 -1.187 . . . . 0.0 110.396 178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.23 -42.55 99.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.359 -0.838 . . . . 0.0 110.363 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 73.1 mttt -72.54 -51.54 19.46 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.711 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.547 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 20.1 pt20 -70.7 -42.4 70.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.547 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.5 mmm180 -74.59 -43.85 53.61 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 111.084 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.684 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 50.6 m-85 -135.2 -39.48 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.658 -1.276 . . . . 0.0 111.986 -169.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.524 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 49.5 t30 -161.03 105.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.716 -1.24 . . . . 0.0 111.588 -168.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 42.0 mt -57.57 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.899 -1.125 . . . . 0.0 109.075 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.512 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 33.7 tpt85 -135.09 163.73 29.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.006 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -134.03 -156.25 0.72 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.903 -1.123 . . . . 0.0 110.457 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 46.7 ptt85 -97.4 161.43 13.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.505 0.669 . . . . 0.0 110.717 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -128.08 41.77 3.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.305 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.946 HG21 ' CE1' ' A' ' 374' ' ' PHE . 88.5 t -73.49 -49.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.413 -0.804 . . . . 0.0 110.464 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -69.16 -23.87 64.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 111.073 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -31.94 31.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 109.691 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.989 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.2 mt -101.57 -3.61 28.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 110.554 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 371' ' ' HIS . 8.6 m170 63.74 53.93 1.91 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.931 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -96.72 175.01 6.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.6 m -117.45 135.14 54.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.57 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.946 ' CE1' HG21 ' A' ' 367' ' ' VAL . 93.0 m-85 -90.28 143.11 27.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.653 HG21 HD21 ' A' ' 387' ' ' ASN . 19.8 t -116.68 101.23 53.66 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.973 . . . . 0.0 109.608 175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -55.13 151.53 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.034 1.544 . . . . 0.0 110.603 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 13.1 t80 -64.43 132.0 48.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.1 p -120.43 152.37 38.05 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.84 . . . . 0.0 109.664 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.63 -6.63 54.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.504 -0.747 . . . . 0.0 109.918 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.86 -32.84 66.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.843 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 3.3 m -139.05 9.97 2.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.371 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 71.1 mtt85 56.93 51.27 10.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.203 -0.936 . . . . 0.0 109.485 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.825 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.4 ptp -158.18 167.65 29.21 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.236 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.8 p -155.38 165.19 37.38 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.58 -165.55 33.83 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.618 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.774 HD11 HG22 ' A' ' 367' ' ' VAL . 1.5 tt -140.21 149.51 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.631 -0.923 . . . . 0.0 110.104 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.653 HD21 HG21 ' A' ' 375' ' ' VAL . 31.3 m-20 -127.23 134.62 50.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 109.756 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.989 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -139.82 154.87 24.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.875 -1.141 . . . . 0.0 109.381 171.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.262 89.8 m-20 -25.53 -63.09 0.06 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.407 0.622 . . . . 0.0 112.251 172.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.453 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 51.2 t30 -91.62 -7.76 49.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 111.692 -168.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.561 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 34.3 mtp180 -144.7 144.65 31.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.636 -1.29 . . . . 0.0 110.536 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.4 mtm -134.93 110.46 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.871 -1.143 . . . . 0.0 109.067 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 339' ' ' LEU . 8.7 mt -131.3 145.91 34.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.057 -1.027 . . . . 0.0 110.201 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 49.6 mtt-85 -134.94 160.95 36.66 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.834 175.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.521 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.52 128.74 33.93 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.582 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -157.03 174.31 34.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -174.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 42.4 m -57.27 151.09 16.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.934 -1.333 . . . . 0.0 108.597 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.12 HG21 HG11 ' A' ' 420' ' ' VAL . 60.1 t -56.62 -35.1 43.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.075 -1.016 . . . . 0.0 109.894 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 22.3 t70 -63.03 -46.13 89.01 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.306 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.825 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.82 -51.82 36.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.985 -1.072 . . . . 0.0 110.482 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.582 HD11 ' N ' ' A' ' 396' ' ' GLY . 36.7 mm -63.51 -42.77 97.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 121.126 -0.984 . . . . 0.0 110.64 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.624 ' NH1' ' CE1' ' A' ' 412' ' ' PHE . 9.1 ttt180 -60.24 -43.21 96.26 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 52.1 mtp85 -61.62 -35.86 79.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.052 -1.03 . . . . 0.0 109.562 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.505 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.5 t-80 -67.45 -37.72 83.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.187 -0.945 . . . . 0.0 111.269 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.517 ' CG2' HG11 ' A' ' 434' ' ' VAL . 59.5 t -65.66 -47.7 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.558 -1.339 . . . . 0.0 110.16 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.1 -34.98 78.77 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.795 -1.19 . . . . 0.0 110.28 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -35.92 79.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.505 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.2 m-80 -61.53 -27.47 68.63 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.159 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.43 19.69 29.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.85 -169.38 16.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.445 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.8 m-70 -143.31 153.52 42.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.094 -1.239 . . . . 0.0 111.488 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.624 ' CE1' ' NH1' ' A' ' 402' ' ' ARG . 7.5 p90 -107.5 150.27 39.88 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.772 -0.58 . . . . 0.0 110.202 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.828 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.75 123.14 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.904 1.476 . . . . 0.0 110.495 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.2 t -66.82 -32.6 73.99 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.098 -1.002 . . . . 0.0 111.026 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.6 m-20 -61.96 -32.88 73.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.896 -1.128 . . . . 0.0 108.844 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.035 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.3 t -83.6 -42.4 17.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.999 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.584 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 67.9 m-20 -55.39 -37.13 67.17 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.616 171.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 96.0 mt-30 -63.75 -48.76 75.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.337 -1.477 . . . . 0.0 110.099 171.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.531 ' CD ' HG21 ' A' ' 323' ' ' ILE . 95.9 mttt -57.22 -34.7 68.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.68 -1.262 . . . . 0.0 110.355 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.12 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.5 -40.76 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 0.0 109.257 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -66.81 -36.74 83.07 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.873 0.844 . . . . 0.0 109.448 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 83.9 mt-30 -67.48 -36.66 81.56 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.622 -0.673 . . . . 0.0 110.472 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 428' ' ' ALA . 71.0 t -62.97 -37.89 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 110.029 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.86 -40.16 83.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.335 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -69.07 -31.06 69.54 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.287 -0.883 . . . . 0.0 110.942 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -83.25 -3.02 57.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.808 176.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.6 21.94 27.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.763 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.43 161.62 14.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -1.097 . . . . 0.0 109.478 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 445' ' ' LEU . 28.2 m -109.02 107.22 59.84 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.03 . . . . 0.0 109.703 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.546 ' CG ' HG13 ' A' ' 420' ' ' VAL . 39.0 Cg_endo -76.26 107.94 2.56 Favored 'Trans proline' 0 C--N 1.298 -2.09 0 O-C-N 123.924 1.486 . . . . 0.0 110.643 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.903 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.0 mt -93.04 134.43 35.19 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.825 -1.172 . . . . 0.0 108.677 167.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 1.009 ' CG2' HG22 ' A' ' 398' ' ' VAL . 91.3 t -100.74 134.93 39.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 120.72 -1.238 . . . . 0.0 109.504 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.741 ' CG1' HD11 ' A' ' 440' ' ' LEU . 45.2 t -115.38 137.02 50.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.8 m -117.56 159.59 17.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.373 -0.829 . . . . 0.0 109.676 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.553 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.17 132.45 35.98 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.28 -129.3 31.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.498 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -107.93 11.87 27.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -1.218 . . . . 0.0 110.945 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -126.18 170.89 11.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.697 -1.252 . . . . 0.0 109.908 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.837 ' HA ' HG12 ' A' ' 434' ' ' VAL . 22.7 t -90.3 134.77 28.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.342 -0.849 . . . . 0.0 109.874 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.8 pp -94.77 -22.12 18.28 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.85 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.986 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.11 176.6 38.71 Favored Glycine 0 N--CA 1.499 2.88 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.997 169.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.046 HG21 HG23 ' A' ' 420' ' ' VAL . 48.0 t -107.77 141.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.216 -1.167 . . . . 0.0 109.887 173.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.721 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.3 mt -101.31 111.71 31.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.486 -0.759 . . . . 0.0 108.987 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.531 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.22 119.39 31.8 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 109.85 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.903 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.25 143.22 32.31 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 10.5 mtmt -106.73 157.99 17.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.619 -1.301 . . . . 0.0 110.984 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -91.08 146.07 24.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.71 . . . . 0.0 110.35 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.8 tp -119.18 155.64 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.85 . . . . 0.0 110.117 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.1 t -101.34 134.52 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.148 -0.97 . . . . 0.0 110.294 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 451' ' ' GLY . 57.0 mtpt -93.88 145.53 24.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.9 . . . . 0.0 110.234 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 450' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.292 0.567 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 90.9 mtm-85 -122.91 145.96 48.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 110.183 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 24.9 mt-30 -131.97 148.6 52.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.721 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.66 136.63 57.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.957 -1.09 . . . . 0.0 109.889 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -121.24 -34.5 3.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.484 ' N ' HD11 ' A' ' 355' ' ' LEU . 46.5 tt0 -165.61 147.04 7.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.182 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.016 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 12.9 p90 -136.51 147.66 47.22 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.827 -1.17 . . . . 0.0 111.663 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.528 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -118.85 144.13 35.07 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.728 -0.607 . . . . 0.0 109.593 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -72.53 143.85 39.17 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.76 1.4 . . . . 0.0 111.521 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.041 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.39 152.48 42.0 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 108.818 165.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.407 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 0.6 OUTLIER -58.32 128.55 37.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.682 -1.261 . . . . 0.0 110.126 -172.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.98 -0.77 44.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.4 t -136.49 139.92 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.481 . . . . 0.0 110.73 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.459 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.0 m-20 -74.12 152.48 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 86.1 tt0 -62.61 -40.23 96.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.487 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -59.18 -43.29 92.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.57 -1.331 . . . . 0.0 109.63 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.525 HG21 HG13 ' A' ' 328' ' ' VAL . 94.1 m -55.73 -43.55 76.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.857 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 1.001 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.8 tp -59.71 -40.17 87.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.251 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.016 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -66.59 -40.79 89.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.92 -1.112 . . . . 0.0 110.917 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 82.3 m-20 -64.62 -50.2 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.895 -1.128 . . . . 0.0 109.766 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 1.012 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.7 -30.79 70.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.951 -1.093 . . . . 0.0 109.636 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 443' ' ' ILE . . . -55.42 -35.54 65.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.103 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.561 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.3 mt-30 -73.43 -55.69 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.551 -0.718 . . . . 0.0 111.06 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.057 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -62.97 -35.72 81.1 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.559 -1.257 . . . . 0.0 109.894 -172.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.524 ' HB1' ' HG2' ' A' ' 395' ' ' LYS . . . -66.72 -20.73 66.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.088 -1.007 . . . . 0.0 110.053 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.649 ' OG ' HG22 ' A' ' 353' ' ' VAL . 94.2 p -107.03 8.84 30.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.121 -0.987 . . . . 0.0 111.579 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 41.4 mt -66.5 -44.47 82.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.531 -1.355 . . . . 0.0 109.584 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.76 1.0 50.36 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 -170.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.478 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 12.5 p30 -63.67 130.53 44.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.714 -1.241 . . . . 0.0 109.979 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.62 5.61 51.03 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.511 0.672 . . . . 0.0 109.845 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.5 p -77.35 150.17 79.69 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.652 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -53.68 -38.21 84.37 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.678 1.357 . . . . 0.0 109.172 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.7 mt-10 -64.23 -28.55 69.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 110.393 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.82 -36.93 67.51 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.53 ' O ' HD12 ' A' ' 354' ' ' ILE . 42.2 mmt180 -76.65 -37.93 55.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.118 -1.225 . . . . 0.0 110.525 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.41 -38.17 86.14 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.962 -1.086 . . . . 0.0 110.372 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.5 HG23 HD13 ' A' ' 443' ' ' ILE . 86.0 mt -68.55 -49.42 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.005 -1.059 . . . . 0.0 110.594 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.649 HG22 ' OG ' ' A' ' 341' ' ' SER . 23.9 t -60.56 -33.67 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.1 mt -72.23 -33.3 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.689 -1.257 . . . . 0.0 110.68 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.003 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -59.57 -40.8 88.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -61.92 -43.1 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 110.273 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 83.3 mttt -69.64 -48.73 58.87 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.886 -1.126 . . . . 0.0 110.745 -174.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 10.2 pt20 -70.75 -43.46 68.78 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 110.499 -173.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.2 mmm180 -73.98 -46.09 45.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 111.312 -173.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 330' ' ' GLU . 27.8 m-85 -135.67 -35.97 0.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.666 -167.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.536 ' ND2' ' HD3' ' A' ' 363' ' ' ARG . 55.9 t-20 -158.59 93.89 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.512 -1.368 . . . . 0.0 111.808 -169.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -61.35 95.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.987 -1.07 . . . . 0.0 110.178 172.087 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.536 ' HD3' ' ND2' ' A' ' 361' ' ' ASN . 30.8 ptt85 -150.01 -179.06 6.86 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 363' ' ' ARG . 22.2 pt-20 -124.78 -157.39 0.77 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 110.531 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 40.9 ptt180 -90.62 165.59 13.65 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.743 -0.598 . . . . 0.0 110.492 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.6 m-20 -123.99 38.63 4.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.422 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.022 HG21 ' CE1' ' A' ' 374' ' ' PHE . 43.9 t -74.34 -49.82 30.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 110.376 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -67.75 -25.1 65.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 111.039 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.08 -30.09 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.99 . . . . 0.0 109.8 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 1.0 ' HB3' HD11 ' A' ' 388' ' ' ILE . 19.3 mt -103.65 -4.19 24.12 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 110.672 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 367' ' ' VAL . 31.1 m80 62.84 53.94 2.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.427 -0.796 . . . . 0.0 110.168 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.923 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.9 175.03 6.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 110.606 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.9 m -116.67 134.27 55.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.022 ' CE1' HG21 ' A' ' 367' ' ' VAL . 84.2 m-85 -88.89 147.96 24.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.578 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 25.9 t -122.93 100.97 39.61 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.13 -0.981 . . . . 0.0 109.604 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.64 151.15 40.39 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.983 1.518 . . . . 0.0 110.475 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.6 t80 -65.16 131.55 46.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 110.07 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.8 p -120.77 152.89 37.76 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.99 -6.12 53.45 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.526 -0.734 . . . . 0.0 109.936 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -57.01 -33.04 66.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.804 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 383' ' ' MET . 0.5 OUTLIER -138.26 9.39 2.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 110.315 174.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 57.88 51.14 9.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.542 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.644 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.4 ptp -161.0 169.34 22.75 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.408 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 5.2 p -156.88 165.3 36.57 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.78 -165.18 33.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.859 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.3 tt -138.82 149.08 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.698 -0.884 . . . . 0.0 110.125 -176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.462 HD21 HG21 ' A' ' 375' ' ' VAL . 31.6 m-20 -127.79 135.15 49.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 109.654 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 1.0 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.8 tt -140.06 154.86 23.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.875 -1.14 . . . . 0.0 109.389 171.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.26 89.6 m-20 -25.6 -63.17 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.434 0.635 . . . . 0.0 112.242 172.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 40.8 t-20 -91.66 -7.89 48.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.51 -0.744 . . . . 0.0 111.755 -168.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 31.2 mtp180 -144.19 145.67 32.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.707 -1.246 . . . . 0.0 110.605 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 61.4 mtt -135.49 110.8 9.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.903 -1.123 . . . . 0.0 108.999 169.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.057 HD12 HD11 ' A' ' 339' ' ' LEU . 8.9 mt -130.35 146.13 34.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.989 -176.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.519 ' HA ' ' HA3' ' A' ' 385' ' ' GLY . 25.4 mmt85 -134.13 159.69 40.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.109 -0.994 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.691 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -132.61 137.55 47.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.484 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -164.37 174.36 40.42 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.267 -1.444 . . . . 0.0 109.625 -173.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.5 m -56.94 149.93 17.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.278 . . . . 0.0 108.684 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.08 HG21 HG11 ' A' ' 420' ' ' VAL . 22.8 t -55.03 -37.62 43.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 109.975 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.7 m-20 -64.24 -44.35 92.12 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.221 -0.924 . . . . 0.0 110.343 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.644 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.21 -50.24 55.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.963 -1.085 . . . . 0.0 110.662 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.587 HD13 ' CE ' ' A' ' 383' ' ' MET . 30.9 mm -64.78 -43.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.746 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.5 ttp85 -59.85 -42.92 94.68 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 90.1 mtt180 -61.47 -36.3 80.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.576 173.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.489 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.5 t-80 -66.61 -38.5 87.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 111.245 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.512 ' CG2' HG11 ' A' ' 434' ' ' VAL . 71.3 t -65.47 -47.28 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.623 -1.298 . . . . 0.0 110.268 178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.48 -34.8 78.56 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.785 -1.197 . . . . 0.0 110.436 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.933 -1.104 . . . . 0.0 109.951 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.489 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 27.1 m-80 -62.04 -27.1 68.65 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.26 18.93 31.94 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -169.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -111.58 -169.95 18.73 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.426 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.9 m-70 -144.1 153.69 42.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -1.223 . . . . 0.0 111.461 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.593 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 7.7 p90 -108.88 150.43 40.86 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.719 -0.613 . . . . 0.0 110.143 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.82 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -74.9 124.01 8.36 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.845 1.445 . . . . 0.0 110.488 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.32 -32.77 73.95 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.928 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.8 m-20 -61.65 -32.84 73.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.863 -1.148 . . . . 0.0 108.872 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.041 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.0 t -83.76 -42.55 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.391 -0.818 . . . . 0.0 110.975 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.581 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 68.8 m-20 -55.17 -37.2 66.72 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.584 171.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.8 mm-40 -63.94 -48.76 75.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.254 -1.529 . . . . 0.0 110.232 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.528 ' CD ' HG21 ' A' ' 323' ' ' ILE . 43.2 mttt -57.56 -34.27 69.02 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.638 -1.289 . . . . 0.0 110.416 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.08 HG11 HG21 ' A' ' 398' ' ' VAL . 2.5 t -59.21 -41.24 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.206 171.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -66.46 -36.22 82.22 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.921 0.867 . . . . 0.0 109.418 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.2 mm-40 -67.45 -37.63 83.25 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 110.798 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.8 t -63.31 -37.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.005 -1.059 . . . . 0.0 110.088 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.12 84.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.329 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -68.51 -31.18 70.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.394 -0.816 . . . . 0.0 110.889 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.507 ' NE2' ' HE2' ' A' ' 446' ' ' LYS . 2.0 tt0 -82.59 -3.01 55.42 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.852 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.85 27.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.67 163.18 13.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -1.064 . . . . 0.0 109.64 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.493 ' HB ' HD12 ' A' ' 445' ' ' LEU . 53.7 m -110.12 107.12 58.66 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.029 -1.045 . . . . 0.0 109.809 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.578 ' CG ' HG13 ' A' ' 420' ' ' VAL . 37.5 Cg_endo -75.82 108.22 2.64 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 123.979 1.515 . . . . 0.0 110.773 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.856 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.3 mt -92.71 135.05 34.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.854 -1.154 . . . . 0.0 108.599 166.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.968 ' CG2' HG22 ' A' ' 398' ' ' VAL . 97.9 t -100.08 136.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.651 -1.28 . . . . 0.0 109.568 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.705 ' CG1' HD11 ' A' ' 440' ' ' LEU . 44.5 t -117.33 136.96 52.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 108.992 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -117.75 160.03 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.532 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.07 132.08 35.7 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -128.65 31.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.503 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.11 11.36 27.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.185 -1.185 . . . . 0.0 110.968 -179.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -123.45 170.78 10.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.633 -1.292 . . . . 0.0 109.925 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 434' ' ' VAL . 22.5 t -91.39 134.03 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.7 pp -94.79 -21.71 18.54 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.862 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 1.001 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.99 177.02 38.97 Favored Glycine 0 N--CA 1.499 2.896 0 C-N-CA 118.847 -1.644 . . . . 0.0 110.985 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.045 HG21 HG23 ' A' ' 420' ' ' VAL . 47.1 t -107.78 142.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.183 -1.187 . . . . 0.0 109.819 173.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.652 HD11 ' CB ' ' A' ' 337' ' ' ALA . 80.1 mt -101.29 111.28 30.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 108.94 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.55 118.93 31.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.99 -1.069 . . . . 0.0 109.7 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.856 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -99.72 143.43 29.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.507 ' HE2' ' NE2' ' A' ' 426' ' ' GLN . 53.1 mttt -120.37 161.15 21.68 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.623 -1.298 . . . . 0.0 111.146 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.91 143.46 34.23 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.385 0.612 . . . . 0.0 110.216 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 12.1 tt -112.04 153.79 13.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 110.242 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.81 134.52 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.182 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -91.74 145.54 24.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.202 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.227 0.537 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -65.69 145.96 55.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.191 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 14.4 pt20 -143.33 155.8 44.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.0 110.273 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 355' ' ' LEU . . . -60.75 137.59 58.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.636 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -118.49 -35.79 3.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.479 ' N ' HD11 ' A' ' 355' ' ' LEU . 49.6 tt0 -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 110.121 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.008 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 14.3 p90 -135.69 142.76 45.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.821 -1.174 . . . . 0.0 111.676 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.525 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.6 mp -114.38 144.59 32.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.725 -0.61 . . . . 0.0 109.706 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.555 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.72 143.49 37.64 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.738 1.388 . . . . 0.0 111.448 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.051 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.94 152.0 42.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.821 165.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 1.7 tp-100 -57.59 128.61 37.9 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.803 -1.186 . . . . 0.0 110.11 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.17 -1.33 43.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.6 t -136.56 140.03 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.706 -1.467 . . . . 0.0 110.751 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.23 152.42 39.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 85.1 tt0 -62.3 -40.33 95.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.459 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -59.2 -43.33 92.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.6 -1.313 . . . . 0.0 109.639 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.519 HG21 HG13 ' A' ' 328' ' ' VAL . 93.7 m -55.97 -43.81 77.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 173.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 1.007 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.9 tp -59.21 -39.45 82.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.319 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.16 -41.31 86.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.11 . . . . 0.0 110.777 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.554 ' O ' HD23 ' A' ' 339' ' ' LEU . 90.3 m-20 -63.87 -50.03 70.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.926 -1.109 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.49 -31.13 70.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.981 -1.074 . . . . 0.0 109.722 176.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.749 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.21 -35.66 65.11 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.912 172.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.569 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.6 mt-30 -74.77 -55.84 5.42 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.583 -0.698 . . . . 0.0 110.9 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -63.72 -34.46 77.93 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.846 -171.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.458 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.04 -21.4 65.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.934 -1.104 . . . . 0.0 110.076 173.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.707 ' OG ' HG22 ' A' ' 353' ' ' VAL . 77.3 p -107.27 10.4 29.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.16 -0.963 . . . . 0.0 111.538 -174.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.573 ' CG ' ' HA ' ' A' ' 339' ' ' LEU . 45.9 mt -66.34 -43.78 85.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.55 -1.344 . . . . 0.0 109.502 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.25 0.38 48.09 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.931 -170.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.486 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.3 p30 -62.37 130.44 45.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.742 -1.224 . . . . 0.0 109.872 175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.54 5.39 51.66 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.6 0.714 . . . . 0.0 109.886 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.7 p -76.45 151.91 83.31 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.52 -0.737 . . . . 0.0 109.451 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.64 -39.53 90.54 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.643 1.338 . . . . 0.0 109.09 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 352' ' ' ILE . 98.5 mt-10 -64.56 -27.83 69.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.503 -0.748 . . . . 0.0 110.436 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.66 -37.94 70.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.567 ' O ' HD12 ' A' ' 354' ' ' ILE . 90.2 mtt-85 -76.14 -36.59 58.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.018 -1.284 . . . . 0.0 110.376 172.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 29.3 p -62.72 -37.22 85.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.957 -1.089 . . . . 0.0 110.377 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.607 HG23 HD13 ' A' ' 443' ' ' ILE . 87.6 mt -68.53 -49.48 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.536 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.707 HG22 ' OG ' ' A' ' 341' ' ' SER . 26.2 t -61.24 -33.61 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 0.0 110.148 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 350' ' ' ARG . 29.9 mt -72.2 -32.9 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.601 -1.312 . . . . 0.0 110.523 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.947 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.7 OUTLIER -60.43 -40.21 90.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.832 -1.168 . . . . 0.0 110.528 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.487 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.03 -43.18 99.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 77.3 mttt -71.65 -48.53 47.13 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.769 -175.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.549 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -70.26 -42.8 71.69 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.587 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 31.3 mmm180 -74.23 -46.51 41.25 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 111.214 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.548 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 76.4 m-85 -136.28 -34.45 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 118.252 -1.379 . . . . 0.0 112.564 -169.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.497 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 18.0 t-20 -160.11 98.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.441 -1.412 . . . . 0.0 111.763 -168.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.781 HD12 ' H ' ' A' ' 362' ' ' LEU . 5.5 mp -58.96 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.029 -1.045 . . . . 0.0 109.705 171.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.538 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.5 tpt180 -142.15 163.45 32.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.86 . . . . 0.0 109.344 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 84.0 mt-10 -127.37 -153.81 0.59 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.01 -1.056 . . . . 0.0 110.629 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.573 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 35.2 ptt-85 -95.51 163.58 13.16 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.638 -0.664 . . . . 0.0 110.733 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 54.4 p30 -128.19 40.71 3.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.553 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.927 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.6 t -73.47 -46.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.192 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -67.79 -26.6 66.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.465 -0.772 . . . . 0.0 111.11 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.44 -30.66 29.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.107 -0.995 . . . . 0.0 109.745 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.789 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.6 mt -101.41 -3.96 27.76 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.541 -0.724 . . . . 0.0 110.636 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 367' ' ' VAL . 50.7 m80 59.3 52.51 5.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.957 . . . . 0.0 109.795 -175.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.835 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.61 174.6 7.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 110.378 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.9 m -116.38 134.94 54.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 110.473 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.927 ' CE1' HG21 ' A' ' 367' ' ' VAL . 88.0 m-85 -89.73 147.39 23.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.441 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 40.1 t -120.33 101.18 46.96 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.5 Cg_endo -54.54 153.7 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.003 1.528 . . . . 0.0 110.545 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.556 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.7 t80 -70.68 134.8 47.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.829 . . . . 0.0 110.383 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 6.4 p -115.64 143.42 45.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.855 . . . . 0.0 109.832 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.29 -24.4 59.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.656 -0.652 . . . . 0.0 110.341 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.84 -45.49 94.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.714 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.489 ' OG ' ' HG3' ' A' ' 383' ' ' MET . 97.1 p -94.31 -12.76 27.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.256 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 98.2 mtt180 57.16 47.9 16.3 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.592 -0.692 . . . . 0.0 109.67 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.891 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.9 ptp -165.45 170.98 13.86 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.795 0.807 . . . . 0.0 111.287 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.6 p -155.54 165.53 36.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.509 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -179.29 -164.28 31.6 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.756 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.723 HD11 HG22 ' A' ' 367' ' ' VAL . 2.2 tt -142.45 149.48 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.623 -0.928 . . . . 0.0 110.154 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.44 HD21 HG21 ' A' ' 375' ' ' VAL . 39.3 m-20 -127.29 136.32 51.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 109.755 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.789 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -140.8 155.24 22.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.993 -1.067 . . . . 0.0 109.221 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.269 90.5 m-20 -21.96 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.452 0.644 . . . . 0.0 112.62 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 45.9 t-20 -95.99 -7.01 37.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.449 -0.782 . . . . 0.0 111.858 -167.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.555 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 29.8 mtp180 -143.64 146.18 33.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.661 -1.275 . . . . 0.0 110.639 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -136.15 104.3 5.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.863 -1.148 . . . . 0.0 109.119 170.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 339' ' ' LEU . 8.0 mt -125.05 146.07 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.056 -1.027 . . . . 0.0 109.996 -174.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 23.6 mmt85 -134.29 159.55 40.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.011 . . . . 0.0 110.324 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.563 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -133.43 126.03 30.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.684 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.42 174.33 31.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 39.9 m -56.21 151.33 12.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.973 -1.31 . . . . 0.0 108.646 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.041 HG21 HG11 ' A' ' 420' ' ' VAL . 23.0 t -54.57 -37.65 39.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.915 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.2 m-20 -64.62 -44.99 88.78 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.3 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.891 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.14 -48.95 66.52 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.944 -1.097 . . . . 0.0 110.635 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.684 HD11 ' N ' ' A' ' 396' ' ' GLY . 39.9 mm -66.53 -44.31 90.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.029 -1.045 . . . . 0.0 111.007 -176.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HD2' ' CZ ' ' A' ' 412' ' ' PHE . 9.3 ttp180 -59.52 -43.08 93.53 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 92.2 mtt180 -61.69 -37.05 82.68 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.04 -1.038 . . . . 0.0 109.579 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.52 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.2 t-80 -67.3 -36.47 81.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 111.273 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 437' ' ' SER . 54.7 t -65.54 -49.13 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.6 -1.313 . . . . 0.0 110.161 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.47 -34.34 77.55 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.943 -1.098 . . . . 0.0 110.371 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.74 78.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.111 . . . . 0.0 109.982 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.55 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 18.0 m-80 -62.08 -27.05 68.64 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.429 -0.794 . . . . 0.0 109.155 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.83 19.35 29.39 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -170.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -113.89 -169.66 16.88 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.434 ' C ' HG11 ' A' ' 405' ' ' VAL . 98.7 m-70 -143.09 153.36 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.139 -1.212 . . . . 0.0 111.395 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.587 ' CZ ' ' HD2' ' A' ' 402' ' ' ARG . 7.9 p90 -108.17 149.32 39.04 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.635 -0.665 . . . . 0.0 110.182 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.815 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -75.1 125.14 9.06 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.873 1.459 . . . . 0.0 110.531 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -68.09 -32.32 72.55 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.122 -0.986 . . . . 0.0 111.142 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.478 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.6 m-20 -63.24 -31.81 73.06 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.878 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.051 HG21 ' HA ' ' A' ' 325' ' ' ALA . 46.6 t -83.57 -42.77 17.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.88 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.58 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 69.1 m-20 -55.08 -36.34 65.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.729 -1.232 . . . . 0.0 109.648 171.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.39 -50.13 68.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.434 -1.416 . . . . 0.0 109.639 173.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 85.9 mttt -56.83 -34.53 67.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.757 -1.215 . . . . 0.0 110.286 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.101 HG23 HG21 ' A' ' 442' ' ' VAL . 2.5 t -58.99 -41.6 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 171.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -66.07 -36.18 82.52 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.955 0.883 . . . . 0.0 109.409 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 95.5 mm-40 -67.25 -38.25 84.86 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.602 -0.686 . . . . 0.0 110.725 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.809 HG13 ' HB3' ' A' ' 428' ' ' ALA . 68.2 t -62.61 -37.13 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.074 . . . . 0.0 110.125 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.29 84.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -68.18 -32.38 72.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 0.0 110.983 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -82.73 -2.89 55.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.77 22.56 30.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.809 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.19 163.5 12.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -1.143 . . . . 0.0 109.538 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.772 ' HB ' HD12 ' A' ' 445' ' ' LEU . 18.5 m -110.5 107.0 58.26 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.058 -1.026 . . . . 0.0 109.855 -175.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.566 ' CG ' HG13 ' A' ' 420' ' ' VAL . 33.6 Cg_endo -74.82 107.93 2.59 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 O-C-N 123.984 1.518 . . . . 0.0 110.73 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.864 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.3 mt -92.69 132.76 36.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 108.509 166.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.904 ' CG2' HG22 ' A' ' 398' ' ' VAL . 99.8 t -100.04 134.98 37.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 O-C-N 120.746 -1.222 . . . . 0.0 109.512 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.822 ' CG1' HD11 ' A' ' 440' ' ' LEU . 40.8 t -114.73 138.46 44.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.116 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 1.9 m -119.56 160.55 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 109.655 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.477 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.34 129.64 33.74 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.2 -131.79 30.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -167.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.561 ' O ' HG13 ' A' ' 405' ' ' VAL . 79.6 p -102.93 7.75 39.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -1.23 . . . . 0.0 111.071 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -118.4 170.71 8.69 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.647 -1.283 . . . . 0.0 110.127 -175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 24.6 t -93.58 134.48 31.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.336 -0.853 . . . . 0.0 109.719 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.4 pp -95.3 -21.72 18.23 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.772 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 1.007 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.7 176.77 39.16 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.003 169.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.101 HG21 HG23 ' A' ' 420' ' ' VAL . 44.4 t -107.74 141.45 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.153 -1.204 . . . . 0.0 109.923 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.749 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.7 mt -101.45 111.06 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.448 -0.782 . . . . 0.0 108.986 170.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.94 119.35 31.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.956 -1.09 . . . . 0.0 109.801 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.864 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.0 OUTLIER -100.09 142.75 31.14 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -122.35 161.18 23.88 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.848 -1.158 . . . . 0.0 111.078 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -87.07 141.39 28.7 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.375 0.607 . . . . 0.0 110.105 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 448' ' ' ILE . 10.3 tp -122.65 152.19 26.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.331 -0.855 . . . . 0.0 110.311 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.6 t -105.21 134.55 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.28 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -92.68 144.47 25.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.185 -0.947 . . . . 0.0 110.224 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.187 0.518 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.485 ' HD3' ' OG1' ' A' ' 429' ' ' THR . 62.4 mtt85 -123.07 146.67 47.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.558 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.9 tt0 -124.21 132.72 53.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.492 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.79 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -57.05 139.76 51.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.1 -1.0 . . . . 0.0 109.946 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.512 ' CB ' ' HG3' ' A' ' 446' ' ' LYS . 74.5 m -122.69 -36.71 2.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.502 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.5 tt0 -165.7 150.82 8.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.054 -1.029 . . . . 0.0 110.184 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.038 ' CD1' HD21 ' A' ' 355' ' ' LEU . 13.4 p90 -135.13 158.26 44.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.839 -1.163 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.7 HG21 ' HD3' ' A' ' 419' ' ' LYS . 1.2 mp -134.17 139.04 31.85 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.552 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -70.11 144.82 53.32 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.65 1.342 . . . . 0.0 111.824 -171.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.045 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -69.32 152.47 44.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 108.768 165.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.404 ' H ' ' CB ' ' A' ' 413' ' ' PRO . 1.7 tp-100 -57.79 128.99 39.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.658 -1.276 . . . . 0.0 110.269 -172.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 109.54 -21.39 26.12 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.943 HG21 ' HA ' ' A' ' 440' ' ' LEU . 53.3 t -114.0 138.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.393 . . . . 0.0 110.907 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.469 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.0 m-20 -72.21 145.08 48.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 109.891 173.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.565 ' HG2' ' CE2' ' A' ' 322' ' ' PHE . 84.3 tt0 -59.87 -34.01 72.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.917 -1.114 . . . . 0.0 109.868 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.51 ' CA ' ' HE3' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -58.51 -42.41 87.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 109.25 175.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 99.5 m -61.59 -42.76 99.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.3 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.961 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.28 -39.8 88.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.451 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.973 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.74 -43.3 80.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.083 . . . . 0.0 110.772 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.552 ' O ' HD23 ' A' ' 339' ' ' LEU . 47.8 t0 -63.41 -49.9 71.93 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.912 -1.117 . . . . 0.0 110.055 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.929 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.88 -31.02 70.53 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.762 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.8 -35.78 66.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.079 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 14.0 mt-30 -73.3 -55.75 5.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.565 -0.709 . . . . 0.0 110.996 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.075 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -65.1 -33.83 76.96 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.205 -171.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.52 -20.89 65.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.971 -1.081 . . . . 0.0 110.067 173.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 353' ' ' VAL . 91.2 p -107.29 10.65 29.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.225 -0.922 . . . . 0.0 111.521 -174.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.583 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 44.3 mt -66.66 -45.48 78.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.546 -1.346 . . . . 0.0 109.73 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.59 0.14 49.53 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.986 -171.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.473 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.0 p30 -62.93 130.66 45.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.214 . . . . 0.0 109.898 176.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.67 5.32 51.73 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.516 0.674 . . . . 0.0 109.864 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 346' ' ' THR . 2.8 p -76.05 150.87 83.69 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 109.467 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.51 -38.32 83.34 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.708 1.373 . . . . 0.0 109.132 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.482 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.3 mt-10 -64.53 -28.6 69.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -0.764 . . . . 0.0 110.404 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.27 -37.83 75.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 354' ' ' ILE . 97.8 mtt180 -77.29 -38.64 50.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.095 -1.238 . . . . 0.0 110.631 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 3.8 m -62.35 -37.8 87.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.919 -1.113 . . . . 0.0 110.466 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.695 HG23 HD13 ' A' ' 443' ' ' ILE . 87.9 mt -68.13 -48.66 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.936 -1.103 . . . . 0.0 110.492 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.635 HG22 ' OG ' ' A' ' 341' ' ' SER . 24.4 t -60.62 -33.17 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.23 . . . . 0.0 109.772 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.498 HG22 ' OE1' ' A' ' 358' ' ' GLN . 38.7 mt -72.76 -31.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.79 -1.194 . . . . 0.0 110.722 171.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.038 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.9 -41.5 91.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.866 -1.146 . . . . 0.0 110.242 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.526 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -63.36 -43.18 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 110.422 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.953 ' HB3' HD23 ' A' ' 362' ' ' LEU . 78.8 mttt -72.08 -51.23 22.58 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.635 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.552 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 19.7 pt20 -71.17 -42.61 68.86 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.352 -0.843 . . . . 0.0 110.508 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.552 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 39.5 mmt180 -73.66 -44.31 57.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 111.101 -172.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 81.6 m-85 -135.31 -37.57 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.623 -1.298 . . . . 0.0 112.159 -169.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.521 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 60.9 t-20 -162.68 105.38 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.489 -1.382 . . . . 0.0 111.55 -168.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.953 HD23 ' HB3' ' A' ' 357' ' ' LYS . 46.9 mt -57.56 88.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.858 -1.151 . . . . 0.0 109.056 173.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 335' ' ' ASP . 56.5 ttt180 -129.21 168.14 16.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.454 -0.779 . . . . 0.0 109.489 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.449 ' N ' ' HG2' ' A' ' 363' ' ' ARG . 87.5 mt-10 -139.69 -157.82 0.8 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.583 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.8 ptt-85 -98.1 165.45 11.89 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.627 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.814 ' O ' HD12 ' A' ' 370' ' ' LEU . 89.9 m-20 -131.47 42.47 3.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 110.56 175.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.081 HG21 ' CE1' ' A' ' 374' ' ' PHE . 47.6 t -72.19 -45.77 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.439 -0.788 . . . . 0.0 110.152 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.34 -23.91 64.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.862 . . . . 0.0 111.166 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -31.85 30.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.122 -0.986 . . . . 0.0 109.778 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 366' ' ' ASP . 9.3 mt -104.42 -2.77 24.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.536 -0.727 . . . . 0.0 110.624 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 367' ' ' VAL . 81.7 m-70 59.25 52.37 6.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.698 -175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.781 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -91.79 174.49 7.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 110.308 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 27.6 m -118.46 135.5 54.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.478 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.081 ' CE1' HG21 ' A' ' 367' ' ' VAL . 90.8 m-85 -90.36 145.22 25.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 376' ' ' PRO . 9.1 t -118.45 101.36 51.04 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.776 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.8 Cg_endo -54.72 154.23 21.47 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.079 1.568 . . . . 0.0 110.524 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.58 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.1 t80 -69.66 134.64 48.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.37 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 15.8 p -115.37 144.86 43.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.6 -19.88 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.641 -0.662 . . . . 0.0 110.355 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -62.34 -46.02 90.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.99 . . . . 0.0 109.695 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 383' ' ' MET . 70.9 m -95.97 -12.29 25.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 110.28 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 95.6 mtt180 58.02 49.89 10.98 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.597 -0.689 . . . . 0.0 109.629 -174.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.936 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.1 ptp -165.15 171.26 13.96 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.822 0.82 . . . . 0.0 111.225 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 47.9 p -155.92 165.32 36.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.58 -165.57 34.3 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.704 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 367' ' ' VAL . 4.5 tt -139.82 152.57 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.666 -0.902 . . . . 0.0 110.232 -175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -127.24 138.4 53.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.045 -1.034 . . . . 0.0 109.458 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.744 ' CD1' HD13 ' A' ' 370' ' ' LEU . 1.7 tt -140.85 154.36 21.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.842 -1.161 . . . . 0.0 109.362 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.267 89.0 m-20 -21.37 -61.83 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.438 0.637 . . . . 0.0 112.53 172.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 51.9 t-20 -98.99 -7.14 27.34 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.512 -0.742 . . . . 0.0 111.901 -166.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.559 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 15.9 mtp180 -142.91 147.97 36.18 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.681 -1.262 . . . . 0.0 110.573 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.6 mtm -134.98 111.07 9.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.942 -1.099 . . . . 0.0 108.995 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.075 HD12 HD11 ' A' ' 339' ' ' LEU . 8.1 mt -129.52 146.09 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.557 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 31.2 mtt85 -136.76 161.92 34.63 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.16 -0.962 . . . . 0.0 111.035 176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.536 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.88 128.24 32.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.637 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -153.78 174.34 32.34 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 37.7 m -56.49 150.98 14.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.848 -1.384 . . . . 0.0 108.526 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.045 HG21 ' CG1' ' A' ' 420' ' ' VAL . 63.2 t -56.82 -35.33 46.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -0.999 . . . . 0.0 109.81 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.473 ' OD1' ' HD2' ' A' ' 403' ' ' ARG . 55.2 t0 -63.07 -46.75 85.97 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.315 176.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.936 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.18 -49.13 65.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.065 -1.022 . . . . 0.0 110.514 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.637 HD11 ' N ' ' A' ' 396' ' ' GLY . 41.7 mm -66.41 -43.84 90.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.099 -1.001 . . . . 0.0 110.931 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.595 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 7.8 ttp180 -59.86 -43.58 94.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.211 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.473 ' HD2' ' OD1' ' A' ' 399' ' ' ASP . 14.6 mtp-105 -61.8 -36.54 81.41 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.459 173.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.557 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 3.0 t-80 -68.69 -35.55 77.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.231 -0.918 . . . . 0.0 111.378 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 437' ' ' SER . 52.1 t -66.06 -50.42 69.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.533 -1.354 . . . . 0.0 110.171 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.966 -1.084 . . . . 0.0 110.37 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.26 76.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.924 -1.11 . . . . 0.0 110.085 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.547 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 10.9 m-80 -62.58 -26.81 68.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.132 174.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 98.12 17.83 28.56 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.43 -169.04 16.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.485 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.2 m-70 -142.87 153.62 43.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.112 -1.228 . . . . 0.0 111.351 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.595 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 9.5 p90 -105.82 147.64 35.1 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.272 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.85 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.7 Cg_endo -74.95 123.95 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.808 1.425 . . . . 0.0 110.407 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 418' ' ' GLN . 1.2 t -67.15 -32.73 74.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 111.033 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.9 m-20 -61.92 -33.04 73.53 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 0.0 108.963 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.045 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.8 t -83.63 -42.83 17.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.37 -0.832 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 74.4 m-20 -54.55 -37.46 65.46 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.76 -1.213 . . . . 0.0 109.507 171.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 98.5 mm-40 -63.38 -48.18 78.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.265 -1.522 . . . . 0.0 110.077 171.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.7 ' HD3' HG21 ' A' ' 323' ' ' ILE . 20.1 mttp -56.64 -35.24 68.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.072 HG23 HG21 ' A' ' 442' ' ' VAL . 2.4 t -59.78 -40.68 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.979 -1.075 . . . . 0.0 109.285 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.76 -36.25 82.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.842 0.829 . . . . 0.0 109.46 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.1 mm-40 -67.37 -36.81 82.1 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.63 -0.669 . . . . 0.0 110.62 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.769 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.0 t -62.88 -37.9 80.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.954 -1.091 . . . . 0.0 110.009 175.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.6 -40.01 84.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 0.0 110.385 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -68.11 -31.53 71.2 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.282 -0.886 . . . . 0.0 110.955 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.55 -3.11 55.47 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.783 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.51 22.14 29.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.769 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -106.34 163.48 12.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -1.079 . . . . 0.0 109.541 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.851 ' HB ' HD12 ' A' ' 445' ' ' LEU . 1.3 m -109.98 107.12 58.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.582 ' CG ' HG13 ' A' ' 420' ' ' VAL . 40.1 Cg_endo -75.79 108.28 2.65 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 O-C-N 123.97 1.511 . . . . 0.0 110.589 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.896 ' HG ' HD11 ' A' ' 445' ' ' LEU . 13.9 mt -92.81 134.77 34.74 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 108.598 167.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.953 ' CG2' HG22 ' A' ' 398' ' ' VAL . 96.8 t -100.7 134.27 41.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.754 -1.216 . . . . 0.0 109.428 176.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.771 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.5 t -114.82 137.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 176.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.1 m -118.09 160.27 17.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.413 -0.804 . . . . 0.0 109.721 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.483 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.3 tt0 -135.39 130.77 35.39 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 67.07 -132.32 30.86 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 405' ' ' VAL . 82.9 p -102.75 7.52 39.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.081 -1.247 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -120.05 171.09 8.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.661 -1.275 . . . . 0.0 110.142 -175.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 26.0 t -92.25 133.4 33.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.418 -0.801 . . . . 0.0 109.8 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.943 ' HA ' HG21 ' A' ' 328' ' ' VAL . 1.6 pp -92.93 -22.2 19.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.961 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 167.29 177.62 39.01 Favored Glycine 0 N--CA 1.5 2.939 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.987 169.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.072 HG21 HG23 ' A' ' 420' ' ' VAL . 51.2 t -107.81 142.95 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.22 -1.165 . . . . 0.0 110.075 174.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.762 HD11 ' HB1' ' A' ' 337' ' ' ALA . 75.8 mt -101.79 112.62 35.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.456 -0.778 . . . . 0.0 108.974 170.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.576 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -93.13 119.31 32.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.987 -1.071 . . . . 0.0 109.891 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.896 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -103.17 144.17 31.66 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.396 -0.815 . . . . 0.0 108.808 -175.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.512 ' HG3' ' CB ' ' A' ' 320' ' ' SER . 16.2 mtmt -105.72 156.87 17.87 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.585 -1.322 . . . . 0.0 110.833 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -104.25 148.17 26.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.653 -0.654 . . . . 0.0 110.366 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 9.0 tp -119.31 153.16 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 110.11 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.9 t -104.16 135.18 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.97 . . . . 0.0 110.319 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -144.58 145.86 32.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 0.0 110.197 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.971 -1.461 . . . . 0.0 109.529 -179.899 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.223 0.535 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 66.7 mtt85 -122.04 148.85 44.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 92.2 mt-30 -124.91 144.96 50.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.154 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.773 ' HA ' HD23 ' A' ' 445' ' ' LEU . . . -59.93 138.64 57.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.07 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.515 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -122.31 -37.62 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 110.433 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.483 ' N ' HD11 ' A' ' 355' ' ' LEU . 47.1 tt0 -162.84 148.32 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.187 -178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.078 ' CD1' HD21 ' A' ' 355' ' ' LEU . 14.1 p90 -133.95 142.88 47.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.803 -1.186 . . . . 0.0 111.704 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.568 HG21 ' CD ' ' A' ' 419' ' ' LYS . 4.4 mt -113.84 141.57 26.37 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.552 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.64 142.73 40.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.656 1.345 . . . . 0.0 111.528 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.062 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.83 151.13 45.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 108.856 165.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.46 128.88 39.28 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.744 -1.222 . . . . 0.0 110.098 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.66 -1.35 45.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' A' ' 440' ' ' LEU . 45.6 t -135.68 137.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.645 -1.503 . . . . 0.0 110.649 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 332' ' ' THR . 92.8 m-20 -72.74 150.44 42.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.4 tt0 -60.87 -38.04 84.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 360' ' ' PHE . 0.0 OUTLIER -59.88 -40.3 88.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.929 -1.107 . . . . 0.0 109.224 177.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.546 HG21 HG13 ' A' ' 328' ' ' VAL . 98.9 m -60.51 -43.13 97.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 110.0 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.986 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.8 tp -60.12 -38.43 83.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.373 -0.83 . . . . 0.0 110.502 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.971 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.75 -44.42 77.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.706 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.567 ' O ' HD23 ' A' ' 339' ' ' LEU . 89.9 m-20 -63.69 -48.74 75.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 110.017 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.921 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.61 -32.03 72.47 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.03 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.686 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.22 -36.0 65.5 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.011 172.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.2 mt-30 -74.1 -55.67 5.82 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.546 -0.721 . . . . 0.0 111.064 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.072 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -64.4 -33.96 77.07 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.066 -171.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.617 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.89 -20.31 65.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.982 -1.074 . . . . 0.0 109.991 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.594 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.3 p -107.62 10.42 29.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.134 -0.979 . . . . 0.0 111.502 -174.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.65 HD12 HD12 ' A' ' 386' ' ' ILE . 47.3 mt -66.53 -45.04 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.622 -1.299 . . . . 0.0 109.821 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.03 2.05 50.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.842 -170.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.485 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.9 p30 -65.09 130.29 42.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.798 -1.189 . . . . 0.0 110.061 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.7 4.47 52.97 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.574 0.702 . . . . 0.0 109.887 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 346' ' ' THR . 3.0 p -74.47 150.84 87.21 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.572 -0.705 . . . . 0.0 109.426 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -53.78 -40.74 78.96 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.723 1.381 . . . . 0.0 109.358 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 98.6 mt-10 -64.65 -28.07 69.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.1 -38.11 65.53 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.532 ' O ' HD12 ' A' ' 354' ' ' ILE . 68.5 mtt85 -77.4 -37.3 52.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.239 . . . . 0.0 110.501 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 4.2 m -61.36 -37.83 84.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.069 . . . . 0.0 110.324 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.664 HG23 HD13 ' A' ' 443' ' ' ILE . 83.1 mt -69.55 -49.38 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.631 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.594 HG22 ' OG ' ' A' ' 341' ' ' SER . 23.4 t -59.9 -32.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.865 -1.147 . . . . 0.0 109.813 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.536 HG22 ' NE2' ' A' ' 358' ' ' GLN . 34.6 mt -72.74 -34.22 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 110.637 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.078 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -58.06 -40.25 80.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.817 -1.177 . . . . 0.0 110.239 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -64.02 -45.77 87.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 362' ' ' LEU . 48.2 mtmt -72.02 -49.25 38.5 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.844 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.55 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 10.6 pt20 -70.87 -42.96 69.38 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.668 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.55 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 39.3 mmt180 -74.42 -45.36 47.04 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 111.145 -171.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 322' ' ' PHE . 90.9 m-85 -135.57 -37.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.446 -1.301 . . . . 0.0 112.218 -169.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.508 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 51.2 t30 -162.91 105.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.494 -1.379 . . . . 0.0 111.652 -168.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 357' ' ' LYS . 0.5 OUTLIER -57.87 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.754 -1.216 . . . . 0.0 109.203 171.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.539 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 29.0 tpt180 -126.64 164.02 22.17 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 109.11 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 83.9 mt-10 -137.22 -159.38 0.95 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.933 -1.105 . . . . 0.0 110.369 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 40.8 ptt180 -97.69 163.82 12.66 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 110.586 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.9 m-20 -130.87 42.13 3.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.366 -0.834 . . . . 0.0 110.544 175.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.022 HG21 ' CE1' ' A' ' 374' ' ' PHE . 64.8 t -73.52 -48.43 41.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.312 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.56 -26.09 66.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 111.067 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -30.14 27.91 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 176.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.985 ' HB3' HD11 ' A' ' 388' ' ' ILE . 20.6 mt -103.25 -4.0 24.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 110.731 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 367' ' ' VAL . 61.4 m-70 63.11 53.04 2.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.317 -0.864 . . . . 0.0 110.148 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.939 ' HB2' HD12 ' A' ' 388' ' ' ILE . . . -95.57 174.89 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.618 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.3 m -116.89 133.5 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.47 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.022 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.8 m-85 -87.67 143.42 27.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.472 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 387' ' ' ASN . 16.8 t -117.14 101.15 53.32 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 109.628 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.23 151.27 36.47 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.056 1.556 . . . . 0.0 110.55 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.7 t80 -62.32 130.86 47.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.038 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.3 p -120.23 153.7 35.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.07 -4.95 49.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.517 -0.739 . . . . 0.0 109.948 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.42 -33.2 65.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.762 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 400' ' ' ALA . 22.5 m -141.49 10.85 2.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.361 -0.837 . . . . 0.0 110.374 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 93.9 mtt180 57.55 51.8 9.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.467 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.589 ' CE ' HD13 ' A' ' 401' ' ' ILE . 2.1 ptp -157.98 167.53 29.67 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.852 0.834 . . . . 0.0 111.174 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.9 p -153.65 165.26 36.49 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . 179.8 -166.24 35.29 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.524 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.838 HD11 HG22 ' A' ' 367' ' ' VAL . 14.5 tt -139.51 150.75 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.634 -0.921 . . . . 0.0 110.176 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.64 HD21 HG21 ' A' ' 375' ' ' VAL . 37.8 m-20 -127.6 133.26 49.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 0.0 109.755 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.985 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -139.57 154.81 24.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.84 -1.162 . . . . 0.0 109.302 170.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.263 88.6 m-20 -25.62 -62.99 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.429 0.633 . . . . 0.0 112.266 172.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.461 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 52.0 t30 -90.96 -8.56 48.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 111.767 -168.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.565 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 35.7 mtp180 -143.38 143.93 31.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.643 -1.286 . . . . 0.0 110.627 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 67.7 mtm -134.08 107.47 7.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.752 -1.217 . . . . 0.0 108.909 168.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.072 HD12 HD11 ' A' ' 339' ' ' LEU . 7.4 mt -129.45 146.11 34.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.128 -0.982 . . . . 0.0 110.21 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 20.8 mtt-85 -135.64 162.12 33.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 110.995 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.516 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -135.22 127.79 30.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.557 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.7 174.05 33.04 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.7 m -57.28 150.73 17.35 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.978 -1.307 . . . . 0.0 108.601 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.055 HG21 HG11 ' A' ' 420' ' ' VAL . 20.0 t -54.82 -37.91 42.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.849 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.8 m-20 -63.72 -44.01 94.85 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.29 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 383' ' ' MET . . . -68.29 -52.14 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.876 -1.14 . . . . 0.0 110.535 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.614 HG21 HG12 ' A' ' 432' ' ' VAL . 27.6 mm -64.29 -42.22 94.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.106 -0.996 . . . . 0.0 110.828 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.2 ttp85 -59.94 -43.96 94.67 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.228 -0.92 . . . . 0.0 110.313 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 95.1 mtt180 -61.5 -37.16 82.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.515 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.8 t-80 -68.21 -36.24 79.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.869 . . . . 0.0 111.319 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 437' ' ' SER . 55.3 t -65.65 -48.99 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.534 -1.354 . . . . 0.0 110.126 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.18 -34.33 77.4 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.914 -1.116 . . . . 0.0 110.145 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.72 -36.23 80.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.952 -1.092 . . . . 0.0 109.958 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 14.0 m-80 -61.82 -27.33 68.69 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.202 173.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.79 19.46 29.17 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 -169.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -114.49 -170.67 16.81 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -144.3 153.62 42.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -1.233 . . . . 0.0 111.231 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.595 ' HB3' HG21 ' A' ' 439' ' ' VAL . 9.8 p90 -108.85 149.97 40.25 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.475 -0.766 . . . . 0.0 110.068 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.865 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -73.02 126.31 11.11 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.877 1.462 . . . . 0.0 110.455 -175.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 414' ' ' THR . 1.3 t -67.18 -33.49 75.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 111.04 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.9 m-20 -63.36 -32.19 73.54 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.984 -1.072 . . . . 0.0 108.77 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.062 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.2 t -83.64 -41.69 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.395 -0.816 . . . . 0.0 110.824 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 56.4 t0 -54.9 -37.19 66.03 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 109.444 171.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -64.28 -50.99 65.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.447 -1.408 . . . . 0.0 109.635 172.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.568 ' CD ' HG21 ' A' ' 323' ' ' ILE . 45.0 mttm -55.77 -34.56 65.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.868 -1.145 . . . . 0.0 110.263 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.055 HG11 HG21 ' A' ' 398' ' ' VAL . 2.6 t -58.9 -42.5 86.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.172 170.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.5 -36.1 82.85 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 109.425 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.5 mm-40 -67.87 -37.13 81.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.697 -0.627 . . . . 0.0 110.65 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 428' ' ' ALA . 67.4 t -63.34 -37.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.025 . . . . 0.0 110.044 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.54 85.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -69.08 -30.38 68.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.296 -0.878 . . . . 0.0 110.888 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -82.75 -3.56 56.72 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.045 -1.034 . . . . 0.0 109.717 175.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 93.19 21.84 28.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.81 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.62 163.47 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -1.067 . . . . 0.0 109.626 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.468 ' HB ' HD12 ' A' ' 445' ' ' LEU . 22.1 m -109.75 107.2 59.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.989 -1.069 . . . . 0.0 109.731 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.562 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.2 Cg_endo -76.18 108.13 2.61 Favored 'Trans proline' 0 C--N 1.297 -2.158 0 O-C-N 123.878 1.462 . . . . 0.0 110.462 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.907 ' HG ' HD11 ' A' ' 445' ' ' LEU . 14.5 mt -92.29 136.31 33.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 0.0 108.64 167.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.879 ' CG2' HG22 ' A' ' 398' ' ' VAL . 94.6 t -99.93 135.06 37.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.675 -1.266 . . . . 0.0 109.462 175.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.904 ' CG1' HD11 ' A' ' 440' ' ' LEU . 27.3 t -115.83 137.76 48.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.291 -0.88 . . . . 0.0 108.831 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.84 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.7 m -120.45 160.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.272 -0.892 . . . . 0.0 109.734 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.494 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.5 tt0 -134.37 132.9 40.0 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.18 -130.09 32.29 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.607 ' O ' HG13 ' A' ' 405' ' ' VAL . 74.1 p -105.64 8.71 33.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.034 -1.274 . . . . 0.0 111.129 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -122.12 170.64 9.67 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.588 -1.32 . . . . 0.0 110.107 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.84 ' HA ' HG12 ' A' ' 434' ' ' VAL . 47.0 t -89.48 133.86 30.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 109.95 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.904 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -92.22 -22.83 19.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 175.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.986 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.32 177.51 40.55 Favored Glycine 0 N--CA 1.5 2.943 0 C-N-CA 118.945 -1.598 . . . . 0.0 110.87 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.051 HG21 HG23 ' A' ' 420' ' ' VAL . 47.9 t -107.9 142.36 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.119 -1.224 . . . . 0.0 109.869 172.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.686 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.9 mt -101.3 112.02 32.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.416 -0.802 . . . . 0.0 108.941 170.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.09 119.38 31.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 109.837 -178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.907 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.8 OUTLIER -102.29 142.82 32.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 320' ' ' SER . 28.9 mtmt -111.08 158.23 19.08 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.657 -1.277 . . . . 0.0 111.056 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -87.93 146.79 25.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.671 -0.643 . . . . 0.0 110.319 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 448' ' ' ILE . 10.7 tp -117.78 154.7 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.854 . . . . 0.0 110.169 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.0 t -102.58 134.11 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.258 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -93.67 146.0 24.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.232 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 118.011 -1.439 . . . . 0.0 109.526 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.302 0.573 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.482 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 74.9 mtt85 -122.72 143.31 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.153 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.561 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.3 tt0 -124.82 131.8 53.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.266 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.92 138.91 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.064 . . . . 0.0 109.884 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 1.8 m -120.54 -44.34 2.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.07 -1.019 . . . . 0.0 110.278 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 320' ' ' SER . 70.1 mt-10 -154.44 152.34 30.04 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.427 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.008 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 16.5 p90 -137.22 143.15 42.15 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.731 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.525 HG21 ' CD ' ' A' ' 419' ' ' LYS . 1.4 mp -114.93 144.66 32.44 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.747 -0.596 . . . . 0.0 109.657 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -72.7 143.71 38.15 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.758 1.399 . . . . 0.0 111.525 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.04 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.39 152.72 41.85 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 108.847 165.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.408 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 1.4 tp-100 -57.87 128.43 37.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.654 -1.279 . . . . 0.0 110.081 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.67 -0.82 45.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.9 t -136.61 140.08 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.686 -1.479 . . . . 0.0 110.743 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.4 m-20 -74.15 152.67 39.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 85.0 tt0 -62.37 -40.76 97.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.985 -1.072 . . . . 0.0 110.471 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.25 -43.09 92.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.682 -1.261 . . . . 0.0 109.612 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 328' ' ' VAL . 93.3 m -55.53 -43.93 76.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.75 173.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 1.023 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.7 tp -59.77 -39.24 84.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 110.285 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.008 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.0 -41.85 86.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.837 -1.164 . . . . 0.0 110.841 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.0 t0 -63.83 -49.83 71.3 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.832 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.918 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.27 -31.44 71.77 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.046 -1.034 . . . . 0.0 109.718 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.96 -35.09 66.33 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 109.142 172.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 18.0 mt-30 -73.85 -55.79 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.596 -0.69 . . . . 0.0 110.815 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.074 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.71 -34.7 76.24 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.894 -173.197 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.437 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.54 -20.43 65.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.927 174.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.626 ' OG ' HG22 ' A' ' 353' ' ' VAL . 97.1 p -108.91 9.75 26.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.199 -0.938 . . . . 0.0 111.631 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.708 HD22 ' HD2' ' A' ' 365' ' ' ARG . 35.5 mt -64.1 -45.78 87.14 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.652 -1.28 . . . . 0.0 109.806 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -98.7 -0.8 42.12 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.788 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 10.5 p30 -61.8 130.51 46.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.927 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.03 5.89 50.13 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.612 0.72 . . . . 0.0 109.951 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 346' ' ' THR . 2.5 p -77.56 154.59 81.42 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.579 -0.7 . . . . 0.0 109.45 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.15 -36.85 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.624 1.329 . . . . 0.0 109.128 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.482 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.3 mt-10 -64.3 -29.2 70.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.448 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -57.47 -38.54 87.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 354' ' ' ILE . 98.0 mtt180 -77.33 -37.38 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -1.177 . . . . 0.0 110.629 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.561 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.0 m -61.68 -38.85 89.34 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.042 -1.036 . . . . 0.0 110.368 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.551 HG23 HD13 ' A' ' 443' ' ' ILE . 84.7 mt -69.18 -48.37 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.693 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.626 HG22 ' OG ' ' A' ' 341' ' ' SER . 28.7 t -60.64 -34.54 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.06 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 350' ' ' ARG . 36.4 mt -72.54 -32.26 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.628 -1.295 . . . . 0.0 110.653 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.004 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.87 -41.06 90.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.937 -1.102 . . . . 0.0 110.394 179.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.79 -42.85 99.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 0.0 110.383 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.997 ' HB3' HD23 ' A' ' 362' ' ' LEU . 83.4 mttt -70.69 -50.55 35.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.913 -1.117 . . . . 0.0 110.772 -174.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.513 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.9 pt20 -71.0 -42.59 69.43 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 110.561 -173.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.595 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 40.1 mmt180 -73.06 -46.16 53.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 111.21 -173.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.647 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 79.3 m-85 -135.96 -36.03 0.76 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.542 -1.349 . . . . 0.0 112.39 -169.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.522 ' ND2' ' HD2' ' A' ' 363' ' ' ARG . 56.0 t-20 -158.59 98.55 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.557 -1.34 . . . . 0.0 111.7 -169.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.997 HD23 ' HB3' ' A' ' 357' ' ' LYS . 24.3 mt -58.38 91.17 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 0.0 109.509 171.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.522 ' HD2' ' ND2' ' A' ' 361' ' ' ASN . 13.8 ptm180 -145.6 -176.81 5.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.287 -0.883 . . . . 0.0 109.983 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.28 -158.53 0.9 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 110.329 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.708 ' HD2' HD22 ' A' ' 342' ' ' LEU . 0.0 OUTLIER -97.96 166.81 11.27 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.661 -0.649 . . . . 0.0 110.558 -178.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.0 m-20 -121.02 41.1 3.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.009 HG11 ' CE2' ' A' ' 374' ' ' PHE . 43.0 t -70.45 -45.54 74.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 110.21 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -68.2 -29.02 67.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.159 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -29.66 27.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.07 -1.019 . . . . 0.0 109.767 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.811 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.6 mt -102.66 -3.22 26.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 110.777 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 367' ' ' VAL . 54.1 m80 58.82 53.8 5.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 0.0 109.895 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.842 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.89 174.68 7.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.419 -0.801 . . . . 0.0 110.513 -177.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.1 m -114.79 134.02 55.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.357 -0.84 . . . . 0.0 110.396 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.009 ' CE2' HG11 ' A' ' 367' ' ' VAL . 72.4 m-85 -88.7 149.38 23.52 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 5.0 t -122.75 100.81 40.32 Favored Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -56.3 150.66 48.48 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.031 1.543 . . . . 0.0 110.473 -177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 6.6 t80 -66.91 131.75 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 110.141 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.4 p -121.3 153.13 38.11 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 109.639 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.56 -6.35 53.38 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.606 -0.684 . . . . 0.0 109.897 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -54.77 -34.48 62.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 109.685 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 383' ' ' MET . 1.8 m -139.11 10.27 2.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 110.241 175.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 73.2 mtt85 57.21 50.97 10.83 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.877 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.8 ptp -158.6 169.71 23.81 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.949 0.881 . . . . 0.0 111.339 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.524 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 31.1 p -154.84 165.22 37.33 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.15 -165.33 33.25 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.897 -1.621 . . . . 0.0 110.751 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.929 HG21 ' HB2' ' A' ' 339' ' ' LEU . 2.4 tt -142.28 149.38 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.63 -0.923 . . . . 0.0 110.054 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -127.91 136.0 50.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.957 -1.09 . . . . 0.0 109.911 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -140.45 155.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.859 -1.151 . . . . 0.0 109.22 171.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.498 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 91.2 m-20 -23.46 -63.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.398 0.618 . . . . 0.0 112.436 171.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.458 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 46.4 t-20 -95.82 -5.56 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.513 -0.742 . . . . 0.0 111.871 -167.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.562 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 30.6 mtp180 -143.98 143.8 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.66 -1.275 . . . . 0.0 110.375 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.3 mtm -134.02 112.25 11.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.822 -1.174 . . . . 0.0 108.913 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.074 HD12 HD11 ' A' ' 339' ' ' LEU . 9.6 mt -131.49 146.16 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 35.1 mtt180 -133.75 159.92 39.15 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.078 -1.014 . . . . 0.0 110.58 174.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.627 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.09 128.92 35.18 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.611 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -155.87 174.22 33.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -174.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 40.6 m -56.91 151.58 14.37 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.871 -1.37 . . . . 0.0 108.653 170.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.027 HG21 HG11 ' A' ' 420' ' ' VAL . 53.5 t -56.51 -34.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 109.942 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.516 ' OD1' ' NE ' ' A' ' 403' ' ' ARG . 46.2 t0 -63.26 -47.19 83.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.323 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.877 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -67.77 -50.05 59.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.523 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.611 HD11 ' N ' ' A' ' 396' ' ' GLY . 35.8 mm -64.97 -42.99 96.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.053 -1.029 . . . . 0.0 110.794 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.582 ' HD2' ' CZ ' ' A' ' 412' ' ' PHE . 9.5 ttp180 -59.36 -43.39 92.84 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.309 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.516 ' NE ' ' OD1' ' A' ' 399' ' ' ASP . 88.9 mtt180 -61.31 -37.16 82.25 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.517 173.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.513 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.4 t-80 -67.5 -36.95 82.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 0.0 111.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.55 ' CG2' HG11 ' A' ' 434' ' ' VAL . 53.4 t -65.93 -48.35 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.5 -1.375 . . . . 0.0 110.206 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.6 -34.24 77.38 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.901 -1.124 . . . . 0.0 110.355 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.77 -36.26 80.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.939 -1.101 . . . . 0.0 109.886 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.513 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 9.4 m-80 -61.03 -27.84 68.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 109.124 173.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.35 27.2 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -169.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.59 -169.05 15.59 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -144.36 153.66 42.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.131 -1.217 . . . . 0.0 111.404 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.585 ' CD1' ' OD2' ' A' ' 417' ' ' ASP . 6.7 p90 -108.22 150.35 40.39 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.769 -0.582 . . . . 0.0 110.258 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.817 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -75.0 125.53 9.39 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.812 1.427 . . . . 0.0 110.572 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 t -67.39 -33.82 75.98 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.172 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.3 m-20 -62.12 -32.01 72.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.98 -1.075 . . . . 0.0 108.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.04 HG21 ' HA ' ' A' ' 325' ' ' ALA . 50.4 t -83.72 -42.69 17.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 110.942 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.585 ' OD2' ' CD1' ' A' ' 412' ' ' PHE . 66.8 m-20 -55.28 -36.22 65.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.629 171.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.88 -50.85 67.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.377 -1.452 . . . . 0.0 109.537 172.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.525 ' CD ' HG21 ' A' ' 323' ' ' ILE . 81.9 mttt -56.46 -34.36 66.8 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.338 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.05 HG23 HG21 ' A' ' 442' ' ' VAL . 2.4 t -58.86 -41.65 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.964 -1.085 . . . . 0.0 109.171 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -66.34 -36.51 83.08 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.936 0.874 . . . . 0.0 109.414 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.502 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 95.4 mm-40 -67.24 -37.28 83.28 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.586 -0.696 . . . . 0.0 110.703 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.745 HG13 ' HB3' ' A' ' 428' ' ' ALA . 77.0 t -62.39 -37.86 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 110.063 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.18 -37.97 86.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -66.26 -33.81 76.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.193 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.9 OUTLIER -83.23 -1.82 54.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 176.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 91.05 22.54 32.44 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.745 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -104.12 162.47 13.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -1.084 . . . . 0.0 109.485 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.683 ' HB ' HD12 ' A' ' 445' ' ' LEU . 34.8 m -109.5 107.0 59.24 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.054 -1.029 . . . . 0.0 109.741 -176.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.547 ' CG ' HG13 ' A' ' 420' ' ' VAL . 36.9 Cg_endo -74.98 108.09 2.64 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 O-C-N 124.05 1.553 . . . . 0.0 110.596 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.865 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.7 mt -92.54 134.18 35.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.816 -1.177 . . . . 0.0 108.578 167.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.953 ' CG2' HG22 ' A' ' 398' ' ' VAL . 74.6 t -100.35 134.17 40.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.669 -1.269 . . . . 0.0 109.457 176.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.661 ' CG1' HD11 ' A' ' 440' ' ' LEU . 55.3 t -115.78 136.42 52.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.063 175.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.4 m -117.75 160.15 17.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.484 -0.76 . . . . 0.0 109.632 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.518 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.22 133.19 36.82 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.83 -123.57 22.24 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -168.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 405' ' ' VAL . 2.3 p -114.2 11.37 17.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.095 -1.238 . . . . 0.0 110.987 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -123.88 171.08 9.96 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.629 -1.294 . . . . 0.0 109.907 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 434' ' ' VAL . 40.3 t -90.04 134.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.312 -0.867 . . . . 0.0 109.821 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.6 pp -94.33 -21.77 18.77 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 109.693 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 1.023 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.02 176.12 38.28 Favored Glycine 0 N--CA 1.499 2.883 0 C-N-CA 118.938 -1.601 . . . . 0.0 110.904 170.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.05 HG21 HG23 ' A' ' 420' ' ' VAL . 49.7 t -107.87 142.06 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.12 -1.224 . . . . 0.0 109.953 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.706 HD11 ' HB1' ' A' ' 337' ' ' ALA . 80.1 mt -101.32 110.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.424 -0.798 . . . . 0.0 108.961 170.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.625 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -92.36 118.18 30.67 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.031 -1.043 . . . . 0.0 109.864 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.865 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -102.08 144.32 30.81 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -109.37 159.38 17.04 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.675 -1.266 . . . . 0.0 110.905 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -83.23 140.69 32.38 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.433 0.635 . . . . 0.0 110.332 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 7.4 tt -115.07 152.42 16.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 110.278 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.2 t -104.53 135.47 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.369 -0.832 . . . . 0.0 110.308 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -92.23 144.56 25.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 CA-C-O 118.02 -1.433 . . . . 0.0 109.548 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.25 0.547 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 97.3 mtt180 -123.02 149.66 44.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.245 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.468 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 50.9 tt0 -122.73 137.96 54.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.877 . . . . 0.0 110.076 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.755 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -59.59 142.37 52.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.528 ' OG ' ' CE ' ' A' ' 446' ' ' LYS . 1.8 m -117.54 -34.17 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -0.981 . . . . 0.0 110.439 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -169.45 150.57 4.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 0.0 110.029 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.004 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 13.9 p90 -134.87 143.98 47.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.85 -1.156 . . . . 0.0 111.643 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.52 HG21 ' CD ' ' A' ' 419' ' ' LYS . 2.3 mt -114.49 144.03 31.02 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.611 -0.681 . . . . 0.0 109.666 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -72.88 143.78 37.49 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.767 1.404 . . . . 0.0 111.357 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.05 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -72.0 152.26 42.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 108.831 165.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.16 128.77 38.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.665 -1.272 . . . . 0.0 110.188 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.49 -1.54 42.83 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 45.0 t -136.48 139.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.65 -1.5 . . . . 0.0 110.736 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.7 m-20 -74.18 152.44 39.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.154 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.565 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.8 tt0 -62.47 -40.13 95.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.993 . . . . 0.0 110.437 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -59.09 -43.15 91.81 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.701 -1.25 . . . . 0.0 109.62 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.531 HG21 HG13 ' A' ' 328' ' ' VAL . 94.3 m -56.11 -43.54 78.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.885 173.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 1.01 HD22 ' HA3' ' A' ' 441' ' ' GLY . 4.2 tp -59.68 -40.08 86.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.291 -0.881 . . . . 0.0 110.281 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.004 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -66.66 -41.21 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.914 -1.116 . . . . 0.0 110.742 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.546 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.3 t0 -64.22 -50.87 66.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.854 -1.153 . . . . 0.0 109.928 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.949 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.03 -30.62 69.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.909 -1.119 . . . . 0.0 109.779 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.17 -35.91 65.29 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.133 -0.979 . . . . 0.0 109.028 171.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.574 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 17.3 mt-30 -74.25 -55.71 5.73 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.569 -0.707 . . . . 0.0 110.914 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.04 HD11 HD12 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -63.92 -33.78 76.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.639 -1.224 . . . . 0.0 109.908 -171.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.467 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -66.77 -21.48 66.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.986 -1.072 . . . . 0.0 110.045 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.609 ' OG ' HG22 ' A' ' 353' ' ' VAL . 97.5 p -107.65 10.79 28.95 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.04 -1.037 . . . . 0.0 111.598 -173.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.589 HD13 ' CB ' ' A' ' 365' ' ' ARG . 46.3 mt -67.15 -43.75 81.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.624 -1.297 . . . . 0.0 109.652 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -96.52 2.67 52.64 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.863 -171.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.515 ' OD2' ' CA ' ' A' ' 349' ' ' GLY . 18.3 p30 -65.0 130.0 41.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.773 -1.204 . . . . 0.0 110.088 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.72 4.43 52.98 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.573 0.701 . . . . 0.0 109.909 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.38 151.77 85.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.711 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -56.38 -39.4 91.53 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.702 1.369 . . . . 0.0 109.09 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 317' ' ' ARG . 97.6 mt-10 -64.31 -29.63 70.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.484 -0.76 . . . . 0.0 110.367 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -55.31 -36.04 61.91 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 354' ' ' ILE . 65.9 mtt85 -77.18 -36.53 54.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 0.0 110.543 174.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.468 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 13.2 m -60.78 -39.08 87.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 443' ' ' ILE . 81.0 mt -68.19 -48.99 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.005 -1.059 . . . . 0.0 110.562 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.609 HG22 ' OG ' ' A' ' 341' ' ' SER . 27.5 t -62.18 -33.94 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.945 -1.097 . . . . 0.0 110.192 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 350' ' ' ARG . 31.7 mt -72.22 -31.98 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.597 -1.314 . . . . 0.0 110.576 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.997 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -60.61 -40.61 92.48 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 110.568 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.531 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.33 -42.93 99.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 0.0 110.274 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.961 ' HB3' HD23 ' A' ' 362' ' ' LEU . 70.4 mttt -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.73 -175.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.9 pt20 -70.09 -42.22 73.0 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 110.785 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' A' ' 358' ' ' GLN . 29.6 mmm180 -74.68 -46.24 39.18 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 111.189 -171.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.592 ' CD1' ' CZ ' ' A' ' 322' ' ' PHE . 77.8 m-85 -136.22 -34.97 0.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.399 -1.321 . . . . 0.0 112.31 -170.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.516 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 53.5 t-20 -159.66 103.33 1.55 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.551 -1.343 . . . . 0.0 111.598 -169.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 357' ' ' LYS . 37.0 mt -57.66 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.872 -1.142 . . . . 0.0 109.066 170.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 25.3 tpt180 -134.19 163.83 28.73 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.419 -0.8 . . . . 0.0 109.344 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.3 mt-10 -136.12 -158.05 0.84 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.589 ' CB ' HD13 ' A' ' 342' ' ' LEU . 46.3 ptt85 -97.66 163.69 12.72 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.661 -0.649 . . . . 0.0 110.841 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 90.9 m-20 -134.5 44.49 2.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.821 . . . . 0.0 110.554 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 1.017 HG21 ' CE1' ' A' ' 374' ' ' PHE . 61.0 t -72.41 -46.95 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.44 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -67.9 -26.15 65.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 111.264 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.79 -31.18 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.057 . . . . 0.0 109.715 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 388' ' ' ILE . 19.8 mt -100.68 -4.09 28.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.498 -0.751 . . . . 0.0 110.606 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 367' ' ' VAL . 46.8 m80 59.99 51.73 5.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -174.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.819 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.06 172.99 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.9 m -118.82 135.61 54.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 110.374 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 1.017 ' CE1' HG21 ' A' ' 367' ' ' VAL . 86.3 m-85 -90.01 145.16 25.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.651 175.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.6 HG21 HD21 ' A' ' 387' ' ' ASN . 47.9 t -118.73 100.99 50.92 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 174.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.16 150.75 38.24 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.068 1.562 . . . . 0.0 110.526 -175.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 8.4 t80 -63.27 131.35 48.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.357 -0.839 . . . . 0.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.7 p -120.5 153.0 37.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.706 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.69 -5.86 51.94 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.919 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.7 -33.18 66.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -0.867 . . . . 0.0 109.836 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 383' ' ' MET . 1.8 m -139.47 10.25 2.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 110.293 174.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 88.7 mtt180 57.08 51.01 10.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.79 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 2.6 ptp -158.75 168.48 26.73 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.26 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 12.2 p -155.39 165.16 37.49 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.6 -164.16 31.55 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.956 -1.592 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 367' ' ' VAL . 1.9 tt -141.96 149.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.665 -0.903 . . . . 0.0 110.173 -174.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.6 HD21 HG21 ' A' ' 375' ' ' VAL . 26.5 m-20 -127.22 138.86 53.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 176.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.9 tt -141.37 154.59 20.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.87 -1.144 . . . . 0.0 109.365 172.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.264 88.3 m-20 -21.4 -62.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.391 0.615 . . . . 0.0 112.608 171.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 391' ' ' ARG . 24.8 t-20 -99.03 -6.78 27.89 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 111.819 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.551 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 18.3 mtp180 -142.97 145.86 33.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.746 -1.221 . . . . 0.0 110.553 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 89.9 mtp -134.16 113.27 11.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.909 -1.119 . . . . 0.0 109.08 169.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.04 HD12 HD11 ' A' ' 339' ' ' LEU . 9.3 mt -131.75 146.05 34.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.051 -1.031 . . . . 0.0 110.142 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 32.8 mtt180 -135.92 161.9 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.005 . . . . 0.0 110.779 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.643 ' HB3' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.45 134.23 41.34 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.531 -0.731 . . . . 0.0 109.11 174.132 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.504 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -159.76 174.06 36.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 53.4 p -58.51 153.0 16.93 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.921 -1.34 . . . . 0.0 108.438 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.031 HG21 HG11 ' A' ' 420' ' ' VAL . 20.8 t -54.87 -37.52 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.82 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.1 m-20 -64.25 -44.51 91.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.79 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.78 -51.84 36.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.923 -1.111 . . . . 0.0 110.503 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.504 HD11 ' N ' ' A' ' 396' ' ' GLY . 25.2 mm -63.82 -42.28 95.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.096 -1.003 . . . . 0.0 110.805 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.4 ttt180 -60.81 -43.29 98.38 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.299 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 89.8 mtt180 -61.15 -36.54 80.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.07 -1.019 . . . . 0.0 109.643 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.511 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.3 t-80 -67.45 -38.15 84.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 111.33 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 437' ' ' SER . 63.7 t -66.07 -47.22 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.473 -1.392 . . . . 0.0 110.219 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.73 -34.63 78.3 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.738 -1.226 . . . . 0.0 110.337 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.47 -36.29 80.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.986 -1.071 . . . . 0.0 109.893 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.511 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 12.1 m-80 -61.15 -27.81 68.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.442 -0.786 . . . . 0.0 109.126 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.61 19.85 28.51 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -115.01 -170.26 16.3 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -144.61 153.98 42.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.247 . . . . 0.0 111.321 -174.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.601 ' HB3' HG21 ' A' ' 439' ' ' VAL . 6.1 p90 -106.87 150.99 40.43 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.63 -0.669 . . . . 0.0 110.096 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.858 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.81 125.61 10.64 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.853 1.449 . . . . 0.0 110.237 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.2 t -66.69 -34.13 77.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 111.136 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.482 ' HA ' ' OE1' ' A' ' 418' ' ' GLN . 89.9 m-20 -62.97 -32.31 73.61 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.931 -1.106 . . . . 0.0 108.858 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.05 HG21 ' HA ' ' A' ' 325' ' ' ALA . 48.4 t -83.41 -42.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -0.846 . . . . 0.0 110.809 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 5.3 m-20 -55.58 -36.42 66.84 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.595 171.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 0.0 OUTLIER -63.94 -50.16 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 0.0 109.686 172.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.52 ' CD ' HG21 ' A' ' 323' ' ' ILE . 35.7 mttt -56.65 -34.6 67.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.764 -1.21 . . . . 0.0 110.332 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.112 HG23 HG21 ' A' ' 442' ' ' VAL . 2.8 t -59.09 -41.78 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.932 -1.105 . . . . 0.0 109.369 170.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -65.66 -35.95 82.26 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.943 0.878 . . . . 0.0 109.296 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.4 mm-40 -67.39 -37.92 83.89 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.566 -0.709 . . . . 0.0 110.769 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 428' ' ' ALA . 64.5 t -63.44 -36.81 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.0 110.193 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.34 85.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -70.08 -28.95 65.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.326 -0.859 . . . . 0.0 110.599 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 1.9 tt0 -80.36 -3.75 50.82 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.085 -1.009 . . . . 0.0 109.74 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.7 21.96 35.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.733 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.74 175.96 5.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.722 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.657 ' O ' HD12 ' A' ' 445' ' ' LEU . 59.1 m -119.15 106.92 42.4 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.942 -1.099 . . . . 0.0 109.874 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.591 ' CG ' HG13 ' A' ' 420' ' ' VAL . 31.4 Cg_endo -74.06 106.78 2.28 Favored 'Trans proline' 0 C--N 1.296 -2.204 0 O-C-N 123.911 1.479 . . . . 0.0 110.354 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 445' ' ' LEU . 15.8 mt -93.08 131.79 37.78 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 167.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.81 ' CG2' HG22 ' A' ' 398' ' ' VAL . 72.6 t -100.57 137.54 27.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.823 -1.173 . . . . 0.0 109.777 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.775 ' CG1' HD11 ' A' ' 440' ' ' LEU . 42.7 t -116.2 137.74 48.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 108.928 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.851 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.05 159.98 20.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 121.351 -0.843 . . . . 0.0 109.757 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.48 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.4 tt0 -136.11 132.77 36.52 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.41 -126.82 31.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -168.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.495 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -109.91 13.41 23.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.238 . . . . 0.0 111.123 -178.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -128.33 170.66 12.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.017 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.851 ' HA ' HG12 ' A' ' 434' ' ' VAL . 53.3 t -88.35 134.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.361 -0.837 . . . . 0.0 109.776 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.806 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.5 pp -92.3 -22.3 19.81 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.665 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 1.01 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.88 176.36 40.09 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.963 168.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.112 HG21 HG23 ' A' ' 420' ' ' VAL . 46.9 t -107.94 142.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.16 -1.2 . . . . 0.0 109.539 171.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.721 HD11 ' HB1' ' A' ' 337' ' ' ALA . 78.3 mt -101.67 119.24 49.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 169.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -99.0 117.49 33.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.744 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 3.6 mp -113.63 146.34 39.9 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.095 -1.003 . . . . 0.0 109.819 -173.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.528 ' CE ' ' OG ' ' A' ' 320' ' ' SER . 0.7 OUTLIER -134.53 170.28 16.02 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.749 -1.22 . . . . 0.0 110.773 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -71.16 145.59 49.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 110.113 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.423 ' HA ' HD12 ' A' ' 448' ' ' ILE . 10.5 tp -119.72 153.49 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.246 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.24 135.6 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.197 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -92.49 144.73 25.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.297 -0.877 . . . . 0.0 110.22 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.231 0.539 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.48 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 97.7 mtt180 -122.45 147.53 46.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 110.181 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 50.5 tt0 -121.53 133.05 55.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.239 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.74 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -54.57 138.6 40.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 0.0 109.802 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.511 ' O ' ' NE ' ' A' ' 359' ' ' ARG . 4.9 m -119.53 -44.7 2.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.086 -1.009 . . . . 0.0 110.197 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 320' ' ' SER . 69.7 mt-10 -154.59 152.33 29.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.298 -0.876 . . . . 0.0 110.448 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.009 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 16.9 p90 -136.12 141.82 44.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.755 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.643 HG21 ' CD ' ' A' ' 419' ' ' LYS . 4.3 mt -114.79 141.76 27.3 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.73 -0.607 . . . . 0.0 109.598 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.553 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_endo -71.61 142.86 40.97 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.708 1.373 . . . . 0.0 111.55 -176.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.046 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -71.01 152.56 43.44 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 108.829 165.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.44 128.35 36.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.692 -1.255 . . . . 0.0 110.143 -172.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 103.94 -0.75 44.76 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 440' ' ' LEU . 44.8 t -136.13 139.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.716 -1.461 . . . . 0.0 110.727 177.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 332' ' ' THR . 89.3 m-20 -73.93 152.07 40.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.163 177.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 360' ' ' PHE . 84.6 tt0 -62.17 -39.76 93.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.057 -1.027 . . . . 0.0 110.457 -176.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 361' ' ' ASN . 31.3 ttmt -59.19 -43.38 92.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.806 -1.184 . . . . 0.0 109.56 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.529 HG21 HG13 ' A' ' 328' ' ' VAL . 95.8 m -56.15 -43.63 78.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.817 173.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.988 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.1 tp -59.69 -39.64 85.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.009 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.37 -42.04 84.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.089 . . . . 0.0 110.757 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.544 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.4 m-20 -64.19 -49.48 71.88 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.118 . . . . 0.0 109.921 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.947 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -68.17 -31.3 70.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.937 -1.102 . . . . 0.0 109.664 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.751 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.19 -35.64 65.05 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.964 172.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.564 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 30.3 mt-30 -74.52 -55.81 5.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.476 -0.765 . . . . 0.0 110.989 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.38 -35.71 78.23 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.787 -172.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.89 66.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.592 ' OG ' HG22 ' A' ' 353' ' ' VAL . 95.9 p -108.4 10.15 27.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -174.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.581 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 42.2 mt -65.98 -44.95 83.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.657 -1.277 . . . . 0.0 109.802 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.54 0.72 47.94 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.821 -170.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.479 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 11.9 p30 -63.87 130.29 43.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.841 -1.162 . . . . 0.0 109.925 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -95.76 4.76 52.64 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.512 0.672 . . . . 0.0 109.886 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.8 p -75.3 152.88 86.03 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.592 -0.693 . . . . 0.0 109.443 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -56.0 -38.14 95.14 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.74 1.39 . . . . 0.0 109.132 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.48 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 98.3 mt-10 -64.19 -29.23 70.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.484 -0.76 . . . . 0.0 110.406 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -56.47 -38.56 80.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.531 ' O ' HD12 ' A' ' 354' ' ' ILE . 69.9 mtt85 -78.2 -37.76 44.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.075 -1.25 . . . . 0.0 110.591 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.7 m -61.4 -38.02 85.58 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.932 -1.105 . . . . 0.0 110.352 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 443' ' ' ILE . 90.7 mt -68.92 -49.09 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 0.0 110.625 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.592 HG22 ' OG ' ' A' ' 341' ' ' SER . 38.4 t -60.87 -34.06 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.864 -1.147 . . . . 0.0 110.101 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.964 HG22 ' OE1' ' A' ' 358' ' ' GLN . 32.3 mt -72.62 -33.22 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.681 -1.262 . . . . 0.0 110.621 170.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.961 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -59.46 -40.35 86.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.938 -1.101 . . . . 0.0 110.489 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.27 88.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 110.47 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.872 ' HB3' HD23 ' A' ' 362' ' ' LEU . 18.0 mtmt -72.35 -49.48 33.82 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.743 -1.183 . . . . 0.0 110.6 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.964 ' OE1' HG22 ' A' ' 354' ' ' ILE . 13.7 pt20 -71.3 -42.43 68.69 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 110.814 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.58 ' HB3' ' CD2' ' A' ' 360' ' ' PHE . 41.1 mmt180 -72.63 -46.31 54.68 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.109 -0.995 . . . . 0.0 111.078 -172.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.58 ' CD2' ' HB3' ' A' ' 359' ' ' ARG . 84.0 m-85 -136.5 -36.69 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.205 -169.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.491 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 15.2 t-20 -160.02 106.64 1.6 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.605 -1.309 . . . . 0.0 111.508 -168.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.872 HD23 ' HB3' ' A' ' 357' ' ' LYS . 59.9 mt -57.56 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.368 172.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.534 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 30.7 tpt180 -125.64 164.39 20.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 109.325 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 85.4 mt-10 -140.06 -161.77 1.25 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.0 -1.062 . . . . 0.0 110.121 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.581 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.2 ptt-85 -95.67 162.45 13.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.747 . . . . 0.0 110.521 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 89.8 m-20 -130.3 41.74 3.36 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.381 175.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.947 HG11 ' CE2' ' A' ' 374' ' ' PHE . 59.4 t -74.16 -46.23 45.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.09 -27.46 66.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.344 -0.848 . . . . 0.0 111.122 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.78 -30.55 28.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.965 . . . . 0.0 109.656 175.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.781 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.9 mt -102.5 -3.66 26.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.557 -0.714 . . . . 0.0 110.674 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 367' ' ' VAL . 51.6 m80 59.11 52.57 6.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.753 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -93.55 174.67 7.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 110.51 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 25.1 m -116.45 134.62 54.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.396 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.947 ' CE2' HG11 ' A' ' 367' ' ' VAL . 83.6 m-85 -88.61 147.8 24.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 387' ' ' ASN . 87.2 t -120.34 101.12 46.99 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.616 175.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.5 Cg_endo -55.22 150.36 40.68 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.077 1.567 . . . . 0.0 110.511 -175.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 382' ' ' ARG . 9.2 t80 -65.47 131.41 46.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 22.3 p -120.3 152.79 37.31 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 109.695 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.74 -5.82 51.9 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.91 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.78 -33.15 66.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.843 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' A' ' 400' ' ' ALA . 3.2 m -139.54 10.27 2.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 110.278 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 74.0 mtt85 57.0 51.19 10.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.233 -0.917 . . . . 0.0 109.363 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.827 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 3.3 ptp -157.44 167.38 30.4 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.993 0.901 . . . . 0.0 111.4 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 26.9 p -154.43 165.36 36.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.503 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.8 -166.55 35.05 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.705 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.879 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.8 tt -140.92 149.84 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.995 . . . . 0.0 110.208 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.471 HD21 HG21 ' A' ' 375' ' ' VAL . 47.8 m-20 -127.25 134.73 50.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.045 . . . . 0.0 109.804 177.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' A' ' 370' ' ' LEU . 2.0 tt -140.73 155.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.965 -1.084 . . . . 0.0 109.211 171.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.266 90.0 m-20 -21.65 -63.03 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.388 0.614 . . . . 0.0 112.583 170.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.449 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 22.9 t-20 -96.49 -7.14 35.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 111.931 -167.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.571 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 32.9 mtp180 -141.86 145.84 35.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.594 -1.317 . . . . 0.0 110.503 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 68.7 mtm -136.22 100.93 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.132 . . . . 0.0 109.18 170.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.031 HD12 HD11 ' A' ' 339' ' ' LEU . 7.7 mt -122.96 146.18 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.04 -1.037 . . . . 0.0 110.092 -172.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.503 ' HD3' ' HA3' ' A' ' 385' ' ' GLY . 26.0 mmt85 -133.19 159.1 41.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.329 175.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.556 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.41 126.84 30.36 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.56 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -154.44 174.0 32.86 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.596 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 41.4 m -56.47 150.84 14.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.863 -1.375 . . . . 0.0 108.592 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.037 HG21 ' CG1' ' A' ' 420' ' ' VAL . 56.5 t -57.72 -34.6 48.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.887 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.4 t0 -62.55 -45.81 91.23 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.827 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.85 -51.07 44.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.93 -1.106 . . . . 0.0 110.61 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.56 HD11 ' N ' ' A' ' 396' ' ' GLY . 34.2 mm -63.98 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.063 -1.023 . . . . 0.0 110.59 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.593 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 12.0 ttp180 -58.47 -43.69 89.0 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.461 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 55.2 mtp85 -61.54 -36.12 79.67 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.061 -1.024 . . . . 0.0 109.459 173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.503 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 3.4 t-80 -67.65 -38.5 83.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 111.299 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.472 HG12 ' C ' ' A' ' 410' ' ' GLY . 66.7 t -65.91 -47.29 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.616 -1.302 . . . . 0.0 110.26 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.21 -34.21 77.57 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.814 -1.178 . . . . 0.0 110.362 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.65 -36.3 80.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.092 . . . . 0.0 109.895 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 26.7 m-80 -62.12 -27.09 68.68 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 109.225 173.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 94.86 19.56 31.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.24 -171.13 18.52 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.418 ' C ' HG11 ' A' ' 405' ' ' VAL . 99.1 m-70 -144.81 153.85 42.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.168 -1.195 . . . . 0.0 111.07 -175.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.64 ' HB3' HG21 ' A' ' 439' ' ' VAL . 8.5 p90 -109.51 151.92 42.46 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.54 -0.725 . . . . 0.0 109.978 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.857 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.15 124.76 10.27 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.913 1.48 . . . . 0.0 110.221 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 418' ' ' GLN . 1.3 t -66.95 -33.21 75.08 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.892 -176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 89.3 m-20 -63.45 -32.48 73.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 108.853 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.046 HG21 ' HA ' ' A' ' 325' ' ' ALA . 49.3 t -83.64 -41.89 17.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.908 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 55.7 t0 -55.04 -37.55 66.83 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.404 171.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 419' ' ' LYS . 0.0 OUTLIER -63.66 -49.71 72.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.457 -1.402 . . . . 0.0 109.697 172.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.643 ' CD ' HG21 ' A' ' 323' ' ' ILE . 57.1 mttm -56.28 -34.79 66.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.802 -1.187 . . . . 0.0 110.444 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.088 HG23 HG21 ' A' ' 442' ' ' VAL . 2.6 t -59.32 -41.85 85.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.962 -1.086 . . . . 0.0 109.21 171.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.84 -36.26 82.97 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.906 0.86 . . . . 0.0 109.414 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 95.3 mm-40 -68.02 -37.89 81.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.609 -0.682 . . . . 0.0 110.74 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.765 HG13 ' HB3' ' A' ' 428' ' ' ALA . 72.2 t -62.28 -37.65 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 109.979 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.09 87.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 110.151 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -67.02 -33.43 75.54 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.285 -0.884 . . . . 0.0 111.229 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 0.1 OUTLIER -83.0 -3.4 57.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.012 -1.055 . . . . 0.0 109.597 176.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.33 29.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.765 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -103.72 163.34 12.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.651 ' HB ' HD12 ' A' ' 445' ' ' LEU . 70.5 m -109.65 107.02 59.1 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.081 -1.012 . . . . 0.0 109.744 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.56 ' CG ' HG13 ' A' ' 420' ' ' VAL . 38.6 Cg_endo -75.6 107.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.07 0 O-C-N 123.893 1.47 . . . . 0.0 110.52 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.867 ' HG ' HD11 ' A' ' 445' ' ' LEU . 11.5 mt -92.44 134.24 35.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.886 -1.134 . . . . 0.0 108.625 167.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.99 ' CG2' HG22 ' A' ' 398' ' ' VAL . 96.8 t -100.32 134.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.701 -1.25 . . . . 0.0 109.477 176.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.81 ' CG1' HD11 ' A' ' 440' ' ' LEU . 40.9 t -114.95 137.33 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.243 -0.91 . . . . 0.0 108.955 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.841 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.5 m -120.28 160.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.589 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.482 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.2 tt0 -136.82 129.89 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.56 -128.42 29.84 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -168.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 0.7 OUTLIER -108.53 15.41 23.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.052 -1.263 . . . . 0.0 111.171 -179.109 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -125.76 170.27 11.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.532 -1.355 . . . . 0.0 109.878 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.841 ' HA ' HG12 ' A' ' 434' ' ' VAL . 46.7 t -91.7 134.31 30.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.189 -0.945 . . . . 0.0 109.57 176.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 441' ' ' GLY . 1.5 pp -94.36 -21.28 19.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.691 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.988 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 168.27 176.39 38.64 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 118.794 -1.669 . . . . 0.0 110.962 169.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.088 HG21 HG23 ' A' ' 420' ' ' VAL . 53.9 t -107.97 142.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.124 -1.221 . . . . 0.0 109.982 173.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.751 HD11 ' HB1' ' A' ' 337' ' ' ALA . 82.2 mt -101.32 110.91 29.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.99 118.12 30.47 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.863 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.867 HD11 ' HG ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -101.6 144.28 30.54 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -114.63 159.87 19.98 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.612 -1.305 . . . . 0.0 111.121 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -83.97 144.71 28.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.722 -0.611 . . . . 0.0 110.223 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.831 HD13 ' N ' ' A' ' 449' ' ' VAL . 0.0 OUTLIER -121.29 150.73 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.831 ' N ' HD13 ' A' ' 448' ' ' ILE . 46.7 t -136.26 136.1 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.161 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -92.87 144.8 24.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.237 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.979 . . . . . . . . 0 0 . 1 stop_ save_